data_2myn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2myn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 tpp . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.656 -0.211 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -68.9 135.5 51.13 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.668 1.187 . . . . 0.0 112.467 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -108.96 128.24 54.76 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.942 0.897 . . . . 0.0 111.862 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.31 120.69 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.871 1.668 . . . . 0.0 110.051 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.5 tpp -99.62 126.84 45.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -98.4 123.44 42.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.223 0.609 . . . . 0.0 111.197 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 m -125.84 141.64 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.22 1.008 . . . . 0.0 113.004 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t . . . . . 0 CA--C 1.551 0.996 0 O-C-N 121.404 -0.81 . . . . 0.0 112.357 179.487 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 p -66.4 -48.06 71.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.124 1.329 . . . . 0.0 111.232 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.77 -39.07 93.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.298 1.439 . . . . 0.0 111.719 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -40.53 77.15 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.944 1.297 . . . . 0.0 112.018 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.97 95.46 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.651 -0.656 . . . . 0.0 112.427 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -58.79 -41.08 85.86 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.789 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.7 -52.82 45.81 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.484 1.038 . . . . 0.0 113.25 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -65.3 -41.16 94.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.083 -1.246 . . . . 0.0 111.801 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.27 87.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -73.17 -20.93 60.8 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.536 1.062 . . . . 0.0 113.028 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -87.92 -44.84 10.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.225 1.01 . . . . 0.0 112.187 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.02 -37.58 10.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.213 1.005 . . . . 0.0 112.819 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.94 6.96 68.1 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.653 1.597 . . . . 0.0 113.99 170.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.27 -43.4 4.86 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.5 16.18 48.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.583 1.563 . . . . 0.0 114.651 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.09 -34.08 3.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.034 1.333 . . . . 0.0 112.477 -169.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -152.98 165.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.678 1.591 . . . . 0.0 113.149 -173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.77 153.77 17.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 167.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.19 143.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.278 -1.514 . . . . 0.0 114.615 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.82 168.07 20.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.473 1.909 . . . . 0.0 108.933 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -140.49 153.7 46.32 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.859 -1.15 . . . . 0.0 112.167 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 p -153.82 -175.27 5.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.525 1.13 . . . . 0.0 110.186 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.14 166.53 26.68 Favored Glycine 0 N--CA 1.471 1.016 0 O-C-N 120.836 -1.165 . . . . 0.0 113.15 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.09 -38.34 85.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 122.013 -0.698 . . . . 0.0 112.076 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.21 40.6 3.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.125 1.77 . . . . 0.0 109.135 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t 73.84 178.09 0.23 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.661 2.384 . . . . 0.0 113.71 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -144.84 174.75 10.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.348 2.259 . . . . 0.0 110.935 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.4 ptt85 -140.37 158.45 44.0 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.16 156.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -135.15 131.05 19.57 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-O 117.38 -1.295 . . . . 0.0 111.386 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -55.46 -39.52 90.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.131 2.554 . . . . 0.0 114.721 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -67.65 -30.38 69.92 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.041 -1.037 . . . . 0.0 111.784 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.25 -10.14 59.19 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.824 -1.172 . . . . 0.0 113.432 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.74 -55.04 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.19 62.8 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -73.57 -9.69 58.94 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.2 mmt -121.79 -28.47 4.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.502 1.121 . . . . 0.0 112.311 -171.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -21.56 66.73 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.135 -0.978 . . . . 0.0 112.895 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.34 -11.09 60.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.4 1.08 . . . . 0.0 113.28 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -102.64 0.63 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 126.86 2.064 . . . . 0.0 110.452 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.71 13.77 79.2 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.143 1.354 . . . . 0.0 114.474 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mm -87.58 152.39 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.449 1.099 . . . . 0.0 110.96 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -127.68 137.33 52.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.975 1.31 . . . . 0.0 111.429 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 pt -139.56 -7.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.402 1.081 . . . . 0.0 113.551 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -57.22 -35.07 69.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.836 1.654 . . . . 0.0 114.973 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.78 -3.17 88.28 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.366 0.984 . . . . 0.0 115.293 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -78.76 157.96 28.36 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.037 1.418 . . . . 0.0 113.707 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -132.74 175.27 9.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.024 2.13 . . . . 0.0 111.287 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.4 t -154.09 156.48 37.34 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.164 0.985 . . . . 0.0 112.775 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -142.59 161.8 47.72 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.643 1.977 . . . . 0.0 108.598 169.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.99 135.64 70.04 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.844 2.363 . . . . 0.0 112.577 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 tt -53.85 -33.33 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.36 -12.28 61.47 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.86 59.0 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.114 0.87 . . . . 0.0 112.309 169.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.11 171.95 8.75 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.15 1.38 . . . . 0.0 112.07 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -98.11 -17.12 19.25 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -168.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 60.15 -29.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.085 2.954 . . . . 0.0 116.947 -170.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.75 -36.25 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 113.07 -169.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -81.58 -0.7 43.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 111.909 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -112.25 77.83 1.08 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.714 2.006 . . . . 0.0 108.442 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.98 -24.17 8.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.07 1.748 . . . . 0.0 113.236 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.07 130.19 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.072 1.749 . . . . 0.0 108.778 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.78 121.61 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.661 -1.274 . . . . 0.0 110.29 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.58 120.22 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.072 1.349 . . . . 0.0 108.345 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -89.16 157.04 18.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.852 1.261 . . . . 0.0 109.667 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.46 43.19 3.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.442 1.097 . . . . 0.0 111.563 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.9 m . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 124.878 1.271 . . . . 0.0 112.151 -179.468 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.3 mt -142.41 138.0 16.04 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.47 1.108 . . . . 0.0 112.951 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -62.6 149.55 90.7 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.681 2.254 . . . . 0.0 110.664 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.83 -34.26 84.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.13 2.553 . . . . 0.0 115.121 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -63.04 -20.39 65.28 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -88.61 -6.34 57.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.32 1.448 . . . . 0.0 114.619 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.7 m -117.26 -20.81 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 -1.67 28.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.998 1.719 . . . . 0.0 114.243 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -49.88 155.98 0.8 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.031 2.532 . . . . 0.0 114.547 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.24 -34.1 73.21 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.61 128.5 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.63 1.172 . . . . 0.0 109.344 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.14 147.79 50.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.213 1.405 . . . . 0.0 111.239 171.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -141.77 159.49 42.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.045 1.338 . . . . 0.0 111.289 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -141.26 87.41 2.08 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.824 0.85 . . . . 0.0 110.318 169.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -67.29 140.74 57.34 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 113.477 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -91.17 55.25 2.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.959 2.104 . . . . 0.0 107.607 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.65 125.12 49.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.635 1.974 . . . . 0.0 111.117 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.45 162.19 22.18 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.541 1.536 . . . . 0.0 112.382 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.04 128.75 42.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 O-C-N 121.5 -0.75 . . . . 0.0 111.076 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 C-N-CA 121.84 1.693 . . . . 0.0 112.55 175.173 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 120.964 0.412 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.3 -25.49 68.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.929 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.0 -30.45 71.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.301 -0.874 . . . . 0.0 111.571 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.37 -40.88 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.91 -1.119 . . . . 0.0 110.541 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -57.23 -48.49 78.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.034 1.288 . . . . 0.0 111.275 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -69.36 -18.94 63.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.1 m -82.06 -55.55 4.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.838 1.255 . . . . 0.0 111.541 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.57 -29.57 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.093 0.957 . . . . 0.0 111.675 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -55.62 -42.75 75.38 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.533 1.06 . . . . 0.0 113.37 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 -32.38 62.89 Favored Glycine 0 N--CA 1.472 1.038 0 O-C-N 121.905 -0.497 . . . . 0.0 112.507 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.97 -39.01 83.43 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.95 -0.735 . . . . 0.0 111.43 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.37 -48.79 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 110.183 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.26 -48.85 70.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.009 0.924 . . . . 0.0 112.069 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -71.32 -28.58 64.19 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.887 1.221 . . . . 0.0 112.936 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -70.11 -49.72 47.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.783 0.833 . . . . 0.0 110.639 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.2 t -55.03 -49.35 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.499 1.12 . . . . 0.0 111.358 169.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.66 -51.46 65.06 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.409 1.004 . . . . 0.0 112.487 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.77 -30.88 68.56 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.832 0.742 . . . . 0.0 112.056 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.69 -50.5 66.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.541 0.737 . . . . 0.0 110.877 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.42 -37.82 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.028 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -26.67 68.89 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -85.17 -13.01 51.4 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 174.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -109.32 -25.38 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.911 1.684 . . . . 0.0 112.104 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 119.767 -0.158 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -70.32 141.02 52.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.069 0.948 . . . . 0.0 111.447 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -109.5 126.36 53.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.161 0.984 . . . . 0.0 111.6 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.9 t -96.98 111.67 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.947 1.699 . . . . 0.0 110.354 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.2 tpp -90.82 127.45 36.36 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.47 122.23 43.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.235 1.014 . . . . 0.0 111.124 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.96 142.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.1 t . . . . . 0 CA--C 1.548 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 112.425 -175.272 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -62.93 -50.96 68.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.255 1.389 . . . . 0.0 112.692 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -62.06 -38.53 89.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.255 1.022 . . . . 0.0 111.552 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.4 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 7.2 tpt -74.87 -39.26 61.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.004 0.922 . . . . 0.0 112.336 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.91 88.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.407 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -58.15 -49.5 76.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.492 169.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.53 -47.54 63.14 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 121.0 1.727 . . . . 0.0 114.409 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -67.28 -42.95 82.96 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.018 -1.283 . . . . 0.0 112.032 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.63 -31.59 69.78 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.981 -1.074 . . . . 0.0 113.338 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -65.14 -29.39 70.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 128.876 2.871 . . . . 0.0 112.751 172.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -90.49 -45.47 8.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.836 0.855 . . . . 0.0 112.102 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.03 -31.83 13.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.265 1.026 . . . . 0.0 113.345 -170.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.22 1.6 88.42 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.421 1.486 . . . . 0.0 114.166 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.78 117.56 2.57 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 118.453 1.126 . . . . 0.0 111.403 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.3 15.58 81.09 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.91 -40.03 2.34 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.075 1.437 . . . . 0.0 111.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.25 164.39 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.831 1.652 . . . . 0.0 111.553 170.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 153.96 19.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.94 0.896 . . . . 0.0 108.804 169.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.52 147.56 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 m -152.1 160.89 43.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.994 1.718 . . . . 0.0 108.83 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.3 p -135.05 154.91 51.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.211 -0.931 . . . . 0.0 112.68 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 t -150.76 129.63 12.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.044 0.938 . . . . 0.0 110.276 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.94 141.49 20.14 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.02 -34.55 63.58 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.038 1.419 . . . . 0.0 112.482 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.95 41.45 3.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.958 1.703 . . . . 0.0 110.956 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t 72.69 168.66 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.627 1.971 . . . . 0.0 112.894 -168.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -158.1 172.16 18.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.724 1.61 . . . . 0.0 112.372 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -126.14 162.94 24.21 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 0.0 114.506 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.0 m -121.89 116.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.691 1.596 . . . . 0.0 109.739 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.16 148.32 44.69 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.794 0.838 . . . . 0.0 111.398 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.5 -35.76 77.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.291 2.661 . . . . 0.0 113.852 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.0 m -61.19 -38.4 86.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.748 0.819 . . . . 0.0 112.061 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.49 60.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.078 -1.014 . . . . 0.0 113.357 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.47 -54.9 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.31 72.36 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -71.17 -7.71 48.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.217 1.007 . . . . 0.0 113.604 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.4 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 15.8 mmt -125.34 -27.24 3.5 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.59 1.156 . . . . 0.0 112.021 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.95 -27.39 66.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.064 -1.023 . . . . 0.0 112.139 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.37 -5.43 42.31 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.148 0.979 . . . . 0.0 113.041 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 t -108.99 3.14 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.622 2.369 . . . . 0.0 110.541 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.87 13.8 81.74 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.393 1.473 . . . . 0.0 114.667 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.95 151.57 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -133.17 135.05 44.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.698 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 pt -128.74 1.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.726 1.61 . . . . 0.0 112.465 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.9 p -65.48 -30.72 71.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.629 1.172 . . . . 0.0 113.769 -169.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.64 -0.42 89.24 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.431 1.015 . . . . 0.0 114.976 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -81.81 151.82 27.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.397 1.598 . . . . 0.0 112.697 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.7 p -124.94 176.02 6.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.353 1.861 . . . . 0.0 111.088 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -152.66 156.1 38.56 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 112.593 173.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -153.54 160.45 30.93 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.76 2.024 . . . . 0.0 109.272 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.35 140.07 87.76 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.341 2.694 . . . . 0.0 112.485 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.94 -30.41 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -11.9 60.39 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -21.51 56.23 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.061 0.846 . . . . 0.0 112.935 171.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -93.14 166.49 12.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.645 1.178 . . . . 0.0 112.805 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.19 109.02 17.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.542 1.537 . . . . 0.0 110.965 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.22 -15.06 62.86 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.625 -1.297 . . . . 0.0 113.666 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -57.54 -22.05 42.14 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.065 1.346 . . . . 0.0 113.131 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.17 -0.56 38.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.219 1.808 . . . . 0.0 113.037 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -124.92 76.96 1.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.242 1.817 . . . . 0.0 109.686 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -23.68 8.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.71 2.004 . . . . 0.0 113.38 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -133.33 127.86 54.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.642 1.577 . . . . 0.0 108.537 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.9 t -132.97 118.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.077 -1.015 . . . . 0.0 110.275 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -110.99 118.06 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.865 1.266 . . . . 0.0 107.932 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -87.9 155.8 19.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.123 0.969 . . . . 0.0 109.027 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.68 39.67 3.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.09 0.956 . . . . 0.0 110.885 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 CA--C 1.542 0.638 0 C-N-CA 124.972 1.309 . . . . 0.0 111.914 178.787 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -144.14 140.54 17.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.29 1.036 . . . . 0.0 113.155 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.47 153.73 72.93 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.549 2.166 . . . . 0.0 110.068 168.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.27 -32.48 96.96 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.184 2.589 . . . . 0.0 114.311 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.99 -24.39 67.0 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.932 -1.105 . . . . 0.0 113.765 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.4 -10.66 58.29 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.4 -22.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.125 1.37 . . . . 0.0 113.584 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -84.55 11.65 8.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.39 1.876 . . . . 0.0 113.527 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -67.68 166.8 14.42 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.722 1.609 . . . . 0.0 112.812 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.24 -35.89 82.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -133.32 128.69 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.472 0.709 . . . . 0.0 110.888 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -130.75 148.46 52.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.089 1.356 . . . . 0.0 111.613 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -142.06 161.16 38.68 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.448 1.499 . . . . 0.0 111.455 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.44 86.84 1.97 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.633 -0.667 . . . . 0.0 111.913 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -73.38 160.51 31.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.234 1.814 . . . . 0.0 114.017 -172.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -93.28 -84.39 0.3 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.156 0.983 . . . . 0.0 110.94 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 50.14 -166.21 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.51 1.924 . . . . 0.0 112.293 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.94 147.75 46.55 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.489 1.515 . . . . 0.0 107.443 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.98 129.79 52.81 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.314 0.961 . . . . 0.0 111.035 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo . . . . . 0 CA--C 1.54 0.777 0 C-N-CA 121.632 1.555 . . . . 0.0 114.731 178.594 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 120.759 0.314 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.96 -22.36 66.89 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.213 -0.929 . . . . 0.0 111.721 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.57 -32.39 73.7 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.047 -1.033 . . . . 0.0 111.305 169.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.22 -44.05 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.858 -1.151 . . . . 0.0 110.694 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -53.79 -49.26 68.67 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.285 0.948 . . . . 0.0 111.29 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -71.42 -16.41 62.39 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 m -95.6 -35.62 11.56 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.451 1.101 . . . . 0.0 112.755 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.81 -37.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 120.274 -1.517 . . . . 0.0 111.414 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -55.1 -42.71 73.23 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.51 -32.63 67.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.182 0.896 . . . . 0.0 113.023 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -69.8 -44.89 69.12 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.84 -0.8 . . . . 0.0 110.659 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.4 t -60.23 -42.54 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.158 -0.964 . . . . 0.0 111.063 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.17 -47.65 77.87 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.034 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.93 -29.25 65.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.139 1.336 . . . . 0.0 113.562 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -62.44 -54.3 42.16 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.022 0.828 . . . . 0.0 109.979 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.37 -51.08 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.28 1.432 . . . . 0.0 112.636 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.7 -49.64 75.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.996 1.271 . . . . 0.0 112.492 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -30.19 67.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.298 0.499 . . . . 0.0 111.875 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.47 -50.21 66.21 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.768 0.827 . . . . 0.0 111.168 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.73 -41.38 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.508 1.049 . . . . 0.0 110.944 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -23.81 66.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.36 -17.27 37.23 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.1 -23.47 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.253 1.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.884 179.695 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 119.761 -0.162 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mtmm -77.45 146.28 36.59 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 112.612 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -113.56 126.11 54.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.902 1.281 . . . . 0.0 111.189 170.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.75 109.17 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.675 1.59 . . . . 0.0 110.207 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.6 tpp -87.04 128.13 35.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.525 0.602 . . . . 0.0 109.849 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -98.75 123.43 42.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.688 1.195 . . . . 0.0 109.745 169.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.34 146.21 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.724 1.21 . . . . 0.0 112.788 -176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.474 0.726 0 O-C-N 121.487 -0.758 . . . . 0.0 111.401 172.634 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -66.96 -48.33 68.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.92 1.236 . . . . 0.0 112.01 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -65.76 -42.92 90.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.59 0.756 . . . . 0.0 111.941 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 tpt -64.92 -42.41 94.74 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.867 -1.146 . . . . 0.0 112.717 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.51 88.2 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.947 0.499 . . . . 0.0 112.149 173.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.82 -36.18 78.4 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.567 -0.708 . . . . 0.0 111.841 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.57 -53.08 46.19 Favored Glycine 0 N--CA 1.471 1.004 0 CA-C-N 119.472 1.033 . . . . 0.0 112.613 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -60.33 -38.93 85.29 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.683 -0.892 . . . . 0.0 111.409 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.83 73.16 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -75.28 -22.16 57.99 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.905 1.684 . . . . 0.0 113.07 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -79.41 -45.35 19.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.314 0.646 . . . . 0.0 111.688 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -98.24 -27.2 14.25 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.46 1.104 . . . . 0.0 113.113 -172.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.87 2.66 88.08 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.253 1.883 . . . . 0.0 113.903 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 112.15 0.44 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.512 1.156 . . . . 0.0 112.656 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.67 15.57 81.47 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.373 1.309 . . . . 0.0 116.373 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.99 -40.47 3.49 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.393 1.596 . . . . 0.0 112.314 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.33 165.84 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.361 2.264 . . . . 0.0 109.931 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.27 149.12 21.89 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 170.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.43 143.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.316 -0.865 . . . . 0.0 112.493 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 m -148.23 156.72 42.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.976 1.31 . . . . 0.0 110.187 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 p -128.3 150.47 50.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 113.321 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 t -155.43 156.71 35.8 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 110.124 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.59 153.05 17.61 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 169.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.1 mt -55.48 -34.52 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.997 1.398 . . . . 0.0 111.612 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -131.03 49.86 2.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.862 1.665 . . . . 0.0 109.715 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 t 68.63 170.37 0.29 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.475 1.91 . . . . 0.0 113.437 -169.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.2 p -146.08 169.56 18.45 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.42 1.888 . . . . 0.0 111.009 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -116.78 160.29 21.02 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.37 148.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.402 1.881 . . . . 0.0 107.058 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -136.4 131.53 18.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.748 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -54.81 -38.79 91.99 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.352 2.702 . . . . 0.0 115.273 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.0 m -67.77 -31.06 70.68 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.094 -1.004 . . . . 0.0 111.718 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.4 60.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.917 -1.114 . . . . 0.0 112.673 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.2 mt -72.19 -53.62 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 -35.68 60.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -170.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.68 -8.53 54.71 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.16 -0.962 . . . . 0.0 113.444 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.0 mmt -123.64 -28.49 3.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 112.261 -171.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.43 -26.69 68.04 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.681 1.128 . . . . 0.0 112.171 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -70.34 -12.05 61.32 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 113.799 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 3.6 m -114.7 13.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.046 1.339 . . . . 0.0 111.509 168.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.044 1.783 . . . . 0.0 116.298 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.4 mm -85.07 149.56 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.334 1.567 . . . . 0.0 111.872 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -122.27 133.08 54.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.178 1.391 . . . . 0.0 111.053 169.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.56 -13.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.641 1.177 . . . . 0.0 113.837 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 m -57.68 -31.91 66.81 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.368 1.467 . . . . 0.0 114.227 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.26 2.69 81.51 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.263 1.411 . . . . 0.0 115.728 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.32 161.62 29.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.509 1.655 . . . . 0.0 112.566 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -143.4 166.3 25.13 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 0.0 110.902 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -143.81 161.26 39.1 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.304 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -151.09 160.04 32.67 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.012 1.725 . . . . 0.0 109.973 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.51 135.02 67.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.805 3.004 . . . . 0.0 112.595 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.8 -31.76 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -12.1 60.68 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -21.19 57.85 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.071 0.851 . . . . 0.0 112.77 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -94.87 167.34 11.48 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.091 1.356 . . . . 0.0 112.825 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.46 109.56 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.761 1.624 . . . . 0.0 110.967 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 -20.05 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -170.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.51 -27.36 69.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.332 1.053 . . . . 0.0 112.422 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.92 -2.17 58.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.633 1.573 . . . . 0.0 112.386 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.92 80.05 1.49 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.938 2.095 . . . . 0.0 107.92 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -25.75 11.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.234 1.814 . . . . 0.0 113.165 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.1 t -132.3 132.47 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.194 1.798 . . . . 0.0 108.969 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.4 t -134.65 121.01 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.99 122.21 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.125 1.37 . . . . 0.0 108.552 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.9 t -93.33 155.05 17.63 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.674 1.19 . . . . 0.0 109.577 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.56 46.0 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.765 1.226 . . . . 0.0 111.387 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.4 m . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 124.804 1.242 . . . . 0.0 112.21 -178.622 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -141.14 138.6 18.01 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.45 1.1 . . . . 0.0 112.298 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 152.96 76.62 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.259 1.973 . . . . 0.0 110.244 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 -29.24 86.33 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.837 2.358 . . . . 0.0 115.501 -169.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.36 -17.9 64.93 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -90.99 -3.18 57.47 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.88 -2.04 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.963 1.305 . . . . 0.0 114.337 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -101.37 0.95 37.93 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.141 1.776 . . . . 0.0 113.287 -171.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -53.85 159.05 1.8 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.921 2.488 . . . . 0.0 113.988 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.91 -34.57 78.25 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -134.05 130.37 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.005 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -133.12 149.03 52.13 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.336 1.454 . . . . 0.0 111.435 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -141.59 157.91 44.5 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.91 1.284 . . . . 0.0 111.351 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.5 88.73 2.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.795 0.838 . . . . 0.0 110.832 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -70.94 145.69 49.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.13 1.372 . . . . 0.0 113.752 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -101.73 60.56 0.88 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.727 2.011 . . . . 0.0 107.726 -174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.7 131.2 56.65 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.575 1.95 . . . . 0.0 111.148 -168.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -88.19 151.5 22.64 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.991 1.316 . . . . 0.0 112.138 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -93.72 126.2 50.56 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.975 0.51 . . . . 0.0 111.611 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo . . . . . 0 CA--C 1.548 1.187 0 C-N-CA 123.077 2.518 . . . . 0.0 114.074 -178.781 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.13 -26.12 68.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.108 0.963 . . . . 0.0 111.62 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.34 -34.28 77.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.412 -0.805 . . . . 0.0 111.25 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -69.02 -41.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.644 -1.285 . . . . 0.0 110.476 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -56.3 -48.25 77.04 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.996 1.271 . . . . 0.0 111.421 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -70.44 -17.73 63.0 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.0 m -89.22 -41.08 12.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.048 1.339 . . . . 0.0 112.293 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.69 -36.31 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.538 -1.351 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -56.15 -42.29 76.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.27 -31.5 63.64 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 123.328 0.489 . . . . 0.0 112.42 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -70.03 -39.0 76.04 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.901 -0.764 . . . . 0.0 111.527 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.46 -46.74 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.366 0.667 . . . . 0.0 110.036 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.87 -51.23 66.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.366 1.066 . . . . 0.0 112.008 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.91 -29.6 67.9 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.022 1.283 . . . . 0.0 112.487 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.4 mtt85 -69.83 -53.85 16.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.382 -0.824 . . . . 0.0 111.025 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -53.54 -49.89 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.899 1.279 . . . . 0.0 112.439 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -66.21 -47.11 74.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.52 1.055 . . . . 0.0 112.135 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -31.58 68.47 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.423 1.011 . . . . 0.0 111.973 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.23 -51.13 68.98 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.518 0.727 . . . . 0.0 110.53 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.2 mt -69.11 -38.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.496 -0.753 . . . . 0.0 111.173 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.82 -26.82 68.8 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -87.79 -15.61 36.42 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -109.67 -18.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 124.661 1.185 . . . . 0.0 113.143 179.303 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 119.908 -0.092 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -72.64 142.53 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.971 0.908 . . . . 0.0 112.07 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.15 127.72 54.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.373 1.069 . . . . 0.0 111.308 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.88 116.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.2 ttm -99.8 124.97 45.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 110.076 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -95.3 127.64 41.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.22 0.608 . . . . 0.0 110.207 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.49 139.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 0.0 112.731 -176.779 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 118.289 -0.863 . . . . 0.0 113.084 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 p -71.61 -49.9 35.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.971 1.26 . . . . 0.0 112.13 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -63.65 -33.1 74.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.263 0.625 . . . . 0.0 112.291 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 tpt -76.87 -41.58 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.174 -0.954 . . . . 0.0 112.337 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.85 94.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.39 -45.26 88.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.11 -46.59 77.75 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 119.778 1.172 . . . . 0.0 114.806 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.447 1.123 . . . . 0.0 111.593 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.14 -32.94 63.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.468 -1.395 . . . . 0.0 113.989 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -67.48 -22.67 65.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.323 1.419 . . . . 0.0 113.05 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.4 m -87.28 -47.64 8.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.496 1.118 . . . . 0.0 111.581 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.7 mt -95.42 -31.86 13.18 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.468 1.107 . . . . 0.0 113.313 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.47 3.08 87.26 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.704 1.621 . . . . 0.0 113.159 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.36 122.0 5.64 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 117.919 0.86 . . . . 0.0 111.841 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.44 79.29 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 118.732 -1.038 . . . . 0.0 115.453 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -121.66 -42.22 2.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.341 1.57 . . . . 0.0 111.039 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.93 161.18 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 112.95 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 153.76 18.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.74 145.39 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.812 -1.18 . . . . 0.0 113.661 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 m -142.84 147.36 35.28 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.435 1.894 . . . . 0.0 109.784 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -115.02 148.82 38.36 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.024 -1.048 . . . . 0.0 112.407 170.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 t -153.35 159.26 42.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.793 1.237 . . . . 0.0 110.531 -170.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.86 154.8 19.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.9 0.762 . . . . 0.0 112.036 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.79 -34.08 72.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.318 1.059 . . . . 0.0 112.132 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -132.49 29.59 4.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.234 1.414 . . . . 0.0 111.538 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 63.81 168.34 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.955 1.702 . . . . 0.0 114.712 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t -163.21 -178.66 6.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.5 2.32 . . . . 0.0 111.828 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -123.48 172.45 8.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.249 1.82 . . . . 0.0 114.485 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 147.02 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 125.675 1.59 . . . . 0.0 108.647 168.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.06 148.46 39.08 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 125.545 1.538 . . . . 0.0 111.511 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -54.81 -34.5 85.25 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.3 2.667 . . . . 0.0 113.871 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -61.25 -36.31 79.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.631 0.772 . . . . 0.0 112.099 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.34 -10.83 59.81 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.935 -1.103 . . . . 0.0 113.558 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.37 -53.1 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 168.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.05 68.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mmt -72.72 -9.52 58.73 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 mmt -124.56 -27.59 3.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.144 -170.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.3 -25.34 68.27 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.836 -1.165 . . . . 0.0 112.28 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.93 -9.47 58.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 t -105.69 4.67 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 126.888 2.075 . . . . 0.0 110.376 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.97 12.49 83.34 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.529 -1.357 . . . . 0.0 114.935 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.71 150.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 118.572 1.186 . . . . 0.0 111.069 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -135.46 97.24 3.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.286 1.434 . . . . 0.0 111.357 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.2 11.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.6 p -61.93 -27.52 68.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.632 -1.293 . . . . 0.0 113.365 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.28 -2.68 90.34 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.901 1.239 . . . . 0.0 115.031 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -87.7 156.24 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.849 1.324 . . . . 0.0 112.373 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 t -147.56 -178.24 6.14 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.715 1.606 . . . . 0.0 109.53 172.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.9 167.49 10.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.482 1.113 . . . . 0.0 112.606 175.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.49 155.52 39.1 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.2 1.4 . . . . 0.0 110.91 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.61 136.6 50.7 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.676 2.917 . . . . 0.0 113.755 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.8 tp -52.83 -36.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.719 1.207 . . . . 0.0 114.12 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.38 -10.81 59.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -17.37 52.25 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.09 0.859 . . . . 0.0 113.085 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -93.1 175.48 6.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.505 1.522 . . . . 0.0 112.9 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.16 109.55 13.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.929 1.692 . . . . 0.0 110.86 174.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.3 -16.41 64.02 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -169.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.51 -23.7 66.28 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.846 0.858 . . . . 0.0 112.413 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.15 -0.99 57.42 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.289 1.835 . . . . 0.0 112.077 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -119.22 82.33 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.176 2.19 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.11 -27.64 14.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.223 1.809 . . . . 0.0 113.09 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.99 127.8 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.584 1.554 . . . . 0.0 108.966 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -133.54 124.69 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.956 -1.09 . . . . 0.0 109.763 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mm -124.42 110.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.032 1.333 . . . . 0.0 109.358 -170.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 m -86.15 154.53 21.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.649 0.779 . . . . 0.0 110.983 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.47 44.0 2.84 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.234 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 125.782 1.633 . . . . 0.0 113.653 -179.377 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.3 mt -146.55 148.48 33.99 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.136 0.974 . . . . 0.0 112.99 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.66 152.51 80.09 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.663 2.242 . . . . 0.0 109.897 168.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.28 -23.77 75.51 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.303 2.668 . . . . 0.0 115.391 -169.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -16.36 62.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -91.34 -3.3 56.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.36 9.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 125.618 1.567 . . . . 0.0 113.85 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -111.39 -3.09 15.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.392 1.877 . . . . 0.0 113.152 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -58.0 158.62 6.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.432 2.693 . . . . 0.0 114.31 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.42 -33.67 76.41 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.86 127.39 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.979 0.912 . . . . 0.0 109.825 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -135.84 148.43 48.66 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.621 1.568 . . . . 0.0 111.756 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -149.16 157.74 43.62 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.597 1.959 . . . . 0.0 110.366 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -137.66 77.32 1.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.423 0.63 . . . . 0.0 111.42 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -64.17 160.0 19.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.12 1.768 . . . . 0.0 114.417 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.15 43.17 1.51 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.139 1.776 . . . . 0.0 113.75 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.13 138.49 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.507 -0.746 . . . . 0.0 111.05 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -85.82 148.77 25.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.67 131.11 46.47 Favored Pre-proline 0 CA--C 1.538 0.498 0 O-C-N 121.464 -0.773 . . . . 0.0 111.162 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 CA--C 1.544 1.022 0 C-N-CA 122.054 1.836 . . . . 0.0 113.495 176.067 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.274 0.559 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.01 -27.61 69.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.379 1.072 . . . . 0.0 111.376 175.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.34 -31.7 72.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.953 . . . . 0.0 111.911 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.87 -41.73 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.978 -1.076 . . . . 0.0 110.438 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -56.05 -49.0 74.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.759 1.163 . . . . 0.0 111.442 170.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -70.13 -19.28 63.23 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.1 m -81.17 -54.36 5.58 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.857 1.263 . . . . 0.0 111.324 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.17 -34.52 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.555 1.142 . . . . 0.0 111.541 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -55.65 -41.01 72.98 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.213 0.915 . . . . 0.0 112.684 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.55 -33.02 64.08 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.774 0.702 . . . . 0.0 113.002 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -68.86 -40.53 79.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.113 0.956 . . . . 0.0 111.183 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.34 -49.92 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.167 0.987 . . . . 0.0 110.318 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -54.12 -49.01 70.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.411 1.084 . . . . 0.0 112.045 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -70.54 -28.98 65.34 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.802 1.183 . . . . 0.0 112.697 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -72.59 -47.98 43.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.78 -42.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.102 0.961 . . . . 0.0 111.626 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -61.29 -47.22 86.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.79 1.177 . . . . 0.0 112.183 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.13 -35.73 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.569 0.622 . . . . 0.0 112.016 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.501 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.9 tm? -56.96 -52.03 66.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.56 1.144 . . . . 0.0 110.699 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.86 -42.23 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.614 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.99 68.81 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -91.23 -6.62 53.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.68 -16.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.255 1.389 0 C-N-CA 125.467 1.507 . . . . 0.0 112.104 172.078 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -73.75 143.16 46.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.914 0.886 . . . . 0.0 111.835 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -108.67 124.37 50.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.731 1.212 . . . . 0.0 111.236 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.5 t -96.02 109.17 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 110.173 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -88.31 130.62 35.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.504 0.321 . . . . 0.0 110.201 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -104.01 124.29 48.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.302 1.041 . . . . 0.0 110.73 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.2 138.07 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.309 1.044 . . . . 0.0 113.757 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t . . . . . 0 CA--C 1.549 0.941 0 C-N-CA 124.213 1.005 . . . . 0.0 112.64 179.679 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -63.58 -43.36 97.21 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.196 0.907 . . . . 0.0 110.759 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -69.27 -40.09 78.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.626 0.77 . . . . 0.0 111.769 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.2 tpt -71.1 -38.21 72.36 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.234 -0.916 . . . . 0.0 112.562 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.57 98.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.333 0.653 . . . . 0.0 111.116 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.28 -40.19 77.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.914 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.05 -53.3 46.93 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 119.573 1.079 . . . . 0.0 113.53 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -61.52 -39.99 93.04 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.608 -0.937 . . . . 0.0 110.993 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.035 -1.041 . . . . 0.0 113.8 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -71.61 -22.04 61.76 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.789 1.177 . . . . 0.0 112.835 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -86.49 -43.91 12.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.939 0.895 . . . . 0.0 112.083 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.1 -35.13 11.45 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.775 0.83 . . . . 0.0 112.973 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.61 8.76 76.3 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 125.719 1.628 . . . . 0.0 114.188 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.17 -41.83 1.36 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -172.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 18.47 30.84 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.335 1.445 . . . . 0.0 115.078 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.69 -43.79 2.88 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.291 1.546 . . . . 0.0 111.941 -169.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -149.24 165.67 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.851 1.66 . . . . 0.0 112.087 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.55 152.08 22.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.625 0.77 . . . . 0.0 109.241 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.3 t -135.89 137.61 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.802 1.241 . . . . 0.0 111.047 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 m -144.6 154.26 42.64 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.102 1.361 . . . . 0.0 110.433 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -126.47 156.17 41.11 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.041 -1.037 . . . . 0.0 113.687 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -156.46 162.55 39.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 110.231 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.82 155.32 20.57 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.32 -0.862 . . . . 0.0 111.327 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.0 -30.42 70.93 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.527 -0.984 . . . . 0.0 112.006 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -129.46 38.53 3.86 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 72.2 177.91 0.25 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.224 1.809 . . . . 0.0 112.138 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -137.35 -173.39 3.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.462 1.905 . . . . 0.0 111.623 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.09 158.69 43.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 113.326 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.3 t -101.92 146.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -129.57 123.86 21.55 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.997 -1.002 . . . . 0.0 112.567 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.73 -37.76 91.7 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.264 2.643 . . . . 0.0 115.116 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -66.82 -31.44 72.07 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.457 -0.777 . . . . 0.0 111.763 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.13 80.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.647 1.112 . . . . 0.0 110.838 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 mt -54.87 -49.58 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.042 0.537 . . . . 0.0 109.552 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.76 61.92 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.9 mmt -78.21 -22.39 48.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.204 -0.935 . . . . 0.0 112.857 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.8 mmt -106.39 -16.84 14.45 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.59 -25.42 67.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.185 1.357 . . . . 0.0 112.835 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.47 -7.0 51.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.34 1.056 . . . . 0.0 113.319 172.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.9 t -106.33 3.08 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.914 2.086 . . . . 0.0 110.312 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.47 81.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.238 1.399 . . . . 0.0 114.815 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -90.88 154.73 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.577 1.151 . . . . 0.0 110.497 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -141.85 133.46 26.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.71 0.804 . . . . 0.0 111.549 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 pt -132.29 12.19 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.056 0.942 . . . . 0.0 113.535 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -57.44 -33.83 68.34 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.628 1.104 . . . . 0.0 112.593 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.33 3.29 86.66 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.029 1.3 . . . . 0.0 115.923 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -76.03 160.41 29.85 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.028 1.914 . . . . 0.0 113.183 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.3 p -133.31 171.82 13.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.28 1.832 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 t -149.64 161.82 41.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.413 1.085 . . . . 0.0 111.298 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.65 160.49 35.87 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.139 1.776 . . . . 0.0 109.62 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.7 135.52 64.53 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.179 2.586 . . . . 0.0 112.294 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.93 -30.92 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -171.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.85 -14.24 62.79 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -20.56 57.9 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 119.305 0.957 . . . . 0.0 113.029 173.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -95.39 167.42 11.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.774 1.23 . . . . 0.0 112.982 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 110.61 20.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.826 1.65 . . . . 0.0 111.098 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.52 -18.83 65.19 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -170.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.15 -26.88 68.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.665 1.186 . . . . 0.0 112.677 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.57 -2.84 58.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.73 1.612 . . . . 0.0 112.253 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -116.54 80.49 1.47 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.806 2.042 . . . . 0.0 107.882 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.65 -26.6 14.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 113.012 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -132.81 131.19 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.79 1.636 . . . . 0.0 109.381 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.52 120.69 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.238 -0.913 . . . . 0.0 110.598 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.91 120.62 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.079 1.352 . . . . 0.0 108.106 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -91.9 157.01 17.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.047 1.339 . . . . 0.0 109.848 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.41 45.35 2.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.607 0.763 . . . . 0.0 111.636 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.533 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -143.57 141.79 19.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.994 0.917 . . . . 0.0 113.142 -170.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.42 155.11 67.93 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.463 2.109 . . . . 0.0 110.11 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.38 -22.95 71.78 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.93 2.42 . . . . 0.0 115.016 -169.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.25 -16.97 61.93 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -91.07 -1.68 57.74 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.66 2.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.66 1.584 . . . . 0.0 114.085 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -109.19 7.94 25.65 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.923 1.689 . . . . 0.0 113.231 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -62.06 162.91 8.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.446 2.298 . . . . 0.0 113.21 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.01 129.55 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.909 0.883 . . . . 0.0 110.177 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -133.21 148.53 52.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.557 1.543 . . . . 0.0 111.34 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -141.1 159.0 43.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.975 1.31 . . . . 0.0 111.871 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -141.75 99.18 3.49 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 0.0 110.19 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.88 153.84 34.35 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.893 1.277 . . . . 0.0 113.194 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -101.59 39.2 1.47 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.645 1.578 . . . . 0.0 112.374 -168.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 162.86 14.87 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.141 1.377 . . . . 0.0 113.684 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.22 154.23 40.46 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.774 1.629 . . . . 0.0 111.267 -174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -86.73 126.84 62.39 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 121.686 -0.634 . . . . 0.0 111.659 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 C-N-CA 122.746 2.297 . . . . 0.0 114.004 -179.159 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.75 -22.58 66.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.092 0.957 . . . . 0.0 111.625 170.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.76 -33.8 76.46 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.037 -1.039 . . . . 0.0 110.478 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.0 t -72.89 -35.96 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.799 -1.188 . . . . 0.0 110.649 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.03 -47.41 83.18 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.54 1.518 . . . . 0.0 110.417 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -68.78 -17.05 63.97 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.7 m -88.67 -41.38 12.64 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.224 1.409 . . . . 0.0 112.629 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -73.96 -34.15 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 120.533 -1.354 . . . . 0.0 111.371 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.93 -40.63 73.42 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.84 60.77 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.749 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.93 -43.04 75.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.902 0.851 . . . . 0.0 110.722 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.58 -48.12 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.294 0.638 . . . . 0.0 110.56 169.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -58.47 -49.58 76.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.731 1.212 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.47 -29.0 64.34 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.018 1.281 . . . . 0.0 112.263 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -68.41 -50.7 50.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.59 0.756 . . . . 0.0 111.214 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.53 -48.62 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.162 0.985 . . . . 0.0 111.527 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.88 -50.93 66.83 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.557 1.071 . . . . 0.0 112.625 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -31.09 67.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.652 0.66 . . . . 0.0 111.998 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.45 -51.69 66.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.394 0.677 . . . . 0.0 110.314 169.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.8 -36.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.148 -0.97 . . . . 0.0 111.464 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -85.48 -20.03 30.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 pt -101.59 -18.07 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 124.971 1.308 . . . . 0.0 113.071 177.614 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 119.192 -0.432 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -70.44 138.64 51.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.124 0.875 . . . . 0.0 111.242 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -111.17 125.47 53.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.472 1.109 . . . . 0.0 111.361 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 68.5 t -95.72 114.11 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.048 1.739 . . . . 0.0 110.037 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -96.53 125.78 41.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.897 0.771 . . . . 0.0 110.891 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -92.01 124.08 35.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.715 0.806 . . . . 0.0 108.886 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.55 132.24 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.293 1.037 . . . . 0.0 112.469 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 m -64.16 -38.99 93.06 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.622 1.101 . . . . 0.0 112.4 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -66.55 -44.24 82.88 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.734 0.413 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -39.24 82.12 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.773 0.829 . . . . 0.0 111.99 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.72 -46.01 92.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.43 -41.06 79.69 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.89 -63.76 4.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.722 1.153 . . . . 0.0 113.72 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -62.64 -34.85 77.9 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.699 1.25 . . . . 0.0 111.946 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.18 77.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -70.53 -27.89 64.51 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.883 1.674 . . . . 0.0 112.441 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.7 m -77.27 -46.02 24.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.363 1.065 . . . . 0.0 112.275 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.24 -27.76 14.85 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.036 0.934 . . . . 0.0 113.239 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 2.1 88.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.126 2.298 . . . . 0.0 113.608 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.42 114.79 1.03 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.409 1.104 . . . . 0.0 112.419 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.69 16.62 76.14 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.636 1.014 . . . . 0.0 115.636 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -119.08 -36.24 3.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.204 1.502 . . . . 0.0 111.92 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -150.61 166.32 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 127.544 2.338 . . . . 0.0 110.393 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.76 153.84 18.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 168.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.48 144.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.458 -1.401 . . . . 0.0 114.682 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -150.61 158.22 43.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.636 1.574 . . . . 0.0 110.726 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -123.55 149.18 45.56 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.016 1.726 . . . . 0.0 111.825 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 t -152.04 147.54 26.62 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.296 . . . . 0.0 110.586 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.87 143.47 17.09 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 168.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.69 -38.51 33.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.214 1.507 . . . . 0.0 112.22 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -123.74 40.87 3.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.838 1.655 . . . . 0.0 111.354 171.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 73.38 164.91 0.29 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.051 2.14 . . . . 0.0 114.333 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -148.4 166.84 26.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.294 2.238 . . . . 0.0 112.338 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -121.65 147.59 45.66 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.526 1.13 . . . . 0.0 113.756 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -80.18 -38.59 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 62.98 123.79 0.02 OUTLIER Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 128.815 2.846 . . . . 0.0 116.489 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 -38.95 79.79 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.929 3.086 . . . . 0.0 116.318 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -31.96 73.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.657 -1.277 . . . . 0.0 111.823 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.44 -8.19 58.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.653 -1.279 . . . . 0.0 113.603 172.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.81 -53.72 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 168.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.49 -33.52 60.8 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 mmt -71.86 -12.65 61.38 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.298 -0.876 . . . . 0.0 113.262 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.1 mmt -120.35 -27.25 5.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.593 1.157 . . . . 0.0 112.476 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.74 -25.15 68.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.852 -1.155 . . . . 0.0 112.637 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -70.63 -15.06 62.7 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.01 5.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 126.47 1.908 . . . . 0.0 110.664 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.18 12.37 83.31 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.389 1.471 . . . . 0.0 114.617 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -87.28 149.16 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.354 1.077 . . . . 0.0 111.312 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.47 125.52 44.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.45 1.5 . . . . 0.0 111.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.5 pt -134.49 -7.03 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.1 p -67.42 -28.23 67.73 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.125 1.33 . . . . 0.0 113.849 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.78 -2.11 90.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.843 1.211 . . . . 0.0 115.023 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -81.64 161.68 23.36 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.001 1.401 . . . . 0.0 112.469 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -140.31 -179.9 6.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.03 1.332 . . . . 0.0 111.376 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -154.44 160.84 41.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.066 1.346 . . . . 0.0 111.823 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -159.46 155.98 24.39 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.784 1.634 . . . . 0.0 108.799 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.56 136.26 63.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.361 2.707 . . . . 0.0 113.047 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.0 -33.15 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.68 -11.41 60.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.07 -24.44 59.5 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.215 -0.928 . . . . 0.0 112.373 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -93.35 165.65 12.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.906 1.282 . . . . 0.0 112.402 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.9 110.55 20.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.521 1.528 . . . . 0.0 111.118 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.54 -19.32 65.27 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.38 -26.37 67.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.28 1.032 . . . . 0.0 112.403 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -87.51 -1.67 58.09 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.002 1.721 . . . . 0.0 112.037 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.07 82.0 1.76 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.711 2.004 . . . . 0.0 108.154 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.28 -24.82 12.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.167 1.787 . . . . 0.0 113.018 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.7 t -133.9 130.74 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.777 1.631 . . . . 0.0 108.969 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.92 123.78 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.309 -0.869 . . . . 0.0 110.633 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.6 121.23 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.178 1.391 . . . . 0.0 107.962 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 t -85.21 147.71 26.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.511 1.124 . . . . 0.0 109.985 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -124.06 24.82 8.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.524 1.129 . . . . 0.0 112.456 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.8 m . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -171.7 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -139.84 136.95 17.77 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.615 1.166 . . . . 0.0 111.673 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.96 153.14 70.67 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.424 2.082 . . . . 0.0 110.064 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.71 -26.96 80.5 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.954 2.436 . . . . 0.0 114.104 -169.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.4 -19.62 65.85 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -90.1 -3.64 57.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -118.53 -9.76 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.79 1.236 . . . . 0.0 114.311 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -93.09 2.75 56.59 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.939 1.695 . . . . 0.0 113.511 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -53.42 158.76 1.62 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.404 2.281 . . . . 0.0 113.775 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -34.03 76.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -133.65 127.86 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.385 1.074 . . . . 0.0 110.05 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -130.91 148.27 52.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 111.103 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -141.88 159.09 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.672 1.189 . . . . 0.0 112.031 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.27 110.57 8.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.21 1.004 . . . . 0.0 108.882 168.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -87.68 145.66 26.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.6 1.16 . . . . 0.0 111.529 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -104.96 46.19 0.93 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.686 1.595 . . . . 0.0 108.555 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -102.02 132.81 47.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.572 2.349 . . . . 0.0 111.359 -168.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -90.34 151.85 21.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.317 1.447 . . . . 0.0 112.319 -173.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -88.75 131.71 40.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.768 -0.582 . . . . 0.0 111.86 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.544 0.996 0 C-N-CA 122.7 2.267 . . . . 0.0 115.371 -177.077 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.341 0.591 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.87 -25.2 66.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.136 -0.977 . . . . 0.0 111.754 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.29 -29.37 70.46 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.228 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -72.0 -36.86 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 120.803 -1.186 . . . . 0.0 111.047 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -58.93 -46.73 87.25 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.435 1.471 . . . . 0.0 110.452 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -71.73 -18.21 62.15 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.109 0.964 . . . . 0.0 113.59 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 m -85.06 -52.87 5.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.575 1.55 . . . . 0.0 111.923 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.6 -31.92 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.934 1.294 . . . . 0.0 111.863 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -53.97 -43.42 69.91 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.601 1.091 . . . . 0.0 113.432 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.97 -32.74 65.93 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.771 0.701 . . . . 0.0 112.853 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -69.98 -40.34 75.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.41 -47.82 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.854 0.862 . . . . 0.0 110.329 171.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.0 -49.01 77.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.33 -28.36 66.17 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 121.376 1.898 . . . . 0.0 112.999 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -68.41 -49.0 63.17 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.473 -0.767 . . . . 0.0 111.654 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.24 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.022 0.828 . . . . 0.0 112.526 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -63.7 -50.72 68.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 120.207 1.367 . . . . 0.0 112.45 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.31 -31.06 69.29 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.951 0.796 . . . . 0.0 112.149 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.77 -49.72 69.63 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.396 0.678 . . . . 0.0 110.723 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.67 -40.76 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.988 -174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -27.04 68.84 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -88.49 -18.94 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -105.35 -18.36 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.256 1.4 0 C-N-CA 124.773 1.229 . . . . 0.0 113.222 179.054 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 119.75 -0.166 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -70.55 143.16 51.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.947 . . . . 0.0 111.94 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -110.73 126.23 54.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.015 . . . . 0.0 111.092 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.38 118.03 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.814 1.646 . . . . 0.0 109.995 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.5 tpp -97.81 119.44 36.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.651 0.659 . . . . 0.0 109.861 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.32 124.09 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.178 0.591 . . . . 0.0 110.391 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.03 144.54 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.242 1.017 . . . . 0.0 112.832 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.6 t . . . . . 0 N--CA 1.471 0.582 0 C-N-CA 125.243 1.417 . . . . 0.0 109.497 178.322 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -63.91 -44.48 92.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.701 1.592 . . . . 0.0 112.942 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -63.08 -37.31 86.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.731 0.812 . . . . 0.0 111.543 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.412 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 8.1 tpt -74.83 -36.95 62.4 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.35 94.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.946 0.898 . . . . 0.0 109.917 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.86 -43.88 94.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.157 0.89 . . . . 0.0 111.769 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.1 -52.56 48.47 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 119.556 1.071 . . . . 0.0 113.83 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -68.18 -39.39 82.53 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.81 -1.406 . . . . 0.0 111.588 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.13 74.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.855 -1.153 . . . . 0.0 113.699 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -78.31 -15.54 58.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.2 1.364 . . . . 0.0 113.579 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.5 m -89.46 -44.95 9.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.255 1.022 . . . . 0.0 111.917 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.71 -29.07 14.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.673 1.189 . . . . 0.0 113.375 -174.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.35 2.27 88.17 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 126.419 1.961 . . . . 0.0 113.977 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.55 115.46 1.14 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.438 1.119 . . . . 0.0 112.385 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.64 10.83 85.86 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.85 -40.36 4.02 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.652 1.726 . . . . 0.0 112.493 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -148.29 161.7 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.51 2.324 . . . . 0.0 109.782 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 144.34 26.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.84 142.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.198 -0.939 . . . . 0.0 112.576 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -148.96 160.27 43.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.849 1.66 . . . . 0.0 109.435 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 p -136.84 153.46 50.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.9 t -152.27 152.91 32.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.283 1.433 . . . . 0.0 110.611 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.59 140.98 16.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.71 -37.63 84.86 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.499 1.65 . . . . 0.0 111.018 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.74 33.78 4.36 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.814 1.646 . . . . 0.0 111.064 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 64.01 168.84 0.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.789 2.035 . . . . 0.0 114.491 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 81.9 p -150.3 167.35 27.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.746 1.619 . . . . 0.0 112.526 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -137.44 170.96 15.18 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.039 1.336 . . . . 0.0 112.099 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.23 112.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.99 0.9 . . . . 0.0 110.762 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -78.78 134.72 60.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.01 1.324 . . . . 0.0 110.534 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.54 -37.49 90.32 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.985 2.457 . . . . 0.0 115.092 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 m -65.98 -32.32 73.74 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.86 -1.15 . . . . 0.0 111.604 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.37 -5.76 44.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.573 -1.329 . . . . 0.0 113.93 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.31 -55.93 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 167.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.22 78.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 82.3 mmm -73.38 -1.75 19.43 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.412 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.5 mmt -121.34 -29.02 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.64 1.176 . . . . 0.0 111.207 -173.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.68 -27.5 64.88 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.324 0.65 . . . . 0.0 111.951 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.83 -15.87 63.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.595 1.158 . . . . 0.0 113.935 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -120.19 24.58 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 126.175 1.79 . . . . 0.0 111.042 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.92 12.36 84.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.723 1.63 . . . . 0.0 116.128 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mm -93.13 152.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 118.855 1.328 . . . . 0.0 111.466 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -134.54 136.26 42.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.004 1.322 . . . . 0.0 110.97 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.34 0.74 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.543 1.537 . . . . 0.0 112.485 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.6 p -62.37 -28.17 69.58 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -169.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.86 -4.48 88.69 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.625 1.107 . . . . 0.0 115.167 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -81.8 154.54 25.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.108 1.454 . . . . 0.0 113.406 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -134.12 178.87 6.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.007 2.123 . . . . 0.0 110.805 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -153.22 162.89 40.81 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.178 -0.951 . . . . 0.0 112.26 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.44 158.17 38.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.35 1.86 . . . . 0.0 109.085 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.02 136.55 73.47 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.262 2.641 . . . . 0.0 112.14 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.62 -29.95 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.23 -14.78 62.47 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.27 -19.87 59.47 Favored 'General case' 0 CA--C 1.553 1.079 0 O-C-N 121.421 -0.799 . . . . 0.0 113.149 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.44 170.39 9.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.176 1.39 . . . . 0.0 112.866 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.8 108.28 14.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 111.287 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.27 -18.66 65.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -170.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.01 -26.12 68.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.156 0.982 . . . . 0.0 112.507 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.16 -1.72 58.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.109 1.764 . . . . 0.0 111.851 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -118.11 82.02 1.77 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 127.122 2.169 . . . . 0.0 108.651 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.19 -27.06 13.14 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.095 1.758 . . . . 0.0 113.067 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.1 t -131.4 130.85 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.802 1.641 . . . . 0.0 108.706 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.7 t -133.77 126.33 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.079 -1.013 . . . . 0.0 109.838 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.2 mm -126.64 111.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.61 1.164 . . . . 0.0 109.687 -170.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.2 t -87.49 156.87 19.35 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.493 1.117 . . . . 0.0 112.145 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.6 41.48 3.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.643 1.577 . . . . 0.0 111.68 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 124.783 1.233 . . . . 0.0 112.4 -178.118 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 121.532 0.682 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.96 142.78 65.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.52 154.29 72.64 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.342 2.028 . . . . 0.0 109.952 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.17 -25.27 76.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.935 2.423 . . . . 0.0 114.868 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.07 -16.37 63.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -93.16 -2.23 55.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.94 0.93 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.345 1.458 . . . . 0.0 113.941 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -103.14 -1.14 29.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.319 1.848 . . . . 0.0 113.222 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -54.88 161.55 1.56 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.241 2.616 . . . . 0.0 114.352 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.98 -35.01 79.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.8 mt -133.84 131.59 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.444 1.098 . . . . 0.0 110.465 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -141.32 149.4 41.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.403 1.481 . . . . 0.0 112.349 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -146.11 159.09 43.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.056 1.742 . . . . 0.0 110.304 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -138.99 86.62 2.15 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.403 0.681 . . . . 0.0 111.44 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -67.68 146.71 53.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.792 1.637 . . . . 0.0 113.631 -170.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -98.97 60.49 1.22 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.528 1.931 . . . . 0.0 107.691 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.27 127.52 55.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.116 1.766 . . . . 0.0 112.349 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.59 169.95 12.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.009 1.324 . . . . 0.0 113.96 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.91 119.61 57.77 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.185 0.994 . . . . 0.0 110.982 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo . . . . . 0 CA--C 1.542 0.904 0 C-N-CA 122.64 2.227 . . . . 0.0 113.521 176.423 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.99 -25.46 68.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.19 0.996 . . . . 0.0 111.884 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.44 -32.18 73.39 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.523 -0.736 . . . . 0.0 111.571 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.03 -38.66 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.276 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -58.04 -48.44 80.09 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.085 1.311 . . . . 0.0 110.882 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -66.82 -26.67 67.04 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -74.28 -55.46 6.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.569 0.748 . . . . 0.0 111.33 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -34.28 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 110.89 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -58.3 -42.15 86.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.452 1.024 . . . . 0.0 112.691 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.37 -34.4 74.39 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.408 0.528 . . . . 0.0 112.726 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -68.97 -39.76 79.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.357 1.079 . . . . 0.0 111.332 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.63 -51.41 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.1 0.96 . . . . 0.0 110.522 170.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -54.59 -47.58 73.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.701 1.201 . . . . 0.0 112.554 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -68.44 -27.94 66.62 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.659 1.572 . . . . 0.0 112.842 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -72.48 -49.74 30.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.215 1.006 . . . . 0.0 111.52 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.83 -40.66 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 118.323 -0.846 . . . . 0.0 113.244 172.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.29 -46.71 82.47 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.824 1.647 . . . . 0.0 111.689 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -70.31 -33.21 71.25 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.526 0.603 . . . . 0.0 112.56 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.94 -46.63 87.53 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.136 0.974 . . . . 0.0 111.092 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt -73.56 -43.4 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.365 -0.834 . . . . 0.0 110.56 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.38 -27.69 69.25 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -85.9 -12.74 49.82 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -114.93 -18.52 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.393 0 C-N-CA 124.676 1.19 . . . . 0.0 113.1 -179.623 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.5 2.051 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -71.96 142.5 49.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.215 1.006 . . . . 0.0 111.896 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -108.2 126.16 52.48 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.571 1.148 . . . . 0.0 111.028 171.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.36 113.89 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.881 2.072 . . . . 0.0 110.092 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.9 ttm -98.71 126.48 44.34 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.148 0.885 . . . . 0.0 110.627 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -93.28 127.05 38.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.184 0.994 . . . . 0.0 109.408 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.06 135.26 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.703 1.201 . . . . 0.0 113.197 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 p . . . . . 0 CA--C 1.543 0.674 0 C-N-CA 124.21 1.004 . . . . 0.0 112.6 -174.34 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -63.88 -37.32 86.94 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.323 1.42 . . . . 0.0 113.329 170.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.17 -45.62 66.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.827 0.451 . . . . 0.0 110.14 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.417 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 6.7 tpt -72.32 -38.62 68.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.3 86.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.551 0.614 . . . . 0.0 111.688 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -38.82 89.62 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.824 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.34 29.61 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 119.671 1.123 . . . . 0.0 113.655 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.47 -38.33 90.71 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.396 -1.061 . . . . 0.0 111.39 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.76 -34.7 76.02 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -72.12 -19.17 61.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.845 1.657 . . . . 0.0 113.215 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.2 m -89.26 -45.12 9.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.808 0.843 . . . . 0.0 111.971 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.94 -33.68 12.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.679 1.192 . . . . 0.0 113.009 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 4.94 81.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 125.679 1.609 . . . . 0.0 113.27 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.12 116.88 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 118.32 1.06 . . . . 0.0 111.725 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 14.63 76.91 Favored Glycine 0 CA--C 1.537 1.462 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.95 -44.39 3.81 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.245 1.522 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -145.71 162.21 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 126.465 1.906 . . . . 0.0 111.48 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.52 149.08 24.6 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -145.89 143.43 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.832 -1.167 . . . . 0.0 114.049 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.4 m -143.8 143.27 31.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.522 1.529 . . . . 0.0 110.871 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.3 p -106.86 145.25 32.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 0.0 111.677 170.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -156.36 154.46 30.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.533 1.133 . . . . 0.0 110.735 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.98 150.2 17.04 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.004 1.288 . . . . 0.0 110.653 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -52.88 -37.55 60.58 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.571 1.185 . . . . 0.0 112.413 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -126.11 39.42 3.95 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.47 . . . . 0.0 111.287 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 69.08 170.65 0.3 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.667 1.987 . . . . 0.0 114.177 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -159.15 167.84 28.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.113 2.565 . . . . 0.0 109.978 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 156.19 28.52 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -173.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.6 146.61 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.916 1.286 . . . . 0.0 109.542 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -126.23 126.76 24.72 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.885 -169.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.519 2.813 . . . . 0.0 115.085 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 m -64.4 -34.11 77.42 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.022 -1.049 . . . . 0.0 111.526 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.17 -10.15 59.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.161 -0.962 . . . . 0.0 113.186 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.6 mt -80.13 -56.83 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 167.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.68 72.61 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.7 mmt -69.75 -8.19 45.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.417 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.4 mmt -124.63 -26.38 3.84 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.459 1.104 . . . . 0.0 112.263 -169.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -26.66 68.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.844 -1.16 . . . . 0.0 111.658 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.37 -9.14 55.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.0 0.92 . . . . 0.0 113.372 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.47 1.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.466 2.306 . . . . 0.0 110.765 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.04 81.75 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.693 1.616 . . . . 0.0 114.836 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.16 150.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.857 1.263 . . . . 0.0 111.293 -174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -126.92 142.29 51.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.199 1.4 . . . . 0.0 112.489 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 pt -137.53 -1.96 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.422 1.889 . . . . 0.0 111.783 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.8 p -63.18 -34.02 76.73 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.73 2.8 87.78 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.635 1.112 . . . . 0.0 115.369 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -72.57 159.71 33.46 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 p -118.0 -176.24 3.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.072 2.549 . . . . 0.0 108.911 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.0 t -146.07 -73.27 0.23 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.011 -1.055 . . . . 0.0 111.216 170.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 63.95 154.18 0.12 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.556 2.343 . . . . 0.0 115.211 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.87 133.79 46.61 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.726 2.284 . . . . 0.0 111.991 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.5 tt -55.98 -34.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.38 -8.6 51.93 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -20.68 60.24 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.254 -0.904 . . . . 0.0 112.692 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.54 171.42 8.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.181 1.392 . . . . 0.0 112.807 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.9 114.54 27.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.016 1.726 . . . . 0.0 110.934 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.21 -18.3 63.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.88 -26.44 66.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.784 0.833 . . . . 0.0 112.542 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -86.98 -2.81 58.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.056 1.742 . . . . 0.0 112.132 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -114.86 81.9 1.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.8 2.04 . . . . 0.0 107.972 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.23 -28.7 12.21 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.755 1.622 . . . . 0.0 112.88 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -131.0 130.5 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 126.01 1.724 . . . . 0.0 108.851 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -133.23 128.8 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.153 -0.967 . . . . 0.0 109.763 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 mm -125.19 117.14 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 109.053 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.7 t -89.89 153.57 20.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 111.316 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -133.26 35.91 3.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.43 1.092 . . . . 0.0 111.972 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.6 m . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -169.007 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -143.44 140.51 17.66 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.711 1.204 . . . . 0.0 112.613 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -63.91 154.01 72.45 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.591 2.194 . . . . 0.0 110.449 168.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.48 -32.29 96.09 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.371 2.048 . . . . 0.0 114.728 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.28 -22.19 66.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -89.29 -3.16 58.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.46 -19.95 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 t -81.96 6.8 14.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.754 1.622 . . . . 0.0 114.354 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -55.78 160.68 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.035 2.134 . . . . 0.0 113.721 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.36 -33.53 74.92 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.7 mt -131.69 124.58 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.114 0.966 . . . . 0.0 110.173 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -135.31 141.88 45.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.427 1.491 . . . . 0.0 110.521 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.4 159.1 39.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.011 1.324 . . . . 0.0 110.871 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.24 131.94 54.52 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.602 1.161 . . . . 0.0 111.327 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.9 m0 -103.48 162.42 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.786 1.635 . . . . 0.0 112.77 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -119.89 40.13 3.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.874 1.27 . . . . 0.0 112.871 -168.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.94 159.58 34.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.874 0.87 . . . . 0.0 111.081 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -106.06 162.08 13.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.412 1.485 . . . . 0.0 109.795 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -88.52 128.55 52.45 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.78 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 CA--C 1.546 1.092 0 C-N-CA 122.278 1.985 . . . . 0.0 112.804 169.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.21 -30.13 71.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.818 1.247 . . . . 0.0 111.858 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.05 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.346 -0.846 . . . . 0.0 111.749 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.53 -39.05 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 110.824 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -56.59 -47.2 80.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.09 1.314 . . . . 0.0 110.518 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -70.69 -19.28 62.79 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.1 m -82.03 -50.83 8.66 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.874 1.27 . . . . 0.0 112.211 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.74 -33.71 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.398 1.079 . . . . 0.0 111.517 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -54.1 -40.21 67.07 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.852 0.751 . . . . 0.0 112.922 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.68 -32.89 63.82 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.282 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -70.95 -40.77 71.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.396 1.098 . . . . 0.0 110.273 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.13 -52.42 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.133 0.973 . . . . 0.0 110.66 170.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -55.47 -48.82 73.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.009 1.324 . . . . 0.0 112.462 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.99 -28.8 66.93 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.905 1.684 . . . . 0.0 112.51 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -71.94 -47.48 52.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.474 0.709 . . . . 0.0 111.861 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.54 -35.32 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.008 0.822 . . . . 0.0 112.897 170.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.77 -46.21 90.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.887 1.221 . . . . 0.0 111.389 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.55 97.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.329 0.513 . . . . 0.0 111.051 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.496 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -59.31 -48.96 79.65 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.771 0.828 . . . . 0.0 111.199 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.51 -44.23 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.868 -0.52 . . . . 0.0 110.489 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.58 70.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.4 pttt -86.86 -13.24 45.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -115.24 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 124.516 1.127 . . . . 0.0 113.091 178.518 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 119.765 -0.159 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -69.85 138.68 52.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.479 1.112 . . . . 0.0 111.4 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -108.05 127.39 53.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.05 0.94 . . . . 0.0 110.923 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.84 119.48 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.063 1.745 . . . . 0.0 109.685 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.5 tpp -97.8 126.78 43.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.73 123.34 45.54 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.063 0.545 . . . . 0.0 111.152 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.17 149.22 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.164 0.985 . . . . 0.0 113.546 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 125.155 1.382 . . . . 0.0 109.007 176.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.6 p -70.69 -55.97 7.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.328 1.051 . . . . 0.0 113.543 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.66 -33.66 74.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.021 0.528 . . . . 0.0 110.232 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.9 tpt -71.89 -43.78 64.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.12 99.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.508 0.723 . . . . 0.0 111.637 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -43.91 95.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.858 169.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.38 -53.05 43.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.525 1.057 . . . . 0.0 113.176 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -61.38 -36.34 79.99 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.697 1.249 . . . . 0.0 111.535 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.98 -27.17 62.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -65.91 -46.31 78.77 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.844 1.656 . . . . 0.0 111.375 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -74.48 -38.27 62.96 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.0 1.32 . . . . 0.0 112.332 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.8 mt -96.29 -29.83 13.78 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.17 0.988 . . . . 0.0 113.038 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.59 6.34 77.86 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.772 1.653 . . . . 0.0 113.829 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.0 118.82 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.467 1.134 . . . . 0.0 111.408 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.08 14.97 80.04 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 118.743 -1.032 . . . . 0.0 115.589 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -124.27 -43.3 2.07 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.27 1.535 . . . . 0.0 111.913 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.98 157.87 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.663 1.185 . . . . 0.0 113.191 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.83 154.02 20.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.471 1.108 . . . . 0.0 109.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.97 140.54 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 121.238 -0.914 . . . . 0.0 113.093 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 m -144.89 154.02 42.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.328 1.451 . . . . 0.0 109.538 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.3 p -121.6 152.1 39.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.719 0.808 . . . . 0.0 112.794 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 t -151.83 150.71 30.42 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.324 1.049 . . . . 0.0 110.846 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.12 140.75 15.77 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 169.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.9 -41.99 92.86 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.518 1.659 . . . . 0.0 110.995 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.59 33.63 3.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.532 170.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t 64.27 170.93 0.18 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.387 1.875 . . . . 0.0 113.932 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.1 p -153.13 -172.62 4.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.098 1.759 . . . . 0.0 111.546 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -137.6 -147.92 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.258 1.423 . . . . 0.0 111.82 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.23 151.06 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 126.5 1.92 . . . . 0.0 107.304 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -123.74 126.64 25.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 CA-C-O 117.604 -1.189 . . . . 0.0 111.206 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -54.41 -39.22 88.51 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.324 2.683 . . . . 0.0 114.898 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 m -66.03 -32.57 74.13 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.996 -1.065 . . . . 0.0 111.872 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.2 -10.66 59.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.13 -0.981 . . . . 0.0 113.285 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.83 -53.77 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.39 61.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -170.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.05 -6.64 43.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.3 mmt -128.12 -29.51 2.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.93 0.892 . . . . 0.0 112.532 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.8 -25.49 67.52 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.893 -1.129 . . . . 0.0 111.855 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.95 -14.31 62.96 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.6 19.06 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.38 1.472 . . . . 0.0 111.584 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.81 76.08 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.801 1.667 . . . . 0.0 116.591 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mm -80.13 148.6 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.45 1.625 . . . . 0.0 112.151 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.55 111.4 11.72 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.166 1.786 . . . . 0.0 112.024 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.5 pt -140.98 -1.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.145 1.378 . . . . 0.0 113.693 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -61.84 -35.78 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -169.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.54 -2.45 90.05 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.332 0.968 . . . . 0.0 115.236 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -85.41 167.28 15.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.895 1.347 . . . . 0.0 114.327 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -139.88 -175.27 4.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.053 1.741 . . . . 0.0 110.586 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 t -145.24 165.49 28.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.67 1.588 . . . . 0.0 112.101 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.31 157.23 45.81 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.732 1.613 . . . . 0.0 110.299 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.12 139.55 90.28 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.418 2.745 . . . . 0.0 112.103 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -58.35 -31.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.18 -10.51 58.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.57 57.7 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.08 0.855 . . . . 0.0 112.789 170.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -94.4 170.4 9.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.061 1.345 . . . . 0.0 112.41 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 108.72 15.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.567 1.547 . . . . 0.0 111.155 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.66 -19.35 65.74 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.44 -26.53 68.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.866 0.866 . . . . 0.0 112.567 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.87 -2.67 58.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.343 1.857 . . . . 0.0 111.936 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -116.1 83.98 2.04 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.207 2.203 . . . . 0.0 108.235 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.21 -25.91 6.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.087 1.755 . . . . 0.0 113.049 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -133.36 130.26 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.848 1.659 . . . . 0.0 108.902 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -134.13 126.63 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.083 -1.01 . . . . 0.0 109.471 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.1 mm -127.03 116.58 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.589 1.156 . . . . 0.0 109.901 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -91.15 157.31 17.28 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.061 1.344 . . . . 0.0 111.651 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.65 35.89 4.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.176 1.39 . . . . 0.0 112.287 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 124.791 1.236 . . . . 0.0 112.204 -178.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 121.475 0.655 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 mt -84.23 142.42 40.93 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.85 154.97 70.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.612 2.208 . . . . 0.0 109.915 168.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.91 -28.99 81.67 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.917 2.411 . . . . 0.0 114.276 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.33 -19.44 65.81 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.82 -1.175 . . . . 0.0 113.814 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -91.6 -3.26 56.61 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 m -115.91 -16.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -83.79 4.24 29.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.863 1.665 . . . . 0.0 114.13 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -58.07 159.74 5.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.972 2.109 . . . . 0.0 113.986 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -62.99 -34.05 76.71 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.32 127.85 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.817 0.847 . . . . 0.0 109.864 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.64 148.31 48.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.291 1.436 . . . . 0.0 111.821 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -147.22 157.41 43.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.829 1.652 . . . . 0.0 110.391 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -135.98 86.06 2.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.619 0.768 . . . . 0.0 111.018 169.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -66.98 146.61 54.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.836 1.655 . . . . 0.0 115.02 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -96.53 49.09 1.09 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.526 2.33 . . . . 0.0 108.742 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.14 134.51 40.37 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.254 1.822 . . . . 0.0 112.654 -167.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.1 179.27 6.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.098 1.359 . . . . 0.0 113.897 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -101.61 113.97 65.73 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.868 0.867 . . . . 0.0 111.806 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo . . . . . 0 CA--C 1.54 0.825 0 C-N-CA 121.559 1.506 . . . . 0.0 113.264 176.673 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.37 -30.07 67.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.814 0.846 . . . . 0.0 111.373 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.62 -35.15 79.49 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.242 -0.912 . . . . 0.0 110.919 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.97 -39.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.404 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -55.77 -47.75 76.48 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 121.147 1.794 . . . . 0.0 111.427 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -69.27 -15.04 63.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.267 1.027 . . . . 0.0 113.564 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.6 m -88.77 -49.23 6.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.659 1.584 . . . . 0.0 112.641 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -70.38 -31.76 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.24 -0.913 . . . . 0.0 111.073 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -56.24 -39.83 73.16 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 0.0 112.453 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.48 -34.6 68.06 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.071 0.843 . . . . 0.0 112.63 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -69.49 -43.2 73.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.059 0.93 . . . . 0.0 110.513 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.94 -47.2 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.377 0.671 . . . . 0.0 110.685 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -56.45 -49.41 74.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.55 1.14 . . . . 0.0 112.3 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.7 -29.84 62.52 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.017 1.28 . . . . 0.0 113.13 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -64.8 -50.85 65.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.477 0.711 . . . . 0.0 110.866 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.4 t -56.36 -46.21 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.868 1.267 . . . . 0.0 112.611 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.63 -49.05 78.11 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 120.099 1.318 . . . . 0.0 111.874 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -71.47 -32.61 68.48 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.433 0.561 . . . . 0.0 111.948 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.52 -48.33 81.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.971 0.908 . . . . 0.0 111.308 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.8 -43.17 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.683 0.674 . . . . 0.0 110.7 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.82 68.68 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.62 -11.84 58.09 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.9 pt -111.44 -28.3 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.256 1.418 0 C-N-CA 125.629 1.572 . . . . 0.0 112.108 -178.183 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttp . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -72.77 144.19 47.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.636 1.174 . . . . 0.0 112.316 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -112.06 125.76 54.44 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.196 0.998 . . . . 0.0 111.836 170.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.79 116.55 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.821 1.649 . . . . 0.0 110.585 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.52 126.08 43.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.375 0.989 . . . . 0.0 110.454 168.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -95.36 121.45 37.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.894 0.878 . . . . 0.0 110.323 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.29 136.35 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.086 0.954 . . . . 0.0 113.275 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 123.825 0.85 . . . . 0.0 112.216 -179.591 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -68.51 -47.29 67.36 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.621 1.555 . . . . 0.0 111.331 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.19 -38.58 91.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.581 1.153 . . . . 0.0 111.759 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 tpt -73.58 -38.23 65.22 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.687 0.795 . . . . 0.0 112.244 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.69 -44.14 90.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.229 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.87 -44.05 91.0 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.144 0.884 . . . . 0.0 112.052 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.51 -49.77 67.19 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 119.598 1.09 . . . . 0.0 113.267 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.3 -43.15 87.09 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.135 -1.215 . . . . 0.0 111.666 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.82 82.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.844 -1.16 . . . . 0.0 113.797 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -72.55 -16.54 61.76 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.57 1.077 . . . . 0.0 113.254 174.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.9 m -88.21 -44.71 10.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.69 1.196 . . . . 0.0 111.99 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -95.99 -34.6 11.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.21 1.004 . . . . 0.0 113.539 -171.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.94 5.33 85.03 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.77 1.652 . . . . 0.0 113.85 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.43 -44.9 4.19 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.25 18.99 41.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.416 1.484 . . . . 0.0 114.536 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -127.19 -38.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.767 1.227 . . . . 0.0 112.504 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.52 163.27 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.646 1.579 . . . . 0.0 112.248 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.25 152.6 18.22 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 168.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -148.61 145.22 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 120.631 -1.293 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -147.11 163.45 36.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.053 1.741 . . . . 0.0 108.827 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.4 p -134.01 154.55 51.05 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.725 -1.234 . . . . 0.0 111.747 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 t -145.94 142.25 28.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.481 1.112 . . . . 0.0 109.935 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.96 137.21 13.68 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.975 -0.453 . . . . 0.0 112.19 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.15 121.29 13.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 64.47 28.67 13.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.296 1.839 . . . . 0.0 113.775 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t 70.41 170.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.432 2.293 . . . . 0.0 114.062 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 82.1 p -152.71 179.12 8.91 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.699 1.6 . . . . 0.0 112.062 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 160.77 38.19 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.27 147.07 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.918 1.287 . . . . 0.0 109.07 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -119.63 132.19 24.12 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.65 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.88 -36.15 82.26 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.039 2.493 . . . . 0.0 114.795 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -69.57 -33.15 72.32 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.017 -1.052 . . . . 0.0 112.096 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 -13.44 61.14 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.044 -1.035 . . . . 0.0 113.21 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.07 -57.33 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.37 78.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -169.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mmt -68.46 -8.5 41.43 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.3 mmt -123.15 -27.25 4.2 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 -169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.87 -27.59 68.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.173 -0.954 . . . . 0.0 111.891 169.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.29 -8.13 53.22 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.332 1.053 . . . . 0.0 113.408 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.61 -0.46 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.516 2.326 . . . . 0.0 110.772 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.54 14.44 78.22 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.276 1.417 . . . . 0.0 114.629 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 mm -92.62 153.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.872 1.269 . . . . 0.0 111.192 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -130.92 139.0 50.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.444 1.498 . . . . 0.0 111.859 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.6 pt -135.58 -6.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.694 1.198 . . . . 0.0 112.49 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -58.35 -34.41 70.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.583 1.553 . . . . 0.0 114.526 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.69 -3.82 89.32 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.474 1.035 . . . . 0.0 115.295 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -81.71 154.84 25.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.961 1.381 . . . . 0.0 113.424 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -130.42 178.06 6.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.83 2.052 . . . . 0.0 110.681 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.7 t -148.73 158.58 44.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.121 -0.987 . . . . 0.0 112.444 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -152.04 158.1 33.92 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.687 1.995 . . . . 0.0 109.284 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.03 140.89 95.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.344 2.696 . . . . 0.0 112.474 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -60.11 -29.62 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.54 -12.04 60.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -21.42 59.22 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.252 -0.905 . . . . 0.0 112.735 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 166.25 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.359 . . . . 0.0 112.523 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.89 107.05 14.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.485 1.514 . . . . 0.0 111.086 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.38 -16.18 53.11 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.874 -1.141 . . . . 0.0 113.799 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -59.26 -18.83 40.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.572 1.549 . . . . 0.0 113.063 176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.18 -0.51 28.41 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.463 1.905 . . . . 0.0 112.877 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -123.61 76.62 1.43 Allowed 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.831 1.652 . . . . 0.0 109.894 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.56 -23.75 11.61 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.661 1.984 . . . . 0.0 113.256 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.54 131.46 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.193 1.397 . . . . 0.0 109.329 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.62 126.35 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.876 -1.14 . . . . 0.0 110.391 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.07 119.69 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.364 1.465 . . . . 0.0 108.206 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 t -83.43 151.06 25.67 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.781 1.633 . . . . 0.0 110.112 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.05 38.25 4.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.129 -0.982 . . . . 0.0 111.765 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 98.7 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -169.768 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.83 131.87 12.69 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.599 1.16 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.97 148.28 89.51 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.762 2.308 . . . . 0.0 110.126 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.18 -29.55 83.95 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.657 2.905 . . . . 0.0 115.483 -169.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -63.84 -20.96 66.2 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.487 -1.383 . . . . 0.0 114.014 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -81.76 -15.42 54.34 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.401 -1.437 . . . . 0.0 114.526 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.22 -21.25 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.851 1.261 . . . . 0.0 113.524 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 t -84.56 13.37 5.67 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.974 1.71 . . . . 0.0 113.568 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -67.8 164.54 19.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 112.786 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.31 -34.85 78.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.6 mt -133.5 126.59 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 110.072 169.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.08 148.07 48.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.931 1.292 . . . . 0.0 110.79 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -141.53 162.34 35.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.519 1.128 . . . . 0.0 112.402 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.68 130.81 32.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 108.749 168.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -108.28 135.26 49.89 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.399 1.479 . . . . 0.0 111.014 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -93.81 44.24 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.18 1.392 . . . . 0.0 110.92 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.19 150.92 24.06 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.659 1.583 . . . . 0.0 112.651 -173.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.92 165.16 13.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.889 1.276 . . . . 0.0 110.477 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.1 134.23 19.9 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.853 -0.529 . . . . 0.0 112.168 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 CA--C 1.544 1.0 0 C-N-CA 121.866 1.71 . . . . 0.0 113.187 176.691 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.12 -33.12 74.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.919 0.887 . . . . 0.0 111.476 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.44 -34.89 79.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.726 -0.609 . . . . 0.0 111.198 169.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.8 t -69.53 -42.47 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 117.805 -1.093 . . . . 0.0 111.85 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -55.65 -48.9 74.22 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.951 1.705 . . . . 0.0 111.195 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -69.74 -19.31 63.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -84.36 -50.41 7.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 0.0 112.024 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.0 t -70.8 -30.97 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.588 1.155 . . . . 0.0 111.812 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -55.04 -42.26 72.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.274 0.943 . . . . 0.0 112.784 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.4 65.36 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.728 0.68 . . . . 0.0 112.849 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -68.57 -48.39 64.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.167 0.983 . . . . 0.0 109.681 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.15 -41.41 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.538 -0.726 . . . . 0.0 111.093 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.21 -50.11 73.89 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.096 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -70.82 -29.41 65.56 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.514 1.506 . . . . 0.0 113.335 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -63.48 -52.72 60.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 172.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.17 -50.84 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.138 1.375 . . . . 0.0 112.219 170.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.7 -49.99 70.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.847 1.203 . . . . 0.0 112.499 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -30.19 68.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.442 0.564 . . . . 0.0 112.142 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.15 -52.59 32.94 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.676 0.79 . . . . 0.0 110.876 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.8 -37.47 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.958 -1.089 . . . . 0.0 111.83 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.06 -26.48 68.86 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -87.78 -23.41 24.09 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -101.85 -20.09 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.254 1.338 0 C-N-CA 124.857 1.263 . . . . 0.0 113.829 -170.361 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -79.61 136.54 36.87 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.097 0.959 . . . . 0.0 112.419 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.33 128.17 53.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.643 1.177 . . . . 0.0 111.556 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.15 111.78 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.488 1.915 . . . . 0.0 110.319 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -92.8 122.45 35.2 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 169.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -93.31 114.91 27.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.998 0.519 . . . . 0.0 109.923 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.84 144.43 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.06 1.344 . . . . 0.0 111.985 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.541 0.624 0 O-C-N 121.274 -0.891 . . . . 0.0 112.855 176.215 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 119.627 -0.225 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -62.44 -46.53 88.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.863 1.265 . . . . 0.0 111.695 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.38 -33.93 67.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.394 0.678 . . . . 0.0 111.805 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -37.68 64.87 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.086 -1.009 . . . . 0.0 113.337 169.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -45.41 90.09 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.114 0.87 . . . . 0.0 110.919 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -57.92 -46.85 84.36 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.058 169.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.42 -49.19 46.26 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.826 1.194 . . . . 0.0 115.405 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -72.64 -36.11 67.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.024 1.412 . . . . 0.0 111.619 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.82 73.23 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -69.02 -26.36 64.95 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.582 1.537 . . . . 0.0 112.504 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.2 m -84.51 -44.93 13.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.08 0.952 . . . . 0.0 111.669 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -95.59 -32.36 12.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.27 1.028 . . . . 0.0 113.308 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 5.76 79.78 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 125.87 1.7 . . . . 0.0 113.351 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 115.42 1.1 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.318 1.059 . . . . 0.0 111.862 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.44 80.26 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 115.821 1.089 . . . . 0.0 115.821 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -119.55 -34.42 3.8 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.238 1.519 . . . . 0.0 111.906 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -149.88 166.96 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.739 2.016 . . . . 0.0 111.623 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.19 152.07 19.44 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -144.69 145.2 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.023 1.283 . . . . 0.0 113.858 -175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -144.55 154.38 42.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.38 1.872 . . . . 0.0 110.001 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.8 p -118.76 152.27 36.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.594 1.088 . . . . 0.0 113.421 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 t -149.66 150.71 32.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.255 1.422 . . . . 0.0 111.012 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.62 18.12 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.2 mt -53.13 -40.8 64.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.668 1.734 . . . . 0.0 112.199 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -122.21 37.03 4.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.932 1.693 . . . . 0.0 111.074 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 72.97 151.5 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.272 2.229 . . . . 0.0 115.094 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -132.01 -169.34 2.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.195 1.798 . . . . 0.0 111.424 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.24 178.81 7.31 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.95 116.47 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.519 1.928 . . . . 0.0 109.25 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.8 148.91 52.51 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 118.673 -0.679 . . . . 0.0 112.065 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.28 -37.65 88.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.359 2.706 . . . . 0.0 113.892 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -65.48 -33.35 75.73 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.027 -1.046 . . . . 0.0 112.018 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.51 -10.74 59.85 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.4 mt -83.9 -53.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.17 68.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.86 -8.14 54.15 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 mmt -126.08 -27.35 3.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.284 1.033 . . . . 0.0 112.555 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.05 -25.13 67.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.787 -1.196 . . . . 0.0 111.985 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.39 -13.82 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.375 1.07 . . . . 0.0 113.544 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.28 18.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.422 1.489 . . . . 0.0 111.557 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.59 76.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.741 1.639 . . . . 0.0 116.611 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.2 mm -75.51 145.15 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.537 1.669 . . . . 0.0 111.6 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -133.77 97.92 4.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.641 1.576 . . . . 0.0 110.887 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 pt -132.75 11.93 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -58.47 -30.54 67.05 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.806 1.243 . . . . 0.0 113.333 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.43 -1.08 75.35 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.907 1.241 . . . . 0.0 115.348 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -74.76 140.13 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.703 1.751 . . . . 0.0 112.375 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.6 p -114.78 172.6 6.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.547 1.939 . . . . 0.0 110.343 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -145.44 158.71 43.79 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.304 -0.872 . . . . 0.0 111.783 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -150.03 157.59 37.53 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.779 1.632 . . . . 0.0 110.569 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.72 142.92 91.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.62 2.88 . . . . 0.0 113.098 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.88 -31.09 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -67.14 -13.22 61.74 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -21.02 57.16 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 112.916 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -94.62 166.85 11.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.878 1.271 . . . . 0.0 112.691 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.3 107.64 15.52 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 111.126 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.87 -21.4 66.46 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.57 -27.41 68.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.179 0.991 . . . . 0.0 112.487 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.16 -3.85 59.05 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.939 1.696 . . . . 0.0 112.187 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.15 80.32 1.44 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 127.119 2.168 . . . . 0.0 108.556 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.37 -27.65 10.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.767 1.627 . . . . 0.0 112.942 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.59 127.54 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.184 1.794 . . . . 0.0 108.835 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.82 124.65 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.15 -0.969 . . . . 0.0 109.251 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.17 124.25 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.417 1.087 . . . . 0.0 109.215 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -99.59 154.07 18.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.572 1.149 . . . . 0.0 111.938 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.87 35.15 3.79 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.111 1.364 . . . . 0.0 111.764 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.171 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.1 mt -142.51 139.93 18.11 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.62 1.168 . . . . 0.0 112.75 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.32 153.81 72.05 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.448 2.098 . . . . 0.0 110.167 168.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.86 -22.45 73.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.089 2.526 . . . . 0.0 115.167 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.99 -15.0 62.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -92.08 -1.56 57.13 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.78 10.62 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 125.887 1.675 . . . . 0.0 113.894 -175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -112.52 -2.62 14.59 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.399 1.88 . . . . 0.0 112.826 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -56.72 160.4 3.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.551 2.74 . . . . 0.0 113.95 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.84 -32.59 74.2 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.65 127.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.146 0.978 . . . . 0.0 110.513 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -139.38 141.33 37.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.247 1.419 . . . . 0.0 111.624 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -157.3 161.64 39.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 110.665 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.44 134.01 52.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 111.8 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -108.78 163.35 13.35 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.202 1.801 . . . . 0.0 112.104 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -130.33 62.14 1.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.856 1.262 . . . . 0.0 112.337 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.55 167.21 20.37 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.542 1.537 . . . . 0.0 111.418 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -117.52 158.83 23.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.967 1.307 . . . . 0.0 110.397 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -98.35 120.72 58.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 CA--C 1.542 0.885 0 C-N-CA 123.061 2.507 . . . . 0.0 114.094 -178.927 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.8 t . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.108 0.48 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.9 -25.09 67.36 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.996 0.918 . . . . 0.0 111.692 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.44 -31.97 73.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.887 -1.133 . . . . 0.0 111.729 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.1 t -72.73 -39.0 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.901 -1.125 . . . . 0.0 110.193 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -56.53 -49.33 75.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.687 1.131 . . . . 0.0 111.15 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -70.67 -17.05 62.85 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -83.07 -51.4 7.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.063 1.345 . . . . 0.0 111.967 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.35 -34.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.748 1.219 . . . . 0.0 111.484 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -57.12 -39.5 75.24 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.101 0.864 . . . . 0.0 112.728 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.12 -32.26 69.23 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.988 0.804 . . . . 0.0 112.935 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -71.78 -39.76 69.71 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.476 1.138 . . . . 0.0 110.967 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.38 -50.93 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.63 0.772 . . . . 0.0 110.552 170.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -54.08 -48.01 71.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 112.367 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -68.32 -26.66 65.73 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 120.984 1.72 . . . . 0.0 112.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -75.54 -47.69 25.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.904 0.882 . . . . 0.0 111.8 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.19 -36.5 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.8 0.727 . . . . 0.0 112.252 169.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -61.78 -47.26 85.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.9 1.227 . . . . 0.0 111.833 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -40.16 95.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.46 0.573 . . . . 0.0 111.106 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.485 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -58.74 -48.21 81.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.801 0.84 . . . . 0.0 111.388 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -73.13 -47.95 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.34 -25.42 68.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.9 pttt -87.68 -7.49 57.35 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.13 -18.36 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.0 p . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.135 1.374 . . . . 0.0 113.617 178.238 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -71.18 141.45 50.69 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.403 1.081 . . . . 0.0 111.221 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.96 128.57 55.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.072 0.949 . . . . 0.0 111.769 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.4 t -99.64 110.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.624 1.57 . . . . 0.0 110.161 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 tpp -90.65 124.07 34.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.181 0.446 . . . . 0.0 110.475 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.3 123.57 39.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.832 0.853 . . . . 0.0 109.918 169.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 m -118.98 134.51 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.08 0.855 . . . . 0.0 112.623 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t . . . . . 0 CA--C 1.55 0.944 0 C-N-CA 125.121 1.368 . . . . 0.0 110.43 174.528 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 p -70.28 -43.69 69.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.119 1.327 . . . . 0.0 112.119 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.38 -34.3 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.456 0.703 . . . . 0.0 111.634 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 tpt -74.93 -38.37 61.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.07 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.13 87.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.431 0.559 . . . . 0.0 111.495 169.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -58.84 -40.85 85.44 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.349 -0.844 . . . . 0.0 111.824 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.97 -48.82 83.93 Favored Glycine 0 N--CA 1.474 1.228 0 CA-C-N 119.433 1.015 . . . . 0.0 113.784 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -66.28 -40.01 89.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.073 -1.251 . . . . 0.0 111.365 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.12 85.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -68.77 -28.95 67.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.168 1.349 . . . . 0.0 112.641 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 m -78.42 -44.47 24.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.693 0.797 . . . . 0.0 111.773 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.5 mt -96.99 -31.77 12.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.973 0.909 . . . . 0.0 113.216 -171.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.13 7.03 72.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.821 1.677 . . . . 0.0 113.602 169.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.51 118.73 2.35 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.514 1.157 . . . . 0.0 112.024 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.35 11.61 85.14 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -116.9 -40.63 3.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.721 1.76 . . . . 0.0 112.377 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -150.51 162.65 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.784 1.633 . . . . 0.0 111.644 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.56 150.18 21.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.49 148.43 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.139 -0.975 . . . . 0.0 112.634 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -150.86 154.35 37.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.362 1.465 . . . . 0.0 109.248 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.3 p -127.49 155.01 44.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.6 t -155.78 167.12 31.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.585 1.554 . . . . 0.0 110.234 -170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.96 159.31 26.96 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.242 -0.911 . . . . 0.0 112.332 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -62.0 -38.26 87.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.324 1.062 . . . . 0.0 111.9 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.78 44.4 2.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.699 2.0 . . . . 0.0 108.756 170.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 t 66.5 176.96 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.15 1.78 . . . . 0.0 113.394 -169.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 94.9 p -146.23 -175.14 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.975 2.11 . . . . 0.0 110.423 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -145.78 172.64 13.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.13 141.75 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.758 1.623 . . . . 0.0 108.197 168.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -123.47 129.11 25.0 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.594 -171.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.68 -38.44 84.52 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.216 2.611 . . . . 0.0 115.381 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -63.74 -36.43 83.85 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.856 -0.528 . . . . 0.0 111.533 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.23 85.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.157 0.89 . . . . 0.0 111.171 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.5 mt -53.57 -51.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.36 79.37 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.1 mmt -67.09 -23.35 65.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 mmt -106.68 -18.93 13.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -61.32 -29.25 69.76 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.482 -1.386 . . . . 0.0 112.497 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -6.85 49.37 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.057 0.943 . . . . 0.0 113.302 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.8 0.49 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 126.943 2.097 . . . . 0.0 110.508 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 14.38 79.9 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.204 1.383 . . . . 0.0 114.629 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 mm -88.89 157.3 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.1 1.36 . . . . 0.0 110.619 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.87 143.26 49.4 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.463 1.105 . . . . 0.0 112.188 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.74 4.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.088 1.755 . . . . 0.0 112.106 168.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.4 p -63.2 -30.56 71.68 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.48 -4.14 73.94 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.76 1.171 . . . . 0.0 115.565 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -87.73 148.81 24.58 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.304 1.552 . . . . 0.0 113.043 -174.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.2 t -144.42 172.63 12.68 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.362 1.865 . . . . 0.0 109.951 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 t -133.31 167.19 20.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.929 1.292 . . . . 0.0 112.867 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -146.11 157.89 49.17 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.427 1.491 . . . . 0.0 111.034 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 134.97 65.52 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.723 2.948 . . . . 0.0 112.828 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -57.48 -32.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -169.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.93 -9.16 54.04 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.79 59.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 121.365 -0.835 . . . . 0.0 112.9 170.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.95 167.78 11.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 113.219 -175.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.02 112.19 22.27 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.595 1.558 . . . . 0.0 111.056 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.15 -15.55 63.78 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.455 -1.403 . . . . 0.0 113.529 -175.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.9 -20.44 23.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.845 1.258 . . . . 0.0 113.191 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.72 -0.39 34.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.596 1.959 . . . . 0.0 113.053 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.5 77.03 1.61 Allowed 'General case' 0 C--N 1.346 0.428 0 C-N-CA 125.97 1.708 . . . . 0.0 109.739 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.29 -23.56 15.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.831 2.052 . . . . 0.0 113.252 -177.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.66 127.76 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.313 1.445 . . . . 0.0 108.8 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.0 t -136.18 124.87 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.01 -1.056 . . . . 0.0 111.055 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.36 121.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.559 1.544 . . . . 0.0 108.612 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -87.29 137.99 31.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.672 1.189 . . . . 0.0 111.449 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.85 11.7 20.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.505 1.122 . . . . 0.0 112.735 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m . . . . . 0 CA--C 1.55 0.969 0 C-N-CA 125.622 1.569 . . . . 0.0 112.537 169.909 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -141.68 137.67 16.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.22 1.008 . . . . 0.0 112.454 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.46 151.35 80.32 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.541 2.16 . . . . 0.0 110.032 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.67 -31.28 94.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.084 2.523 . . . . 0.0 114.672 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.89 -23.81 66.55 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.862 -1.148 . . . . 0.0 113.756 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -83.87 -9.72 58.54 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.47 -1.394 . . . . 0.0 114.686 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.1 m -117.04 -21.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.19 1.396 . . . . 0.0 113.569 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -83.55 14.29 3.89 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.154 1.782 . . . . 0.0 113.562 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -71.69 168.21 18.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.88 1.672 . . . . 0.0 113.078 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.84 -35.97 82.84 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.503 -0.748 . . . . 0.0 112.747 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.68 125.98 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.761 0.709 . . . . 0.0 110.731 170.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -122.18 144.43 48.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.742 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -133.82 154.36 51.08 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.272 1.029 . . . . 0.0 112.463 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.15 125.08 34.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.073 0.949 . . . . 0.0 110.523 169.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -110.99 150.74 28.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.775 1.63 . . . . 0.0 110.354 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -119.57 47.1 1.77 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.18 1.792 . . . . 0.0 108.253 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -96.71 126.9 42.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.058 2.143 . . . . 0.0 112.303 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -84.26 147.61 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.159 1.784 . . . . 0.0 112.556 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.06 123.31 69.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.286 1.434 . . . . 0.0 112.066 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 122.946 2.431 . . . . 0.0 114.482 -175.061 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 120.957 0.408 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.62 -20.13 64.47 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 0.0 112.137 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.43 -31.58 72.74 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.012 -1.055 . . . . 0.0 110.218 168.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 t -72.62 -38.64 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.425 175.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.53 -49.14 73.41 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.164 1.347 . . . . 0.0 110.848 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.84 -15.86 63.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 m -87.12 -41.46 13.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.557 1.543 . . . . 0.0 112.744 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.05 -40.06 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.13 -1.606 . . . . 0.0 111.311 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -57.79 -42.2 83.68 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.53 65.82 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 123.701 0.667 . . . . 0.0 112.388 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -69.15 -39.07 79.02 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.596 -0.943 . . . . 0.0 111.879 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.46 -49.19 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.392 0.677 . . . . 0.0 110.388 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -56.96 -48.01 79.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.047 1.339 . . . . 0.0 112.725 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -68.26 -27.97 66.8 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.766 1.621 . . . . 0.0 112.33 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -71.35 -50.47 31.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.95 0.9 . . . . 0.0 111.567 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.2 m -59.83 -43.27 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.373 0.988 . . . . 0.0 112.6 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.07 -51.66 63.05 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 120.161 1.346 . . . . 0.0 112.393 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.667 0.667 . . . . 0.0 111.728 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.48 -48.03 76.76 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.24 0.616 . . . . 0.0 111.304 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.96 -43.93 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.924 0.784 . . . . 0.0 110.747 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.6 -25.8 66.79 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.19 -16.78 54.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -107.59 -26.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.252 1.421 . . . . 0.0 112.051 -179.862 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.819 -0.134 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -70.45 142.28 51.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.39 1.076 . . . . 0.0 111.809 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -110.92 129.34 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.478 1.111 . . . . 0.0 111.351 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.9 t -99.63 114.96 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.292 1.837 . . . . 0.0 110.085 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.6 tpp -94.85 128.46 41.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.434 0.561 . . . . 0.0 110.369 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -100.28 113.41 26.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.156 0.982 . . . . 0.0 110.591 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.44 137.59 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 p . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 110.944 171.523 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.4 p -71.2 -59.93 2.51 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -73.63 -26.75 60.92 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.637 -0.664 . . . . 0.0 111.859 -172.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.15 -37.41 69.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.22 95.4 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.609 0.641 . . . . 0.0 111.188 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -57.95 -43.97 86.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.115 0.87 . . . . 0.0 111.684 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.39 -50.98 60.47 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.409 1.004 . . . . 0.0 113.556 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -68.8 -40.82 79.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.208 -1.172 . . . . 0.0 111.705 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.39 95.67 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -71.46 -28.46 63.97 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.242 0.928 . . . . 0.0 112.386 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 m -79.18 -42.55 25.82 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.358 0.663 . . . . 0.0 111.77 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -90.14 -32.95 16.43 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.889 0.876 . . . . 0.0 112.716 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 10.66 68.22 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.885 1.707 . . . . 0.0 113.906 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.29 119.18 2.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.491 1.146 . . . . 0.0 111.615 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.98 13.22 83.91 Favored Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -120.2 -41.72 2.61 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.284 1.542 . . . . 0.0 111.423 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.59 159.3 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.894 1.677 . . . . 0.0 112.072 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.66 20.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.15 0.98 . . . . 0.0 109.193 169.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -141.64 141.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.009 -1.057 . . . . 0.0 112.925 -173.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 m -146.18 163.71 34.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.397 1.879 . . . . 0.0 109.514 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 p -140.61 153.54 46.1 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.785 -1.197 . . . . 0.0 112.542 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t -151.66 150.51 30.33 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.095 0.958 . . . . 0.0 111.215 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.01 134.35 9.81 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.24 1.4 . . . . 0.0 110.054 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 72.4 mt -50.34 -35.9 29.77 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.281 1.041 . . . . 0.0 112.907 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -118.69 28.95 8.0 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.953 1.701 . . . . 0.0 112.462 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 m 64.63 168.59 0.18 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.402 1.881 . . . . 0.0 114.124 -170.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t -164.33 173.58 12.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.454 1.102 . . . . 0.0 112.179 172.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -133.7 146.89 51.24 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.441 1.496 . . . . 0.0 113.099 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.2 m -64.82 140.23 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.411 0.624 . . . . 0.0 111.676 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -103.15 122.36 45.64 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.161 1.384 . . . . 0.0 111.584 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.8 -37.83 77.02 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.466 2.778 . . . . 0.0 115.305 -172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.6 m -64.39 -40.02 95.01 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.629 -0.67 . . . . 0.0 111.384 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.1 97.29 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.135 0.88 . . . . 0.0 111.664 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -54.8 -52.55 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 118.558 0.617 . . . . 0.0 109.554 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.79 82.91 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.6 mmt -67.56 -24.46 65.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.25 1.02 . . . . 0.0 113.198 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mmt -108.69 -19.59 13.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.02 -28.72 69.25 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.541 -1.349 . . . . 0.0 112.563 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.9 -8.31 53.64 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.172 -0.955 . . . . 0.0 113.347 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.85 3.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 127.153 2.181 . . . . 0.0 110.635 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 13.85 82.76 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.385 1.469 . . . . 0.0 114.762 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.3 mm -83.62 147.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 118.557 1.178 . . . . 0.0 111.184 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.74 126.42 52.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.978 1.711 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.86 -5.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 169.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.9 p -62.49 -27.02 68.85 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.09 1.314 . . . . 0.0 114.458 -169.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.54 -6.35 88.68 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.759 1.171 . . . . 0.0 115.476 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -84.7 149.14 26.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.27 1.535 . . . . 0.0 112.644 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 t -144.25 165.64 27.31 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.009 1.724 . . . . 0.0 109.618 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -132.76 144.19 50.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.163 0.985 . . . . 0.0 112.835 -171.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -139.76 159.8 63.55 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.112 1.765 . . . . 0.0 111.413 -171.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.91 138.5 79.34 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.632 2.888 . . . . 0.0 112.537 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.98 -29.49 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.44 -11.26 60.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -18.35 58.83 Favored 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.359 -0.838 . . . . 0.0 112.544 169.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -99.07 170.99 8.31 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.68 1.592 . . . . 0.0 112.238 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.62 113.61 18.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 110.749 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.89 -20.28 65.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -169.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.74 -27.34 68.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.078 0.951 . . . . 0.0 112.376 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.28 -3.22 58.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.133 1.773 . . . . 0.0 112.152 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -116.96 82.11 1.75 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.877 2.071 . . . . 0.0 108.108 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.21 -25.46 9.24 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.182 1.793 . . . . 0.0 113.138 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.69 131.28 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.108 1.763 . . . . 0.0 109.279 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -136.43 120.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 120.992 -1.068 . . . . 0.0 110.721 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.77 120.25 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 108.092 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -88.46 149.24 23.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.015 0.926 . . . . 0.0 110.078 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -123.7 30.78 6.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.127 0.971 . . . . 0.0 111.32 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -169.634 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 121.096 0.474 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.1 mt -74.76 136.57 73.88 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.217 -0.927 . . . . 0.0 112.188 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.68 150.86 86.56 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 122.35 2.033 . . . . 0.0 110.281 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.94 -22.0 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.353 2.702 . . . . 0.0 115.221 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.75 -13.52 61.74 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -91.89 -3.52 55.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.47 14.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.565 1.546 . . . . 0.0 113.425 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -120.65 -0.99 10.11 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.21 1.804 . . . . 0.0 112.996 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -58.29 160.05 5.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.389 2.676 . . . . 0.0 114.138 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -63.81 -34.49 78.02 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.37 122.51 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.93 . . . . 0.0 109.086 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -124.25 146.74 48.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.188 1.395 . . . . 0.0 110.963 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -140.83 159.1 42.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.222 1.009 . . . . 0.0 112.437 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -132.22 117.14 17.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.681 1.192 . . . . 0.0 109.692 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -106.85 153.13 22.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.069 1.348 . . . . 0.0 111.586 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.08 79.86 1.75 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 110.379 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.62 152.46 18.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.024 1.33 . . . . 0.0 111.354 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -84.85 148.16 26.43 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.211 0.605 . . . . 0.0 109.445 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.04 130.73 59.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.556 -0.715 . . . . 0.0 112.143 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 CA--C 1.54 0.782 0 C-N-CA 121.908 1.739 . . . . 0.0 114.216 -177.127 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.9 -26.91 66.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.858 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.88 -39.1 93.41 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.935 -1.103 . . . . 0.0 110.415 169.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.65 -36.69 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.208 0.913 . . . . 0.0 111.587 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -55.42 -45.41 76.72 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.888 1.676 . . . . 0.0 110.529 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -69.46 -19.93 63.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.0 m -79.36 -52.41 8.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.761 1.224 . . . . 0.0 111.718 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.24 -33.34 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.338 1.055 . . . . 0.0 111.317 -172.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -56.67 -39.44 73.78 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.924 0.783 . . . . 0.0 112.765 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.23 65.9 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.079 0.847 . . . . 0.0 112.878 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -69.82 -39.36 76.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.092 0.946 . . . . 0.0 111.166 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.11 -47.57 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.813 0.845 . . . . 0.0 110.966 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -55.25 -47.7 75.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.187 1.395 . . . . 0.0 112.792 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -68.64 -27.46 66.03 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.651 1.568 . . . . 0.0 112.686 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -71.58 -49.44 40.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.064 0.945 . . . . 0.0 111.693 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.9 -41.1 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.947 0.794 . . . . 0.0 112.891 170.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -63.9 -51.69 63.33 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.15 1.341 . . . . 0.0 112.485 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -69.31 -30.14 68.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.914 0.779 . . . . 0.0 112.375 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.88 -49.74 71.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.966 0.907 . . . . 0.0 110.901 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.57 -39.94 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.182 -0.949 . . . . 0.0 110.585 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.27 -26.72 67.96 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -90.77 -18.12 25.48 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -104.37 -16.99 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.649 1.179 . . . . 0.0 112.935 178.785 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.5 2.057 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -71.29 143.48 50.31 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.151 0.98 . . . . 0.0 111.804 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.6 129.36 55.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.363 1.065 . . . . 0.0 111.469 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.45 116.28 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.452 1.901 . . . . 0.0 109.9 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -94.6 125.47 39.27 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 169.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -99.32 113.39 25.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.577 0.751 . . . . 0.0 111.275 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.07 144.06 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.392 1.077 . . . . 0.0 112.69 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 t . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 124.03 0.932 . . . . 0.0 111.583 171.559 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 p -64.5 -52.92 55.42 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.363 0.983 . . . . 0.0 111.213 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -63.49 -39.04 93.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.547 1.139 . . . . 0.0 111.643 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.2 tpt -77.25 -35.2 55.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.903 0.881 . . . . 0.0 112.312 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.48 95.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.459 0.572 . . . . 0.0 110.736 169.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.35 -43.81 98.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.933 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.56 -48.02 73.36 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.666 1.121 . . . . 0.0 113.705 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -66.44 -44.23 83.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.129 0.964 . . . . 0.0 111.739 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.36 75.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -27.67 64.09 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.423 1.011 . . . . 0.0 112.584 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 m -88.71 -41.65 12.45 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.908 0.883 . . . . 0.0 112.548 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.58 -34.63 14.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.7 0.8 . . . . 0.0 112.617 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.34 8.55 64.05 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.598 1.57 . . . . 0.0 113.696 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.36 117.85 1.94 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.341 1.071 . . . . 0.0 112.0 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.72 13.91 82.6 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -119.19 -40.14 2.85 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.165 1.482 . . . . 0.0 111.847 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.11 160.01 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.355 1.862 . . . . 0.0 110.998 171.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 150.86 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.466 0.707 . . . . 0.0 109.469 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -141.23 140.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.223 -0.923 . . . . 0.0 112.531 -173.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -144.4 159.49 42.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.205 1.802 . . . . 0.0 109.051 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.9 p -133.72 158.83 42.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 113.46 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.1 t -148.1 146.15 28.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.98 1.312 . . . . 0.0 111.192 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.01 139.25 15.17 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.5 mt -52.8 -42.96 65.57 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.019 1.909 . . . . 0.0 113.002 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.4 38.95 3.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.28 1.432 . . . . 0.0 110.89 171.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t 69.58 171.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.068 2.147 . . . . 0.0 114.302 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 t -157.91 -169.1 2.71 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.284 1.833 . . . . 0.0 110.038 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 167.7 21.58 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.87 166.49 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.402 1.081 . . . . 0.0 109.159 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -138.11 126.94 14.51 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.432 -1.418 . . . . 0.0 111.626 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.61 -40.22 85.96 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.926 2.417 . . . . 0.0 114.304 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.91 -34.3 77.81 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.243 -0.91 . . . . 0.0 111.273 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 -2.74 23.43 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.371 -1.456 . . . . 0.0 114.154 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -87.43 -54.78 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 167.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -28.85 61.65 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 73.2 mmm -78.27 -6.01 53.72 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.326 -0.859 . . . . 0.0 113.205 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.3 mmt -120.33 -26.36 5.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.71 1.204 . . . . 0.0 111.815 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.13 -20.52 65.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 112.439 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.07 -11.15 60.62 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 171.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 t -107.98 5.88 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 127.092 2.157 . . . . 0.0 110.622 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.07 14.04 82.63 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.561 -1.337 . . . . 0.0 114.396 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.21 154.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.999 1.32 . . . . 0.0 110.27 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.18 149.12 41.02 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.291 1.037 . . . . 0.0 110.957 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.3 pt -133.78 -2.1 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.171 1.789 . . . . 0.0 113.122 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -54.66 -37.91 66.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.598 1.159 . . . . 0.0 113.836 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.32 -1.2 90.37 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 116.145 1.218 . . . . 0.0 116.145 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -76.61 160.77 29.12 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.748 1.774 . . . . 0.0 113.319 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 57.9 p -135.24 167.52 20.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.713 2.005 . . . . 0.0 110.484 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 t -144.18 158.83 43.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.535 1.134 . . . . 0.0 111.376 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -150.95 163.71 22.77 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 126.352 1.861 . . . . 0.0 110.177 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -60.49 146.22 97.27 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.5 2.8 . . . . 0.0 113.566 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.16 -32.31 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.076 0.95 . . . . 0.0 113.486 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.46 -13.76 61.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -21.19 46.61 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.332 0.969 . . . . 0.0 113.354 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.77 169.46 10.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.054 1.342 . . . . 0.0 112.825 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.0 108.41 15.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 110.892 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.3 65.94 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -169.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.68 -24.89 67.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.028 0.931 . . . . 0.0 112.533 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.57 -2.01 58.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.456 1.902 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.89 82.05 1.74 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.946 2.098 . . . . 0.0 108.11 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.35 -28.19 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.765 1.626 . . . . 0.0 113.004 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -130.15 130.29 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.893 1.677 . . . . 0.0 108.627 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -131.49 126.51 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.095 -1.003 . . . . 0.0 109.262 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.3 mm -126.72 133.92 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.697 1.199 . . . . 0.0 109.214 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.2 t -109.01 148.67 30.41 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.969 1.308 . . . . 0.0 112.098 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.21 55.55 1.66 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.974 1.31 . . . . 0.0 109.677 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -169.601 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.8 mt -141.74 140.28 19.82 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.386 1.074 . . . . 0.0 112.443 -175.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 151.5 82.51 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.252 1.968 . . . . 0.0 110.286 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.44 -26.91 79.93 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 115.535 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -89.16 -3.05 58.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.58 18.0 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.295 1.438 . . . . 0.0 113.352 -173.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -122.29 -0.7 9.3 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.402 1.881 . . . . 0.0 112.87 -172.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -57.24 163.62 2.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.861 2.864 . . . . 0.0 113.987 174.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.09 -34.79 78.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -131.62 127.46 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.906 0.883 . . . . 0.0 111.037 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -137.28 140.3 41.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.492 1.517 . . . . 0.0 111.333 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -156.57 156.38 33.49 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.116 1.366 . . . . 0.0 111.006 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -113.78 142.85 45.55 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.876 1.27 . . . . 0.0 110.954 170.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -110.82 142.28 43.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.964 1.705 . . . . 0.0 111.572 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -104.73 59.59 0.7 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.957 1.703 . . . . 0.0 107.29 -169.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.02 132.0 53.44 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.422 1.889 . . . . 0.0 112.002 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -88.65 163.26 15.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.748 1.619 . . . . 0.0 112.869 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.66 138.82 37.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 122.1 -0.375 . . . . 0.0 111.136 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 CA--C 1.54 0.776 0 C-N-CA 122.342 2.028 . . . . 0.0 114.46 174.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.479 0.975 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.07 -27.7 68.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.148 0.979 . . . . 0.0 112.455 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.6 -25.83 61.47 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.692 -1.255 . . . . 0.0 111.85 169.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 71.3 t -75.37 -33.38 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.876 -1.14 . . . . 0.0 109.866 169.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.37 -44.63 92.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.035 1.743 . . . . 0.0 109.594 168.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.2 m -76.8 -54.03 7.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.487 0.715 . . . . 0.0 111.461 170.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.98 -34.8 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 0.0 111.344 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -57.85 -44.53 86.62 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 112.255 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.41 -29.65 67.9 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.691 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -67.55 -51.07 55.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.38 1.09 . . . . 0.0 110.256 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.6 t -57.44 -43.66 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.521 -0.737 . . . . 0.0 110.857 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.25 -48.65 73.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.709 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -72.8 -29.79 63.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.132 1.333 . . . . 0.0 113.504 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -63.74 -52.23 61.39 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.075 0.852 . . . . 0.0 109.937 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.49 -42.99 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.021 1.328 . . . . 0.0 112.546 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -61.69 -45.97 91.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.976 1.262 . . . . 0.0 111.633 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -38.39 89.22 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.535 0.607 . . . . 0.0 111.302 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.474 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -58.96 -51.13 71.39 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.898 0.879 . . . . 0.0 110.928 174.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.0 -44.3 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.651 0.66 . . . . 0.0 111.032 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.96 -23.52 66.44 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.6 pttt -94.17 -6.87 43.83 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -122.15 -17.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.168 1.787 . . . . 0.0 112.339 -178.822 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 111.244 0.091 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -69.1 133.49 48.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.835 1.254 . . . . 0.0 112.141 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -103.82 123.47 47.15 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.19 0.996 . . . . 0.0 111.129 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 111.0 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 126.104 1.762 . . . . 0.0 109.897 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.1 tpp -90.67 129.65 36.75 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.684 0.393 . . . . 0.0 110.091 168.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -100.0 124.67 45.62 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.727 0.811 . . . . 0.0 109.731 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.95 143.05 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.701 1.2 . . . . 0.0 112.525 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.4 t . . . . . 0 CA--C 1.544 0.75 0 C-N-CA 124.738 1.215 . . . . 0.0 110.369 175.611 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 . . . . . 0 C--O 1.216 -0.709 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -63.59 -52.96 58.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.788 1.235 . . . . 0.0 112.217 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -67.08 -34.89 78.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.272 0.629 . . . . 0.0 111.466 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.91 71.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.058 0.543 . . . . 0.0 112.313 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.71 86.67 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.508 -0.745 . . . . 0.0 112.698 173.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.15 -40.68 77.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.921 0.782 . . . . 0.0 111.896 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.27 -53.54 43.99 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-N 119.188 0.904 . . . . 0.0 112.961 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -65.97 -40.97 91.71 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.243 -1.151 . . . . 0.0 111.881 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.81 94.27 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -76.41 -29.05 56.89 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.53 1.059 . . . . 0.0 112.624 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m -77.5 -43.57 31.71 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 0.0 111.647 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.51 -33.12 13.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.67 0.788 . . . . 0.0 112.491 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.5 11.82 57.6 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.671 1.605 . . . . 0.0 113.221 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.11 122.77 5.49 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.433 1.116 . . . . 0.0 111.551 171.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.01 8.8 87.3 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 116.029 1.172 . . . . 0.0 116.029 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -118.68 -31.04 4.96 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.649 1.724 . . . . 0.0 112.998 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.13 156.52 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 112.248 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.73 144.73 25.02 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.98 138.64 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.451 1.478 . . . . 0.0 113.487 -169.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 m -149.43 161.5 41.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.577 1.551 . . . . 0.0 110.274 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 p -137.4 150.62 47.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.314 1.054 . . . . 0.0 113.759 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 t -145.43 157.93 43.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.435 1.894 . . . . 0.0 110.099 -169.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.15 146.03 18.08 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.462 -0.774 . . . . 0.0 111.614 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -58.52 -42.68 88.26 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.976 0.888 . . . . 0.0 110.728 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.91 40.44 1.81 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.352 1.461 . . . . 0.0 111.287 173.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 t 65.17 178.56 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.407 1.883 . . . . 0.0 114.417 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -152.99 165.61 35.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 112.453 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.61 -179.82 6.54 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.76 -173.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.75 113.61 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.065 0.946 . . . . 0.0 110.186 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.73 143.92 44.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.458 1.103 . . . . 0.0 110.993 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.87 -37.12 76.8 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.354 2.703 . . . . 0.0 113.857 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -61.21 -39.63 90.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.63 0.772 . . . . 0.0 112.17 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -13.21 60.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.8 mt -78.19 -53.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.43 64.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.8 mmt -70.47 -12.06 61.32 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 mmt -121.9 -28.64 4.42 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.269 1.028 . . . . 0.0 112.603 -169.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.35 -24.72 67.97 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.724 -1.235 . . . . 0.0 112.568 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.22 -10.73 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 11.5 p -121.38 26.2 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.188 1.795 . . . . 0.0 110.397 169.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.66 9.31 86.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.014 1.768 . . . . 0.0 116.774 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.06 147.76 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 118.84 1.32 . . . . 0.0 111.915 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.78 127.87 54.76 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.696 1.598 . . . . 0.0 111.506 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.0 pt -138.04 -6.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 p -64.19 -27.52 69.12 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.73 -1.231 . . . . 0.0 114.318 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.56 -6.72 89.16 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.594 1.092 . . . . 0.0 115.211 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -83.64 152.25 24.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.195 1.497 . . . . 0.0 113.116 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -145.32 177.62 8.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.481 1.912 . . . . 0.0 108.819 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -152.68 174.88 13.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.487 1.04 . . . . 0.0 113.765 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.87 163.14 28.62 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.937 2.095 . . . . 0.0 110.159 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.15 142.42 94.4 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.458 2.772 . . . . 0.0 113.247 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.97 -35.09 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.41 -11.81 60.22 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 CA--C 1.553 1.085 0 O-C-N 121.25 -0.906 . . . . 0.0 113.117 172.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -94.14 169.18 10.44 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.987 1.315 . . . . 0.0 112.832 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.23 107.47 12.59 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.411 1.484 . . . . 0.0 111.725 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.44 -20.16 65.47 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.42 -24.99 68.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.793 1.237 . . . . 0.0 112.895 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.74 -4.11 56.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.084 1.754 . . . . 0.0 112.106 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -114.7 82.97 1.81 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.452 1.901 . . . . 0.0 108.114 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -51.15 -26.9 7.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.857 1.663 . . . . 0.0 113.364 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -134.25 133.25 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.722 1.609 . . . . 0.0 109.287 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.62 121.19 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.866 -1.146 . . . . 0.0 110.91 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.08 124.19 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 108.522 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 t -91.19 152.29 20.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.666 1.586 . . . . 0.0 110.957 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.77 52.32 2.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.005 1.322 . . . . 0.0 110.028 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.84 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 121.359 0.6 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.52 139.01 41.11 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.926 0.891 . . . . 0.0 112.996 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -63.29 152.69 78.61 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.301 2.0 . . . . 0.0 109.662 168.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.18 -22.1 73.61 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.218 2.612 . . . . 0.0 115.384 -169.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.54 -14.29 61.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -91.92 -1.43 57.29 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.8 14.76 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.904 1.682 . . . . 0.0 113.757 -174.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -118.89 -0.96 11.1 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.246 1.819 . . . . 0.0 112.877 -171.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -59.8 161.44 6.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.251 2.62 . . . . 0.0 113.897 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.03 -33.93 76.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.5 mt -132.9 127.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.791 0.836 . . . . 0.0 110.394 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -130.03 149.26 51.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.178 1.391 . . . . 0.0 111.568 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -144.83 161.12 40.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.758 1.223 . . . . 0.0 112.182 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.21 128.54 26.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 167.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -106.86 146.81 30.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.368 1.467 . . . . 0.0 111.379 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -107.83 59.3 0.62 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.4 1.88 . . . . 0.0 106.864 -173.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.56 117.32 33.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.493 1.917 . . . . 0.0 112.335 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.89 159.47 32.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.823 1.296 . . . . 0.0 113.64 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.21 118.8 70.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 126.568 1.947 . . . . 0.0 113.113 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 C-N-CA 121.887 1.725 . . . . 0.0 113.385 175.01 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.015 0.436 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.78 -30.03 71.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.833 1.253 . . . . 0.0 111.542 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -72.73 -23.8 60.89 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.741 -1.225 . . . . 0.0 112.301 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.94 -35.9 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.958 -1.089 . . . . 0.0 109.961 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.95 -47.63 84.38 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.656 1.571 . . . . 0.0 110.593 169.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -65.87 -21.85 66.49 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -80.03 -53.96 6.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.608 1.163 . . . . 0.0 111.845 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.79 -32.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.383 1.073 . . . . 0.0 111.343 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -57.17 -39.79 76.01 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.355 0.98 . . . . 0.0 113.016 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.65 -35.43 74.18 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.746 0.688 . . . . 0.0 112.171 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -68.59 -39.15 81.06 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.954 -0.733 . . . . 0.0 111.578 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.02 -49.08 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.637 170.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.13 -47.42 78.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.983 1.313 . . . . 0.0 112.417 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -69.18 -26.79 65.02 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.824 1.647 . . . . 0.0 112.624 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -72.98 -50.07 25.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.913 0.885 . . . . 0.0 111.299 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.79 -42.14 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.213 0.915 . . . . 0.0 112.565 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.24 -51.41 63.79 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.31 1.414 . . . . 0.0 112.464 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -31.97 70.71 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.917 0.781 . . . . 0.0 112.08 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.49 -48.44 75.17 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.425 0.69 . . . . 0.0 111.019 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.5 mt -72.95 -41.02 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.856 -174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.62 -26.25 68.59 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.83 -14.49 44.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.18 -23.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.601 1.56 . . . . 0.0 112.035 -179.478 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.0 tpp . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -70.22 150.67 46.19 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.178 0.899 . . . . 0.0 111.447 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.54 118.08 32.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 110.169 170.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.75 112.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.918 1.687 . . . . 0.0 109.584 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.3 ttm -95.1 122.34 37.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.851 0.75 . . . . 0.0 109.899 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -88.16 127.82 35.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.116 0.566 . . . . 0.0 109.982 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.97 145.94 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.686 1.194 . . . . 0.0 112.492 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 123.733 0.813 . . . . 0.0 111.801 -177.677 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.7 p -68.83 -43.14 76.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.408 1.003 . . . . 0.0 112.411 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.0 -35.03 71.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.719 0.808 . . . . 0.0 111.424 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.3 tpt -73.06 -37.63 66.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.063 1.345 . . . . 0.0 112.18 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.94 -44.87 91.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.25 0.477 . . . . 0.0 111.786 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -60.84 -38.83 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.379 -0.819 . . . . 0.0 111.823 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.62 72.89 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.113 1.324 . . . . 0.0 113.089 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -66.86 -44.43 81.02 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.169 -1.195 . . . . 0.0 111.81 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.44 72.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.778 -1.201 . . . . 0.0 114.05 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -72.23 -23.03 61.17 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.87 1.214 . . . . 0.0 112.867 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -86.07 -44.66 12.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.188 0.995 . . . . 0.0 112.037 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 mt -95.84 -35.85 11.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.23 1.012 . . . . 0.0 113.031 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.96 7.69 80.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.964 1.745 . . . . 0.0 113.575 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -38.93 -45.34 1.17 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.7 17.92 27.47 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.485 1.517 . . . . 0.0 114.787 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -116.63 -28.68 6.33 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.6 pt -157.59 163.97 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 127.603 2.361 . . . . 0.0 110.485 -171.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 147.03 24.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 167.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.5 145.43 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.745 -1.222 . . . . 0.0 113.62 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -148.88 157.97 43.82 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.791 2.036 . . . . 0.0 109.237 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.4 p -131.12 156.8 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.6 -1.312 . . . . 0.0 112.914 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -153.56 155.87 36.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.704 1.202 . . . . 0.0 109.793 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.3 145.46 18.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.31 -31.83 69.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.646 1.223 . . . . 0.0 111.913 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -123.33 35.48 4.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.161 1.785 . . . . 0.0 110.215 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t 71.36 170.37 0.32 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.142 1.777 . . . . 0.0 112.151 -168.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -155.63 -177.38 6.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.051 1.74 . . . . 0.0 110.966 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -144.76 178.39 8.03 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -113.15 140.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.375 1.47 . . . . 0.0 109.346 169.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -110.96 135.63 20.82 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.497 -1.239 . . . . 0.0 110.92 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.02 -36.69 85.18 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.294 2.662 . . . . 0.0 115.467 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -67.51 -31.88 72.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 120.9 -1.125 . . . . 0.0 111.779 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.88 -10.83 59.75 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.303 -1.498 . . . . 0.0 113.438 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.61 -58.89 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.41 -38.54 77.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.1 mmm -73.99 -6.69 48.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 mmt -118.01 -23.96 7.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.745 1.218 . . . . 0.0 111.516 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.88 -28.16 68.67 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.261 -0.9 . . . . 0.0 111.609 169.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.85 -5.61 42.07 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.48 1.06 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.412 2.285 . . . . 0.0 110.581 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.41 13.15 82.19 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.23 1.395 . . . . 0.0 114.553 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mm -89.29 152.01 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.47 1.135 . . . . 0.0 111.022 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -129.65 138.6 51.29 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 111.002 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 pt -135.8 -5.26 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -57.42 -33.11 67.54 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.26 -5.75 85.03 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -83.14 144.44 29.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.337 1.569 . . . . 0.0 112.873 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.3 p -133.79 171.72 13.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.845 2.058 . . . . 0.0 110.302 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.7 t -141.0 165.81 26.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.212 1.005 . . . . 0.0 112.398 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.25 155.02 30.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.61 1.564 . . . . 0.0 109.267 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.85 135.46 67.08 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.874 2.383 . . . . 0.0 113.215 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -54.52 -33.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -10.26 55.75 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -25.26 59.2 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.247 -0.908 . . . . 0.0 112.669 170.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.21 167.68 11.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.832 1.253 . . . . 0.0 112.499 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.94 115.86 30.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.122 1.369 . . . . 0.0 111.362 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.31 62.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.09 -27.0 66.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.648 0.737 . . . . 0.0 112.304 -172.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.01 -10.88 57.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.037 1.735 . . . . 0.0 111.806 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -107.37 79.57 1.32 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 126.548 1.939 . . . . 0.0 108.786 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -66.13 -12.42 55.63 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -129.9 130.77 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.516 1.527 . . . . 0.0 109.169 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.4 t -134.14 128.77 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.134 -0.979 . . . . 0.0 109.512 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.8 121.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.253 1.021 . . . . 0.0 110.079 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -96.61 150.02 21.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 112.32 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.8 mp -126.27 35.13 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.829 1.252 . . . . 0.0 111.455 171.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 123.783 0.833 . . . . 0.0 112.98 -174.856 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.8 mt -142.37 139.81 18.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.534 -170.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -63.22 154.65 66.45 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.503 2.135 . . . . 0.0 110.188 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -58.36 -32.65 96.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.551 2.168 . . . . 0.0 114.691 -170.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -88.13 -3.25 58.91 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 m -118.81 -22.08 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.8 t -77.42 2.06 17.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.066 1.746 . . . . 0.0 114.514 -173.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -49.64 158.26 0.47 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.497 2.319 . . . . 0.0 114.24 171.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.71 -33.37 73.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.34 126.51 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.419 1.087 . . . . 0.0 111.008 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -136.05 139.09 42.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.844 1.657 . . . . 0.0 110.255 169.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.95 157.83 39.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.636 1.174 . . . . 0.0 110.871 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -117.6 140.97 48.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.942 1.297 . . . . 0.0 110.571 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -108.63 140.15 42.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.582 1.553 . . . . 0.0 111.469 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.43 60.76 1.02 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.169 1.788 . . . . 0.0 106.495 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -107.64 124.56 50.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.073 2.149 . . . . 0.0 111.167 -167.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -81.27 157.98 24.96 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.324 1.05 . . . . 0.0 112.664 -172.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -95.07 123.81 56.08 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.592 1.157 . . . . 0.0 111.556 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.546 1.102 0 C-N-CA 122.56 2.173 . . . . 0.0 114.862 178.402 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.22 -24.15 66.14 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.144 -0.972 . . . . 0.0 111.365 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -66.38 -32.29 73.58 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.433 -0.792 . . . . 0.0 111.537 169.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.36 -39.18 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.94 -1.1 . . . . 0.0 110.425 173.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -59.03 -47.25 85.91 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.037 1.289 . . . . 0.0 111.289 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -68.23 -22.28 64.79 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.0 m -77.73 -57.34 3.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.97 -34.68 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 -171.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -55.88 -43.24 77.02 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.001 0.819 . . . . 0.0 112.953 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.04 -32.05 61.09 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.766 0.698 . . . . 0.0 112.051 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -68.44 -41.05 80.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.773 -0.84 . . . . 0.0 111.376 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.7 -49.11 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 0.0 110.174 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -54.42 -49.23 70.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.172 0.989 . . . . 0.0 112.202 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -71.57 -28.39 63.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.19 0.904 . . . . 0.0 112.696 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -72.16 -46.13 57.66 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.393 0.677 . . . . 0.0 111.181 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.6 t -58.05 -42.27 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.048 0.939 . . . . 0.0 111.289 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.06 -46.29 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.511 1.051 . . . . 0.0 111.935 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -40.45 95.99 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.58 0.627 . . . . 0.0 110.808 176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.47 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -57.89 -51.24 70.41 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.215 1.006 . . . . 0.0 110.632 176.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.2 mt -70.6 -45.47 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.11 -26.0 68.05 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.9 pttt -91.21 -7.82 50.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.08 -16.71 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.883 1.673 . . . . 0.0 112.805 -175.782 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.39 138.94 49.55 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.192 0.906 . . . . 0.0 111.627 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -111.31 123.14 49.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.478 1.111 . . . . 0.0 111.161 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -93.21 107.08 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.875 1.67 . . . . 0.0 110.354 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -85.74 128.99 34.94 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.77 118.52 37.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.751 1.22 . . . . 0.0 108.727 169.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.3 136.18 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 0.0 111.163 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 174.263 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 p -65.71 -42.56 90.97 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.8 . . . . 0.0 111.736 169.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -64.14 -43.1 96.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.994 0.518 . . . . 0.0 112.175 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -39.54 91.63 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.454 -0.779 . . . . 0.0 111.874 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.21 -48.42 80.06 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.76 -38.73 75.9 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.597 0.635 . . . . 0.0 111.434 171.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.11 -62.38 6.19 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.106 1.336 . . . . 0.0 112.723 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -58.73 -33.61 70.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.004 1.402 . . . . 0.0 111.498 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.46 -30.36 64.5 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.684 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -73.99 -29.76 62.13 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.354 1.888 . . . . 0.0 112.771 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 m -74.98 -45.64 40.69 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.882 0.765 . . . . 0.0 112.22 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.3 -37.15 12.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.022 0.929 . . . . 0.0 112.588 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.82 2.18 60.44 Favored Glycine 0 N--CA 1.469 0.835 0 C-N-CA 125.527 1.537 . . . . 0.0 114.333 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 113.66 0.76 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.622 1.211 . . . . 0.0 111.724 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.1 19.96 79.79 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -124.0 -41.42 2.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.61 1.705 . . . . 0.0 112.383 -174.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -153.23 168.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.872 2.069 . . . . 0.0 110.424 177.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.3 153.95 18.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 109.795 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.04 144.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.14 -0.975 . . . . 0.0 112.945 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -150.43 142.58 24.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.526 1.13 . . . . 0.0 110.721 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -103.52 148.62 25.73 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.188 1.395 . . . . 0.0 112.802 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -154.21 165.48 36.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 111.159 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.92 158.64 27.74 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -55.17 -36.8 66.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 118.124 0.962 . . . . 0.0 113.235 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.69 41.74 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.782 1.633 . . . . 0.0 109.651 169.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t 67.45 168.18 0.25 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.569 2.347 . . . . 0.0 115.983 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -137.92 170.61 15.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.708 2.403 . . . . 0.0 110.029 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -131.04 168.22 17.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -107.82 150.4 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.518 1.527 . . . . 0.0 108.164 169.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -136.92 133.41 18.7 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.888 -1.529 . . . . 0.0 109.94 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -52.98 -36.38 75.38 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.9 2.4 . . . . 0.0 115.139 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.1 m -69.36 -34.25 74.29 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.976 -1.078 . . . . 0.0 111.782 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.56 -13.29 60.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.031 -1.043 . . . . 0.0 113.184 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -77.69 -54.64 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.75 64.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -70.25 -9.84 57.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mmt -122.45 -29.89 4.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.449 1.1 . . . . 0.0 112.261 -169.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.59 -25.56 67.41 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.82 -1.175 . . . . 0.0 112.29 170.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.68 -13.88 62.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.274 1.03 . . . . 0.0 113.746 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.259 4.0 m -114.5 16.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.691 1.196 . . . . 0.0 111.604 168.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.03 73.36 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.036 1.779 . . . . 0.0 116.264 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.16 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.039 1.419 . . . . 0.0 112.05 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -129.16 121.38 27.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.27 3.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.351 1.46 . . . . 0.0 111.906 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -70.25 -34.11 72.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.572 -169.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.22 4.54 82.83 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.474 1.035 . . . . 0.0 114.645 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.78 156.68 26.81 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.08 1.44 . . . . 0.0 113.803 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -156.01 162.0 40.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.726 1.61 . . . . 0.0 110.21 173.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -103.26 172.51 6.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.904 1.281 . . . . 0.0 112.453 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -138.03 159.31 68.94 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.037 1.335 . . . . 0.0 109.981 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.78 138.06 83.57 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.336 2.691 . . . . 0.0 112.879 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 tt -58.1 -31.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.23 -11.13 60.68 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -20.95 57.75 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.246 -0.909 . . . . 0.0 112.642 171.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.28 167.56 11.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.79 1.236 . . . . 0.0 112.837 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.07 112.22 20.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.925 1.69 . . . . 0.0 110.358 175.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.23 -17.63 64.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.43 -26.06 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.183 0.993 . . . . 0.0 112.474 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.02 -1.3 57.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.913 1.685 . . . . 0.0 112.155 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -118.05 80.15 1.47 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.808 2.043 . . . . 0.0 108.115 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.05 -24.53 17.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.977 1.711 . . . . 0.0 113.186 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -134.28 130.65 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.789 1.635 . . . . 0.0 108.983 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.8 t -134.42 122.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.285 -0.884 . . . . 0.0 110.834 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.51 122.92 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.751 1.62 . . . . 0.0 108.899 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -88.9 144.54 26.13 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.243 1.417 . . . . 0.0 109.994 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.13 27.22 9.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.553 1.141 . . . . 0.0 111.781 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.799 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 121.61 0.719 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -74.58 140.22 75.07 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.076 0.95 . . . . 0.0 112.491 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.95 151.56 83.87 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.151 1.9 . . . . 0.0 109.774 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.89 -21.11 72.9 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.104 2.536 . . . . 0.0 115.463 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.27 -13.19 61.45 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -91.48 -1.85 57.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.21 17.52 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.605 1.562 . . . . 0.0 113.427 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 t -124.64 1.48 8.22 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.095 1.758 . . . . 0.0 113.023 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -58.9 163.4 3.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.771 2.829 . . . . 0.0 113.986 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.41 -35.62 81.5 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.7 125.9 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.976 0.91 . . . . 0.0 109.985 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -125.59 147.22 49.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.256 1.423 . . . . 0.0 110.715 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -139.33 157.79 45.28 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.39 1.076 . . . . 0.0 112.505 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -135.97 126.65 27.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.764 1.226 . . . . 0.0 108.234 168.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -111.28 132.14 54.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.678 1.591 . . . . 0.0 110.218 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -92.38 64.15 4.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.159 1.383 . . . . 0.0 109.771 -171.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.03 144.82 25.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.569 1.548 . . . . 0.0 114.075 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -93.88 160.4 14.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.596 1.558 . . . . 0.0 111.0 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -106.31 126.39 30.6 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.083 0.953 . . . . 0.0 111.787 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo . . . . . 0 CA--C 1.543 0.952 0 C-N-CA 122.306 2.004 . . . . 0.0 113.64 -178.588 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.693 0.282 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.53 -21.61 64.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.002 -1.061 . . . . 0.0 112.079 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.72 -28.08 67.35 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.232 -0.917 . . . . 0.0 111.244 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.86 -41.19 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.938 -1.101 . . . . 0.0 110.309 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -56.81 -48.45 77.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.946 1.248 . . . . 0.0 111.145 169.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -69.57 -18.73 63.66 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.3 m -82.71 -52.29 6.91 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.183 1.393 . . . . 0.0 111.945 169.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.13 -34.53 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.461 1.105 . . . . 0.0 111.396 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -54.12 -42.57 69.61 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.835 0.743 . . . . 0.0 112.099 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.64 -31.42 65.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.67 0.653 . . . . 0.0 112.913 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.16 -41.18 70.74 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.141 0.971 . . . . 0.0 110.782 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.72 -47.47 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.426 0.69 . . . . 0.0 110.549 169.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.24 -50.4 67.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.922 1.289 . . . . 0.0 112.639 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -70.12 -26.43 63.96 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.787 1.176 . . . . 0.0 112.635 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -72.96 -51.08 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.213 1.005 . . . . 0.0 110.807 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.59 -47.54 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.263 1.025 . . . . 0.0 111.735 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -62.5 -51.75 66.2 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.697 1.135 . . . . 0.0 112.574 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.14 -31.4 68.89 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.125 0.875 . . . . 0.0 111.964 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.12 -50.04 73.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.475 0.71 . . . . 0.0 110.784 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.23 -38.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 121.369 -0.832 . . . . 0.0 111.375 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -25.51 67.2 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -91.23 -11.92 36.78 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.8 pt -114.14 -17.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.254 1.316 0 C-N-CA 125.582 1.553 . . . . 0.0 111.973 172.099 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttm . . . . . 0 N--CA 1.501 2.075 0 CA-C-O 119.786 -0.149 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -71.31 143.44 50.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.183 0.993 . . . . 0.0 112.028 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -110.06 122.84 48.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.71 109.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.532 1.533 . . . . 0.0 110.352 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 ttm -89.63 126.93 35.82 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.586 0.63 . . . . 0.0 109.59 169.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -95.56 124.25 39.49 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.021 1.329 . . . . 0.0 109.343 169.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.9 m -128.13 143.09 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.524 1.13 . . . . 0.0 112.554 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -174.987 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -66.28 -44.14 84.38 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.195 0.907 . . . . 0.0 111.995 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -65.2 -43.97 89.89 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.493 -0.754 . . . . 0.0 111.887 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -39.11 79.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.6 1.16 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.53 92.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.34 -38.46 77.21 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.428 -0.795 . . . . 0.0 110.732 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.73 -58.6 9.94 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.522 1.534 . . . . 0.0 113.943 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -65.23 -30.54 71.43 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.969 1.384 . . . . 0.0 111.982 174.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.53 -32.82 70.43 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.903 -1.123 . . . . 0.0 113.962 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -70.57 -26.89 63.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 121.315 1.871 . . . . 0.0 112.666 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.5 m -74.91 -46.47 35.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.663 0.785 . . . . 0.0 112.454 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.6 mt -98.75 -29.34 13.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -169.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.18 2.2 87.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.78 1.657 . . . . 0.0 113.229 170.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.13 116.22 1.46 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.406 1.103 . . . . 0.0 112.284 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.78 11.42 84.58 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -119.84 -38.04 3.02 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.16 1.48 . . . . 0.0 111.793 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 pt -148.28 161.68 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.539 1.936 . . . . 0.0 112.001 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.56 147.75 22.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.97 142.86 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.993 -1.067 . . . . 0.0 112.465 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -146.43 153.04 40.0 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 p -128.71 144.02 51.07 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.515 1.126 . . . . 0.0 112.615 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t -155.29 162.27 40.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.282 1.433 . . . . 0.0 110.268 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.37 154.36 20.31 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.04 -1.038 . . . . 0.0 111.403 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.05 -40.27 97.2 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.067 -1.255 . . . . 0.0 111.519 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -111.17 34.23 4.18 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.654 1.582 . . . . 0.0 109.625 169.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 t 71.44 170.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.546 1.938 . . . . 0.0 111.357 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.5 p -149.41 -162.52 1.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.598 1.559 . . . . 0.0 110.294 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -155.35 174.88 14.6 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.683 -1.261 . . . . 0.0 114.388 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.39 154.14 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -127.78 130.83 23.6 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.174 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -54.78 -39.61 88.87 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.991 2.461 . . . . 0.0 114.503 -173.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -67.56 -31.69 71.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.11 -10.33 59.33 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.678 -1.263 . . . . 0.0 113.127 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.6 -57.77 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.13 79.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 75.4 mmm -73.97 -8.5 56.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.1 mmt -118.15 -25.91 6.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.086 1.355 . . . . 0.0 111.76 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.9 -30.61 67.93 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.986 -1.071 . . . . 0.0 111.783 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.91 -11.08 60.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 t -100.9 3.03 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 126.606 1.962 . . . . 0.0 110.477 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.75 12.25 81.74 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.383 1.468 . . . . 0.0 114.848 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -87.45 148.12 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 118.494 1.147 . . . . 0.0 111.197 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -132.46 101.11 5.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.462 1.505 . . . . 0.0 111.21 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.4 pt -125.38 -4.13 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.3 p -63.94 -27.02 68.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.609 1.095 . . . . 0.0 113.546 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.39 -5.25 89.73 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.877 1.227 . . . . 0.0 115.311 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -78.47 157.93 28.79 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.522 1.661 . . . . 0.0 113.374 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -134.41 -177.61 4.68 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.858 2.063 . . . . 0.0 110.887 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 t -151.07 161.44 42.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.29 1.036 . . . . 0.0 112.047 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -147.6 160.01 39.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.173 1.789 . . . . 0.0 109.671 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.85 133.99 54.26 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.347 2.698 . . . . 0.0 111.955 174.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.47 -32.32 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -9.63 51.36 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -22.03 59.15 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.167 0.894 . . . . 0.0 112.605 170.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.88 171.57 8.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.851 1.261 . . . . 0.0 112.8 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.49 113.96 21.56 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.574 1.55 . . . . 0.0 111.074 176.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.14 -11.73 59.66 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.706 -1.247 . . . . 0.0 113.857 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.15 -20.88 57.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.838 1.255 . . . . 0.0 112.98 174.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -103.25 -0.63 30.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.117 1.767 . . . . 0.0 113.166 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -125.26 77.5 1.64 Allowed 'General case' 0 C--N 1.345 0.406 0 C-N-CA 125.799 1.639 . . . . 0.0 109.206 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.99 -23.57 13.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.085 2.154 . . . . 0.0 113.488 -175.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.74 133.81 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.768 1.627 . . . . 0.0 108.186 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.57 122.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.988 -1.07 . . . . 0.0 110.353 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.63 118.05 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 108.167 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -88.64 154.91 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.083 0.953 . . . . 0.0 109.856 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.07 46.59 2.48 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.079 1.351 . . . . 0.0 110.852 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t . . . . . 0 CA--C 1.544 0.72 0 C-N-CA 125.394 1.478 . . . . 0.0 111.868 179.253 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.1 t30 . . . . . 0 CA--C 1.548 0.867 0 CA-C-O 121.571 0.7 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -87.4 146.3 39.46 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -65.68 154.3 74.41 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 122.824 2.349 . . . . 0.0 110.153 168.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.72 -35.55 98.76 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.51 2.14 . . . . 0.0 115.668 -169.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.57 -23.76 67.18 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.086 -1.009 . . . . 0.0 113.355 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.4 -7.57 58.88 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.17 -22.82 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.25 1.42 . . . . 0.0 113.411 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -83.16 11.9 5.86 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.782 1.633 . . . . 0.0 113.508 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.65 165.92 11.65 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.767 1.627 . . . . 0.0 112.603 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.29 -36.51 83.91 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.659 -0.651 . . . . 0.0 112.726 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.7 130.0 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.861 0.865 . . . . 0.0 110.119 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -134.89 150.6 50.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.134 1.373 . . . . 0.0 111.873 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -141.74 158.04 44.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -139.63 81.17 1.81 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.668 0.787 . . . . 0.0 111.218 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -66.47 149.5 50.34 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.126 1.771 . . . . 0.0 113.127 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -114.04 60.6 0.67 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.339 1.856 . . . . 0.0 107.858 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -100.57 134.68 43.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.169 2.187 . . . . 0.0 112.527 -168.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.44 140.24 56.36 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.335 1.854 . . . . 0.0 112.644 -173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -93.04 112.06 54.39 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 CA--C 1.542 0.905 0 C-N-CA 122.471 2.114 . . . . 0.0 113.496 -178.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.373 0.606 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.02 -24.97 66.86 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.164 -0.96 . . . . 0.0 111.676 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.84 -28.33 69.49 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.161 -0.962 . . . . 0.0 111.796 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 -39.92 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.463 -1.398 . . . . 0.0 109.484 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -63.18 -36.55 84.01 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.433 1.015 . . . . 0.0 112.166 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -77.57 -20.8 53.47 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.125 -1.609 . . . . 0.0 113.827 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.3 m -91.73 -39.58 11.73 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.967 0.907 . . . . 0.0 111.63 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.8 p -59.27 -42.7 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 120.404 -1.435 . . . . 0.0 111.797 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -59.83 -43.34 94.63 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -32.05 65.51 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.849 -0.532 . . . . 0.0 112.828 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.37 -39.14 81.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.888 0.844 . . . . 0.0 112.064 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.64 -51.47 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.58 0.752 . . . . 0.0 109.91 169.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.19 -47.0 82.35 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.359 1.064 . . . . 0.0 112.61 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -68.73 -27.06 65.6 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.773 1.624 . . . . 0.0 112.531 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -73.16 -51.43 17.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 111.655 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.52 -41.05 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.115 0.871 . . . . 0.0 112.761 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.84 -50.32 69.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.701 1.591 . . . . 0.0 112.389 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -70.61 -30.0 66.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.905 0.775 . . . . 0.0 112.063 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -50.0 70.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.698 0.799 . . . . 0.0 110.815 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -69.78 -41.17 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.274 -0.891 . . . . 0.0 110.705 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.65 -26.38 68.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.31 -14.79 34.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.9 pt -111.58 -18.3 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.543 1.137 . . . . 0.0 113.154 179.058 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -71.56 140.85 50.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.779 0.832 . . . . 0.0 111.851 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -111.09 126.46 54.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.325 1.05 . . . . 0.0 111.28 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.12 107.63 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.208 1.803 . . . . 0.0 109.826 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -87.64 127.9 35.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.141 0.428 . . . . 0.0 109.989 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.11 114.71 28.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.5 1.12 . . . . 0.0 109.69 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -111.46 136.26 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.699 1.2 . . . . 0.0 112.524 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.474 0.744 0 O-C-N 121.206 -0.934 . . . . 0.0 112.577 178.644 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -62.3 -46.17 89.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.298 1.039 . . . . 0.0 111.621 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.04 -40.4 78.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.554 1.142 . . . . 0.0 111.979 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.7 mmm -68.6 -36.91 79.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.436 -0.79 . . . . 0.0 112.745 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.68 95.89 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.001 0.819 . . . . 0.0 111.451 173.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -60.46 -39.75 88.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.899 0.772 . . . . 0.0 111.323 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.55 -60.96 7.53 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.975 1.274 . . . . 0.0 112.894 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -60.31 -34.01 73.19 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.554 1.177 . . . . 0.0 111.734 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.12 -27.16 61.52 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 117.839 -1.077 . . . . 0.0 113.884 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -75.42 -28.66 59.47 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.295 1.861 . . . . 0.0 112.656 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -76.05 -45.99 31.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.623 0.769 . . . . 0.0 112.267 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.16 -30.36 12.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.436 1.094 . . . . 0.0 113.267 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.0 4.98 81.51 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.94 1.733 . . . . 0.0 113.692 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.69 109.33 0.19 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.553 1.176 . . . . 0.0 112.813 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.61 19.41 79.7 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -118.48 -37.2 3.35 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.079 1.439 . . . . 0.0 112.08 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -152.28 166.58 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.051 2.541 . . . . 0.0 109.82 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.57 151.27 21.39 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.385 0.674 . . . . 0.0 109.737 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 142.1 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.039 -1.038 . . . . 0.0 112.666 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 m -149.28 154.91 39.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.92 1.288 . . . . 0.0 110.578 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 p -127.11 145.61 50.68 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.61 1.164 . . . . 0.0 112.598 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -148.46 146.5 28.42 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.859 1.264 . . . . 0.0 111.243 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.87 143.05 17.64 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.5 -38.57 66.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.587 1.694 . . . . 0.0 112.604 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -122.74 45.44 2.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.789 1.635 . . . . 0.0 110.307 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.2 p 68.99 143.62 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.434 3.094 . . . . 0.0 116.776 -170.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -107.69 171.39 7.42 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.644 2.378 . . . . 0.0 111.566 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -141.3 144.17 34.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.916 1.286 . . . . 0.0 112.496 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.26 152.73 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.093 1.757 . . . . 0.0 110.75 171.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.48 149.82 68.62 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.522 1.129 . . . . 0.0 111.776 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.08 -35.83 74.02 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.404 2.736 . . . . 0.0 114.224 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -63.54 -39.39 94.29 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.492 -0.755 . . . . 0.0 112.006 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.72 -20.57 61.18 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.171 -0.956 . . . . 0.0 112.808 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.94 -54.26 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.14 67.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -170.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -69.72 -9.67 55.34 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 mmt -125.85 -28.89 3.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.309 1.044 . . . . 0.0 112.499 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.28 -24.85 67.52 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.868 -1.145 . . . . 0.0 112.101 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.35 -13.68 62.45 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.74 15.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.974 1.31 . . . . 0.0 111.641 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.94 10.94 71.14 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.957 1.742 . . . . 0.0 116.176 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -84.9 146.76 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.404 1.602 . . . . 0.0 111.958 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -116.13 129.34 56.28 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.79 1.636 . . . . 0.0 111.96 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.0 pt -135.29 -8.94 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.943 1.297 . . . . 0.0 113.707 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -60.29 -30.64 69.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.869 1.268 . . . . 0.0 114.094 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.33 1.9 84.66 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.76 1.171 . . . . 0.0 115.353 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -77.56 156.75 30.7 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.77 1.785 . . . . 0.0 112.674 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.3 p -133.25 175.43 9.41 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.564 1.946 . . . . 0.0 110.231 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -155.91 155.55 33.04 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -148.45 159.2 39.48 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.231 2.212 . . . . 0.0 109.472 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -55.38 143.11 78.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.389 2.726 . . . . 0.0 113.127 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.74 -31.49 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -169.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -13.7 60.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -20.01 58.53 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 119.084 0.856 . . . . 0.0 112.926 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -96.33 164.35 12.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.943 1.297 . . . . 0.0 112.625 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.11 109.71 19.24 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 111.348 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.88 -22.06 65.99 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.24 -25.61 68.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.696 1.198 . . . . 0.0 112.834 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.15 -3.07 58.74 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.993 1.717 . . . . 0.0 112.103 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -116.17 82.26 1.75 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.887 2.075 . . . . 0.0 108.428 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -25.52 21.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.835 1.654 . . . . 0.0 113.079 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.6 t -132.97 129.78 57.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.079 1.752 . . . . 0.0 109.085 -176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.61 120.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.196 -0.94 . . . . 0.0 110.719 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.51 120.46 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.169 1.388 . . . . 0.0 108.159 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -86.02 150.29 24.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.42 1.088 . . . . 0.0 109.721 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.83 44.09 3.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.082 1.353 . . . . 0.0 110.522 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.983 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.0 mt -140.26 133.81 15.2 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.388 1.475 . . . . 0.0 111.027 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -60.39 152.27 68.5 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.293 1.995 . . . . 0.0 110.243 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.13 -21.84 73.17 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.035 2.49 . . . . 0.0 114.912 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -15.56 62.73 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -90.26 -3.16 57.98 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.15 13.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.674 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -118.12 -1.2 11.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.493 1.917 . . . . 0.0 112.775 -171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -56.05 159.67 3.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.587 2.755 . . . . 0.0 113.89 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.28 -34.98 79.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.22 129.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.172 0.989 . . . . 0.0 110.368 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -130.62 148.19 52.39 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.423 1.489 . . . . 0.0 111.29 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -142.0 161.75 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.759 1.224 . . . . 0.0 112.554 176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.08 124.24 21.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.85 1.26 . . . . 0.0 109.102 168.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -110.85 160.32 16.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.206 1.802 . . . . 0.0 112.4 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -122.79 50.6 1.5 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.475 1.51 . . . . 0.0 112.333 -168.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.19 137.52 36.7 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.229 -0.92 . . . . 0.0 112.636 -172.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 146.5 52.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.863 1.265 . . . . 0.0 108.556 169.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.46 119.22 65.66 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.95 0.9 . . . . 0.0 111.024 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 C-N-CA 122.143 1.895 . . . . 0.0 113.447 -177.317 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.043 0.449 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.91 -30.09 70.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.47 1.108 . . . . 0.0 111.646 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.98 -21.42 63.24 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.671 -1.268 . . . . 0.0 113.12 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.7 t -71.2 -40.52 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 120.36 -1.463 . . . . 0.0 110.102 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -56.83 -46.68 81.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.571 1.078 . . . . 0.0 110.826 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -68.77 -17.86 64.11 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.8 m -87.67 -43.47 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.912 1.285 . . . . 0.0 112.236 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -66.76 -38.74 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.703 -1.248 . . . . 0.0 111.501 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -57.46 -40.2 77.97 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.34 64.94 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.431 0.539 . . . . 0.0 112.881 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -68.76 -43.59 75.49 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.957 -0.731 . . . . 0.0 110.978 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.5 t -58.81 -47.49 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.747 -0.596 . . . . 0.0 110.414 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -57.12 -50.71 71.97 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.678 1.191 . . . . 0.0 112.422 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.19 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.878 1.217 . . . . 0.0 112.794 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -68.42 -50.72 50.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.472 0.709 . . . . 0.0 110.924 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.34 -48.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.646 1.178 . . . . 0.0 112.174 169.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -62.52 -50.82 69.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.832 1.196 . . . . 0.0 112.475 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -30.19 67.43 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.772 0.715 . . . . 0.0 111.899 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.43 -50.82 68.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.697 0.799 . . . . 0.0 110.613 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -70.74 -39.98 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.22 0.918 . . . . 0.0 111.165 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 -20.6 60.84 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -97.64 -10.9 24.25 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -113.55 -17.64 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 126.21 1.804 . . . . 0.0 112.499 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -71.42 144.07 49.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.063 0.945 . . . . 0.0 111.702 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.18 128.39 55.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.109 0.964 . . . . 0.0 111.284 170.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.66 118.33 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.249 1.819 . . . . 0.0 110.221 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.2 tpp -96.95 122.7 40.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -95.56 114.95 26.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.421 0.689 . . . . 0.0 110.438 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.91 147.06 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.45 1.1 . . . . 0.0 113.46 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.63 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.536 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.1 p -71.99 -40.44 68.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.535 1.061 . . . . 0.0 112.83 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.31 -32.15 71.1 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.91 0.777 . . . . 0.0 111.145 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -43.18 80.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.04 1.291 . . . . 0.0 112.378 169.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -43.52 97.02 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.266 0.485 . . . . 0.0 110.922 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.76 -43.71 97.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.817 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -44.86 96.67 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 119.805 1.184 . . . . 0.0 113.79 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.93 -37.9 76.03 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.444 -1.033 . . . . 0.0 111.14 171.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.47 -34.2 65.24 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.697 -1.252 . . . . 0.0 113.67 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.86 -22.52 64.21 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.908 1.231 . . . . 0.0 112.63 171.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 m -88.8 -46.88 8.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.814 1.246 . . . . 0.0 112.262 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.62 -33.45 12.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 112.886 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 5.76 77.67 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.939 1.733 . . . . 0.0 113.059 170.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.38 120.62 4.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.349 1.075 . . . . 0.0 111.433 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.95 77.88 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -110.42 -40.82 4.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.339 1.455 . . . . 0.0 111.045 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -148.6 159.35 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 112.762 -171.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.61 151.27 19.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.122 1.369 . . . . 0.0 107.53 168.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 t -139.9 139.88 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 120.89 -1.131 . . . . 0.0 112.177 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -141.6 154.68 45.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.677 1.591 . . . . 0.0 109.865 170.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.3 p -124.11 152.35 42.86 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.084 -1.01 . . . . 0.0 112.126 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 t -151.01 124.54 8.98 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.433 0.693 . . . . 0.0 112.717 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.24 127.14 8.64 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.98 -35.12 23.24 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -169.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -123.0 34.56 5.1 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.234 1.414 . . . . 0.0 112.605 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 p 66.99 161.83 0.17 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 127.759 2.423 . . . . 0.0 115.499 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -161.58 -163.52 1.0 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.165 1.386 . . . . 0.0 111.528 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -133.16 173.25 11.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.241 1.817 . . . . 0.0 113.21 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 t -85.55 167.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -129.43 125.71 22.59 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 120.337 -1.477 . . . . 0.0 111.714 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -55.79 -40.17 86.76 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.176 2.584 . . . . 0.0 114.651 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -64.42 -30.32 71.36 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.117 -0.989 . . . . 0.0 111.859 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.36 -5.43 52.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.3 mt -86.14 -57.05 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 168.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.11 75.34 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -170.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.4 -9.34 58.0 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 mmt -119.12 -27.85 5.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.127 0.971 . . . . 0.0 112.34 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.92 -30.38 65.87 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.786 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.8 -10.64 59.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.811 1.244 . . . . 0.0 113.923 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 8.5 p -121.77 24.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.932 1.693 . . . . 0.0 110.829 169.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.6 83.46 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.211 1.863 . . . . 0.0 116.63 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.22 147.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.789 1.295 . . . . 0.0 111.76 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -131.63 107.82 9.09 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.191 1.796 . . . . 0.0 110.597 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 pt -140.22 15.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 p -60.05 -27.64 67.11 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.698 -1.251 . . . . 0.0 113.825 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.08 9.22 39.36 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.161 1.362 . . . . 0.0 116.153 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -65.09 -50.58 65.55 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.264 2.032 . . . . 0.0 114.203 -169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p 58.71 167.27 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.245 1.818 . . . . 0.0 114.38 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -144.63 131.15 19.87 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.027 -1.046 . . . . 0.0 112.166 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -132.53 158.61 75.23 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.001 1.721 . . . . 0.0 112.289 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.06 145.14 89.18 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.478 2.785 . . . . 0.0 113.524 -170.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.52 -34.23 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -169.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.52 -7.0 50.07 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -20.47 55.79 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.294 -0.879 . . . . 0.0 112.133 169.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -94.99 170.21 9.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.182 1.393 . . . . 0.0 112.264 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.22 111.69 18.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.974 1.71 . . . . 0.0 110.535 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.46 -23.05 66.82 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -169.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.29 -25.14 67.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.92 0.888 . . . . 0.0 112.758 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.73 -2.75 58.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.224 1.81 . . . . 0.0 111.946 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.9 84.65 2.11 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.117 2.167 . . . . 0.0 108.022 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.86 -28.05 8.73 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.055 1.742 . . . . 0.0 112.725 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.56 130.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.832 1.653 . . . . 0.0 109.003 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.1 t -131.5 126.99 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.297 -0.877 . . . . 0.0 109.097 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -126.2 124.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.464 1.106 . . . . 0.0 108.904 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -99.35 156.4 17.02 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.113 0.965 . . . . 0.0 111.599 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.24 52.88 2.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 110.937 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.3 m . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 125.26 1.424 . . . . 0.0 114.763 -170.758 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.63 138.63 20.42 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.119 0.967 . . . . 0.0 112.914 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.99 151.76 82.97 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.483 2.122 . . . . 0.0 109.896 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -57.57 -29.97 86.9 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 115.255 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.73 -19.58 65.95 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -89.77 -3.45 58.15 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.75 -12.83 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -88.52 5.5 42.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.696 1.599 . . . . 0.0 113.765 -171.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -59.23 160.43 6.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.146 2.179 . . . . 0.0 113.878 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.98 -33.24 75.28 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 127.06 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.834 0.854 . . . . 0.0 110.36 169.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -138.28 141.43 39.85 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.777 1.631 . . . . 0.0 111.127 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.96 162.44 38.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.405 1.482 . . . . 0.0 110.72 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -128.85 124.67 35.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.571 1.148 . . . . 0.0 111.581 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -102.89 161.67 13.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.197 1.799 . . . . 0.0 113.091 -172.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -95.64 -82.06 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.528 1.131 . . . . 0.0 111.496 -170.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 55.09 156.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.3 2.64 . . . . 0.0 115.853 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -90.25 178.05 6.26 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -117.74 117.84 35.46 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.462 -1.399 . . . . 0.0 111.209 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 C-N-CA 121.449 1.433 . . . . 0.0 113.261 179.798 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.48 -32.9 69.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.353 1.461 . . . . 0.0 111.295 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.19 -29.62 70.45 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 0.0 112.374 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.5 t -72.34 -42.21 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.907 -1.12 . . . . 0.0 110.263 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -58.8 -48.16 82.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.331 0.969 . . . . 0.0 111.56 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -69.83 -20.61 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.7 m -78.88 -56.01 4.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.591 1.156 . . . . 0.0 110.925 169.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.19 -35.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 0.0 111.387 -171.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.77 -42.77 72.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.828 0.74 . . . . 0.0 112.84 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.03 -34.75 61.55 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.808 0.718 . . . . 0.0 112.712 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -70.39 -41.47 72.97 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.457 0.629 . . . . 0.0 110.588 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.64 -45.82 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.651 -0.655 . . . . 0.0 110.975 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -55.28 -50.08 70.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.163 0.985 . . . . 0.0 111.788 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.29 -29.44 66.18 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.862 1.21 . . . . 0.0 113.013 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -68.6 -49.85 56.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.453 0.701 . . . . 0.0 111.196 173.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.64 -41.31 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.833 1.253 . . . . 0.0 111.731 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -62.04 -47.27 85.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.529 1.059 . . . . 0.0 112.131 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -38.77 92.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.553 0.615 . . . . 0.0 111.092 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.489 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.7 tm? -59.25 -53.52 57.38 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.5 1.12 . . . . 0.0 110.598 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.82 -42.34 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 118.754 0.706 . . . . 0.0 111.384 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.15 70.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -90.89 -20.1 22.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.4 -24.93 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 124.919 1.288 . . . . 0.0 114.273 -169.637 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 tpp . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.656 -0.211 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -68.9 135.5 51.13 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.668 1.187 . . . . 0.0 112.467 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -108.96 128.24 54.76 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.942 0.897 . . . . 0.0 111.862 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.31 120.69 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.871 1.668 . . . . 0.0 110.051 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.5 tpp -99.62 126.84 45.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -98.4 123.44 42.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.223 0.609 . . . . 0.0 111.197 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 m -125.84 141.64 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.22 1.008 . . . . 0.0 113.004 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t -153.56 -174.48 4.97 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 121.404 -0.81 . . . . 0.0 112.357 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -72.23 164.99 25.32 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.085 1.754 . . . . 0.0 112.509 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.74 -47.36 70.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.795 1.638 . . . . 0.0 115.188 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -92.31 5.81 49.18 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.1 m -85.75 151.64 23.68 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.083 1.353 . . . . 0.0 113.315 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.9 p -111.89 -11.89 13.84 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.492 1.117 . . . . 0.0 113.605 169.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -62.0 -24.13 66.85 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.249 -1.532 . . . . 0.0 114.407 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 p -66.4 -48.06 71.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.124 1.329 . . . . 0.0 111.232 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.77 -39.07 93.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.298 1.439 . . . . 0.0 111.719 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -40.53 77.15 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.944 1.297 . . . . 0.0 112.018 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.97 95.46 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.651 -0.656 . . . . 0.0 112.427 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -58.79 -41.08 85.86 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.789 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.7 -52.82 45.81 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.484 1.038 . . . . 0.0 113.25 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -65.3 -41.16 94.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.083 -1.246 . . . . 0.0 111.801 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.27 87.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -73.17 -20.93 60.8 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.536 1.062 . . . . 0.0 113.028 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -87.92 -44.84 10.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.225 1.01 . . . . 0.0 112.187 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.02 -37.58 10.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.213 1.005 . . . . 0.0 112.819 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.94 6.96 68.1 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.653 1.597 . . . . 0.0 113.99 170.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.27 -43.4 4.86 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.5 16.18 48.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.583 1.563 . . . . 0.0 114.651 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.09 -34.08 3.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.034 1.333 . . . . 0.0 112.477 -169.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -152.98 165.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.678 1.591 . . . . 0.0 113.149 -173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.77 153.77 17.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 167.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.19 143.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.278 -1.514 . . . . 0.0 114.615 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.82 168.07 20.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.473 1.909 . . . . 0.0 108.933 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -140.49 153.7 46.32 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.859 -1.15 . . . . 0.0 112.167 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 p -153.82 -175.27 5.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.525 1.13 . . . . 0.0 110.186 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.14 166.53 26.68 Favored Glycine 0 N--CA 1.471 1.016 0 O-C-N 120.836 -1.165 . . . . 0.0 113.15 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.09 -38.34 85.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 122.013 -0.698 . . . . 0.0 112.076 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.21 40.6 3.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.125 1.77 . . . . 0.0 109.135 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t 73.84 178.09 0.23 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.661 2.384 . . . . 0.0 113.71 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -144.84 174.75 10.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.348 2.259 . . . . 0.0 110.935 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.446 HH22 ' CG ' ' A' ' 105' ' ' ASP . 34.4 ptt85 -140.37 158.45 44.0 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.16 156.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -135.15 131.05 19.57 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-O 117.38 -1.295 . . . . 0.0 111.386 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -55.46 -39.52 90.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.131 2.554 . . . . 0.0 114.721 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -67.65 -30.38 69.92 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.041 -1.037 . . . . 0.0 111.784 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.25 -10.14 59.19 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.824 -1.172 . . . . 0.0 113.432 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.74 -55.04 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.19 62.8 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -73.57 -9.69 58.94 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.2 mmt -121.79 -28.47 4.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.502 1.121 . . . . 0.0 112.311 -171.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -21.56 66.73 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.135 -0.978 . . . . 0.0 112.895 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.34 -11.09 60.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.4 1.08 . . . . 0.0 113.28 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -102.64 0.63 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 126.86 2.064 . . . . 0.0 110.452 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.71 13.77 79.2 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.143 1.354 . . . . 0.0 114.474 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mm -87.58 152.39 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.449 1.099 . . . . 0.0 110.96 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -127.68 137.33 52.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.975 1.31 . . . . 0.0 111.429 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 pt -139.56 -7.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.402 1.081 . . . . 0.0 113.551 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -57.22 -35.07 69.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.836 1.654 . . . . 0.0 114.973 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.78 -3.17 88.28 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.366 0.984 . . . . 0.0 115.293 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -78.76 157.96 28.36 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.037 1.418 . . . . 0.0 113.707 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -132.74 175.27 9.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.024 2.13 . . . . 0.0 111.287 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.4 t -154.09 156.48 37.34 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.164 0.985 . . . . 0.0 112.775 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -142.59 161.8 47.72 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.643 1.977 . . . . 0.0 108.598 169.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.99 135.64 70.04 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.844 2.363 . . . . 0.0 112.577 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 tt -53.85 -33.33 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.36 -12.28 61.47 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.86 59.0 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.114 0.87 . . . . 0.0 112.309 169.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.11 171.95 8.75 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.15 1.38 . . . . 0.0 112.07 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -98.11 -17.12 19.25 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -168.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 60.15 -29.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.085 2.954 . . . . 0.0 116.947 -170.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.75 -36.25 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 113.07 -169.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -81.58 -0.7 43.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 111.909 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -112.25 77.83 1.08 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.714 2.006 . . . . 0.0 108.442 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.98 -24.17 8.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.07 1.748 . . . . 0.0 113.236 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.07 130.19 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.072 1.749 . . . . 0.0 108.778 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.78 121.61 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.661 -1.274 . . . . 0.0 110.29 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.58 120.22 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.072 1.349 . . . . 0.0 108.345 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -89.16 157.04 18.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.852 1.261 . . . . 0.0 109.667 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.46 43.19 3.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.442 1.097 . . . . 0.0 111.563 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.9 m -108.15 -28.93 9.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.878 1.271 . . . . 0.0 112.151 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.47 100.36 1.06 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.985 1.755 . . . . 0.0 113.666 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 67.8 m 49.17 34.02 5.56 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.65 1.58 . . . . 0.0 114.647 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.03 105.18 0.18 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.758 1.171 . . . . 0.0 112.464 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 p -142.38 143.76 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.266 1.426 . . . . 0.0 111.15 174.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -89.35 114.25 25.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.435 0.694 . . . . 0.0 109.627 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.3 mt -142.41 138.0 16.04 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.47 1.108 . . . . 0.0 112.951 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -62.6 149.55 90.7 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.681 2.254 . . . . 0.0 110.664 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.83 -34.26 84.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.13 2.553 . . . . 0.0 115.121 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -63.04 -20.39 65.28 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -88.61 -6.34 57.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.32 1.448 . . . . 0.0 114.619 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.7 m -117.26 -20.81 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 -1.67 28.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.998 1.719 . . . . 0.0 114.243 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -49.88 155.98 0.8 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.031 2.532 . . . . 0.0 114.547 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.24 -34.1 73.21 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.61 128.5 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.63 1.172 . . . . 0.0 109.344 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.14 147.79 50.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.213 1.405 . . . . 0.0 111.239 171.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -141.77 159.49 42.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.045 1.338 . . . . 0.0 111.289 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -141.26 87.41 2.08 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.824 0.85 . . . . 0.0 110.318 169.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -67.29 140.74 57.34 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 113.477 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -91.17 55.25 2.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.959 2.104 . . . . 0.0 107.607 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.65 125.12 49.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.635 1.974 . . . . 0.0 111.117 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.45 162.19 22.18 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.541 1.536 . . . . 0.0 112.382 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.04 128.75 42.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 O-C-N 121.5 -0.75 . . . . 0.0 111.076 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.23 -12.56 19.14 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.84 1.693 . . . . 0.0 112.55 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.446 ' CG ' HH22 ' A' ' 41' ' ' ARG . 30.8 t70 -49.41 126.72 13.78 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.462 1.028 . . . . 0.0 112.705 173.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.01 0.04 59.57 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 115.623 1.009 . . . . 0.0 115.623 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -101.74 -174.85 2.69 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.239 1.416 . . . . 0.0 112.29 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 t -76.3 156.58 33.3 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.481 0.712 . . . . 0.0 111.94 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.3 -25.49 68.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.929 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.0 -30.45 71.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.301 -0.874 . . . . 0.0 111.571 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.37 -40.88 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.91 -1.119 . . . . 0.0 110.541 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -57.23 -48.49 78.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.034 1.288 . . . . 0.0 111.275 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -69.36 -18.94 63.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.1 m -82.06 -55.55 4.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.838 1.255 . . . . 0.0 111.541 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.57 -29.57 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.093 0.957 . . . . 0.0 111.675 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -55.62 -42.75 75.38 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.533 1.06 . . . . 0.0 113.37 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 -32.38 62.89 Favored Glycine 0 N--CA 1.472 1.038 0 O-C-N 121.905 -0.497 . . . . 0.0 112.507 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.97 -39.01 83.43 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.95 -0.735 . . . . 0.0 111.43 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.37 -48.79 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 110.183 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.26 -48.85 70.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.009 0.924 . . . . 0.0 112.069 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -71.32 -28.58 64.19 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.887 1.221 . . . . 0.0 112.936 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -70.11 -49.72 47.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.783 0.833 . . . . 0.0 110.639 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.2 t -55.03 -49.35 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.499 1.12 . . . . 0.0 111.358 169.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.66 -51.46 65.06 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.409 1.004 . . . . 0.0 112.487 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.77 -30.88 68.56 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.832 0.742 . . . . 0.0 112.056 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.69 -50.5 66.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.541 0.737 . . . . 0.0 110.877 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.42 -37.82 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.028 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -26.67 68.89 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -85.17 -13.01 51.4 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 174.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -109.32 -25.38 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.911 1.684 . . . . 0.0 112.104 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 119.767 -0.158 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -70.32 141.02 52.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.069 0.948 . . . . 0.0 111.447 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -109.5 126.36 53.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.161 0.984 . . . . 0.0 111.6 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.9 t -96.98 111.67 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.947 1.699 . . . . 0.0 110.354 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.2 tpp -90.82 127.45 36.36 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.47 122.23 43.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.235 1.014 . . . . 0.0 111.124 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.96 142.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.1 t -157.33 174.75 14.96 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 112.425 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.88 159.65 19.24 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.962 1.305 . . . . 0.0 112.523 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -55.39 -45.46 76.63 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -169.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -82.65 -16.64 47.51 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 m -76.25 152.48 36.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.807 1.243 . . . . 0.0 113.338 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.0 p -111.11 -7.4 14.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -49.98 -37.19 31.25 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 120.959 1.709 . . . . 0.0 113.52 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -62.93 -50.96 68.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.255 1.389 . . . . 0.0 112.692 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -62.06 -38.53 89.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.255 1.022 . . . . 0.0 111.552 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.4 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 7.2 tpt -74.87 -39.26 61.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.004 0.922 . . . . 0.0 112.336 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.91 88.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.407 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -58.15 -49.5 76.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.492 169.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.53 -47.54 63.14 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 121.0 1.727 . . . . 0.0 114.409 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -67.28 -42.95 82.96 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.018 -1.283 . . . . 0.0 112.032 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.63 -31.59 69.78 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.981 -1.074 . . . . 0.0 113.338 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -65.14 -29.39 70.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 128.876 2.871 . . . . 0.0 112.751 172.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -90.49 -45.47 8.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.836 0.855 . . . . 0.0 112.102 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.03 -31.83 13.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.265 1.026 . . . . 0.0 113.345 -170.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.22 1.6 88.42 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.421 1.486 . . . . 0.0 114.166 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.78 117.56 2.57 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 118.453 1.126 . . . . 0.0 111.403 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.3 15.58 81.09 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.91 -40.03 2.34 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.075 1.437 . . . . 0.0 111.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.25 164.39 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.831 1.652 . . . . 0.0 111.553 170.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 153.96 19.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.94 0.896 . . . . 0.0 108.804 169.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.52 147.56 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 m -152.1 160.89 43.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.994 1.718 . . . . 0.0 108.83 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.3 p -135.05 154.91 51.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.211 -0.931 . . . . 0.0 112.68 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 t -150.76 129.63 12.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.044 0.938 . . . . 0.0 110.276 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.94 141.49 20.14 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.02 -34.55 63.58 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.038 1.419 . . . . 0.0 112.482 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.95 41.45 3.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.958 1.703 . . . . 0.0 110.956 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t 72.69 168.66 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.627 1.971 . . . . 0.0 112.894 -168.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -158.1 172.16 18.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.724 1.61 . . . . 0.0 112.372 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -126.14 162.94 24.21 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 0.0 114.506 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.0 m -121.89 116.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.691 1.596 . . . . 0.0 109.739 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.16 148.32 44.69 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.794 0.838 . . . . 0.0 111.398 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.5 -35.76 77.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.291 2.661 . . . . 0.0 113.852 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.0 m -61.19 -38.4 86.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.748 0.819 . . . . 0.0 112.061 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.49 60.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.078 -1.014 . . . . 0.0 113.357 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.47 -54.9 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.31 72.36 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -71.17 -7.71 48.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.217 1.007 . . . . 0.0 113.604 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.4 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 15.8 mmt -125.34 -27.24 3.5 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.59 1.156 . . . . 0.0 112.021 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.95 -27.39 66.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.064 -1.023 . . . . 0.0 112.139 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.37 -5.43 42.31 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.148 0.979 . . . . 0.0 113.041 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 t -108.99 3.14 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.622 2.369 . . . . 0.0 110.541 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.87 13.8 81.74 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.393 1.473 . . . . 0.0 114.667 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.95 151.57 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -133.17 135.05 44.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.698 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 pt -128.74 1.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.726 1.61 . . . . 0.0 112.465 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.9 p -65.48 -30.72 71.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.629 1.172 . . . . 0.0 113.769 -169.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.64 -0.42 89.24 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.431 1.015 . . . . 0.0 114.976 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -81.81 151.82 27.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.397 1.598 . . . . 0.0 112.697 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.7 p -124.94 176.02 6.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.353 1.861 . . . . 0.0 111.088 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -152.66 156.1 38.56 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 112.593 173.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -153.54 160.45 30.93 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.76 2.024 . . . . 0.0 109.272 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.35 140.07 87.76 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.341 2.694 . . . . 0.0 112.485 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.94 -30.41 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -11.9 60.39 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -21.51 56.23 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.061 0.846 . . . . 0.0 112.935 171.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -93.14 166.49 12.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.645 1.178 . . . . 0.0 112.805 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.19 109.02 17.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.542 1.537 . . . . 0.0 110.965 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.22 -15.06 62.86 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.625 -1.297 . . . . 0.0 113.666 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -57.54 -22.05 42.14 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.065 1.346 . . . . 0.0 113.131 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.17 -0.56 38.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.219 1.808 . . . . 0.0 113.037 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -124.92 76.96 1.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.242 1.817 . . . . 0.0 109.686 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -23.68 8.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.71 2.004 . . . . 0.0 113.38 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -133.33 127.86 54.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.642 1.577 . . . . 0.0 108.537 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.9 t -132.97 118.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.077 -1.015 . . . . 0.0 110.275 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -110.99 118.06 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.865 1.266 . . . . 0.0 107.932 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -87.9 155.8 19.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.123 0.969 . . . . 0.0 109.027 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.68 39.67 3.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.09 0.956 . . . . 0.0 110.885 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.7 m -102.6 -26.68 13.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.972 1.309 . . . . 0.0 111.914 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.03 102.18 1.39 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.018 1.771 . . . . 0.0 113.038 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . 0.257 28.6 p 39.03 40.41 0.46 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.884 2.074 . . . . 0.0 115.33 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.81 108.05 0.2 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.567 1.556 . . . . 0.0 111.803 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.69 142.22 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.131 1.372 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -89.87 114.84 26.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.578 0.751 . . . . 0.0 110.072 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -144.14 140.54 17.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.29 1.036 . . . . 0.0 113.155 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.47 153.73 72.93 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.549 2.166 . . . . 0.0 110.068 168.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.27 -32.48 96.96 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.184 2.589 . . . . 0.0 114.311 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.99 -24.39 67.0 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.932 -1.105 . . . . 0.0 113.765 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.4 -10.66 58.29 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.4 -22.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.125 1.37 . . . . 0.0 113.584 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -84.55 11.65 8.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.39 1.876 . . . . 0.0 113.527 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -67.68 166.8 14.42 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.722 1.609 . . . . 0.0 112.812 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.24 -35.89 82.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -133.32 128.69 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.472 0.709 . . . . 0.0 110.888 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -130.75 148.46 52.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.089 1.356 . . . . 0.0 111.613 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -142.06 161.16 38.68 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.448 1.499 . . . . 0.0 111.455 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.44 86.84 1.97 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.633 -0.667 . . . . 0.0 111.913 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -73.38 160.51 31.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.234 1.814 . . . . 0.0 114.017 -172.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -93.28 -84.39 0.3 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.156 0.983 . . . . 0.0 110.94 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 50.14 -166.21 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.51 1.924 . . . . 0.0 112.293 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.94 147.75 46.55 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.489 1.515 . . . . 0.0 107.443 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.98 129.79 52.81 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.314 0.961 . . . . 0.0 111.035 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -69.37 -14.99 38.26 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.632 1.555 . . . . 0.0 114.731 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -53.43 124.45 14.84 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.367 0.985 . . . . 0.0 112.867 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.78 3.73 60.13 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.405 1.002 . . . . 0.0 115.452 -177.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -103.62 -177.9 3.5 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.388 1.475 . . . . 0.0 112.68 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t -73.75 155.13 39.21 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.59 -0.694 . . . . 0.0 111.606 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.96 -22.36 66.89 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.213 -0.929 . . . . 0.0 111.721 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.57 -32.39 73.7 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.047 -1.033 . . . . 0.0 111.305 169.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.22 -44.05 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.858 -1.151 . . . . 0.0 110.694 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -53.79 -49.26 68.67 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.285 0.948 . . . . 0.0 111.29 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -71.42 -16.41 62.39 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 m -95.6 -35.62 11.56 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.451 1.101 . . . . 0.0 112.755 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.81 -37.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 120.274 -1.517 . . . . 0.0 111.414 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -55.1 -42.71 73.23 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.51 -32.63 67.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.182 0.896 . . . . 0.0 113.023 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -69.8 -44.89 69.12 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.84 -0.8 . . . . 0.0 110.659 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.4 t -60.23 -42.54 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.158 -0.964 . . . . 0.0 111.063 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.17 -47.65 77.87 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.034 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.93 -29.25 65.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.139 1.336 . . . . 0.0 113.562 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -62.44 -54.3 42.16 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.022 0.828 . . . . 0.0 109.979 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.37 -51.08 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.28 1.432 . . . . 0.0 112.636 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.7 -49.64 75.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.996 1.271 . . . . 0.0 112.492 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -30.19 67.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.298 0.499 . . . . 0.0 111.875 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.47 -50.21 66.21 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.768 0.827 . . . . 0.0 111.168 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.73 -41.38 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.508 1.049 . . . . 0.0 110.944 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -23.81 66.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.36 -17.27 37.23 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.1 -23.47 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.253 1.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.884 179.695 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 119.761 -0.162 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mtmm -77.45 146.28 36.59 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 112.612 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -113.56 126.11 54.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.902 1.281 . . . . 0.0 111.189 170.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.75 109.17 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.675 1.59 . . . . 0.0 110.207 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.6 tpp -87.04 128.13 35.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.525 0.602 . . . . 0.0 109.849 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -98.75 123.43 42.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.688 1.195 . . . . 0.0 109.745 169.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.34 146.21 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.724 1.21 . . . . 0.0 112.788 -176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -149.45 171.03 17.23 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.487 -0.758 . . . . 0.0 111.401 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -67.77 159.28 30.56 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.144 -0.973 . . . . 0.0 111.573 169.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.25 6.0 ppt_? -61.13 -32.93 72.63 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 -168.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -87.47 57.09 4.23 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.971 0.805 . . . . 0.0 111.284 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -153.71 156.73 38.35 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.255 1.022 . . . . 0.0 113.746 -171.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.7 p -110.7 -5.24 15.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.058 1.743 . . . . 0.0 112.974 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -60.05 -37.88 81.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.592 1.957 . . . . 0.0 114.268 -169.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -66.96 -48.33 68.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.92 1.236 . . . . 0.0 112.01 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -65.76 -42.92 90.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.59 0.756 . . . . 0.0 111.941 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 tpt -64.92 -42.41 94.74 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.867 -1.146 . . . . 0.0 112.717 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.51 88.2 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.947 0.499 . . . . 0.0 112.149 173.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.82 -36.18 78.4 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.567 -0.708 . . . . 0.0 111.841 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.57 -53.08 46.19 Favored Glycine 0 N--CA 1.471 1.004 0 CA-C-N 119.472 1.033 . . . . 0.0 112.613 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -60.33 -38.93 85.29 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.683 -0.892 . . . . 0.0 111.409 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.83 73.16 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -75.28 -22.16 57.99 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.905 1.684 . . . . 0.0 113.07 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -79.41 -45.35 19.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.314 0.646 . . . . 0.0 111.688 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -98.24 -27.2 14.25 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.46 1.104 . . . . 0.0 113.113 -172.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.87 2.66 88.08 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.253 1.883 . . . . 0.0 113.903 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 112.15 0.44 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.512 1.156 . . . . 0.0 112.656 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.67 15.57 81.47 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.373 1.309 . . . . 0.0 116.373 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.99 -40.47 3.49 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.393 1.596 . . . . 0.0 112.314 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.33 165.84 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.361 2.264 . . . . 0.0 109.931 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.27 149.12 21.89 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 170.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.43 143.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.316 -0.865 . . . . 0.0 112.493 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 m -148.23 156.72 42.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.976 1.31 . . . . 0.0 110.187 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 p -128.3 150.47 50.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 113.321 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 t -155.43 156.71 35.8 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 110.124 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.59 153.05 17.61 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 169.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.1 mt -55.48 -34.52 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.997 1.398 . . . . 0.0 111.612 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -131.03 49.86 2.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.862 1.665 . . . . 0.0 109.715 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 t 68.63 170.37 0.29 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.475 1.91 . . . . 0.0 113.437 -169.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.2 p -146.08 169.56 18.45 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.42 1.888 . . . . 0.0 111.009 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -116.78 160.29 21.02 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.37 148.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.402 1.881 . . . . 0.0 107.058 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -136.4 131.53 18.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.748 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -54.81 -38.79 91.99 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.352 2.702 . . . . 0.0 115.273 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.0 m -67.77 -31.06 70.68 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.094 -1.004 . . . . 0.0 111.718 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.4 60.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.917 -1.114 . . . . 0.0 112.673 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.2 mt -72.19 -53.62 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 -35.68 60.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -170.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.68 -8.53 54.71 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.16 -0.962 . . . . 0.0 113.444 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.0 mmt -123.64 -28.49 3.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 112.261 -171.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.43 -26.69 68.04 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.681 1.128 . . . . 0.0 112.171 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -70.34 -12.05 61.32 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 113.799 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 3.6 m -114.7 13.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.046 1.339 . . . . 0.0 111.509 168.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.044 1.783 . . . . 0.0 116.298 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.4 mm -85.07 149.56 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.334 1.567 . . . . 0.0 111.872 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -122.27 133.08 54.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.178 1.391 . . . . 0.0 111.053 169.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.56 -13.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.641 1.177 . . . . 0.0 113.837 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 m -57.68 -31.91 66.81 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.368 1.467 . . . . 0.0 114.227 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.26 2.69 81.51 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.263 1.411 . . . . 0.0 115.728 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.32 161.62 29.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.509 1.655 . . . . 0.0 112.566 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -143.4 166.3 25.13 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 0.0 110.902 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -143.81 161.26 39.1 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.304 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -151.09 160.04 32.67 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.012 1.725 . . . . 0.0 109.973 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.51 135.02 67.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.805 3.004 . . . . 0.0 112.595 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.8 -31.76 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -12.1 60.68 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -21.19 57.85 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.071 0.851 . . . . 0.0 112.77 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -94.87 167.34 11.48 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.091 1.356 . . . . 0.0 112.825 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.46 109.56 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.761 1.624 . . . . 0.0 110.967 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 -20.05 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -170.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.51 -27.36 69.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.332 1.053 . . . . 0.0 112.422 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.92 -2.17 58.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.633 1.573 . . . . 0.0 112.386 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.92 80.05 1.49 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.938 2.095 . . . . 0.0 107.92 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -25.75 11.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.234 1.814 . . . . 0.0 113.165 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.1 t -132.3 132.47 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.194 1.798 . . . . 0.0 108.969 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.4 t -134.65 121.01 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.99 122.21 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.125 1.37 . . . . 0.0 108.552 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.9 t -93.33 155.05 17.63 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.674 1.19 . . . . 0.0 109.577 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.56 46.0 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.765 1.226 . . . . 0.0 111.387 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.4 m -109.26 -32.63 7.12 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.804 1.242 . . . . 0.0 112.21 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.63 97.24 1.29 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.076 1.798 . . . . 0.0 113.538 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.1 m 48.11 36.36 6.42 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.968 1.707 . . . . 0.0 114.661 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.53 106.33 0.19 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.578 1.085 . . . . 0.0 112.449 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.4 p -141.09 141.62 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.413 1.485 . . . . 0.0 110.718 173.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -84.45 115.88 22.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.686 -0.633 . . . . 0.0 109.455 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -141.14 138.6 18.01 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.45 1.1 . . . . 0.0 112.298 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 152.96 76.62 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.259 1.973 . . . . 0.0 110.244 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 -29.24 86.33 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.837 2.358 . . . . 0.0 115.501 -169.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.36 -17.9 64.93 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -90.99 -3.18 57.47 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.88 -2.04 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.963 1.305 . . . . 0.0 114.337 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -101.37 0.95 37.93 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.141 1.776 . . . . 0.0 113.287 -171.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -53.85 159.05 1.8 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.921 2.488 . . . . 0.0 113.988 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.91 -34.57 78.25 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -134.05 130.37 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.005 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -133.12 149.03 52.13 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.336 1.454 . . . . 0.0 111.435 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -141.59 157.91 44.5 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.91 1.284 . . . . 0.0 111.351 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.5 88.73 2.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.795 0.838 . . . . 0.0 110.832 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -70.94 145.69 49.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.13 1.372 . . . . 0.0 113.752 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -101.73 60.56 0.88 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.727 2.011 . . . . 0.0 107.726 -174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.7 131.2 56.65 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.575 1.95 . . . . 0.0 111.148 -168.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -88.19 151.5 22.64 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.991 1.316 . . . . 0.0 112.138 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -93.72 126.2 50.56 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.975 0.51 . . . . 0.0 111.611 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.37 -5.29 13.42 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.077 2.518 . . . . 0.0 114.074 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -64.25 111.51 2.64 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 119.998 -1.689 . . . . 0.0 112.766 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.68 -3.66 74.89 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.538 1.542 . . . . 0.0 114.435 -173.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -98.54 178.18 5.09 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.171 1.788 . . . . 0.0 111.055 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t -70.57 156.44 39.42 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.559 0.743 . . . . 0.0 112.279 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.13 -26.12 68.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.108 0.963 . . . . 0.0 111.62 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.34 -34.28 77.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.412 -0.805 . . . . 0.0 111.25 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -69.02 -41.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.644 -1.285 . . . . 0.0 110.476 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -56.3 -48.25 77.04 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.996 1.271 . . . . 0.0 111.421 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -70.44 -17.73 63.0 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.0 m -89.22 -41.08 12.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.048 1.339 . . . . 0.0 112.293 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.69 -36.31 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.538 -1.351 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -56.15 -42.29 76.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.27 -31.5 63.64 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 123.328 0.489 . . . . 0.0 112.42 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -70.03 -39.0 76.04 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.901 -0.764 . . . . 0.0 111.527 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.46 -46.74 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.366 0.667 . . . . 0.0 110.036 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.87 -51.23 66.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.366 1.066 . . . . 0.0 112.008 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.91 -29.6 67.9 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.022 1.283 . . . . 0.0 112.487 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.4 mtt85 -69.83 -53.85 16.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.382 -0.824 . . . . 0.0 111.025 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -53.54 -49.89 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.899 1.279 . . . . 0.0 112.439 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -66.21 -47.11 74.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.52 1.055 . . . . 0.0 112.135 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -31.58 68.47 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.423 1.011 . . . . 0.0 111.973 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.23 -51.13 68.98 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.518 0.727 . . . . 0.0 110.53 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.2 mt -69.11 -38.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.496 -0.753 . . . . 0.0 111.173 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.82 -26.82 68.8 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -87.79 -15.61 36.42 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -109.67 -18.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 124.661 1.185 . . . . 0.0 113.143 179.303 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 119.908 -0.092 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -72.64 142.53 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.971 0.908 . . . . 0.0 112.07 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.15 127.72 54.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.373 1.069 . . . . 0.0 111.308 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.88 116.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.2 ttm -99.8 124.97 45.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 110.076 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -95.3 127.64 41.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.22 0.608 . . . . 0.0 110.207 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.49 139.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.55 166.53 24.34 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 0.0 112.731 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -86.22 177.8 7.39 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.944 0.897 . . . . 0.0 111.553 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -54.26 150.64 8.29 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.961 1.304 . . . . 0.0 113.428 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t30 51.43 58.6 5.33 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.973 1.709 . . . . 0.0 112.562 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.8 t -138.9 143.98 38.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.333 1.053 . . . . 0.0 113.086 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.2 p -106.51 -6.38 18.16 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.662 0.785 . . . . 0.0 112.897 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -64.5 -28.02 69.37 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.641 1.176 . . . . 0.0 113.084 -169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 p -71.61 -49.9 35.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.971 1.26 . . . . 0.0 112.13 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -63.65 -33.1 74.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.263 0.625 . . . . 0.0 112.291 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 tpt -76.87 -41.58 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.174 -0.954 . . . . 0.0 112.337 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.85 94.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.39 -45.26 88.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.11 -46.59 77.75 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 119.778 1.172 . . . . 0.0 114.806 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.447 1.123 . . . . 0.0 111.593 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.14 -32.94 63.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.468 -1.395 . . . . 0.0 113.989 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -67.48 -22.67 65.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.323 1.419 . . . . 0.0 113.05 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.4 m -87.28 -47.64 8.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.496 1.118 . . . . 0.0 111.581 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.7 mt -95.42 -31.86 13.18 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.468 1.107 . . . . 0.0 113.313 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.47 3.08 87.26 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.704 1.621 . . . . 0.0 113.159 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.36 122.0 5.64 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 117.919 0.86 . . . . 0.0 111.841 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.44 79.29 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 118.732 -1.038 . . . . 0.0 115.453 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -121.66 -42.22 2.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.341 1.57 . . . . 0.0 111.039 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.93 161.18 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 112.95 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 153.76 18.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.74 145.39 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.812 -1.18 . . . . 0.0 113.661 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 m -142.84 147.36 35.28 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.435 1.894 . . . . 0.0 109.784 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -115.02 148.82 38.36 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.024 -1.048 . . . . 0.0 112.407 170.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 t -153.35 159.26 42.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.793 1.237 . . . . 0.0 110.531 -170.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.86 154.8 19.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.9 0.762 . . . . 0.0 112.036 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.79 -34.08 72.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.318 1.059 . . . . 0.0 112.132 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -132.49 29.59 4.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.234 1.414 . . . . 0.0 111.538 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 63.81 168.34 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.955 1.702 . . . . 0.0 114.712 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t -163.21 -178.66 6.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.5 2.32 . . . . 0.0 111.828 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -123.48 172.45 8.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.249 1.82 . . . . 0.0 114.485 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 147.02 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 125.675 1.59 . . . . 0.0 108.647 168.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.06 148.46 39.08 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 125.545 1.538 . . . . 0.0 111.511 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -54.81 -34.5 85.25 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.3 2.667 . . . . 0.0 113.871 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -61.25 -36.31 79.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.631 0.772 . . . . 0.0 112.099 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.34 -10.83 59.81 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.935 -1.103 . . . . 0.0 113.558 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.37 -53.1 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 168.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.05 68.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mmt -72.72 -9.52 58.73 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 mmt -124.56 -27.59 3.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.144 -170.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.3 -25.34 68.27 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.836 -1.165 . . . . 0.0 112.28 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.93 -9.47 58.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 t -105.69 4.67 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 126.888 2.075 . . . . 0.0 110.376 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.97 12.49 83.34 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.529 -1.357 . . . . 0.0 114.935 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.71 150.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 118.572 1.186 . . . . 0.0 111.069 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -135.46 97.24 3.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.286 1.434 . . . . 0.0 111.357 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.2 11.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.6 p -61.93 -27.52 68.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.632 -1.293 . . . . 0.0 113.365 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.28 -2.68 90.34 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.901 1.239 . . . . 0.0 115.031 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -87.7 156.24 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.849 1.324 . . . . 0.0 112.373 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 t -147.56 -178.24 6.14 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.715 1.606 . . . . 0.0 109.53 172.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.9 167.49 10.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.482 1.113 . . . . 0.0 112.606 175.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.49 155.52 39.1 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.2 1.4 . . . . 0.0 110.91 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.61 136.6 50.7 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.676 2.917 . . . . 0.0 113.755 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.8 tp -52.83 -36.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.719 1.207 . . . . 0.0 114.12 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.38 -10.81 59.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -17.37 52.25 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.09 0.859 . . . . 0.0 113.085 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -93.1 175.48 6.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.505 1.522 . . . . 0.0 112.9 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.16 109.55 13.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.929 1.692 . . . . 0.0 110.86 174.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.3 -16.41 64.02 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -169.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.51 -23.7 66.28 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.846 0.858 . . . . 0.0 112.413 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.15 -0.99 57.42 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.289 1.835 . . . . 0.0 112.077 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -119.22 82.33 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.176 2.19 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.11 -27.64 14.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.223 1.809 . . . . 0.0 113.09 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.99 127.8 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.584 1.554 . . . . 0.0 108.966 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -133.54 124.69 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.956 -1.09 . . . . 0.0 109.763 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mm -124.42 110.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.032 1.333 . . . . 0.0 109.358 -170.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 m -86.15 154.53 21.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.649 0.779 . . . . 0.0 110.983 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.47 44.0 2.84 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.234 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.1 m -106.39 0.94 25.3 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.782 1.633 . . . . 0.0 113.653 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.25 69.07 1.44 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.518 1.532 . . . . 0.0 114.042 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 63.2 m 48.75 45.83 21.79 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.45 1.5 . . . . 0.0 113.778 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.13 14.76 0.07 OUTLIER Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.968 1.27 . . . . 0.0 115.887 -172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -63.02 144.97 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.265 1.533 . . . . 0.0 111.265 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -106.09 128.76 54.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.963 0.905 . . . . 0.0 109.159 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.3 mt -146.55 148.48 33.99 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.136 0.974 . . . . 0.0 112.99 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.66 152.51 80.09 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.663 2.242 . . . . 0.0 109.897 168.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.28 -23.77 75.51 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.303 2.668 . . . . 0.0 115.391 -169.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -16.36 62.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -91.34 -3.3 56.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.36 9.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 125.618 1.567 . . . . 0.0 113.85 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -111.39 -3.09 15.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.392 1.877 . . . . 0.0 113.152 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -58.0 158.62 6.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.432 2.693 . . . . 0.0 114.31 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.42 -33.67 76.41 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.86 127.39 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.979 0.912 . . . . 0.0 109.825 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -135.84 148.43 48.66 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.621 1.568 . . . . 0.0 111.756 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -149.16 157.74 43.62 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.597 1.959 . . . . 0.0 110.366 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -137.66 77.32 1.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.423 0.63 . . . . 0.0 111.42 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -64.17 160.0 19.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.12 1.768 . . . . 0.0 114.417 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.15 43.17 1.51 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.139 1.776 . . . . 0.0 113.75 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.13 138.49 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.507 -0.746 . . . . 0.0 111.05 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -85.82 148.77 25.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.67 131.11 46.47 Favored Pre-proline 0 CA--C 1.538 0.498 0 O-C-N 121.464 -0.773 . . . . 0.0 111.162 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.15 -7.56 17.23 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.054 1.836 . . . . 0.0 113.495 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -52.61 124.38 13.56 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.304 1.411 . . . . 0.0 112.062 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.78 4.53 66.64 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -107.07 178.7 4.48 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.523 1.529 . . . . 0.0 112.657 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t -72.04 158.49 35.87 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.944 0.898 . . . . 0.0 112.229 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.01 -27.61 69.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.379 1.072 . . . . 0.0 111.376 175.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.34 -31.7 72.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.953 . . . . 0.0 111.911 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.87 -41.73 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.978 -1.076 . . . . 0.0 110.438 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -56.05 -49.0 74.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.759 1.163 . . . . 0.0 111.442 170.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -70.13 -19.28 63.23 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.1 m -81.17 -54.36 5.58 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.857 1.263 . . . . 0.0 111.324 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.17 -34.52 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.555 1.142 . . . . 0.0 111.541 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -55.65 -41.01 72.98 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.213 0.915 . . . . 0.0 112.684 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.55 -33.02 64.08 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.774 0.702 . . . . 0.0 113.002 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -68.86 -40.53 79.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.113 0.956 . . . . 0.0 111.183 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.34 -49.92 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.167 0.987 . . . . 0.0 110.318 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -54.12 -49.01 70.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.411 1.084 . . . . 0.0 112.045 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -70.54 -28.98 65.34 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.802 1.183 . . . . 0.0 112.697 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -72.59 -47.98 43.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.78 -42.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.102 0.961 . . . . 0.0 111.626 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -61.29 -47.22 86.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.79 1.177 . . . . 0.0 112.183 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.13 -35.73 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.569 0.622 . . . . 0.0 112.016 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.501 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.9 tm? -56.96 -52.03 66.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.56 1.144 . . . . 0.0 110.699 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.86 -42.23 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.614 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.99 68.81 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -91.23 -6.62 53.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.68 -16.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.255 1.389 0 C-N-CA 125.467 1.507 . . . . 0.0 112.104 172.078 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -73.75 143.16 46.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.914 0.886 . . . . 0.0 111.835 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -108.67 124.37 50.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.731 1.212 . . . . 0.0 111.236 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.5 t -96.02 109.17 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 110.173 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -88.31 130.62 35.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.504 0.321 . . . . 0.0 110.201 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -104.01 124.29 48.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.302 1.041 . . . . 0.0 110.73 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.2 138.07 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.309 1.044 . . . . 0.0 113.757 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -144.08 176.96 8.91 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.213 1.005 . . . . 0.0 112.64 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -79.01 158.51 27.91 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.785 1.234 . . . . 0.0 111.884 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -50.68 -40.95 55.14 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -168.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -72.57 -17.04 61.74 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.1 t -90.79 159.92 16.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.5 p -113.44 4.65 16.37 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.064 1.746 . . . . 0.0 111.877 168.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 -73.58 -25.58 60.42 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.056 -1.653 . . . . 0.0 113.098 -170.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -63.58 -43.36 97.21 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.196 0.907 . . . . 0.0 110.759 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -69.27 -40.09 78.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.626 0.77 . . . . 0.0 111.769 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.2 tpt -71.1 -38.21 72.36 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.234 -0.916 . . . . 0.0 112.562 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.57 98.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.333 0.653 . . . . 0.0 111.116 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.28 -40.19 77.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.914 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.05 -53.3 46.93 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 119.573 1.079 . . . . 0.0 113.53 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -61.52 -39.99 93.04 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.608 -0.937 . . . . 0.0 110.993 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.035 -1.041 . . . . 0.0 113.8 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -71.61 -22.04 61.76 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.789 1.177 . . . . 0.0 112.835 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -86.49 -43.91 12.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.939 0.895 . . . . 0.0 112.083 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.1 -35.13 11.45 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.775 0.83 . . . . 0.0 112.973 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.61 8.76 76.3 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 125.719 1.628 . . . . 0.0 114.188 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.17 -41.83 1.36 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -172.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 18.47 30.84 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.335 1.445 . . . . 0.0 115.078 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.69 -43.79 2.88 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.291 1.546 . . . . 0.0 111.941 -169.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -149.24 165.67 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.851 1.66 . . . . 0.0 112.087 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.55 152.08 22.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.625 0.77 . . . . 0.0 109.241 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.3 t -135.89 137.61 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.802 1.241 . . . . 0.0 111.047 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 m -144.6 154.26 42.64 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.102 1.361 . . . . 0.0 110.433 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -126.47 156.17 41.11 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.041 -1.037 . . . . 0.0 113.687 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -156.46 162.55 39.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 110.231 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.82 155.32 20.57 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.32 -0.862 . . . . 0.0 111.327 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.0 -30.42 70.93 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.527 -0.984 . . . . 0.0 112.006 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -129.46 38.53 3.86 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 72.2 177.91 0.25 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.224 1.809 . . . . 0.0 112.138 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -137.35 -173.39 3.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.462 1.905 . . . . 0.0 111.623 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.09 158.69 43.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 113.326 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.3 t -101.92 146.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -129.57 123.86 21.55 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.997 -1.002 . . . . 0.0 112.567 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.73 -37.76 91.7 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.264 2.643 . . . . 0.0 115.116 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -66.82 -31.44 72.07 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.457 -0.777 . . . . 0.0 111.763 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.13 80.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.647 1.112 . . . . 0.0 110.838 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 mt -54.87 -49.58 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.042 0.537 . . . . 0.0 109.552 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.76 61.92 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.9 mmt -78.21 -22.39 48.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.204 -0.935 . . . . 0.0 112.857 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.8 mmt -106.39 -16.84 14.45 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.59 -25.42 67.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.185 1.357 . . . . 0.0 112.835 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.47 -7.0 51.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.34 1.056 . . . . 0.0 113.319 172.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.9 t -106.33 3.08 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.914 2.086 . . . . 0.0 110.312 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.47 81.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.238 1.399 . . . . 0.0 114.815 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -90.88 154.73 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.577 1.151 . . . . 0.0 110.497 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -141.85 133.46 26.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.71 0.804 . . . . 0.0 111.549 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 pt -132.29 12.19 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.056 0.942 . . . . 0.0 113.535 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -57.44 -33.83 68.34 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.628 1.104 . . . . 0.0 112.593 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.33 3.29 86.66 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.029 1.3 . . . . 0.0 115.923 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -76.03 160.41 29.85 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.028 1.914 . . . . 0.0 113.183 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.3 p -133.31 171.82 13.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.28 1.832 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 t -149.64 161.82 41.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.413 1.085 . . . . 0.0 111.298 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.65 160.49 35.87 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.139 1.776 . . . . 0.0 109.62 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.7 135.52 64.53 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.179 2.586 . . . . 0.0 112.294 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.93 -30.92 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -171.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.85 -14.24 62.79 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -20.56 57.9 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 119.305 0.957 . . . . 0.0 113.029 173.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -95.39 167.42 11.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.774 1.23 . . . . 0.0 112.982 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 110.61 20.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.826 1.65 . . . . 0.0 111.098 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.52 -18.83 65.19 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -170.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.15 -26.88 68.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.665 1.186 . . . . 0.0 112.677 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.57 -2.84 58.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.73 1.612 . . . . 0.0 112.253 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -116.54 80.49 1.47 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.806 2.042 . . . . 0.0 107.882 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.65 -26.6 14.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 113.012 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -132.81 131.19 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.79 1.636 . . . . 0.0 109.381 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.52 120.69 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.238 -0.913 . . . . 0.0 110.598 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.91 120.62 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.079 1.352 . . . . 0.0 108.106 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -91.9 157.01 17.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.047 1.339 . . . . 0.0 109.848 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.41 45.35 2.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.607 0.763 . . . . 0.0 111.636 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -122.84 16.53 10.16 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.48 44.51 95.11 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.695 1.134 . . . . 0.0 114.116 171.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 78.2 m 64.1 5.22 2.35 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.21 1.804 . . . . 0.0 114.83 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.57 18.71 49.99 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.307 1.908 . . . . 0.0 115.109 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -71.93 141.42 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.42 1.61 . . . . 0.0 110.959 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -108.95 125.95 52.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.887 1.275 . . . . 0.0 108.954 169.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -143.57 141.79 19.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.994 0.917 . . . . 0.0 113.142 -170.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.42 155.11 67.93 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.463 2.109 . . . . 0.0 110.11 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.38 -22.95 71.78 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.93 2.42 . . . . 0.0 115.016 -169.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.25 -16.97 61.93 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -91.07 -1.68 57.74 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.66 2.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.66 1.584 . . . . 0.0 114.085 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -109.19 7.94 25.65 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.923 1.689 . . . . 0.0 113.231 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -62.06 162.91 8.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.446 2.298 . . . . 0.0 113.21 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.01 129.55 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.909 0.883 . . . . 0.0 110.177 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -133.21 148.53 52.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.557 1.543 . . . . 0.0 111.34 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -141.1 159.0 43.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.975 1.31 . . . . 0.0 111.871 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -141.75 99.18 3.49 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 0.0 110.19 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.88 153.84 34.35 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.893 1.277 . . . . 0.0 113.194 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -101.59 39.2 1.47 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.645 1.578 . . . . 0.0 112.374 -168.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 162.86 14.87 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.141 1.377 . . . . 0.0 113.684 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.22 154.23 40.46 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.774 1.629 . . . . 0.0 111.267 -174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -86.73 126.84 62.39 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 121.686 -0.634 . . . . 0.0 111.659 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.06 -13.92 4.31 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.746 2.297 . . . . 0.0 114.004 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -63.56 -34.35 77.6 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.549 1.068 . . . . 0.0 113.207 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.02 5.07 51.67 Favored Glycine 0 CA--C 1.541 1.683 0 O-C-N 121.409 -0.807 . . . . 0.0 114.43 171.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -136.95 -165.63 1.77 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.769 2.028 . . . . 0.0 111.875 -169.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.4 t -78.85 158.75 28.07 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.216 1.006 . . . . 0.0 112.599 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.75 -22.58 66.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.092 0.957 . . . . 0.0 111.625 170.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.76 -33.8 76.46 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.037 -1.039 . . . . 0.0 110.478 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.0 t -72.89 -35.96 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.799 -1.188 . . . . 0.0 110.649 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.03 -47.41 83.18 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.54 1.518 . . . . 0.0 110.417 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -68.78 -17.05 63.97 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.7 m -88.67 -41.38 12.64 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.224 1.409 . . . . 0.0 112.629 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -73.96 -34.15 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 120.533 -1.354 . . . . 0.0 111.371 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.93 -40.63 73.42 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.84 60.77 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.749 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.93 -43.04 75.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.902 0.851 . . . . 0.0 110.722 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.58 -48.12 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.294 0.638 . . . . 0.0 110.56 169.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -58.47 -49.58 76.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.731 1.212 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.47 -29.0 64.34 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.018 1.281 . . . . 0.0 112.263 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -68.41 -50.7 50.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.59 0.756 . . . . 0.0 111.214 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.53 -48.62 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.162 0.985 . . . . 0.0 111.527 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.88 -50.93 66.83 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.557 1.071 . . . . 0.0 112.625 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -31.09 67.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.652 0.66 . . . . 0.0 111.998 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.45 -51.69 66.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.394 0.677 . . . . 0.0 110.314 169.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.8 -36.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.148 -0.97 . . . . 0.0 111.464 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -85.48 -20.03 30.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 pt -101.59 -18.07 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 124.971 1.308 . . . . 0.0 113.071 177.614 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 119.192 -0.432 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -70.44 138.64 51.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.124 0.875 . . . . 0.0 111.242 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -111.17 125.47 53.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.472 1.109 . . . . 0.0 111.361 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 68.5 t -95.72 114.11 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.048 1.739 . . . . 0.0 110.037 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -96.53 125.78 41.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.897 0.771 . . . . 0.0 110.891 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -92.01 124.08 35.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.715 0.806 . . . . 0.0 108.886 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.55 132.24 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.293 1.037 . . . . 0.0 112.469 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.9 p -138.26 172.04 13.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.17 169.16 18.13 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.972 0.909 . . . . 0.0 111.019 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -46.68 89.11 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -87.05 61.26 6.68 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.052 0.941 . . . . 0.0 111.443 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 t -150.35 149.23 29.8 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.243 1.017 . . . . 0.0 113.436 -171.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.2 m -113.81 -1.29 13.95 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.223 1.809 . . . . 0.0 112.101 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -62.58 -45.22 93.9 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.196 1.798 . . . . 0.0 112.696 -169.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 m -64.16 -38.99 93.06 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.622 1.101 . . . . 0.0 112.4 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -66.55 -44.24 82.88 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.734 0.413 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -39.24 82.12 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.773 0.829 . . . . 0.0 111.99 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.72 -46.01 92.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.43 -41.06 79.69 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.89 -63.76 4.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.722 1.153 . . . . 0.0 113.72 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -62.64 -34.85 77.9 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.699 1.25 . . . . 0.0 111.946 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.18 77.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -70.53 -27.89 64.51 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.883 1.674 . . . . 0.0 112.441 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.7 m -77.27 -46.02 24.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.363 1.065 . . . . 0.0 112.275 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.24 -27.76 14.85 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.036 0.934 . . . . 0.0 113.239 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 2.1 88.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.126 2.298 . . . . 0.0 113.608 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.42 114.79 1.03 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.409 1.104 . . . . 0.0 112.419 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.69 16.62 76.14 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.636 1.014 . . . . 0.0 115.636 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -119.08 -36.24 3.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.204 1.502 . . . . 0.0 111.92 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -150.61 166.32 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 127.544 2.338 . . . . 0.0 110.393 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.76 153.84 18.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 168.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.48 144.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.458 -1.401 . . . . 0.0 114.682 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -150.61 158.22 43.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.636 1.574 . . . . 0.0 110.726 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -123.55 149.18 45.56 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.016 1.726 . . . . 0.0 111.825 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 t -152.04 147.54 26.62 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.296 . . . . 0.0 110.586 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.87 143.47 17.09 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 168.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.69 -38.51 33.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.214 1.507 . . . . 0.0 112.22 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -123.74 40.87 3.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.838 1.655 . . . . 0.0 111.354 171.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 73.38 164.91 0.29 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.051 2.14 . . . . 0.0 114.333 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -148.4 166.84 26.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.294 2.238 . . . . 0.0 112.338 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -121.65 147.59 45.66 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.526 1.13 . . . . 0.0 113.756 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -80.18 -38.59 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 62.98 123.79 0.02 OUTLIER Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 128.815 2.846 . . . . 0.0 116.489 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 -38.95 79.79 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.929 3.086 . . . . 0.0 116.318 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -31.96 73.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.657 -1.277 . . . . 0.0 111.823 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.44 -8.19 58.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.653 -1.279 . . . . 0.0 113.603 172.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.81 -53.72 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 168.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.49 -33.52 60.8 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 mmt -71.86 -12.65 61.38 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.298 -0.876 . . . . 0.0 113.262 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.1 mmt -120.35 -27.25 5.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.593 1.157 . . . . 0.0 112.476 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.74 -25.15 68.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.852 -1.155 . . . . 0.0 112.637 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -70.63 -15.06 62.7 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.01 5.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 126.47 1.908 . . . . 0.0 110.664 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.18 12.37 83.31 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.389 1.471 . . . . 0.0 114.617 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -87.28 149.16 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.354 1.077 . . . . 0.0 111.312 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.47 125.52 44.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.45 1.5 . . . . 0.0 111.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.5 pt -134.49 -7.03 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.1 p -67.42 -28.23 67.73 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.125 1.33 . . . . 0.0 113.849 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.78 -2.11 90.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.843 1.211 . . . . 0.0 115.023 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -81.64 161.68 23.36 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.001 1.401 . . . . 0.0 112.469 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -140.31 -179.9 6.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.03 1.332 . . . . 0.0 111.376 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -154.44 160.84 41.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.066 1.346 . . . . 0.0 111.823 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -159.46 155.98 24.39 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.784 1.634 . . . . 0.0 108.799 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.56 136.26 63.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.361 2.707 . . . . 0.0 113.047 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.0 -33.15 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.68 -11.41 60.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.07 -24.44 59.5 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.215 -0.928 . . . . 0.0 112.373 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -93.35 165.65 12.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.906 1.282 . . . . 0.0 112.402 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.9 110.55 20.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.521 1.528 . . . . 0.0 111.118 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.54 -19.32 65.27 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.38 -26.37 67.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.28 1.032 . . . . 0.0 112.403 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -87.51 -1.67 58.09 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.002 1.721 . . . . 0.0 112.037 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.07 82.0 1.76 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.711 2.004 . . . . 0.0 108.154 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.28 -24.82 12.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.167 1.787 . . . . 0.0 113.018 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.7 t -133.9 130.74 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.777 1.631 . . . . 0.0 108.969 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.92 123.78 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.309 -0.869 . . . . 0.0 110.633 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.6 121.23 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.178 1.391 . . . . 0.0 107.962 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 t -85.21 147.71 26.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.511 1.124 . . . . 0.0 109.985 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -124.06 24.82 8.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.524 1.129 . . . . 0.0 112.456 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.8 m -83.59 -19.6 35.23 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -171.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.75 60.1 5.58 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.002 0.811 . . . . 0.0 112.122 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.4 t 62.56 173.02 0.14 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.098 2.159 . . . . 0.0 113.5 -169.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.17 33.84 86.42 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 121.113 -0.992 . . . . 0.0 114.643 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.9 p -90.93 137.12 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.405 1.082 . . . . 0.0 111.592 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -95.38 122.91 38.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.432 1.093 . . . . 0.0 109.54 170.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -139.84 136.95 17.77 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.615 1.166 . . . . 0.0 111.673 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.96 153.14 70.67 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.424 2.082 . . . . 0.0 110.064 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.71 -26.96 80.5 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.954 2.436 . . . . 0.0 114.104 -169.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.4 -19.62 65.85 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -90.1 -3.64 57.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -118.53 -9.76 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.79 1.236 . . . . 0.0 114.311 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -93.09 2.75 56.59 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.939 1.695 . . . . 0.0 113.511 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -53.42 158.76 1.62 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.404 2.281 . . . . 0.0 113.775 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -34.03 76.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -133.65 127.86 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.385 1.074 . . . . 0.0 110.05 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -130.91 148.27 52.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 111.103 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -141.88 159.09 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.672 1.189 . . . . 0.0 112.031 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.27 110.57 8.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.21 1.004 . . . . 0.0 108.882 168.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -87.68 145.66 26.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.6 1.16 . . . . 0.0 111.529 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -104.96 46.19 0.93 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.686 1.595 . . . . 0.0 108.555 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -102.02 132.81 47.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.572 2.349 . . . . 0.0 111.359 -168.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -90.34 151.85 21.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.317 1.447 . . . . 0.0 112.319 -173.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -88.75 131.71 40.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.768 -0.582 . . . . 0.0 111.86 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -86.85 -15.01 4.05 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.7 2.267 . . . . 0.0 115.371 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -70.0 -30.0 67.21 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.016 1.735 . . . . 0.0 113.289 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.7 4.03 46.35 Favored Glycine 0 CA--C 1.54 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 114.046 169.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -136.49 -169.64 2.5 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.156 1.783 . . . . 0.0 113.063 -169.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 t -77.23 161.33 28.24 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.019 0.928 . . . . 0.0 112.157 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.87 -25.2 66.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.136 -0.977 . . . . 0.0 111.754 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.29 -29.37 70.46 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.228 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -72.0 -36.86 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 120.803 -1.186 . . . . 0.0 111.047 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -58.93 -46.73 87.25 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.435 1.471 . . . . 0.0 110.452 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -71.73 -18.21 62.15 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.109 0.964 . . . . 0.0 113.59 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 m -85.06 -52.87 5.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.575 1.55 . . . . 0.0 111.923 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.6 -31.92 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.934 1.294 . . . . 0.0 111.863 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -53.97 -43.42 69.91 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.601 1.091 . . . . 0.0 113.432 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.97 -32.74 65.93 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.771 0.701 . . . . 0.0 112.853 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -69.98 -40.34 75.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.41 -47.82 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.854 0.862 . . . . 0.0 110.329 171.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.0 -49.01 77.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.33 -28.36 66.17 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 121.376 1.898 . . . . 0.0 112.999 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -68.41 -49.0 63.17 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.473 -0.767 . . . . 0.0 111.654 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.24 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.022 0.828 . . . . 0.0 112.526 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -63.7 -50.72 68.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 120.207 1.367 . . . . 0.0 112.45 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.31 -31.06 69.29 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.951 0.796 . . . . 0.0 112.149 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.77 -49.72 69.63 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.396 0.678 . . . . 0.0 110.723 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.67 -40.76 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.988 -174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -27.04 68.84 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -88.49 -18.94 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -105.35 -18.36 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.256 1.4 0 C-N-CA 124.773 1.229 . . . . 0.0 113.222 179.054 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 119.75 -0.166 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -70.55 143.16 51.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.947 . . . . 0.0 111.94 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -110.73 126.23 54.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.015 . . . . 0.0 111.092 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.38 118.03 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.814 1.646 . . . . 0.0 109.995 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.5 tpp -97.81 119.44 36.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.651 0.659 . . . . 0.0 109.861 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.32 124.09 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.178 0.591 . . . . 0.0 110.391 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.03 144.54 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.242 1.017 . . . . 0.0 112.832 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.6 t -147.44 164.17 34.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.243 1.417 . . . . 0.0 109.497 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -73.1 -55.86 5.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.186 1.357 . . . . 0.0 113.201 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -146.46 178.04 8.58 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 127.063 2.145 . . . . 0.0 113.122 -169.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.266 39.6 t30 60.61 -128.01 0.96 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.925 2.49 . . . . 0.0 116.361 169.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 t -139.5 -169.88 2.79 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.049 1.339 . . . . 0.0 113.245 -169.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.7 t 50.86 -128.45 2.32 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.119 1.768 . . . . 0.0 110.262 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 39.43 -102.87 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.588 1.955 . . . . 0.0 114.762 169.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -63.91 -44.48 92.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.701 1.592 . . . . 0.0 112.942 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -63.08 -37.31 86.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.731 0.812 . . . . 0.0 111.543 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.412 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 8.1 tpt -74.83 -36.95 62.4 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.35 94.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.946 0.898 . . . . 0.0 109.917 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.86 -43.88 94.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.157 0.89 . . . . 0.0 111.769 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.1 -52.56 48.47 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 119.556 1.071 . . . . 0.0 113.83 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -68.18 -39.39 82.53 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.81 -1.406 . . . . 0.0 111.588 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.13 74.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.855 -1.153 . . . . 0.0 113.699 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -78.31 -15.54 58.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.2 1.364 . . . . 0.0 113.579 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.5 m -89.46 -44.95 9.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.255 1.022 . . . . 0.0 111.917 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.71 -29.07 14.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.673 1.189 . . . . 0.0 113.375 -174.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.35 2.27 88.17 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 126.419 1.961 . . . . 0.0 113.977 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.55 115.46 1.14 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.438 1.119 . . . . 0.0 112.385 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.64 10.83 85.86 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.85 -40.36 4.02 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.652 1.726 . . . . 0.0 112.493 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -148.29 161.7 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.51 2.324 . . . . 0.0 109.782 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 144.34 26.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.84 142.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.198 -0.939 . . . . 0.0 112.576 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -148.96 160.27 43.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.849 1.66 . . . . 0.0 109.435 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 p -136.84 153.46 50.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.9 t -152.27 152.91 32.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.283 1.433 . . . . 0.0 110.611 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.59 140.98 16.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.71 -37.63 84.86 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.499 1.65 . . . . 0.0 111.018 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.74 33.78 4.36 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.814 1.646 . . . . 0.0 111.064 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 64.01 168.84 0.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.789 2.035 . . . . 0.0 114.491 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 81.9 p -150.3 167.35 27.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.746 1.619 . . . . 0.0 112.526 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -137.44 170.96 15.18 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.039 1.336 . . . . 0.0 112.099 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.23 112.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.99 0.9 . . . . 0.0 110.762 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -78.78 134.72 60.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.01 1.324 . . . . 0.0 110.534 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.54 -37.49 90.32 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.985 2.457 . . . . 0.0 115.092 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 m -65.98 -32.32 73.74 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.86 -1.15 . . . . 0.0 111.604 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.37 -5.76 44.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.573 -1.329 . . . . 0.0 113.93 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.31 -55.93 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 167.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.22 78.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 82.3 mmm -73.38 -1.75 19.43 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.412 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.5 mmt -121.34 -29.02 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.64 1.176 . . . . 0.0 111.207 -173.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.68 -27.5 64.88 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.324 0.65 . . . . 0.0 111.951 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.83 -15.87 63.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.595 1.158 . . . . 0.0 113.935 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -120.19 24.58 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 126.175 1.79 . . . . 0.0 111.042 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.92 12.36 84.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.723 1.63 . . . . 0.0 116.128 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mm -93.13 152.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 118.855 1.328 . . . . 0.0 111.466 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -134.54 136.26 42.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.004 1.322 . . . . 0.0 110.97 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.34 0.74 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.543 1.537 . . . . 0.0 112.485 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.6 p -62.37 -28.17 69.58 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -169.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.86 -4.48 88.69 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.625 1.107 . . . . 0.0 115.167 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -81.8 154.54 25.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.108 1.454 . . . . 0.0 113.406 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -134.12 178.87 6.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.007 2.123 . . . . 0.0 110.805 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -153.22 162.89 40.81 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.178 -0.951 . . . . 0.0 112.26 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.44 158.17 38.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.35 1.86 . . . . 0.0 109.085 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.02 136.55 73.47 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.262 2.641 . . . . 0.0 112.14 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.62 -29.95 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.23 -14.78 62.47 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.27 -19.87 59.47 Favored 'General case' 0 CA--C 1.553 1.079 0 O-C-N 121.421 -0.799 . . . . 0.0 113.149 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.44 170.39 9.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.176 1.39 . . . . 0.0 112.866 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.8 108.28 14.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 111.287 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.27 -18.66 65.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -170.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.01 -26.12 68.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.156 0.982 . . . . 0.0 112.507 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.16 -1.72 58.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.109 1.764 . . . . 0.0 111.851 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -118.11 82.02 1.77 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 127.122 2.169 . . . . 0.0 108.651 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.19 -27.06 13.14 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.095 1.758 . . . . 0.0 113.067 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.1 t -131.4 130.85 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.802 1.641 . . . . 0.0 108.706 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.7 t -133.77 126.33 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.079 -1.013 . . . . 0.0 109.838 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.2 mm -126.64 111.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.61 1.164 . . . . 0.0 109.687 -170.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.2 t -87.49 156.87 19.35 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.493 1.117 . . . . 0.0 112.145 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.6 41.48 3.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.643 1.577 . . . . 0.0 111.68 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.6 m -106.32 -27.81 10.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.783 1.233 . . . . 0.0 112.4 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.05 88.48 1.65 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.774 1.654 . . . . 0.0 113.995 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.0 t 46.3 42.97 11.06 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.843 1.657 . . . . 0.0 114.233 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.85 106.96 0.19 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.165 1.364 . . . . 0.0 111.941 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -145.49 142.46 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.153 1.381 . . . . 0.0 111.545 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -88.79 52.14 2.34 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.4 1.08 . . . . 0.0 112.502 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.96 142.78 65.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.52 154.29 72.64 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.342 2.028 . . . . 0.0 109.952 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.17 -25.27 76.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.935 2.423 . . . . 0.0 114.868 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.07 -16.37 63.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -93.16 -2.23 55.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.94 0.93 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.345 1.458 . . . . 0.0 113.941 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -103.14 -1.14 29.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.319 1.848 . . . . 0.0 113.222 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -54.88 161.55 1.56 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.241 2.616 . . . . 0.0 114.352 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.98 -35.01 79.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.8 mt -133.84 131.59 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.444 1.098 . . . . 0.0 110.465 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -141.32 149.4 41.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.403 1.481 . . . . 0.0 112.349 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -146.11 159.09 43.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.056 1.742 . . . . 0.0 110.304 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -138.99 86.62 2.15 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.403 0.681 . . . . 0.0 111.44 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -67.68 146.71 53.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.792 1.637 . . . . 0.0 113.631 -170.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -98.97 60.49 1.22 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.528 1.931 . . . . 0.0 107.691 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.27 127.52 55.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.116 1.766 . . . . 0.0 112.349 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.59 169.95 12.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.009 1.324 . . . . 0.0 113.96 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.91 119.61 57.77 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.185 0.994 . . . . 0.0 110.982 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.18 -10.92 19.43 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.64 2.227 . . . . 0.0 113.521 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -58.16 127.59 32.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.106 1.321 . . . . 0.0 111.573 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.2 2.62 87.59 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.189 0.9 . . . . 0.0 115.012 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -111.66 -179.54 3.73 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.773 1.629 . . . . 0.0 111.835 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 t -73.95 159.61 32.52 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.709 0.804 . . . . 0.0 112.573 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.99 -25.46 68.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.19 0.996 . . . . 0.0 111.884 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.44 -32.18 73.39 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.523 -0.736 . . . . 0.0 111.571 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.03 -38.66 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.276 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -58.04 -48.44 80.09 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.085 1.311 . . . . 0.0 110.882 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -66.82 -26.67 67.04 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -74.28 -55.46 6.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.569 0.748 . . . . 0.0 111.33 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -34.28 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 110.89 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -58.3 -42.15 86.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.452 1.024 . . . . 0.0 112.691 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.37 -34.4 74.39 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.408 0.528 . . . . 0.0 112.726 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -68.97 -39.76 79.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.357 1.079 . . . . 0.0 111.332 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.63 -51.41 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.1 0.96 . . . . 0.0 110.522 170.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -54.59 -47.58 73.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.701 1.201 . . . . 0.0 112.554 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -68.44 -27.94 66.62 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.659 1.572 . . . . 0.0 112.842 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -72.48 -49.74 30.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.215 1.006 . . . . 0.0 111.52 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.83 -40.66 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 118.323 -0.846 . . . . 0.0 113.244 172.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.29 -46.71 82.47 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.824 1.647 . . . . 0.0 111.689 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -70.31 -33.21 71.25 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.526 0.603 . . . . 0.0 112.56 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.94 -46.63 87.53 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.136 0.974 . . . . 0.0 111.092 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt -73.56 -43.4 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.365 -0.834 . . . . 0.0 110.56 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.38 -27.69 69.25 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -85.9 -12.74 49.82 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -114.93 -18.52 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.393 0 C-N-CA 124.676 1.19 . . . . 0.0 113.1 -179.623 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.5 2.051 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -71.96 142.5 49.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.215 1.006 . . . . 0.0 111.896 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -108.2 126.16 52.48 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.571 1.148 . . . . 0.0 111.028 171.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.36 113.89 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.881 2.072 . . . . 0.0 110.092 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.9 ttm -98.71 126.48 44.34 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.148 0.885 . . . . 0.0 110.627 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -93.28 127.05 38.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.184 0.994 . . . . 0.0 109.408 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.06 135.26 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.703 1.201 . . . . 0.0 113.197 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 p -146.08 178.45 8.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.21 1.004 . . . . 0.0 112.6 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -89.11 161.2 16.65 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.212 1.005 . . . . 0.0 111.797 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -35.22 64.63 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -86.36 5.15 36.17 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.408 1.483 . . . . 0.0 114.747 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 p -117.21 158.02 25.01 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.6 p -114.95 4.3 14.75 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.8 1.24 . . . . 0.0 114.209 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -66.04 -34.57 78.39 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.984 1.714 . . . . 0.0 112.452 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -63.88 -37.32 86.94 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.323 1.42 . . . . 0.0 113.329 170.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.17 -45.62 66.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.827 0.451 . . . . 0.0 110.14 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.417 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 6.7 tpt -72.32 -38.62 68.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.3 86.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.551 0.614 . . . . 0.0 111.688 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -38.82 89.62 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.824 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.34 29.61 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 119.671 1.123 . . . . 0.0 113.655 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.47 -38.33 90.71 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.396 -1.061 . . . . 0.0 111.39 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.76 -34.7 76.02 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -72.12 -19.17 61.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.845 1.657 . . . . 0.0 113.215 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.2 m -89.26 -45.12 9.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.808 0.843 . . . . 0.0 111.971 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.94 -33.68 12.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.679 1.192 . . . . 0.0 113.009 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 4.94 81.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 125.679 1.609 . . . . 0.0 113.27 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.12 116.88 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 118.32 1.06 . . . . 0.0 111.725 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 14.63 76.91 Favored Glycine 0 CA--C 1.537 1.462 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.95 -44.39 3.81 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.245 1.522 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -145.71 162.21 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 126.465 1.906 . . . . 0.0 111.48 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.52 149.08 24.6 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -145.89 143.43 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.832 -1.167 . . . . 0.0 114.049 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.4 m -143.8 143.27 31.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.522 1.529 . . . . 0.0 110.871 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.3 p -106.86 145.25 32.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 0.0 111.677 170.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -156.36 154.46 30.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.533 1.133 . . . . 0.0 110.735 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.98 150.2 17.04 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.004 1.288 . . . . 0.0 110.653 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -52.88 -37.55 60.58 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.571 1.185 . . . . 0.0 112.413 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -126.11 39.42 3.95 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.47 . . . . 0.0 111.287 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 69.08 170.65 0.3 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.667 1.987 . . . . 0.0 114.177 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -159.15 167.84 28.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.113 2.565 . . . . 0.0 109.978 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 156.19 28.52 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -173.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.6 146.61 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.916 1.286 . . . . 0.0 109.542 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -126.23 126.76 24.72 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.885 -169.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.519 2.813 . . . . 0.0 115.085 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 m -64.4 -34.11 77.42 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.022 -1.049 . . . . 0.0 111.526 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.17 -10.15 59.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.161 -0.962 . . . . 0.0 113.186 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.6 mt -80.13 -56.83 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 167.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.68 72.61 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.7 mmt -69.75 -8.19 45.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.417 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.4 mmt -124.63 -26.38 3.84 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.459 1.104 . . . . 0.0 112.263 -169.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -26.66 68.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.844 -1.16 . . . . 0.0 111.658 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.37 -9.14 55.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.0 0.92 . . . . 0.0 113.372 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.47 1.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.466 2.306 . . . . 0.0 110.765 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.04 81.75 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.693 1.616 . . . . 0.0 114.836 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.16 150.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.857 1.263 . . . . 0.0 111.293 -174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -126.92 142.29 51.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.199 1.4 . . . . 0.0 112.489 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 pt -137.53 -1.96 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.422 1.889 . . . . 0.0 111.783 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.8 p -63.18 -34.02 76.73 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.73 2.8 87.78 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.635 1.112 . . . . 0.0 115.369 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -72.57 159.71 33.46 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 p -118.0 -176.24 3.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.072 2.549 . . . . 0.0 108.911 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.0 t -146.07 -73.27 0.23 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.011 -1.055 . . . . 0.0 111.216 170.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 63.95 154.18 0.12 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.556 2.343 . . . . 0.0 115.211 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.87 133.79 46.61 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.726 2.284 . . . . 0.0 111.991 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.5 tt -55.98 -34.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.38 -8.6 51.93 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -20.68 60.24 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.254 -0.904 . . . . 0.0 112.692 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.54 171.42 8.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.181 1.392 . . . . 0.0 112.807 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.9 114.54 27.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.016 1.726 . . . . 0.0 110.934 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.21 -18.3 63.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.88 -26.44 66.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.784 0.833 . . . . 0.0 112.542 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -86.98 -2.81 58.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.056 1.742 . . . . 0.0 112.132 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -114.86 81.9 1.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.8 2.04 . . . . 0.0 107.972 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.23 -28.7 12.21 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.755 1.622 . . . . 0.0 112.88 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -131.0 130.5 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 126.01 1.724 . . . . 0.0 108.851 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -133.23 128.8 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.153 -0.967 . . . . 0.0 109.763 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 mm -125.19 117.14 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 109.053 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.7 t -89.89 153.57 20.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 111.316 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -133.26 35.91 3.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.43 1.092 . . . . 0.0 111.972 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.6 m -96.61 -12.54 23.8 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.86 57.52 7.78 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 119.62 1.1 . . . . 0.0 112.613 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 67.4 m 64.26 -25.1 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 129.311 3.044 . . . . 0.0 116.311 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.21 39.89 1.68 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.988 1.756 . . . . 0.0 115.889 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 p -98.74 151.0 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.385 1.474 . . . . 0.0 111.711 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -128.73 129.53 45.86 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.425 1.49 . . . . 0.0 108.977 169.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -143.44 140.51 17.66 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.711 1.204 . . . . 0.0 112.613 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -63.91 154.01 72.45 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.591 2.194 . . . . 0.0 110.449 168.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.48 -32.29 96.09 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.371 2.048 . . . . 0.0 114.728 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.28 -22.19 66.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -89.29 -3.16 58.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.46 -19.95 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 t -81.96 6.8 14.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.754 1.622 . . . . 0.0 114.354 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -55.78 160.68 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.035 2.134 . . . . 0.0 113.721 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.36 -33.53 74.92 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.7 mt -131.69 124.58 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.114 0.966 . . . . 0.0 110.173 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -135.31 141.88 45.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.427 1.491 . . . . 0.0 110.521 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.4 159.1 39.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.011 1.324 . . . . 0.0 110.871 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.24 131.94 54.52 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.602 1.161 . . . . 0.0 111.327 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.9 m0 -103.48 162.42 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.786 1.635 . . . . 0.0 112.77 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -119.89 40.13 3.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.874 1.27 . . . . 0.0 112.871 -168.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.94 159.58 34.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.874 0.87 . . . . 0.0 111.081 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -106.06 162.08 13.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.412 1.485 . . . . 0.0 109.795 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -88.52 128.55 52.45 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.78 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.51 -13.53 16.5 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.278 1.985 . . . . 0.0 112.804 169.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -51.23 -42.99 61.36 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.647 1.979 . . . . 0.0 114.67 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -89.51 10.63 72.74 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.547 1.07 . . . . 0.0 114.62 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -132.14 -173.0 3.03 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.697 1.599 . . . . 0.0 113.015 -169.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.9 t -80.0 164.18 23.65 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.465 1.106 . . . . 0.0 113.024 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.21 -30.13 71.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.818 1.247 . . . . 0.0 111.858 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.05 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.346 -0.846 . . . . 0.0 111.749 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.53 -39.05 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 110.824 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -56.59 -47.2 80.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.09 1.314 . . . . 0.0 110.518 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -70.69 -19.28 62.79 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.1 m -82.03 -50.83 8.66 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.874 1.27 . . . . 0.0 112.211 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.74 -33.71 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.398 1.079 . . . . 0.0 111.517 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -54.1 -40.21 67.07 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.852 0.751 . . . . 0.0 112.922 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.68 -32.89 63.82 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.282 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -70.95 -40.77 71.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.396 1.098 . . . . 0.0 110.273 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.13 -52.42 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.133 0.973 . . . . 0.0 110.66 170.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -55.47 -48.82 73.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.009 1.324 . . . . 0.0 112.462 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.99 -28.8 66.93 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.905 1.684 . . . . 0.0 112.51 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -71.94 -47.48 52.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.474 0.709 . . . . 0.0 111.861 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.54 -35.32 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.008 0.822 . . . . 0.0 112.897 170.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.77 -46.21 90.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.887 1.221 . . . . 0.0 111.389 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.55 97.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.329 0.513 . . . . 0.0 111.051 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.496 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -59.31 -48.96 79.65 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.771 0.828 . . . . 0.0 111.199 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.51 -44.23 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.868 -0.52 . . . . 0.0 110.489 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.58 70.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.4 pttt -86.86 -13.24 45.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -115.24 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 124.516 1.127 . . . . 0.0 113.091 178.518 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 119.765 -0.159 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -69.85 138.68 52.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.479 1.112 . . . . 0.0 111.4 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -108.05 127.39 53.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.05 0.94 . . . . 0.0 110.923 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.84 119.48 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.063 1.745 . . . . 0.0 109.685 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.5 tpp -97.8 126.78 43.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.73 123.34 45.54 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.063 0.545 . . . . 0.0 111.152 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.17 149.22 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.164 0.985 . . . . 0.0 113.546 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -146.53 158.7 43.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.155 1.382 . . . . 0.0 109.007 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -62.55 -47.8 82.28 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.524 1.056 . . . . 0.0 111.706 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.01 -40.3 0.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -76.29 109.81 10.29 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -169.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -25.59 65.8 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.046 1.738 . . . . 0.0 113.947 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.5 m -62.7 -7.4 4.8 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -104.47 -55.47 2.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.114 0.966 . . . . 0.0 111.656 168.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.6 p -70.69 -55.97 7.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.328 1.051 . . . . 0.0 113.543 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.66 -33.66 74.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.021 0.528 . . . . 0.0 110.232 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.9 tpt -71.89 -43.78 64.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.12 99.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.508 0.723 . . . . 0.0 111.637 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -43.91 95.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.858 169.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.38 -53.05 43.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.525 1.057 . . . . 0.0 113.176 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -61.38 -36.34 79.99 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.697 1.249 . . . . 0.0 111.535 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.98 -27.17 62.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -65.91 -46.31 78.77 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.844 1.656 . . . . 0.0 111.375 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -74.48 -38.27 62.96 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.0 1.32 . . . . 0.0 112.332 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.8 mt -96.29 -29.83 13.78 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.17 0.988 . . . . 0.0 113.038 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.59 6.34 77.86 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.772 1.653 . . . . 0.0 113.829 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.0 118.82 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.467 1.134 . . . . 0.0 111.408 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.08 14.97 80.04 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 118.743 -1.032 . . . . 0.0 115.589 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -124.27 -43.3 2.07 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.27 1.535 . . . . 0.0 111.913 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.98 157.87 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.663 1.185 . . . . 0.0 113.191 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.83 154.02 20.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.471 1.108 . . . . 0.0 109.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.97 140.54 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 121.238 -0.914 . . . . 0.0 113.093 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 m -144.89 154.02 42.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.328 1.451 . . . . 0.0 109.538 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.3 p -121.6 152.1 39.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.719 0.808 . . . . 0.0 112.794 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 t -151.83 150.71 30.42 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.324 1.049 . . . . 0.0 110.846 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.12 140.75 15.77 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 169.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.9 -41.99 92.86 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.518 1.659 . . . . 0.0 110.995 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.59 33.63 3.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.532 170.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t 64.27 170.93 0.18 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.387 1.875 . . . . 0.0 113.932 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.1 p -153.13 -172.62 4.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.098 1.759 . . . . 0.0 111.546 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -137.6 -147.92 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.258 1.423 . . . . 0.0 111.82 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.23 151.06 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 126.5 1.92 . . . . 0.0 107.304 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -123.74 126.64 25.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 CA-C-O 117.604 -1.189 . . . . 0.0 111.206 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -54.41 -39.22 88.51 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.324 2.683 . . . . 0.0 114.898 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 m -66.03 -32.57 74.13 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.996 -1.065 . . . . 0.0 111.872 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.2 -10.66 59.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.13 -0.981 . . . . 0.0 113.285 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.83 -53.77 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.39 61.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -170.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.05 -6.64 43.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.3 mmt -128.12 -29.51 2.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.93 0.892 . . . . 0.0 112.532 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.8 -25.49 67.52 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.893 -1.129 . . . . 0.0 111.855 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.95 -14.31 62.96 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.6 19.06 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.38 1.472 . . . . 0.0 111.584 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.81 76.08 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.801 1.667 . . . . 0.0 116.591 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mm -80.13 148.6 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.45 1.625 . . . . 0.0 112.151 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.55 111.4 11.72 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.166 1.786 . . . . 0.0 112.024 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.5 pt -140.98 -1.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.145 1.378 . . . . 0.0 113.693 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -61.84 -35.78 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -169.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.54 -2.45 90.05 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.332 0.968 . . . . 0.0 115.236 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -85.41 167.28 15.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.895 1.347 . . . . 0.0 114.327 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -139.88 -175.27 4.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.053 1.741 . . . . 0.0 110.586 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 t -145.24 165.49 28.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.67 1.588 . . . . 0.0 112.101 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.31 157.23 45.81 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.732 1.613 . . . . 0.0 110.299 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.12 139.55 90.28 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.418 2.745 . . . . 0.0 112.103 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -58.35 -31.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.18 -10.51 58.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.57 57.7 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.08 0.855 . . . . 0.0 112.789 170.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -94.4 170.4 9.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.061 1.345 . . . . 0.0 112.41 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 108.72 15.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.567 1.547 . . . . 0.0 111.155 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.66 -19.35 65.74 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.44 -26.53 68.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.866 0.866 . . . . 0.0 112.567 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.87 -2.67 58.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.343 1.857 . . . . 0.0 111.936 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -116.1 83.98 2.04 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.207 2.203 . . . . 0.0 108.235 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.21 -25.91 6.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.087 1.755 . . . . 0.0 113.049 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -133.36 130.26 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.848 1.659 . . . . 0.0 108.902 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -134.13 126.63 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.083 -1.01 . . . . 0.0 109.471 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.1 mm -127.03 116.58 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.589 1.156 . . . . 0.0 109.901 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -91.15 157.31 17.28 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.061 1.344 . . . . 0.0 111.651 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.65 35.89 4.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.176 1.39 . . . . 0.0 112.287 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -95.77 -32.76 12.55 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.791 1.236 . . . . 0.0 112.204 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.18 93.41 1.97 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.711 1.624 . . . . 0.0 113.388 170.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 61.6 m 48.58 34.82 5.29 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.045 1.738 . . . . 0.0 114.93 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.7 105.79 0.19 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.591 1.567 . . . . 0.0 111.924 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.77 143.24 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.091 1.356 . . . . 0.0 111.373 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -88.93 55.28 3.29 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.339 1.055 . . . . 0.0 112.436 -172.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 mt -84.23 142.42 40.93 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.85 154.97 70.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.612 2.208 . . . . 0.0 109.915 168.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.91 -28.99 81.67 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.917 2.411 . . . . 0.0 114.276 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.33 -19.44 65.81 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.82 -1.175 . . . . 0.0 113.814 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -91.6 -3.26 56.61 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 m -115.91 -16.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -83.79 4.24 29.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.863 1.665 . . . . 0.0 114.13 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -58.07 159.74 5.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.972 2.109 . . . . 0.0 113.986 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -62.99 -34.05 76.71 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.32 127.85 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.817 0.847 . . . . 0.0 109.864 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.64 148.31 48.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.291 1.436 . . . . 0.0 111.821 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -147.22 157.41 43.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.829 1.652 . . . . 0.0 110.391 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -135.98 86.06 2.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.619 0.768 . . . . 0.0 111.018 169.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -66.98 146.61 54.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.836 1.655 . . . . 0.0 115.02 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -96.53 49.09 1.09 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.526 2.33 . . . . 0.0 108.742 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.14 134.51 40.37 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.254 1.822 . . . . 0.0 112.654 -167.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.1 179.27 6.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.098 1.359 . . . . 0.0 113.897 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -101.61 113.97 65.73 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.868 0.867 . . . . 0.0 111.806 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -77.32 -25.43 8.41 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.559 1.506 . . . . 0.0 113.264 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.87 -19.77 64.25 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -86.57 3.59 86.9 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.838 0.732 . . . . 0.0 113.705 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -136.82 -168.74 2.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.369 1.868 . . . . 0.0 112.408 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 p -74.8 168.62 19.52 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.37 -30.07 67.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.814 0.846 . . . . 0.0 111.373 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.62 -35.15 79.49 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.242 -0.912 . . . . 0.0 110.919 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.97 -39.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.404 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -55.77 -47.75 76.48 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 121.147 1.794 . . . . 0.0 111.427 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -69.27 -15.04 63.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.267 1.027 . . . . 0.0 113.564 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.6 m -88.77 -49.23 6.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.659 1.584 . . . . 0.0 112.641 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -70.38 -31.76 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.24 -0.913 . . . . 0.0 111.073 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -56.24 -39.83 73.16 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 0.0 112.453 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.48 -34.6 68.06 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.071 0.843 . . . . 0.0 112.63 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -69.49 -43.2 73.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.059 0.93 . . . . 0.0 110.513 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.94 -47.2 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.377 0.671 . . . . 0.0 110.685 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -56.45 -49.41 74.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.55 1.14 . . . . 0.0 112.3 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.7 -29.84 62.52 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.017 1.28 . . . . 0.0 113.13 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -64.8 -50.85 65.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.477 0.711 . . . . 0.0 110.866 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.4 t -56.36 -46.21 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.868 1.267 . . . . 0.0 112.611 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.63 -49.05 78.11 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 120.099 1.318 . . . . 0.0 111.874 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -71.47 -32.61 68.48 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.433 0.561 . . . . 0.0 111.948 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.52 -48.33 81.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.971 0.908 . . . . 0.0 111.308 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.8 -43.17 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.683 0.674 . . . . 0.0 110.7 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.82 68.68 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.62 -11.84 58.09 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.9 pt -111.44 -28.3 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.256 1.418 0 C-N-CA 125.629 1.572 . . . . 0.0 112.108 -178.183 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttp . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -72.77 144.19 47.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.636 1.174 . . . . 0.0 112.316 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -112.06 125.76 54.44 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.196 0.998 . . . . 0.0 111.836 170.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.79 116.55 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.821 1.649 . . . . 0.0 110.585 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.52 126.08 43.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.375 0.989 . . . . 0.0 110.454 168.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -95.36 121.45 37.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.894 0.878 . . . . 0.0 110.323 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.29 136.35 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.086 0.954 . . . . 0.0 113.275 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -148.62 176.35 10.41 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.825 0.85 . . . . 0.0 112.216 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -72.46 164.38 26.48 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.706 1.203 . . . . 0.0 112.925 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -51.15 -48.62 61.8 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -169.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -82.52 -6.48 59.35 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.6 m -94.43 144.79 25.26 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.201 1.4 . . . . 0.0 113.066 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.9 p -103.03 -11.48 18.11 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -61.41 -22.81 65.35 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.028 -1.67 . . . . 0.0 115.165 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -68.51 -47.29 67.36 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.621 1.555 . . . . 0.0 111.331 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.19 -38.58 91.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.581 1.153 . . . . 0.0 111.759 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 tpt -73.58 -38.23 65.22 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.687 0.795 . . . . 0.0 112.244 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.69 -44.14 90.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.229 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.87 -44.05 91.0 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.144 0.884 . . . . 0.0 112.052 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.51 -49.77 67.19 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 119.598 1.09 . . . . 0.0 113.267 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.3 -43.15 87.09 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.135 -1.215 . . . . 0.0 111.666 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.82 82.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.844 -1.16 . . . . 0.0 113.797 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -72.55 -16.54 61.76 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.57 1.077 . . . . 0.0 113.254 174.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.9 m -88.21 -44.71 10.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.69 1.196 . . . . 0.0 111.99 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -95.99 -34.6 11.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.21 1.004 . . . . 0.0 113.539 -171.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.94 5.33 85.03 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.77 1.652 . . . . 0.0 113.85 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.43 -44.9 4.19 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.25 18.99 41.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.416 1.484 . . . . 0.0 114.536 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -127.19 -38.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.767 1.227 . . . . 0.0 112.504 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.52 163.27 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.646 1.579 . . . . 0.0 112.248 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.25 152.6 18.22 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 168.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -148.61 145.22 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 120.631 -1.293 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -147.11 163.45 36.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.053 1.741 . . . . 0.0 108.827 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.4 p -134.01 154.55 51.05 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.725 -1.234 . . . . 0.0 111.747 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 t -145.94 142.25 28.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.481 1.112 . . . . 0.0 109.935 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.96 137.21 13.68 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.975 -0.453 . . . . 0.0 112.19 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.15 121.29 13.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 64.47 28.67 13.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.296 1.839 . . . . 0.0 113.775 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t 70.41 170.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.432 2.293 . . . . 0.0 114.062 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 82.1 p -152.71 179.12 8.91 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.699 1.6 . . . . 0.0 112.062 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 160.77 38.19 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.27 147.07 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.918 1.287 . . . . 0.0 109.07 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -119.63 132.19 24.12 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.65 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.88 -36.15 82.26 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.039 2.493 . . . . 0.0 114.795 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -69.57 -33.15 72.32 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.017 -1.052 . . . . 0.0 112.096 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 -13.44 61.14 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.044 -1.035 . . . . 0.0 113.21 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.07 -57.33 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.37 78.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -169.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mmt -68.46 -8.5 41.43 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.3 mmt -123.15 -27.25 4.2 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 -169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.87 -27.59 68.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.173 -0.954 . . . . 0.0 111.891 169.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.29 -8.13 53.22 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.332 1.053 . . . . 0.0 113.408 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.61 -0.46 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.516 2.326 . . . . 0.0 110.772 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.54 14.44 78.22 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.276 1.417 . . . . 0.0 114.629 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 mm -92.62 153.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.872 1.269 . . . . 0.0 111.192 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -130.92 139.0 50.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.444 1.498 . . . . 0.0 111.859 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.6 pt -135.58 -6.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.694 1.198 . . . . 0.0 112.49 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -58.35 -34.41 70.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.583 1.553 . . . . 0.0 114.526 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.69 -3.82 89.32 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.474 1.035 . . . . 0.0 115.295 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -81.71 154.84 25.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.961 1.381 . . . . 0.0 113.424 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -130.42 178.06 6.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.83 2.052 . . . . 0.0 110.681 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.7 t -148.73 158.58 44.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.121 -0.987 . . . . 0.0 112.444 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -152.04 158.1 33.92 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.687 1.995 . . . . 0.0 109.284 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.03 140.89 95.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.344 2.696 . . . . 0.0 112.474 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -60.11 -29.62 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.54 -12.04 60.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -21.42 59.22 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.252 -0.905 . . . . 0.0 112.735 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 166.25 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.359 . . . . 0.0 112.523 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.89 107.05 14.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.485 1.514 . . . . 0.0 111.086 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.38 -16.18 53.11 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.874 -1.141 . . . . 0.0 113.799 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -59.26 -18.83 40.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.572 1.549 . . . . 0.0 113.063 176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.18 -0.51 28.41 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.463 1.905 . . . . 0.0 112.877 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -123.61 76.62 1.43 Allowed 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.831 1.652 . . . . 0.0 109.894 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.56 -23.75 11.61 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.661 1.984 . . . . 0.0 113.256 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.54 131.46 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.193 1.397 . . . . 0.0 109.329 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.62 126.35 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.876 -1.14 . . . . 0.0 110.391 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.07 119.69 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.364 1.465 . . . . 0.0 108.206 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 t -83.43 151.06 25.67 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.781 1.633 . . . . 0.0 110.112 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.05 38.25 4.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.129 -0.982 . . . . 0.0 111.765 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 98.7 m -127.2 17.2 7.17 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.64 34.07 88.51 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 120.716 -1.24 . . . . 0.0 113.821 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 75.1 m 61.41 -1.15 0.32 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.881 2.472 . . . . 0.0 115.841 -169.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.84 57.96 4.53 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.474 1.512 . . . . 0.0 111.524 169.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.35 139.35 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.301 1.44 . . . . 0.0 111.673 -169.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -99.44 117.71 34.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.125 0.97 . . . . 0.0 109.521 172.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.83 131.87 12.69 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.599 1.16 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.97 148.28 89.51 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.762 2.308 . . . . 0.0 110.126 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.18 -29.55 83.95 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.657 2.905 . . . . 0.0 115.483 -169.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -63.84 -20.96 66.2 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.487 -1.383 . . . . 0.0 114.014 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -81.76 -15.42 54.34 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.401 -1.437 . . . . 0.0 114.526 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.22 -21.25 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.851 1.261 . . . . 0.0 113.524 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 t -84.56 13.37 5.67 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.974 1.71 . . . . 0.0 113.568 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -67.8 164.54 19.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 112.786 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.31 -34.85 78.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.6 mt -133.5 126.59 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 110.072 169.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.08 148.07 48.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.931 1.292 . . . . 0.0 110.79 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -141.53 162.34 35.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.519 1.128 . . . . 0.0 112.402 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.68 130.81 32.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 108.749 168.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -108.28 135.26 49.89 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.399 1.479 . . . . 0.0 111.014 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -93.81 44.24 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.18 1.392 . . . . 0.0 110.92 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.19 150.92 24.06 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.659 1.583 . . . . 0.0 112.651 -173.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.92 165.16 13.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.889 1.276 . . . . 0.0 110.477 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.1 134.23 19.9 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.853 -0.529 . . . . 0.0 112.168 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -85.44 -12.03 6.84 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 121.866 1.71 . . . . 0.0 113.187 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -45.38 -42.08 9.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.688 1.995 . . . . 0.0 114.587 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.32 15.04 57.95 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.194 1.378 . . . . 0.0 115.903 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -126.08 -174.62 3.15 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 119.044 1.422 . . . . 0.0 114.071 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.5 p -71.81 164.7 25.53 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.451 1.5 . . . . 0.0 114.415 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.12 -33.12 74.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.919 0.887 . . . . 0.0 111.476 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.44 -34.89 79.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.726 -0.609 . . . . 0.0 111.198 169.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.8 t -69.53 -42.47 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 117.805 -1.093 . . . . 0.0 111.85 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -55.65 -48.9 74.22 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.951 1.705 . . . . 0.0 111.195 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -69.74 -19.31 63.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -84.36 -50.41 7.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 0.0 112.024 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.0 t -70.8 -30.97 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.588 1.155 . . . . 0.0 111.812 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -55.04 -42.26 72.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.274 0.943 . . . . 0.0 112.784 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.4 65.36 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.728 0.68 . . . . 0.0 112.849 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -68.57 -48.39 64.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.167 0.983 . . . . 0.0 109.681 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.15 -41.41 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.538 -0.726 . . . . 0.0 111.093 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.21 -50.11 73.89 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.096 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -70.82 -29.41 65.56 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.514 1.506 . . . . 0.0 113.335 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -63.48 -52.72 60.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 172.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.17 -50.84 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.138 1.375 . . . . 0.0 112.219 170.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.7 -49.99 70.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.847 1.203 . . . . 0.0 112.499 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -30.19 68.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.442 0.564 . . . . 0.0 112.142 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.15 -52.59 32.94 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.676 0.79 . . . . 0.0 110.876 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.8 -37.47 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.958 -1.089 . . . . 0.0 111.83 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.06 -26.48 68.86 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -87.78 -23.41 24.09 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -101.85 -20.09 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.254 1.338 0 C-N-CA 124.857 1.263 . . . . 0.0 113.829 -170.361 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -79.61 136.54 36.87 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.097 0.959 . . . . 0.0 112.419 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.33 128.17 53.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.643 1.177 . . . . 0.0 111.556 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.15 111.78 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.488 1.915 . . . . 0.0 110.319 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -92.8 122.45 35.2 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 169.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -93.31 114.91 27.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.998 0.519 . . . . 0.0 109.923 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.84 144.43 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.06 1.344 . . . . 0.0 111.985 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t -148.16 170.46 17.79 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.274 -0.891 . . . . 0.0 112.855 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -62.59 163.23 9.27 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.437 1.495 . . . . 0.0 110.781 169.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -59.15 143.29 49.26 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.282 1.033 . . . . 0.0 112.474 -173.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 52.51 44.51 29.92 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.855 1.262 . . . . 0.0 113.303 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.3 p -109.32 -26.66 9.92 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -169.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 t 57.52 1.89 0.13 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.452 1.901 . . . . 0.0 116.026 -169.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -76.27 -37.69 57.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 119.131 -2.231 . . . . 0.0 110.397 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -62.44 -46.53 88.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.863 1.265 . . . . 0.0 111.695 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.38 -33.93 67.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.394 0.678 . . . . 0.0 111.805 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -37.68 64.87 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.086 -1.009 . . . . 0.0 113.337 169.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -45.41 90.09 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.114 0.87 . . . . 0.0 110.919 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -57.92 -46.85 84.36 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.058 169.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.42 -49.19 46.26 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.826 1.194 . . . . 0.0 115.405 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -72.64 -36.11 67.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.024 1.412 . . . . 0.0 111.619 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.82 73.23 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -69.02 -26.36 64.95 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.582 1.537 . . . . 0.0 112.504 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.2 m -84.51 -44.93 13.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.08 0.952 . . . . 0.0 111.669 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -95.59 -32.36 12.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.27 1.028 . . . . 0.0 113.308 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 5.76 79.78 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 125.87 1.7 . . . . 0.0 113.351 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 115.42 1.1 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.318 1.059 . . . . 0.0 111.862 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.44 80.26 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 115.821 1.089 . . . . 0.0 115.821 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -119.55 -34.42 3.8 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.238 1.519 . . . . 0.0 111.906 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -149.88 166.96 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.739 2.016 . . . . 0.0 111.623 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.19 152.07 19.44 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -144.69 145.2 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.023 1.283 . . . . 0.0 113.858 -175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -144.55 154.38 42.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.38 1.872 . . . . 0.0 110.001 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.8 p -118.76 152.27 36.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.594 1.088 . . . . 0.0 113.421 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 t -149.66 150.71 32.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.255 1.422 . . . . 0.0 111.012 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.62 18.12 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.2 mt -53.13 -40.8 64.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.668 1.734 . . . . 0.0 112.199 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -122.21 37.03 4.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.932 1.693 . . . . 0.0 111.074 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 72.97 151.5 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.272 2.229 . . . . 0.0 115.094 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -132.01 -169.34 2.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.195 1.798 . . . . 0.0 111.424 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.24 178.81 7.31 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.95 116.47 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.519 1.928 . . . . 0.0 109.25 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.8 148.91 52.51 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 118.673 -0.679 . . . . 0.0 112.065 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.28 -37.65 88.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.359 2.706 . . . . 0.0 113.892 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -65.48 -33.35 75.73 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.027 -1.046 . . . . 0.0 112.018 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.51 -10.74 59.85 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.4 mt -83.9 -53.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.17 68.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.86 -8.14 54.15 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 mmt -126.08 -27.35 3.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.284 1.033 . . . . 0.0 112.555 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.05 -25.13 67.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.787 -1.196 . . . . 0.0 111.985 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.39 -13.82 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.375 1.07 . . . . 0.0 113.544 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.28 18.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.422 1.489 . . . . 0.0 111.557 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.59 76.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.741 1.639 . . . . 0.0 116.611 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.2 mm -75.51 145.15 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.537 1.669 . . . . 0.0 111.6 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -133.77 97.92 4.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.641 1.576 . . . . 0.0 110.887 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 pt -132.75 11.93 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -58.47 -30.54 67.05 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.806 1.243 . . . . 0.0 113.333 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.43 -1.08 75.35 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.907 1.241 . . . . 0.0 115.348 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -74.76 140.13 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.703 1.751 . . . . 0.0 112.375 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.6 p -114.78 172.6 6.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.547 1.939 . . . . 0.0 110.343 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -145.44 158.71 43.79 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.304 -0.872 . . . . 0.0 111.783 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -150.03 157.59 37.53 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.779 1.632 . . . . 0.0 110.569 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.72 142.92 91.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.62 2.88 . . . . 0.0 113.098 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.88 -31.09 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -67.14 -13.22 61.74 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -21.02 57.16 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 112.916 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -94.62 166.85 11.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.878 1.271 . . . . 0.0 112.691 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.3 107.64 15.52 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 111.126 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.87 -21.4 66.46 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.57 -27.41 68.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.179 0.991 . . . . 0.0 112.487 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.16 -3.85 59.05 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.939 1.696 . . . . 0.0 112.187 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.15 80.32 1.44 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 127.119 2.168 . . . . 0.0 108.556 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.37 -27.65 10.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.767 1.627 . . . . 0.0 112.942 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.59 127.54 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.184 1.794 . . . . 0.0 108.835 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.82 124.65 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.15 -0.969 . . . . 0.0 109.251 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.17 124.25 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.417 1.087 . . . . 0.0 109.215 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -99.59 154.07 18.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.572 1.149 . . . . 0.0 111.938 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.87 35.15 3.79 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.111 1.364 . . . . 0.0 111.764 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.1 m -91.83 -11.82 35.42 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.74 56.11 8.78 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-N 119.464 1.029 . . . . 0.0 112.979 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 75.8 m 64.88 162.25 0.13 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 128.377 2.671 . . . . 0.0 114.582 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.78 27.68 72.94 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 115.776 1.07 . . . . 0.0 115.776 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.14 123.69 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.614 1.207 . . . . 0.0 111.15 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -84.3 121.82 28.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.874 0.87 . . . . 0.0 109.516 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.1 mt -142.51 139.93 18.11 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.62 1.168 . . . . 0.0 112.75 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.32 153.81 72.05 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.448 2.098 . . . . 0.0 110.167 168.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.86 -22.45 73.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.089 2.526 . . . . 0.0 115.167 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.99 -15.0 62.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -92.08 -1.56 57.13 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.78 10.62 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 125.887 1.675 . . . . 0.0 113.894 -175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -112.52 -2.62 14.59 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.399 1.88 . . . . 0.0 112.826 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -56.72 160.4 3.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.551 2.74 . . . . 0.0 113.95 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.84 -32.59 74.2 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.65 127.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.146 0.978 . . . . 0.0 110.513 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -139.38 141.33 37.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.247 1.419 . . . . 0.0 111.624 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -157.3 161.64 39.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 110.665 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.44 134.01 52.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 111.8 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -108.78 163.35 13.35 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.202 1.801 . . . . 0.0 112.104 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -130.33 62.14 1.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.856 1.262 . . . . 0.0 112.337 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.55 167.21 20.37 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.542 1.537 . . . . 0.0 111.418 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -117.52 158.83 23.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.967 1.307 . . . . 0.0 110.397 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -98.35 120.72 58.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.69 -5.74 16.28 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.061 2.507 . . . . 0.0 114.094 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -56.44 131.29 48.02 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.881 1.219 . . . . 0.0 111.691 170.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.99 0.73 65.85 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.075 0.845 . . . . 0.0 114.767 -171.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -108.49 -178.47 3.61 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.213 1.805 . . . . 0.0 111.239 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.8 t -73.34 157.12 37.58 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.051 -1.031 . . . . 0.0 112.177 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.9 -25.09 67.36 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.996 0.918 . . . . 0.0 111.692 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.44 -31.97 73.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.887 -1.133 . . . . 0.0 111.729 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.1 t -72.73 -39.0 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.901 -1.125 . . . . 0.0 110.193 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -56.53 -49.33 75.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.687 1.131 . . . . 0.0 111.15 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -70.67 -17.05 62.85 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -83.07 -51.4 7.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.063 1.345 . . . . 0.0 111.967 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.35 -34.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.748 1.219 . . . . 0.0 111.484 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -57.12 -39.5 75.24 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.101 0.864 . . . . 0.0 112.728 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.12 -32.26 69.23 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.988 0.804 . . . . 0.0 112.935 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -71.78 -39.76 69.71 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.476 1.138 . . . . 0.0 110.967 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.38 -50.93 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.63 0.772 . . . . 0.0 110.552 170.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -54.08 -48.01 71.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 112.367 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -68.32 -26.66 65.73 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 120.984 1.72 . . . . 0.0 112.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -75.54 -47.69 25.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.904 0.882 . . . . 0.0 111.8 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.19 -36.5 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.8 0.727 . . . . 0.0 112.252 169.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -61.78 -47.26 85.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.9 1.227 . . . . 0.0 111.833 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -40.16 95.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.46 0.573 . . . . 0.0 111.106 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.485 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -58.74 -48.21 81.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.801 0.84 . . . . 0.0 111.388 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -73.13 -47.95 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.34 -25.42 68.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.9 pttt -87.68 -7.49 57.35 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.13 -18.36 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.0 p . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.135 1.374 . . . . 0.0 113.617 178.238 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -71.18 141.45 50.69 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.403 1.081 . . . . 0.0 111.221 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.96 128.57 55.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.072 0.949 . . . . 0.0 111.769 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.4 t -99.64 110.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.624 1.57 . . . . 0.0 110.161 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 tpp -90.65 124.07 34.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.181 0.446 . . . . 0.0 110.475 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.3 123.57 39.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.832 0.853 . . . . 0.0 109.918 169.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 m -118.98 134.51 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.08 0.855 . . . . 0.0 112.623 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -140.22 -152.77 0.43 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.121 1.368 . . . . 0.0 110.43 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -148.13 156.18 42.3 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.019 -1.676 . . . . 0.0 115.373 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 45.3 -110.53 0.22 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 129.151 2.98 . . . . 0.0 116.294 169.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -85.02 -19.52 31.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -168.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 p -82.57 149.76 27.29 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.01 1.277 . . . . 0.0 112.538 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.9 p -94.96 6.18 49.79 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -56.59 -39.23 73.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.116 1.766 . . . . 0.0 113.79 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 p -70.28 -43.69 69.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.119 1.327 . . . . 0.0 112.119 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.38 -34.3 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.456 0.703 . . . . 0.0 111.634 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 tpt -74.93 -38.37 61.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.07 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.13 87.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.431 0.559 . . . . 0.0 111.495 169.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -58.84 -40.85 85.44 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.349 -0.844 . . . . 0.0 111.824 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.97 -48.82 83.93 Favored Glycine 0 N--CA 1.474 1.228 0 CA-C-N 119.433 1.015 . . . . 0.0 113.784 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -66.28 -40.01 89.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.073 -1.251 . . . . 0.0 111.365 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.12 85.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -68.77 -28.95 67.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.168 1.349 . . . . 0.0 112.641 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 m -78.42 -44.47 24.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.693 0.797 . . . . 0.0 111.773 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.5 mt -96.99 -31.77 12.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.973 0.909 . . . . 0.0 113.216 -171.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.13 7.03 72.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.821 1.677 . . . . 0.0 113.602 169.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.51 118.73 2.35 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.514 1.157 . . . . 0.0 112.024 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.35 11.61 85.14 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -116.9 -40.63 3.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.721 1.76 . . . . 0.0 112.377 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -150.51 162.65 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.784 1.633 . . . . 0.0 111.644 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.56 150.18 21.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.49 148.43 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.139 -0.975 . . . . 0.0 112.634 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -150.86 154.35 37.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.362 1.465 . . . . 0.0 109.248 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.3 p -127.49 155.01 44.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.6 t -155.78 167.12 31.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.585 1.554 . . . . 0.0 110.234 -170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.96 159.31 26.96 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.242 -0.911 . . . . 0.0 112.332 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -62.0 -38.26 87.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.324 1.062 . . . . 0.0 111.9 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.78 44.4 2.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.699 2.0 . . . . 0.0 108.756 170.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 t 66.5 176.96 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.15 1.78 . . . . 0.0 113.394 -169.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 94.9 p -146.23 -175.14 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.975 2.11 . . . . 0.0 110.423 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -145.78 172.64 13.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.13 141.75 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.758 1.623 . . . . 0.0 108.197 168.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -123.47 129.11 25.0 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.594 -171.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.68 -38.44 84.52 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.216 2.611 . . . . 0.0 115.381 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -63.74 -36.43 83.85 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.856 -0.528 . . . . 0.0 111.533 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.23 85.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.157 0.89 . . . . 0.0 111.171 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.5 mt -53.57 -51.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.36 79.37 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.1 mmt -67.09 -23.35 65.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 mmt -106.68 -18.93 13.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -61.32 -29.25 69.76 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.482 -1.386 . . . . 0.0 112.497 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -6.85 49.37 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.057 0.943 . . . . 0.0 113.302 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.8 0.49 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 126.943 2.097 . . . . 0.0 110.508 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 14.38 79.9 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.204 1.383 . . . . 0.0 114.629 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 mm -88.89 157.3 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.1 1.36 . . . . 0.0 110.619 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.87 143.26 49.4 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.463 1.105 . . . . 0.0 112.188 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.74 4.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.088 1.755 . . . . 0.0 112.106 168.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.4 p -63.2 -30.56 71.68 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.48 -4.14 73.94 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.76 1.171 . . . . 0.0 115.565 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -87.73 148.81 24.58 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.304 1.552 . . . . 0.0 113.043 -174.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.2 t -144.42 172.63 12.68 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.362 1.865 . . . . 0.0 109.951 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 t -133.31 167.19 20.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.929 1.292 . . . . 0.0 112.867 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -146.11 157.89 49.17 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.427 1.491 . . . . 0.0 111.034 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 134.97 65.52 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.723 2.948 . . . . 0.0 112.828 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -57.48 -32.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -169.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.93 -9.16 54.04 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.79 59.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 121.365 -0.835 . . . . 0.0 112.9 170.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.95 167.78 11.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 113.219 -175.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.02 112.19 22.27 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.595 1.558 . . . . 0.0 111.056 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.15 -15.55 63.78 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.455 -1.403 . . . . 0.0 113.529 -175.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.9 -20.44 23.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.845 1.258 . . . . 0.0 113.191 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.72 -0.39 34.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.596 1.959 . . . . 0.0 113.053 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.5 77.03 1.61 Allowed 'General case' 0 C--N 1.346 0.428 0 C-N-CA 125.97 1.708 . . . . 0.0 109.739 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.29 -23.56 15.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.831 2.052 . . . . 0.0 113.252 -177.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.66 127.76 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.313 1.445 . . . . 0.0 108.8 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.0 t -136.18 124.87 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.01 -1.056 . . . . 0.0 111.055 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.36 121.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.559 1.544 . . . . 0.0 108.612 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -87.29 137.99 31.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.672 1.189 . . . . 0.0 111.449 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.85 11.7 20.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.505 1.122 . . . . 0.0 112.735 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m -105.02 12.23 32.49 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.622 1.569 . . . . 0.0 112.537 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.75 -178.84 35.31 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.688 1.137 . . . . 0.0 114.06 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.3 t -63.47 -24.87 68.01 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.103 0.961 . . . . 0.0 112.738 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.78 3.59 12.15 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 125.444 1.497 . . . . 0.0 115.62 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.27 137.46 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.204 1.402 . . . . 0.0 110.73 173.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -85.73 119.22 25.82 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -141.68 137.67 16.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.22 1.008 . . . . 0.0 112.454 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.46 151.35 80.32 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.541 2.16 . . . . 0.0 110.032 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.67 -31.28 94.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.084 2.523 . . . . 0.0 114.672 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.89 -23.81 66.55 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.862 -1.148 . . . . 0.0 113.756 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -83.87 -9.72 58.54 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.47 -1.394 . . . . 0.0 114.686 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.1 m -117.04 -21.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.19 1.396 . . . . 0.0 113.569 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -83.55 14.29 3.89 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.154 1.782 . . . . 0.0 113.562 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -71.69 168.21 18.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.88 1.672 . . . . 0.0 113.078 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.84 -35.97 82.84 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.503 -0.748 . . . . 0.0 112.747 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.68 125.98 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.761 0.709 . . . . 0.0 110.731 170.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -122.18 144.43 48.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.742 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -133.82 154.36 51.08 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.272 1.029 . . . . 0.0 112.463 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.15 125.08 34.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.073 0.949 . . . . 0.0 110.523 169.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -110.99 150.74 28.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.775 1.63 . . . . 0.0 110.354 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -119.57 47.1 1.77 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.18 1.792 . . . . 0.0 108.253 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -96.71 126.9 42.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.058 2.143 . . . . 0.0 112.303 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -84.26 147.61 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.159 1.784 . . . . 0.0 112.556 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.06 123.31 69.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.286 1.434 . . . . 0.0 112.066 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.91 -11.62 3.15 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.946 2.431 . . . . 0.0 114.482 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.73 -20.22 65.92 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -169.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.93 9.47 63.77 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.746 1.165 . . . . 0.0 114.195 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -120.02 -172.57 2.37 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.981 1.712 . . . . 0.0 113.512 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 t -74.29 158.16 34.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.988 0.915 . . . . 0.0 111.348 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.62 -20.13 64.47 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 0.0 112.137 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.43 -31.58 72.74 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.012 -1.055 . . . . 0.0 110.218 168.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 t -72.62 -38.64 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.425 175.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.53 -49.14 73.41 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.164 1.347 . . . . 0.0 110.848 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.84 -15.86 63.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 m -87.12 -41.46 13.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.557 1.543 . . . . 0.0 112.744 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.05 -40.06 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.13 -1.606 . . . . 0.0 111.311 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -57.79 -42.2 83.68 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.53 65.82 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 123.701 0.667 . . . . 0.0 112.388 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -69.15 -39.07 79.02 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.596 -0.943 . . . . 0.0 111.879 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.46 -49.19 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.392 0.677 . . . . 0.0 110.388 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -56.96 -48.01 79.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.047 1.339 . . . . 0.0 112.725 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -68.26 -27.97 66.8 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.766 1.621 . . . . 0.0 112.33 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -71.35 -50.47 31.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.95 0.9 . . . . 0.0 111.567 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.2 m -59.83 -43.27 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.373 0.988 . . . . 0.0 112.6 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.07 -51.66 63.05 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 120.161 1.346 . . . . 0.0 112.393 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.667 0.667 . . . . 0.0 111.728 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.48 -48.03 76.76 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.24 0.616 . . . . 0.0 111.304 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.96 -43.93 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.924 0.784 . . . . 0.0 110.747 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.6 -25.8 66.79 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.19 -16.78 54.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -107.59 -26.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.252 1.421 . . . . 0.0 112.051 -179.862 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.819 -0.134 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -70.45 142.28 51.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.39 1.076 . . . . 0.0 111.809 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -110.92 129.34 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.478 1.111 . . . . 0.0 111.351 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.9 t -99.63 114.96 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.292 1.837 . . . . 0.0 110.085 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.6 tpp -94.85 128.46 41.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.434 0.561 . . . . 0.0 110.369 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -100.28 113.41 26.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.156 0.982 . . . . 0.0 110.591 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.44 137.59 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 p -132.07 178.73 6.57 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 110.944 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -73.66 -61.0 1.99 Allowed 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.849 -1.157 . . . . 0.0 111.833 170.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -152.82 25.38 0.57 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -174.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -133.59 106.42 7.4 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.9 m -67.48 -22.62 65.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.7 m -66.93 -15.92 63.99 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.245 0.929 . . . . 0.0 111.891 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -94.07 -64.41 1.08 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.744 0.818 . . . . 0.0 109.579 168.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.4 p -71.2 -59.93 2.51 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -73.63 -26.75 60.92 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.637 -0.664 . . . . 0.0 111.859 -172.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.15 -37.41 69.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.22 95.4 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.609 0.641 . . . . 0.0 111.188 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -57.95 -43.97 86.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.115 0.87 . . . . 0.0 111.684 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.39 -50.98 60.47 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.409 1.004 . . . . 0.0 113.556 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -68.8 -40.82 79.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.208 -1.172 . . . . 0.0 111.705 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.39 95.67 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -71.46 -28.46 63.97 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.242 0.928 . . . . 0.0 112.386 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 m -79.18 -42.55 25.82 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.358 0.663 . . . . 0.0 111.77 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -90.14 -32.95 16.43 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.889 0.876 . . . . 0.0 112.716 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 10.66 68.22 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.885 1.707 . . . . 0.0 113.906 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.29 119.18 2.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.491 1.146 . . . . 0.0 111.615 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.98 13.22 83.91 Favored Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -120.2 -41.72 2.61 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.284 1.542 . . . . 0.0 111.423 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.59 159.3 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.894 1.677 . . . . 0.0 112.072 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.66 20.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.15 0.98 . . . . 0.0 109.193 169.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -141.64 141.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.009 -1.057 . . . . 0.0 112.925 -173.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 m -146.18 163.71 34.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.397 1.879 . . . . 0.0 109.514 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 p -140.61 153.54 46.1 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.785 -1.197 . . . . 0.0 112.542 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t -151.66 150.51 30.33 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.095 0.958 . . . . 0.0 111.215 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.01 134.35 9.81 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.24 1.4 . . . . 0.0 110.054 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 72.4 mt -50.34 -35.9 29.77 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.281 1.041 . . . . 0.0 112.907 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -118.69 28.95 8.0 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.953 1.701 . . . . 0.0 112.462 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 m 64.63 168.59 0.18 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.402 1.881 . . . . 0.0 114.124 -170.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t -164.33 173.58 12.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.454 1.102 . . . . 0.0 112.179 172.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -133.7 146.89 51.24 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.441 1.496 . . . . 0.0 113.099 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.2 m -64.82 140.23 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.411 0.624 . . . . 0.0 111.676 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -103.15 122.36 45.64 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.161 1.384 . . . . 0.0 111.584 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.8 -37.83 77.02 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.466 2.778 . . . . 0.0 115.305 -172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.6 m -64.39 -40.02 95.01 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.629 -0.67 . . . . 0.0 111.384 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.1 97.29 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.135 0.88 . . . . 0.0 111.664 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -54.8 -52.55 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 118.558 0.617 . . . . 0.0 109.554 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.79 82.91 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.6 mmt -67.56 -24.46 65.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.25 1.02 . . . . 0.0 113.198 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mmt -108.69 -19.59 13.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.02 -28.72 69.25 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.541 -1.349 . . . . 0.0 112.563 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.9 -8.31 53.64 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.172 -0.955 . . . . 0.0 113.347 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.85 3.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 127.153 2.181 . . . . 0.0 110.635 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 13.85 82.76 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.385 1.469 . . . . 0.0 114.762 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.3 mm -83.62 147.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 118.557 1.178 . . . . 0.0 111.184 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.74 126.42 52.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.978 1.711 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.86 -5.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 169.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.9 p -62.49 -27.02 68.85 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.09 1.314 . . . . 0.0 114.458 -169.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.54 -6.35 88.68 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.759 1.171 . . . . 0.0 115.476 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -84.7 149.14 26.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.27 1.535 . . . . 0.0 112.644 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 t -144.25 165.64 27.31 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.009 1.724 . . . . 0.0 109.618 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -132.76 144.19 50.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.163 0.985 . . . . 0.0 112.835 -171.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -139.76 159.8 63.55 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.112 1.765 . . . . 0.0 111.413 -171.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.91 138.5 79.34 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.632 2.888 . . . . 0.0 112.537 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.98 -29.49 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.44 -11.26 60.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -18.35 58.83 Favored 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.359 -0.838 . . . . 0.0 112.544 169.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -99.07 170.99 8.31 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.68 1.592 . . . . 0.0 112.238 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.62 113.61 18.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 110.749 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.89 -20.28 65.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -169.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.74 -27.34 68.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.078 0.951 . . . . 0.0 112.376 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.28 -3.22 58.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.133 1.773 . . . . 0.0 112.152 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -116.96 82.11 1.75 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.877 2.071 . . . . 0.0 108.108 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.21 -25.46 9.24 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.182 1.793 . . . . 0.0 113.138 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.69 131.28 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.108 1.763 . . . . 0.0 109.279 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -136.43 120.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 120.992 -1.068 . . . . 0.0 110.721 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.77 120.25 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 108.092 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -88.46 149.24 23.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.015 0.926 . . . . 0.0 110.078 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -123.7 30.78 6.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.127 0.971 . . . . 0.0 111.32 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m -99.69 -17.92 17.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.88 41.25 6.39 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-N 119.45 1.023 . . . . 0.0 113.857 -174.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.9 t 66.59 -39.94 0.35 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.274 3.03 . . . . 0.0 116.365 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.66 97.07 0.87 Allowed Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.472 1.034 . . . . 0.0 110.678 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.03 142.73 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.377 1.071 . . . . 0.0 111.806 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -89.87 48.99 1.65 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.95 1.3 . . . . 0.0 112.275 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.1 mt -74.76 136.57 73.88 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.217 -0.927 . . . . 0.0 112.188 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.68 150.86 86.56 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 122.35 2.033 . . . . 0.0 110.281 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.94 -22.0 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.353 2.702 . . . . 0.0 115.221 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.75 -13.52 61.74 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -91.89 -3.52 55.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.47 14.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.565 1.546 . . . . 0.0 113.425 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -120.65 -0.99 10.11 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.21 1.804 . . . . 0.0 112.996 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -58.29 160.05 5.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.389 2.676 . . . . 0.0 114.138 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -63.81 -34.49 78.02 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.37 122.51 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.93 . . . . 0.0 109.086 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -124.25 146.74 48.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.188 1.395 . . . . 0.0 110.963 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -140.83 159.1 42.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.222 1.009 . . . . 0.0 112.437 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -132.22 117.14 17.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.681 1.192 . . . . 0.0 109.692 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -106.85 153.13 22.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.069 1.348 . . . . 0.0 111.586 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.08 79.86 1.75 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 110.379 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.62 152.46 18.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.024 1.33 . . . . 0.0 111.354 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -84.85 148.16 26.43 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.211 0.605 . . . . 0.0 109.445 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.04 130.73 59.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.556 -0.715 . . . . 0.0 112.143 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.96 -24.35 1.37 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.908 1.739 . . . . 0.0 114.216 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -71.82 -28.22 63.44 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.045 1.293 . . . . 0.0 113.628 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.59 2.63 52.92 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 123.856 0.741 . . . . 0.0 113.472 169.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -136.1 -165.03 1.64 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.106 2.162 . . . . 0.0 111.326 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.6 p -78.31 166.0 23.19 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.9 -26.91 66.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.858 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.88 -39.1 93.41 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.935 -1.103 . . . . 0.0 110.415 169.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.65 -36.69 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.208 0.913 . . . . 0.0 111.587 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -55.42 -45.41 76.72 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.888 1.676 . . . . 0.0 110.529 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -69.46 -19.93 63.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.0 m -79.36 -52.41 8.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.761 1.224 . . . . 0.0 111.718 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.24 -33.34 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.338 1.055 . . . . 0.0 111.317 -172.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -56.67 -39.44 73.78 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.924 0.783 . . . . 0.0 112.765 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.23 65.9 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.079 0.847 . . . . 0.0 112.878 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -69.82 -39.36 76.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.092 0.946 . . . . 0.0 111.166 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.11 -47.57 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.813 0.845 . . . . 0.0 110.966 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -55.25 -47.7 75.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.187 1.395 . . . . 0.0 112.792 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -68.64 -27.46 66.03 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.651 1.568 . . . . 0.0 112.686 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -71.58 -49.44 40.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.064 0.945 . . . . 0.0 111.693 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.9 -41.1 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.947 0.794 . . . . 0.0 112.891 170.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -63.9 -51.69 63.33 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.15 1.341 . . . . 0.0 112.485 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -69.31 -30.14 68.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.914 0.779 . . . . 0.0 112.375 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.88 -49.74 71.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.966 0.907 . . . . 0.0 110.901 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.57 -39.94 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.182 -0.949 . . . . 0.0 110.585 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.27 -26.72 67.96 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -90.77 -18.12 25.48 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -104.37 -16.99 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.649 1.179 . . . . 0.0 112.935 178.785 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.5 2.057 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -71.29 143.48 50.31 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.151 0.98 . . . . 0.0 111.804 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.6 129.36 55.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.363 1.065 . . . . 0.0 111.469 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.45 116.28 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.452 1.901 . . . . 0.0 109.9 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -94.6 125.47 39.27 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 169.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -99.32 113.39 25.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.577 0.751 . . . . 0.0 111.275 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.07 144.06 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.392 1.077 . . . . 0.0 112.69 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 t -144.43 167.31 22.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.03 0.932 . . . . 0.0 111.583 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -65.15 162.23 17.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.331 1.453 . . . . 0.0 111.005 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -59.5 148.11 34.3 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.175 0.99 . . . . 0.0 112.675 -170.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.5 t30 54.55 46.63 24.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.971 1.308 . . . . 0.0 113.237 171.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.0 t -136.57 143.57 43.7 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.378 1.471 . . . . 0.0 111.611 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.7 p -83.43 -10.21 58.54 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -65.27 -35.32 80.66 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.772 1.629 . . . . 0.0 113.653 -169.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 p -64.5 -52.92 55.42 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.363 0.983 . . . . 0.0 111.213 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -63.49 -39.04 93.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.547 1.139 . . . . 0.0 111.643 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.2 tpt -77.25 -35.2 55.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.903 0.881 . . . . 0.0 112.312 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.48 95.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.459 0.572 . . . . 0.0 110.736 169.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.35 -43.81 98.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.933 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.56 -48.02 73.36 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.666 1.121 . . . . 0.0 113.705 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -66.44 -44.23 83.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.129 0.964 . . . . 0.0 111.739 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.36 75.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -27.67 64.09 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.423 1.011 . . . . 0.0 112.584 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 m -88.71 -41.65 12.45 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.908 0.883 . . . . 0.0 112.548 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.58 -34.63 14.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.7 0.8 . . . . 0.0 112.617 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.34 8.55 64.05 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.598 1.57 . . . . 0.0 113.696 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.36 117.85 1.94 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.341 1.071 . . . . 0.0 112.0 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.72 13.91 82.6 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -119.19 -40.14 2.85 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.165 1.482 . . . . 0.0 111.847 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.11 160.01 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.355 1.862 . . . . 0.0 110.998 171.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 150.86 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.466 0.707 . . . . 0.0 109.469 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -141.23 140.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.223 -0.923 . . . . 0.0 112.531 -173.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -144.4 159.49 42.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.205 1.802 . . . . 0.0 109.051 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.9 p -133.72 158.83 42.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 113.46 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.1 t -148.1 146.15 28.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.98 1.312 . . . . 0.0 111.192 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.01 139.25 15.17 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.5 mt -52.8 -42.96 65.57 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.019 1.909 . . . . 0.0 113.002 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.4 38.95 3.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.28 1.432 . . . . 0.0 110.89 171.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t 69.58 171.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.068 2.147 . . . . 0.0 114.302 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 t -157.91 -169.1 2.71 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.284 1.833 . . . . 0.0 110.038 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 167.7 21.58 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.87 166.49 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.402 1.081 . . . . 0.0 109.159 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -138.11 126.94 14.51 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.432 -1.418 . . . . 0.0 111.626 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.61 -40.22 85.96 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.926 2.417 . . . . 0.0 114.304 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.91 -34.3 77.81 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.243 -0.91 . . . . 0.0 111.273 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 -2.74 23.43 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.371 -1.456 . . . . 0.0 114.154 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -87.43 -54.78 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 167.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -28.85 61.65 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 73.2 mmm -78.27 -6.01 53.72 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.326 -0.859 . . . . 0.0 113.205 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.3 mmt -120.33 -26.36 5.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.71 1.204 . . . . 0.0 111.815 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.13 -20.52 65.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 112.439 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.07 -11.15 60.62 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 171.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 t -107.98 5.88 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 127.092 2.157 . . . . 0.0 110.622 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.07 14.04 82.63 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.561 -1.337 . . . . 0.0 114.396 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.21 154.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.999 1.32 . . . . 0.0 110.27 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.18 149.12 41.02 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.291 1.037 . . . . 0.0 110.957 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.3 pt -133.78 -2.1 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.171 1.789 . . . . 0.0 113.122 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -54.66 -37.91 66.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.598 1.159 . . . . 0.0 113.836 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.32 -1.2 90.37 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 116.145 1.218 . . . . 0.0 116.145 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -76.61 160.77 29.12 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.748 1.774 . . . . 0.0 113.319 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 57.9 p -135.24 167.52 20.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.713 2.005 . . . . 0.0 110.484 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 t -144.18 158.83 43.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.535 1.134 . . . . 0.0 111.376 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -150.95 163.71 22.77 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 126.352 1.861 . . . . 0.0 110.177 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -60.49 146.22 97.27 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.5 2.8 . . . . 0.0 113.566 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.16 -32.31 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.076 0.95 . . . . 0.0 113.486 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.46 -13.76 61.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -21.19 46.61 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.332 0.969 . . . . 0.0 113.354 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.77 169.46 10.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.054 1.342 . . . . 0.0 112.825 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.0 108.41 15.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 110.892 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.3 65.94 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -169.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.68 -24.89 67.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.028 0.931 . . . . 0.0 112.533 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.57 -2.01 58.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.456 1.902 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.89 82.05 1.74 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.946 2.098 . . . . 0.0 108.11 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.35 -28.19 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.765 1.626 . . . . 0.0 113.004 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -130.15 130.29 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.893 1.677 . . . . 0.0 108.627 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -131.49 126.51 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.095 -1.003 . . . . 0.0 109.262 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.3 mm -126.72 133.92 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.697 1.199 . . . . 0.0 109.214 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.2 t -109.01 148.67 30.41 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.969 1.308 . . . . 0.0 112.098 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.21 55.55 1.66 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.974 1.31 . . . . 0.0 109.677 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -114.68 -13.39 12.1 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.28 61.39 1.91 Allowed Glycine 0 CA--C 1.535 1.294 0 CA-C-N 119.664 1.12 . . . . 0.0 114.249 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.2 m 58.48 29.74 18.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.285 1.834 . . . . 0.0 114.801 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -169.88 112.93 0.49 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.301 0.953 . . . . 0.0 111.495 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.19 133.25 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.889 1.276 . . . . 0.0 110.691 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -89.6 119.38 29.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.63 0.772 . . . . 0.0 109.512 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.8 mt -141.74 140.28 19.82 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.386 1.074 . . . . 0.0 112.443 -175.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 151.5 82.51 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.252 1.968 . . . . 0.0 110.286 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.44 -26.91 79.93 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 115.535 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -89.16 -3.05 58.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.58 18.0 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.295 1.438 . . . . 0.0 113.352 -173.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -122.29 -0.7 9.3 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.402 1.881 . . . . 0.0 112.87 -172.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -57.24 163.62 2.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.861 2.864 . . . . 0.0 113.987 174.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.09 -34.79 78.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -131.62 127.46 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.906 0.883 . . . . 0.0 111.037 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -137.28 140.3 41.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.492 1.517 . . . . 0.0 111.333 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -156.57 156.38 33.49 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.116 1.366 . . . . 0.0 111.006 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -113.78 142.85 45.55 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.876 1.27 . . . . 0.0 110.954 170.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -110.82 142.28 43.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.964 1.705 . . . . 0.0 111.572 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -104.73 59.59 0.7 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.957 1.703 . . . . 0.0 107.29 -169.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.02 132.0 53.44 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.422 1.889 . . . . 0.0 112.002 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -88.65 163.26 15.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.748 1.619 . . . . 0.0 112.869 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.66 138.82 37.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 122.1 -0.375 . . . . 0.0 111.136 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -91.54 -22.06 0.56 Allowed 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.342 2.028 . . . . 0.0 114.46 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.33 -34.51 74.74 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -169.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.81 -8.7 73.54 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 119.555 -0.581 . . . . 0.0 113.849 171.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -110.79 -83.85 0.57 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.53 1.532 . . . . 0.0 112.831 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t -168.78 156.16 7.5 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.314 1.046 . . . . 0.0 112.18 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.07 -27.7 68.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.148 0.979 . . . . 0.0 112.455 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.6 -25.83 61.47 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.692 -1.255 . . . . 0.0 111.85 169.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 71.3 t -75.37 -33.38 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.876 -1.14 . . . . 0.0 109.866 169.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.37 -44.63 92.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.035 1.743 . . . . 0.0 109.594 168.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.2 m -76.8 -54.03 7.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.487 0.715 . . . . 0.0 111.461 170.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.98 -34.8 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 0.0 111.344 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -57.85 -44.53 86.62 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 112.255 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.41 -29.65 67.9 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.691 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -67.55 -51.07 55.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.38 1.09 . . . . 0.0 110.256 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.6 t -57.44 -43.66 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.521 -0.737 . . . . 0.0 110.857 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.25 -48.65 73.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.709 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -72.8 -29.79 63.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.132 1.333 . . . . 0.0 113.504 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -63.74 -52.23 61.39 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.075 0.852 . . . . 0.0 109.937 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.49 -42.99 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.021 1.328 . . . . 0.0 112.546 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -61.69 -45.97 91.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.976 1.262 . . . . 0.0 111.633 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -38.39 89.22 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.535 0.607 . . . . 0.0 111.302 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.474 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -58.96 -51.13 71.39 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.898 0.879 . . . . 0.0 110.928 174.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.0 -44.3 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.651 0.66 . . . . 0.0 111.032 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.96 -23.52 66.44 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.6 pttt -94.17 -6.87 43.83 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -122.15 -17.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.168 1.787 . . . . 0.0 112.339 -178.822 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 111.244 0.091 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -69.1 133.49 48.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.835 1.254 . . . . 0.0 112.141 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -103.82 123.47 47.15 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.19 0.996 . . . . 0.0 111.129 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 111.0 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 126.104 1.762 . . . . 0.0 109.897 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.1 tpp -90.67 129.65 36.75 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.684 0.393 . . . . 0.0 110.091 168.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -100.0 124.67 45.62 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.727 0.811 . . . . 0.0 109.731 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.95 143.05 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.701 1.2 . . . . 0.0 112.525 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.4 t -143.02 168.12 20.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.738 1.215 . . . . 0.0 110.369 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -64.85 -66.79 0.5 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.491 1.041 . . . . 0.0 111.223 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -166.96 -50.59 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.133 1.773 . . . . 0.0 112.761 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -55.34 129.34 38.16 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.587 1.555 . . . . 0.0 114.491 -169.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 t 60.41 9.75 2.15 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.311 2.245 . . . . 0.0 116.358 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.8 m 43.88 44.23 5.7 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.695 1.998 . . . . 0.0 115.968 169.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -60.43 -23.04 64.1 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 126.949 2.1 . . . . 0.0 111.851 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -63.59 -52.96 58.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.788 1.235 . . . . 0.0 112.217 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -67.08 -34.89 78.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.272 0.629 . . . . 0.0 111.466 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.91 71.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.058 0.543 . . . . 0.0 112.313 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.71 86.67 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.508 -0.745 . . . . 0.0 112.698 173.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.15 -40.68 77.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.921 0.782 . . . . 0.0 111.896 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.27 -53.54 43.99 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-N 119.188 0.904 . . . . 0.0 112.961 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -65.97 -40.97 91.71 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.243 -1.151 . . . . 0.0 111.881 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.81 94.27 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -76.41 -29.05 56.89 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.53 1.059 . . . . 0.0 112.624 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m -77.5 -43.57 31.71 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 0.0 111.647 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.51 -33.12 13.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.67 0.788 . . . . 0.0 112.491 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.5 11.82 57.6 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.671 1.605 . . . . 0.0 113.221 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.11 122.77 5.49 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.433 1.116 . . . . 0.0 111.551 171.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.01 8.8 87.3 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 116.029 1.172 . . . . 0.0 116.029 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -118.68 -31.04 4.96 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.649 1.724 . . . . 0.0 112.998 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.13 156.52 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 112.248 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.73 144.73 25.02 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.98 138.64 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.451 1.478 . . . . 0.0 113.487 -169.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 m -149.43 161.5 41.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.577 1.551 . . . . 0.0 110.274 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 p -137.4 150.62 47.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.314 1.054 . . . . 0.0 113.759 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 t -145.43 157.93 43.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.435 1.894 . . . . 0.0 110.099 -169.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.15 146.03 18.08 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.462 -0.774 . . . . 0.0 111.614 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -58.52 -42.68 88.26 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.976 0.888 . . . . 0.0 110.728 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.91 40.44 1.81 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.352 1.461 . . . . 0.0 111.287 173.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 t 65.17 178.56 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.407 1.883 . . . . 0.0 114.417 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -152.99 165.61 35.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 112.453 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.61 -179.82 6.54 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.76 -173.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.75 113.61 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.065 0.946 . . . . 0.0 110.186 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.73 143.92 44.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.458 1.103 . . . . 0.0 110.993 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.87 -37.12 76.8 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.354 2.703 . . . . 0.0 113.857 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -61.21 -39.63 90.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.63 0.772 . . . . 0.0 112.17 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -13.21 60.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.8 mt -78.19 -53.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.43 64.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.8 mmt -70.47 -12.06 61.32 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 mmt -121.9 -28.64 4.42 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.269 1.028 . . . . 0.0 112.603 -169.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.35 -24.72 67.97 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.724 -1.235 . . . . 0.0 112.568 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.22 -10.73 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 11.5 p -121.38 26.2 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.188 1.795 . . . . 0.0 110.397 169.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.66 9.31 86.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.014 1.768 . . . . 0.0 116.774 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.06 147.76 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 118.84 1.32 . . . . 0.0 111.915 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.78 127.87 54.76 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.696 1.598 . . . . 0.0 111.506 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.0 pt -138.04 -6.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 p -64.19 -27.52 69.12 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.73 -1.231 . . . . 0.0 114.318 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.56 -6.72 89.16 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.594 1.092 . . . . 0.0 115.211 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -83.64 152.25 24.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.195 1.497 . . . . 0.0 113.116 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -145.32 177.62 8.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.481 1.912 . . . . 0.0 108.819 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -152.68 174.88 13.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.487 1.04 . . . . 0.0 113.765 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.87 163.14 28.62 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.937 2.095 . . . . 0.0 110.159 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.15 142.42 94.4 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.458 2.772 . . . . 0.0 113.247 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.97 -35.09 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.41 -11.81 60.22 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 CA--C 1.553 1.085 0 O-C-N 121.25 -0.906 . . . . 0.0 113.117 172.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -94.14 169.18 10.44 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.987 1.315 . . . . 0.0 112.832 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.23 107.47 12.59 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.411 1.484 . . . . 0.0 111.725 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.44 -20.16 65.47 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.42 -24.99 68.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.793 1.237 . . . . 0.0 112.895 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.74 -4.11 56.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.084 1.754 . . . . 0.0 112.106 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -114.7 82.97 1.81 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.452 1.901 . . . . 0.0 108.114 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -51.15 -26.9 7.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.857 1.663 . . . . 0.0 113.364 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -134.25 133.25 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.722 1.609 . . . . 0.0 109.287 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.62 121.19 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.866 -1.146 . . . . 0.0 110.91 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.08 124.19 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 108.522 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 t -91.19 152.29 20.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.666 1.586 . . . . 0.0 110.957 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.77 52.32 2.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.005 1.322 . . . . 0.0 110.028 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m -116.38 -20.79 9.57 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.17 52.21 6.36 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 119.096 0.862 . . . . 0.0 113.114 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.3 t 61.77 172.11 0.12 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.643 2.377 . . . . 0.0 114.06 -172.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.25 20.37 73.16 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.496 1.045 . . . . 0.0 115.165 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.32 130.68 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.39 1.076 . . . . 0.0 111.436 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -84.46 62.52 7.3 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.725 1.21 . . . . 0.0 111.456 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.52 139.01 41.11 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.926 0.891 . . . . 0.0 112.996 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -63.29 152.69 78.61 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.301 2.0 . . . . 0.0 109.662 168.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.18 -22.1 73.61 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.218 2.612 . . . . 0.0 115.384 -169.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.54 -14.29 61.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -91.92 -1.43 57.29 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.8 14.76 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.904 1.682 . . . . 0.0 113.757 -174.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -118.89 -0.96 11.1 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.246 1.819 . . . . 0.0 112.877 -171.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -59.8 161.44 6.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.251 2.62 . . . . 0.0 113.897 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.03 -33.93 76.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.5 mt -132.9 127.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.791 0.836 . . . . 0.0 110.394 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -130.03 149.26 51.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.178 1.391 . . . . 0.0 111.568 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -144.83 161.12 40.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.758 1.223 . . . . 0.0 112.182 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.21 128.54 26.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 167.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -106.86 146.81 30.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.368 1.467 . . . . 0.0 111.379 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -107.83 59.3 0.62 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.4 1.88 . . . . 0.0 106.864 -173.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.56 117.32 33.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.493 1.917 . . . . 0.0 112.335 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.89 159.47 32.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.823 1.296 . . . . 0.0 113.64 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.21 118.8 70.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 126.568 1.947 . . . . 0.0 113.113 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -81.2 -25.1 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 121.887 1.725 . . . . 0.0 113.385 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -62.7 126.1 26.2 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.365 0.984 . . . . 0.0 111.576 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.47 -1.38 87.75 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.369 -1.239 . . . . 0.0 115.287 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -93.65 -88.61 0.23 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.691 1.746 . . . . 0.0 112.193 170.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.0 t -161.79 156.09 22.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.385 1.074 . . . . 0.0 110.957 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.78 -30.03 71.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.833 1.253 . . . . 0.0 111.542 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -72.73 -23.8 60.89 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.741 -1.225 . . . . 0.0 112.301 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.94 -35.9 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.958 -1.089 . . . . 0.0 109.961 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.95 -47.63 84.38 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.656 1.571 . . . . 0.0 110.593 169.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -65.87 -21.85 66.49 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -80.03 -53.96 6.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.608 1.163 . . . . 0.0 111.845 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.79 -32.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.383 1.073 . . . . 0.0 111.343 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -57.17 -39.79 76.01 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.355 0.98 . . . . 0.0 113.016 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.65 -35.43 74.18 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.746 0.688 . . . . 0.0 112.171 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -68.59 -39.15 81.06 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.954 -0.733 . . . . 0.0 111.578 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.02 -49.08 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.637 170.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.13 -47.42 78.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.983 1.313 . . . . 0.0 112.417 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -69.18 -26.79 65.02 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.824 1.647 . . . . 0.0 112.624 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -72.98 -50.07 25.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.913 0.885 . . . . 0.0 111.299 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.79 -42.14 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.213 0.915 . . . . 0.0 112.565 169.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.24 -51.41 63.79 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.31 1.414 . . . . 0.0 112.464 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -31.97 70.71 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.917 0.781 . . . . 0.0 112.08 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.49 -48.44 75.17 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.425 0.69 . . . . 0.0 111.019 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.5 mt -72.95 -41.02 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.856 -174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.62 -26.25 68.59 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.83 -14.49 44.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.18 -23.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.601 1.56 . . . . 0.0 112.035 -179.478 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.0 tpp . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -70.22 150.67 46.19 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.178 0.899 . . . . 0.0 111.447 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.54 118.08 32.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 110.169 170.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.75 112.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.918 1.687 . . . . 0.0 109.584 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.3 ttm -95.1 122.34 37.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.851 0.75 . . . . 0.0 109.899 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -88.16 127.82 35.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.116 0.566 . . . . 0.0 109.982 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.97 145.94 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.686 1.194 . . . . 0.0 112.492 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.0 t -154.9 162.72 41.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.733 0.813 . . . . 0.0 111.801 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.94 165.79 24.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.778 0.831 . . . . 0.0 110.858 169.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -64.07 -18.28 64.21 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -169.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -73.63 -10.31 59.57 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -169.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 p -146.62 179.02 7.84 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -169.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.6 p -100.0 13.66 33.22 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.49 1.516 . . . . 0.0 113.904 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.38 -37.7 78.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.604 1.547 . . . . 0.0 113.356 -169.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.7 p -68.83 -43.14 76.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.408 1.003 . . . . 0.0 112.411 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.0 -35.03 71.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.719 0.808 . . . . 0.0 111.424 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.3 tpt -73.06 -37.63 66.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.063 1.345 . . . . 0.0 112.18 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.94 -44.87 91.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.25 0.477 . . . . 0.0 111.786 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -60.84 -38.83 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.379 -0.819 . . . . 0.0 111.823 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.62 72.89 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.113 1.324 . . . . 0.0 113.089 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -66.86 -44.43 81.02 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.169 -1.195 . . . . 0.0 111.81 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.44 72.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.778 -1.201 . . . . 0.0 114.05 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -72.23 -23.03 61.17 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.87 1.214 . . . . 0.0 112.867 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -86.07 -44.66 12.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.188 0.995 . . . . 0.0 112.037 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 mt -95.84 -35.85 11.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.23 1.012 . . . . 0.0 113.031 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.96 7.69 80.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.964 1.745 . . . . 0.0 113.575 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -38.93 -45.34 1.17 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.7 17.92 27.47 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.485 1.517 . . . . 0.0 114.787 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -116.63 -28.68 6.33 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.6 pt -157.59 163.97 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 127.603 2.361 . . . . 0.0 110.485 -171.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 147.03 24.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 167.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.5 145.43 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.745 -1.222 . . . . 0.0 113.62 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -148.88 157.97 43.82 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.791 2.036 . . . . 0.0 109.237 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.4 p -131.12 156.8 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.6 -1.312 . . . . 0.0 112.914 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -153.56 155.87 36.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.704 1.202 . . . . 0.0 109.793 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.3 145.46 18.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.31 -31.83 69.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.646 1.223 . . . . 0.0 111.913 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -123.33 35.48 4.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.161 1.785 . . . . 0.0 110.215 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t 71.36 170.37 0.32 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.142 1.777 . . . . 0.0 112.151 -168.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -155.63 -177.38 6.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.051 1.74 . . . . 0.0 110.966 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -144.76 178.39 8.03 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -113.15 140.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.375 1.47 . . . . 0.0 109.346 169.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -110.96 135.63 20.82 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.497 -1.239 . . . . 0.0 110.92 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.02 -36.69 85.18 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.294 2.662 . . . . 0.0 115.467 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -67.51 -31.88 72.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 120.9 -1.125 . . . . 0.0 111.779 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.88 -10.83 59.75 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.303 -1.498 . . . . 0.0 113.438 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.61 -58.89 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.41 -38.54 77.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.1 mmm -73.99 -6.69 48.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 mmt -118.01 -23.96 7.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.745 1.218 . . . . 0.0 111.516 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.88 -28.16 68.67 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.261 -0.9 . . . . 0.0 111.609 169.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.85 -5.61 42.07 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.48 1.06 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.412 2.285 . . . . 0.0 110.581 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.41 13.15 82.19 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.23 1.395 . . . . 0.0 114.553 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mm -89.29 152.01 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.47 1.135 . . . . 0.0 111.022 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -129.65 138.6 51.29 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 111.002 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 pt -135.8 -5.26 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -57.42 -33.11 67.54 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.26 -5.75 85.03 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -83.14 144.44 29.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.337 1.569 . . . . 0.0 112.873 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.3 p -133.79 171.72 13.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.845 2.058 . . . . 0.0 110.302 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.7 t -141.0 165.81 26.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.212 1.005 . . . . 0.0 112.398 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.25 155.02 30.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.61 1.564 . . . . 0.0 109.267 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.85 135.46 67.08 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.874 2.383 . . . . 0.0 113.215 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -54.52 -33.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -10.26 55.75 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -25.26 59.2 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.247 -0.908 . . . . 0.0 112.669 170.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.21 167.68 11.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.832 1.253 . . . . 0.0 112.499 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.94 115.86 30.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.122 1.369 . . . . 0.0 111.362 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.46 -19.31 62.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.09 -27.0 66.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.648 0.737 . . . . 0.0 112.304 -172.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.01 -10.88 57.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.037 1.735 . . . . 0.0 111.806 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -107.37 79.57 1.32 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 126.548 1.939 . . . . 0.0 108.786 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -66.13 -12.42 55.63 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -129.9 130.77 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.516 1.527 . . . . 0.0 109.169 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.4 t -134.14 128.77 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.134 -0.979 . . . . 0.0 109.512 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.8 121.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.253 1.021 . . . . 0.0 110.079 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -96.61 150.02 21.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 112.32 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.8 mp -126.27 35.13 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.829 1.252 . . . . 0.0 111.455 171.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.3 m -84.9 -30.28 24.53 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.783 0.833 . . . . 0.0 112.98 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.36 61.44 2.62 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.742 0.687 . . . . 0.0 111.98 -172.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 81.9 m 61.89 168.86 0.11 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.442 2.297 . . . . 0.0 113.799 -169.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.13 30.0 73.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.118 -0.988 . . . . 0.0 114.782 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.93 104.77 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.347 1.059 . . . . 0.0 110.264 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -81.75 116.29 21.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.891 0.876 . . . . 0.0 110.547 -175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.8 mt -142.37 139.81 18.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.534 -170.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -63.22 154.65 66.45 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.503 2.135 . . . . 0.0 110.188 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -58.36 -32.65 96.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.551 2.168 . . . . 0.0 114.691 -170.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -88.13 -3.25 58.91 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 m -118.81 -22.08 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.8 t -77.42 2.06 17.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.066 1.746 . . . . 0.0 114.514 -173.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -49.64 158.26 0.47 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.497 2.319 . . . . 0.0 114.24 171.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.71 -33.37 73.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.34 126.51 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.419 1.087 . . . . 0.0 111.008 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -136.05 139.09 42.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.844 1.657 . . . . 0.0 110.255 169.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.95 157.83 39.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.636 1.174 . . . . 0.0 110.871 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -117.6 140.97 48.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.942 1.297 . . . . 0.0 110.571 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -108.63 140.15 42.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.582 1.553 . . . . 0.0 111.469 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.43 60.76 1.02 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.169 1.788 . . . . 0.0 106.495 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -107.64 124.56 50.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.073 2.149 . . . . 0.0 111.167 -167.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -81.27 157.98 24.96 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.324 1.05 . . . . 0.0 112.664 -172.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -95.07 123.81 56.08 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.592 1.157 . . . . 0.0 111.556 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.42 -9.47 11.35 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.56 2.173 . . . . 0.0 114.862 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -63.93 117.32 6.83 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 121.187 1.812 . . . . 0.0 112.595 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.61 -5.16 84.94 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.176 1.369 . . . . 0.0 114.694 -173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.8 178.1 5.42 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.741 1.616 . . . . 0.0 110.81 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.2 t -68.02 157.0 36.11 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.237 -0.915 . . . . 0.0 112.302 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.22 -24.15 66.14 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.144 -0.972 . . . . 0.0 111.365 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -66.38 -32.29 73.58 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.433 -0.792 . . . . 0.0 111.537 169.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.36 -39.18 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.94 -1.1 . . . . 0.0 110.425 173.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -59.03 -47.25 85.91 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.037 1.289 . . . . 0.0 111.289 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -68.23 -22.28 64.79 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.0 m -77.73 -57.34 3.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.97 -34.68 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 -171.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -55.88 -43.24 77.02 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.001 0.819 . . . . 0.0 112.953 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.04 -32.05 61.09 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.766 0.698 . . . . 0.0 112.051 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -68.44 -41.05 80.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.773 -0.84 . . . . 0.0 111.376 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.7 -49.11 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 0.0 110.174 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -54.42 -49.23 70.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.172 0.989 . . . . 0.0 112.202 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -71.57 -28.39 63.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.19 0.904 . . . . 0.0 112.696 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -72.16 -46.13 57.66 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.393 0.677 . . . . 0.0 111.181 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.6 t -58.05 -42.27 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.048 0.939 . . . . 0.0 111.289 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.06 -46.29 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.511 1.051 . . . . 0.0 111.935 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -40.45 95.99 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.58 0.627 . . . . 0.0 110.808 176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.47 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -57.89 -51.24 70.41 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.215 1.006 . . . . 0.0 110.632 176.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.2 mt -70.6 -45.47 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.11 -26.0 68.05 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.9 pttt -91.21 -7.82 50.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.08 -16.71 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.883 1.673 . . . . 0.0 112.805 -175.782 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.39 138.94 49.55 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.192 0.906 . . . . 0.0 111.627 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -111.31 123.14 49.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.478 1.111 . . . . 0.0 111.161 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -93.21 107.08 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.875 1.67 . . . . 0.0 110.354 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -85.74 128.99 34.94 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.77 118.52 37.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.751 1.22 . . . . 0.0 108.727 169.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.3 136.18 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 0.0 111.163 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.2 t -130.43 173.43 10.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -64.93 152.0 44.32 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.62 150.91 46.11 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -169.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.4 t30 60.93 9.23 2.2 Favored 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -76.68 172.29 13.29 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.997 1.319 . . . . 0.0 111.368 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 p -118.21 3.27 12.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.617 1.167 . . . . 0.0 113.615 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -74.11 -33.31 63.55 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.518 1.508 . . . . 0.0 112.654 -169.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 p -65.71 -42.56 90.97 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.8 . . . . 0.0 111.736 169.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -64.14 -43.1 96.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.994 0.518 . . . . 0.0 112.175 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -39.54 91.63 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.454 -0.779 . . . . 0.0 111.874 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.21 -48.42 80.06 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.76 -38.73 75.9 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.597 0.635 . . . . 0.0 111.434 171.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.11 -62.38 6.19 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.106 1.336 . . . . 0.0 112.723 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -58.73 -33.61 70.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.004 1.402 . . . . 0.0 111.498 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.46 -30.36 64.5 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.684 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -73.99 -29.76 62.13 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.354 1.888 . . . . 0.0 112.771 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 m -74.98 -45.64 40.69 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.882 0.765 . . . . 0.0 112.22 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.3 -37.15 12.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.022 0.929 . . . . 0.0 112.588 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.82 2.18 60.44 Favored Glycine 0 N--CA 1.469 0.835 0 C-N-CA 125.527 1.537 . . . . 0.0 114.333 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 113.66 0.76 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.622 1.211 . . . . 0.0 111.724 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.1 19.96 79.79 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -124.0 -41.42 2.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.61 1.705 . . . . 0.0 112.383 -174.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -153.23 168.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.872 2.069 . . . . 0.0 110.424 177.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.3 153.95 18.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 109.795 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.04 144.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.14 -0.975 . . . . 0.0 112.945 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -150.43 142.58 24.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.526 1.13 . . . . 0.0 110.721 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -103.52 148.62 25.73 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.188 1.395 . . . . 0.0 112.802 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -154.21 165.48 36.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 111.159 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.92 158.64 27.74 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -55.17 -36.8 66.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 118.124 0.962 . . . . 0.0 113.235 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.69 41.74 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.782 1.633 . . . . 0.0 109.651 169.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t 67.45 168.18 0.25 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.569 2.347 . . . . 0.0 115.983 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -137.92 170.61 15.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.708 2.403 . . . . 0.0 110.029 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -131.04 168.22 17.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -107.82 150.4 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.518 1.527 . . . . 0.0 108.164 169.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -136.92 133.41 18.7 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.888 -1.529 . . . . 0.0 109.94 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -52.98 -36.38 75.38 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.9 2.4 . . . . 0.0 115.139 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.1 m -69.36 -34.25 74.29 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.976 -1.078 . . . . 0.0 111.782 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.56 -13.29 60.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.031 -1.043 . . . . 0.0 113.184 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -77.69 -54.64 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.75 64.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -70.25 -9.84 57.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mmt -122.45 -29.89 4.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.449 1.1 . . . . 0.0 112.261 -169.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.59 -25.56 67.41 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.82 -1.175 . . . . 0.0 112.29 170.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.68 -13.88 62.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.274 1.03 . . . . 0.0 113.746 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.259 4.0 m -114.5 16.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.691 1.196 . . . . 0.0 111.604 168.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.03 73.36 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.036 1.779 . . . . 0.0 116.264 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.16 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.039 1.419 . . . . 0.0 112.05 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -129.16 121.38 27.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.27 3.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.351 1.46 . . . . 0.0 111.906 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -70.25 -34.11 72.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.572 -169.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.22 4.54 82.83 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.474 1.035 . . . . 0.0 114.645 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.78 156.68 26.81 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.08 1.44 . . . . 0.0 113.803 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -156.01 162.0 40.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.726 1.61 . . . . 0.0 110.21 173.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -103.26 172.51 6.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.904 1.281 . . . . 0.0 112.453 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -138.03 159.31 68.94 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.037 1.335 . . . . 0.0 109.981 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.78 138.06 83.57 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.336 2.691 . . . . 0.0 112.879 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 tt -58.1 -31.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.23 -11.13 60.68 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -20.95 57.75 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.246 -0.909 . . . . 0.0 112.642 171.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.28 167.56 11.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.79 1.236 . . . . 0.0 112.837 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.07 112.22 20.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.925 1.69 . . . . 0.0 110.358 175.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.23 -17.63 64.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.43 -26.06 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.183 0.993 . . . . 0.0 112.474 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.02 -1.3 57.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.913 1.685 . . . . 0.0 112.155 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -118.05 80.15 1.47 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.808 2.043 . . . . 0.0 108.115 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.05 -24.53 17.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.977 1.711 . . . . 0.0 113.186 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -134.28 130.65 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.789 1.635 . . . . 0.0 108.983 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.8 t -134.42 122.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.285 -0.884 . . . . 0.0 110.834 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.51 122.92 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.751 1.62 . . . . 0.0 108.899 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -88.9 144.54 26.13 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.243 1.417 . . . . 0.0 109.994 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.13 27.22 9.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.553 1.141 . . . . 0.0 111.781 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.8 m -92.6 -16.33 25.78 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.66 42.13 63.12 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-N 118.649 0.659 . . . . 0.0 113.06 -171.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.8 t 61.54 179.56 0.12 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.226 2.211 . . . . 0.0 113.556 -173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.77 24.38 74.16 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.317 0.96 . . . . 0.0 114.07 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 p -87.39 129.92 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.13 1.372 . . . . 0.0 111.108 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -83.87 57.77 4.31 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.583 1.153 . . . . 0.0 111.924 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -74.58 140.22 75.07 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.076 0.95 . . . . 0.0 112.491 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.95 151.56 83.87 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.151 1.9 . . . . 0.0 109.774 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.89 -21.11 72.9 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.104 2.536 . . . . 0.0 115.463 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.27 -13.19 61.45 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -91.48 -1.85 57.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.21 17.52 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.605 1.562 . . . . 0.0 113.427 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 t -124.64 1.48 8.22 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.095 1.758 . . . . 0.0 113.023 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -58.9 163.4 3.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.771 2.829 . . . . 0.0 113.986 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.41 -35.62 81.5 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.7 125.9 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.976 0.91 . . . . 0.0 109.985 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -125.59 147.22 49.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.256 1.423 . . . . 0.0 110.715 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -139.33 157.79 45.28 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.39 1.076 . . . . 0.0 112.505 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -135.97 126.65 27.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.764 1.226 . . . . 0.0 108.234 168.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -111.28 132.14 54.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.678 1.591 . . . . 0.0 110.218 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -92.38 64.15 4.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.159 1.383 . . . . 0.0 109.771 -171.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.03 144.82 25.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.569 1.548 . . . . 0.0 114.075 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -93.88 160.4 14.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.596 1.558 . . . . 0.0 111.0 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -106.31 126.39 30.6 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.083 0.953 . . . . 0.0 111.787 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.41 -6.41 15.5 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.306 2.004 . . . . 0.0 113.64 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.95 125.08 17.39 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.084 1.311 . . . . 0.0 112.058 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.6 4.29 60.85 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.476 1.036 . . . . 0.0 115.422 -176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -93.03 178.27 5.8 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.985 1.393 . . . . 0.0 113.121 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.2 t -72.06 156.0 39.69 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.279 0.632 . . . . 0.0 110.554 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.53 -21.61 64.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.002 -1.061 . . . . 0.0 112.079 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.72 -28.08 67.35 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.232 -0.917 . . . . 0.0 111.244 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.86 -41.19 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.938 -1.101 . . . . 0.0 110.309 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -56.81 -48.45 77.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.946 1.248 . . . . 0.0 111.145 169.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -69.57 -18.73 63.66 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.3 m -82.71 -52.29 6.91 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.183 1.393 . . . . 0.0 111.945 169.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.13 -34.53 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.461 1.105 . . . . 0.0 111.396 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -54.12 -42.57 69.61 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.835 0.743 . . . . 0.0 112.099 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.64 -31.42 65.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.67 0.653 . . . . 0.0 112.913 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.16 -41.18 70.74 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.141 0.971 . . . . 0.0 110.782 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.72 -47.47 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.426 0.69 . . . . 0.0 110.549 169.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.24 -50.4 67.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.922 1.289 . . . . 0.0 112.639 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -70.12 -26.43 63.96 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.787 1.176 . . . . 0.0 112.635 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -72.96 -51.08 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.213 1.005 . . . . 0.0 110.807 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.59 -47.54 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.263 1.025 . . . . 0.0 111.735 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -62.5 -51.75 66.2 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.697 1.135 . . . . 0.0 112.574 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.14 -31.4 68.89 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.125 0.875 . . . . 0.0 111.964 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.12 -50.04 73.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.475 0.71 . . . . 0.0 110.784 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.23 -38.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 121.369 -0.832 . . . . 0.0 111.375 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -25.51 67.2 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -91.23 -11.92 36.78 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.8 pt -114.14 -17.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.254 1.316 0 C-N-CA 125.582 1.553 . . . . 0.0 111.973 172.099 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttm . . . . . 0 N--CA 1.501 2.075 0 CA-C-O 119.786 -0.149 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -71.31 143.44 50.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.183 0.993 . . . . 0.0 112.028 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -110.06 122.84 48.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.71 109.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.532 1.533 . . . . 0.0 110.352 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 ttm -89.63 126.93 35.82 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.586 0.63 . . . . 0.0 109.59 169.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -95.56 124.25 39.49 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.021 1.329 . . . . 0.0 109.343 169.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.9 m -128.13 143.09 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.524 1.13 . . . . 0.0 112.554 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.0 t -153.36 177.3 11.03 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -77.01 167.76 21.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.432 1.493 . . . . 0.0 111.846 170.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -63.58 -36.33 83.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 -169.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -69.7 -37.81 76.74 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 p -94.27 173.04 7.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -169.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.3 p -106.79 16.45 24.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.106 1.363 . . . . 0.0 111.841 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -62.4 -35.91 80.7 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.497 -1.377 . . . . 0.0 112.598 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -66.28 -44.14 84.38 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.195 0.907 . . . . 0.0 111.995 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -65.2 -43.97 89.89 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.493 -0.754 . . . . 0.0 111.887 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -39.11 79.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.6 1.16 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.53 92.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.34 -38.46 77.21 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.428 -0.795 . . . . 0.0 110.732 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.73 -58.6 9.94 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.522 1.534 . . . . 0.0 113.943 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -65.23 -30.54 71.43 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.969 1.384 . . . . 0.0 111.982 174.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.53 -32.82 70.43 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.903 -1.123 . . . . 0.0 113.962 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -70.57 -26.89 63.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 121.315 1.871 . . . . 0.0 112.666 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.5 m -74.91 -46.47 35.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.663 0.785 . . . . 0.0 112.454 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.6 mt -98.75 -29.34 13.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -169.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.18 2.2 87.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.78 1.657 . . . . 0.0 113.229 170.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.13 116.22 1.46 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.406 1.103 . . . . 0.0 112.284 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.78 11.42 84.58 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -119.84 -38.04 3.02 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.16 1.48 . . . . 0.0 111.793 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 pt -148.28 161.68 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.539 1.936 . . . . 0.0 112.001 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.56 147.75 22.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.97 142.86 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.993 -1.067 . . . . 0.0 112.465 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -146.43 153.04 40.0 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 p -128.71 144.02 51.07 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.515 1.126 . . . . 0.0 112.615 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t -155.29 162.27 40.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.282 1.433 . . . . 0.0 110.268 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.37 154.36 20.31 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.04 -1.038 . . . . 0.0 111.403 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.05 -40.27 97.2 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.067 -1.255 . . . . 0.0 111.519 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -111.17 34.23 4.18 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.654 1.582 . . . . 0.0 109.625 169.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 t 71.44 170.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.546 1.938 . . . . 0.0 111.357 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.5 p -149.41 -162.52 1.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.598 1.559 . . . . 0.0 110.294 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -155.35 174.88 14.6 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.683 -1.261 . . . . 0.0 114.388 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.39 154.14 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -127.78 130.83 23.6 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.174 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -54.78 -39.61 88.87 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.991 2.461 . . . . 0.0 114.503 -173.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -67.56 -31.69 71.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.11 -10.33 59.33 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.678 -1.263 . . . . 0.0 113.127 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.6 -57.77 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.13 79.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 75.4 mmm -73.97 -8.5 56.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.1 mmt -118.15 -25.91 6.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.086 1.355 . . . . 0.0 111.76 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.9 -30.61 67.93 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.986 -1.071 . . . . 0.0 111.783 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.91 -11.08 60.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 t -100.9 3.03 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 126.606 1.962 . . . . 0.0 110.477 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.75 12.25 81.74 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.383 1.468 . . . . 0.0 114.848 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -87.45 148.12 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 118.494 1.147 . . . . 0.0 111.197 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -132.46 101.11 5.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.462 1.505 . . . . 0.0 111.21 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.4 pt -125.38 -4.13 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.3 p -63.94 -27.02 68.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.609 1.095 . . . . 0.0 113.546 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.39 -5.25 89.73 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.877 1.227 . . . . 0.0 115.311 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -78.47 157.93 28.79 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.522 1.661 . . . . 0.0 113.374 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -134.41 -177.61 4.68 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.858 2.063 . . . . 0.0 110.887 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 t -151.07 161.44 42.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.29 1.036 . . . . 0.0 112.047 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -147.6 160.01 39.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.173 1.789 . . . . 0.0 109.671 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.85 133.99 54.26 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.347 2.698 . . . . 0.0 111.955 174.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.47 -32.32 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -9.63 51.36 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -22.03 59.15 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.167 0.894 . . . . 0.0 112.605 170.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.88 171.57 8.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.851 1.261 . . . . 0.0 112.8 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.49 113.96 21.56 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.574 1.55 . . . . 0.0 111.074 176.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.14 -11.73 59.66 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.706 -1.247 . . . . 0.0 113.857 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.15 -20.88 57.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.838 1.255 . . . . 0.0 112.98 174.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -103.25 -0.63 30.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.117 1.767 . . . . 0.0 113.166 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -125.26 77.5 1.64 Allowed 'General case' 0 C--N 1.345 0.406 0 C-N-CA 125.799 1.639 . . . . 0.0 109.206 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.99 -23.57 13.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.085 2.154 . . . . 0.0 113.488 -175.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.74 133.81 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.768 1.627 . . . . 0.0 108.186 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.57 122.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.988 -1.07 . . . . 0.0 110.353 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.63 118.05 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 108.167 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -88.64 154.91 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.083 0.953 . . . . 0.0 109.856 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.07 46.59 2.48 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.079 1.351 . . . . 0.0 110.852 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t -105.25 -36.31 7.27 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.394 1.478 . . . . 0.0 111.868 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.08 90.05 2.08 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.868 1.699 . . . . 0.0 112.379 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.3 p 37.08 45.33 0.46 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.255 2.222 . . . . 0.0 115.6 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -176.13 15.9 0.04 OUTLIER Glycine 0 CA--C 1.538 1.497 0 N-CA-C 117.017 1.567 . . . . 0.0 117.017 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.3 147.5 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.385 1.593 . . . . 0.0 111.978 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -99.46 59.5 1.11 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.357 1.063 . . . . 0.0 111.503 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -87.4 146.3 39.46 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -65.68 154.3 74.41 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 122.824 2.349 . . . . 0.0 110.153 168.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.72 -35.55 98.76 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.51 2.14 . . . . 0.0 115.668 -169.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.57 -23.76 67.18 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.086 -1.009 . . . . 0.0 113.355 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.4 -7.57 58.88 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.17 -22.82 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.25 1.42 . . . . 0.0 113.411 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -83.16 11.9 5.86 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.782 1.633 . . . . 0.0 113.508 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.65 165.92 11.65 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.767 1.627 . . . . 0.0 112.603 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.29 -36.51 83.91 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.659 -0.651 . . . . 0.0 112.726 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.7 130.0 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.861 0.865 . . . . 0.0 110.119 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -134.89 150.6 50.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.134 1.373 . . . . 0.0 111.873 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -141.74 158.04 44.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -139.63 81.17 1.81 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.668 0.787 . . . . 0.0 111.218 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -66.47 149.5 50.34 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.126 1.771 . . . . 0.0 113.127 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -114.04 60.6 0.67 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.339 1.856 . . . . 0.0 107.858 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -100.57 134.68 43.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.169 2.187 . . . . 0.0 112.527 -168.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.44 140.24 56.36 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.335 1.854 . . . . 0.0 112.644 -173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -93.04 112.06 54.39 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -78.69 -6.05 15.08 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.471 2.114 . . . . 0.0 113.496 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -53.72 122.79 10.64 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.689 1.131 . . . . 0.0 112.628 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.06 4.14 47.73 Favored Glycine 0 CA--C 1.541 1.695 0 N-CA-C 115.446 0.938 . . . . 0.0 115.446 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -101.18 -178.88 3.87 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.14 1.376 . . . . 0.0 112.476 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.7 m -78.04 162.31 26.81 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.977 0.911 . . . . 0.0 112.023 -171.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.02 -24.97 66.86 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.164 -0.96 . . . . 0.0 111.676 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.84 -28.33 69.49 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.161 -0.962 . . . . 0.0 111.796 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 -39.92 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.463 -1.398 . . . . 0.0 109.484 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -63.18 -36.55 84.01 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.433 1.015 . . . . 0.0 112.166 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -77.57 -20.8 53.47 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.125 -1.609 . . . . 0.0 113.827 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.3 m -91.73 -39.58 11.73 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.967 0.907 . . . . 0.0 111.63 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.8 p -59.27 -42.7 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 120.404 -1.435 . . . . 0.0 111.797 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -59.83 -43.34 94.63 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -32.05 65.51 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.849 -0.532 . . . . 0.0 112.828 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.37 -39.14 81.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.888 0.844 . . . . 0.0 112.064 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.64 -51.47 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.58 0.752 . . . . 0.0 109.91 169.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.19 -47.0 82.35 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.359 1.064 . . . . 0.0 112.61 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -68.73 -27.06 65.6 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.773 1.624 . . . . 0.0 112.531 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -73.16 -51.43 17.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 111.655 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.52 -41.05 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.115 0.871 . . . . 0.0 112.761 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.84 -50.32 69.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.701 1.591 . . . . 0.0 112.389 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -70.61 -30.0 66.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.905 0.775 . . . . 0.0 112.063 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -50.0 70.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.698 0.799 . . . . 0.0 110.815 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -69.78 -41.17 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.274 -0.891 . . . . 0.0 110.705 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.65 -26.38 68.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.31 -14.79 34.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.9 pt -111.58 -18.3 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.543 1.137 . . . . 0.0 113.154 179.058 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -71.56 140.85 50.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.779 0.832 . . . . 0.0 111.851 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -111.09 126.46 54.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.325 1.05 . . . . 0.0 111.28 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.12 107.63 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.208 1.803 . . . . 0.0 109.826 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -87.64 127.9 35.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.141 0.428 . . . . 0.0 109.989 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.11 114.71 28.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.5 1.12 . . . . 0.0 109.69 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -111.46 136.26 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.699 1.2 . . . . 0.0 112.524 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.2 t -138.52 168.82 18.95 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.206 -0.934 . . . . 0.0 112.577 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -60.55 147.84 40.11 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.934 0.894 . . . . 0.0 109.86 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.21 154.57 37.69 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 52.23 42.36 30.75 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.582 1.553 . . . . 0.0 113.36 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -123.47 168.62 12.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.723 1.609 . . . . 0.0 110.686 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.8 t -117.96 6.02 12.16 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.248 1.019 . . . . 0.0 113.634 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -72.39 -37.49 68.7 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.248 -1.533 . . . . 0.0 111.175 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -62.3 -46.17 89.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.298 1.039 . . . . 0.0 111.621 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.04 -40.4 78.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.554 1.142 . . . . 0.0 111.979 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.7 mmm -68.6 -36.91 79.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.436 -0.79 . . . . 0.0 112.745 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.68 95.89 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.001 0.819 . . . . 0.0 111.451 173.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -60.46 -39.75 88.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.899 0.772 . . . . 0.0 111.323 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.55 -60.96 7.53 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.975 1.274 . . . . 0.0 112.894 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -60.31 -34.01 73.19 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.554 1.177 . . . . 0.0 111.734 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.12 -27.16 61.52 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 117.839 -1.077 . . . . 0.0 113.884 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -75.42 -28.66 59.47 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.295 1.861 . . . . 0.0 112.656 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -76.05 -45.99 31.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.623 0.769 . . . . 0.0 112.267 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.16 -30.36 12.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.436 1.094 . . . . 0.0 113.267 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.0 4.98 81.51 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.94 1.733 . . . . 0.0 113.692 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.69 109.33 0.19 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.553 1.176 . . . . 0.0 112.813 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.61 19.41 79.7 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -118.48 -37.2 3.35 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.079 1.439 . . . . 0.0 112.08 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -152.28 166.58 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.051 2.541 . . . . 0.0 109.82 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.57 151.27 21.39 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.385 0.674 . . . . 0.0 109.737 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 142.1 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.039 -1.038 . . . . 0.0 112.666 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 m -149.28 154.91 39.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.92 1.288 . . . . 0.0 110.578 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 p -127.11 145.61 50.68 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.61 1.164 . . . . 0.0 112.598 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -148.46 146.5 28.42 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.859 1.264 . . . . 0.0 111.243 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.87 143.05 17.64 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.5 -38.57 66.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.587 1.694 . . . . 0.0 112.604 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -122.74 45.44 2.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.789 1.635 . . . . 0.0 110.307 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.2 p 68.99 143.62 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.434 3.094 . . . . 0.0 116.776 -170.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -107.69 171.39 7.42 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.644 2.378 . . . . 0.0 111.566 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -141.3 144.17 34.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.916 1.286 . . . . 0.0 112.496 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.26 152.73 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.093 1.757 . . . . 0.0 110.75 171.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.48 149.82 68.62 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.522 1.129 . . . . 0.0 111.776 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.08 -35.83 74.02 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.404 2.736 . . . . 0.0 114.224 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -63.54 -39.39 94.29 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.492 -0.755 . . . . 0.0 112.006 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.72 -20.57 61.18 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.171 -0.956 . . . . 0.0 112.808 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.94 -54.26 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.14 67.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -170.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -69.72 -9.67 55.34 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 mmt -125.85 -28.89 3.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.309 1.044 . . . . 0.0 112.499 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.28 -24.85 67.52 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.868 -1.145 . . . . 0.0 112.101 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.35 -13.68 62.45 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.74 15.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.974 1.31 . . . . 0.0 111.641 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.94 10.94 71.14 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.957 1.742 . . . . 0.0 116.176 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -84.9 146.76 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.404 1.602 . . . . 0.0 111.958 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -116.13 129.34 56.28 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.79 1.636 . . . . 0.0 111.96 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.0 pt -135.29 -8.94 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.943 1.297 . . . . 0.0 113.707 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -60.29 -30.64 69.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.869 1.268 . . . . 0.0 114.094 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.33 1.9 84.66 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.76 1.171 . . . . 0.0 115.353 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -77.56 156.75 30.7 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.77 1.785 . . . . 0.0 112.674 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.3 p -133.25 175.43 9.41 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.564 1.946 . . . . 0.0 110.231 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -155.91 155.55 33.04 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -148.45 159.2 39.48 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.231 2.212 . . . . 0.0 109.472 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -55.38 143.11 78.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.389 2.726 . . . . 0.0 113.127 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.74 -31.49 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -169.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -13.7 60.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -20.01 58.53 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 119.084 0.856 . . . . 0.0 112.926 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -96.33 164.35 12.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.943 1.297 . . . . 0.0 112.625 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.11 109.71 19.24 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 111.348 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.88 -22.06 65.99 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.24 -25.61 68.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.696 1.198 . . . . 0.0 112.834 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.15 -3.07 58.74 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.993 1.717 . . . . 0.0 112.103 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -116.17 82.26 1.75 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.887 2.075 . . . . 0.0 108.428 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -25.52 21.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.835 1.654 . . . . 0.0 113.079 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.6 t -132.97 129.78 57.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.079 1.752 . . . . 0.0 109.085 -176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.61 120.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.196 -0.94 . . . . 0.0 110.719 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.51 120.46 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.169 1.388 . . . . 0.0 108.159 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -86.02 150.29 24.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.42 1.088 . . . . 0.0 109.721 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.83 44.09 3.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.082 1.353 . . . . 0.0 110.522 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.1 m -114.16 -13.36 12.41 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.11 13.54 82.63 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.409 1.005 . . . . 0.0 114.213 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.7 p -157.09 171.56 20.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.163 2.185 . . . . 0.0 110.643 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.54 -28.81 65.62 Favored Glycine 0 CA--C 1.542 1.77 0 O-C-N 121.608 -0.682 . . . . 0.0 113.607 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.304 0.3 OUTLIER 61.2 161.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 129.609 3.163 . . . . 0.0 115.288 173.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -70.4 108.54 4.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.975 -1.078 . . . . 0.0 110.122 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.0 mt -140.26 133.81 15.2 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.388 1.475 . . . . 0.0 111.027 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -60.39 152.27 68.5 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.293 1.995 . . . . 0.0 110.243 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.13 -21.84 73.17 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.035 2.49 . . . . 0.0 114.912 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -15.56 62.73 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -90.26 -3.16 57.98 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.15 13.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.674 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -118.12 -1.2 11.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.493 1.917 . . . . 0.0 112.775 -171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -56.05 159.67 3.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.587 2.755 . . . . 0.0 113.89 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.28 -34.98 79.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.22 129.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.172 0.989 . . . . 0.0 110.368 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -130.62 148.19 52.39 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.423 1.489 . . . . 0.0 111.29 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -142.0 161.75 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.759 1.224 . . . . 0.0 112.554 176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.08 124.24 21.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.85 1.26 . . . . 0.0 109.102 168.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -110.85 160.32 16.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.206 1.802 . . . . 0.0 112.4 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -122.79 50.6 1.5 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.475 1.51 . . . . 0.0 112.333 -168.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.19 137.52 36.7 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.229 -0.92 . . . . 0.0 112.636 -172.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 146.5 52.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.863 1.265 . . . . 0.0 108.556 169.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.46 119.22 65.66 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.95 0.9 . . . . 0.0 111.024 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.76 -11.31 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.143 1.895 . . . . 0.0 113.447 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.1 121.9 10.46 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.267 1.027 . . . . 0.0 112.076 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.22 1.76 64.97 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -100.58 -174.61 2.69 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.15 1.38 . . . . 0.0 111.89 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.5 t -74.01 157.5 36.02 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.476 -0.765 . . . . 0.0 112.028 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.91 -30.09 70.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.47 1.108 . . . . 0.0 111.646 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.98 -21.42 63.24 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.671 -1.268 . . . . 0.0 113.12 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.7 t -71.2 -40.52 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 120.36 -1.463 . . . . 0.0 110.102 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -56.83 -46.68 81.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.571 1.078 . . . . 0.0 110.826 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -68.77 -17.86 64.11 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.8 m -87.67 -43.47 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.912 1.285 . . . . 0.0 112.236 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -66.76 -38.74 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.703 -1.248 . . . . 0.0 111.501 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -57.46 -40.2 77.97 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.34 64.94 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.431 0.539 . . . . 0.0 112.881 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -68.76 -43.59 75.49 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.957 -0.731 . . . . 0.0 110.978 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.5 t -58.81 -47.49 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.747 -0.596 . . . . 0.0 110.414 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -57.12 -50.71 71.97 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.678 1.191 . . . . 0.0 112.422 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.19 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.878 1.217 . . . . 0.0 112.794 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -68.42 -50.72 50.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.472 0.709 . . . . 0.0 110.924 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.34 -48.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.646 1.178 . . . . 0.0 112.174 169.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -62.52 -50.82 69.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.832 1.196 . . . . 0.0 112.475 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -30.19 67.43 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.772 0.715 . . . . 0.0 111.899 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.43 -50.82 68.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.697 0.799 . . . . 0.0 110.613 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -70.74 -39.98 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.22 0.918 . . . . 0.0 111.165 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 -20.6 60.84 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -97.64 -10.9 24.25 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -113.55 -17.64 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 126.21 1.804 . . . . 0.0 112.499 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -71.42 144.07 49.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.063 0.945 . . . . 0.0 111.702 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.18 128.39 55.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.109 0.964 . . . . 0.0 111.284 170.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.66 118.33 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.249 1.819 . . . . 0.0 110.221 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.2 tpp -96.95 122.7 40.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -95.56 114.95 26.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.421 0.689 . . . . 0.0 110.438 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.91 147.06 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.45 1.1 . . . . 0.0 113.46 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 t -146.41 151.99 38.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -73.05 98.85 2.62 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.613 1.165 . . . . 0.0 109.818 174.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 52.55 -95.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.949 2.1 . . . . 0.0 113.046 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -40.0 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.172 2.189 . . . . 0.0 112.701 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.0 m -88.76 17.67 5.38 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -173.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.87 -33.51 75.86 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.508 1.504 . . . . 0.0 111.66 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.29 -39.72 24.78 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.839 1.256 . . . . 0.0 111.536 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.1 p -71.99 -40.44 68.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.535 1.061 . . . . 0.0 112.83 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.31 -32.15 71.1 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.91 0.777 . . . . 0.0 111.145 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -43.18 80.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.04 1.291 . . . . 0.0 112.378 169.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -43.52 97.02 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.266 0.485 . . . . 0.0 110.922 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.76 -43.71 97.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.817 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -44.86 96.67 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 119.805 1.184 . . . . 0.0 113.79 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.93 -37.9 76.03 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.444 -1.033 . . . . 0.0 111.14 171.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.47 -34.2 65.24 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.697 -1.252 . . . . 0.0 113.67 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.86 -22.52 64.21 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.908 1.231 . . . . 0.0 112.63 171.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 m -88.8 -46.88 8.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.814 1.246 . . . . 0.0 112.262 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.62 -33.45 12.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 112.886 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 5.76 77.67 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.939 1.733 . . . . 0.0 113.059 170.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.38 120.62 4.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.349 1.075 . . . . 0.0 111.433 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.95 77.88 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -110.42 -40.82 4.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.339 1.455 . . . . 0.0 111.045 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -148.6 159.35 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 112.762 -171.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.61 151.27 19.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.122 1.369 . . . . 0.0 107.53 168.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 t -139.9 139.88 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 120.89 -1.131 . . . . 0.0 112.177 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -141.6 154.68 45.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.677 1.591 . . . . 0.0 109.865 170.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.3 p -124.11 152.35 42.86 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.084 -1.01 . . . . 0.0 112.126 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 t -151.01 124.54 8.98 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.433 0.693 . . . . 0.0 112.717 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.24 127.14 8.64 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.98 -35.12 23.24 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -169.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -123.0 34.56 5.1 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.234 1.414 . . . . 0.0 112.605 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 p 66.99 161.83 0.17 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 127.759 2.423 . . . . 0.0 115.499 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -161.58 -163.52 1.0 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.165 1.386 . . . . 0.0 111.528 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -133.16 173.25 11.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.241 1.817 . . . . 0.0 113.21 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 t -85.55 167.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -129.43 125.71 22.59 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 120.337 -1.477 . . . . 0.0 111.714 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -55.79 -40.17 86.76 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.176 2.584 . . . . 0.0 114.651 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -64.42 -30.32 71.36 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.117 -0.989 . . . . 0.0 111.859 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.36 -5.43 52.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.3 mt -86.14 -57.05 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 168.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.11 75.34 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -170.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.4 -9.34 58.0 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 mmt -119.12 -27.85 5.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.127 0.971 . . . . 0.0 112.34 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.92 -30.38 65.87 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.786 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.8 -10.64 59.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.811 1.244 . . . . 0.0 113.923 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 8.5 p -121.77 24.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.932 1.693 . . . . 0.0 110.829 169.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.6 83.46 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.211 1.863 . . . . 0.0 116.63 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.22 147.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.789 1.295 . . . . 0.0 111.76 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -131.63 107.82 9.09 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.191 1.796 . . . . 0.0 110.597 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 pt -140.22 15.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 p -60.05 -27.64 67.11 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.698 -1.251 . . . . 0.0 113.825 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.08 9.22 39.36 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.161 1.362 . . . . 0.0 116.153 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -65.09 -50.58 65.55 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.264 2.032 . . . . 0.0 114.203 -169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p 58.71 167.27 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.245 1.818 . . . . 0.0 114.38 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -144.63 131.15 19.87 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.027 -1.046 . . . . 0.0 112.166 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -132.53 158.61 75.23 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.001 1.721 . . . . 0.0 112.289 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.06 145.14 89.18 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.478 2.785 . . . . 0.0 113.524 -170.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.52 -34.23 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -169.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.52 -7.0 50.07 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -20.47 55.79 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.294 -0.879 . . . . 0.0 112.133 169.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -94.99 170.21 9.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.182 1.393 . . . . 0.0 112.264 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.22 111.69 18.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.974 1.71 . . . . 0.0 110.535 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.46 -23.05 66.82 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -169.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.29 -25.14 67.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.92 0.888 . . . . 0.0 112.758 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.73 -2.75 58.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.224 1.81 . . . . 0.0 111.946 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.9 84.65 2.11 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.117 2.167 . . . . 0.0 108.022 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.86 -28.05 8.73 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.055 1.742 . . . . 0.0 112.725 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.56 130.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.832 1.653 . . . . 0.0 109.003 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.1 t -131.5 126.99 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.297 -0.877 . . . . 0.0 109.097 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -126.2 124.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.464 1.106 . . . . 0.0 108.904 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -99.35 156.4 17.02 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.113 0.965 . . . . 0.0 111.599 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.24 52.88 2.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 110.937 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.3 m -116.6 -0.91 12.28 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.26 1.424 . . . . 0.0 114.763 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.5 49.01 4.54 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.086 0.857 . . . . 0.0 115.199 173.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.4 t 58.39 52.1 7.56 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.0 1.72 . . . . 0.0 112.761 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.06 111.15 0.24 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.137 1.351 . . . . 0.0 112.074 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.32 140.22 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.781 1.232 . . . . 0.0 111.228 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -88.37 115.5 25.92 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.805 0.842 . . . . 0.0 109.86 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.63 138.63 20.42 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.119 0.967 . . . . 0.0 112.914 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.99 151.76 82.97 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.483 2.122 . . . . 0.0 109.896 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -57.57 -29.97 86.9 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 115.255 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.73 -19.58 65.95 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -89.77 -3.45 58.15 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.75 -12.83 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -88.52 5.5 42.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.696 1.599 . . . . 0.0 113.765 -171.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -59.23 160.43 6.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.146 2.179 . . . . 0.0 113.878 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.98 -33.24 75.28 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 127.06 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.834 0.854 . . . . 0.0 110.36 169.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -138.28 141.43 39.85 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.777 1.631 . . . . 0.0 111.127 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.96 162.44 38.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.405 1.482 . . . . 0.0 110.72 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -128.85 124.67 35.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.571 1.148 . . . . 0.0 111.581 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -102.89 161.67 13.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.197 1.799 . . . . 0.0 113.091 -172.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -95.64 -82.06 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.528 1.131 . . . . 0.0 111.496 -170.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 55.09 156.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.3 2.64 . . . . 0.0 115.853 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -90.25 178.05 6.26 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -117.74 117.84 35.46 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.462 -1.399 . . . . 0.0 111.209 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.03 -11.34 7.64 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.449 1.433 . . . . 0.0 113.261 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.25 106.1 0.69 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 120.644 1.565 . . . . 0.0 112.779 -172.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.76 1.06 85.55 Favored Glycine 0 CA--C 1.543 1.785 0 C-N-CA 125.063 1.315 . . . . 0.0 115.718 -173.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -97.98 -171.7 2.21 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.09 1.756 . . . . 0.0 111.378 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.2 t -76.11 159.74 30.45 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.181 -0.949 . . . . 0.0 112.641 -170.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.48 -32.9 69.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.353 1.461 . . . . 0.0 111.295 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.19 -29.62 70.45 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 0.0 112.374 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.5 t -72.34 -42.21 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.907 -1.12 . . . . 0.0 110.263 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -58.8 -48.16 82.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.331 0.969 . . . . 0.0 111.56 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -69.83 -20.61 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.7 m -78.88 -56.01 4.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.591 1.156 . . . . 0.0 110.925 169.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.19 -35.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 0.0 111.387 -171.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.77 -42.77 72.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.828 0.74 . . . . 0.0 112.84 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.03 -34.75 61.55 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.808 0.718 . . . . 0.0 112.712 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -70.39 -41.47 72.97 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.457 0.629 . . . . 0.0 110.588 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.64 -45.82 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.651 -0.655 . . . . 0.0 110.975 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -55.28 -50.08 70.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.163 0.985 . . . . 0.0 111.788 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.29 -29.44 66.18 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.862 1.21 . . . . 0.0 113.013 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -68.6 -49.85 56.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.453 0.701 . . . . 0.0 111.196 173.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.64 -41.31 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.833 1.253 . . . . 0.0 111.731 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -62.04 -47.27 85.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.529 1.059 . . . . 0.0 112.131 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -38.77 92.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.553 0.615 . . . . 0.0 111.092 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.489 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.7 tm? -59.25 -53.52 57.38 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.5 1.12 . . . . 0.0 110.598 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.82 -42.34 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 118.754 0.706 . . . . 0.0 111.384 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.15 70.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -90.89 -20.1 22.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.4 -24.93 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 124.919 1.288 . . . . 0.0 114.273 -169.637 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 tpp . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.656 -0.211 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -68.9 135.5 51.13 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.668 1.187 . . . . 0.0 112.467 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -108.96 128.24 54.76 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.942 0.897 . . . . 0.0 111.862 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.31 120.69 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.871 1.668 . . . . 0.0 110.051 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.5 tpp -99.62 126.84 45.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -98.4 123.44 42.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.223 0.609 . . . . 0.0 111.197 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 m -125.84 141.64 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.22 1.008 . . . . 0.0 113.004 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t . . . . . 0 CA--C 1.551 0.996 0 O-C-N 121.404 -0.81 . . . . 0.0 112.357 179.487 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 p -66.4 -48.06 71.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.124 1.329 . . . . 0.0 111.232 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.77 -39.07 93.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.298 1.439 . . . . 0.0 111.719 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -40.53 77.15 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.944 1.297 . . . . 0.0 112.018 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.97 95.46 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.651 -0.656 . . . . 0.0 112.427 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -58.79 -41.08 85.86 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.789 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.7 -52.82 45.81 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.484 1.038 . . . . 0.0 113.25 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -65.3 -41.16 94.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.083 -1.246 . . . . 0.0 111.801 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.27 87.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -73.17 -20.93 60.8 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.536 1.062 . . . . 0.0 113.028 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -87.92 -44.84 10.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.225 1.01 . . . . 0.0 112.187 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.02 -37.58 10.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.213 1.005 . . . . 0.0 112.819 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.94 6.96 68.1 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.653 1.597 . . . . 0.0 113.99 170.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.27 -43.4 4.86 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.5 16.18 48.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.583 1.563 . . . . 0.0 114.651 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.09 -34.08 3.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.034 1.333 . . . . 0.0 112.477 -169.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -152.98 165.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.678 1.591 . . . . 0.0 113.149 -173.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.77 153.77 17.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 167.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.19 143.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.278 -1.514 . . . . 0.0 114.615 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.82 168.07 20.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.473 1.909 . . . . 0.0 108.933 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -140.49 153.7 46.32 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.859 -1.15 . . . . 0.0 112.167 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 p -153.82 -175.27 5.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.525 1.13 . . . . 0.0 110.186 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.14 166.53 26.68 Favored Glycine 0 N--CA 1.471 1.016 0 O-C-N 120.836 -1.165 . . . . 0.0 113.15 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.09 -38.34 85.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 122.013 -0.698 . . . . 0.0 112.076 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.21 40.6 3.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.125 1.77 . . . . 0.0 109.135 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t 73.84 178.09 0.23 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.661 2.384 . . . . 0.0 113.71 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -144.84 174.75 10.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.348 2.259 . . . . 0.0 110.935 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.4 ptt85 -140.37 158.45 44.0 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.16 156.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -135.15 131.05 19.57 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-O 117.38 -1.295 . . . . 0.0 111.386 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -55.46 -39.52 90.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.131 2.554 . . . . 0.0 114.721 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -67.65 -30.38 69.92 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.041 -1.037 . . . . 0.0 111.784 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.25 -10.14 59.19 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.824 -1.172 . . . . 0.0 113.432 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.74 -55.04 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.19 62.8 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -73.57 -9.69 58.94 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.2 mmt -121.79 -28.47 4.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.502 1.121 . . . . 0.0 112.311 -171.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -21.56 66.73 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.135 -0.978 . . . . 0.0 112.895 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.34 -11.09 60.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.4 1.08 . . . . 0.0 113.28 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -102.64 0.63 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 126.86 2.064 . . . . 0.0 110.452 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.71 13.77 79.2 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.143 1.354 . . . . 0.0 114.474 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mm -87.58 152.39 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.449 1.099 . . . . 0.0 110.96 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -127.68 137.33 52.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.975 1.31 . . . . 0.0 111.429 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 pt -139.56 -7.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.402 1.081 . . . . 0.0 113.551 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -57.22 -35.07 69.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.836 1.654 . . . . 0.0 114.973 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.78 -3.17 88.28 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.366 0.984 . . . . 0.0 115.293 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -78.76 157.96 28.36 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.037 1.418 . . . . 0.0 113.707 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -132.74 175.27 9.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.024 2.13 . . . . 0.0 111.287 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.4 t -154.09 156.48 37.34 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.164 0.985 . . . . 0.0 112.775 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -142.59 161.8 47.72 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.643 1.977 . . . . 0.0 108.598 169.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.99 135.64 70.04 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.844 2.363 . . . . 0.0 112.577 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 tt -53.85 -33.33 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.36 -12.28 61.47 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.86 59.0 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.114 0.87 . . . . 0.0 112.309 169.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.11 171.95 8.75 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.15 1.38 . . . . 0.0 112.07 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -98.11 -17.12 19.25 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -168.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.531 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . 60.15 -29.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.085 2.954 . . . . 0.0 116.947 -170.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.75 -36.25 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 113.07 -169.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -81.58 -0.7 43.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 111.909 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -112.25 77.83 1.08 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.714 2.006 . . . . 0.0 108.442 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.98 -24.17 8.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.07 1.748 . . . . 0.0 113.236 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.07 130.19 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.072 1.749 . . . . 0.0 108.778 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.78 121.61 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.661 -1.274 . . . . 0.0 110.29 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.58 120.22 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.072 1.349 . . . . 0.0 108.345 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -89.16 157.04 18.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.852 1.261 . . . . 0.0 109.667 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.46 43.19 3.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.442 1.097 . . . . 0.0 111.563 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.9 m . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 124.878 1.271 . . . . 0.0 112.151 -179.468 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.3 mt -142.41 138.0 16.04 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.47 1.108 . . . . 0.0 112.951 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -62.6 149.55 90.7 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.681 2.254 . . . . 0.0 110.664 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.83 -34.26 84.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.13 2.553 . . . . 0.0 115.121 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -63.04 -20.39 65.28 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.531 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 94.2 m95 -88.61 -6.34 57.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.32 1.448 . . . . 0.0 114.619 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.7 m -117.26 -20.81 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 -1.67 28.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.998 1.719 . . . . 0.0 114.243 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -49.88 155.98 0.8 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.031 2.532 . . . . 0.0 114.547 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.24 -34.1 73.21 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.61 128.5 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.63 1.172 . . . . 0.0 109.344 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.14 147.79 50.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.213 1.405 . . . . 0.0 111.239 171.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -141.77 159.49 42.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.045 1.338 . . . . 0.0 111.289 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -141.26 87.41 2.08 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.824 0.85 . . . . 0.0 110.318 169.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -67.29 140.74 57.34 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 113.477 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -91.17 55.25 2.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.959 2.104 . . . . 0.0 107.607 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.65 125.12 49.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.635 1.974 . . . . 0.0 111.117 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.45 162.19 22.18 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.541 1.536 . . . . 0.0 112.382 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.04 128.75 42.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 O-C-N 121.5 -0.75 . . . . 0.0 111.076 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 C-N-CA 121.84 1.693 . . . . 0.0 112.55 175.173 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 120.964 0.412 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.3 -25.49 68.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.929 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.0 -30.45 71.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.301 -0.874 . . . . 0.0 111.571 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.37 -40.88 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.91 -1.119 . . . . 0.0 110.541 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -57.23 -48.49 78.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.034 1.288 . . . . 0.0 111.275 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -69.36 -18.94 63.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.1 m -82.06 -55.55 4.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.838 1.255 . . . . 0.0 111.541 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.57 -29.57 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.093 0.957 . . . . 0.0 111.675 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -55.62 -42.75 75.38 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.533 1.06 . . . . 0.0 113.37 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 -32.38 62.89 Favored Glycine 0 N--CA 1.472 1.038 0 O-C-N 121.905 -0.497 . . . . 0.0 112.507 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.97 -39.01 83.43 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.95 -0.735 . . . . 0.0 111.43 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.37 -48.79 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 110.183 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.26 -48.85 70.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.009 0.924 . . . . 0.0 112.069 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -71.32 -28.58 64.19 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.887 1.221 . . . . 0.0 112.936 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -70.11 -49.72 47.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.783 0.833 . . . . 0.0 110.639 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.2 t -55.03 -49.35 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.499 1.12 . . . . 0.0 111.358 169.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.66 -51.46 65.06 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.409 1.004 . . . . 0.0 112.487 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.77 -30.88 68.56 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.832 0.742 . . . . 0.0 112.056 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.69 -50.5 66.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.541 0.737 . . . . 0.0 110.877 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.42 -37.82 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.028 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -26.67 68.89 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -85.17 -13.01 51.4 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 174.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -109.32 -25.38 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.911 1.684 . . . . 0.0 112.104 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 119.767 -0.158 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -70.32 141.02 52.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.069 0.948 . . . . 0.0 111.447 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -109.5 126.36 53.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.161 0.984 . . . . 0.0 111.6 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.9 t -96.98 111.67 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.947 1.699 . . . . 0.0 110.354 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.2 tpp -90.82 127.45 36.36 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.47 122.23 43.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.235 1.014 . . . . 0.0 111.124 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.96 142.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.1 t . . . . . 0 CA--C 1.548 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 112.425 -175.272 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -62.93 -50.96 68.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.255 1.389 . . . . 0.0 112.692 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -62.06 -38.53 89.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.255 1.022 . . . . 0.0 111.552 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.406 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 7.2 tpt -74.87 -39.26 61.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.004 0.922 . . . . 0.0 112.336 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.91 88.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.407 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -58.15 -49.5 76.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.492 169.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.53 -47.54 63.14 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 121.0 1.727 . . . . 0.0 114.409 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -67.28 -42.95 82.96 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.018 -1.283 . . . . 0.0 112.032 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.63 -31.59 69.78 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.981 -1.074 . . . . 0.0 113.338 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -65.14 -29.39 70.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 128.876 2.871 . . . . 0.0 112.751 172.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -90.49 -45.47 8.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.836 0.855 . . . . 0.0 112.102 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.03 -31.83 13.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.265 1.026 . . . . 0.0 113.345 -170.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.22 1.6 88.42 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.421 1.486 . . . . 0.0 114.166 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.78 117.56 2.57 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 118.453 1.126 . . . . 0.0 111.403 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.3 15.58 81.09 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.91 -40.03 2.34 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.075 1.437 . . . . 0.0 111.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.25 164.39 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.831 1.652 . . . . 0.0 111.553 170.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 153.96 19.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.94 0.896 . . . . 0.0 108.804 169.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.52 147.56 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 m -152.1 160.89 43.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.994 1.718 . . . . 0.0 108.83 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.3 p -135.05 154.91 51.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.211 -0.931 . . . . 0.0 112.68 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 t -150.76 129.63 12.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.044 0.938 . . . . 0.0 110.276 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.94 141.49 20.14 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.02 -34.55 63.58 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.038 1.419 . . . . 0.0 112.482 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.95 41.45 3.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.958 1.703 . . . . 0.0 110.956 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t 72.69 168.66 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.627 1.971 . . . . 0.0 112.894 -168.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -158.1 172.16 18.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.724 1.61 . . . . 0.0 112.372 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -126.14 162.94 24.21 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 0.0 114.506 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.0 m -121.89 116.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.691 1.596 . . . . 0.0 109.739 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.16 148.32 44.69 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.794 0.838 . . . . 0.0 111.398 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.5 -35.76 77.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.291 2.661 . . . . 0.0 113.852 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.0 m -61.19 -38.4 86.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.748 0.819 . . . . 0.0 112.061 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.49 60.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.078 -1.014 . . . . 0.0 113.357 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.47 -54.9 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.31 72.36 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -71.17 -7.71 48.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.217 1.007 . . . . 0.0 113.604 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.406 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 15.8 mmt -125.34 -27.24 3.5 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.59 1.156 . . . . 0.0 112.021 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.95 -27.39 66.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.064 -1.023 . . . . 0.0 112.139 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.37 -5.43 42.31 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.148 0.979 . . . . 0.0 113.041 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 t -108.99 3.14 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.622 2.369 . . . . 0.0 110.541 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.87 13.8 81.74 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.393 1.473 . . . . 0.0 114.667 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.95 151.57 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -133.17 135.05 44.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.698 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 pt -128.74 1.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.726 1.61 . . . . 0.0 112.465 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.9 p -65.48 -30.72 71.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.629 1.172 . . . . 0.0 113.769 -169.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.64 -0.42 89.24 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.431 1.015 . . . . 0.0 114.976 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -81.81 151.82 27.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.397 1.598 . . . . 0.0 112.697 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.7 p -124.94 176.02 6.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.353 1.861 . . . . 0.0 111.088 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -152.66 156.1 38.56 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 112.593 173.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -153.54 160.45 30.93 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.76 2.024 . . . . 0.0 109.272 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.35 140.07 87.76 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.341 2.694 . . . . 0.0 112.485 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.94 -30.41 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -11.9 60.39 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -21.51 56.23 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.061 0.846 . . . . 0.0 112.935 171.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -93.14 166.49 12.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.645 1.178 . . . . 0.0 112.805 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.19 109.02 17.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.542 1.537 . . . . 0.0 110.965 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.22 -15.06 62.86 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.625 -1.297 . . . . 0.0 113.666 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -57.54 -22.05 42.14 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.065 1.346 . . . . 0.0 113.131 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.17 -0.56 38.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.219 1.808 . . . . 0.0 113.037 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -124.92 76.96 1.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.242 1.817 . . . . 0.0 109.686 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -23.68 8.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.71 2.004 . . . . 0.0 113.38 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -133.33 127.86 54.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.642 1.577 . . . . 0.0 108.537 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.9 t -132.97 118.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.077 -1.015 . . . . 0.0 110.275 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -110.99 118.06 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.865 1.266 . . . . 0.0 107.932 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -87.9 155.8 19.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.123 0.969 . . . . 0.0 109.027 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.68 39.67 3.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.09 0.956 . . . . 0.0 110.885 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 CA--C 1.542 0.638 0 C-N-CA 124.972 1.309 . . . . 0.0 111.914 178.787 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -144.14 140.54 17.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.29 1.036 . . . . 0.0 113.155 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.47 153.73 72.93 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.549 2.166 . . . . 0.0 110.068 168.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.27 -32.48 96.96 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.184 2.589 . . . . 0.0 114.311 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.99 -24.39 67.0 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.932 -1.105 . . . . 0.0 113.765 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.4 -10.66 58.29 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.4 -22.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.125 1.37 . . . . 0.0 113.584 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -84.55 11.65 8.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.39 1.876 . . . . 0.0 113.527 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -67.68 166.8 14.42 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.722 1.609 . . . . 0.0 112.812 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.24 -35.89 82.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -133.32 128.69 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.472 0.709 . . . . 0.0 110.888 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -130.75 148.46 52.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.089 1.356 . . . . 0.0 111.613 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -142.06 161.16 38.68 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.448 1.499 . . . . 0.0 111.455 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.44 86.84 1.97 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.633 -0.667 . . . . 0.0 111.913 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -73.38 160.51 31.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.234 1.814 . . . . 0.0 114.017 -172.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -93.28 -84.39 0.3 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.156 0.983 . . . . 0.0 110.94 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 50.14 -166.21 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.51 1.924 . . . . 0.0 112.293 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.94 147.75 46.55 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.489 1.515 . . . . 0.0 107.443 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.98 129.79 52.81 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.314 0.961 . . . . 0.0 111.035 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo . . . . . 0 CA--C 1.54 0.777 0 C-N-CA 121.632 1.555 . . . . 0.0 114.731 178.594 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 120.759 0.314 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.96 -22.36 66.89 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.213 -0.929 . . . . 0.0 111.721 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.57 -32.39 73.7 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.047 -1.033 . . . . 0.0 111.305 169.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.22 -44.05 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.858 -1.151 . . . . 0.0 110.694 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -53.79 -49.26 68.67 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.285 0.948 . . . . 0.0 111.29 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -71.42 -16.41 62.39 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 m -95.6 -35.62 11.56 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.451 1.101 . . . . 0.0 112.755 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.81 -37.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 120.274 -1.517 . . . . 0.0 111.414 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -55.1 -42.71 73.23 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.51 -32.63 67.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.182 0.896 . . . . 0.0 113.023 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -69.8 -44.89 69.12 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.84 -0.8 . . . . 0.0 110.659 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.4 t -60.23 -42.54 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.158 -0.964 . . . . 0.0 111.063 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.17 -47.65 77.87 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.034 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.93 -29.25 65.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.139 1.336 . . . . 0.0 113.562 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -62.44 -54.3 42.16 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.022 0.828 . . . . 0.0 109.979 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.37 -51.08 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.28 1.432 . . . . 0.0 112.636 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.7 -49.64 75.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.996 1.271 . . . . 0.0 112.492 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -30.19 67.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.298 0.499 . . . . 0.0 111.875 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.47 -50.21 66.21 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.768 0.827 . . . . 0.0 111.168 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.73 -41.38 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.508 1.049 . . . . 0.0 110.944 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -23.81 66.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.36 -17.27 37.23 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.1 -23.47 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.253 1.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.884 179.695 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 119.761 -0.162 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mtmm -77.45 146.28 36.59 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 112.612 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -113.56 126.11 54.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.902 1.281 . . . . 0.0 111.189 170.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.75 109.17 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.675 1.59 . . . . 0.0 110.207 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.6 tpp -87.04 128.13 35.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.525 0.602 . . . . 0.0 109.849 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -98.75 123.43 42.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.688 1.195 . . . . 0.0 109.745 169.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.34 146.21 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.724 1.21 . . . . 0.0 112.788 -176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.474 0.726 0 O-C-N 121.487 -0.758 . . . . 0.0 111.401 172.634 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -66.96 -48.33 68.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.92 1.236 . . . . 0.0 112.01 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -65.76 -42.92 90.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.59 0.756 . . . . 0.0 111.941 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 tpt -64.92 -42.41 94.74 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.867 -1.146 . . . . 0.0 112.717 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.51 88.2 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.947 0.499 . . . . 0.0 112.149 173.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.82 -36.18 78.4 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.567 -0.708 . . . . 0.0 111.841 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.57 -53.08 46.19 Favored Glycine 0 N--CA 1.471 1.004 0 CA-C-N 119.472 1.033 . . . . 0.0 112.613 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -60.33 -38.93 85.29 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.683 -0.892 . . . . 0.0 111.409 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.83 73.16 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -75.28 -22.16 57.99 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.905 1.684 . . . . 0.0 113.07 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -79.41 -45.35 19.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.314 0.646 . . . . 0.0 111.688 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -98.24 -27.2 14.25 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.46 1.104 . . . . 0.0 113.113 -172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.87 2.66 88.08 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.253 1.883 . . . . 0.0 113.903 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 112.15 0.44 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.512 1.156 . . . . 0.0 112.656 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.67 15.57 81.47 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.373 1.309 . . . . 0.0 116.373 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.99 -40.47 3.49 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.393 1.596 . . . . 0.0 112.314 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.33 165.84 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.361 2.264 . . . . 0.0 109.931 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.27 149.12 21.89 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 170.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.43 143.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.316 -0.865 . . . . 0.0 112.493 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 m -148.23 156.72 42.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.976 1.31 . . . . 0.0 110.187 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 p -128.3 150.47 50.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 113.321 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 t -155.43 156.71 35.8 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 110.124 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.59 153.05 17.61 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 169.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.1 mt -55.48 -34.52 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.997 1.398 . . . . 0.0 111.612 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -131.03 49.86 2.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.862 1.665 . . . . 0.0 109.715 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 t 68.63 170.37 0.29 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.475 1.91 . . . . 0.0 113.437 -169.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.2 p -146.08 169.56 18.45 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.42 1.888 . . . . 0.0 111.009 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -116.78 160.29 21.02 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.37 148.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.402 1.881 . . . . 0.0 107.058 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -136.4 131.53 18.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.748 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -54.81 -38.79 91.99 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.352 2.702 . . . . 0.0 115.273 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.0 m -67.77 -31.06 70.68 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.094 -1.004 . . . . 0.0 111.718 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.4 60.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.917 -1.114 . . . . 0.0 112.673 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.2 mt -72.19 -53.62 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 -35.68 60.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -170.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.68 -8.53 54.71 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.16 -0.962 . . . . 0.0 113.444 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.0 mmt -123.64 -28.49 3.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 112.261 -171.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.43 -26.69 68.04 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.681 1.128 . . . . 0.0 112.171 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -70.34 -12.05 61.32 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 113.799 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 3.6 m -114.7 13.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.046 1.339 . . . . 0.0 111.509 168.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.044 1.783 . . . . 0.0 116.298 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.4 mm -85.07 149.56 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.334 1.567 . . . . 0.0 111.872 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -122.27 133.08 54.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.178 1.391 . . . . 0.0 111.053 169.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.56 -13.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.641 1.177 . . . . 0.0 113.837 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 m -57.68 -31.91 66.81 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.368 1.467 . . . . 0.0 114.227 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.26 2.69 81.51 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.263 1.411 . . . . 0.0 115.728 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.32 161.62 29.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.509 1.655 . . . . 0.0 112.566 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -143.4 166.3 25.13 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 0.0 110.902 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -143.81 161.26 39.1 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.304 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -151.09 160.04 32.67 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.012 1.725 . . . . 0.0 109.973 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.51 135.02 67.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.805 3.004 . . . . 0.0 112.595 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.8 -31.76 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -12.1 60.68 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -21.19 57.85 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.071 0.851 . . . . 0.0 112.77 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -94.87 167.34 11.48 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.091 1.356 . . . . 0.0 112.825 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.46 109.56 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.761 1.624 . . . . 0.0 110.967 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.67 -20.05 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -170.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.51 -27.36 69.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.332 1.053 . . . . 0.0 112.422 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.92 -2.17 58.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.633 1.573 . . . . 0.0 112.386 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.92 80.05 1.49 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.938 2.095 . . . . 0.0 107.92 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -25.75 11.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.234 1.814 . . . . 0.0 113.165 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.1 t -132.3 132.47 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.194 1.798 . . . . 0.0 108.969 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.4 t -134.65 121.01 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.99 122.21 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.125 1.37 . . . . 0.0 108.552 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.9 t -93.33 155.05 17.63 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.674 1.19 . . . . 0.0 109.577 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.56 46.0 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.765 1.226 . . . . 0.0 111.387 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.4 m . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 124.804 1.242 . . . . 0.0 112.21 -178.622 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -141.14 138.6 18.01 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.45 1.1 . . . . 0.0 112.298 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 152.96 76.62 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.259 1.973 . . . . 0.0 110.244 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 -29.24 86.33 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.837 2.358 . . . . 0.0 115.501 -169.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.36 -17.9 64.93 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.506 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.3 m95 -90.99 -3.18 57.47 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.88 -2.04 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.963 1.305 . . . . 0.0 114.337 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -101.37 0.95 37.93 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.141 1.776 . . . . 0.0 113.287 -171.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.484 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.5 mp0 -53.85 159.05 1.8 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.921 2.488 . . . . 0.0 113.988 174.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.91 -34.57 78.25 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -134.05 130.37 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.005 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -133.12 149.03 52.13 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.336 1.454 . . . . 0.0 111.435 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -141.59 157.91 44.5 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.91 1.284 . . . . 0.0 111.351 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.5 88.73 2.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.795 0.838 . . . . 0.0 110.832 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -70.94 145.69 49.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.13 1.372 . . . . 0.0 113.752 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -101.73 60.56 0.88 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.727 2.011 . . . . 0.0 107.726 -174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.7 131.2 56.65 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.575 1.95 . . . . 0.0 111.148 -168.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -88.19 151.5 22.64 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.991 1.316 . . . . 0.0 112.138 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -93.72 126.2 50.56 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.975 0.51 . . . . 0.0 111.611 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo . . . . . 0 CA--C 1.548 1.187 0 C-N-CA 123.077 2.518 . . . . 0.0 114.074 -178.781 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.13 -26.12 68.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.108 0.963 . . . . 0.0 111.62 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.34 -34.28 77.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.412 -0.805 . . . . 0.0 111.25 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -69.02 -41.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.644 -1.285 . . . . 0.0 110.476 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -56.3 -48.25 77.04 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.996 1.271 . . . . 0.0 111.421 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -70.44 -17.73 63.0 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.0 m -89.22 -41.08 12.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.048 1.339 . . . . 0.0 112.293 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.69 -36.31 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.538 -1.351 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -56.15 -42.29 76.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.27 -31.5 63.64 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 123.328 0.489 . . . . 0.0 112.42 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -70.03 -39.0 76.04 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.901 -0.764 . . . . 0.0 111.527 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.46 -46.74 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.366 0.667 . . . . 0.0 110.036 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.87 -51.23 66.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.366 1.066 . . . . 0.0 112.008 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.91 -29.6 67.9 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.022 1.283 . . . . 0.0 112.487 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.4 mtt85 -69.83 -53.85 16.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.382 -0.824 . . . . 0.0 111.025 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -53.54 -49.89 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.899 1.279 . . . . 0.0 112.439 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -66.21 -47.11 74.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.52 1.055 . . . . 0.0 112.135 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -31.58 68.47 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.423 1.011 . . . . 0.0 111.973 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.23 -51.13 68.98 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.518 0.727 . . . . 0.0 110.53 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.2 mt -69.11 -38.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.496 -0.753 . . . . 0.0 111.173 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.82 -26.82 68.8 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -87.79 -15.61 36.42 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -109.67 -18.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 124.661 1.185 . . . . 0.0 113.143 179.303 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 119.908 -0.092 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -72.64 142.53 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.971 0.908 . . . . 0.0 112.07 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.15 127.72 54.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.373 1.069 . . . . 0.0 111.308 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.88 116.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.2 ttm -99.8 124.97 45.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 110.076 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -95.3 127.64 41.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.22 0.608 . . . . 0.0 110.207 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.49 139.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 0.0 112.731 -176.779 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 118.289 -0.863 . . . . 0.0 113.084 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 p -71.61 -49.9 35.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.971 1.26 . . . . 0.0 112.13 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -63.65 -33.1 74.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.263 0.625 . . . . 0.0 112.291 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 tpt -76.87 -41.58 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.174 -0.954 . . . . 0.0 112.337 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.85 94.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.39 -45.26 88.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.11 -46.59 77.75 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 119.778 1.172 . . . . 0.0 114.806 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.447 1.123 . . . . 0.0 111.593 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.14 -32.94 63.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.468 -1.395 . . . . 0.0 113.989 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -67.48 -22.67 65.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.323 1.419 . . . . 0.0 113.05 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.4 m -87.28 -47.64 8.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.496 1.118 . . . . 0.0 111.581 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.7 mt -95.42 -31.86 13.18 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.468 1.107 . . . . 0.0 113.313 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.47 3.08 87.26 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.704 1.621 . . . . 0.0 113.159 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.36 122.0 5.64 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 117.919 0.86 . . . . 0.0 111.841 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.44 79.29 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 118.732 -1.038 . . . . 0.0 115.453 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -121.66 -42.22 2.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.341 1.57 . . . . 0.0 111.039 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.93 161.18 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 112.95 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 153.76 18.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.74 145.39 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.812 -1.18 . . . . 0.0 113.661 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 m -142.84 147.36 35.28 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.435 1.894 . . . . 0.0 109.784 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -115.02 148.82 38.36 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.024 -1.048 . . . . 0.0 112.407 170.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 t -153.35 159.26 42.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.793 1.237 . . . . 0.0 110.531 -170.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.86 154.8 19.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.9 0.762 . . . . 0.0 112.036 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.79 -34.08 72.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.318 1.059 . . . . 0.0 112.132 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -132.49 29.59 4.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.234 1.414 . . . . 0.0 111.538 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 63.81 168.34 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.955 1.702 . . . . 0.0 114.712 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.491 ' H ' ' HB3' ' A' ' 62' ' ' SER . 7.5 t -163.21 -178.66 6.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.5 2.32 . . . . 0.0 111.828 -175.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -123.48 172.45 8.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.249 1.82 . . . . 0.0 114.485 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 147.02 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 125.675 1.59 . . . . 0.0 108.647 168.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.06 148.46 39.08 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 125.545 1.538 . . . . 0.0 111.511 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -54.81 -34.5 85.25 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.3 2.667 . . . . 0.0 113.871 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -61.25 -36.31 79.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.631 0.772 . . . . 0.0 112.099 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.34 -10.83 59.81 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.935 -1.103 . . . . 0.0 113.558 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.37 -53.1 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 168.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.05 68.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mmt -72.72 -9.52 58.73 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 mmt -124.56 -27.59 3.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.144 -170.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.3 -25.34 68.27 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.836 -1.165 . . . . 0.0 112.28 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.93 -9.47 58.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 t -105.69 4.67 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 126.888 2.075 . . . . 0.0 110.376 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.97 12.49 83.34 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.529 -1.357 . . . . 0.0 114.935 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.71 150.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 118.572 1.186 . . . . 0.0 111.069 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -135.46 97.24 3.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.286 1.434 . . . . 0.0 111.357 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.2 11.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.6 p -61.93 -27.52 68.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.632 -1.293 . . . . 0.0 113.365 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.28 -2.68 90.34 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.901 1.239 . . . . 0.0 115.031 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -87.7 156.24 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.849 1.324 . . . . 0.0 112.373 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 t -147.56 -178.24 6.14 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.715 1.606 . . . . 0.0 109.53 172.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.491 ' HB3' ' H ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -115.9 167.49 10.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.482 1.113 . . . . 0.0 112.606 175.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.49 155.52 39.1 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.2 1.4 . . . . 0.0 110.91 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.61 136.6 50.7 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.676 2.917 . . . . 0.0 113.755 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.406 HD11 ' CD2' ' A' ' 90' ' ' TRP . 10.8 tp -52.83 -36.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.719 1.207 . . . . 0.0 114.12 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.38 -10.81 59.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -17.37 52.25 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.09 0.859 . . . . 0.0 113.085 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -93.1 175.48 6.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.505 1.522 . . . . 0.0 112.9 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.16 109.55 13.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.929 1.692 . . . . 0.0 110.86 174.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.3 -16.41 64.02 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -169.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.51 -23.7 66.28 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.846 0.858 . . . . 0.0 112.413 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.15 -0.99 57.42 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.289 1.835 . . . . 0.0 112.077 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -119.22 82.33 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.176 2.19 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.11 -27.64 14.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.223 1.809 . . . . 0.0 113.09 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.99 127.8 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.584 1.554 . . . . 0.0 108.966 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -133.54 124.69 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.956 -1.09 . . . . 0.0 109.763 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mm -124.42 110.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.032 1.333 . . . . 0.0 109.358 -170.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 m -86.15 154.53 21.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.649 0.779 . . . . 0.0 110.983 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.47 44.0 2.84 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.234 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 125.782 1.633 . . . . 0.0 113.653 -179.377 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.3 mt -146.55 148.48 33.99 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.136 0.974 . . . . 0.0 112.99 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.66 152.51 80.09 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.663 2.242 . . . . 0.0 109.897 168.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.28 -23.77 75.51 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.303 2.668 . . . . 0.0 115.391 -169.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -16.36 62.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.8 m95 -91.34 -3.3 56.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.36 9.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 125.618 1.567 . . . . 0.0 113.85 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -111.39 -3.09 15.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.392 1.877 . . . . 0.0 113.152 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.446 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.5 mp0 -58.0 158.62 6.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.432 2.693 . . . . 0.0 114.31 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.42 -33.67 76.41 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.86 127.39 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.979 0.912 . . . . 0.0 109.825 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -135.84 148.43 48.66 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.621 1.568 . . . . 0.0 111.756 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -149.16 157.74 43.62 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.597 1.959 . . . . 0.0 110.366 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -137.66 77.32 1.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.423 0.63 . . . . 0.0 111.42 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -64.17 160.0 19.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.12 1.768 . . . . 0.0 114.417 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.15 43.17 1.51 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.139 1.776 . . . . 0.0 113.75 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.13 138.49 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.507 -0.746 . . . . 0.0 111.05 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -85.82 148.77 25.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.67 131.11 46.47 Favored Pre-proline 0 CA--C 1.538 0.498 0 O-C-N 121.464 -0.773 . . . . 0.0 111.162 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 CA--C 1.544 1.022 0 C-N-CA 122.054 1.836 . . . . 0.0 113.495 176.067 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.274 0.559 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.442 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -63.01 -27.61 69.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.379 1.072 . . . . 0.0 111.376 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.34 -31.7 72.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.953 . . . . 0.0 111.911 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.87 -41.73 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.978 -1.076 . . . . 0.0 110.438 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -56.05 -49.0 74.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.759 1.163 . . . . 0.0 111.442 170.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -70.13 -19.28 63.23 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.1 m -81.17 -54.36 5.58 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.857 1.263 . . . . 0.0 111.324 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.17 -34.52 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.555 1.142 . . . . 0.0 111.541 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -55.65 -41.01 72.98 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.213 0.915 . . . . 0.0 112.684 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.55 -33.02 64.08 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.774 0.702 . . . . 0.0 113.002 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -68.86 -40.53 79.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.113 0.956 . . . . 0.0 111.183 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.34 -49.92 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.167 0.987 . . . . 0.0 110.318 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -54.12 -49.01 70.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.411 1.084 . . . . 0.0 112.045 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -70.54 -28.98 65.34 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.802 1.183 . . . . 0.0 112.697 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -72.59 -47.98 43.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.78 -42.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.102 0.961 . . . . 0.0 111.626 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -61.29 -47.22 86.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.79 1.177 . . . . 0.0 112.183 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.13 -35.73 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.569 0.622 . . . . 0.0 112.016 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.487 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.9 tm? -56.96 -52.03 66.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.56 1.144 . . . . 0.0 110.699 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.86 -42.23 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.614 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.99 68.81 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -91.23 -6.62 53.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.68 -16.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.255 1.389 0 C-N-CA 125.467 1.507 . . . . 0.0 112.104 172.078 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -73.75 143.16 46.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.914 0.886 . . . . 0.0 111.835 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -108.67 124.37 50.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.731 1.212 . . . . 0.0 111.236 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.5 t -96.02 109.17 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 110.173 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -88.31 130.62 35.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.504 0.321 . . . . 0.0 110.201 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -104.01 124.29 48.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.302 1.041 . . . . 0.0 110.73 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.2 138.07 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.309 1.044 . . . . 0.0 113.757 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t . . . . . 0 CA--C 1.549 0.941 0 C-N-CA 124.213 1.005 . . . . 0.0 112.64 179.679 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -63.58 -43.36 97.21 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.196 0.907 . . . . 0.0 110.759 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -69.27 -40.09 78.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.626 0.77 . . . . 0.0 111.769 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.2 tpt -71.1 -38.21 72.36 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.234 -0.916 . . . . 0.0 112.562 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.57 98.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.333 0.653 . . . . 0.0 111.116 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.28 -40.19 77.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.914 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.05 -53.3 46.93 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 119.573 1.079 . . . . 0.0 113.53 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -61.52 -39.99 93.04 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.608 -0.937 . . . . 0.0 110.993 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.035 -1.041 . . . . 0.0 113.8 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -71.61 -22.04 61.76 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.789 1.177 . . . . 0.0 112.835 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -86.49 -43.91 12.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.939 0.895 . . . . 0.0 112.083 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.1 -35.13 11.45 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.775 0.83 . . . . 0.0 112.973 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.61 8.76 76.3 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 125.719 1.628 . . . . 0.0 114.188 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.17 -41.83 1.36 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -172.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 18.47 30.84 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.335 1.445 . . . . 0.0 115.078 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.69 -43.79 2.88 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.291 1.546 . . . . 0.0 111.941 -169.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -149.24 165.67 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.851 1.66 . . . . 0.0 112.087 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.55 152.08 22.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.625 0.77 . . . . 0.0 109.241 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.3 t -135.89 137.61 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.802 1.241 . . . . 0.0 111.047 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 m -144.6 154.26 42.64 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.102 1.361 . . . . 0.0 110.433 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -126.47 156.17 41.11 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.041 -1.037 . . . . 0.0 113.687 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -156.46 162.55 39.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 110.231 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.82 155.32 20.57 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.32 -0.862 . . . . 0.0 111.327 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.0 -30.42 70.93 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.527 -0.984 . . . . 0.0 112.006 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -129.46 38.53 3.86 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 72.2 177.91 0.25 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.224 1.809 . . . . 0.0 112.138 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -137.35 -173.39 3.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.462 1.905 . . . . 0.0 111.623 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.09 158.69 43.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 113.326 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.3 t -101.92 146.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -129.57 123.86 21.55 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.997 -1.002 . . . . 0.0 112.567 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.73 -37.76 91.7 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.264 2.643 . . . . 0.0 115.116 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -66.82 -31.44 72.07 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.457 -0.777 . . . . 0.0 111.763 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.13 80.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.647 1.112 . . . . 0.0 110.838 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 mt -54.87 -49.58 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.042 0.537 . . . . 0.0 109.552 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.76 61.92 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.9 mmt -78.21 -22.39 48.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.204 -0.935 . . . . 0.0 112.857 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.8 mmt -106.39 -16.84 14.45 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.59 -25.42 67.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.185 1.357 . . . . 0.0 112.835 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.47 -7.0 51.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.34 1.056 . . . . 0.0 113.319 172.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.9 t -106.33 3.08 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.914 2.086 . . . . 0.0 110.312 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.47 81.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.238 1.399 . . . . 0.0 114.815 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -90.88 154.73 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.577 1.151 . . . . 0.0 110.497 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -141.85 133.46 26.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.71 0.804 . . . . 0.0 111.549 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 pt -132.29 12.19 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.056 0.942 . . . . 0.0 113.535 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -57.44 -33.83 68.34 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.628 1.104 . . . . 0.0 112.593 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.33 3.29 86.66 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.029 1.3 . . . . 0.0 115.923 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -76.03 160.41 29.85 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.028 1.914 . . . . 0.0 113.183 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.3 p -133.31 171.82 13.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.28 1.832 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 t -149.64 161.82 41.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.413 1.085 . . . . 0.0 111.298 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.65 160.49 35.87 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.139 1.776 . . . . 0.0 109.62 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.7 135.52 64.53 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.179 2.586 . . . . 0.0 112.294 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.93 -30.92 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -171.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.85 -14.24 62.79 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -20.56 57.9 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 119.305 0.957 . . . . 0.0 113.029 173.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -95.39 167.42 11.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.774 1.23 . . . . 0.0 112.982 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 110.61 20.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.826 1.65 . . . . 0.0 111.098 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB1' HE22 ' A' ' 93' ' ' GLN . . . -67.52 -18.83 65.19 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -170.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.15 -26.88 68.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.665 1.186 . . . . 0.0 112.677 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.57 -2.84 58.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.73 1.612 . . . . 0.0 112.253 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -116.54 80.49 1.47 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.806 2.042 . . . . 0.0 107.882 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.65 -26.6 14.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 113.012 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -132.81 131.19 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.79 1.636 . . . . 0.0 109.381 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.52 120.69 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.238 -0.913 . . . . 0.0 110.598 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.91 120.62 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.079 1.352 . . . . 0.0 108.106 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -91.9 157.01 17.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.047 1.339 . . . . 0.0 109.848 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.41 45.35 2.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.607 0.763 . . . . 0.0 111.636 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.533 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -143.57 141.79 19.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.994 0.917 . . . . 0.0 113.142 -170.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.42 155.11 67.93 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.463 2.109 . . . . 0.0 110.11 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.38 -22.95 71.78 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.93 2.42 . . . . 0.0 115.016 -169.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.25 -16.97 61.93 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.489 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -91.07 -1.68 57.74 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.66 2.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.66 1.584 . . . . 0.0 114.085 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -109.19 7.94 25.65 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.923 1.689 . . . . 0.0 113.231 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.506 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.8 mp0 -62.06 162.91 8.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.446 2.298 . . . . 0.0 113.21 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.01 129.55 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.909 0.883 . . . . 0.0 110.177 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -133.21 148.53 52.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.557 1.543 . . . . 0.0 111.34 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -141.1 159.0 43.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.975 1.31 . . . . 0.0 111.871 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -141.75 99.18 3.49 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 0.0 110.19 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.88 153.84 34.35 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.893 1.277 . . . . 0.0 113.194 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -101.59 39.2 1.47 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.645 1.578 . . . . 0.0 112.374 -168.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 162.86 14.87 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.141 1.377 . . . . 0.0 113.684 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.22 154.23 40.46 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.774 1.629 . . . . 0.0 111.267 -174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -86.73 126.84 62.39 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 121.686 -0.634 . . . . 0.0 111.659 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 C-N-CA 122.746 2.297 . . . . 0.0 114.004 -179.159 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.75 -22.58 66.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.092 0.957 . . . . 0.0 111.625 170.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.76 -33.8 76.46 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.037 -1.039 . . . . 0.0 110.478 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.0 t -72.89 -35.96 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.799 -1.188 . . . . 0.0 110.649 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.03 -47.41 83.18 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.54 1.518 . . . . 0.0 110.417 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -68.78 -17.05 63.97 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.7 m -88.67 -41.38 12.64 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.224 1.409 . . . . 0.0 112.629 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -73.96 -34.15 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 120.533 -1.354 . . . . 0.0 111.371 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.93 -40.63 73.42 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.84 60.77 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.749 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.93 -43.04 75.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.902 0.851 . . . . 0.0 110.722 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.58 -48.12 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.294 0.638 . . . . 0.0 110.56 169.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -58.47 -49.58 76.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.731 1.212 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.47 -29.0 64.34 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.018 1.281 . . . . 0.0 112.263 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -68.41 -50.7 50.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.59 0.756 . . . . 0.0 111.214 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.53 -48.62 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.162 0.985 . . . . 0.0 111.527 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.88 -50.93 66.83 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.557 1.071 . . . . 0.0 112.625 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -31.09 67.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.652 0.66 . . . . 0.0 111.998 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.45 -51.69 66.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.394 0.677 . . . . 0.0 110.314 169.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.8 -36.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.148 -0.97 . . . . 0.0 111.464 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -85.48 -20.03 30.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 pt -101.59 -18.07 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 124.971 1.308 . . . . 0.0 113.071 177.614 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 119.192 -0.432 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -70.44 138.64 51.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.124 0.875 . . . . 0.0 111.242 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -111.17 125.47 53.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.472 1.109 . . . . 0.0 111.361 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 68.5 t -95.72 114.11 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.048 1.739 . . . . 0.0 110.037 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -96.53 125.78 41.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.897 0.771 . . . . 0.0 110.891 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -92.01 124.08 35.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.715 0.806 . . . . 0.0 108.886 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.55 132.24 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.293 1.037 . . . . 0.0 112.469 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.971 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 m -64.16 -38.99 93.06 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.622 1.101 . . . . 0.0 112.4 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -66.55 -44.24 82.88 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.734 0.413 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -39.24 82.12 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.773 0.829 . . . . 0.0 111.99 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.72 -46.01 92.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.43 -41.06 79.69 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.89 -63.76 4.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.722 1.153 . . . . 0.0 113.72 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -62.64 -34.85 77.9 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.699 1.25 . . . . 0.0 111.946 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.18 77.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -70.53 -27.89 64.51 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.883 1.674 . . . . 0.0 112.441 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.7 m -77.27 -46.02 24.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.363 1.065 . . . . 0.0 112.275 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.24 -27.76 14.85 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.036 0.934 . . . . 0.0 113.239 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 2.1 88.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.126 2.298 . . . . 0.0 113.608 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.42 114.79 1.03 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.409 1.104 . . . . 0.0 112.419 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.69 16.62 76.14 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.636 1.014 . . . . 0.0 115.636 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -119.08 -36.24 3.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.204 1.502 . . . . 0.0 111.92 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -150.61 166.32 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 127.544 2.338 . . . . 0.0 110.393 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.76 153.84 18.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 168.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.48 144.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.458 -1.401 . . . . 0.0 114.682 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -150.61 158.22 43.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.636 1.574 . . . . 0.0 110.726 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -123.55 149.18 45.56 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.016 1.726 . . . . 0.0 111.825 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 t -152.04 147.54 26.62 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.296 . . . . 0.0 110.586 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.87 143.47 17.09 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 168.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.69 -38.51 33.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.214 1.507 . . . . 0.0 112.22 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -123.74 40.87 3.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.838 1.655 . . . . 0.0 111.354 171.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 73.38 164.91 0.29 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.051 2.14 . . . . 0.0 114.333 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -148.4 166.84 26.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.294 2.238 . . . . 0.0 112.338 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -121.65 147.59 45.66 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.526 1.13 . . . . 0.0 113.756 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -80.18 -38.59 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 62.98 123.79 0.02 OUTLIER Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 128.815 2.846 . . . . 0.0 116.489 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 -38.95 79.79 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.929 3.086 . . . . 0.0 116.318 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -31.96 73.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.657 -1.277 . . . . 0.0 111.823 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.44 -8.19 58.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.653 -1.279 . . . . 0.0 113.603 172.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.81 -53.72 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 168.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.49 -33.52 60.8 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 mmt -71.86 -12.65 61.38 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.298 -0.876 . . . . 0.0 113.262 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.1 mmt -120.35 -27.25 5.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.593 1.157 . . . . 0.0 112.476 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.74 -25.15 68.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.852 -1.155 . . . . 0.0 112.637 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -70.63 -15.06 62.7 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.01 5.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 126.47 1.908 . . . . 0.0 110.664 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.18 12.37 83.31 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.389 1.471 . . . . 0.0 114.617 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -87.28 149.16 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.354 1.077 . . . . 0.0 111.312 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.47 125.52 44.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.45 1.5 . . . . 0.0 111.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.5 pt -134.49 -7.03 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.1 p -67.42 -28.23 67.73 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.125 1.33 . . . . 0.0 113.849 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.78 -2.11 90.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.843 1.211 . . . . 0.0 115.023 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -81.64 161.68 23.36 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.001 1.401 . . . . 0.0 112.469 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -140.31 -179.9 6.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.03 1.332 . . . . 0.0 111.376 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -154.44 160.84 41.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.066 1.346 . . . . 0.0 111.823 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -159.46 155.98 24.39 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.784 1.634 . . . . 0.0 108.799 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.56 136.26 63.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.361 2.707 . . . . 0.0 113.047 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.0 -33.15 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.68 -11.41 60.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.07 -24.44 59.5 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.215 -0.928 . . . . 0.0 112.373 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -93.35 165.65 12.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.906 1.282 . . . . 0.0 112.402 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.9 110.55 20.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.521 1.528 . . . . 0.0 111.118 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.54 -19.32 65.27 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -171.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.38 -26.37 67.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.28 1.032 . . . . 0.0 112.403 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -87.51 -1.67 58.09 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.002 1.721 . . . . 0.0 112.037 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.07 82.0 1.76 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.711 2.004 . . . . 0.0 108.154 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.28 -24.82 12.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.167 1.787 . . . . 0.0 113.018 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.7 t -133.9 130.74 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.777 1.631 . . . . 0.0 108.969 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.92 123.78 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.309 -0.869 . . . . 0.0 110.633 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.6 121.23 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.178 1.391 . . . . 0.0 107.962 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 t -85.21 147.71 26.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.511 1.124 . . . . 0.0 109.985 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -124.06 24.82 8.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.524 1.129 . . . . 0.0 112.456 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.8 m . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -171.7 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -139.84 136.95 17.77 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.615 1.166 . . . . 0.0 111.673 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.96 153.14 70.67 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.424 2.082 . . . . 0.0 110.064 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.71 -26.96 80.5 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.954 2.436 . . . . 0.0 114.104 -169.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.4 -19.62 65.85 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.499 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -90.1 -3.64 57.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -118.53 -9.76 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.79 1.236 . . . . 0.0 114.311 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -93.09 2.75 56.59 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.939 1.695 . . . . 0.0 113.511 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.1 mp0 -53.42 158.76 1.62 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.404 2.281 . . . . 0.0 113.775 174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -34.03 76.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -133.65 127.86 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.385 1.074 . . . . 0.0 110.05 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -130.91 148.27 52.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 111.103 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -141.88 159.09 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.672 1.189 . . . . 0.0 112.031 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.27 110.57 8.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.21 1.004 . . . . 0.0 108.882 168.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -87.68 145.66 26.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.6 1.16 . . . . 0.0 111.529 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -104.96 46.19 0.93 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.686 1.595 . . . . 0.0 108.555 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -102.02 132.81 47.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.572 2.349 . . . . 0.0 111.359 -168.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -90.34 151.85 21.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.317 1.447 . . . . 0.0 112.319 -173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -88.75 131.71 40.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.768 -0.582 . . . . 0.0 111.86 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.544 0.996 0 C-N-CA 122.7 2.267 . . . . 0.0 115.371 -177.077 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.341 0.591 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.87 -25.2 66.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.136 -0.977 . . . . 0.0 111.754 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.29 -29.37 70.46 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.228 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -72.0 -36.86 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 120.803 -1.186 . . . . 0.0 111.047 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -58.93 -46.73 87.25 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.435 1.471 . . . . 0.0 110.452 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -71.73 -18.21 62.15 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.109 0.964 . . . . 0.0 113.59 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 m -85.06 -52.87 5.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.575 1.55 . . . . 0.0 111.923 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.6 -31.92 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.934 1.294 . . . . 0.0 111.863 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -53.97 -43.42 69.91 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.601 1.091 . . . . 0.0 113.432 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.97 -32.74 65.93 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.771 0.701 . . . . 0.0 112.853 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -69.98 -40.34 75.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.41 -47.82 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.854 0.862 . . . . 0.0 110.329 171.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -57.0 -49.01 77.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.33 -28.36 66.17 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 121.376 1.898 . . . . 0.0 112.999 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -68.41 -49.0 63.17 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.473 -0.767 . . . . 0.0 111.654 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.7 m -62.24 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.022 0.828 . . . . 0.0 112.526 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -63.7 -50.72 68.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 120.207 1.367 . . . . 0.0 112.45 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.31 -31.06 69.29 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.951 0.796 . . . . 0.0 112.149 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.77 -49.72 69.63 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.396 0.678 . . . . 0.0 110.723 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.67 -40.76 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.988 -174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -27.04 68.84 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -88.49 -18.94 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -105.35 -18.36 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.256 1.4 0 C-N-CA 124.773 1.229 . . . . 0.0 113.222 179.054 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 119.75 -0.166 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -70.55 143.16 51.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.947 . . . . 0.0 111.94 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -110.73 126.23 54.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.015 . . . . 0.0 111.092 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.38 118.03 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.814 1.646 . . . . 0.0 109.995 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.5 tpp -97.81 119.44 36.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.651 0.659 . . . . 0.0 109.861 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.32 124.09 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.178 0.591 . . . . 0.0 110.391 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.03 144.54 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.242 1.017 . . . . 0.0 112.832 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.6 t . . . . . 0 N--CA 1.471 0.582 0 C-N-CA 125.243 1.417 . . . . 0.0 109.497 178.322 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -63.91 -44.48 92.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.701 1.592 . . . . 0.0 112.942 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -63.08 -37.31 86.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.731 0.812 . . . . 0.0 111.543 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.411 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 8.1 tpt -74.83 -36.95 62.4 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.35 94.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.946 0.898 . . . . 0.0 109.917 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.86 -43.88 94.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.157 0.89 . . . . 0.0 111.769 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.1 -52.56 48.47 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 119.556 1.071 . . . . 0.0 113.83 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -68.18 -39.39 82.53 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.81 -1.406 . . . . 0.0 111.588 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.13 74.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.855 -1.153 . . . . 0.0 113.699 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -78.31 -15.54 58.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.2 1.364 . . . . 0.0 113.579 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.5 m -89.46 -44.95 9.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.255 1.022 . . . . 0.0 111.917 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.71 -29.07 14.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.673 1.189 . . . . 0.0 113.375 -174.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.35 2.27 88.17 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 126.419 1.961 . . . . 0.0 113.977 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.55 115.46 1.14 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.438 1.119 . . . . 0.0 112.385 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.64 10.83 85.86 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.85 -40.36 4.02 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.652 1.726 . . . . 0.0 112.493 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -148.29 161.7 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.51 2.324 . . . . 0.0 109.782 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 144.34 26.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.84 142.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.198 -0.939 . . . . 0.0 112.576 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -148.96 160.27 43.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.849 1.66 . . . . 0.0 109.435 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 p -136.84 153.46 50.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.9 t -152.27 152.91 32.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.283 1.433 . . . . 0.0 110.611 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.59 140.98 16.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.71 -37.63 84.86 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.499 1.65 . . . . 0.0 111.018 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.74 33.78 4.36 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.814 1.646 . . . . 0.0 111.064 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 64.01 168.84 0.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.789 2.035 . . . . 0.0 114.491 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 81.9 p -150.3 167.35 27.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.746 1.619 . . . . 0.0 112.526 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -137.44 170.96 15.18 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.039 1.336 . . . . 0.0 112.099 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.23 112.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.99 0.9 . . . . 0.0 110.762 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -78.78 134.72 60.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.01 1.324 . . . . 0.0 110.534 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.54 -37.49 90.32 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.985 2.457 . . . . 0.0 115.092 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 m -65.98 -32.32 73.74 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.86 -1.15 . . . . 0.0 111.604 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.37 -5.76 44.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.573 -1.329 . . . . 0.0 113.93 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.31 -55.93 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 167.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.22 78.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 82.3 mmm -73.38 -1.75 19.43 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.411 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.5 mmt -121.34 -29.02 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.64 1.176 . . . . 0.0 111.207 -173.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.68 -27.5 64.88 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.324 0.65 . . . . 0.0 111.951 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.83 -15.87 63.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.595 1.158 . . . . 0.0 113.935 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -120.19 24.58 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 126.175 1.79 . . . . 0.0 111.042 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.92 12.36 84.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.723 1.63 . . . . 0.0 116.128 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mm -93.13 152.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 118.855 1.328 . . . . 0.0 111.466 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -134.54 136.26 42.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.004 1.322 . . . . 0.0 110.97 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.34 0.74 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.543 1.537 . . . . 0.0 112.485 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.6 p -62.37 -28.17 69.58 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -169.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.86 -4.48 88.69 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.625 1.107 . . . . 0.0 115.167 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -81.8 154.54 25.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.108 1.454 . . . . 0.0 113.406 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -134.12 178.87 6.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.007 2.123 . . . . 0.0 110.805 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -153.22 162.89 40.81 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.178 -0.951 . . . . 0.0 112.26 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.44 158.17 38.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.35 1.86 . . . . 0.0 109.085 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.02 136.55 73.47 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.262 2.641 . . . . 0.0 112.14 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.62 -29.95 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.23 -14.78 62.47 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.27 -19.87 59.47 Favored 'General case' 0 CA--C 1.553 1.079 0 O-C-N 121.421 -0.799 . . . . 0.0 113.149 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.44 170.39 9.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.176 1.39 . . . . 0.0 112.866 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.8 108.28 14.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 111.287 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.27 -18.66 65.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -170.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.01 -26.12 68.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.156 0.982 . . . . 0.0 112.507 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.16 -1.72 58.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.109 1.764 . . . . 0.0 111.851 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -118.11 82.02 1.77 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 127.122 2.169 . . . . 0.0 108.651 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.19 -27.06 13.14 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.095 1.758 . . . . 0.0 113.067 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.1 t -131.4 130.85 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.802 1.641 . . . . 0.0 108.706 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.7 t -133.77 126.33 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.079 -1.013 . . . . 0.0 109.838 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.2 mm -126.64 111.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.61 1.164 . . . . 0.0 109.687 -170.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.2 t -87.49 156.87 19.35 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.493 1.117 . . . . 0.0 112.145 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.6 41.48 3.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.643 1.577 . . . . 0.0 111.68 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 124.783 1.233 . . . . 0.0 112.4 -178.118 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 121.532 0.682 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.96 142.78 65.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.52 154.29 72.64 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.342 2.028 . . . . 0.0 109.952 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.17 -25.27 76.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.935 2.423 . . . . 0.0 114.868 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.07 -16.37 63.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.506 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.5 m95 -93.16 -2.23 55.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.94 0.93 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.345 1.458 . . . . 0.0 113.941 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -103.14 -1.14 29.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.319 1.848 . . . . 0.0 113.222 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.489 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.7 mp0 -54.88 161.55 1.56 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.241 2.616 . . . . 0.0 114.352 174.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.98 -35.01 79.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.8 mt -133.84 131.59 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.444 1.098 . . . . 0.0 110.465 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -141.32 149.4 41.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.403 1.481 . . . . 0.0 112.349 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -146.11 159.09 43.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.056 1.742 . . . . 0.0 110.304 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -138.99 86.62 2.15 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.403 0.681 . . . . 0.0 111.44 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -67.68 146.71 53.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.792 1.637 . . . . 0.0 113.631 -170.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -98.97 60.49 1.22 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.528 1.931 . . . . 0.0 107.691 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.27 127.52 55.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.116 1.766 . . . . 0.0 112.349 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.59 169.95 12.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.009 1.324 . . . . 0.0 113.96 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.91 119.61 57.77 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.185 0.994 . . . . 0.0 110.982 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo . . . . . 0 CA--C 1.542 0.904 0 C-N-CA 122.64 2.227 . . . . 0.0 113.521 176.423 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.404 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -62.99 -25.46 68.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.19 0.996 . . . . 0.0 111.884 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.44 -32.18 73.39 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.523 -0.736 . . . . 0.0 111.571 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.03 -38.66 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.276 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -58.04 -48.44 80.09 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.085 1.311 . . . . 0.0 110.882 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -66.82 -26.67 67.04 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -74.28 -55.46 6.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.569 0.748 . . . . 0.0 111.33 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -34.28 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 110.89 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -58.3 -42.15 86.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.452 1.024 . . . . 0.0 112.691 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.37 -34.4 74.39 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.408 0.528 . . . . 0.0 112.726 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -68.97 -39.76 79.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.357 1.079 . . . . 0.0 111.332 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.63 -51.41 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.1 0.96 . . . . 0.0 110.522 170.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 123' ' ' VAL . 14.6 tmtt? -54.59 -47.58 73.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.701 1.201 . . . . 0.0 112.554 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -68.44 -27.94 66.62 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.659 1.572 . . . . 0.0 112.842 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -72.48 -49.74 30.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.215 1.006 . . . . 0.0 111.52 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 120' ' ' LYS . 35.8 m -62.83 -40.66 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 118.323 -0.846 . . . . 0.0 113.244 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.29 -46.71 82.47 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.824 1.647 . . . . 0.0 111.689 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -70.31 -33.21 71.25 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.526 0.603 . . . . 0.0 112.56 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.94 -46.63 87.53 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.136 0.974 . . . . 0.0 111.092 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt -73.56 -43.4 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.365 -0.834 . . . . 0.0 110.56 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.38 -27.69 69.25 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -85.9 -12.74 49.82 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -114.93 -18.52 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.393 0 C-N-CA 124.676 1.19 . . . . 0.0 113.1 -179.623 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.5 2.051 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -71.96 142.5 49.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.215 1.006 . . . . 0.0 111.896 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -108.2 126.16 52.48 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.571 1.148 . . . . 0.0 111.028 171.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.36 113.89 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.881 2.072 . . . . 0.0 110.092 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.9 ttm -98.71 126.48 44.34 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.148 0.885 . . . . 0.0 110.627 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -93.28 127.05 38.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.184 0.994 . . . . 0.0 109.408 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.06 135.26 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.703 1.201 . . . . 0.0 113.197 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 p . . . . . 0 CA--C 1.543 0.674 0 C-N-CA 124.21 1.004 . . . . 0.0 112.6 -174.34 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -63.88 -37.32 86.94 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.323 1.42 . . . . 0.0 113.329 170.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.17 -45.62 66.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.827 0.451 . . . . 0.0 110.14 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.422 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 6.7 tpt -72.32 -38.62 68.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.3 86.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.551 0.614 . . . . 0.0 111.688 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -38.82 89.62 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.824 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.34 29.61 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 119.671 1.123 . . . . 0.0 113.655 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.47 -38.33 90.71 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.396 -1.061 . . . . 0.0 111.39 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.76 -34.7 76.02 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -72.12 -19.17 61.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.845 1.657 . . . . 0.0 113.215 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.2 m -89.26 -45.12 9.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.808 0.843 . . . . 0.0 111.971 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.94 -33.68 12.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.679 1.192 . . . . 0.0 113.009 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 4.94 81.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 125.679 1.609 . . . . 0.0 113.27 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.12 116.88 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 118.32 1.06 . . . . 0.0 111.725 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 14.63 76.91 Favored Glycine 0 CA--C 1.537 1.462 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.95 -44.39 3.81 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.245 1.522 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -145.71 162.21 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 126.465 1.906 . . . . 0.0 111.48 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.52 149.08 24.6 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -145.89 143.43 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.832 -1.167 . . . . 0.0 114.049 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.4 m -143.8 143.27 31.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.522 1.529 . . . . 0.0 110.871 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.3 p -106.86 145.25 32.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 0.0 111.677 170.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -156.36 154.46 30.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.533 1.133 . . . . 0.0 110.735 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.98 150.2 17.04 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.004 1.288 . . . . 0.0 110.653 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -52.88 -37.55 60.58 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.571 1.185 . . . . 0.0 112.413 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -126.11 39.42 3.95 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.47 . . . . 0.0 111.287 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 69.08 170.65 0.3 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.667 1.987 . . . . 0.0 114.177 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -159.15 167.84 28.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.113 2.565 . . . . 0.0 109.978 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 156.19 28.52 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -173.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.6 146.61 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.916 1.286 . . . . 0.0 109.542 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -126.23 126.76 24.72 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.885 -169.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.519 2.813 . . . . 0.0 115.085 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 m -64.4 -34.11 77.42 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.022 -1.049 . . . . 0.0 111.526 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.17 -10.15 59.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.161 -0.962 . . . . 0.0 113.186 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.6 mt -80.13 -56.83 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 167.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.68 72.61 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.7 mmt -69.75 -8.19 45.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.422 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.4 mmt -124.63 -26.38 3.84 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.459 1.104 . . . . 0.0 112.263 -169.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -26.66 68.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.844 -1.16 . . . . 0.0 111.658 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.37 -9.14 55.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.0 0.92 . . . . 0.0 113.372 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.47 1.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.466 2.306 . . . . 0.0 110.765 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.04 81.75 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.693 1.616 . . . . 0.0 114.836 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.16 150.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.857 1.263 . . . . 0.0 111.293 -174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -126.92 142.29 51.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.199 1.4 . . . . 0.0 112.489 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 pt -137.53 -1.96 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.422 1.889 . . . . 0.0 111.783 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.8 p -63.18 -34.02 76.73 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.73 2.8 87.78 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.635 1.112 . . . . 0.0 115.369 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -72.57 159.71 33.46 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 p -118.0 -176.24 3.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.072 2.549 . . . . 0.0 108.911 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.0 t -146.07 -73.27 0.23 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.011 -1.055 . . . . 0.0 111.216 170.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 63.95 154.18 0.12 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.556 2.343 . . . . 0.0 115.211 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.87 133.79 46.61 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.726 2.284 . . . . 0.0 111.991 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.5 tt -55.98 -34.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.38 -8.6 51.93 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -20.68 60.24 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.254 -0.904 . . . . 0.0 112.692 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.54 171.42 8.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.181 1.392 . . . . 0.0 112.807 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.9 114.54 27.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.016 1.726 . . . . 0.0 110.934 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -69.21 -18.3 63.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.88 -26.44 66.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.784 0.833 . . . . 0.0 112.542 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -86.98 -2.81 58.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.056 1.742 . . . . 0.0 112.132 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -114.86 81.9 1.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.8 2.04 . . . . 0.0 107.972 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.23 -28.7 12.21 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.755 1.622 . . . . 0.0 112.88 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -131.0 130.5 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 126.01 1.724 . . . . 0.0 108.851 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -133.23 128.8 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.153 -0.967 . . . . 0.0 109.763 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 mm -125.19 117.14 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 109.053 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.7 t -89.89 153.57 20.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 111.316 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -133.26 35.91 3.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.43 1.092 . . . . 0.0 111.972 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.6 m . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -169.007 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -143.44 140.51 17.66 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.711 1.204 . . . . 0.0 112.613 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -63.91 154.01 72.45 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.591 2.194 . . . . 0.0 110.449 168.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.48 -32.29 96.09 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.371 2.048 . . . . 0.0 114.728 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.28 -22.19 66.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.1 m95 -89.29 -3.16 58.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.46 -19.95 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 t -81.96 6.8 14.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.754 1.622 . . . . 0.0 114.354 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.6 mp0 -55.78 160.68 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.035 2.134 . . . . 0.0 113.721 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.36 -33.53 74.92 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.7 mt -131.69 124.58 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.114 0.966 . . . . 0.0 110.173 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -135.31 141.88 45.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.427 1.491 . . . . 0.0 110.521 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.4 159.1 39.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.011 1.324 . . . . 0.0 110.871 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.24 131.94 54.52 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.602 1.161 . . . . 0.0 111.327 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.9 m0 -103.48 162.42 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.786 1.635 . . . . 0.0 112.77 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -119.89 40.13 3.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.874 1.27 . . . . 0.0 112.871 -168.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.94 159.58 34.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.874 0.87 . . . . 0.0 111.081 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -106.06 162.08 13.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.412 1.485 . . . . 0.0 109.795 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -88.52 128.55 52.45 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.78 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 CA--C 1.546 1.092 0 C-N-CA 122.278 1.985 . . . . 0.0 112.804 169.988 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.41 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.6 mm? -63.21 -30.13 71.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.818 1.247 . . . . 0.0 111.858 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.05 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.346 -0.846 . . . . 0.0 111.749 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.53 -39.05 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 110.824 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -56.59 -47.2 80.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.09 1.314 . . . . 0.0 110.518 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -70.69 -19.28 62.79 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.1 m -82.03 -50.83 8.66 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.874 1.27 . . . . 0.0 112.211 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.74 -33.71 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.398 1.079 . . . . 0.0 111.517 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -54.1 -40.21 67.07 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.852 0.751 . . . . 0.0 112.922 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.68 -32.89 63.82 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.282 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -70.95 -40.77 71.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.396 1.098 . . . . 0.0 110.273 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.13 -52.42 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.133 0.973 . . . . 0.0 110.66 170.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -55.47 -48.82 73.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.009 1.324 . . . . 0.0 112.462 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.99 -28.8 66.93 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.905 1.684 . . . . 0.0 112.51 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -71.94 -47.48 52.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.474 0.709 . . . . 0.0 111.861 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.6 m -62.54 -35.32 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.008 0.822 . . . . 0.0 112.897 170.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.77 -46.21 90.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.887 1.221 . . . . 0.0 111.389 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.55 97.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.329 0.513 . . . . 0.0 111.051 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.492 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -59.31 -48.96 79.65 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.771 0.828 . . . . 0.0 111.199 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.51 -44.23 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.868 -0.52 . . . . 0.0 110.489 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.58 70.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.4 pttt -86.86 -13.24 45.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -115.24 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 124.516 1.127 . . . . 0.0 113.091 178.518 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 119.765 -0.159 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -69.85 138.68 52.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.479 1.112 . . . . 0.0 111.4 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -108.05 127.39 53.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.05 0.94 . . . . 0.0 110.923 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.84 119.48 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.063 1.745 . . . . 0.0 109.685 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.5 tpp -97.8 126.78 43.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.73 123.34 45.54 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.063 0.545 . . . . 0.0 111.152 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.17 149.22 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.164 0.985 . . . . 0.0 113.546 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 125.155 1.382 . . . . 0.0 109.007 176.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.6 p -70.69 -55.97 7.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.328 1.051 . . . . 0.0 113.543 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.66 -33.66 74.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.021 0.528 . . . . 0.0 110.232 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.9 tpt -71.89 -43.78 64.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.12 99.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.508 0.723 . . . . 0.0 111.637 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -43.91 95.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.858 169.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.38 -53.05 43.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.525 1.057 . . . . 0.0 113.176 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -61.38 -36.34 79.99 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.697 1.249 . . . . 0.0 111.535 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.98 -27.17 62.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -65.91 -46.31 78.77 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.844 1.656 . . . . 0.0 111.375 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -74.48 -38.27 62.96 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.0 1.32 . . . . 0.0 112.332 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.8 mt -96.29 -29.83 13.78 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.17 0.988 . . . . 0.0 113.038 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.59 6.34 77.86 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.772 1.653 . . . . 0.0 113.829 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.0 118.82 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.467 1.134 . . . . 0.0 111.408 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.08 14.97 80.04 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 118.743 -1.032 . . . . 0.0 115.589 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -124.27 -43.3 2.07 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.27 1.535 . . . . 0.0 111.913 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.98 157.87 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.663 1.185 . . . . 0.0 113.191 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.83 154.02 20.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.471 1.108 . . . . 0.0 109.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.97 140.54 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 121.238 -0.914 . . . . 0.0 113.093 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 m -144.89 154.02 42.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.328 1.451 . . . . 0.0 109.538 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.3 p -121.6 152.1 39.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.719 0.808 . . . . 0.0 112.794 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 t -151.83 150.71 30.42 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.324 1.049 . . . . 0.0 110.846 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.12 140.75 15.77 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 169.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.9 -41.99 92.86 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.518 1.659 . . . . 0.0 110.995 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.59 33.63 3.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.532 170.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t 64.27 170.93 0.18 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.387 1.875 . . . . 0.0 113.932 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.1 p -153.13 -172.62 4.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.098 1.759 . . . . 0.0 111.546 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -137.6 -147.92 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.258 1.423 . . . . 0.0 111.82 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.23 151.06 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 126.5 1.92 . . . . 0.0 107.304 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -123.74 126.64 25.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 CA-C-O 117.604 -1.189 . . . . 0.0 111.206 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -54.41 -39.22 88.51 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.324 2.683 . . . . 0.0 114.898 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 m -66.03 -32.57 74.13 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.996 -1.065 . . . . 0.0 111.872 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.2 -10.66 59.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.13 -0.981 . . . . 0.0 113.285 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.83 -53.77 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.39 61.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -170.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.05 -6.64 43.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.3 mmt -128.12 -29.51 2.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.93 0.892 . . . . 0.0 112.532 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.8 -25.49 67.52 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.893 -1.129 . . . . 0.0 111.855 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.95 -14.31 62.96 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.6 19.06 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.38 1.472 . . . . 0.0 111.584 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.81 76.08 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.801 1.667 . . . . 0.0 116.591 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mm -80.13 148.6 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.45 1.625 . . . . 0.0 112.151 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.55 111.4 11.72 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.166 1.786 . . . . 0.0 112.024 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.5 pt -140.98 -1.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.145 1.378 . . . . 0.0 113.693 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -61.84 -35.78 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -169.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.54 -2.45 90.05 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.332 0.968 . . . . 0.0 115.236 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -85.41 167.28 15.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.895 1.347 . . . . 0.0 114.327 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -139.88 -175.27 4.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.053 1.741 . . . . 0.0 110.586 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 t -145.24 165.49 28.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.67 1.588 . . . . 0.0 112.101 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.31 157.23 45.81 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.732 1.613 . . . . 0.0 110.299 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.12 139.55 90.28 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.418 2.745 . . . . 0.0 112.103 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -58.35 -31.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.18 -10.51 58.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.57 57.7 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.08 0.855 . . . . 0.0 112.789 170.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -94.4 170.4 9.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.061 1.345 . . . . 0.0 112.41 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 108.72 15.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.567 1.547 . . . . 0.0 111.155 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.66 -19.35 65.74 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.44 -26.53 68.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.866 0.866 . . . . 0.0 112.567 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.87 -2.67 58.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.343 1.857 . . . . 0.0 111.936 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -116.1 83.98 2.04 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.207 2.203 . . . . 0.0 108.235 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.21 -25.91 6.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.087 1.755 . . . . 0.0 113.049 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -133.36 130.26 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.848 1.659 . . . . 0.0 108.902 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -134.13 126.63 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.083 -1.01 . . . . 0.0 109.471 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.1 mm -127.03 116.58 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.589 1.156 . . . . 0.0 109.901 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -91.15 157.31 17.28 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.061 1.344 . . . . 0.0 111.651 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.65 35.89 4.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.176 1.39 . . . . 0.0 112.287 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 124.791 1.236 . . . . 0.0 112.204 -178.943 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 121.475 0.655 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 mt -84.23 142.42 40.93 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.85 154.97 70.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.612 2.208 . . . . 0.0 109.915 168.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.91 -28.99 81.67 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.917 2.411 . . . . 0.0 114.276 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.33 -19.44 65.81 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.82 -1.175 . . . . 0.0 113.814 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.494 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.5 m95 -91.6 -3.26 56.61 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 m -115.91 -16.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -83.79 4.24 29.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.863 1.665 . . . . 0.0 114.13 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.473 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.1 mp0 -58.07 159.74 5.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.972 2.109 . . . . 0.0 113.986 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -62.99 -34.05 76.71 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.32 127.85 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.817 0.847 . . . . 0.0 109.864 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.64 148.31 48.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.291 1.436 . . . . 0.0 111.821 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -147.22 157.41 43.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.829 1.652 . . . . 0.0 110.391 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -135.98 86.06 2.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.619 0.768 . . . . 0.0 111.018 169.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -66.98 146.61 54.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.836 1.655 . . . . 0.0 115.02 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -96.53 49.09 1.09 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.526 2.33 . . . . 0.0 108.742 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.14 134.51 40.37 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.254 1.822 . . . . 0.0 112.654 -167.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.1 179.27 6.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.098 1.359 . . . . 0.0 113.897 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -101.61 113.97 65.73 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.868 0.867 . . . . 0.0 111.806 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo . . . . . 0 CA--C 1.54 0.825 0 C-N-CA 121.559 1.506 . . . . 0.0 113.264 176.673 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.37 -30.07 67.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.814 0.846 . . . . 0.0 111.373 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.62 -35.15 79.49 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.242 -0.912 . . . . 0.0 110.919 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.97 -39.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.404 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -55.77 -47.75 76.48 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 121.147 1.794 . . . . 0.0 111.427 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -69.27 -15.04 63.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.267 1.027 . . . . 0.0 113.564 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.6 m -88.77 -49.23 6.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.659 1.584 . . . . 0.0 112.641 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -70.38 -31.76 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.24 -0.913 . . . . 0.0 111.073 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -56.24 -39.83 73.16 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 0.0 112.453 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.48 -34.6 68.06 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.071 0.843 . . . . 0.0 112.63 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -69.49 -43.2 73.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.059 0.93 . . . . 0.0 110.513 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.94 -47.2 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.377 0.671 . . . . 0.0 110.685 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -56.45 -49.41 74.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.55 1.14 . . . . 0.0 112.3 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.7 -29.84 62.52 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.017 1.28 . . . . 0.0 113.13 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -64.8 -50.85 65.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.477 0.711 . . . . 0.0 110.866 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.4 t -56.36 -46.21 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.868 1.267 . . . . 0.0 112.611 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.63 -49.05 78.11 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 120.099 1.318 . . . . 0.0 111.874 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -71.47 -32.61 68.48 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.433 0.561 . . . . 0.0 111.948 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.52 -48.33 81.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.971 0.908 . . . . 0.0 111.308 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.8 -43.17 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.683 0.674 . . . . 0.0 110.7 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.82 68.68 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.62 -11.84 58.09 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.9 pt -111.44 -28.3 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.256 1.418 0 C-N-CA 125.629 1.572 . . . . 0.0 112.108 -178.183 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttp . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -72.77 144.19 47.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.636 1.174 . . . . 0.0 112.316 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -112.06 125.76 54.44 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.196 0.998 . . . . 0.0 111.836 170.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.79 116.55 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.821 1.649 . . . . 0.0 110.585 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.52 126.08 43.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.375 0.989 . . . . 0.0 110.454 168.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -95.36 121.45 37.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.894 0.878 . . . . 0.0 110.323 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.29 136.35 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.086 0.954 . . . . 0.0 113.275 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 123.825 0.85 . . . . 0.0 112.216 -179.591 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -68.51 -47.29 67.36 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.621 1.555 . . . . 0.0 111.331 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.19 -38.58 91.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.581 1.153 . . . . 0.0 111.759 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.402 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 7.7 tpt -73.58 -38.23 65.22 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.687 0.795 . . . . 0.0 112.244 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.69 -44.14 90.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.229 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.87 -44.05 91.0 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.144 0.884 . . . . 0.0 112.052 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.51 -49.77 67.19 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 119.598 1.09 . . . . 0.0 113.267 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.3 -43.15 87.09 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.135 -1.215 . . . . 0.0 111.666 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.82 82.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.844 -1.16 . . . . 0.0 113.797 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -72.55 -16.54 61.76 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.57 1.077 . . . . 0.0 113.254 174.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.9 m -88.21 -44.71 10.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.69 1.196 . . . . 0.0 111.99 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -95.99 -34.6 11.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.21 1.004 . . . . 0.0 113.539 -171.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.94 5.33 85.03 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.77 1.652 . . . . 0.0 113.85 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.43 -44.9 4.19 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.25 18.99 41.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.416 1.484 . . . . 0.0 114.536 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -127.19 -38.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.767 1.227 . . . . 0.0 112.504 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.52 163.27 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.646 1.579 . . . . 0.0 112.248 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.25 152.6 18.22 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 168.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -148.61 145.22 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 120.631 -1.293 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -147.11 163.45 36.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.053 1.741 . . . . 0.0 108.827 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.4 p -134.01 154.55 51.05 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.725 -1.234 . . . . 0.0 111.747 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 t -145.94 142.25 28.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.481 1.112 . . . . 0.0 109.935 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.96 137.21 13.68 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.975 -0.453 . . . . 0.0 112.19 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.15 121.29 13.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 64.47 28.67 13.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.296 1.839 . . . . 0.0 113.775 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t 70.41 170.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.432 2.293 . . . . 0.0 114.062 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 62' ' ' SER . 82.1 p -152.71 179.12 8.91 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.699 1.6 . . . . 0.0 112.062 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 160.77 38.19 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.27 147.07 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.918 1.287 . . . . 0.0 109.07 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -119.63 132.19 24.12 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.65 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.88 -36.15 82.26 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.039 2.493 . . . . 0.0 114.795 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -69.57 -33.15 72.32 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.017 -1.052 . . . . 0.0 112.096 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 -13.44 61.14 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.044 -1.035 . . . . 0.0 113.21 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.07 -57.33 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.37 78.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -169.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mmt -68.46 -8.5 41.43 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.402 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 14.3 mmt -123.15 -27.25 4.2 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 -169.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.87 -27.59 68.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.173 -0.954 . . . . 0.0 111.891 169.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.29 -8.13 53.22 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.332 1.053 . . . . 0.0 113.408 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.61 -0.46 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.516 2.326 . . . . 0.0 110.772 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.54 14.44 78.22 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.276 1.417 . . . . 0.0 114.629 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 mm -92.62 153.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.872 1.269 . . . . 0.0 111.192 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -130.92 139.0 50.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.444 1.498 . . . . 0.0 111.859 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.6 pt -135.58 -6.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.694 1.198 . . . . 0.0 112.49 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -58.35 -34.41 70.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.583 1.553 . . . . 0.0 114.526 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.69 -3.82 89.32 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.474 1.035 . . . . 0.0 115.295 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -81.71 154.84 25.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.961 1.381 . . . . 0.0 113.424 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -130.42 178.06 6.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.83 2.052 . . . . 0.0 110.681 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 40' ' ' SER . 3.7 t -148.73 158.58 44.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.121 -0.987 . . . . 0.0 112.444 173.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -152.04 158.1 33.92 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.687 1.995 . . . . 0.0 109.284 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.03 140.89 95.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.344 2.696 . . . . 0.0 112.474 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -60.11 -29.62 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.54 -12.04 60.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -21.42 59.22 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.252 -0.905 . . . . 0.0 112.735 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 166.25 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.359 . . . . 0.0 112.523 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.89 107.05 14.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.485 1.514 . . . . 0.0 111.086 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -62.38 -16.18 53.11 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.874 -1.141 . . . . 0.0 113.799 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -59.26 -18.83 40.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.572 1.549 . . . . 0.0 113.063 176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.18 -0.51 28.41 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.463 1.905 . . . . 0.0 112.877 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -123.61 76.62 1.43 Allowed 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.831 1.652 . . . . 0.0 109.894 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.56 -23.75 11.61 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.661 1.984 . . . . 0.0 113.256 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.54 131.46 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.193 1.397 . . . . 0.0 109.329 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.62 126.35 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.876 -1.14 . . . . 0.0 110.391 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.07 119.69 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.364 1.465 . . . . 0.0 108.206 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 t -83.43 151.06 25.67 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.781 1.633 . . . . 0.0 110.112 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.05 38.25 4.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.129 -0.982 . . . . 0.0 111.765 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 98.7 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -169.768 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.83 131.87 12.69 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.599 1.16 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.97 148.28 89.51 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.762 2.308 . . . . 0.0 110.126 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.18 -29.55 83.95 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.657 2.905 . . . . 0.0 115.483 -169.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -63.84 -20.96 66.2 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.487 -1.383 . . . . 0.0 114.014 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.453 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 99.0 m95 -81.76 -15.42 54.34 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.401 -1.437 . . . . 0.0 114.526 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.22 -21.25 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.851 1.261 . . . . 0.0 113.524 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 t -84.56 13.37 5.67 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.974 1.71 . . . . 0.0 113.568 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -67.8 164.54 19.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 112.786 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.31 -34.85 78.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.6 mt -133.5 126.59 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 110.072 169.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.08 148.07 48.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.931 1.292 . . . . 0.0 110.79 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -141.53 162.34 35.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.519 1.128 . . . . 0.0 112.402 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.68 130.81 32.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 108.749 168.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -108.28 135.26 49.89 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.399 1.479 . . . . 0.0 111.014 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -93.81 44.24 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.18 1.392 . . . . 0.0 110.92 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.19 150.92 24.06 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.659 1.583 . . . . 0.0 112.651 -173.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.92 165.16 13.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.889 1.276 . . . . 0.0 110.477 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.1 134.23 19.9 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.853 -0.529 . . . . 0.0 112.168 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 CA--C 1.544 1.0 0 C-N-CA 121.866 1.71 . . . . 0.0 113.187 176.691 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.12 -33.12 74.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.919 0.887 . . . . 0.0 111.476 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.44 -34.89 79.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.726 -0.609 . . . . 0.0 111.198 169.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.8 t -69.53 -42.47 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 117.805 -1.093 . . . . 0.0 111.85 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -55.65 -48.9 74.22 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.951 1.705 . . . . 0.0 111.195 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -69.74 -19.31 63.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -84.36 -50.41 7.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 0.0 112.024 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.0 t -70.8 -30.97 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.588 1.155 . . . . 0.0 111.812 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -55.04 -42.26 72.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.274 0.943 . . . . 0.0 112.784 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.4 65.36 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.728 0.68 . . . . 0.0 112.849 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -68.57 -48.39 64.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.167 0.983 . . . . 0.0 109.681 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.15 -41.41 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.538 -0.726 . . . . 0.0 111.093 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.21 -50.11 73.89 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.096 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -70.82 -29.41 65.56 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.514 1.506 . . . . 0.0 113.335 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -63.48 -52.72 60.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 172.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.17 -50.84 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.138 1.375 . . . . 0.0 112.219 170.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.7 -49.99 70.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.847 1.203 . . . . 0.0 112.499 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -30.19 68.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.442 0.564 . . . . 0.0 112.142 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.15 -52.59 32.94 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.676 0.79 . . . . 0.0 110.876 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.8 -37.47 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.958 -1.089 . . . . 0.0 111.83 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.06 -26.48 68.86 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -87.78 -23.41 24.09 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -101.85 -20.09 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.254 1.338 0 C-N-CA 124.857 1.263 . . . . 0.0 113.829 -170.361 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -79.61 136.54 36.87 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.097 0.959 . . . . 0.0 112.419 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.33 128.17 53.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.643 1.177 . . . . 0.0 111.556 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.15 111.78 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.488 1.915 . . . . 0.0 110.319 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -92.8 122.45 35.2 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 169.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -93.31 114.91 27.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.998 0.519 . . . . 0.0 109.923 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.84 144.43 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.06 1.344 . . . . 0.0 111.985 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.541 0.624 0 O-C-N 121.274 -0.891 . . . . 0.0 112.855 176.215 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 119.627 -0.225 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -62.44 -46.53 88.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.863 1.265 . . . . 0.0 111.695 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.38 -33.93 67.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.394 0.678 . . . . 0.0 111.805 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -37.68 64.87 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.086 -1.009 . . . . 0.0 113.337 169.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -45.41 90.09 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.114 0.87 . . . . 0.0 110.919 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -57.92 -46.85 84.36 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.058 169.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.42 -49.19 46.26 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.826 1.194 . . . . 0.0 115.405 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -72.64 -36.11 67.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.024 1.412 . . . . 0.0 111.619 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.82 73.23 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -69.02 -26.36 64.95 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.582 1.537 . . . . 0.0 112.504 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.2 m -84.51 -44.93 13.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.08 0.952 . . . . 0.0 111.669 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -95.59 -32.36 12.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.27 1.028 . . . . 0.0 113.308 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 5.76 79.78 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 125.87 1.7 . . . . 0.0 113.351 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 115.42 1.1 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.318 1.059 . . . . 0.0 111.862 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.44 80.26 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 115.821 1.089 . . . . 0.0 115.821 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -119.55 -34.42 3.8 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.238 1.519 . . . . 0.0 111.906 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -149.88 166.96 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.739 2.016 . . . . 0.0 111.623 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.19 152.07 19.44 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -144.69 145.2 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.023 1.283 . . . . 0.0 113.858 -175.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -144.55 154.38 42.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.38 1.872 . . . . 0.0 110.001 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.8 p -118.76 152.27 36.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.594 1.088 . . . . 0.0 113.421 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 t -149.66 150.71 32.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.255 1.422 . . . . 0.0 111.012 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.62 18.12 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.2 mt -53.13 -40.8 64.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.668 1.734 . . . . 0.0 112.199 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -122.21 37.03 4.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.932 1.693 . . . . 0.0 111.074 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 72.97 151.5 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.272 2.229 . . . . 0.0 115.094 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -132.01 -169.34 2.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.195 1.798 . . . . 0.0 111.424 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.24 178.81 7.31 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.95 116.47 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.519 1.928 . . . . 0.0 109.25 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.8 148.91 52.51 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 118.673 -0.679 . . . . 0.0 112.065 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.28 -37.65 88.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.359 2.706 . . . . 0.0 113.892 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -65.48 -33.35 75.73 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.027 -1.046 . . . . 0.0 112.018 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.51 -10.74 59.85 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.4 mt -83.9 -53.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.17 68.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.86 -8.14 54.15 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 mmt -126.08 -27.35 3.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.284 1.033 . . . . 0.0 112.555 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.05 -25.13 67.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.787 -1.196 . . . . 0.0 111.985 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.39 -13.82 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.375 1.07 . . . . 0.0 113.544 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.28 18.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.422 1.489 . . . . 0.0 111.557 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.59 76.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.741 1.639 . . . . 0.0 116.611 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.2 mm -75.51 145.15 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.537 1.669 . . . . 0.0 111.6 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -133.77 97.92 4.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.641 1.576 . . . . 0.0 110.887 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 pt -132.75 11.93 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -58.47 -30.54 67.05 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.806 1.243 . . . . 0.0 113.333 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.43 -1.08 75.35 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.907 1.241 . . . . 0.0 115.348 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -74.76 140.13 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.703 1.751 . . . . 0.0 112.375 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.6 p -114.78 172.6 6.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.547 1.939 . . . . 0.0 110.343 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -145.44 158.71 43.79 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.304 -0.872 . . . . 0.0 111.783 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -150.03 157.59 37.53 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.779 1.632 . . . . 0.0 110.569 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.72 142.92 91.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.62 2.88 . . . . 0.0 113.098 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.88 -31.09 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -67.14 -13.22 61.74 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -21.02 57.16 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 112.916 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -94.62 166.85 11.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.878 1.271 . . . . 0.0 112.691 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.3 107.64 15.52 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 111.126 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -65.87 -21.4 66.46 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -169.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.57 -27.41 68.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.179 0.991 . . . . 0.0 112.487 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.16 -3.85 59.05 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.939 1.696 . . . . 0.0 112.187 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.15 80.32 1.44 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 127.119 2.168 . . . . 0.0 108.556 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.37 -27.65 10.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.767 1.627 . . . . 0.0 112.942 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.59 127.54 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.184 1.794 . . . . 0.0 108.835 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.82 124.65 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.15 -0.969 . . . . 0.0 109.251 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.17 124.25 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.417 1.087 . . . . 0.0 109.215 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -99.59 154.07 18.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.572 1.149 . . . . 0.0 111.938 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.87 35.15 3.79 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.111 1.364 . . . . 0.0 111.764 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.171 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.1 mt -142.51 139.93 18.11 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.62 1.168 . . . . 0.0 112.75 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.32 153.81 72.05 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.448 2.098 . . . . 0.0 110.167 168.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.86 -22.45 73.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.089 2.526 . . . . 0.0 115.167 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.99 -15.0 62.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.49 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.7 m95 -92.08 -1.56 57.13 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.78 10.62 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 125.887 1.675 . . . . 0.0 113.894 -175.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -112.52 -2.62 14.59 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.399 1.88 . . . . 0.0 112.826 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.445 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.7 mp0 -56.72 160.4 3.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.551 2.74 . . . . 0.0 113.95 175.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.84 -32.59 74.2 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.65 127.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.146 0.978 . . . . 0.0 110.513 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -139.38 141.33 37.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.247 1.419 . . . . 0.0 111.624 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -157.3 161.64 39.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 110.665 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.44 134.01 52.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 111.8 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -108.78 163.35 13.35 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.202 1.801 . . . . 0.0 112.104 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -130.33 62.14 1.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.856 1.262 . . . . 0.0 112.337 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.55 167.21 20.37 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.542 1.537 . . . . 0.0 111.418 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -117.52 158.83 23.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.967 1.307 . . . . 0.0 110.397 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -98.35 120.72 58.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 CA--C 1.542 0.885 0 C-N-CA 123.061 2.507 . . . . 0.0 114.094 -178.927 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.8 t . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.108 0.48 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.9 -25.09 67.36 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.996 0.918 . . . . 0.0 111.692 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.44 -31.97 73.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.887 -1.133 . . . . 0.0 111.729 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.1 t -72.73 -39.0 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.901 -1.125 . . . . 0.0 110.193 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -56.53 -49.33 75.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.687 1.131 . . . . 0.0 111.15 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -70.67 -17.05 62.85 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -83.07 -51.4 7.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.063 1.345 . . . . 0.0 111.967 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.35 -34.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.748 1.219 . . . . 0.0 111.484 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -57.12 -39.5 75.24 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.101 0.864 . . . . 0.0 112.728 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.12 -32.26 69.23 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.988 0.804 . . . . 0.0 112.935 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -71.78 -39.76 69.71 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.476 1.138 . . . . 0.0 110.967 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.38 -50.93 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.63 0.772 . . . . 0.0 110.552 170.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.448 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -54.08 -48.01 71.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 112.367 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -68.32 -26.66 65.73 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 120.984 1.72 . . . . 0.0 112.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -75.54 -47.69 25.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.904 0.882 . . . . 0.0 111.8 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.9 m -61.19 -36.5 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.8 0.727 . . . . 0.0 112.252 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -61.78 -47.26 85.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.9 1.227 . . . . 0.0 111.833 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -40.16 95.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.46 0.573 . . . . 0.0 111.106 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.485 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -58.74 -48.21 81.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.801 0.84 . . . . 0.0 111.388 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -73.13 -47.95 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.34 -25.42 68.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.9 pttt -87.68 -7.49 57.35 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.13 -18.36 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.0 p . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.135 1.374 . . . . 0.0 113.617 178.238 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -71.18 141.45 50.69 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.403 1.081 . . . . 0.0 111.221 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.96 128.57 55.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.072 0.949 . . . . 0.0 111.769 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.4 t -99.64 110.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.624 1.57 . . . . 0.0 110.161 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 tpp -90.65 124.07 34.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.181 0.446 . . . . 0.0 110.475 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.3 123.57 39.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.832 0.853 . . . . 0.0 109.918 169.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 m -118.98 134.51 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.08 0.855 . . . . 0.0 112.623 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t . . . . . 0 CA--C 1.55 0.944 0 C-N-CA 125.121 1.368 . . . . 0.0 110.43 174.528 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 p -70.28 -43.69 69.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.119 1.327 . . . . 0.0 112.119 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.38 -34.3 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.456 0.703 . . . . 0.0 111.634 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 tpt -74.93 -38.37 61.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.07 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.13 87.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.431 0.559 . . . . 0.0 111.495 169.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -58.84 -40.85 85.44 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.349 -0.844 . . . . 0.0 111.824 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.97 -48.82 83.93 Favored Glycine 0 N--CA 1.474 1.228 0 CA-C-N 119.433 1.015 . . . . 0.0 113.784 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB3' HG21 ' A' ' 123' ' ' VAL . 40.0 m-85 -66.28 -40.01 89.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.073 -1.251 . . . . 0.0 111.365 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.12 85.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -68.77 -28.95 67.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.168 1.349 . . . . 0.0 112.641 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 m -78.42 -44.47 24.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.693 0.797 . . . . 0.0 111.773 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.5 mt -96.99 -31.77 12.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.973 0.909 . . . . 0.0 113.216 -171.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.13 7.03 72.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.821 1.677 . . . . 0.0 113.602 169.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.51 118.73 2.35 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.514 1.157 . . . . 0.0 112.024 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.35 11.61 85.14 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -116.9 -40.63 3.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.721 1.76 . . . . 0.0 112.377 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -150.51 162.65 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.784 1.633 . . . . 0.0 111.644 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.56 150.18 21.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.49 148.43 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.139 -0.975 . . . . 0.0 112.634 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -150.86 154.35 37.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.362 1.465 . . . . 0.0 109.248 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.3 p -127.49 155.01 44.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.6 t -155.78 167.12 31.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.585 1.554 . . . . 0.0 110.234 -170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.96 159.31 26.96 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.242 -0.911 . . . . 0.0 112.332 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -62.0 -38.26 87.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.324 1.062 . . . . 0.0 111.9 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.78 44.4 2.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.699 2.0 . . . . 0.0 108.756 170.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 t 66.5 176.96 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.15 1.78 . . . . 0.0 113.394 -169.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 94.9 p -146.23 -175.14 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.975 2.11 . . . . 0.0 110.423 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -145.78 172.64 13.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.13 141.75 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.758 1.623 . . . . 0.0 108.197 168.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -123.47 129.11 25.0 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.594 -171.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.68 -38.44 84.52 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.216 2.611 . . . . 0.0 115.381 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -63.74 -36.43 83.85 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.856 -0.528 . . . . 0.0 111.533 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.23 85.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.157 0.89 . . . . 0.0 111.171 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.5 mt -53.57 -51.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.36 79.37 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.1 mmt -67.09 -23.35 65.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 mmt -106.68 -18.93 13.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -61.32 -29.25 69.76 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.482 -1.386 . . . . 0.0 112.497 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -6.85 49.37 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.057 0.943 . . . . 0.0 113.302 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.8 0.49 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 126.943 2.097 . . . . 0.0 110.508 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 14.38 79.9 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.204 1.383 . . . . 0.0 114.629 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 mm -88.89 157.3 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.1 1.36 . . . . 0.0 110.619 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.87 143.26 49.4 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.463 1.105 . . . . 0.0 112.188 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.74 4.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.088 1.755 . . . . 0.0 112.106 168.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.4 p -63.2 -30.56 71.68 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.48 -4.14 73.94 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.76 1.171 . . . . 0.0 115.565 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -87.73 148.81 24.58 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.304 1.552 . . . . 0.0 113.043 -174.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.2 t -144.42 172.63 12.68 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.362 1.865 . . . . 0.0 109.951 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 t -133.31 167.19 20.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.929 1.292 . . . . 0.0 112.867 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -146.11 157.89 49.17 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.427 1.491 . . . . 0.0 111.034 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 134.97 65.52 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.723 2.948 . . . . 0.0 112.828 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -57.48 -32.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -169.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.93 -9.16 54.04 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.79 59.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 121.365 -0.835 . . . . 0.0 112.9 170.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.95 167.78 11.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 113.219 -175.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.02 112.19 22.27 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.595 1.558 . . . . 0.0 111.056 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.15 -15.55 63.78 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.455 -1.403 . . . . 0.0 113.529 -175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.9 -20.44 23.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.845 1.258 . . . . 0.0 113.191 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.72 -0.39 34.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.596 1.959 . . . . 0.0 113.053 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.5 77.03 1.61 Allowed 'General case' 0 C--N 1.346 0.428 0 C-N-CA 125.97 1.708 . . . . 0.0 109.739 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.29 -23.56 15.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.831 2.052 . . . . 0.0 113.252 -177.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.66 127.76 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.313 1.445 . . . . 0.0 108.8 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.0 t -136.18 124.87 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.01 -1.056 . . . . 0.0 111.055 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.36 121.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.559 1.544 . . . . 0.0 108.612 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -87.29 137.99 31.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.672 1.189 . . . . 0.0 111.449 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.85 11.7 20.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.505 1.122 . . . . 0.0 112.735 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m . . . . . 0 CA--C 1.55 0.969 0 C-N-CA 125.622 1.569 . . . . 0.0 112.537 169.909 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -141.68 137.67 16.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.22 1.008 . . . . 0.0 112.454 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.46 151.35 80.32 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.541 2.16 . . . . 0.0 110.032 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.67 -31.28 94.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.084 2.523 . . . . 0.0 114.672 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.89 -23.81 66.55 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.862 -1.148 . . . . 0.0 113.756 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.6 m95 -83.87 -9.72 58.54 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.47 -1.394 . . . . 0.0 114.686 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.1 m -117.04 -21.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.19 1.396 . . . . 0.0 113.569 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -83.55 14.29 3.89 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.154 1.782 . . . . 0.0 113.562 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -71.69 168.21 18.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.88 1.672 . . . . 0.0 113.078 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.84 -35.97 82.84 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.503 -0.748 . . . . 0.0 112.747 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.68 125.98 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.761 0.709 . . . . 0.0 110.731 170.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -122.18 144.43 48.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.742 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -133.82 154.36 51.08 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.272 1.029 . . . . 0.0 112.463 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.15 125.08 34.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.073 0.949 . . . . 0.0 110.523 169.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -110.99 150.74 28.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.775 1.63 . . . . 0.0 110.354 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -119.57 47.1 1.77 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.18 1.792 . . . . 0.0 108.253 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -96.71 126.9 42.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.058 2.143 . . . . 0.0 112.303 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -84.26 147.61 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.159 1.784 . . . . 0.0 112.556 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.06 123.31 69.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.286 1.434 . . . . 0.0 112.066 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 122.946 2.431 . . . . 0.0 114.482 -175.061 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 120.957 0.408 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.62 -20.13 64.47 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 0.0 112.137 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.43 -31.58 72.74 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.012 -1.055 . . . . 0.0 110.218 168.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 t -72.62 -38.64 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.425 175.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.53 -49.14 73.41 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.164 1.347 . . . . 0.0 110.848 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.84 -15.86 63.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 m -87.12 -41.46 13.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.557 1.543 . . . . 0.0 112.744 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.05 -40.06 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.13 -1.606 . . . . 0.0 111.311 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -57.79 -42.2 83.68 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.53 65.82 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 123.701 0.667 . . . . 0.0 112.388 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -69.15 -39.07 79.02 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.596 -0.943 . . . . 0.0 111.879 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.46 -49.19 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.392 0.677 . . . . 0.0 110.388 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -56.96 -48.01 79.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.047 1.339 . . . . 0.0 112.725 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -68.26 -27.97 66.8 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.766 1.621 . . . . 0.0 112.33 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -71.35 -50.47 31.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.95 0.9 . . . . 0.0 111.567 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.477 HG21 ' HB3' ' A' ' 21' ' ' PHE . 31.2 m -59.83 -43.27 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.373 0.988 . . . . 0.0 112.6 170.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.07 -51.66 63.05 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 120.161 1.346 . . . . 0.0 112.393 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.667 0.667 . . . . 0.0 111.728 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.48 -48.03 76.76 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.24 0.616 . . . . 0.0 111.304 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.96 -43.93 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.924 0.784 . . . . 0.0 110.747 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.6 -25.8 66.79 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.19 -16.78 54.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -107.59 -26.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.252 1.421 . . . . 0.0 112.051 -179.862 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.819 -0.134 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -70.45 142.28 51.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.39 1.076 . . . . 0.0 111.809 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -110.92 129.34 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.478 1.111 . . . . 0.0 111.351 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.9 t -99.63 114.96 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.292 1.837 . . . . 0.0 110.085 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.6 tpp -94.85 128.46 41.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.434 0.561 . . . . 0.0 110.369 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -100.28 113.41 26.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.156 0.982 . . . . 0.0 110.591 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.44 137.59 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 p . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 110.944 171.523 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.4 p -71.2 -59.93 2.51 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -73.63 -26.75 60.92 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.637 -0.664 . . . . 0.0 111.859 -172.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.15 -37.41 69.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.22 95.4 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.609 0.641 . . . . 0.0 111.188 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -57.95 -43.97 86.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.115 0.87 . . . . 0.0 111.684 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.39 -50.98 60.47 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.409 1.004 . . . . 0.0 113.556 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -68.8 -40.82 79.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.208 -1.172 . . . . 0.0 111.705 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.39 95.67 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -71.46 -28.46 63.97 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.242 0.928 . . . . 0.0 112.386 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 m -79.18 -42.55 25.82 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.358 0.663 . . . . 0.0 111.77 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -90.14 -32.95 16.43 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.889 0.876 . . . . 0.0 112.716 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 10.66 68.22 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.885 1.707 . . . . 0.0 113.906 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.29 119.18 2.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.491 1.146 . . . . 0.0 111.615 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.98 13.22 83.91 Favored Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -120.2 -41.72 2.61 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.284 1.542 . . . . 0.0 111.423 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.59 159.3 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.894 1.677 . . . . 0.0 112.072 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.66 20.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.15 0.98 . . . . 0.0 109.193 169.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -141.64 141.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.009 -1.057 . . . . 0.0 112.925 -173.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 m -146.18 163.71 34.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.397 1.879 . . . . 0.0 109.514 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 p -140.61 153.54 46.1 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.785 -1.197 . . . . 0.0 112.542 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t -151.66 150.51 30.33 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.095 0.958 . . . . 0.0 111.215 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.01 134.35 9.81 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.24 1.4 . . . . 0.0 110.054 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 72.4 mt -50.34 -35.9 29.77 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.281 1.041 . . . . 0.0 112.907 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -118.69 28.95 8.0 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.953 1.701 . . . . 0.0 112.462 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 m 64.63 168.59 0.18 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.402 1.881 . . . . 0.0 114.124 -170.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t -164.33 173.58 12.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.454 1.102 . . . . 0.0 112.179 172.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -133.7 146.89 51.24 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.441 1.496 . . . . 0.0 113.099 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.2 m -64.82 140.23 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.411 0.624 . . . . 0.0 111.676 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -103.15 122.36 45.64 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.161 1.384 . . . . 0.0 111.584 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.8 -37.83 77.02 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.466 2.778 . . . . 0.0 115.305 -172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.6 m -64.39 -40.02 95.01 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.629 -0.67 . . . . 0.0 111.384 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.1 97.29 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.135 0.88 . . . . 0.0 111.664 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -54.8 -52.55 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 118.558 0.617 . . . . 0.0 109.554 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.79 82.91 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.6 mmt -67.56 -24.46 65.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.25 1.02 . . . . 0.0 113.198 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mmt -108.69 -19.59 13.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.02 -28.72 69.25 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.541 -1.349 . . . . 0.0 112.563 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.9 -8.31 53.64 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.172 -0.955 . . . . 0.0 113.347 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.85 3.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 127.153 2.181 . . . . 0.0 110.635 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 13.85 82.76 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.385 1.469 . . . . 0.0 114.762 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.3 mm -83.62 147.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 118.557 1.178 . . . . 0.0 111.184 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.74 126.42 52.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.978 1.711 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.86 -5.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 169.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.9 p -62.49 -27.02 68.85 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.09 1.314 . . . . 0.0 114.458 -169.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.54 -6.35 88.68 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.759 1.171 . . . . 0.0 115.476 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -84.7 149.14 26.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.27 1.535 . . . . 0.0 112.644 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 t -144.25 165.64 27.31 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.009 1.724 . . . . 0.0 109.618 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -132.76 144.19 50.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.163 0.985 . . . . 0.0 112.835 -171.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -139.76 159.8 63.55 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.112 1.765 . . . . 0.0 111.413 -171.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.91 138.5 79.34 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.632 2.888 . . . . 0.0 112.537 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.98 -29.49 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.44 -11.26 60.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -18.35 58.83 Favored 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.359 -0.838 . . . . 0.0 112.544 169.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -99.07 170.99 8.31 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.68 1.592 . . . . 0.0 112.238 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.62 113.61 18.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 110.749 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.89 -20.28 65.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -169.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.74 -27.34 68.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.078 0.951 . . . . 0.0 112.376 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.28 -3.22 58.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.133 1.773 . . . . 0.0 112.152 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -116.96 82.11 1.75 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.877 2.071 . . . . 0.0 108.108 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.21 -25.46 9.24 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.182 1.793 . . . . 0.0 113.138 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.69 131.28 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.108 1.763 . . . . 0.0 109.279 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -136.43 120.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 120.992 -1.068 . . . . 0.0 110.721 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.77 120.25 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 108.092 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -88.46 149.24 23.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.015 0.926 . . . . 0.0 110.078 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -123.7 30.78 6.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.127 0.971 . . . . 0.0 111.32 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -169.634 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 121.096 0.474 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.1 mt -74.76 136.57 73.88 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.217 -0.927 . . . . 0.0 112.188 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.68 150.86 86.56 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 122.35 2.033 . . . . 0.0 110.281 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.94 -22.0 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.353 2.702 . . . . 0.0 115.221 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.75 -13.52 61.74 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 96.9 m95 -91.89 -3.52 55.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.47 14.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.565 1.546 . . . . 0.0 113.425 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -120.65 -0.99 10.11 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.21 1.804 . . . . 0.0 112.996 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.485 HE22 ' HB1' ' A' ' 70' ' ' ALA . 13.7 mp0 -58.29 160.05 5.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.389 2.676 . . . . 0.0 114.138 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -63.81 -34.49 78.02 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.37 122.51 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.93 . . . . 0.0 109.086 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -124.25 146.74 48.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.188 1.395 . . . . 0.0 110.963 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -140.83 159.1 42.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.222 1.009 . . . . 0.0 112.437 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -132.22 117.14 17.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.681 1.192 . . . . 0.0 109.692 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -106.85 153.13 22.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.069 1.348 . . . . 0.0 111.586 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.08 79.86 1.75 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 110.379 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.62 152.46 18.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.024 1.33 . . . . 0.0 111.354 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -84.85 148.16 26.43 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.211 0.605 . . . . 0.0 109.445 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.04 130.73 59.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.556 -0.715 . . . . 0.0 112.143 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 CA--C 1.54 0.782 0 C-N-CA 121.908 1.739 . . . . 0.0 114.216 -177.127 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.9 -26.91 66.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.858 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.88 -39.1 93.41 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.935 -1.103 . . . . 0.0 110.415 169.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.65 -36.69 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.208 0.913 . . . . 0.0 111.587 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -55.42 -45.41 76.72 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.888 1.676 . . . . 0.0 110.529 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -69.46 -19.93 63.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.0 m -79.36 -52.41 8.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.761 1.224 . . . . 0.0 111.718 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.24 -33.34 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.338 1.055 . . . . 0.0 111.317 -172.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -56.67 -39.44 73.78 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.924 0.783 . . . . 0.0 112.765 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.23 65.9 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.079 0.847 . . . . 0.0 112.878 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -69.82 -39.36 76.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.092 0.946 . . . . 0.0 111.166 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.11 -47.57 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.813 0.845 . . . . 0.0 110.966 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.461 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -55.25 -47.7 75.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.187 1.395 . . . . 0.0 112.792 177.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -68.64 -27.46 66.03 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.651 1.568 . . . . 0.0 112.686 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -71.58 -49.44 40.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.064 0.945 . . . . 0.0 111.693 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.2 m -60.9 -41.1 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.947 0.794 . . . . 0.0 112.891 170.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -63.9 -51.69 63.33 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.15 1.341 . . . . 0.0 112.485 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -69.31 -30.14 68.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.914 0.779 . . . . 0.0 112.375 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.88 -49.74 71.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.966 0.907 . . . . 0.0 110.901 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.57 -39.94 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.182 -0.949 . . . . 0.0 110.585 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.27 -26.72 67.96 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -90.77 -18.12 25.48 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -104.37 -16.99 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.649 1.179 . . . . 0.0 112.935 178.785 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.5 2.057 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -71.29 143.48 50.31 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.151 0.98 . . . . 0.0 111.804 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.6 129.36 55.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.363 1.065 . . . . 0.0 111.469 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.45 116.28 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.452 1.901 . . . . 0.0 109.9 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -94.6 125.47 39.27 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 169.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -99.32 113.39 25.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.577 0.751 . . . . 0.0 111.275 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.07 144.06 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.392 1.077 . . . . 0.0 112.69 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 t . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 124.03 0.932 . . . . 0.0 111.583 171.559 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 p -64.5 -52.92 55.42 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.363 0.983 . . . . 0.0 111.213 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -63.49 -39.04 93.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.547 1.139 . . . . 0.0 111.643 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.2 tpt -77.25 -35.2 55.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.903 0.881 . . . . 0.0 112.312 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.48 95.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.459 0.572 . . . . 0.0 110.736 169.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.35 -43.81 98.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.933 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.56 -48.02 73.36 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.666 1.121 . . . . 0.0 113.705 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -66.44 -44.23 83.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.129 0.964 . . . . 0.0 111.739 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.36 75.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -27.67 64.09 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.423 1.011 . . . . 0.0 112.584 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 m -88.71 -41.65 12.45 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.908 0.883 . . . . 0.0 112.548 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.58 -34.63 14.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.7 0.8 . . . . 0.0 112.617 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.34 8.55 64.05 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.598 1.57 . . . . 0.0 113.696 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.36 117.85 1.94 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.341 1.071 . . . . 0.0 112.0 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.72 13.91 82.6 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -119.19 -40.14 2.85 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.165 1.482 . . . . 0.0 111.847 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.11 160.01 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.355 1.862 . . . . 0.0 110.998 171.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 150.86 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.466 0.707 . . . . 0.0 109.469 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -141.23 140.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.223 -0.923 . . . . 0.0 112.531 -173.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -144.4 159.49 42.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.205 1.802 . . . . 0.0 109.051 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.9 p -133.72 158.83 42.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 113.46 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.1 t -148.1 146.15 28.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.98 1.312 . . . . 0.0 111.192 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.01 139.25 15.17 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.5 mt -52.8 -42.96 65.57 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.019 1.909 . . . . 0.0 113.002 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.4 38.95 3.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.28 1.432 . . . . 0.0 110.89 171.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t 69.58 171.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.068 2.147 . . . . 0.0 114.302 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 t -157.91 -169.1 2.71 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.284 1.833 . . . . 0.0 110.038 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 167.7 21.58 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.87 166.49 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.402 1.081 . . . . 0.0 109.159 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -138.11 126.94 14.51 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.432 -1.418 . . . . 0.0 111.626 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.61 -40.22 85.96 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.926 2.417 . . . . 0.0 114.304 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.91 -34.3 77.81 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.243 -0.91 . . . . 0.0 111.273 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 -2.74 23.43 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.371 -1.456 . . . . 0.0 114.154 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -87.43 -54.78 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 167.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -28.85 61.65 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 73.2 mmm -78.27 -6.01 53.72 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.326 -0.859 . . . . 0.0 113.205 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.3 mmt -120.33 -26.36 5.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.71 1.204 . . . . 0.0 111.815 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.13 -20.52 65.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 112.439 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.07 -11.15 60.62 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 171.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 t -107.98 5.88 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 127.092 2.157 . . . . 0.0 110.622 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.07 14.04 82.63 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.561 -1.337 . . . . 0.0 114.396 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.21 154.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.999 1.32 . . . . 0.0 110.27 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.18 149.12 41.02 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.291 1.037 . . . . 0.0 110.957 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.3 pt -133.78 -2.1 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.171 1.789 . . . . 0.0 113.122 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -54.66 -37.91 66.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.598 1.159 . . . . 0.0 113.836 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.32 -1.2 90.37 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 116.145 1.218 . . . . 0.0 116.145 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -76.61 160.77 29.12 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.748 1.774 . . . . 0.0 113.319 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 57.9 p -135.24 167.52 20.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.713 2.005 . . . . 0.0 110.484 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 t -144.18 158.83 43.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.535 1.134 . . . . 0.0 111.376 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -150.95 163.71 22.77 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 126.352 1.861 . . . . 0.0 110.177 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -60.49 146.22 97.27 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.5 2.8 . . . . 0.0 113.566 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.16 -32.31 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.076 0.95 . . . . 0.0 113.486 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.46 -13.76 61.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -21.19 46.61 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.332 0.969 . . . . 0.0 113.354 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.77 169.46 10.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.054 1.342 . . . . 0.0 112.825 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.0 108.41 15.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 110.892 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.71 -20.3 65.94 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -169.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.68 -24.89 67.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.028 0.931 . . . . 0.0 112.533 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.57 -2.01 58.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.456 1.902 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.89 82.05 1.74 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.946 2.098 . . . . 0.0 108.11 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.35 -28.19 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.765 1.626 . . . . 0.0 113.004 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -130.15 130.29 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.893 1.677 . . . . 0.0 108.627 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -131.49 126.51 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.095 -1.003 . . . . 0.0 109.262 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.3 mm -126.72 133.92 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.697 1.199 . . . . 0.0 109.214 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.2 t -109.01 148.67 30.41 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.969 1.308 . . . . 0.0 112.098 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.21 55.55 1.66 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.974 1.31 . . . . 0.0 109.677 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -169.601 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.8 mt -141.74 140.28 19.82 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.386 1.074 . . . . 0.0 112.443 -175.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 151.5 82.51 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.252 1.968 . . . . 0.0 110.286 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.44 -26.91 79.93 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 115.535 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.512 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.0 m95 -89.16 -3.05 58.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.58 18.0 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.295 1.438 . . . . 0.0 113.352 -173.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -122.29 -0.7 9.3 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.402 1.881 . . . . 0.0 112.87 -172.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.4 mp0 -57.24 163.62 2.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.861 2.864 . . . . 0.0 113.987 174.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.09 -34.79 78.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -131.62 127.46 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.906 0.883 . . . . 0.0 111.037 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -137.28 140.3 41.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.492 1.517 . . . . 0.0 111.333 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -156.57 156.38 33.49 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.116 1.366 . . . . 0.0 111.006 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -113.78 142.85 45.55 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.876 1.27 . . . . 0.0 110.954 170.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -110.82 142.28 43.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.964 1.705 . . . . 0.0 111.572 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -104.73 59.59 0.7 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.957 1.703 . . . . 0.0 107.29 -169.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.02 132.0 53.44 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.422 1.889 . . . . 0.0 112.002 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -88.65 163.26 15.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.748 1.619 . . . . 0.0 112.869 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.66 138.82 37.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 122.1 -0.375 . . . . 0.0 111.136 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 CA--C 1.54 0.776 0 C-N-CA 122.342 2.028 . . . . 0.0 114.46 174.95 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.479 0.975 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.07 -27.7 68.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.148 0.979 . . . . 0.0 112.455 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.6 -25.83 61.47 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.692 -1.255 . . . . 0.0 111.85 169.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 71.3 t -75.37 -33.38 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.876 -1.14 . . . . 0.0 109.866 169.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.37 -44.63 92.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.035 1.743 . . . . 0.0 109.594 168.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.2 m -76.8 -54.03 7.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.487 0.715 . . . . 0.0 111.461 170.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.98 -34.8 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 0.0 111.344 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -57.85 -44.53 86.62 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 112.255 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.41 -29.65 67.9 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.691 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -67.55 -51.07 55.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.38 1.09 . . . . 0.0 110.256 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.6 t -57.44 -43.66 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.521 -0.737 . . . . 0.0 110.857 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.25 -48.65 73.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.709 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -72.8 -29.79 63.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.132 1.333 . . . . 0.0 113.504 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -63.74 -52.23 61.39 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.075 0.852 . . . . 0.0 109.937 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.49 -42.99 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.021 1.328 . . . . 0.0 112.546 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -61.69 -45.97 91.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.976 1.262 . . . . 0.0 111.633 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -38.39 89.22 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.535 0.607 . . . . 0.0 111.302 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.469 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -58.96 -51.13 71.39 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.898 0.879 . . . . 0.0 110.928 174.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.0 -44.3 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.651 0.66 . . . . 0.0 111.032 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.96 -23.52 66.44 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.6 pttt -94.17 -6.87 43.83 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -122.15 -17.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.168 1.787 . . . . 0.0 112.339 -178.822 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 111.244 0.091 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -69.1 133.49 48.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.835 1.254 . . . . 0.0 112.141 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -103.82 123.47 47.15 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.19 0.996 . . . . 0.0 111.129 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 111.0 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 126.104 1.762 . . . . 0.0 109.897 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.1 tpp -90.67 129.65 36.75 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.684 0.393 . . . . 0.0 110.091 168.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -100.0 124.67 45.62 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.727 0.811 . . . . 0.0 109.731 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.95 143.05 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.701 1.2 . . . . 0.0 112.525 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.4 t . . . . . 0 CA--C 1.544 0.75 0 C-N-CA 124.738 1.215 . . . . 0.0 110.369 175.611 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 . . . . . 0 C--O 1.216 -0.709 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -63.59 -52.96 58.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.788 1.235 . . . . 0.0 112.217 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -67.08 -34.89 78.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.272 0.629 . . . . 0.0 111.466 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.91 71.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.058 0.543 . . . . 0.0 112.313 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.71 86.67 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.508 -0.745 . . . . 0.0 112.698 173.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.15 -40.68 77.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.921 0.782 . . . . 0.0 111.896 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.27 -53.54 43.99 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-N 119.188 0.904 . . . . 0.0 112.961 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.47 ' HB3' HG21 ' A' ' 123' ' ' VAL . 43.2 m-85 -65.97 -40.97 91.71 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.243 -1.151 . . . . 0.0 111.881 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.81 94.27 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -76.41 -29.05 56.89 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.53 1.059 . . . . 0.0 112.624 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m -77.5 -43.57 31.71 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 0.0 111.647 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.51 -33.12 13.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.67 0.788 . . . . 0.0 112.491 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.5 11.82 57.6 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.671 1.605 . . . . 0.0 113.221 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.11 122.77 5.49 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.433 1.116 . . . . 0.0 111.551 171.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.01 8.8 87.3 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 116.029 1.172 . . . . 0.0 116.029 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -118.68 -31.04 4.96 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.649 1.724 . . . . 0.0 112.998 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.13 156.52 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 112.248 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.73 144.73 25.02 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.98 138.64 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.451 1.478 . . . . 0.0 113.487 -169.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 m -149.43 161.5 41.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.577 1.551 . . . . 0.0 110.274 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 p -137.4 150.62 47.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.314 1.054 . . . . 0.0 113.759 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 t -145.43 157.93 43.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.435 1.894 . . . . 0.0 110.099 -169.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.15 146.03 18.08 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.462 -0.774 . . . . 0.0 111.614 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -58.52 -42.68 88.26 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.976 0.888 . . . . 0.0 110.728 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.91 40.44 1.81 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.352 1.461 . . . . 0.0 111.287 173.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 t 65.17 178.56 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.407 1.883 . . . . 0.0 114.417 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -152.99 165.61 35.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 112.453 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.61 -179.82 6.54 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.76 -173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.75 113.61 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.065 0.946 . . . . 0.0 110.186 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.73 143.92 44.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.458 1.103 . . . . 0.0 110.993 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.87 -37.12 76.8 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.354 2.703 . . . . 0.0 113.857 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -61.21 -39.63 90.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.63 0.772 . . . . 0.0 112.17 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -13.21 60.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.8 mt -78.19 -53.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.43 64.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.8 mmt -70.47 -12.06 61.32 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 mmt -121.9 -28.64 4.42 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.269 1.028 . . . . 0.0 112.603 -169.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.35 -24.72 67.97 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.724 -1.235 . . . . 0.0 112.568 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.22 -10.73 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 11.5 p -121.38 26.2 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.188 1.795 . . . . 0.0 110.397 169.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.66 9.31 86.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.014 1.768 . . . . 0.0 116.774 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.06 147.76 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 118.84 1.32 . . . . 0.0 111.915 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.78 127.87 54.76 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.696 1.598 . . . . 0.0 111.506 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.0 pt -138.04 -6.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 p -64.19 -27.52 69.12 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.73 -1.231 . . . . 0.0 114.318 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.56 -6.72 89.16 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.594 1.092 . . . . 0.0 115.211 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -83.64 152.25 24.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.195 1.497 . . . . 0.0 113.116 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -145.32 177.62 8.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.481 1.912 . . . . 0.0 108.819 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -152.68 174.88 13.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.487 1.04 . . . . 0.0 113.765 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.87 163.14 28.62 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.937 2.095 . . . . 0.0 110.159 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.15 142.42 94.4 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.458 2.772 . . . . 0.0 113.247 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.97 -35.09 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.41 -11.81 60.22 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 CA--C 1.553 1.085 0 O-C-N 121.25 -0.906 . . . . 0.0 113.117 172.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -94.14 169.18 10.44 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.987 1.315 . . . . 0.0 112.832 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.23 107.47 12.59 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.411 1.484 . . . . 0.0 111.725 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.44 -20.16 65.47 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.42 -24.99 68.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.793 1.237 . . . . 0.0 112.895 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.74 -4.11 56.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.084 1.754 . . . . 0.0 112.106 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -114.7 82.97 1.81 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.452 1.901 . . . . 0.0 108.114 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -51.15 -26.9 7.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.857 1.663 . . . . 0.0 113.364 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -134.25 133.25 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.722 1.609 . . . . 0.0 109.287 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.62 121.19 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.866 -1.146 . . . . 0.0 110.91 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.08 124.19 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 108.522 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 t -91.19 152.29 20.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.666 1.586 . . . . 0.0 110.957 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.77 52.32 2.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.005 1.322 . . . . 0.0 110.028 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.84 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 121.359 0.6 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.52 139.01 41.11 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.926 0.891 . . . . 0.0 112.996 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -63.29 152.69 78.61 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.301 2.0 . . . . 0.0 109.662 168.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.18 -22.1 73.61 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.218 2.612 . . . . 0.0 115.384 -169.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.54 -14.29 61.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.493 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -91.92 -1.43 57.29 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.8 14.76 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.904 1.682 . . . . 0.0 113.757 -174.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -118.89 -0.96 11.1 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.246 1.819 . . . . 0.0 112.877 -171.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.471 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.7 mp0 -59.8 161.44 6.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.251 2.62 . . . . 0.0 113.897 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.03 -33.93 76.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.5 mt -132.9 127.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.791 0.836 . . . . 0.0 110.394 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -130.03 149.26 51.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.178 1.391 . . . . 0.0 111.568 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -144.83 161.12 40.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.758 1.223 . . . . 0.0 112.182 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.21 128.54 26.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 167.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -106.86 146.81 30.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.368 1.467 . . . . 0.0 111.379 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -107.83 59.3 0.62 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.4 1.88 . . . . 0.0 106.864 -173.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.56 117.32 33.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.493 1.917 . . . . 0.0 112.335 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.89 159.47 32.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.823 1.296 . . . . 0.0 113.64 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.21 118.8 70.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 126.568 1.947 . . . . 0.0 113.113 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 C-N-CA 121.887 1.725 . . . . 0.0 113.385 175.01 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.015 0.436 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.78 -30.03 71.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.833 1.253 . . . . 0.0 111.542 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -72.73 -23.8 60.89 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.741 -1.225 . . . . 0.0 112.301 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.94 -35.9 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.958 -1.089 . . . . 0.0 109.961 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.95 -47.63 84.38 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.656 1.571 . . . . 0.0 110.593 169.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -65.87 -21.85 66.49 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -80.03 -53.96 6.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.608 1.163 . . . . 0.0 111.845 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.79 -32.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.383 1.073 . . . . 0.0 111.343 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -57.17 -39.79 76.01 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.355 0.98 . . . . 0.0 113.016 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.65 -35.43 74.18 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.746 0.688 . . . . 0.0 112.171 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -68.59 -39.15 81.06 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.954 -0.733 . . . . 0.0 111.578 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.02 -49.08 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.637 170.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -56.13 -47.42 78.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.983 1.313 . . . . 0.0 112.417 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -69.18 -26.79 65.02 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.824 1.647 . . . . 0.0 112.624 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -72.98 -50.07 25.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.913 0.885 . . . . 0.0 111.299 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' A' ' 21' ' ' PHE . 34.8 m -59.79 -42.14 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.213 0.915 . . . . 0.0 112.565 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.24 -51.41 63.79 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.31 1.414 . . . . 0.0 112.464 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -31.97 70.71 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.917 0.781 . . . . 0.0 112.08 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.49 -48.44 75.17 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.425 0.69 . . . . 0.0 111.019 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.5 mt -72.95 -41.02 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.856 -174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.62 -26.25 68.59 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.83 -14.49 44.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.18 -23.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.601 1.56 . . . . 0.0 112.035 -179.478 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.0 tpp . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -70.22 150.67 46.19 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.178 0.899 . . . . 0.0 111.447 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.54 118.08 32.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 110.169 170.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.75 112.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.918 1.687 . . . . 0.0 109.584 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.3 ttm -95.1 122.34 37.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.851 0.75 . . . . 0.0 109.899 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -88.16 127.82 35.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.116 0.566 . . . . 0.0 109.982 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.97 145.94 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.686 1.194 . . . . 0.0 112.492 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 123.733 0.813 . . . . 0.0 111.801 -177.677 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.7 p -68.83 -43.14 76.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.408 1.003 . . . . 0.0 112.411 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.0 -35.03 71.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.719 0.808 . . . . 0.0 111.424 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.3 tpt -73.06 -37.63 66.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.063 1.345 . . . . 0.0 112.18 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.94 -44.87 91.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.25 0.477 . . . . 0.0 111.786 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -60.84 -38.83 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.379 -0.819 . . . . 0.0 111.823 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.62 72.89 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.113 1.324 . . . . 0.0 113.089 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -66.86 -44.43 81.02 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.169 -1.195 . . . . 0.0 111.81 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.44 72.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.778 -1.201 . . . . 0.0 114.05 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -72.23 -23.03 61.17 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.87 1.214 . . . . 0.0 112.867 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -86.07 -44.66 12.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.188 0.995 . . . . 0.0 112.037 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 mt -95.84 -35.85 11.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.23 1.012 . . . . 0.0 113.031 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.96 7.69 80.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.964 1.745 . . . . 0.0 113.575 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -38.93 -45.34 1.17 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.7 17.92 27.47 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.485 1.517 . . . . 0.0 114.787 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -116.63 -28.68 6.33 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.6 pt -157.59 163.97 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 127.603 2.361 . . . . 0.0 110.485 -171.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 147.03 24.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 167.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.5 145.43 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.745 -1.222 . . . . 0.0 113.62 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -148.88 157.97 43.82 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.791 2.036 . . . . 0.0 109.237 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.4 p -131.12 156.8 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.6 -1.312 . . . . 0.0 112.914 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -153.56 155.87 36.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.704 1.202 . . . . 0.0 109.793 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.3 145.46 18.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.31 -31.83 69.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.646 1.223 . . . . 0.0 111.913 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -123.33 35.48 4.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.161 1.785 . . . . 0.0 110.215 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t 71.36 170.37 0.32 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.142 1.777 . . . . 0.0 112.151 -168.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -155.63 -177.38 6.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.051 1.74 . . . . 0.0 110.966 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -144.76 178.39 8.03 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -113.15 140.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.375 1.47 . . . . 0.0 109.346 169.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -110.96 135.63 20.82 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.497 -1.239 . . . . 0.0 110.92 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.02 -36.69 85.18 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.294 2.662 . . . . 0.0 115.467 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -67.51 -31.88 72.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 120.9 -1.125 . . . . 0.0 111.779 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.88 -10.83 59.75 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.303 -1.498 . . . . 0.0 113.438 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.61 -58.89 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.41 -38.54 77.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.1 mmm -73.99 -6.69 48.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 mmt -118.01 -23.96 7.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.745 1.218 . . . . 0.0 111.516 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.88 -28.16 68.67 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.261 -0.9 . . . . 0.0 111.609 169.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.85 -5.61 42.07 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.48 1.06 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.412 2.285 . . . . 0.0 110.581 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.41 13.15 82.19 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.23 1.395 . . . . 0.0 114.553 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mm -89.29 152.01 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.47 1.135 . . . . 0.0 111.022 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -129.65 138.6 51.29 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 111.002 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 pt -135.8 -5.26 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -57.42 -33.11 67.54 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.26 -5.75 85.03 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -83.14 144.44 29.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.337 1.569 . . . . 0.0 112.873 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.3 p -133.79 171.72 13.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.845 2.058 . . . . 0.0 110.302 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.7 t -141.0 165.81 26.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.212 1.005 . . . . 0.0 112.398 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.25 155.02 30.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.61 1.564 . . . . 0.0 109.267 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.85 135.46 67.08 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.874 2.383 . . . . 0.0 113.215 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -54.52 -33.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -10.26 55.75 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -25.26 59.2 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.247 -0.908 . . . . 0.0 112.669 170.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.21 167.68 11.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.832 1.253 . . . . 0.0 112.499 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.94 115.86 30.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.122 1.369 . . . . 0.0 111.362 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.484 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -71.46 -19.31 62.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.09 -27.0 66.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.648 0.737 . . . . 0.0 112.304 -172.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.01 -10.88 57.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.037 1.735 . . . . 0.0 111.806 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -107.37 79.57 1.32 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 126.548 1.939 . . . . 0.0 108.786 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -66.13 -12.42 55.63 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -129.9 130.77 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.516 1.527 . . . . 0.0 109.169 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.4 t -134.14 128.77 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.134 -0.979 . . . . 0.0 109.512 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.8 121.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.253 1.021 . . . . 0.0 110.079 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -96.61 150.02 21.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 112.32 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.8 mp -126.27 35.13 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.829 1.252 . . . . 0.0 111.455 171.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 123.783 0.833 . . . . 0.0 112.98 -174.856 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.8 mt -142.37 139.81 18.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.534 -170.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -63.22 154.65 66.45 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.503 2.135 . . . . 0.0 110.188 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -58.36 -32.65 96.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.551 2.168 . . . . 0.0 114.691 -170.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 96.4 m95 -88.13 -3.25 58.91 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 m -118.81 -22.08 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.8 t -77.42 2.06 17.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.066 1.746 . . . . 0.0 114.514 -173.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.408 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.4 mp0 -49.64 158.26 0.47 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.497 2.319 . . . . 0.0 114.24 171.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.71 -33.37 73.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.34 126.51 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.419 1.087 . . . . 0.0 111.008 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -136.05 139.09 42.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.844 1.657 . . . . 0.0 110.255 169.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.95 157.83 39.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.636 1.174 . . . . 0.0 110.871 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -117.6 140.97 48.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.942 1.297 . . . . 0.0 110.571 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -108.63 140.15 42.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.582 1.553 . . . . 0.0 111.469 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.43 60.76 1.02 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.169 1.788 . . . . 0.0 106.495 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -107.64 124.56 50.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.073 2.149 . . . . 0.0 111.167 -167.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -81.27 157.98 24.96 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.324 1.05 . . . . 0.0 112.664 -172.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -95.07 123.81 56.08 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.592 1.157 . . . . 0.0 111.556 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.546 1.102 0 C-N-CA 122.56 2.173 . . . . 0.0 114.862 178.402 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.22 -24.15 66.14 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.144 -0.972 . . . . 0.0 111.365 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -66.38 -32.29 73.58 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.433 -0.792 . . . . 0.0 111.537 169.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.36 -39.18 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.94 -1.1 . . . . 0.0 110.425 173.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -59.03 -47.25 85.91 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.037 1.289 . . . . 0.0 111.289 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -68.23 -22.28 64.79 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.0 m -77.73 -57.34 3.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.97 -34.68 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 -171.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -55.88 -43.24 77.02 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.001 0.819 . . . . 0.0 112.953 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.04 -32.05 61.09 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.766 0.698 . . . . 0.0 112.051 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -68.44 -41.05 80.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.773 -0.84 . . . . 0.0 111.376 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.7 -49.11 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 0.0 110.174 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -54.42 -49.23 70.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.172 0.989 . . . . 0.0 112.202 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -71.57 -28.39 63.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.19 0.904 . . . . 0.0 112.696 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -72.16 -46.13 57.66 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.393 0.677 . . . . 0.0 111.181 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.6 t -58.05 -42.27 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.048 0.939 . . . . 0.0 111.289 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.06 -46.29 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.511 1.051 . . . . 0.0 111.935 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -40.45 95.99 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.58 0.627 . . . . 0.0 110.808 176.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.465 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -57.89 -51.24 70.41 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.215 1.006 . . . . 0.0 110.632 176.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.2 mt -70.6 -45.47 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.11 -26.0 68.05 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.9 pttt -91.21 -7.82 50.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.08 -16.71 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.883 1.673 . . . . 0.0 112.805 -175.782 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.39 138.94 49.55 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.192 0.906 . . . . 0.0 111.627 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -111.31 123.14 49.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.478 1.111 . . . . 0.0 111.161 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -93.21 107.08 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.875 1.67 . . . . 0.0 110.354 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -85.74 128.99 34.94 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.77 118.52 37.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.751 1.22 . . . . 0.0 108.727 169.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.3 136.18 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 0.0 111.163 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 174.263 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 p -65.71 -42.56 90.97 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.8 . . . . 0.0 111.736 169.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -64.14 -43.1 96.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.994 0.518 . . . . 0.0 112.175 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -39.54 91.63 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.454 -0.779 . . . . 0.0 111.874 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.21 -48.42 80.06 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.76 -38.73 75.9 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.597 0.635 . . . . 0.0 111.434 171.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.11 -62.38 6.19 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.106 1.336 . . . . 0.0 112.723 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -58.73 -33.61 70.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.004 1.402 . . . . 0.0 111.498 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.46 -30.36 64.5 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.684 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -73.99 -29.76 62.13 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.354 1.888 . . . . 0.0 112.771 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 m -74.98 -45.64 40.69 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.882 0.765 . . . . 0.0 112.22 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.3 -37.15 12.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.022 0.929 . . . . 0.0 112.588 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.82 2.18 60.44 Favored Glycine 0 N--CA 1.469 0.835 0 C-N-CA 125.527 1.537 . . . . 0.0 114.333 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 113.66 0.76 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.622 1.211 . . . . 0.0 111.724 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.1 19.96 79.79 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -124.0 -41.42 2.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.61 1.705 . . . . 0.0 112.383 -174.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -153.23 168.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.872 2.069 . . . . 0.0 110.424 177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.3 153.95 18.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 109.795 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.04 144.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.14 -0.975 . . . . 0.0 112.945 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -150.43 142.58 24.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.526 1.13 . . . . 0.0 110.721 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -103.52 148.62 25.73 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.188 1.395 . . . . 0.0 112.802 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -154.21 165.48 36.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 111.159 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.92 158.64 27.74 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -55.17 -36.8 66.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 118.124 0.962 . . . . 0.0 113.235 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.69 41.74 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.782 1.633 . . . . 0.0 109.651 169.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t 67.45 168.18 0.25 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.569 2.347 . . . . 0.0 115.983 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -137.92 170.61 15.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.708 2.403 . . . . 0.0 110.029 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -131.04 168.22 17.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -107.82 150.4 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.518 1.527 . . . . 0.0 108.164 169.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -136.92 133.41 18.7 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.888 -1.529 . . . . 0.0 109.94 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -52.98 -36.38 75.38 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.9 2.4 . . . . 0.0 115.139 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.1 m -69.36 -34.25 74.29 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.976 -1.078 . . . . 0.0 111.782 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.56 -13.29 60.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.031 -1.043 . . . . 0.0 113.184 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -77.69 -54.64 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.75 64.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -70.25 -9.84 57.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mmt -122.45 -29.89 4.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.449 1.1 . . . . 0.0 112.261 -169.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.59 -25.56 67.41 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.82 -1.175 . . . . 0.0 112.29 170.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.68 -13.88 62.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.274 1.03 . . . . 0.0 113.746 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.259 4.0 m -114.5 16.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.691 1.196 . . . . 0.0 111.604 168.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.03 73.36 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.036 1.779 . . . . 0.0 116.264 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.16 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.039 1.419 . . . . 0.0 112.05 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -129.16 121.38 27.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.27 3.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.351 1.46 . . . . 0.0 111.906 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -70.25 -34.11 72.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.572 -169.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.22 4.54 82.83 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.474 1.035 . . . . 0.0 114.645 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.78 156.68 26.81 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.08 1.44 . . . . 0.0 113.803 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -156.01 162.0 40.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.726 1.61 . . . . 0.0 110.21 173.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -103.26 172.51 6.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.904 1.281 . . . . 0.0 112.453 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -138.03 159.31 68.94 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.037 1.335 . . . . 0.0 109.981 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.78 138.06 83.57 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.336 2.691 . . . . 0.0 112.879 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 tt -58.1 -31.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.23 -11.13 60.68 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -20.95 57.75 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.246 -0.909 . . . . 0.0 112.642 171.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.28 167.56 11.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.79 1.236 . . . . 0.0 112.837 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.07 112.22 20.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.925 1.69 . . . . 0.0 110.358 175.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.502 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.23 -17.63 64.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.43 -26.06 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.183 0.993 . . . . 0.0 112.474 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.02 -1.3 57.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.913 1.685 . . . . 0.0 112.155 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -118.05 80.15 1.47 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.808 2.043 . . . . 0.0 108.115 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.05 -24.53 17.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.977 1.711 . . . . 0.0 113.186 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -134.28 130.65 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.789 1.635 . . . . 0.0 108.983 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.8 t -134.42 122.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.285 -0.884 . . . . 0.0 110.834 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.51 122.92 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.751 1.62 . . . . 0.0 108.899 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -88.9 144.54 26.13 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.243 1.417 . . . . 0.0 109.994 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.13 27.22 9.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.553 1.141 . . . . 0.0 111.781 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.799 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 121.61 0.719 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -74.58 140.22 75.07 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.076 0.95 . . . . 0.0 112.491 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.95 151.56 83.87 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.151 1.9 . . . . 0.0 109.774 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.89 -21.11 72.9 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.104 2.536 . . . . 0.0 115.463 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.27 -13.19 61.45 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.502 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 95.5 m95 -91.48 -1.85 57.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.21 17.52 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.605 1.562 . . . . 0.0 113.427 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 t -124.64 1.48 8.22 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.095 1.758 . . . . 0.0 113.023 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.472 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.1 mp0 -58.9 163.4 3.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.771 2.829 . . . . 0.0 113.986 176.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.41 -35.62 81.5 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.7 125.9 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.976 0.91 . . . . 0.0 109.985 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -125.59 147.22 49.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.256 1.423 . . . . 0.0 110.715 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -139.33 157.79 45.28 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.39 1.076 . . . . 0.0 112.505 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -135.97 126.65 27.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.764 1.226 . . . . 0.0 108.234 168.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -111.28 132.14 54.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.678 1.591 . . . . 0.0 110.218 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -92.38 64.15 4.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.159 1.383 . . . . 0.0 109.771 -171.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.03 144.82 25.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.569 1.548 . . . . 0.0 114.075 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -93.88 160.4 14.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.596 1.558 . . . . 0.0 111.0 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -106.31 126.39 30.6 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.083 0.953 . . . . 0.0 111.787 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo . . . . . 0 CA--C 1.543 0.952 0 C-N-CA 122.306 2.004 . . . . 0.0 113.64 -178.588 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.693 0.282 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.53 -21.61 64.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.002 -1.061 . . . . 0.0 112.079 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.72 -28.08 67.35 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.232 -0.917 . . . . 0.0 111.244 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.86 -41.19 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.938 -1.101 . . . . 0.0 110.309 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -56.81 -48.45 77.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.946 1.248 . . . . 0.0 111.145 169.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -69.57 -18.73 63.66 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.3 m -82.71 -52.29 6.91 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.183 1.393 . . . . 0.0 111.945 169.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.13 -34.53 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.461 1.105 . . . . 0.0 111.396 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -54.12 -42.57 69.61 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.835 0.743 . . . . 0.0 112.099 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.64 -31.42 65.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.67 0.653 . . . . 0.0 112.913 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.16 -41.18 70.74 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.141 0.971 . . . . 0.0 110.782 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.72 -47.47 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.426 0.69 . . . . 0.0 110.549 169.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.24 -50.4 67.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.922 1.289 . . . . 0.0 112.639 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -70.12 -26.43 63.96 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.787 1.176 . . . . 0.0 112.635 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -72.96 -51.08 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.213 1.005 . . . . 0.0 110.807 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.59 -47.54 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.263 1.025 . . . . 0.0 111.735 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -62.5 -51.75 66.2 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.697 1.135 . . . . 0.0 112.574 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.14 -31.4 68.89 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.125 0.875 . . . . 0.0 111.964 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.12 -50.04 73.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.475 0.71 . . . . 0.0 110.784 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.23 -38.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 121.369 -0.832 . . . . 0.0 111.375 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -25.51 67.2 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -91.23 -11.92 36.78 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.8 pt -114.14 -17.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.254 1.316 0 C-N-CA 125.582 1.553 . . . . 0.0 111.973 172.099 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttm . . . . . 0 N--CA 1.501 2.075 0 CA-C-O 119.786 -0.149 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -71.31 143.44 50.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.183 0.993 . . . . 0.0 112.028 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -110.06 122.84 48.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.71 109.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.532 1.533 . . . . 0.0 110.352 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 ttm -89.63 126.93 35.82 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.586 0.63 . . . . 0.0 109.59 169.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -95.56 124.25 39.49 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.021 1.329 . . . . 0.0 109.343 169.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.9 m -128.13 143.09 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.524 1.13 . . . . 0.0 112.554 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -174.987 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -66.28 -44.14 84.38 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.195 0.907 . . . . 0.0 111.995 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -65.2 -43.97 89.89 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.493 -0.754 . . . . 0.0 111.887 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -39.11 79.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.6 1.16 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.53 92.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.34 -38.46 77.21 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.428 -0.795 . . . . 0.0 110.732 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.73 -58.6 9.94 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.522 1.534 . . . . 0.0 113.943 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 123' ' ' VAL . 44.9 m-85 -65.23 -30.54 71.43 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.969 1.384 . . . . 0.0 111.982 174.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.53 -32.82 70.43 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.903 -1.123 . . . . 0.0 113.962 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -70.57 -26.89 63.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 121.315 1.871 . . . . 0.0 112.666 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.5 m -74.91 -46.47 35.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.663 0.785 . . . . 0.0 112.454 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.6 mt -98.75 -29.34 13.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -169.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.18 2.2 87.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.78 1.657 . . . . 0.0 113.229 170.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.13 116.22 1.46 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.406 1.103 . . . . 0.0 112.284 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.78 11.42 84.58 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -119.84 -38.04 3.02 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.16 1.48 . . . . 0.0 111.793 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 pt -148.28 161.68 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.539 1.936 . . . . 0.0 112.001 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.56 147.75 22.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.97 142.86 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.993 -1.067 . . . . 0.0 112.465 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -146.43 153.04 40.0 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 p -128.71 144.02 51.07 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.515 1.126 . . . . 0.0 112.615 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t -155.29 162.27 40.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.282 1.433 . . . . 0.0 110.268 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.37 154.36 20.31 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.04 -1.038 . . . . 0.0 111.403 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.05 -40.27 97.2 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.067 -1.255 . . . . 0.0 111.519 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -111.17 34.23 4.18 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.654 1.582 . . . . 0.0 109.625 169.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 t 71.44 170.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.546 1.938 . . . . 0.0 111.357 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.5 p -149.41 -162.52 1.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.598 1.559 . . . . 0.0 110.294 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -155.35 174.88 14.6 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.683 -1.261 . . . . 0.0 114.388 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.39 154.14 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -127.78 130.83 23.6 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.174 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -54.78 -39.61 88.87 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.991 2.461 . . . . 0.0 114.503 -173.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -67.56 -31.69 71.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.11 -10.33 59.33 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.678 -1.263 . . . . 0.0 113.127 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.6 -57.77 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.13 79.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 75.4 mmm -73.97 -8.5 56.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.1 mmt -118.15 -25.91 6.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.086 1.355 . . . . 0.0 111.76 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.9 -30.61 67.93 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.986 -1.071 . . . . 0.0 111.783 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.91 -11.08 60.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 t -100.9 3.03 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 126.606 1.962 . . . . 0.0 110.477 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.75 12.25 81.74 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.383 1.468 . . . . 0.0 114.848 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -87.45 148.12 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 118.494 1.147 . . . . 0.0 111.197 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -132.46 101.11 5.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.462 1.505 . . . . 0.0 111.21 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.4 pt -125.38 -4.13 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.3 p -63.94 -27.02 68.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.609 1.095 . . . . 0.0 113.546 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.39 -5.25 89.73 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.877 1.227 . . . . 0.0 115.311 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -78.47 157.93 28.79 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.522 1.661 . . . . 0.0 113.374 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -134.41 -177.61 4.68 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.858 2.063 . . . . 0.0 110.887 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 t -151.07 161.44 42.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.29 1.036 . . . . 0.0 112.047 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -147.6 160.01 39.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.173 1.789 . . . . 0.0 109.671 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.85 133.99 54.26 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.347 2.698 . . . . 0.0 111.955 174.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.47 -32.32 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -9.63 51.36 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -22.03 59.15 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.167 0.894 . . . . 0.0 112.605 170.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.88 171.57 8.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.851 1.261 . . . . 0.0 112.8 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.49 113.96 21.56 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.574 1.55 . . . . 0.0 111.074 176.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.14 -11.73 59.66 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.706 -1.247 . . . . 0.0 113.857 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.15 -20.88 57.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.838 1.255 . . . . 0.0 112.98 174.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -103.25 -0.63 30.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.117 1.767 . . . . 0.0 113.166 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -125.26 77.5 1.64 Allowed 'General case' 0 C--N 1.345 0.406 0 C-N-CA 125.799 1.639 . . . . 0.0 109.206 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.99 -23.57 13.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.085 2.154 . . . . 0.0 113.488 -175.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.74 133.81 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.768 1.627 . . . . 0.0 108.186 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.57 122.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.988 -1.07 . . . . 0.0 110.353 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.63 118.05 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 108.167 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -88.64 154.91 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.083 0.953 . . . . 0.0 109.856 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.07 46.59 2.48 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.079 1.351 . . . . 0.0 110.852 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t . . . . . 0 CA--C 1.544 0.72 0 C-N-CA 125.394 1.478 . . . . 0.0 111.868 179.253 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.1 t30 . . . . . 0 CA--C 1.548 0.867 0 CA-C-O 121.571 0.7 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -87.4 146.3 39.46 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -65.68 154.3 74.41 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 122.824 2.349 . . . . 0.0 110.153 168.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.72 -35.55 98.76 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.51 2.14 . . . . 0.0 115.668 -169.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.57 -23.76 67.18 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.086 -1.009 . . . . 0.0 113.355 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.4 -7.57 58.88 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.17 -22.82 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.25 1.42 . . . . 0.0 113.411 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -83.16 11.9 5.86 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.782 1.633 . . . . 0.0 113.508 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.65 165.92 11.65 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.767 1.627 . . . . 0.0 112.603 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.29 -36.51 83.91 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.659 -0.651 . . . . 0.0 112.726 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.7 130.0 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.861 0.865 . . . . 0.0 110.119 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -134.89 150.6 50.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.134 1.373 . . . . 0.0 111.873 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -141.74 158.04 44.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -139.63 81.17 1.81 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.668 0.787 . . . . 0.0 111.218 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -66.47 149.5 50.34 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.126 1.771 . . . . 0.0 113.127 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -114.04 60.6 0.67 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.339 1.856 . . . . 0.0 107.858 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -100.57 134.68 43.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.169 2.187 . . . . 0.0 112.527 -168.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.44 140.24 56.36 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.335 1.854 . . . . 0.0 112.644 -173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -93.04 112.06 54.39 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 CA--C 1.542 0.905 0 C-N-CA 122.471 2.114 . . . . 0.0 113.496 -178.964 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.373 0.606 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.02 -24.97 66.86 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.164 -0.96 . . . . 0.0 111.676 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.84 -28.33 69.49 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.161 -0.962 . . . . 0.0 111.796 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 -39.92 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.463 -1.398 . . . . 0.0 109.484 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -63.18 -36.55 84.01 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.433 1.015 . . . . 0.0 112.166 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -77.57 -20.8 53.47 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.125 -1.609 . . . . 0.0 113.827 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.3 m -91.73 -39.58 11.73 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.967 0.907 . . . . 0.0 111.63 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.8 p -59.27 -42.7 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 120.404 -1.435 . . . . 0.0 111.797 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -59.83 -43.34 94.63 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -32.05 65.51 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.849 -0.532 . . . . 0.0 112.828 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.37 -39.14 81.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.888 0.844 . . . . 0.0 112.064 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.64 -51.47 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.58 0.752 . . . . 0.0 109.91 169.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -57.19 -47.0 82.35 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.359 1.064 . . . . 0.0 112.61 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -68.73 -27.06 65.6 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.773 1.624 . . . . 0.0 112.531 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -73.16 -51.43 17.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 111.655 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 21' ' ' PHE . 34.4 m -59.52 -41.05 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.115 0.871 . . . . 0.0 112.761 169.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.84 -50.32 69.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.701 1.591 . . . . 0.0 112.389 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -70.61 -30.0 66.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.905 0.775 . . . . 0.0 112.063 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -50.0 70.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.698 0.799 . . . . 0.0 110.815 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -69.78 -41.17 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.274 -0.891 . . . . 0.0 110.705 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.65 -26.38 68.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.31 -14.79 34.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.9 pt -111.58 -18.3 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.543 1.137 . . . . 0.0 113.154 179.058 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -71.56 140.85 50.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.779 0.832 . . . . 0.0 111.851 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -111.09 126.46 54.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.325 1.05 . . . . 0.0 111.28 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.12 107.63 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.208 1.803 . . . . 0.0 109.826 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -87.64 127.9 35.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.141 0.428 . . . . 0.0 109.989 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.11 114.71 28.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.5 1.12 . . . . 0.0 109.69 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -111.46 136.26 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.699 1.2 . . . . 0.0 112.524 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.474 0.744 0 O-C-N 121.206 -0.934 . . . . 0.0 112.577 178.644 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -62.3 -46.17 89.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.298 1.039 . . . . 0.0 111.621 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.04 -40.4 78.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.554 1.142 . . . . 0.0 111.979 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.7 mmm -68.6 -36.91 79.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.436 -0.79 . . . . 0.0 112.745 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.68 95.89 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.001 0.819 . . . . 0.0 111.451 173.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -60.46 -39.75 88.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.899 0.772 . . . . 0.0 111.323 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.55 -60.96 7.53 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.975 1.274 . . . . 0.0 112.894 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -60.31 -34.01 73.19 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.554 1.177 . . . . 0.0 111.734 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.12 -27.16 61.52 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 117.839 -1.077 . . . . 0.0 113.884 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -75.42 -28.66 59.47 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.295 1.861 . . . . 0.0 112.656 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -76.05 -45.99 31.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.623 0.769 . . . . 0.0 112.267 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.16 -30.36 12.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.436 1.094 . . . . 0.0 113.267 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.0 4.98 81.51 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.94 1.733 . . . . 0.0 113.692 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.69 109.33 0.19 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.553 1.176 . . . . 0.0 112.813 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.61 19.41 79.7 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -118.48 -37.2 3.35 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.079 1.439 . . . . 0.0 112.08 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -152.28 166.58 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.051 2.541 . . . . 0.0 109.82 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.57 151.27 21.39 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.385 0.674 . . . . 0.0 109.737 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 142.1 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.039 -1.038 . . . . 0.0 112.666 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 m -149.28 154.91 39.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.92 1.288 . . . . 0.0 110.578 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 p -127.11 145.61 50.68 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.61 1.164 . . . . 0.0 112.598 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -148.46 146.5 28.42 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.859 1.264 . . . . 0.0 111.243 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.87 143.05 17.64 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.5 -38.57 66.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.587 1.694 . . . . 0.0 112.604 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -122.74 45.44 2.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.789 1.635 . . . . 0.0 110.307 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.2 p 68.99 143.62 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.434 3.094 . . . . 0.0 116.776 -170.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -107.69 171.39 7.42 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.644 2.378 . . . . 0.0 111.566 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -141.3 144.17 34.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.916 1.286 . . . . 0.0 112.496 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.26 152.73 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.093 1.757 . . . . 0.0 110.75 171.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.48 149.82 68.62 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.522 1.129 . . . . 0.0 111.776 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.08 -35.83 74.02 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.404 2.736 . . . . 0.0 114.224 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -63.54 -39.39 94.29 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.492 -0.755 . . . . 0.0 112.006 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.72 -20.57 61.18 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.171 -0.956 . . . . 0.0 112.808 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.94 -54.26 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.14 67.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -170.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -69.72 -9.67 55.34 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 mmt -125.85 -28.89 3.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.309 1.044 . . . . 0.0 112.499 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.28 -24.85 67.52 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.868 -1.145 . . . . 0.0 112.101 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.35 -13.68 62.45 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.74 15.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.974 1.31 . . . . 0.0 111.641 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.94 10.94 71.14 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.957 1.742 . . . . 0.0 116.176 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -84.9 146.76 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.404 1.602 . . . . 0.0 111.958 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -116.13 129.34 56.28 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.79 1.636 . . . . 0.0 111.96 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.0 pt -135.29 -8.94 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.943 1.297 . . . . 0.0 113.707 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -60.29 -30.64 69.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.869 1.268 . . . . 0.0 114.094 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.33 1.9 84.66 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.76 1.171 . . . . 0.0 115.353 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -77.56 156.75 30.7 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.77 1.785 . . . . 0.0 112.674 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.3 p -133.25 175.43 9.41 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.564 1.946 . . . . 0.0 110.231 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -155.91 155.55 33.04 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -148.45 159.2 39.48 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.231 2.212 . . . . 0.0 109.472 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -55.38 143.11 78.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.389 2.726 . . . . 0.0 113.127 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.74 -31.49 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -169.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -13.7 60.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -20.01 58.53 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 119.084 0.856 . . . . 0.0 112.926 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -96.33 164.35 12.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.943 1.297 . . . . 0.0 112.625 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.11 109.71 19.24 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 111.348 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.88 -22.06 65.99 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.24 -25.61 68.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.696 1.198 . . . . 0.0 112.834 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.15 -3.07 58.74 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.993 1.717 . . . . 0.0 112.103 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -116.17 82.26 1.75 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.887 2.075 . . . . 0.0 108.428 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -25.52 21.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.835 1.654 . . . . 0.0 113.079 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.6 t -132.97 129.78 57.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.079 1.752 . . . . 0.0 109.085 -176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.61 120.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.196 -0.94 . . . . 0.0 110.719 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.51 120.46 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.169 1.388 . . . . 0.0 108.159 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -86.02 150.29 24.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.42 1.088 . . . . 0.0 109.721 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.83 44.09 3.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.082 1.353 . . . . 0.0 110.522 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.983 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.0 mt -140.26 133.81 15.2 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.388 1.475 . . . . 0.0 111.027 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -60.39 152.27 68.5 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.293 1.995 . . . . 0.0 110.243 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.13 -21.84 73.17 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.035 2.49 . . . . 0.0 114.912 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -15.56 62.73 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.6 m95 -90.26 -3.16 57.98 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.15 13.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.674 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -118.12 -1.2 11.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.493 1.917 . . . . 0.0 112.775 -171.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.434 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.4 mp0 -56.05 159.67 3.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.587 2.755 . . . . 0.0 113.89 175.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.28 -34.98 79.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.22 129.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.172 0.989 . . . . 0.0 110.368 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -130.62 148.19 52.39 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.423 1.489 . . . . 0.0 111.29 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -142.0 161.75 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.759 1.224 . . . . 0.0 112.554 176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.08 124.24 21.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.85 1.26 . . . . 0.0 109.102 168.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -110.85 160.32 16.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.206 1.802 . . . . 0.0 112.4 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -122.79 50.6 1.5 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.475 1.51 . . . . 0.0 112.333 -168.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.19 137.52 36.7 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.229 -0.92 . . . . 0.0 112.636 -172.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 146.5 52.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.863 1.265 . . . . 0.0 108.556 169.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.46 119.22 65.66 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.95 0.9 . . . . 0.0 111.024 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 C-N-CA 122.143 1.895 . . . . 0.0 113.447 -177.317 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.043 0.449 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.91 -30.09 70.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.47 1.108 . . . . 0.0 111.646 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.98 -21.42 63.24 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.671 -1.268 . . . . 0.0 113.12 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.7 t -71.2 -40.52 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 120.36 -1.463 . . . . 0.0 110.102 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -56.83 -46.68 81.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.571 1.078 . . . . 0.0 110.826 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -68.77 -17.86 64.11 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.8 m -87.67 -43.47 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.912 1.285 . . . . 0.0 112.236 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -66.76 -38.74 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.703 -1.248 . . . . 0.0 111.501 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -57.46 -40.2 77.97 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.34 64.94 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.431 0.539 . . . . 0.0 112.881 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -68.76 -43.59 75.49 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.957 -0.731 . . . . 0.0 110.978 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.5 t -58.81 -47.49 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.747 -0.596 . . . . 0.0 110.414 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -57.12 -50.71 71.97 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.678 1.191 . . . . 0.0 112.422 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.19 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.878 1.217 . . . . 0.0 112.794 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -68.42 -50.72 50.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.472 0.709 . . . . 0.0 110.924 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.34 -48.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.646 1.178 . . . . 0.0 112.174 169.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -62.52 -50.82 69.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.832 1.196 . . . . 0.0 112.475 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -30.19 67.43 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.772 0.715 . . . . 0.0 111.899 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.43 -50.82 68.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.697 0.799 . . . . 0.0 110.613 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -70.74 -39.98 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.22 0.918 . . . . 0.0 111.165 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 -20.6 60.84 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -97.64 -10.9 24.25 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -113.55 -17.64 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 126.21 1.804 . . . . 0.0 112.499 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -71.42 144.07 49.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.063 0.945 . . . . 0.0 111.702 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.18 128.39 55.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.109 0.964 . . . . 0.0 111.284 170.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.66 118.33 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.249 1.819 . . . . 0.0 110.221 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.2 tpp -96.95 122.7 40.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -95.56 114.95 26.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.421 0.689 . . . . 0.0 110.438 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.91 147.06 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.45 1.1 . . . . 0.0 113.46 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.63 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.536 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.1 p -71.99 -40.44 68.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.535 1.061 . . . . 0.0 112.83 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.31 -32.15 71.1 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.91 0.777 . . . . 0.0 111.145 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -43.18 80.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.04 1.291 . . . . 0.0 112.378 169.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -43.52 97.02 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.266 0.485 . . . . 0.0 110.922 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.76 -43.71 97.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.817 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -44.86 96.67 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 119.805 1.184 . . . . 0.0 113.79 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.93 -37.9 76.03 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.444 -1.033 . . . . 0.0 111.14 171.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.47 -34.2 65.24 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.697 -1.252 . . . . 0.0 113.67 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.86 -22.52 64.21 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.908 1.231 . . . . 0.0 112.63 171.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 m -88.8 -46.88 8.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.814 1.246 . . . . 0.0 112.262 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.62 -33.45 12.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 112.886 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 5.76 77.67 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.939 1.733 . . . . 0.0 113.059 170.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.38 120.62 4.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.349 1.075 . . . . 0.0 111.433 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.95 77.88 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -110.42 -40.82 4.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.339 1.455 . . . . 0.0 111.045 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -148.6 159.35 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 112.762 -171.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.61 151.27 19.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.122 1.369 . . . . 0.0 107.53 168.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 t -139.9 139.88 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 120.89 -1.131 . . . . 0.0 112.177 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -141.6 154.68 45.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.677 1.591 . . . . 0.0 109.865 170.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.3 p -124.11 152.35 42.86 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.084 -1.01 . . . . 0.0 112.126 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 t -151.01 124.54 8.98 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.433 0.693 . . . . 0.0 112.717 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.24 127.14 8.64 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.98 -35.12 23.24 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -169.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -123.0 34.56 5.1 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.234 1.414 . . . . 0.0 112.605 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 p 66.99 161.83 0.17 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 127.759 2.423 . . . . 0.0 115.499 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -161.58 -163.52 1.0 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.165 1.386 . . . . 0.0 111.528 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -133.16 173.25 11.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.241 1.817 . . . . 0.0 113.21 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 t -85.55 167.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -129.43 125.71 22.59 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 120.337 -1.477 . . . . 0.0 111.714 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -55.79 -40.17 86.76 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.176 2.584 . . . . 0.0 114.651 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -64.42 -30.32 71.36 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.117 -0.989 . . . . 0.0 111.859 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.36 -5.43 52.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.3 mt -86.14 -57.05 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 168.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.11 75.34 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -170.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.4 -9.34 58.0 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 mmt -119.12 -27.85 5.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.127 0.971 . . . . 0.0 112.34 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.92 -30.38 65.87 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.786 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.8 -10.64 59.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.811 1.244 . . . . 0.0 113.923 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 8.5 p -121.77 24.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.932 1.693 . . . . 0.0 110.829 169.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.6 83.46 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.211 1.863 . . . . 0.0 116.63 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.22 147.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.789 1.295 . . . . 0.0 111.76 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -131.63 107.82 9.09 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.191 1.796 . . . . 0.0 110.597 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 pt -140.22 15.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 p -60.05 -27.64 67.11 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.698 -1.251 . . . . 0.0 113.825 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.08 9.22 39.36 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.161 1.362 . . . . 0.0 116.153 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -65.09 -50.58 65.55 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.264 2.032 . . . . 0.0 114.203 -169.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p 58.71 167.27 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.245 1.818 . . . . 0.0 114.38 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -144.63 131.15 19.87 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.027 -1.046 . . . . 0.0 112.166 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -132.53 158.61 75.23 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.001 1.721 . . . . 0.0 112.289 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.06 145.14 89.18 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.478 2.785 . . . . 0.0 113.524 -170.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.52 -34.23 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -169.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.52 -7.0 50.07 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -20.47 55.79 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.294 -0.879 . . . . 0.0 112.133 169.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -94.99 170.21 9.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.182 1.393 . . . . 0.0 112.264 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.22 111.69 18.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.974 1.71 . . . . 0.0 110.535 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -65.46 -23.05 66.82 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -169.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.29 -25.14 67.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.92 0.888 . . . . 0.0 112.758 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.73 -2.75 58.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.224 1.81 . . . . 0.0 111.946 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.9 84.65 2.11 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.117 2.167 . . . . 0.0 108.022 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.86 -28.05 8.73 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.055 1.742 . . . . 0.0 112.725 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.56 130.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.832 1.653 . . . . 0.0 109.003 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.1 t -131.5 126.99 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.297 -0.877 . . . . 0.0 109.097 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -126.2 124.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.464 1.106 . . . . 0.0 108.904 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -99.35 156.4 17.02 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.113 0.965 . . . . 0.0 111.599 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.24 52.88 2.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 110.937 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.3 m . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 125.26 1.424 . . . . 0.0 114.763 -170.758 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.63 138.63 20.42 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.119 0.967 . . . . 0.0 112.914 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.99 151.76 82.97 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.483 2.122 . . . . 0.0 109.896 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -57.57 -29.97 86.9 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 115.255 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.73 -19.58 65.95 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.8 m95 -89.77 -3.45 58.15 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.75 -12.83 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -88.52 5.5 42.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.696 1.599 . . . . 0.0 113.765 -171.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.438 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.0 mp0 -59.23 160.43 6.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.146 2.179 . . . . 0.0 113.878 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.98 -33.24 75.28 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 127.06 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.834 0.854 . . . . 0.0 110.36 169.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -138.28 141.43 39.85 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.777 1.631 . . . . 0.0 111.127 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.96 162.44 38.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.405 1.482 . . . . 0.0 110.72 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -128.85 124.67 35.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.571 1.148 . . . . 0.0 111.581 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -102.89 161.67 13.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.197 1.799 . . . . 0.0 113.091 -172.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -95.64 -82.06 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.528 1.131 . . . . 0.0 111.496 -170.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 55.09 156.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.3 2.64 . . . . 0.0 115.853 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -90.25 178.05 6.26 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -117.74 117.84 35.46 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.462 -1.399 . . . . 0.0 111.209 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 C-N-CA 121.449 1.433 . . . . 0.0 113.261 179.798 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -58.48 -32.9 69.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.353 1.461 . . . . 0.0 111.295 176.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.19 -29.62 70.45 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 0.0 112.374 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.5 t -72.34 -42.21 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.907 -1.12 . . . . 0.0 110.263 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -58.8 -48.16 82.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.331 0.969 . . . . 0.0 111.56 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -69.83 -20.61 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.7 m -78.88 -56.01 4.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.591 1.156 . . . . 0.0 110.925 169.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.19 -35.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 0.0 111.387 -171.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.77 -42.77 72.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.828 0.74 . . . . 0.0 112.84 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.03 -34.75 61.55 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.808 0.718 . . . . 0.0 112.712 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -70.39 -41.47 72.97 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.457 0.629 . . . . 0.0 110.588 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.64 -45.82 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.651 -0.655 . . . . 0.0 110.975 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -55.28 -50.08 70.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.163 0.985 . . . . 0.0 111.788 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.29 -29.44 66.18 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.862 1.21 . . . . 0.0 113.013 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -68.6 -49.85 56.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.453 0.701 . . . . 0.0 111.196 173.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.64 -41.31 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.833 1.253 . . . . 0.0 111.731 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -62.04 -47.27 85.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.529 1.059 . . . . 0.0 112.131 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -38.77 92.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.553 0.615 . . . . 0.0 111.092 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.48 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.7 tm? -59.25 -53.52 57.38 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.5 1.12 . . . . 0.0 110.598 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.82 -42.34 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 118.754 0.706 . . . . 0.0 111.384 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.15 70.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -90.89 -20.1 22.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.4 -24.93 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 124.919 1.288 . . . . 0.0 114.273 -169.637 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 tpp . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.656 -0.211 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -68.9 135.5 51.13 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.668 1.187 . . . . 0.0 112.467 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -108.96 128.24 54.76 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.942 0.897 . . . . 0.0 111.862 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.31 120.69 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.871 1.668 . . . . 0.0 110.051 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.5 tpp -99.62 126.84 45.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -98.4 123.44 42.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.223 0.609 . . . . 0.0 111.197 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 m -125.84 141.64 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.22 1.008 . . . . 0.0 113.004 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t -153.56 -174.48 4.97 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 121.404 -0.81 . . . . 0.0 112.357 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -72.23 164.99 25.32 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.085 1.754 . . . . 0.0 112.509 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.74 -47.36 70.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.795 1.638 . . . . 0.0 115.188 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -92.31 5.81 49.18 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.1 m -85.75 151.64 23.68 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.083 1.353 . . . . 0.0 113.315 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.9 p -111.89 -11.89 13.84 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.492 1.117 . . . . 0.0 113.605 169.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -62.0 -24.13 66.85 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.249 -1.532 . . . . 0.0 114.407 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 p -66.4 -48.06 71.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.124 1.329 . . . . 0.0 111.232 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.77 -39.07 93.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.298 1.439 . . . . 0.0 111.719 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -40.53 77.15 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.944 1.297 . . . . 0.0 112.018 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.97 95.46 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.651 -0.656 . . . . 0.0 112.427 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -58.79 -41.08 85.86 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.789 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.7 -52.82 45.81 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.484 1.038 . . . . 0.0 113.25 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -65.3 -41.16 94.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.083 -1.246 . . . . 0.0 111.801 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.27 87.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -73.17 -20.93 60.8 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.536 1.062 . . . . 0.0 113.028 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -87.92 -44.84 10.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.225 1.01 . . . . 0.0 112.187 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.02 -37.58 10.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.213 1.005 . . . . 0.0 112.819 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.94 6.96 68.1 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.653 1.597 . . . . 0.0 113.99 170.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.27 -43.4 4.86 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.5 16.18 48.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.583 1.563 . . . . 0.0 114.651 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.09 -34.08 3.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.034 1.333 . . . . 0.0 112.477 -169.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -152.98 165.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.678 1.591 . . . . 0.0 113.149 -173.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.77 153.77 17.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 167.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.19 143.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.278 -1.514 . . . . 0.0 114.615 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.82 168.07 20.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.473 1.909 . . . . 0.0 108.933 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -140.49 153.7 46.32 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.859 -1.15 . . . . 0.0 112.167 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 p -153.82 -175.27 5.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.525 1.13 . . . . 0.0 110.186 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.14 166.53 26.68 Favored Glycine 0 N--CA 1.471 1.016 0 O-C-N 120.836 -1.165 . . . . 0.0 113.15 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.09 -38.34 85.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 122.013 -0.698 . . . . 0.0 112.076 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.21 40.6 3.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.125 1.77 . . . . 0.0 109.135 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t 73.84 178.09 0.23 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.661 2.384 . . . . 0.0 113.71 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -144.84 174.75 10.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.348 2.259 . . . . 0.0 110.935 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.4 ptt85 -140.37 158.45 44.0 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.16 156.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -135.15 131.05 19.57 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-O 117.38 -1.295 . . . . 0.0 111.386 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -55.46 -39.52 90.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.131 2.554 . . . . 0.0 114.721 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -67.65 -30.38 69.92 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.041 -1.037 . . . . 0.0 111.784 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.25 -10.14 59.19 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.824 -1.172 . . . . 0.0 113.432 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.74 -55.04 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.19 62.8 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -73.57 -9.69 58.94 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.2 mmt -121.79 -28.47 4.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.502 1.121 . . . . 0.0 112.311 -171.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -21.56 66.73 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.135 -0.978 . . . . 0.0 112.895 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.34 -11.09 60.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.4 1.08 . . . . 0.0 113.28 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -102.64 0.63 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 126.86 2.064 . . . . 0.0 110.452 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.71 13.77 79.2 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.143 1.354 . . . . 0.0 114.474 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mm -87.58 152.39 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.449 1.099 . . . . 0.0 110.96 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -127.68 137.33 52.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.975 1.31 . . . . 0.0 111.429 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 pt -139.56 -7.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.402 1.081 . . . . 0.0 113.551 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -57.22 -35.07 69.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.836 1.654 . . . . 0.0 114.973 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.78 -3.17 88.28 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.366 0.984 . . . . 0.0 115.293 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -78.76 157.96 28.36 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.037 1.418 . . . . 0.0 113.707 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -132.74 175.27 9.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.024 2.13 . . . . 0.0 111.287 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.4 t -154.09 156.48 37.34 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.164 0.985 . . . . 0.0 112.775 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -142.59 161.8 47.72 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.643 1.977 . . . . 0.0 108.598 169.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.99 135.64 70.04 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.844 2.363 . . . . 0.0 112.577 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 tt -53.85 -33.33 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.36 -12.28 61.47 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.86 59.0 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.114 0.87 . . . . 0.0 112.309 169.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.11 171.95 8.75 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.15 1.38 . . . . 0.0 112.07 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -98.11 -17.12 19.25 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -168.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.531 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . 60.15 -29.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.085 2.954 . . . . 0.0 116.947 -170.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.75 -36.25 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 113.07 -169.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -81.58 -0.7 43.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 111.909 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -112.25 77.83 1.08 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.714 2.006 . . . . 0.0 108.442 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.98 -24.17 8.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.07 1.748 . . . . 0.0 113.236 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.07 130.19 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.072 1.749 . . . . 0.0 108.778 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.78 121.61 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.661 -1.274 . . . . 0.0 110.29 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.58 120.22 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.072 1.349 . . . . 0.0 108.345 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -89.16 157.04 18.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.852 1.261 . . . . 0.0 109.667 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.46 43.19 3.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.442 1.097 . . . . 0.0 111.563 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.9 m -108.15 -28.93 9.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.878 1.271 . . . . 0.0 112.151 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.47 100.36 1.06 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.985 1.755 . . . . 0.0 113.666 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 67.8 m 49.17 34.02 5.56 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.65 1.58 . . . . 0.0 114.647 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.03 105.18 0.18 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.758 1.171 . . . . 0.0 112.464 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 p -142.38 143.76 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.266 1.426 . . . . 0.0 111.15 174.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -89.35 114.25 25.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.435 0.694 . . . . 0.0 109.627 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.3 mt -142.41 138.0 16.04 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.47 1.108 . . . . 0.0 112.951 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -62.6 149.55 90.7 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.681 2.254 . . . . 0.0 110.664 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.83 -34.26 84.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.13 2.553 . . . . 0.0 115.121 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -63.04 -20.39 65.28 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.531 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 94.2 m95 -88.61 -6.34 57.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.32 1.448 . . . . 0.0 114.619 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.7 m -117.26 -20.81 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 -1.67 28.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.998 1.719 . . . . 0.0 114.243 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -49.88 155.98 0.8 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.031 2.532 . . . . 0.0 114.547 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.24 -34.1 73.21 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.61 128.5 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.63 1.172 . . . . 0.0 109.344 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.14 147.79 50.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.213 1.405 . . . . 0.0 111.239 171.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -141.77 159.49 42.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.045 1.338 . . . . 0.0 111.289 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -141.26 87.41 2.08 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.824 0.85 . . . . 0.0 110.318 169.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -67.29 140.74 57.34 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 113.477 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -91.17 55.25 2.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.959 2.104 . . . . 0.0 107.607 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.65 125.12 49.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.635 1.974 . . . . 0.0 111.117 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.45 162.19 22.18 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.541 1.536 . . . . 0.0 112.382 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.04 128.75 42.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 O-C-N 121.5 -0.75 . . . . 0.0 111.076 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.23 -12.56 19.14 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.84 1.693 . . . . 0.0 112.55 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -49.41 126.72 13.78 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.462 1.028 . . . . 0.0 112.705 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.01 0.04 59.57 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 115.623 1.009 . . . . 0.0 115.623 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -101.74 -174.85 2.69 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.239 1.416 . . . . 0.0 112.29 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 t -76.3 156.58 33.3 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.481 0.712 . . . . 0.0 111.94 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.3 -25.49 68.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.929 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.0 -30.45 71.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.301 -0.874 . . . . 0.0 111.571 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.37 -40.88 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.91 -1.119 . . . . 0.0 110.541 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -57.23 -48.49 78.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.034 1.288 . . . . 0.0 111.275 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -69.36 -18.94 63.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.1 m -82.06 -55.55 4.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.838 1.255 . . . . 0.0 111.541 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.57 -29.57 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.093 0.957 . . . . 0.0 111.675 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -55.62 -42.75 75.38 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.533 1.06 . . . . 0.0 113.37 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 -32.38 62.89 Favored Glycine 0 N--CA 1.472 1.038 0 O-C-N 121.905 -0.497 . . . . 0.0 112.507 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.97 -39.01 83.43 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.95 -0.735 . . . . 0.0 111.43 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.37 -48.79 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 110.183 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.26 -48.85 70.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.009 0.924 . . . . 0.0 112.069 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -71.32 -28.58 64.19 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.887 1.221 . . . . 0.0 112.936 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -70.11 -49.72 47.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.783 0.833 . . . . 0.0 110.639 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.2 t -55.03 -49.35 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.499 1.12 . . . . 0.0 111.358 169.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.66 -51.46 65.06 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.409 1.004 . . . . 0.0 112.487 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.77 -30.88 68.56 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.832 0.742 . . . . 0.0 112.056 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.69 -50.5 66.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.541 0.737 . . . . 0.0 110.877 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.42 -37.82 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.028 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -26.67 68.89 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -85.17 -13.01 51.4 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 174.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -109.32 -25.38 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.911 1.684 . . . . 0.0 112.104 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 119.767 -0.158 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -70.32 141.02 52.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.069 0.948 . . . . 0.0 111.447 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -109.5 126.36 53.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.161 0.984 . . . . 0.0 111.6 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.9 t -96.98 111.67 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.947 1.699 . . . . 0.0 110.354 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.2 tpp -90.82 127.45 36.36 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.47 122.23 43.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.235 1.014 . . . . 0.0 111.124 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.96 142.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.1 t -157.33 174.75 14.96 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 112.425 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.88 159.65 19.24 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.962 1.305 . . . . 0.0 112.523 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -55.39 -45.46 76.63 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -169.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -82.65 -16.64 47.51 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 m -76.25 152.48 36.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.807 1.243 . . . . 0.0 113.338 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.0 p -111.11 -7.4 14.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -49.98 -37.19 31.25 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 120.959 1.709 . . . . 0.0 113.52 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -62.93 -50.96 68.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.255 1.389 . . . . 0.0 112.692 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -62.06 -38.53 89.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.255 1.022 . . . . 0.0 111.552 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.406 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 7.2 tpt -74.87 -39.26 61.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.004 0.922 . . . . 0.0 112.336 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.91 88.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.407 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -58.15 -49.5 76.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.492 169.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.53 -47.54 63.14 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 121.0 1.727 . . . . 0.0 114.409 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -67.28 -42.95 82.96 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.018 -1.283 . . . . 0.0 112.032 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.63 -31.59 69.78 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.981 -1.074 . . . . 0.0 113.338 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -65.14 -29.39 70.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 128.876 2.871 . . . . 0.0 112.751 172.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -90.49 -45.47 8.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.836 0.855 . . . . 0.0 112.102 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.03 -31.83 13.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.265 1.026 . . . . 0.0 113.345 -170.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.22 1.6 88.42 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.421 1.486 . . . . 0.0 114.166 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.78 117.56 2.57 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 118.453 1.126 . . . . 0.0 111.403 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.3 15.58 81.09 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.91 -40.03 2.34 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.075 1.437 . . . . 0.0 111.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.25 164.39 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.831 1.652 . . . . 0.0 111.553 170.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 153.96 19.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.94 0.896 . . . . 0.0 108.804 169.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.52 147.56 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 m -152.1 160.89 43.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.994 1.718 . . . . 0.0 108.83 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.3 p -135.05 154.91 51.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.211 -0.931 . . . . 0.0 112.68 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 t -150.76 129.63 12.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.044 0.938 . . . . 0.0 110.276 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.94 141.49 20.14 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.02 -34.55 63.58 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.038 1.419 . . . . 0.0 112.482 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.95 41.45 3.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.958 1.703 . . . . 0.0 110.956 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t 72.69 168.66 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.627 1.971 . . . . 0.0 112.894 -168.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -158.1 172.16 18.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.724 1.61 . . . . 0.0 112.372 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -126.14 162.94 24.21 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 0.0 114.506 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.0 m -121.89 116.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.691 1.596 . . . . 0.0 109.739 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.16 148.32 44.69 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.794 0.838 . . . . 0.0 111.398 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.5 -35.76 77.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.291 2.661 . . . . 0.0 113.852 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.0 m -61.19 -38.4 86.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.748 0.819 . . . . 0.0 112.061 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.49 60.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.078 -1.014 . . . . 0.0 113.357 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.47 -54.9 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.31 72.36 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -71.17 -7.71 48.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.217 1.007 . . . . 0.0 113.604 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.406 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 15.8 mmt -125.34 -27.24 3.5 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.59 1.156 . . . . 0.0 112.021 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.95 -27.39 66.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.064 -1.023 . . . . 0.0 112.139 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.37 -5.43 42.31 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.148 0.979 . . . . 0.0 113.041 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 t -108.99 3.14 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.622 2.369 . . . . 0.0 110.541 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.87 13.8 81.74 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.393 1.473 . . . . 0.0 114.667 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.95 151.57 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -133.17 135.05 44.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.698 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 pt -128.74 1.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.726 1.61 . . . . 0.0 112.465 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.9 p -65.48 -30.72 71.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.629 1.172 . . . . 0.0 113.769 -169.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.64 -0.42 89.24 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.431 1.015 . . . . 0.0 114.976 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -81.81 151.82 27.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.397 1.598 . . . . 0.0 112.697 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.7 p -124.94 176.02 6.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.353 1.861 . . . . 0.0 111.088 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -152.66 156.1 38.56 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 112.593 173.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -153.54 160.45 30.93 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.76 2.024 . . . . 0.0 109.272 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.35 140.07 87.76 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.341 2.694 . . . . 0.0 112.485 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.94 -30.41 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -11.9 60.39 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -21.51 56.23 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.061 0.846 . . . . 0.0 112.935 171.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -93.14 166.49 12.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.645 1.178 . . . . 0.0 112.805 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.19 109.02 17.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.542 1.537 . . . . 0.0 110.965 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.22 -15.06 62.86 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.625 -1.297 . . . . 0.0 113.666 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -57.54 -22.05 42.14 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.065 1.346 . . . . 0.0 113.131 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.17 -0.56 38.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.219 1.808 . . . . 0.0 113.037 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -124.92 76.96 1.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.242 1.817 . . . . 0.0 109.686 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -23.68 8.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.71 2.004 . . . . 0.0 113.38 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -133.33 127.86 54.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.642 1.577 . . . . 0.0 108.537 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.9 t -132.97 118.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.077 -1.015 . . . . 0.0 110.275 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -110.99 118.06 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.865 1.266 . . . . 0.0 107.932 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -87.9 155.8 19.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.123 0.969 . . . . 0.0 109.027 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.68 39.67 3.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.09 0.956 . . . . 0.0 110.885 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.7 m -102.6 -26.68 13.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.972 1.309 . . . . 0.0 111.914 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.03 102.18 1.39 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.018 1.771 . . . . 0.0 113.038 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . 0.257 28.6 p 39.03 40.41 0.46 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.884 2.074 . . . . 0.0 115.33 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.81 108.05 0.2 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.567 1.556 . . . . 0.0 111.803 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.69 142.22 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.131 1.372 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -89.87 114.84 26.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.578 0.751 . . . . 0.0 110.072 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -144.14 140.54 17.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.29 1.036 . . . . 0.0 113.155 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.47 153.73 72.93 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.549 2.166 . . . . 0.0 110.068 168.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.27 -32.48 96.96 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.184 2.589 . . . . 0.0 114.311 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.99 -24.39 67.0 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.932 -1.105 . . . . 0.0 113.765 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.4 -10.66 58.29 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.4 -22.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.125 1.37 . . . . 0.0 113.584 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -84.55 11.65 8.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.39 1.876 . . . . 0.0 113.527 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -67.68 166.8 14.42 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.722 1.609 . . . . 0.0 112.812 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.24 -35.89 82.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -133.32 128.69 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.472 0.709 . . . . 0.0 110.888 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -130.75 148.46 52.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.089 1.356 . . . . 0.0 111.613 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -142.06 161.16 38.68 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.448 1.499 . . . . 0.0 111.455 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.44 86.84 1.97 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.633 -0.667 . . . . 0.0 111.913 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -73.38 160.51 31.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.234 1.814 . . . . 0.0 114.017 -172.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -93.28 -84.39 0.3 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.156 0.983 . . . . 0.0 110.94 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 50.14 -166.21 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.51 1.924 . . . . 0.0 112.293 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.94 147.75 46.55 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.489 1.515 . . . . 0.0 107.443 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.98 129.79 52.81 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.314 0.961 . . . . 0.0 111.035 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -69.37 -14.99 38.26 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.632 1.555 . . . . 0.0 114.731 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -53.43 124.45 14.84 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.367 0.985 . . . . 0.0 112.867 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.78 3.73 60.13 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.405 1.002 . . . . 0.0 115.452 -177.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -103.62 -177.9 3.5 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.388 1.475 . . . . 0.0 112.68 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t -73.75 155.13 39.21 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.59 -0.694 . . . . 0.0 111.606 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.96 -22.36 66.89 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.213 -0.929 . . . . 0.0 111.721 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.57 -32.39 73.7 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.047 -1.033 . . . . 0.0 111.305 169.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.22 -44.05 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.858 -1.151 . . . . 0.0 110.694 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -53.79 -49.26 68.67 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.285 0.948 . . . . 0.0 111.29 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -71.42 -16.41 62.39 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 m -95.6 -35.62 11.56 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.451 1.101 . . . . 0.0 112.755 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.81 -37.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 120.274 -1.517 . . . . 0.0 111.414 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -55.1 -42.71 73.23 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.51 -32.63 67.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.182 0.896 . . . . 0.0 113.023 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -69.8 -44.89 69.12 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.84 -0.8 . . . . 0.0 110.659 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.4 t -60.23 -42.54 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.158 -0.964 . . . . 0.0 111.063 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.17 -47.65 77.87 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.034 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.93 -29.25 65.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.139 1.336 . . . . 0.0 113.562 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -62.44 -54.3 42.16 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.022 0.828 . . . . 0.0 109.979 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.37 -51.08 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.28 1.432 . . . . 0.0 112.636 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.7 -49.64 75.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.996 1.271 . . . . 0.0 112.492 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -30.19 67.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.298 0.499 . . . . 0.0 111.875 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.47 -50.21 66.21 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.768 0.827 . . . . 0.0 111.168 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.73 -41.38 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.508 1.049 . . . . 0.0 110.944 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -23.81 66.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.36 -17.27 37.23 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.1 -23.47 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.253 1.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.884 179.695 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 119.761 -0.162 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mtmm -77.45 146.28 36.59 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 112.612 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -113.56 126.11 54.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.902 1.281 . . . . 0.0 111.189 170.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.75 109.17 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.675 1.59 . . . . 0.0 110.207 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.6 tpp -87.04 128.13 35.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.525 0.602 . . . . 0.0 109.849 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -98.75 123.43 42.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.688 1.195 . . . . 0.0 109.745 169.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.34 146.21 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.724 1.21 . . . . 0.0 112.788 -176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -149.45 171.03 17.23 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.487 -0.758 . . . . 0.0 111.401 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -67.77 159.28 30.56 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.144 -0.973 . . . . 0.0 111.573 169.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.25 6.0 ppt_? -61.13 -32.93 72.63 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 -168.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -87.47 57.09 4.23 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.971 0.805 . . . . 0.0 111.284 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -153.71 156.73 38.35 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.255 1.022 . . . . 0.0 113.746 -171.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.7 p -110.7 -5.24 15.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.058 1.743 . . . . 0.0 112.974 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -60.05 -37.88 81.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.592 1.957 . . . . 0.0 114.268 -169.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -66.96 -48.33 68.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.92 1.236 . . . . 0.0 112.01 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -65.76 -42.92 90.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.59 0.756 . . . . 0.0 111.941 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 tpt -64.92 -42.41 94.74 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.867 -1.146 . . . . 0.0 112.717 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.51 88.2 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.947 0.499 . . . . 0.0 112.149 173.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.82 -36.18 78.4 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.567 -0.708 . . . . 0.0 111.841 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.57 -53.08 46.19 Favored Glycine 0 N--CA 1.471 1.004 0 CA-C-N 119.472 1.033 . . . . 0.0 112.613 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -60.33 -38.93 85.29 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.683 -0.892 . . . . 0.0 111.409 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.83 73.16 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -75.28 -22.16 57.99 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.905 1.684 . . . . 0.0 113.07 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -79.41 -45.35 19.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.314 0.646 . . . . 0.0 111.688 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -98.24 -27.2 14.25 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.46 1.104 . . . . 0.0 113.113 -172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.87 2.66 88.08 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.253 1.883 . . . . 0.0 113.903 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 112.15 0.44 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.512 1.156 . . . . 0.0 112.656 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.67 15.57 81.47 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.373 1.309 . . . . 0.0 116.373 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.99 -40.47 3.49 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.393 1.596 . . . . 0.0 112.314 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.33 165.84 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.361 2.264 . . . . 0.0 109.931 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.27 149.12 21.89 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 170.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.43 143.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.316 -0.865 . . . . 0.0 112.493 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 m -148.23 156.72 42.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.976 1.31 . . . . 0.0 110.187 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 p -128.3 150.47 50.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 113.321 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 t -155.43 156.71 35.8 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 110.124 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.59 153.05 17.61 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 169.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.1 mt -55.48 -34.52 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.997 1.398 . . . . 0.0 111.612 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -131.03 49.86 2.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.862 1.665 . . . . 0.0 109.715 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 t 68.63 170.37 0.29 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.475 1.91 . . . . 0.0 113.437 -169.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.2 p -146.08 169.56 18.45 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.42 1.888 . . . . 0.0 111.009 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -116.78 160.29 21.02 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.37 148.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.402 1.881 . . . . 0.0 107.058 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -136.4 131.53 18.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.748 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -54.81 -38.79 91.99 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.352 2.702 . . . . 0.0 115.273 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.0 m -67.77 -31.06 70.68 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.094 -1.004 . . . . 0.0 111.718 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.4 60.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.917 -1.114 . . . . 0.0 112.673 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.2 mt -72.19 -53.62 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 -35.68 60.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -170.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.68 -8.53 54.71 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.16 -0.962 . . . . 0.0 113.444 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.0 mmt -123.64 -28.49 3.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 112.261 -171.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.43 -26.69 68.04 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.681 1.128 . . . . 0.0 112.171 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -70.34 -12.05 61.32 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 113.799 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 3.6 m -114.7 13.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.046 1.339 . . . . 0.0 111.509 168.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.044 1.783 . . . . 0.0 116.298 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.4 mm -85.07 149.56 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.334 1.567 . . . . 0.0 111.872 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -122.27 133.08 54.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.178 1.391 . . . . 0.0 111.053 169.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.56 -13.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.641 1.177 . . . . 0.0 113.837 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 m -57.68 -31.91 66.81 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.368 1.467 . . . . 0.0 114.227 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.26 2.69 81.51 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.263 1.411 . . . . 0.0 115.728 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.32 161.62 29.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.509 1.655 . . . . 0.0 112.566 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -143.4 166.3 25.13 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 0.0 110.902 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -143.81 161.26 39.1 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.304 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -151.09 160.04 32.67 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.012 1.725 . . . . 0.0 109.973 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.51 135.02 67.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.805 3.004 . . . . 0.0 112.595 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.8 -31.76 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -12.1 60.68 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -21.19 57.85 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.071 0.851 . . . . 0.0 112.77 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -94.87 167.34 11.48 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.091 1.356 . . . . 0.0 112.825 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.46 109.56 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.761 1.624 . . . . 0.0 110.967 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.67 -20.05 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -170.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.51 -27.36 69.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.332 1.053 . . . . 0.0 112.422 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.92 -2.17 58.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.633 1.573 . . . . 0.0 112.386 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.92 80.05 1.49 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.938 2.095 . . . . 0.0 107.92 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -25.75 11.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.234 1.814 . . . . 0.0 113.165 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.1 t -132.3 132.47 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.194 1.798 . . . . 0.0 108.969 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.4 t -134.65 121.01 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.99 122.21 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.125 1.37 . . . . 0.0 108.552 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.9 t -93.33 155.05 17.63 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.674 1.19 . . . . 0.0 109.577 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.56 46.0 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.765 1.226 . . . . 0.0 111.387 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.4 m -109.26 -32.63 7.12 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.804 1.242 . . . . 0.0 112.21 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.63 97.24 1.29 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.076 1.798 . . . . 0.0 113.538 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.1 m 48.11 36.36 6.42 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.968 1.707 . . . . 0.0 114.661 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.53 106.33 0.19 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.578 1.085 . . . . 0.0 112.449 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.4 p -141.09 141.62 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.413 1.485 . . . . 0.0 110.718 173.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -84.45 115.88 22.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.686 -0.633 . . . . 0.0 109.455 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -141.14 138.6 18.01 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.45 1.1 . . . . 0.0 112.298 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 152.96 76.62 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.259 1.973 . . . . 0.0 110.244 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 -29.24 86.33 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.837 2.358 . . . . 0.0 115.501 -169.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.36 -17.9 64.93 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.506 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.3 m95 -90.99 -3.18 57.47 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.88 -2.04 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.963 1.305 . . . . 0.0 114.337 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -101.37 0.95 37.93 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.141 1.776 . . . . 0.0 113.287 -171.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.484 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.5 mp0 -53.85 159.05 1.8 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.921 2.488 . . . . 0.0 113.988 174.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.91 -34.57 78.25 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -134.05 130.37 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.005 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -133.12 149.03 52.13 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.336 1.454 . . . . 0.0 111.435 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -141.59 157.91 44.5 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.91 1.284 . . . . 0.0 111.351 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.5 88.73 2.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.795 0.838 . . . . 0.0 110.832 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -70.94 145.69 49.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.13 1.372 . . . . 0.0 113.752 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -101.73 60.56 0.88 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.727 2.011 . . . . 0.0 107.726 -174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.7 131.2 56.65 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.575 1.95 . . . . 0.0 111.148 -168.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -88.19 151.5 22.64 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.991 1.316 . . . . 0.0 112.138 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -93.72 126.2 50.56 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.975 0.51 . . . . 0.0 111.611 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.37 -5.29 13.42 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.077 2.518 . . . . 0.0 114.074 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -64.25 111.51 2.64 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 119.998 -1.689 . . . . 0.0 112.766 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.68 -3.66 74.89 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.538 1.542 . . . . 0.0 114.435 -173.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -98.54 178.18 5.09 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.171 1.788 . . . . 0.0 111.055 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t -70.57 156.44 39.42 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.559 0.743 . . . . 0.0 112.279 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.13 -26.12 68.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.108 0.963 . . . . 0.0 111.62 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.34 -34.28 77.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.412 -0.805 . . . . 0.0 111.25 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -69.02 -41.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.644 -1.285 . . . . 0.0 110.476 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -56.3 -48.25 77.04 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.996 1.271 . . . . 0.0 111.421 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -70.44 -17.73 63.0 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.0 m -89.22 -41.08 12.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.048 1.339 . . . . 0.0 112.293 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.69 -36.31 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.538 -1.351 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -56.15 -42.29 76.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.27 -31.5 63.64 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 123.328 0.489 . . . . 0.0 112.42 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -70.03 -39.0 76.04 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.901 -0.764 . . . . 0.0 111.527 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.46 -46.74 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.366 0.667 . . . . 0.0 110.036 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.87 -51.23 66.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.366 1.066 . . . . 0.0 112.008 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.91 -29.6 67.9 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.022 1.283 . . . . 0.0 112.487 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.4 mtt85 -69.83 -53.85 16.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.382 -0.824 . . . . 0.0 111.025 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -53.54 -49.89 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.899 1.279 . . . . 0.0 112.439 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -66.21 -47.11 74.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.52 1.055 . . . . 0.0 112.135 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -31.58 68.47 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.423 1.011 . . . . 0.0 111.973 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.23 -51.13 68.98 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.518 0.727 . . . . 0.0 110.53 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.2 mt -69.11 -38.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.496 -0.753 . . . . 0.0 111.173 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.82 -26.82 68.8 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -87.79 -15.61 36.42 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -109.67 -18.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 124.661 1.185 . . . . 0.0 113.143 179.303 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 119.908 -0.092 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -72.64 142.53 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.971 0.908 . . . . 0.0 112.07 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.15 127.72 54.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.373 1.069 . . . . 0.0 111.308 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.88 116.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.2 ttm -99.8 124.97 45.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 110.076 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -95.3 127.64 41.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.22 0.608 . . . . 0.0 110.207 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.49 139.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.55 166.53 24.34 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 0.0 112.731 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -86.22 177.8 7.39 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.944 0.897 . . . . 0.0 111.553 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -54.26 150.64 8.29 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.961 1.304 . . . . 0.0 113.428 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t30 51.43 58.6 5.33 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.973 1.709 . . . . 0.0 112.562 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.8 t -138.9 143.98 38.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.333 1.053 . . . . 0.0 113.086 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.2 p -106.51 -6.38 18.16 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.662 0.785 . . . . 0.0 112.897 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -64.5 -28.02 69.37 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.641 1.176 . . . . 0.0 113.084 -169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 p -71.61 -49.9 35.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.971 1.26 . . . . 0.0 112.13 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -63.65 -33.1 74.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.263 0.625 . . . . 0.0 112.291 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 tpt -76.87 -41.58 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.174 -0.954 . . . . 0.0 112.337 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.85 94.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.39 -45.26 88.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.11 -46.59 77.75 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 119.778 1.172 . . . . 0.0 114.806 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.447 1.123 . . . . 0.0 111.593 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.14 -32.94 63.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.468 -1.395 . . . . 0.0 113.989 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -67.48 -22.67 65.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.323 1.419 . . . . 0.0 113.05 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.4 m -87.28 -47.64 8.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.496 1.118 . . . . 0.0 111.581 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.7 mt -95.42 -31.86 13.18 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.468 1.107 . . . . 0.0 113.313 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.47 3.08 87.26 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.704 1.621 . . . . 0.0 113.159 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.36 122.0 5.64 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 117.919 0.86 . . . . 0.0 111.841 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.44 79.29 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 118.732 -1.038 . . . . 0.0 115.453 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -121.66 -42.22 2.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.341 1.57 . . . . 0.0 111.039 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.93 161.18 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 112.95 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 153.76 18.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.74 145.39 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.812 -1.18 . . . . 0.0 113.661 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 m -142.84 147.36 35.28 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.435 1.894 . . . . 0.0 109.784 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -115.02 148.82 38.36 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.024 -1.048 . . . . 0.0 112.407 170.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 t -153.35 159.26 42.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.793 1.237 . . . . 0.0 110.531 -170.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.86 154.8 19.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.9 0.762 . . . . 0.0 112.036 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.79 -34.08 72.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.318 1.059 . . . . 0.0 112.132 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -132.49 29.59 4.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.234 1.414 . . . . 0.0 111.538 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 63.81 168.34 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.955 1.702 . . . . 0.0 114.712 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.491 ' H ' ' HB3' ' A' ' 62' ' ' SER . 7.5 t -163.21 -178.66 6.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.5 2.32 . . . . 0.0 111.828 -175.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -123.48 172.45 8.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.249 1.82 . . . . 0.0 114.485 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 147.02 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 125.675 1.59 . . . . 0.0 108.647 168.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.06 148.46 39.08 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 125.545 1.538 . . . . 0.0 111.511 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -54.81 -34.5 85.25 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.3 2.667 . . . . 0.0 113.871 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -61.25 -36.31 79.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.631 0.772 . . . . 0.0 112.099 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.34 -10.83 59.81 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.935 -1.103 . . . . 0.0 113.558 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.37 -53.1 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 168.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.05 68.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mmt -72.72 -9.52 58.73 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 mmt -124.56 -27.59 3.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.144 -170.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.3 -25.34 68.27 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.836 -1.165 . . . . 0.0 112.28 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.93 -9.47 58.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 t -105.69 4.67 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 126.888 2.075 . . . . 0.0 110.376 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.97 12.49 83.34 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.529 -1.357 . . . . 0.0 114.935 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.71 150.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 118.572 1.186 . . . . 0.0 111.069 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -135.46 97.24 3.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.286 1.434 . . . . 0.0 111.357 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.2 11.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.6 p -61.93 -27.52 68.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.632 -1.293 . . . . 0.0 113.365 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.28 -2.68 90.34 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.901 1.239 . . . . 0.0 115.031 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -87.7 156.24 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.849 1.324 . . . . 0.0 112.373 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 t -147.56 -178.24 6.14 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.715 1.606 . . . . 0.0 109.53 172.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.491 ' HB3' ' H ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -115.9 167.49 10.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.482 1.113 . . . . 0.0 112.606 175.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.49 155.52 39.1 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.2 1.4 . . . . 0.0 110.91 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.61 136.6 50.7 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.676 2.917 . . . . 0.0 113.755 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.406 HD11 ' CD2' ' A' ' 90' ' ' TRP . 10.8 tp -52.83 -36.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.719 1.207 . . . . 0.0 114.12 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.38 -10.81 59.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -17.37 52.25 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.09 0.859 . . . . 0.0 113.085 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -93.1 175.48 6.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.505 1.522 . . . . 0.0 112.9 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.16 109.55 13.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.929 1.692 . . . . 0.0 110.86 174.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.3 -16.41 64.02 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -169.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.51 -23.7 66.28 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.846 0.858 . . . . 0.0 112.413 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.15 -0.99 57.42 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.289 1.835 . . . . 0.0 112.077 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -119.22 82.33 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.176 2.19 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.11 -27.64 14.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.223 1.809 . . . . 0.0 113.09 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.99 127.8 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.584 1.554 . . . . 0.0 108.966 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -133.54 124.69 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.956 -1.09 . . . . 0.0 109.763 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mm -124.42 110.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.032 1.333 . . . . 0.0 109.358 -170.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 m -86.15 154.53 21.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.649 0.779 . . . . 0.0 110.983 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.47 44.0 2.84 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.234 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.1 m -106.39 0.94 25.3 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.782 1.633 . . . . 0.0 113.653 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.25 69.07 1.44 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.518 1.532 . . . . 0.0 114.042 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 63.2 m 48.75 45.83 21.79 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.45 1.5 . . . . 0.0 113.778 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.13 14.76 0.07 OUTLIER Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.968 1.27 . . . . 0.0 115.887 -172.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -63.02 144.97 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.265 1.533 . . . . 0.0 111.265 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -106.09 128.76 54.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.963 0.905 . . . . 0.0 109.159 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.3 mt -146.55 148.48 33.99 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.136 0.974 . . . . 0.0 112.99 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.66 152.51 80.09 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.663 2.242 . . . . 0.0 109.897 168.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.28 -23.77 75.51 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.303 2.668 . . . . 0.0 115.391 -169.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -16.36 62.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.8 m95 -91.34 -3.3 56.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.36 9.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 125.618 1.567 . . . . 0.0 113.85 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -111.39 -3.09 15.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.392 1.877 . . . . 0.0 113.152 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.446 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.5 mp0 -58.0 158.62 6.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.432 2.693 . . . . 0.0 114.31 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.42 -33.67 76.41 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.86 127.39 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.979 0.912 . . . . 0.0 109.825 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -135.84 148.43 48.66 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.621 1.568 . . . . 0.0 111.756 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -149.16 157.74 43.62 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.597 1.959 . . . . 0.0 110.366 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -137.66 77.32 1.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.423 0.63 . . . . 0.0 111.42 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -64.17 160.0 19.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.12 1.768 . . . . 0.0 114.417 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.15 43.17 1.51 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.139 1.776 . . . . 0.0 113.75 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.13 138.49 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.507 -0.746 . . . . 0.0 111.05 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -85.82 148.77 25.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.67 131.11 46.47 Favored Pre-proline 0 CA--C 1.538 0.498 0 O-C-N 121.464 -0.773 . . . . 0.0 111.162 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.15 -7.56 17.23 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.054 1.836 . . . . 0.0 113.495 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -52.61 124.38 13.56 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.304 1.411 . . . . 0.0 112.062 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.78 4.53 66.64 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -107.07 178.7 4.48 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.523 1.529 . . . . 0.0 112.657 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t -72.04 158.49 35.87 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.944 0.898 . . . . 0.0 112.229 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.442 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -63.01 -27.61 69.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.379 1.072 . . . . 0.0 111.376 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.34 -31.7 72.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.953 . . . . 0.0 111.911 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.87 -41.73 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.978 -1.076 . . . . 0.0 110.438 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -56.05 -49.0 74.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.759 1.163 . . . . 0.0 111.442 170.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -70.13 -19.28 63.23 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.1 m -81.17 -54.36 5.58 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.857 1.263 . . . . 0.0 111.324 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.17 -34.52 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.555 1.142 . . . . 0.0 111.541 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -55.65 -41.01 72.98 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.213 0.915 . . . . 0.0 112.684 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.55 -33.02 64.08 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.774 0.702 . . . . 0.0 113.002 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -68.86 -40.53 79.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.113 0.956 . . . . 0.0 111.183 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.34 -49.92 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.167 0.987 . . . . 0.0 110.318 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -54.12 -49.01 70.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.411 1.084 . . . . 0.0 112.045 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -70.54 -28.98 65.34 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.802 1.183 . . . . 0.0 112.697 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -72.59 -47.98 43.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.78 -42.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.102 0.961 . . . . 0.0 111.626 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -61.29 -47.22 86.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.79 1.177 . . . . 0.0 112.183 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.13 -35.73 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.569 0.622 . . . . 0.0 112.016 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.487 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.9 tm? -56.96 -52.03 66.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.56 1.144 . . . . 0.0 110.699 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.86 -42.23 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.614 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.99 68.81 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -91.23 -6.62 53.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.68 -16.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.255 1.389 0 C-N-CA 125.467 1.507 . . . . 0.0 112.104 172.078 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -73.75 143.16 46.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.914 0.886 . . . . 0.0 111.835 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -108.67 124.37 50.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.731 1.212 . . . . 0.0 111.236 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.5 t -96.02 109.17 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 110.173 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -88.31 130.62 35.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.504 0.321 . . . . 0.0 110.201 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -104.01 124.29 48.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.302 1.041 . . . . 0.0 110.73 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.2 138.07 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.309 1.044 . . . . 0.0 113.757 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -144.08 176.96 8.91 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.213 1.005 . . . . 0.0 112.64 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -79.01 158.51 27.91 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.785 1.234 . . . . 0.0 111.884 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -50.68 -40.95 55.14 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -168.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -72.57 -17.04 61.74 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.1 t -90.79 159.92 16.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.5 p -113.44 4.65 16.37 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.064 1.746 . . . . 0.0 111.877 168.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 -73.58 -25.58 60.42 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.056 -1.653 . . . . 0.0 113.098 -170.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -63.58 -43.36 97.21 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.196 0.907 . . . . 0.0 110.759 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -69.27 -40.09 78.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.626 0.77 . . . . 0.0 111.769 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.2 tpt -71.1 -38.21 72.36 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.234 -0.916 . . . . 0.0 112.562 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.57 98.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.333 0.653 . . . . 0.0 111.116 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.28 -40.19 77.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.914 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.05 -53.3 46.93 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 119.573 1.079 . . . . 0.0 113.53 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -61.52 -39.99 93.04 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.608 -0.937 . . . . 0.0 110.993 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.035 -1.041 . . . . 0.0 113.8 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -71.61 -22.04 61.76 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.789 1.177 . . . . 0.0 112.835 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -86.49 -43.91 12.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.939 0.895 . . . . 0.0 112.083 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.1 -35.13 11.45 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.775 0.83 . . . . 0.0 112.973 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.61 8.76 76.3 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 125.719 1.628 . . . . 0.0 114.188 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.17 -41.83 1.36 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -172.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 18.47 30.84 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.335 1.445 . . . . 0.0 115.078 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.69 -43.79 2.88 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.291 1.546 . . . . 0.0 111.941 -169.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -149.24 165.67 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.851 1.66 . . . . 0.0 112.087 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.55 152.08 22.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.625 0.77 . . . . 0.0 109.241 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.3 t -135.89 137.61 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.802 1.241 . . . . 0.0 111.047 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 m -144.6 154.26 42.64 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.102 1.361 . . . . 0.0 110.433 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -126.47 156.17 41.11 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.041 -1.037 . . . . 0.0 113.687 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -156.46 162.55 39.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 110.231 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.82 155.32 20.57 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.32 -0.862 . . . . 0.0 111.327 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.0 -30.42 70.93 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.527 -0.984 . . . . 0.0 112.006 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -129.46 38.53 3.86 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 72.2 177.91 0.25 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.224 1.809 . . . . 0.0 112.138 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -137.35 -173.39 3.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.462 1.905 . . . . 0.0 111.623 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.09 158.69 43.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 113.326 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.3 t -101.92 146.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -129.57 123.86 21.55 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.997 -1.002 . . . . 0.0 112.567 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.73 -37.76 91.7 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.264 2.643 . . . . 0.0 115.116 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -66.82 -31.44 72.07 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.457 -0.777 . . . . 0.0 111.763 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.13 80.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.647 1.112 . . . . 0.0 110.838 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 mt -54.87 -49.58 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.042 0.537 . . . . 0.0 109.552 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.76 61.92 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.9 mmt -78.21 -22.39 48.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.204 -0.935 . . . . 0.0 112.857 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.8 mmt -106.39 -16.84 14.45 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.59 -25.42 67.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.185 1.357 . . . . 0.0 112.835 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.47 -7.0 51.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.34 1.056 . . . . 0.0 113.319 172.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.9 t -106.33 3.08 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.914 2.086 . . . . 0.0 110.312 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.47 81.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.238 1.399 . . . . 0.0 114.815 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -90.88 154.73 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.577 1.151 . . . . 0.0 110.497 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -141.85 133.46 26.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.71 0.804 . . . . 0.0 111.549 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 pt -132.29 12.19 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.056 0.942 . . . . 0.0 113.535 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -57.44 -33.83 68.34 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.628 1.104 . . . . 0.0 112.593 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.33 3.29 86.66 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.029 1.3 . . . . 0.0 115.923 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -76.03 160.41 29.85 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.028 1.914 . . . . 0.0 113.183 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.3 p -133.31 171.82 13.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.28 1.832 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 t -149.64 161.82 41.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.413 1.085 . . . . 0.0 111.298 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.65 160.49 35.87 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.139 1.776 . . . . 0.0 109.62 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.7 135.52 64.53 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.179 2.586 . . . . 0.0 112.294 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.93 -30.92 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -171.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.85 -14.24 62.79 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -20.56 57.9 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 119.305 0.957 . . . . 0.0 113.029 173.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -95.39 167.42 11.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.774 1.23 . . . . 0.0 112.982 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 110.61 20.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.826 1.65 . . . . 0.0 111.098 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB1' HE22 ' A' ' 93' ' ' GLN . . . -67.52 -18.83 65.19 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -170.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.15 -26.88 68.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.665 1.186 . . . . 0.0 112.677 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.57 -2.84 58.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.73 1.612 . . . . 0.0 112.253 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -116.54 80.49 1.47 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.806 2.042 . . . . 0.0 107.882 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.65 -26.6 14.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 113.012 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -132.81 131.19 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.79 1.636 . . . . 0.0 109.381 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.52 120.69 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.238 -0.913 . . . . 0.0 110.598 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.91 120.62 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.079 1.352 . . . . 0.0 108.106 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -91.9 157.01 17.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.047 1.339 . . . . 0.0 109.848 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.41 45.35 2.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.607 0.763 . . . . 0.0 111.636 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -122.84 16.53 10.16 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.48 44.51 95.11 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.695 1.134 . . . . 0.0 114.116 171.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 78.2 m 64.1 5.22 2.35 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.21 1.804 . . . . 0.0 114.83 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.57 18.71 49.99 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.307 1.908 . . . . 0.0 115.109 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -71.93 141.42 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.42 1.61 . . . . 0.0 110.959 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -108.95 125.95 52.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.887 1.275 . . . . 0.0 108.954 169.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -143.57 141.79 19.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.994 0.917 . . . . 0.0 113.142 -170.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.42 155.11 67.93 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.463 2.109 . . . . 0.0 110.11 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.38 -22.95 71.78 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.93 2.42 . . . . 0.0 115.016 -169.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.25 -16.97 61.93 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.489 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -91.07 -1.68 57.74 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.66 2.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.66 1.584 . . . . 0.0 114.085 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -109.19 7.94 25.65 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.923 1.689 . . . . 0.0 113.231 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.506 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.8 mp0 -62.06 162.91 8.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.446 2.298 . . . . 0.0 113.21 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.01 129.55 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.909 0.883 . . . . 0.0 110.177 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -133.21 148.53 52.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.557 1.543 . . . . 0.0 111.34 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -141.1 159.0 43.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.975 1.31 . . . . 0.0 111.871 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -141.75 99.18 3.49 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 0.0 110.19 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.88 153.84 34.35 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.893 1.277 . . . . 0.0 113.194 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -101.59 39.2 1.47 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.645 1.578 . . . . 0.0 112.374 -168.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 162.86 14.87 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.141 1.377 . . . . 0.0 113.684 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.22 154.23 40.46 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.774 1.629 . . . . 0.0 111.267 -174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -86.73 126.84 62.39 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 121.686 -0.634 . . . . 0.0 111.659 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.06 -13.92 4.31 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.746 2.297 . . . . 0.0 114.004 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -63.56 -34.35 77.6 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.549 1.068 . . . . 0.0 113.207 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.02 5.07 51.67 Favored Glycine 0 CA--C 1.541 1.683 0 O-C-N 121.409 -0.807 . . . . 0.0 114.43 171.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -136.95 -165.63 1.77 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.769 2.028 . . . . 0.0 111.875 -169.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.4 t -78.85 158.75 28.07 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.216 1.006 . . . . 0.0 112.599 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.75 -22.58 66.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.092 0.957 . . . . 0.0 111.625 170.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.76 -33.8 76.46 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.037 -1.039 . . . . 0.0 110.478 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.0 t -72.89 -35.96 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.799 -1.188 . . . . 0.0 110.649 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.03 -47.41 83.18 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.54 1.518 . . . . 0.0 110.417 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -68.78 -17.05 63.97 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.7 m -88.67 -41.38 12.64 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.224 1.409 . . . . 0.0 112.629 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -73.96 -34.15 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 120.533 -1.354 . . . . 0.0 111.371 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.93 -40.63 73.42 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.84 60.77 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.749 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.93 -43.04 75.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.902 0.851 . . . . 0.0 110.722 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.58 -48.12 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.294 0.638 . . . . 0.0 110.56 169.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -58.47 -49.58 76.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.731 1.212 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.47 -29.0 64.34 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.018 1.281 . . . . 0.0 112.263 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -68.41 -50.7 50.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.59 0.756 . . . . 0.0 111.214 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.53 -48.62 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.162 0.985 . . . . 0.0 111.527 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.88 -50.93 66.83 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.557 1.071 . . . . 0.0 112.625 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -31.09 67.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.652 0.66 . . . . 0.0 111.998 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.45 -51.69 66.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.394 0.677 . . . . 0.0 110.314 169.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.8 -36.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.148 -0.97 . . . . 0.0 111.464 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -85.48 -20.03 30.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 pt -101.59 -18.07 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 124.971 1.308 . . . . 0.0 113.071 177.614 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 119.192 -0.432 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -70.44 138.64 51.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.124 0.875 . . . . 0.0 111.242 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -111.17 125.47 53.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.472 1.109 . . . . 0.0 111.361 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 68.5 t -95.72 114.11 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.048 1.739 . . . . 0.0 110.037 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -96.53 125.78 41.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.897 0.771 . . . . 0.0 110.891 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -92.01 124.08 35.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.715 0.806 . . . . 0.0 108.886 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.55 132.24 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.293 1.037 . . . . 0.0 112.469 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.9 p -138.26 172.04 13.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.17 169.16 18.13 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.972 0.909 . . . . 0.0 111.019 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -46.68 89.11 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -87.05 61.26 6.68 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.052 0.941 . . . . 0.0 111.443 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 t -150.35 149.23 29.8 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.243 1.017 . . . . 0.0 113.436 -171.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.2 m -113.81 -1.29 13.95 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.223 1.809 . . . . 0.0 112.101 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -62.58 -45.22 93.9 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.196 1.798 . . . . 0.0 112.696 -169.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 m -64.16 -38.99 93.06 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.622 1.101 . . . . 0.0 112.4 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -66.55 -44.24 82.88 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.734 0.413 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -39.24 82.12 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.773 0.829 . . . . 0.0 111.99 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.72 -46.01 92.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.43 -41.06 79.69 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.89 -63.76 4.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.722 1.153 . . . . 0.0 113.72 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -62.64 -34.85 77.9 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.699 1.25 . . . . 0.0 111.946 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.18 77.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -70.53 -27.89 64.51 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.883 1.674 . . . . 0.0 112.441 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.7 m -77.27 -46.02 24.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.363 1.065 . . . . 0.0 112.275 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.24 -27.76 14.85 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.036 0.934 . . . . 0.0 113.239 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 2.1 88.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.126 2.298 . . . . 0.0 113.608 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.42 114.79 1.03 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.409 1.104 . . . . 0.0 112.419 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.69 16.62 76.14 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.636 1.014 . . . . 0.0 115.636 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -119.08 -36.24 3.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.204 1.502 . . . . 0.0 111.92 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -150.61 166.32 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 127.544 2.338 . . . . 0.0 110.393 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.76 153.84 18.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 168.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.48 144.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.458 -1.401 . . . . 0.0 114.682 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -150.61 158.22 43.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.636 1.574 . . . . 0.0 110.726 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -123.55 149.18 45.56 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.016 1.726 . . . . 0.0 111.825 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 t -152.04 147.54 26.62 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.296 . . . . 0.0 110.586 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.87 143.47 17.09 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 168.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.69 -38.51 33.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.214 1.507 . . . . 0.0 112.22 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -123.74 40.87 3.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.838 1.655 . . . . 0.0 111.354 171.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 73.38 164.91 0.29 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.051 2.14 . . . . 0.0 114.333 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -148.4 166.84 26.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.294 2.238 . . . . 0.0 112.338 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -121.65 147.59 45.66 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.526 1.13 . . . . 0.0 113.756 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -80.18 -38.59 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 62.98 123.79 0.02 OUTLIER Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 128.815 2.846 . . . . 0.0 116.489 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 -38.95 79.79 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.929 3.086 . . . . 0.0 116.318 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -31.96 73.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.657 -1.277 . . . . 0.0 111.823 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.44 -8.19 58.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.653 -1.279 . . . . 0.0 113.603 172.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.81 -53.72 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 168.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.49 -33.52 60.8 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 mmt -71.86 -12.65 61.38 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.298 -0.876 . . . . 0.0 113.262 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.1 mmt -120.35 -27.25 5.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.593 1.157 . . . . 0.0 112.476 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.74 -25.15 68.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.852 -1.155 . . . . 0.0 112.637 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -70.63 -15.06 62.7 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.01 5.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 126.47 1.908 . . . . 0.0 110.664 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.18 12.37 83.31 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.389 1.471 . . . . 0.0 114.617 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -87.28 149.16 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.354 1.077 . . . . 0.0 111.312 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.47 125.52 44.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.45 1.5 . . . . 0.0 111.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.5 pt -134.49 -7.03 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.1 p -67.42 -28.23 67.73 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.125 1.33 . . . . 0.0 113.849 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.78 -2.11 90.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.843 1.211 . . . . 0.0 115.023 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -81.64 161.68 23.36 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.001 1.401 . . . . 0.0 112.469 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -140.31 -179.9 6.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.03 1.332 . . . . 0.0 111.376 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -154.44 160.84 41.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.066 1.346 . . . . 0.0 111.823 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -159.46 155.98 24.39 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.784 1.634 . . . . 0.0 108.799 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.56 136.26 63.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.361 2.707 . . . . 0.0 113.047 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.0 -33.15 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.68 -11.41 60.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.07 -24.44 59.5 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.215 -0.928 . . . . 0.0 112.373 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -93.35 165.65 12.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.906 1.282 . . . . 0.0 112.402 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.9 110.55 20.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.521 1.528 . . . . 0.0 111.118 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.54 -19.32 65.27 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -171.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.38 -26.37 67.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.28 1.032 . . . . 0.0 112.403 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -87.51 -1.67 58.09 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.002 1.721 . . . . 0.0 112.037 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.07 82.0 1.76 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.711 2.004 . . . . 0.0 108.154 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.28 -24.82 12.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.167 1.787 . . . . 0.0 113.018 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.7 t -133.9 130.74 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.777 1.631 . . . . 0.0 108.969 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.92 123.78 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.309 -0.869 . . . . 0.0 110.633 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.6 121.23 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.178 1.391 . . . . 0.0 107.962 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 t -85.21 147.71 26.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.511 1.124 . . . . 0.0 109.985 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -124.06 24.82 8.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.524 1.129 . . . . 0.0 112.456 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.8 m -83.59 -19.6 35.23 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -171.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.75 60.1 5.58 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.002 0.811 . . . . 0.0 112.122 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.4 t 62.56 173.02 0.14 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.098 2.159 . . . . 0.0 113.5 -169.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.17 33.84 86.42 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 121.113 -0.992 . . . . 0.0 114.643 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.9 p -90.93 137.12 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.405 1.082 . . . . 0.0 111.592 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -95.38 122.91 38.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.432 1.093 . . . . 0.0 109.54 170.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -139.84 136.95 17.77 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.615 1.166 . . . . 0.0 111.673 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.96 153.14 70.67 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.424 2.082 . . . . 0.0 110.064 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.71 -26.96 80.5 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.954 2.436 . . . . 0.0 114.104 -169.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.4 -19.62 65.85 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.499 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -90.1 -3.64 57.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -118.53 -9.76 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.79 1.236 . . . . 0.0 114.311 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -93.09 2.75 56.59 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.939 1.695 . . . . 0.0 113.511 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.1 mp0 -53.42 158.76 1.62 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.404 2.281 . . . . 0.0 113.775 174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -34.03 76.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -133.65 127.86 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.385 1.074 . . . . 0.0 110.05 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -130.91 148.27 52.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 111.103 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -141.88 159.09 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.672 1.189 . . . . 0.0 112.031 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.27 110.57 8.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.21 1.004 . . . . 0.0 108.882 168.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -87.68 145.66 26.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.6 1.16 . . . . 0.0 111.529 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -104.96 46.19 0.93 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.686 1.595 . . . . 0.0 108.555 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -102.02 132.81 47.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.572 2.349 . . . . 0.0 111.359 -168.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -90.34 151.85 21.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.317 1.447 . . . . 0.0 112.319 -173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -88.75 131.71 40.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.768 -0.582 . . . . 0.0 111.86 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -86.85 -15.01 4.05 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.7 2.267 . . . . 0.0 115.371 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -70.0 -30.0 67.21 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.016 1.735 . . . . 0.0 113.289 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.7 4.03 46.35 Favored Glycine 0 CA--C 1.54 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 114.046 169.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -136.49 -169.64 2.5 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.156 1.783 . . . . 0.0 113.063 -169.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 t -77.23 161.33 28.24 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.019 0.928 . . . . 0.0 112.157 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.87 -25.2 66.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.136 -0.977 . . . . 0.0 111.754 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.29 -29.37 70.46 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.228 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -72.0 -36.86 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 120.803 -1.186 . . . . 0.0 111.047 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -58.93 -46.73 87.25 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.435 1.471 . . . . 0.0 110.452 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -71.73 -18.21 62.15 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.109 0.964 . . . . 0.0 113.59 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 m -85.06 -52.87 5.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.575 1.55 . . . . 0.0 111.923 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.6 -31.92 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.934 1.294 . . . . 0.0 111.863 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -53.97 -43.42 69.91 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.601 1.091 . . . . 0.0 113.432 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.97 -32.74 65.93 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.771 0.701 . . . . 0.0 112.853 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -69.98 -40.34 75.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.41 -47.82 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.854 0.862 . . . . 0.0 110.329 171.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -57.0 -49.01 77.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.33 -28.36 66.17 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 121.376 1.898 . . . . 0.0 112.999 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -68.41 -49.0 63.17 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.473 -0.767 . . . . 0.0 111.654 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.7 m -62.24 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.022 0.828 . . . . 0.0 112.526 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -63.7 -50.72 68.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 120.207 1.367 . . . . 0.0 112.45 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.31 -31.06 69.29 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.951 0.796 . . . . 0.0 112.149 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.77 -49.72 69.63 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.396 0.678 . . . . 0.0 110.723 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.67 -40.76 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.988 -174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -27.04 68.84 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -88.49 -18.94 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -105.35 -18.36 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.256 1.4 0 C-N-CA 124.773 1.229 . . . . 0.0 113.222 179.054 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 119.75 -0.166 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -70.55 143.16 51.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.947 . . . . 0.0 111.94 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -110.73 126.23 54.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.015 . . . . 0.0 111.092 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.38 118.03 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.814 1.646 . . . . 0.0 109.995 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.5 tpp -97.81 119.44 36.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.651 0.659 . . . . 0.0 109.861 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.32 124.09 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.178 0.591 . . . . 0.0 110.391 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.03 144.54 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.242 1.017 . . . . 0.0 112.832 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.6 t -147.44 164.17 34.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.243 1.417 . . . . 0.0 109.497 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -73.1 -55.86 5.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.186 1.357 . . . . 0.0 113.201 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -146.46 178.04 8.58 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 127.063 2.145 . . . . 0.0 113.122 -169.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.266 39.6 t30 60.61 -128.01 0.96 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.925 2.49 . . . . 0.0 116.361 169.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 t -139.5 -169.88 2.79 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.049 1.339 . . . . 0.0 113.245 -169.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.7 t 50.86 -128.45 2.32 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.119 1.768 . . . . 0.0 110.262 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 39.43 -102.87 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.588 1.955 . . . . 0.0 114.762 169.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -63.91 -44.48 92.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.701 1.592 . . . . 0.0 112.942 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -63.08 -37.31 86.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.731 0.812 . . . . 0.0 111.543 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.411 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 8.1 tpt -74.83 -36.95 62.4 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.35 94.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.946 0.898 . . . . 0.0 109.917 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.86 -43.88 94.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.157 0.89 . . . . 0.0 111.769 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.1 -52.56 48.47 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 119.556 1.071 . . . . 0.0 113.83 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -68.18 -39.39 82.53 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.81 -1.406 . . . . 0.0 111.588 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.13 74.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.855 -1.153 . . . . 0.0 113.699 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -78.31 -15.54 58.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.2 1.364 . . . . 0.0 113.579 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.5 m -89.46 -44.95 9.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.255 1.022 . . . . 0.0 111.917 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.71 -29.07 14.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.673 1.189 . . . . 0.0 113.375 -174.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.35 2.27 88.17 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 126.419 1.961 . . . . 0.0 113.977 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.55 115.46 1.14 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.438 1.119 . . . . 0.0 112.385 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.64 10.83 85.86 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.85 -40.36 4.02 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.652 1.726 . . . . 0.0 112.493 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -148.29 161.7 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.51 2.324 . . . . 0.0 109.782 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 144.34 26.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.84 142.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.198 -0.939 . . . . 0.0 112.576 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -148.96 160.27 43.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.849 1.66 . . . . 0.0 109.435 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 p -136.84 153.46 50.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.9 t -152.27 152.91 32.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.283 1.433 . . . . 0.0 110.611 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.59 140.98 16.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.71 -37.63 84.86 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.499 1.65 . . . . 0.0 111.018 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.74 33.78 4.36 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.814 1.646 . . . . 0.0 111.064 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 64.01 168.84 0.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.789 2.035 . . . . 0.0 114.491 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 81.9 p -150.3 167.35 27.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.746 1.619 . . . . 0.0 112.526 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -137.44 170.96 15.18 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.039 1.336 . . . . 0.0 112.099 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.23 112.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.99 0.9 . . . . 0.0 110.762 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -78.78 134.72 60.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.01 1.324 . . . . 0.0 110.534 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.54 -37.49 90.32 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.985 2.457 . . . . 0.0 115.092 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 m -65.98 -32.32 73.74 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.86 -1.15 . . . . 0.0 111.604 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.37 -5.76 44.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.573 -1.329 . . . . 0.0 113.93 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.31 -55.93 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 167.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.22 78.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 82.3 mmm -73.38 -1.75 19.43 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.411 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.5 mmt -121.34 -29.02 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.64 1.176 . . . . 0.0 111.207 -173.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.68 -27.5 64.88 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.324 0.65 . . . . 0.0 111.951 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.83 -15.87 63.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.595 1.158 . . . . 0.0 113.935 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -120.19 24.58 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 126.175 1.79 . . . . 0.0 111.042 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.92 12.36 84.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.723 1.63 . . . . 0.0 116.128 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mm -93.13 152.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 118.855 1.328 . . . . 0.0 111.466 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -134.54 136.26 42.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.004 1.322 . . . . 0.0 110.97 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.34 0.74 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.543 1.537 . . . . 0.0 112.485 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.6 p -62.37 -28.17 69.58 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -169.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.86 -4.48 88.69 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.625 1.107 . . . . 0.0 115.167 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -81.8 154.54 25.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.108 1.454 . . . . 0.0 113.406 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -134.12 178.87 6.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.007 2.123 . . . . 0.0 110.805 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -153.22 162.89 40.81 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.178 -0.951 . . . . 0.0 112.26 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.44 158.17 38.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.35 1.86 . . . . 0.0 109.085 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.02 136.55 73.47 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.262 2.641 . . . . 0.0 112.14 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.62 -29.95 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.23 -14.78 62.47 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.27 -19.87 59.47 Favored 'General case' 0 CA--C 1.553 1.079 0 O-C-N 121.421 -0.799 . . . . 0.0 113.149 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.44 170.39 9.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.176 1.39 . . . . 0.0 112.866 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.8 108.28 14.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 111.287 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.27 -18.66 65.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -170.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.01 -26.12 68.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.156 0.982 . . . . 0.0 112.507 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.16 -1.72 58.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.109 1.764 . . . . 0.0 111.851 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -118.11 82.02 1.77 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 127.122 2.169 . . . . 0.0 108.651 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.19 -27.06 13.14 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.095 1.758 . . . . 0.0 113.067 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.1 t -131.4 130.85 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.802 1.641 . . . . 0.0 108.706 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.7 t -133.77 126.33 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.079 -1.013 . . . . 0.0 109.838 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.2 mm -126.64 111.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.61 1.164 . . . . 0.0 109.687 -170.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.2 t -87.49 156.87 19.35 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.493 1.117 . . . . 0.0 112.145 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.6 41.48 3.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.643 1.577 . . . . 0.0 111.68 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.6 m -106.32 -27.81 10.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.783 1.233 . . . . 0.0 112.4 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.05 88.48 1.65 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.774 1.654 . . . . 0.0 113.995 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.0 t 46.3 42.97 11.06 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.843 1.657 . . . . 0.0 114.233 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.85 106.96 0.19 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.165 1.364 . . . . 0.0 111.941 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -145.49 142.46 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.153 1.381 . . . . 0.0 111.545 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -88.79 52.14 2.34 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.4 1.08 . . . . 0.0 112.502 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.96 142.78 65.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.52 154.29 72.64 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.342 2.028 . . . . 0.0 109.952 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.17 -25.27 76.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.935 2.423 . . . . 0.0 114.868 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.07 -16.37 63.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.506 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.5 m95 -93.16 -2.23 55.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.94 0.93 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.345 1.458 . . . . 0.0 113.941 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -103.14 -1.14 29.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.319 1.848 . . . . 0.0 113.222 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.489 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.7 mp0 -54.88 161.55 1.56 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.241 2.616 . . . . 0.0 114.352 174.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.98 -35.01 79.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.8 mt -133.84 131.59 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.444 1.098 . . . . 0.0 110.465 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -141.32 149.4 41.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.403 1.481 . . . . 0.0 112.349 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -146.11 159.09 43.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.056 1.742 . . . . 0.0 110.304 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -138.99 86.62 2.15 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.403 0.681 . . . . 0.0 111.44 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -67.68 146.71 53.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.792 1.637 . . . . 0.0 113.631 -170.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -98.97 60.49 1.22 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.528 1.931 . . . . 0.0 107.691 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.27 127.52 55.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.116 1.766 . . . . 0.0 112.349 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.59 169.95 12.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.009 1.324 . . . . 0.0 113.96 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.91 119.61 57.77 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.185 0.994 . . . . 0.0 110.982 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.18 -10.92 19.43 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.64 2.227 . . . . 0.0 113.521 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -58.16 127.59 32.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.106 1.321 . . . . 0.0 111.573 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.2 2.62 87.59 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.189 0.9 . . . . 0.0 115.012 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -111.66 -179.54 3.73 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.773 1.629 . . . . 0.0 111.835 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 t -73.95 159.61 32.52 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.709 0.804 . . . . 0.0 112.573 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.404 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -62.99 -25.46 68.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.19 0.996 . . . . 0.0 111.884 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.44 -32.18 73.39 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.523 -0.736 . . . . 0.0 111.571 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.03 -38.66 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.276 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -58.04 -48.44 80.09 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.085 1.311 . . . . 0.0 110.882 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -66.82 -26.67 67.04 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -74.28 -55.46 6.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.569 0.748 . . . . 0.0 111.33 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -34.28 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 110.89 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -58.3 -42.15 86.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.452 1.024 . . . . 0.0 112.691 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.37 -34.4 74.39 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.408 0.528 . . . . 0.0 112.726 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -68.97 -39.76 79.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.357 1.079 . . . . 0.0 111.332 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.63 -51.41 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.1 0.96 . . . . 0.0 110.522 170.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 123' ' ' VAL . 14.6 tmtt? -54.59 -47.58 73.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.701 1.201 . . . . 0.0 112.554 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -68.44 -27.94 66.62 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.659 1.572 . . . . 0.0 112.842 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -72.48 -49.74 30.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.215 1.006 . . . . 0.0 111.52 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 120' ' ' LYS . 35.8 m -62.83 -40.66 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 118.323 -0.846 . . . . 0.0 113.244 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.29 -46.71 82.47 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.824 1.647 . . . . 0.0 111.689 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -70.31 -33.21 71.25 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.526 0.603 . . . . 0.0 112.56 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.94 -46.63 87.53 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.136 0.974 . . . . 0.0 111.092 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt -73.56 -43.4 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.365 -0.834 . . . . 0.0 110.56 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.38 -27.69 69.25 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -85.9 -12.74 49.82 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -114.93 -18.52 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.393 0 C-N-CA 124.676 1.19 . . . . 0.0 113.1 -179.623 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.5 2.051 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -71.96 142.5 49.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.215 1.006 . . . . 0.0 111.896 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -108.2 126.16 52.48 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.571 1.148 . . . . 0.0 111.028 171.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.36 113.89 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.881 2.072 . . . . 0.0 110.092 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.9 ttm -98.71 126.48 44.34 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.148 0.885 . . . . 0.0 110.627 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -93.28 127.05 38.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.184 0.994 . . . . 0.0 109.408 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.06 135.26 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.703 1.201 . . . . 0.0 113.197 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 p -146.08 178.45 8.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.21 1.004 . . . . 0.0 112.6 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -89.11 161.2 16.65 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.212 1.005 . . . . 0.0 111.797 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -35.22 64.63 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -86.36 5.15 36.17 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.408 1.483 . . . . 0.0 114.747 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 p -117.21 158.02 25.01 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.6 p -114.95 4.3 14.75 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.8 1.24 . . . . 0.0 114.209 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -66.04 -34.57 78.39 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.984 1.714 . . . . 0.0 112.452 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -63.88 -37.32 86.94 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.323 1.42 . . . . 0.0 113.329 170.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.17 -45.62 66.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.827 0.451 . . . . 0.0 110.14 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.422 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 6.7 tpt -72.32 -38.62 68.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.3 86.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.551 0.614 . . . . 0.0 111.688 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -38.82 89.62 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.824 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.34 29.61 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 119.671 1.123 . . . . 0.0 113.655 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.47 -38.33 90.71 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.396 -1.061 . . . . 0.0 111.39 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.76 -34.7 76.02 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -72.12 -19.17 61.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.845 1.657 . . . . 0.0 113.215 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.2 m -89.26 -45.12 9.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.808 0.843 . . . . 0.0 111.971 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.94 -33.68 12.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.679 1.192 . . . . 0.0 113.009 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 4.94 81.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 125.679 1.609 . . . . 0.0 113.27 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.12 116.88 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 118.32 1.06 . . . . 0.0 111.725 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 14.63 76.91 Favored Glycine 0 CA--C 1.537 1.462 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.95 -44.39 3.81 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.245 1.522 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -145.71 162.21 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 126.465 1.906 . . . . 0.0 111.48 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.52 149.08 24.6 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -145.89 143.43 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.832 -1.167 . . . . 0.0 114.049 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.4 m -143.8 143.27 31.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.522 1.529 . . . . 0.0 110.871 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.3 p -106.86 145.25 32.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 0.0 111.677 170.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -156.36 154.46 30.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.533 1.133 . . . . 0.0 110.735 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.98 150.2 17.04 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.004 1.288 . . . . 0.0 110.653 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -52.88 -37.55 60.58 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.571 1.185 . . . . 0.0 112.413 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -126.11 39.42 3.95 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.47 . . . . 0.0 111.287 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 69.08 170.65 0.3 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.667 1.987 . . . . 0.0 114.177 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -159.15 167.84 28.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.113 2.565 . . . . 0.0 109.978 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 156.19 28.52 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -173.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.6 146.61 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.916 1.286 . . . . 0.0 109.542 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -126.23 126.76 24.72 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.885 -169.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.519 2.813 . . . . 0.0 115.085 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 m -64.4 -34.11 77.42 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.022 -1.049 . . . . 0.0 111.526 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.17 -10.15 59.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.161 -0.962 . . . . 0.0 113.186 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.6 mt -80.13 -56.83 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 167.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.68 72.61 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.7 mmt -69.75 -8.19 45.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.422 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.4 mmt -124.63 -26.38 3.84 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.459 1.104 . . . . 0.0 112.263 -169.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -26.66 68.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.844 -1.16 . . . . 0.0 111.658 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.37 -9.14 55.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.0 0.92 . . . . 0.0 113.372 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.47 1.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.466 2.306 . . . . 0.0 110.765 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.04 81.75 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.693 1.616 . . . . 0.0 114.836 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.16 150.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.857 1.263 . . . . 0.0 111.293 -174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -126.92 142.29 51.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.199 1.4 . . . . 0.0 112.489 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 pt -137.53 -1.96 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.422 1.889 . . . . 0.0 111.783 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.8 p -63.18 -34.02 76.73 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.73 2.8 87.78 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.635 1.112 . . . . 0.0 115.369 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -72.57 159.71 33.46 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 p -118.0 -176.24 3.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.072 2.549 . . . . 0.0 108.911 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.0 t -146.07 -73.27 0.23 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.011 -1.055 . . . . 0.0 111.216 170.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 63.95 154.18 0.12 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.556 2.343 . . . . 0.0 115.211 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.87 133.79 46.61 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.726 2.284 . . . . 0.0 111.991 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.5 tt -55.98 -34.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.38 -8.6 51.93 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -20.68 60.24 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.254 -0.904 . . . . 0.0 112.692 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.54 171.42 8.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.181 1.392 . . . . 0.0 112.807 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.9 114.54 27.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.016 1.726 . . . . 0.0 110.934 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -69.21 -18.3 63.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.88 -26.44 66.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.784 0.833 . . . . 0.0 112.542 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -86.98 -2.81 58.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.056 1.742 . . . . 0.0 112.132 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -114.86 81.9 1.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.8 2.04 . . . . 0.0 107.972 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.23 -28.7 12.21 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.755 1.622 . . . . 0.0 112.88 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -131.0 130.5 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 126.01 1.724 . . . . 0.0 108.851 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -133.23 128.8 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.153 -0.967 . . . . 0.0 109.763 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 mm -125.19 117.14 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 109.053 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.7 t -89.89 153.57 20.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 111.316 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -133.26 35.91 3.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.43 1.092 . . . . 0.0 111.972 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.6 m -96.61 -12.54 23.8 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.86 57.52 7.78 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 119.62 1.1 . . . . 0.0 112.613 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 67.4 m 64.26 -25.1 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 129.311 3.044 . . . . 0.0 116.311 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.21 39.89 1.68 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.988 1.756 . . . . 0.0 115.889 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 p -98.74 151.0 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.385 1.474 . . . . 0.0 111.711 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -128.73 129.53 45.86 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.425 1.49 . . . . 0.0 108.977 169.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -143.44 140.51 17.66 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.711 1.204 . . . . 0.0 112.613 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -63.91 154.01 72.45 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.591 2.194 . . . . 0.0 110.449 168.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.48 -32.29 96.09 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.371 2.048 . . . . 0.0 114.728 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.28 -22.19 66.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.1 m95 -89.29 -3.16 58.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.46 -19.95 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 t -81.96 6.8 14.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.754 1.622 . . . . 0.0 114.354 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.6 mp0 -55.78 160.68 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.035 2.134 . . . . 0.0 113.721 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.36 -33.53 74.92 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.7 mt -131.69 124.58 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.114 0.966 . . . . 0.0 110.173 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -135.31 141.88 45.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.427 1.491 . . . . 0.0 110.521 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.4 159.1 39.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.011 1.324 . . . . 0.0 110.871 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.24 131.94 54.52 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.602 1.161 . . . . 0.0 111.327 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.9 m0 -103.48 162.42 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.786 1.635 . . . . 0.0 112.77 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -119.89 40.13 3.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.874 1.27 . . . . 0.0 112.871 -168.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.94 159.58 34.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.874 0.87 . . . . 0.0 111.081 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -106.06 162.08 13.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.412 1.485 . . . . 0.0 109.795 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -88.52 128.55 52.45 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.78 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.51 -13.53 16.5 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.278 1.985 . . . . 0.0 112.804 169.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -51.23 -42.99 61.36 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.647 1.979 . . . . 0.0 114.67 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -89.51 10.63 72.74 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.547 1.07 . . . . 0.0 114.62 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -132.14 -173.0 3.03 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.697 1.599 . . . . 0.0 113.015 -169.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.9 t -80.0 164.18 23.65 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.465 1.106 . . . . 0.0 113.024 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.41 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.6 mm? -63.21 -30.13 71.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.818 1.247 . . . . 0.0 111.858 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.05 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.346 -0.846 . . . . 0.0 111.749 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.53 -39.05 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 110.824 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -56.59 -47.2 80.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.09 1.314 . . . . 0.0 110.518 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -70.69 -19.28 62.79 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.1 m -82.03 -50.83 8.66 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.874 1.27 . . . . 0.0 112.211 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.74 -33.71 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.398 1.079 . . . . 0.0 111.517 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -54.1 -40.21 67.07 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.852 0.751 . . . . 0.0 112.922 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.68 -32.89 63.82 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.282 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -70.95 -40.77 71.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.396 1.098 . . . . 0.0 110.273 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.13 -52.42 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.133 0.973 . . . . 0.0 110.66 170.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -55.47 -48.82 73.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.009 1.324 . . . . 0.0 112.462 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.99 -28.8 66.93 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.905 1.684 . . . . 0.0 112.51 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -71.94 -47.48 52.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.474 0.709 . . . . 0.0 111.861 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.6 m -62.54 -35.32 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.008 0.822 . . . . 0.0 112.897 170.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.77 -46.21 90.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.887 1.221 . . . . 0.0 111.389 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.55 97.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.329 0.513 . . . . 0.0 111.051 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.492 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -59.31 -48.96 79.65 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.771 0.828 . . . . 0.0 111.199 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.51 -44.23 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.868 -0.52 . . . . 0.0 110.489 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.58 70.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.4 pttt -86.86 -13.24 45.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -115.24 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 124.516 1.127 . . . . 0.0 113.091 178.518 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 119.765 -0.159 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -69.85 138.68 52.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.479 1.112 . . . . 0.0 111.4 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -108.05 127.39 53.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.05 0.94 . . . . 0.0 110.923 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.84 119.48 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.063 1.745 . . . . 0.0 109.685 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.5 tpp -97.8 126.78 43.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.73 123.34 45.54 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.063 0.545 . . . . 0.0 111.152 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.17 149.22 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.164 0.985 . . . . 0.0 113.546 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -146.53 158.7 43.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.155 1.382 . . . . 0.0 109.007 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -62.55 -47.8 82.28 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.524 1.056 . . . . 0.0 111.706 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.01 -40.3 0.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -76.29 109.81 10.29 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -169.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -25.59 65.8 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.046 1.738 . . . . 0.0 113.947 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.5 m -62.7 -7.4 4.8 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -104.47 -55.47 2.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.114 0.966 . . . . 0.0 111.656 168.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.6 p -70.69 -55.97 7.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.328 1.051 . . . . 0.0 113.543 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.66 -33.66 74.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.021 0.528 . . . . 0.0 110.232 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.9 tpt -71.89 -43.78 64.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.12 99.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.508 0.723 . . . . 0.0 111.637 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -43.91 95.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.858 169.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.38 -53.05 43.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.525 1.057 . . . . 0.0 113.176 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -61.38 -36.34 79.99 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.697 1.249 . . . . 0.0 111.535 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.98 -27.17 62.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -65.91 -46.31 78.77 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.844 1.656 . . . . 0.0 111.375 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -74.48 -38.27 62.96 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.0 1.32 . . . . 0.0 112.332 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.8 mt -96.29 -29.83 13.78 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.17 0.988 . . . . 0.0 113.038 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.59 6.34 77.86 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.772 1.653 . . . . 0.0 113.829 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.0 118.82 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.467 1.134 . . . . 0.0 111.408 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.08 14.97 80.04 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 118.743 -1.032 . . . . 0.0 115.589 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -124.27 -43.3 2.07 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.27 1.535 . . . . 0.0 111.913 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.98 157.87 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.663 1.185 . . . . 0.0 113.191 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.83 154.02 20.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.471 1.108 . . . . 0.0 109.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.97 140.54 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 121.238 -0.914 . . . . 0.0 113.093 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 m -144.89 154.02 42.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.328 1.451 . . . . 0.0 109.538 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.3 p -121.6 152.1 39.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.719 0.808 . . . . 0.0 112.794 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 t -151.83 150.71 30.42 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.324 1.049 . . . . 0.0 110.846 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.12 140.75 15.77 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 169.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.9 -41.99 92.86 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.518 1.659 . . . . 0.0 110.995 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.59 33.63 3.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.532 170.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t 64.27 170.93 0.18 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.387 1.875 . . . . 0.0 113.932 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.1 p -153.13 -172.62 4.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.098 1.759 . . . . 0.0 111.546 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -137.6 -147.92 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.258 1.423 . . . . 0.0 111.82 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.23 151.06 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 126.5 1.92 . . . . 0.0 107.304 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -123.74 126.64 25.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 CA-C-O 117.604 -1.189 . . . . 0.0 111.206 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -54.41 -39.22 88.51 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.324 2.683 . . . . 0.0 114.898 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 m -66.03 -32.57 74.13 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.996 -1.065 . . . . 0.0 111.872 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.2 -10.66 59.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.13 -0.981 . . . . 0.0 113.285 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.83 -53.77 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.39 61.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -170.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.05 -6.64 43.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.3 mmt -128.12 -29.51 2.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.93 0.892 . . . . 0.0 112.532 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.8 -25.49 67.52 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.893 -1.129 . . . . 0.0 111.855 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.95 -14.31 62.96 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.6 19.06 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.38 1.472 . . . . 0.0 111.584 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.81 76.08 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.801 1.667 . . . . 0.0 116.591 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mm -80.13 148.6 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.45 1.625 . . . . 0.0 112.151 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.55 111.4 11.72 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.166 1.786 . . . . 0.0 112.024 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.5 pt -140.98 -1.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.145 1.378 . . . . 0.0 113.693 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -61.84 -35.78 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -169.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.54 -2.45 90.05 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.332 0.968 . . . . 0.0 115.236 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -85.41 167.28 15.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.895 1.347 . . . . 0.0 114.327 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -139.88 -175.27 4.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.053 1.741 . . . . 0.0 110.586 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 t -145.24 165.49 28.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.67 1.588 . . . . 0.0 112.101 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.31 157.23 45.81 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.732 1.613 . . . . 0.0 110.299 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.12 139.55 90.28 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.418 2.745 . . . . 0.0 112.103 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -58.35 -31.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.18 -10.51 58.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.57 57.7 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.08 0.855 . . . . 0.0 112.789 170.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -94.4 170.4 9.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.061 1.345 . . . . 0.0 112.41 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 108.72 15.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.567 1.547 . . . . 0.0 111.155 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.66 -19.35 65.74 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.44 -26.53 68.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.866 0.866 . . . . 0.0 112.567 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.87 -2.67 58.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.343 1.857 . . . . 0.0 111.936 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -116.1 83.98 2.04 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.207 2.203 . . . . 0.0 108.235 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.21 -25.91 6.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.087 1.755 . . . . 0.0 113.049 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -133.36 130.26 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.848 1.659 . . . . 0.0 108.902 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -134.13 126.63 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.083 -1.01 . . . . 0.0 109.471 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.1 mm -127.03 116.58 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.589 1.156 . . . . 0.0 109.901 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -91.15 157.31 17.28 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.061 1.344 . . . . 0.0 111.651 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.65 35.89 4.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.176 1.39 . . . . 0.0 112.287 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -95.77 -32.76 12.55 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.791 1.236 . . . . 0.0 112.204 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.18 93.41 1.97 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.711 1.624 . . . . 0.0 113.388 170.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 61.6 m 48.58 34.82 5.29 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.045 1.738 . . . . 0.0 114.93 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.7 105.79 0.19 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.591 1.567 . . . . 0.0 111.924 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.77 143.24 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.091 1.356 . . . . 0.0 111.373 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -88.93 55.28 3.29 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.339 1.055 . . . . 0.0 112.436 -172.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 mt -84.23 142.42 40.93 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.85 154.97 70.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.612 2.208 . . . . 0.0 109.915 168.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.91 -28.99 81.67 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.917 2.411 . . . . 0.0 114.276 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.33 -19.44 65.81 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.82 -1.175 . . . . 0.0 113.814 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.494 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.5 m95 -91.6 -3.26 56.61 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 m -115.91 -16.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -83.79 4.24 29.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.863 1.665 . . . . 0.0 114.13 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.473 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.1 mp0 -58.07 159.74 5.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.972 2.109 . . . . 0.0 113.986 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -62.99 -34.05 76.71 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.32 127.85 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.817 0.847 . . . . 0.0 109.864 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.64 148.31 48.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.291 1.436 . . . . 0.0 111.821 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -147.22 157.41 43.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.829 1.652 . . . . 0.0 110.391 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -135.98 86.06 2.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.619 0.768 . . . . 0.0 111.018 169.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -66.98 146.61 54.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.836 1.655 . . . . 0.0 115.02 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -96.53 49.09 1.09 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.526 2.33 . . . . 0.0 108.742 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.14 134.51 40.37 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.254 1.822 . . . . 0.0 112.654 -167.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.1 179.27 6.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.098 1.359 . . . . 0.0 113.897 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -101.61 113.97 65.73 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.868 0.867 . . . . 0.0 111.806 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -77.32 -25.43 8.41 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.559 1.506 . . . . 0.0 113.264 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.87 -19.77 64.25 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -86.57 3.59 86.9 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.838 0.732 . . . . 0.0 113.705 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -136.82 -168.74 2.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.369 1.868 . . . . 0.0 112.408 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 p -74.8 168.62 19.52 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.37 -30.07 67.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.814 0.846 . . . . 0.0 111.373 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.62 -35.15 79.49 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.242 -0.912 . . . . 0.0 110.919 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.97 -39.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.404 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -55.77 -47.75 76.48 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 121.147 1.794 . . . . 0.0 111.427 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -69.27 -15.04 63.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.267 1.027 . . . . 0.0 113.564 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.6 m -88.77 -49.23 6.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.659 1.584 . . . . 0.0 112.641 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -70.38 -31.76 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.24 -0.913 . . . . 0.0 111.073 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -56.24 -39.83 73.16 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 0.0 112.453 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.48 -34.6 68.06 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.071 0.843 . . . . 0.0 112.63 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -69.49 -43.2 73.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.059 0.93 . . . . 0.0 110.513 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.94 -47.2 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.377 0.671 . . . . 0.0 110.685 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -56.45 -49.41 74.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.55 1.14 . . . . 0.0 112.3 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.7 -29.84 62.52 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.017 1.28 . . . . 0.0 113.13 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -64.8 -50.85 65.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.477 0.711 . . . . 0.0 110.866 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.4 t -56.36 -46.21 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.868 1.267 . . . . 0.0 112.611 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.63 -49.05 78.11 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 120.099 1.318 . . . . 0.0 111.874 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -71.47 -32.61 68.48 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.433 0.561 . . . . 0.0 111.948 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.52 -48.33 81.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.971 0.908 . . . . 0.0 111.308 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.8 -43.17 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.683 0.674 . . . . 0.0 110.7 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.82 68.68 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.62 -11.84 58.09 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.9 pt -111.44 -28.3 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.256 1.418 0 C-N-CA 125.629 1.572 . . . . 0.0 112.108 -178.183 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttp . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -72.77 144.19 47.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.636 1.174 . . . . 0.0 112.316 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -112.06 125.76 54.44 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.196 0.998 . . . . 0.0 111.836 170.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.79 116.55 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.821 1.649 . . . . 0.0 110.585 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.52 126.08 43.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.375 0.989 . . . . 0.0 110.454 168.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -95.36 121.45 37.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.894 0.878 . . . . 0.0 110.323 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.29 136.35 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.086 0.954 . . . . 0.0 113.275 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -148.62 176.35 10.41 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.825 0.85 . . . . 0.0 112.216 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -72.46 164.38 26.48 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.706 1.203 . . . . 0.0 112.925 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -51.15 -48.62 61.8 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -169.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -82.52 -6.48 59.35 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.6 m -94.43 144.79 25.26 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.201 1.4 . . . . 0.0 113.066 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.9 p -103.03 -11.48 18.11 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -61.41 -22.81 65.35 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.028 -1.67 . . . . 0.0 115.165 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -68.51 -47.29 67.36 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.621 1.555 . . . . 0.0 111.331 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.19 -38.58 91.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.581 1.153 . . . . 0.0 111.759 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.402 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 7.7 tpt -73.58 -38.23 65.22 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.687 0.795 . . . . 0.0 112.244 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.69 -44.14 90.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.229 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.87 -44.05 91.0 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.144 0.884 . . . . 0.0 112.052 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.51 -49.77 67.19 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 119.598 1.09 . . . . 0.0 113.267 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.3 -43.15 87.09 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.135 -1.215 . . . . 0.0 111.666 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.82 82.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.844 -1.16 . . . . 0.0 113.797 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -72.55 -16.54 61.76 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.57 1.077 . . . . 0.0 113.254 174.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.9 m -88.21 -44.71 10.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.69 1.196 . . . . 0.0 111.99 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -95.99 -34.6 11.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.21 1.004 . . . . 0.0 113.539 -171.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.94 5.33 85.03 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.77 1.652 . . . . 0.0 113.85 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.43 -44.9 4.19 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.25 18.99 41.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.416 1.484 . . . . 0.0 114.536 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -127.19 -38.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.767 1.227 . . . . 0.0 112.504 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.52 163.27 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.646 1.579 . . . . 0.0 112.248 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.25 152.6 18.22 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 168.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -148.61 145.22 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 120.631 -1.293 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -147.11 163.45 36.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.053 1.741 . . . . 0.0 108.827 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.4 p -134.01 154.55 51.05 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.725 -1.234 . . . . 0.0 111.747 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 t -145.94 142.25 28.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.481 1.112 . . . . 0.0 109.935 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.96 137.21 13.68 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.975 -0.453 . . . . 0.0 112.19 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.15 121.29 13.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 64.47 28.67 13.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.296 1.839 . . . . 0.0 113.775 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t 70.41 170.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.432 2.293 . . . . 0.0 114.062 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 62' ' ' SER . 82.1 p -152.71 179.12 8.91 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.699 1.6 . . . . 0.0 112.062 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 160.77 38.19 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.27 147.07 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.918 1.287 . . . . 0.0 109.07 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -119.63 132.19 24.12 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.65 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.88 -36.15 82.26 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.039 2.493 . . . . 0.0 114.795 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -69.57 -33.15 72.32 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.017 -1.052 . . . . 0.0 112.096 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 -13.44 61.14 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.044 -1.035 . . . . 0.0 113.21 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.07 -57.33 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.37 78.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -169.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mmt -68.46 -8.5 41.43 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.402 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 14.3 mmt -123.15 -27.25 4.2 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 -169.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.87 -27.59 68.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.173 -0.954 . . . . 0.0 111.891 169.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.29 -8.13 53.22 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.332 1.053 . . . . 0.0 113.408 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.61 -0.46 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.516 2.326 . . . . 0.0 110.772 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.54 14.44 78.22 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.276 1.417 . . . . 0.0 114.629 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 mm -92.62 153.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.872 1.269 . . . . 0.0 111.192 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -130.92 139.0 50.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.444 1.498 . . . . 0.0 111.859 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.6 pt -135.58 -6.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.694 1.198 . . . . 0.0 112.49 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -58.35 -34.41 70.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.583 1.553 . . . . 0.0 114.526 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.69 -3.82 89.32 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.474 1.035 . . . . 0.0 115.295 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -81.71 154.84 25.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.961 1.381 . . . . 0.0 113.424 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -130.42 178.06 6.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.83 2.052 . . . . 0.0 110.681 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 40' ' ' SER . 3.7 t -148.73 158.58 44.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.121 -0.987 . . . . 0.0 112.444 173.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -152.04 158.1 33.92 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.687 1.995 . . . . 0.0 109.284 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.03 140.89 95.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.344 2.696 . . . . 0.0 112.474 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -60.11 -29.62 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.54 -12.04 60.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -21.42 59.22 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.252 -0.905 . . . . 0.0 112.735 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 166.25 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.359 . . . . 0.0 112.523 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.89 107.05 14.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.485 1.514 . . . . 0.0 111.086 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -62.38 -16.18 53.11 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.874 -1.141 . . . . 0.0 113.799 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -59.26 -18.83 40.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.572 1.549 . . . . 0.0 113.063 176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.18 -0.51 28.41 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.463 1.905 . . . . 0.0 112.877 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -123.61 76.62 1.43 Allowed 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.831 1.652 . . . . 0.0 109.894 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.56 -23.75 11.61 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.661 1.984 . . . . 0.0 113.256 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.54 131.46 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.193 1.397 . . . . 0.0 109.329 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.62 126.35 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.876 -1.14 . . . . 0.0 110.391 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.07 119.69 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.364 1.465 . . . . 0.0 108.206 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 t -83.43 151.06 25.67 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.781 1.633 . . . . 0.0 110.112 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.05 38.25 4.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.129 -0.982 . . . . 0.0 111.765 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 98.7 m -127.2 17.2 7.17 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.64 34.07 88.51 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 120.716 -1.24 . . . . 0.0 113.821 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 75.1 m 61.41 -1.15 0.32 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.881 2.472 . . . . 0.0 115.841 -169.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.84 57.96 4.53 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.474 1.512 . . . . 0.0 111.524 169.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.35 139.35 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.301 1.44 . . . . 0.0 111.673 -169.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -99.44 117.71 34.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.125 0.97 . . . . 0.0 109.521 172.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.83 131.87 12.69 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.599 1.16 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.97 148.28 89.51 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.762 2.308 . . . . 0.0 110.126 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.18 -29.55 83.95 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.657 2.905 . . . . 0.0 115.483 -169.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -63.84 -20.96 66.2 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.487 -1.383 . . . . 0.0 114.014 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.453 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 99.0 m95 -81.76 -15.42 54.34 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.401 -1.437 . . . . 0.0 114.526 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.22 -21.25 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.851 1.261 . . . . 0.0 113.524 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 t -84.56 13.37 5.67 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.974 1.71 . . . . 0.0 113.568 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -67.8 164.54 19.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 112.786 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.31 -34.85 78.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.6 mt -133.5 126.59 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 110.072 169.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.08 148.07 48.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.931 1.292 . . . . 0.0 110.79 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -141.53 162.34 35.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.519 1.128 . . . . 0.0 112.402 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.68 130.81 32.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 108.749 168.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -108.28 135.26 49.89 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.399 1.479 . . . . 0.0 111.014 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -93.81 44.24 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.18 1.392 . . . . 0.0 110.92 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.19 150.92 24.06 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.659 1.583 . . . . 0.0 112.651 -173.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.92 165.16 13.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.889 1.276 . . . . 0.0 110.477 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.1 134.23 19.9 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.853 -0.529 . . . . 0.0 112.168 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -85.44 -12.03 6.84 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 121.866 1.71 . . . . 0.0 113.187 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -45.38 -42.08 9.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.688 1.995 . . . . 0.0 114.587 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.32 15.04 57.95 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.194 1.378 . . . . 0.0 115.903 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -126.08 -174.62 3.15 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 119.044 1.422 . . . . 0.0 114.071 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.5 p -71.81 164.7 25.53 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.451 1.5 . . . . 0.0 114.415 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.12 -33.12 74.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.919 0.887 . . . . 0.0 111.476 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.44 -34.89 79.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.726 -0.609 . . . . 0.0 111.198 169.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.8 t -69.53 -42.47 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 117.805 -1.093 . . . . 0.0 111.85 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -55.65 -48.9 74.22 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.951 1.705 . . . . 0.0 111.195 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -69.74 -19.31 63.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -84.36 -50.41 7.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 0.0 112.024 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.0 t -70.8 -30.97 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.588 1.155 . . . . 0.0 111.812 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -55.04 -42.26 72.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.274 0.943 . . . . 0.0 112.784 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.4 65.36 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.728 0.68 . . . . 0.0 112.849 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -68.57 -48.39 64.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.167 0.983 . . . . 0.0 109.681 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.15 -41.41 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.538 -0.726 . . . . 0.0 111.093 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.21 -50.11 73.89 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.096 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -70.82 -29.41 65.56 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.514 1.506 . . . . 0.0 113.335 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -63.48 -52.72 60.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 172.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.17 -50.84 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.138 1.375 . . . . 0.0 112.219 170.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.7 -49.99 70.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.847 1.203 . . . . 0.0 112.499 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -30.19 68.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.442 0.564 . . . . 0.0 112.142 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.15 -52.59 32.94 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.676 0.79 . . . . 0.0 110.876 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.8 -37.47 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.958 -1.089 . . . . 0.0 111.83 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.06 -26.48 68.86 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -87.78 -23.41 24.09 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -101.85 -20.09 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.254 1.338 0 C-N-CA 124.857 1.263 . . . . 0.0 113.829 -170.361 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -79.61 136.54 36.87 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.097 0.959 . . . . 0.0 112.419 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.33 128.17 53.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.643 1.177 . . . . 0.0 111.556 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.15 111.78 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.488 1.915 . . . . 0.0 110.319 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -92.8 122.45 35.2 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 169.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -93.31 114.91 27.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.998 0.519 . . . . 0.0 109.923 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.84 144.43 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.06 1.344 . . . . 0.0 111.985 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t -148.16 170.46 17.79 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.274 -0.891 . . . . 0.0 112.855 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -62.59 163.23 9.27 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.437 1.495 . . . . 0.0 110.781 169.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -59.15 143.29 49.26 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.282 1.033 . . . . 0.0 112.474 -173.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 52.51 44.51 29.92 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.855 1.262 . . . . 0.0 113.303 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.3 p -109.32 -26.66 9.92 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -169.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 t 57.52 1.89 0.13 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.452 1.901 . . . . 0.0 116.026 -169.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -76.27 -37.69 57.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 119.131 -2.231 . . . . 0.0 110.397 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -62.44 -46.53 88.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.863 1.265 . . . . 0.0 111.695 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.38 -33.93 67.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.394 0.678 . . . . 0.0 111.805 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -37.68 64.87 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.086 -1.009 . . . . 0.0 113.337 169.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -45.41 90.09 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.114 0.87 . . . . 0.0 110.919 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -57.92 -46.85 84.36 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.058 169.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.42 -49.19 46.26 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.826 1.194 . . . . 0.0 115.405 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -72.64 -36.11 67.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.024 1.412 . . . . 0.0 111.619 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.82 73.23 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -69.02 -26.36 64.95 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.582 1.537 . . . . 0.0 112.504 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.2 m -84.51 -44.93 13.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.08 0.952 . . . . 0.0 111.669 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -95.59 -32.36 12.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.27 1.028 . . . . 0.0 113.308 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 5.76 79.78 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 125.87 1.7 . . . . 0.0 113.351 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 115.42 1.1 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.318 1.059 . . . . 0.0 111.862 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.44 80.26 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 115.821 1.089 . . . . 0.0 115.821 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -119.55 -34.42 3.8 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.238 1.519 . . . . 0.0 111.906 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -149.88 166.96 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.739 2.016 . . . . 0.0 111.623 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.19 152.07 19.44 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -144.69 145.2 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.023 1.283 . . . . 0.0 113.858 -175.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -144.55 154.38 42.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.38 1.872 . . . . 0.0 110.001 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.8 p -118.76 152.27 36.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.594 1.088 . . . . 0.0 113.421 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 t -149.66 150.71 32.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.255 1.422 . . . . 0.0 111.012 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.62 18.12 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.2 mt -53.13 -40.8 64.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.668 1.734 . . . . 0.0 112.199 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -122.21 37.03 4.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.932 1.693 . . . . 0.0 111.074 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 72.97 151.5 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.272 2.229 . . . . 0.0 115.094 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -132.01 -169.34 2.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.195 1.798 . . . . 0.0 111.424 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.24 178.81 7.31 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.95 116.47 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.519 1.928 . . . . 0.0 109.25 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.8 148.91 52.51 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 118.673 -0.679 . . . . 0.0 112.065 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.28 -37.65 88.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.359 2.706 . . . . 0.0 113.892 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -65.48 -33.35 75.73 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.027 -1.046 . . . . 0.0 112.018 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.51 -10.74 59.85 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.4 mt -83.9 -53.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.17 68.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.86 -8.14 54.15 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 mmt -126.08 -27.35 3.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.284 1.033 . . . . 0.0 112.555 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.05 -25.13 67.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.787 -1.196 . . . . 0.0 111.985 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.39 -13.82 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.375 1.07 . . . . 0.0 113.544 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.28 18.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.422 1.489 . . . . 0.0 111.557 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.59 76.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.741 1.639 . . . . 0.0 116.611 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.2 mm -75.51 145.15 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.537 1.669 . . . . 0.0 111.6 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -133.77 97.92 4.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.641 1.576 . . . . 0.0 110.887 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 pt -132.75 11.93 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -58.47 -30.54 67.05 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.806 1.243 . . . . 0.0 113.333 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.43 -1.08 75.35 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.907 1.241 . . . . 0.0 115.348 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -74.76 140.13 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.703 1.751 . . . . 0.0 112.375 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.6 p -114.78 172.6 6.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.547 1.939 . . . . 0.0 110.343 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -145.44 158.71 43.79 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.304 -0.872 . . . . 0.0 111.783 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -150.03 157.59 37.53 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.779 1.632 . . . . 0.0 110.569 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.72 142.92 91.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.62 2.88 . . . . 0.0 113.098 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.88 -31.09 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -67.14 -13.22 61.74 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -21.02 57.16 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 112.916 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -94.62 166.85 11.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.878 1.271 . . . . 0.0 112.691 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.3 107.64 15.52 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 111.126 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -65.87 -21.4 66.46 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -169.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.57 -27.41 68.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.179 0.991 . . . . 0.0 112.487 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.16 -3.85 59.05 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.939 1.696 . . . . 0.0 112.187 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.15 80.32 1.44 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 127.119 2.168 . . . . 0.0 108.556 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.37 -27.65 10.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.767 1.627 . . . . 0.0 112.942 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.59 127.54 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.184 1.794 . . . . 0.0 108.835 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.82 124.65 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.15 -0.969 . . . . 0.0 109.251 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.17 124.25 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.417 1.087 . . . . 0.0 109.215 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -99.59 154.07 18.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.572 1.149 . . . . 0.0 111.938 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.87 35.15 3.79 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.111 1.364 . . . . 0.0 111.764 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.1 m -91.83 -11.82 35.42 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.74 56.11 8.78 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-N 119.464 1.029 . . . . 0.0 112.979 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 75.8 m 64.88 162.25 0.13 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 128.377 2.671 . . . . 0.0 114.582 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.78 27.68 72.94 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 115.776 1.07 . . . . 0.0 115.776 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.14 123.69 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.614 1.207 . . . . 0.0 111.15 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -84.3 121.82 28.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.874 0.87 . . . . 0.0 109.516 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.1 mt -142.51 139.93 18.11 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.62 1.168 . . . . 0.0 112.75 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.32 153.81 72.05 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.448 2.098 . . . . 0.0 110.167 168.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.86 -22.45 73.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.089 2.526 . . . . 0.0 115.167 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.99 -15.0 62.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.49 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.7 m95 -92.08 -1.56 57.13 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.78 10.62 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 125.887 1.675 . . . . 0.0 113.894 -175.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -112.52 -2.62 14.59 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.399 1.88 . . . . 0.0 112.826 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.445 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.7 mp0 -56.72 160.4 3.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.551 2.74 . . . . 0.0 113.95 175.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.84 -32.59 74.2 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.65 127.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.146 0.978 . . . . 0.0 110.513 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -139.38 141.33 37.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.247 1.419 . . . . 0.0 111.624 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -157.3 161.64 39.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 110.665 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.44 134.01 52.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 111.8 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -108.78 163.35 13.35 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.202 1.801 . . . . 0.0 112.104 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -130.33 62.14 1.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.856 1.262 . . . . 0.0 112.337 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.55 167.21 20.37 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.542 1.537 . . . . 0.0 111.418 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -117.52 158.83 23.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.967 1.307 . . . . 0.0 110.397 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -98.35 120.72 58.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.69 -5.74 16.28 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.061 2.507 . . . . 0.0 114.094 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -56.44 131.29 48.02 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.881 1.219 . . . . 0.0 111.691 170.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.99 0.73 65.85 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.075 0.845 . . . . 0.0 114.767 -171.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -108.49 -178.47 3.61 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.213 1.805 . . . . 0.0 111.239 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.8 t -73.34 157.12 37.58 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.051 -1.031 . . . . 0.0 112.177 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.9 -25.09 67.36 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.996 0.918 . . . . 0.0 111.692 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.44 -31.97 73.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.887 -1.133 . . . . 0.0 111.729 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.1 t -72.73 -39.0 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.901 -1.125 . . . . 0.0 110.193 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -56.53 -49.33 75.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.687 1.131 . . . . 0.0 111.15 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -70.67 -17.05 62.85 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -83.07 -51.4 7.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.063 1.345 . . . . 0.0 111.967 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.35 -34.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.748 1.219 . . . . 0.0 111.484 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -57.12 -39.5 75.24 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.101 0.864 . . . . 0.0 112.728 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.12 -32.26 69.23 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.988 0.804 . . . . 0.0 112.935 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -71.78 -39.76 69.71 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.476 1.138 . . . . 0.0 110.967 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.38 -50.93 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.63 0.772 . . . . 0.0 110.552 170.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.448 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -54.08 -48.01 71.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 112.367 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -68.32 -26.66 65.73 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 120.984 1.72 . . . . 0.0 112.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -75.54 -47.69 25.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.904 0.882 . . . . 0.0 111.8 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.9 m -61.19 -36.5 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.8 0.727 . . . . 0.0 112.252 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -61.78 -47.26 85.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.9 1.227 . . . . 0.0 111.833 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -40.16 95.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.46 0.573 . . . . 0.0 111.106 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.485 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -58.74 -48.21 81.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.801 0.84 . . . . 0.0 111.388 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -73.13 -47.95 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.34 -25.42 68.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.9 pttt -87.68 -7.49 57.35 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.13 -18.36 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.0 p . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.135 1.374 . . . . 0.0 113.617 178.238 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -71.18 141.45 50.69 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.403 1.081 . . . . 0.0 111.221 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.96 128.57 55.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.072 0.949 . . . . 0.0 111.769 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.4 t -99.64 110.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.624 1.57 . . . . 0.0 110.161 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 tpp -90.65 124.07 34.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.181 0.446 . . . . 0.0 110.475 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.3 123.57 39.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.832 0.853 . . . . 0.0 109.918 169.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 m -118.98 134.51 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.08 0.855 . . . . 0.0 112.623 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -140.22 -152.77 0.43 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.121 1.368 . . . . 0.0 110.43 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -148.13 156.18 42.3 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.019 -1.676 . . . . 0.0 115.373 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 45.3 -110.53 0.22 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 129.151 2.98 . . . . 0.0 116.294 169.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -85.02 -19.52 31.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -168.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 p -82.57 149.76 27.29 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.01 1.277 . . . . 0.0 112.538 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.9 p -94.96 6.18 49.79 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -56.59 -39.23 73.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.116 1.766 . . . . 0.0 113.79 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 p -70.28 -43.69 69.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.119 1.327 . . . . 0.0 112.119 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.38 -34.3 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.456 0.703 . . . . 0.0 111.634 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 tpt -74.93 -38.37 61.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.07 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.13 87.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.431 0.559 . . . . 0.0 111.495 169.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -58.84 -40.85 85.44 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.349 -0.844 . . . . 0.0 111.824 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.97 -48.82 83.93 Favored Glycine 0 N--CA 1.474 1.228 0 CA-C-N 119.433 1.015 . . . . 0.0 113.784 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB3' HG21 ' A' ' 123' ' ' VAL . 40.0 m-85 -66.28 -40.01 89.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.073 -1.251 . . . . 0.0 111.365 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.12 85.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -68.77 -28.95 67.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.168 1.349 . . . . 0.0 112.641 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 m -78.42 -44.47 24.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.693 0.797 . . . . 0.0 111.773 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.5 mt -96.99 -31.77 12.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.973 0.909 . . . . 0.0 113.216 -171.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.13 7.03 72.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.821 1.677 . . . . 0.0 113.602 169.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.51 118.73 2.35 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.514 1.157 . . . . 0.0 112.024 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.35 11.61 85.14 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -116.9 -40.63 3.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.721 1.76 . . . . 0.0 112.377 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -150.51 162.65 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.784 1.633 . . . . 0.0 111.644 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.56 150.18 21.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.49 148.43 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.139 -0.975 . . . . 0.0 112.634 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -150.86 154.35 37.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.362 1.465 . . . . 0.0 109.248 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.3 p -127.49 155.01 44.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.6 t -155.78 167.12 31.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.585 1.554 . . . . 0.0 110.234 -170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.96 159.31 26.96 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.242 -0.911 . . . . 0.0 112.332 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -62.0 -38.26 87.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.324 1.062 . . . . 0.0 111.9 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.78 44.4 2.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.699 2.0 . . . . 0.0 108.756 170.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 t 66.5 176.96 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.15 1.78 . . . . 0.0 113.394 -169.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 94.9 p -146.23 -175.14 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.975 2.11 . . . . 0.0 110.423 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -145.78 172.64 13.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.13 141.75 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.758 1.623 . . . . 0.0 108.197 168.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -123.47 129.11 25.0 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.594 -171.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.68 -38.44 84.52 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.216 2.611 . . . . 0.0 115.381 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -63.74 -36.43 83.85 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.856 -0.528 . . . . 0.0 111.533 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.23 85.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.157 0.89 . . . . 0.0 111.171 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.5 mt -53.57 -51.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.36 79.37 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.1 mmt -67.09 -23.35 65.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 mmt -106.68 -18.93 13.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -61.32 -29.25 69.76 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.482 -1.386 . . . . 0.0 112.497 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -6.85 49.37 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.057 0.943 . . . . 0.0 113.302 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.8 0.49 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 126.943 2.097 . . . . 0.0 110.508 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 14.38 79.9 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.204 1.383 . . . . 0.0 114.629 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 mm -88.89 157.3 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.1 1.36 . . . . 0.0 110.619 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.87 143.26 49.4 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.463 1.105 . . . . 0.0 112.188 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.74 4.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.088 1.755 . . . . 0.0 112.106 168.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.4 p -63.2 -30.56 71.68 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.48 -4.14 73.94 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.76 1.171 . . . . 0.0 115.565 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -87.73 148.81 24.58 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.304 1.552 . . . . 0.0 113.043 -174.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.2 t -144.42 172.63 12.68 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.362 1.865 . . . . 0.0 109.951 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 t -133.31 167.19 20.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.929 1.292 . . . . 0.0 112.867 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -146.11 157.89 49.17 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.427 1.491 . . . . 0.0 111.034 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 134.97 65.52 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.723 2.948 . . . . 0.0 112.828 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -57.48 -32.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -169.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.93 -9.16 54.04 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.79 59.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 121.365 -0.835 . . . . 0.0 112.9 170.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.95 167.78 11.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 113.219 -175.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.02 112.19 22.27 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.595 1.558 . . . . 0.0 111.056 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.15 -15.55 63.78 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.455 -1.403 . . . . 0.0 113.529 -175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.9 -20.44 23.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.845 1.258 . . . . 0.0 113.191 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.72 -0.39 34.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.596 1.959 . . . . 0.0 113.053 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.5 77.03 1.61 Allowed 'General case' 0 C--N 1.346 0.428 0 C-N-CA 125.97 1.708 . . . . 0.0 109.739 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.29 -23.56 15.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.831 2.052 . . . . 0.0 113.252 -177.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.66 127.76 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.313 1.445 . . . . 0.0 108.8 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.0 t -136.18 124.87 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.01 -1.056 . . . . 0.0 111.055 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.36 121.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.559 1.544 . . . . 0.0 108.612 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -87.29 137.99 31.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.672 1.189 . . . . 0.0 111.449 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.85 11.7 20.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.505 1.122 . . . . 0.0 112.735 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m -105.02 12.23 32.49 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.622 1.569 . . . . 0.0 112.537 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.75 -178.84 35.31 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.688 1.137 . . . . 0.0 114.06 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.3 t -63.47 -24.87 68.01 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.103 0.961 . . . . 0.0 112.738 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.78 3.59 12.15 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 125.444 1.497 . . . . 0.0 115.62 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.27 137.46 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.204 1.402 . . . . 0.0 110.73 173.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -85.73 119.22 25.82 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -141.68 137.67 16.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.22 1.008 . . . . 0.0 112.454 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.46 151.35 80.32 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.541 2.16 . . . . 0.0 110.032 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.67 -31.28 94.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.084 2.523 . . . . 0.0 114.672 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.89 -23.81 66.55 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.862 -1.148 . . . . 0.0 113.756 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.6 m95 -83.87 -9.72 58.54 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.47 -1.394 . . . . 0.0 114.686 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.1 m -117.04 -21.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.19 1.396 . . . . 0.0 113.569 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -83.55 14.29 3.89 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.154 1.782 . . . . 0.0 113.562 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -71.69 168.21 18.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.88 1.672 . . . . 0.0 113.078 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.84 -35.97 82.84 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.503 -0.748 . . . . 0.0 112.747 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.68 125.98 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.761 0.709 . . . . 0.0 110.731 170.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -122.18 144.43 48.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.742 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -133.82 154.36 51.08 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.272 1.029 . . . . 0.0 112.463 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.15 125.08 34.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.073 0.949 . . . . 0.0 110.523 169.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -110.99 150.74 28.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.775 1.63 . . . . 0.0 110.354 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -119.57 47.1 1.77 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.18 1.792 . . . . 0.0 108.253 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -96.71 126.9 42.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.058 2.143 . . . . 0.0 112.303 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -84.26 147.61 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.159 1.784 . . . . 0.0 112.556 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.06 123.31 69.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.286 1.434 . . . . 0.0 112.066 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.91 -11.62 3.15 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.946 2.431 . . . . 0.0 114.482 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.73 -20.22 65.92 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -169.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.93 9.47 63.77 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.746 1.165 . . . . 0.0 114.195 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -120.02 -172.57 2.37 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.981 1.712 . . . . 0.0 113.512 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 t -74.29 158.16 34.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.988 0.915 . . . . 0.0 111.348 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.62 -20.13 64.47 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 0.0 112.137 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.43 -31.58 72.74 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.012 -1.055 . . . . 0.0 110.218 168.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 t -72.62 -38.64 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.425 175.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.53 -49.14 73.41 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.164 1.347 . . . . 0.0 110.848 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.84 -15.86 63.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 m -87.12 -41.46 13.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.557 1.543 . . . . 0.0 112.744 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.05 -40.06 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.13 -1.606 . . . . 0.0 111.311 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -57.79 -42.2 83.68 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.53 65.82 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 123.701 0.667 . . . . 0.0 112.388 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -69.15 -39.07 79.02 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.596 -0.943 . . . . 0.0 111.879 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.46 -49.19 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.392 0.677 . . . . 0.0 110.388 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -56.96 -48.01 79.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.047 1.339 . . . . 0.0 112.725 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -68.26 -27.97 66.8 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.766 1.621 . . . . 0.0 112.33 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -71.35 -50.47 31.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.95 0.9 . . . . 0.0 111.567 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.477 HG21 ' HB3' ' A' ' 21' ' ' PHE . 31.2 m -59.83 -43.27 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.373 0.988 . . . . 0.0 112.6 170.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.07 -51.66 63.05 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 120.161 1.346 . . . . 0.0 112.393 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.667 0.667 . . . . 0.0 111.728 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.48 -48.03 76.76 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.24 0.616 . . . . 0.0 111.304 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.96 -43.93 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.924 0.784 . . . . 0.0 110.747 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.6 -25.8 66.79 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.19 -16.78 54.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -107.59 -26.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.252 1.421 . . . . 0.0 112.051 -179.862 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.819 -0.134 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -70.45 142.28 51.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.39 1.076 . . . . 0.0 111.809 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -110.92 129.34 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.478 1.111 . . . . 0.0 111.351 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.9 t -99.63 114.96 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.292 1.837 . . . . 0.0 110.085 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.6 tpp -94.85 128.46 41.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.434 0.561 . . . . 0.0 110.369 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -100.28 113.41 26.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.156 0.982 . . . . 0.0 110.591 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.44 137.59 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 p -132.07 178.73 6.57 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 110.944 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -73.66 -61.0 1.99 Allowed 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.849 -1.157 . . . . 0.0 111.833 170.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -152.82 25.38 0.57 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -174.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -133.59 106.42 7.4 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.9 m -67.48 -22.62 65.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.7 m -66.93 -15.92 63.99 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.245 0.929 . . . . 0.0 111.891 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -94.07 -64.41 1.08 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.744 0.818 . . . . 0.0 109.579 168.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.4 p -71.2 -59.93 2.51 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -73.63 -26.75 60.92 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.637 -0.664 . . . . 0.0 111.859 -172.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.15 -37.41 69.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.22 95.4 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.609 0.641 . . . . 0.0 111.188 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -57.95 -43.97 86.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.115 0.87 . . . . 0.0 111.684 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.39 -50.98 60.47 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.409 1.004 . . . . 0.0 113.556 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -68.8 -40.82 79.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.208 -1.172 . . . . 0.0 111.705 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.39 95.67 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -71.46 -28.46 63.97 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.242 0.928 . . . . 0.0 112.386 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 m -79.18 -42.55 25.82 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.358 0.663 . . . . 0.0 111.77 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -90.14 -32.95 16.43 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.889 0.876 . . . . 0.0 112.716 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 10.66 68.22 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.885 1.707 . . . . 0.0 113.906 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.29 119.18 2.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.491 1.146 . . . . 0.0 111.615 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.98 13.22 83.91 Favored Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -120.2 -41.72 2.61 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.284 1.542 . . . . 0.0 111.423 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.59 159.3 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.894 1.677 . . . . 0.0 112.072 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.66 20.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.15 0.98 . . . . 0.0 109.193 169.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -141.64 141.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.009 -1.057 . . . . 0.0 112.925 -173.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 m -146.18 163.71 34.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.397 1.879 . . . . 0.0 109.514 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 p -140.61 153.54 46.1 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.785 -1.197 . . . . 0.0 112.542 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t -151.66 150.51 30.33 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.095 0.958 . . . . 0.0 111.215 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.01 134.35 9.81 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.24 1.4 . . . . 0.0 110.054 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 72.4 mt -50.34 -35.9 29.77 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.281 1.041 . . . . 0.0 112.907 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -118.69 28.95 8.0 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.953 1.701 . . . . 0.0 112.462 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 m 64.63 168.59 0.18 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.402 1.881 . . . . 0.0 114.124 -170.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t -164.33 173.58 12.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.454 1.102 . . . . 0.0 112.179 172.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -133.7 146.89 51.24 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.441 1.496 . . . . 0.0 113.099 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.2 m -64.82 140.23 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.411 0.624 . . . . 0.0 111.676 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -103.15 122.36 45.64 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.161 1.384 . . . . 0.0 111.584 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.8 -37.83 77.02 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.466 2.778 . . . . 0.0 115.305 -172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.6 m -64.39 -40.02 95.01 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.629 -0.67 . . . . 0.0 111.384 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.1 97.29 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.135 0.88 . . . . 0.0 111.664 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -54.8 -52.55 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 118.558 0.617 . . . . 0.0 109.554 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.79 82.91 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.6 mmt -67.56 -24.46 65.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.25 1.02 . . . . 0.0 113.198 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mmt -108.69 -19.59 13.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.02 -28.72 69.25 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.541 -1.349 . . . . 0.0 112.563 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.9 -8.31 53.64 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.172 -0.955 . . . . 0.0 113.347 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.85 3.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 127.153 2.181 . . . . 0.0 110.635 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 13.85 82.76 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.385 1.469 . . . . 0.0 114.762 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.3 mm -83.62 147.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 118.557 1.178 . . . . 0.0 111.184 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.74 126.42 52.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.978 1.711 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.86 -5.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 169.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.9 p -62.49 -27.02 68.85 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.09 1.314 . . . . 0.0 114.458 -169.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.54 -6.35 88.68 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.759 1.171 . . . . 0.0 115.476 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -84.7 149.14 26.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.27 1.535 . . . . 0.0 112.644 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 t -144.25 165.64 27.31 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.009 1.724 . . . . 0.0 109.618 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -132.76 144.19 50.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.163 0.985 . . . . 0.0 112.835 -171.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -139.76 159.8 63.55 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.112 1.765 . . . . 0.0 111.413 -171.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.91 138.5 79.34 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.632 2.888 . . . . 0.0 112.537 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.98 -29.49 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.44 -11.26 60.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -18.35 58.83 Favored 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.359 -0.838 . . . . 0.0 112.544 169.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -99.07 170.99 8.31 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.68 1.592 . . . . 0.0 112.238 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.62 113.61 18.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 110.749 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.89 -20.28 65.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -169.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.74 -27.34 68.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.078 0.951 . . . . 0.0 112.376 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.28 -3.22 58.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.133 1.773 . . . . 0.0 112.152 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -116.96 82.11 1.75 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.877 2.071 . . . . 0.0 108.108 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.21 -25.46 9.24 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.182 1.793 . . . . 0.0 113.138 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.69 131.28 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.108 1.763 . . . . 0.0 109.279 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -136.43 120.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 120.992 -1.068 . . . . 0.0 110.721 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.77 120.25 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 108.092 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -88.46 149.24 23.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.015 0.926 . . . . 0.0 110.078 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -123.7 30.78 6.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.127 0.971 . . . . 0.0 111.32 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m -99.69 -17.92 17.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.88 41.25 6.39 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-N 119.45 1.023 . . . . 0.0 113.857 -174.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.9 t 66.59 -39.94 0.35 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.274 3.03 . . . . 0.0 116.365 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.66 97.07 0.87 Allowed Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.472 1.034 . . . . 0.0 110.678 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.03 142.73 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.377 1.071 . . . . 0.0 111.806 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -89.87 48.99 1.65 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.95 1.3 . . . . 0.0 112.275 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.1 mt -74.76 136.57 73.88 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.217 -0.927 . . . . 0.0 112.188 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.68 150.86 86.56 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 122.35 2.033 . . . . 0.0 110.281 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.94 -22.0 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.353 2.702 . . . . 0.0 115.221 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.75 -13.52 61.74 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 96.9 m95 -91.89 -3.52 55.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.47 14.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.565 1.546 . . . . 0.0 113.425 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -120.65 -0.99 10.11 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.21 1.804 . . . . 0.0 112.996 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.485 HE22 ' HB1' ' A' ' 70' ' ' ALA . 13.7 mp0 -58.29 160.05 5.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.389 2.676 . . . . 0.0 114.138 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -63.81 -34.49 78.02 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.37 122.51 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.93 . . . . 0.0 109.086 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -124.25 146.74 48.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.188 1.395 . . . . 0.0 110.963 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -140.83 159.1 42.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.222 1.009 . . . . 0.0 112.437 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -132.22 117.14 17.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.681 1.192 . . . . 0.0 109.692 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -106.85 153.13 22.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.069 1.348 . . . . 0.0 111.586 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.08 79.86 1.75 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 110.379 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.62 152.46 18.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.024 1.33 . . . . 0.0 111.354 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -84.85 148.16 26.43 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.211 0.605 . . . . 0.0 109.445 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.04 130.73 59.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.556 -0.715 . . . . 0.0 112.143 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.96 -24.35 1.37 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.908 1.739 . . . . 0.0 114.216 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -71.82 -28.22 63.44 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.045 1.293 . . . . 0.0 113.628 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.59 2.63 52.92 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 123.856 0.741 . . . . 0.0 113.472 169.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -136.1 -165.03 1.64 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.106 2.162 . . . . 0.0 111.326 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.6 p -78.31 166.0 23.19 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.9 -26.91 66.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.858 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.88 -39.1 93.41 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.935 -1.103 . . . . 0.0 110.415 169.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.65 -36.69 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.208 0.913 . . . . 0.0 111.587 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -55.42 -45.41 76.72 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.888 1.676 . . . . 0.0 110.529 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -69.46 -19.93 63.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.0 m -79.36 -52.41 8.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.761 1.224 . . . . 0.0 111.718 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.24 -33.34 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.338 1.055 . . . . 0.0 111.317 -172.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -56.67 -39.44 73.78 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.924 0.783 . . . . 0.0 112.765 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.23 65.9 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.079 0.847 . . . . 0.0 112.878 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -69.82 -39.36 76.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.092 0.946 . . . . 0.0 111.166 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.11 -47.57 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.813 0.845 . . . . 0.0 110.966 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.461 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -55.25 -47.7 75.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.187 1.395 . . . . 0.0 112.792 177.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -68.64 -27.46 66.03 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.651 1.568 . . . . 0.0 112.686 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -71.58 -49.44 40.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.064 0.945 . . . . 0.0 111.693 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.2 m -60.9 -41.1 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.947 0.794 . . . . 0.0 112.891 170.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -63.9 -51.69 63.33 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.15 1.341 . . . . 0.0 112.485 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -69.31 -30.14 68.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.914 0.779 . . . . 0.0 112.375 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.88 -49.74 71.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.966 0.907 . . . . 0.0 110.901 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.57 -39.94 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.182 -0.949 . . . . 0.0 110.585 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.27 -26.72 67.96 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -90.77 -18.12 25.48 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -104.37 -16.99 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.649 1.179 . . . . 0.0 112.935 178.785 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.5 2.057 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -71.29 143.48 50.31 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.151 0.98 . . . . 0.0 111.804 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.6 129.36 55.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.363 1.065 . . . . 0.0 111.469 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.45 116.28 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.452 1.901 . . . . 0.0 109.9 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -94.6 125.47 39.27 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 169.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -99.32 113.39 25.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.577 0.751 . . . . 0.0 111.275 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.07 144.06 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.392 1.077 . . . . 0.0 112.69 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 t -144.43 167.31 22.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.03 0.932 . . . . 0.0 111.583 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -65.15 162.23 17.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.331 1.453 . . . . 0.0 111.005 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -59.5 148.11 34.3 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.175 0.99 . . . . 0.0 112.675 -170.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.5 t30 54.55 46.63 24.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.971 1.308 . . . . 0.0 113.237 171.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.0 t -136.57 143.57 43.7 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.378 1.471 . . . . 0.0 111.611 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.7 p -83.43 -10.21 58.54 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -65.27 -35.32 80.66 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.772 1.629 . . . . 0.0 113.653 -169.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 p -64.5 -52.92 55.42 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.363 0.983 . . . . 0.0 111.213 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -63.49 -39.04 93.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.547 1.139 . . . . 0.0 111.643 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.2 tpt -77.25 -35.2 55.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.903 0.881 . . . . 0.0 112.312 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.48 95.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.459 0.572 . . . . 0.0 110.736 169.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.35 -43.81 98.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.933 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.56 -48.02 73.36 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.666 1.121 . . . . 0.0 113.705 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -66.44 -44.23 83.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.129 0.964 . . . . 0.0 111.739 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.36 75.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -27.67 64.09 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.423 1.011 . . . . 0.0 112.584 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 m -88.71 -41.65 12.45 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.908 0.883 . . . . 0.0 112.548 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.58 -34.63 14.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.7 0.8 . . . . 0.0 112.617 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.34 8.55 64.05 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.598 1.57 . . . . 0.0 113.696 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.36 117.85 1.94 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.341 1.071 . . . . 0.0 112.0 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.72 13.91 82.6 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -119.19 -40.14 2.85 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.165 1.482 . . . . 0.0 111.847 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.11 160.01 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.355 1.862 . . . . 0.0 110.998 171.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 150.86 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.466 0.707 . . . . 0.0 109.469 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -141.23 140.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.223 -0.923 . . . . 0.0 112.531 -173.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -144.4 159.49 42.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.205 1.802 . . . . 0.0 109.051 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.9 p -133.72 158.83 42.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 113.46 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.1 t -148.1 146.15 28.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.98 1.312 . . . . 0.0 111.192 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.01 139.25 15.17 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.5 mt -52.8 -42.96 65.57 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.019 1.909 . . . . 0.0 113.002 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.4 38.95 3.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.28 1.432 . . . . 0.0 110.89 171.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t 69.58 171.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.068 2.147 . . . . 0.0 114.302 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 t -157.91 -169.1 2.71 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.284 1.833 . . . . 0.0 110.038 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 167.7 21.58 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.87 166.49 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.402 1.081 . . . . 0.0 109.159 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -138.11 126.94 14.51 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.432 -1.418 . . . . 0.0 111.626 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.61 -40.22 85.96 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.926 2.417 . . . . 0.0 114.304 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.91 -34.3 77.81 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.243 -0.91 . . . . 0.0 111.273 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 -2.74 23.43 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.371 -1.456 . . . . 0.0 114.154 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -87.43 -54.78 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 167.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -28.85 61.65 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 73.2 mmm -78.27 -6.01 53.72 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.326 -0.859 . . . . 0.0 113.205 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.3 mmt -120.33 -26.36 5.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.71 1.204 . . . . 0.0 111.815 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.13 -20.52 65.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 112.439 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.07 -11.15 60.62 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 171.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 t -107.98 5.88 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 127.092 2.157 . . . . 0.0 110.622 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.07 14.04 82.63 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.561 -1.337 . . . . 0.0 114.396 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.21 154.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.999 1.32 . . . . 0.0 110.27 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.18 149.12 41.02 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.291 1.037 . . . . 0.0 110.957 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.3 pt -133.78 -2.1 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.171 1.789 . . . . 0.0 113.122 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -54.66 -37.91 66.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.598 1.159 . . . . 0.0 113.836 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.32 -1.2 90.37 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 116.145 1.218 . . . . 0.0 116.145 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -76.61 160.77 29.12 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.748 1.774 . . . . 0.0 113.319 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 57.9 p -135.24 167.52 20.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.713 2.005 . . . . 0.0 110.484 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 t -144.18 158.83 43.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.535 1.134 . . . . 0.0 111.376 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -150.95 163.71 22.77 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 126.352 1.861 . . . . 0.0 110.177 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -60.49 146.22 97.27 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.5 2.8 . . . . 0.0 113.566 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.16 -32.31 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.076 0.95 . . . . 0.0 113.486 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.46 -13.76 61.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -21.19 46.61 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.332 0.969 . . . . 0.0 113.354 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.77 169.46 10.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.054 1.342 . . . . 0.0 112.825 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.0 108.41 15.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 110.892 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.71 -20.3 65.94 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -169.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.68 -24.89 67.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.028 0.931 . . . . 0.0 112.533 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.57 -2.01 58.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.456 1.902 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.89 82.05 1.74 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.946 2.098 . . . . 0.0 108.11 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.35 -28.19 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.765 1.626 . . . . 0.0 113.004 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -130.15 130.29 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.893 1.677 . . . . 0.0 108.627 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -131.49 126.51 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.095 -1.003 . . . . 0.0 109.262 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.3 mm -126.72 133.92 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.697 1.199 . . . . 0.0 109.214 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.2 t -109.01 148.67 30.41 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.969 1.308 . . . . 0.0 112.098 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.21 55.55 1.66 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.974 1.31 . . . . 0.0 109.677 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -114.68 -13.39 12.1 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.28 61.39 1.91 Allowed Glycine 0 CA--C 1.535 1.294 0 CA-C-N 119.664 1.12 . . . . 0.0 114.249 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.2 m 58.48 29.74 18.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.285 1.834 . . . . 0.0 114.801 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -169.88 112.93 0.49 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.301 0.953 . . . . 0.0 111.495 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.19 133.25 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.889 1.276 . . . . 0.0 110.691 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -89.6 119.38 29.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.63 0.772 . . . . 0.0 109.512 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.8 mt -141.74 140.28 19.82 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.386 1.074 . . . . 0.0 112.443 -175.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 151.5 82.51 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.252 1.968 . . . . 0.0 110.286 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.44 -26.91 79.93 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 115.535 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.512 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.0 m95 -89.16 -3.05 58.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.58 18.0 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.295 1.438 . . . . 0.0 113.352 -173.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -122.29 -0.7 9.3 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.402 1.881 . . . . 0.0 112.87 -172.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.4 mp0 -57.24 163.62 2.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.861 2.864 . . . . 0.0 113.987 174.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.09 -34.79 78.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -131.62 127.46 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.906 0.883 . . . . 0.0 111.037 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -137.28 140.3 41.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.492 1.517 . . . . 0.0 111.333 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -156.57 156.38 33.49 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.116 1.366 . . . . 0.0 111.006 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -113.78 142.85 45.55 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.876 1.27 . . . . 0.0 110.954 170.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -110.82 142.28 43.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.964 1.705 . . . . 0.0 111.572 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -104.73 59.59 0.7 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.957 1.703 . . . . 0.0 107.29 -169.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.02 132.0 53.44 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.422 1.889 . . . . 0.0 112.002 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -88.65 163.26 15.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.748 1.619 . . . . 0.0 112.869 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.66 138.82 37.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 122.1 -0.375 . . . . 0.0 111.136 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -91.54 -22.06 0.56 Allowed 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.342 2.028 . . . . 0.0 114.46 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.33 -34.51 74.74 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -169.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.81 -8.7 73.54 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 119.555 -0.581 . . . . 0.0 113.849 171.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -110.79 -83.85 0.57 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.53 1.532 . . . . 0.0 112.831 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t -168.78 156.16 7.5 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.314 1.046 . . . . 0.0 112.18 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.07 -27.7 68.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.148 0.979 . . . . 0.0 112.455 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.6 -25.83 61.47 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.692 -1.255 . . . . 0.0 111.85 169.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 71.3 t -75.37 -33.38 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.876 -1.14 . . . . 0.0 109.866 169.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.37 -44.63 92.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.035 1.743 . . . . 0.0 109.594 168.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.2 m -76.8 -54.03 7.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.487 0.715 . . . . 0.0 111.461 170.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.98 -34.8 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 0.0 111.344 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -57.85 -44.53 86.62 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 112.255 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.41 -29.65 67.9 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.691 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -67.55 -51.07 55.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.38 1.09 . . . . 0.0 110.256 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.6 t -57.44 -43.66 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.521 -0.737 . . . . 0.0 110.857 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.25 -48.65 73.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.709 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -72.8 -29.79 63.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.132 1.333 . . . . 0.0 113.504 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -63.74 -52.23 61.39 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.075 0.852 . . . . 0.0 109.937 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.49 -42.99 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.021 1.328 . . . . 0.0 112.546 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -61.69 -45.97 91.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.976 1.262 . . . . 0.0 111.633 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -38.39 89.22 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.535 0.607 . . . . 0.0 111.302 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.469 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -58.96 -51.13 71.39 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.898 0.879 . . . . 0.0 110.928 174.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.0 -44.3 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.651 0.66 . . . . 0.0 111.032 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.96 -23.52 66.44 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.6 pttt -94.17 -6.87 43.83 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -122.15 -17.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.168 1.787 . . . . 0.0 112.339 -178.822 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 111.244 0.091 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -69.1 133.49 48.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.835 1.254 . . . . 0.0 112.141 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -103.82 123.47 47.15 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.19 0.996 . . . . 0.0 111.129 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 111.0 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 126.104 1.762 . . . . 0.0 109.897 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.1 tpp -90.67 129.65 36.75 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.684 0.393 . . . . 0.0 110.091 168.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -100.0 124.67 45.62 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.727 0.811 . . . . 0.0 109.731 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.95 143.05 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.701 1.2 . . . . 0.0 112.525 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.4 t -143.02 168.12 20.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.738 1.215 . . . . 0.0 110.369 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -64.85 -66.79 0.5 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.491 1.041 . . . . 0.0 111.223 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -166.96 -50.59 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.133 1.773 . . . . 0.0 112.761 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -55.34 129.34 38.16 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.587 1.555 . . . . 0.0 114.491 -169.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 t 60.41 9.75 2.15 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.311 2.245 . . . . 0.0 116.358 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.8 m 43.88 44.23 5.7 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.695 1.998 . . . . 0.0 115.968 169.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -60.43 -23.04 64.1 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 126.949 2.1 . . . . 0.0 111.851 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -63.59 -52.96 58.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.788 1.235 . . . . 0.0 112.217 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -67.08 -34.89 78.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.272 0.629 . . . . 0.0 111.466 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.91 71.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.058 0.543 . . . . 0.0 112.313 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.71 86.67 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.508 -0.745 . . . . 0.0 112.698 173.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.15 -40.68 77.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.921 0.782 . . . . 0.0 111.896 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.27 -53.54 43.99 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-N 119.188 0.904 . . . . 0.0 112.961 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.47 ' HB3' HG21 ' A' ' 123' ' ' VAL . 43.2 m-85 -65.97 -40.97 91.71 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.243 -1.151 . . . . 0.0 111.881 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.81 94.27 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -76.41 -29.05 56.89 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.53 1.059 . . . . 0.0 112.624 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m -77.5 -43.57 31.71 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 0.0 111.647 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.51 -33.12 13.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.67 0.788 . . . . 0.0 112.491 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.5 11.82 57.6 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.671 1.605 . . . . 0.0 113.221 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.11 122.77 5.49 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.433 1.116 . . . . 0.0 111.551 171.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.01 8.8 87.3 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 116.029 1.172 . . . . 0.0 116.029 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -118.68 -31.04 4.96 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.649 1.724 . . . . 0.0 112.998 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.13 156.52 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 112.248 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.73 144.73 25.02 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.98 138.64 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.451 1.478 . . . . 0.0 113.487 -169.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 m -149.43 161.5 41.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.577 1.551 . . . . 0.0 110.274 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 p -137.4 150.62 47.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.314 1.054 . . . . 0.0 113.759 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 t -145.43 157.93 43.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.435 1.894 . . . . 0.0 110.099 -169.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.15 146.03 18.08 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.462 -0.774 . . . . 0.0 111.614 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -58.52 -42.68 88.26 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.976 0.888 . . . . 0.0 110.728 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.91 40.44 1.81 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.352 1.461 . . . . 0.0 111.287 173.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 t 65.17 178.56 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.407 1.883 . . . . 0.0 114.417 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -152.99 165.61 35.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 112.453 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.61 -179.82 6.54 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.76 -173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.75 113.61 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.065 0.946 . . . . 0.0 110.186 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.73 143.92 44.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.458 1.103 . . . . 0.0 110.993 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.87 -37.12 76.8 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.354 2.703 . . . . 0.0 113.857 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -61.21 -39.63 90.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.63 0.772 . . . . 0.0 112.17 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -13.21 60.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.8 mt -78.19 -53.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.43 64.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.8 mmt -70.47 -12.06 61.32 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 mmt -121.9 -28.64 4.42 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.269 1.028 . . . . 0.0 112.603 -169.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.35 -24.72 67.97 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.724 -1.235 . . . . 0.0 112.568 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.22 -10.73 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 11.5 p -121.38 26.2 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.188 1.795 . . . . 0.0 110.397 169.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.66 9.31 86.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.014 1.768 . . . . 0.0 116.774 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.06 147.76 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 118.84 1.32 . . . . 0.0 111.915 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.78 127.87 54.76 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.696 1.598 . . . . 0.0 111.506 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.0 pt -138.04 -6.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 p -64.19 -27.52 69.12 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.73 -1.231 . . . . 0.0 114.318 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.56 -6.72 89.16 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.594 1.092 . . . . 0.0 115.211 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -83.64 152.25 24.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.195 1.497 . . . . 0.0 113.116 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -145.32 177.62 8.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.481 1.912 . . . . 0.0 108.819 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -152.68 174.88 13.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.487 1.04 . . . . 0.0 113.765 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.87 163.14 28.62 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.937 2.095 . . . . 0.0 110.159 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.15 142.42 94.4 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.458 2.772 . . . . 0.0 113.247 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.97 -35.09 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.41 -11.81 60.22 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 CA--C 1.553 1.085 0 O-C-N 121.25 -0.906 . . . . 0.0 113.117 172.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -94.14 169.18 10.44 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.987 1.315 . . . . 0.0 112.832 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.23 107.47 12.59 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.411 1.484 . . . . 0.0 111.725 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.44 -20.16 65.47 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.42 -24.99 68.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.793 1.237 . . . . 0.0 112.895 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.74 -4.11 56.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.084 1.754 . . . . 0.0 112.106 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -114.7 82.97 1.81 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.452 1.901 . . . . 0.0 108.114 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -51.15 -26.9 7.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.857 1.663 . . . . 0.0 113.364 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -134.25 133.25 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.722 1.609 . . . . 0.0 109.287 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.62 121.19 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.866 -1.146 . . . . 0.0 110.91 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.08 124.19 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 108.522 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 t -91.19 152.29 20.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.666 1.586 . . . . 0.0 110.957 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.77 52.32 2.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.005 1.322 . . . . 0.0 110.028 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m -116.38 -20.79 9.57 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.17 52.21 6.36 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 119.096 0.862 . . . . 0.0 113.114 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.3 t 61.77 172.11 0.12 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.643 2.377 . . . . 0.0 114.06 -172.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.25 20.37 73.16 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.496 1.045 . . . . 0.0 115.165 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.32 130.68 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.39 1.076 . . . . 0.0 111.436 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -84.46 62.52 7.3 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.725 1.21 . . . . 0.0 111.456 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.52 139.01 41.11 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.926 0.891 . . . . 0.0 112.996 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -63.29 152.69 78.61 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.301 2.0 . . . . 0.0 109.662 168.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.18 -22.1 73.61 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.218 2.612 . . . . 0.0 115.384 -169.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.54 -14.29 61.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.493 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -91.92 -1.43 57.29 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.8 14.76 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.904 1.682 . . . . 0.0 113.757 -174.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -118.89 -0.96 11.1 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.246 1.819 . . . . 0.0 112.877 -171.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.471 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.7 mp0 -59.8 161.44 6.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.251 2.62 . . . . 0.0 113.897 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.03 -33.93 76.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.5 mt -132.9 127.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.791 0.836 . . . . 0.0 110.394 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -130.03 149.26 51.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.178 1.391 . . . . 0.0 111.568 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -144.83 161.12 40.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.758 1.223 . . . . 0.0 112.182 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.21 128.54 26.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 167.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -106.86 146.81 30.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.368 1.467 . . . . 0.0 111.379 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -107.83 59.3 0.62 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.4 1.88 . . . . 0.0 106.864 -173.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.56 117.32 33.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.493 1.917 . . . . 0.0 112.335 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.89 159.47 32.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.823 1.296 . . . . 0.0 113.64 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.21 118.8 70.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 126.568 1.947 . . . . 0.0 113.113 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -81.2 -25.1 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 121.887 1.725 . . . . 0.0 113.385 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -62.7 126.1 26.2 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.365 0.984 . . . . 0.0 111.576 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.47 -1.38 87.75 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.369 -1.239 . . . . 0.0 115.287 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -93.65 -88.61 0.23 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.691 1.746 . . . . 0.0 112.193 170.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.0 t -161.79 156.09 22.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.385 1.074 . . . . 0.0 110.957 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.78 -30.03 71.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.833 1.253 . . . . 0.0 111.542 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -72.73 -23.8 60.89 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.741 -1.225 . . . . 0.0 112.301 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.94 -35.9 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.958 -1.089 . . . . 0.0 109.961 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.95 -47.63 84.38 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.656 1.571 . . . . 0.0 110.593 169.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -65.87 -21.85 66.49 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -80.03 -53.96 6.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.608 1.163 . . . . 0.0 111.845 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.79 -32.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.383 1.073 . . . . 0.0 111.343 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -57.17 -39.79 76.01 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.355 0.98 . . . . 0.0 113.016 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.65 -35.43 74.18 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.746 0.688 . . . . 0.0 112.171 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -68.59 -39.15 81.06 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.954 -0.733 . . . . 0.0 111.578 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.02 -49.08 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.637 170.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -56.13 -47.42 78.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.983 1.313 . . . . 0.0 112.417 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -69.18 -26.79 65.02 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.824 1.647 . . . . 0.0 112.624 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -72.98 -50.07 25.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.913 0.885 . . . . 0.0 111.299 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' A' ' 21' ' ' PHE . 34.8 m -59.79 -42.14 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.213 0.915 . . . . 0.0 112.565 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.24 -51.41 63.79 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.31 1.414 . . . . 0.0 112.464 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -31.97 70.71 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.917 0.781 . . . . 0.0 112.08 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.49 -48.44 75.17 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.425 0.69 . . . . 0.0 111.019 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.5 mt -72.95 -41.02 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.856 -174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.62 -26.25 68.59 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.83 -14.49 44.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.18 -23.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.601 1.56 . . . . 0.0 112.035 -179.478 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.0 tpp . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -70.22 150.67 46.19 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.178 0.899 . . . . 0.0 111.447 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.54 118.08 32.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 110.169 170.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.75 112.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.918 1.687 . . . . 0.0 109.584 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.3 ttm -95.1 122.34 37.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.851 0.75 . . . . 0.0 109.899 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -88.16 127.82 35.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.116 0.566 . . . . 0.0 109.982 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.97 145.94 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.686 1.194 . . . . 0.0 112.492 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.0 t -154.9 162.72 41.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.733 0.813 . . . . 0.0 111.801 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.94 165.79 24.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.778 0.831 . . . . 0.0 110.858 169.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -64.07 -18.28 64.21 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -169.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -73.63 -10.31 59.57 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -169.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 p -146.62 179.02 7.84 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -169.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.6 p -100.0 13.66 33.22 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.49 1.516 . . . . 0.0 113.904 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.38 -37.7 78.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.604 1.547 . . . . 0.0 113.356 -169.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.7 p -68.83 -43.14 76.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.408 1.003 . . . . 0.0 112.411 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.0 -35.03 71.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.719 0.808 . . . . 0.0 111.424 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.3 tpt -73.06 -37.63 66.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.063 1.345 . . . . 0.0 112.18 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.94 -44.87 91.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.25 0.477 . . . . 0.0 111.786 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -60.84 -38.83 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.379 -0.819 . . . . 0.0 111.823 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.62 72.89 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.113 1.324 . . . . 0.0 113.089 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -66.86 -44.43 81.02 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.169 -1.195 . . . . 0.0 111.81 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.44 72.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.778 -1.201 . . . . 0.0 114.05 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -72.23 -23.03 61.17 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.87 1.214 . . . . 0.0 112.867 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -86.07 -44.66 12.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.188 0.995 . . . . 0.0 112.037 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 mt -95.84 -35.85 11.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.23 1.012 . . . . 0.0 113.031 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.96 7.69 80.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.964 1.745 . . . . 0.0 113.575 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -38.93 -45.34 1.17 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.7 17.92 27.47 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.485 1.517 . . . . 0.0 114.787 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -116.63 -28.68 6.33 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.6 pt -157.59 163.97 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 127.603 2.361 . . . . 0.0 110.485 -171.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 147.03 24.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 167.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.5 145.43 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.745 -1.222 . . . . 0.0 113.62 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -148.88 157.97 43.82 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.791 2.036 . . . . 0.0 109.237 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.4 p -131.12 156.8 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.6 -1.312 . . . . 0.0 112.914 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -153.56 155.87 36.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.704 1.202 . . . . 0.0 109.793 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.3 145.46 18.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.31 -31.83 69.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.646 1.223 . . . . 0.0 111.913 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -123.33 35.48 4.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.161 1.785 . . . . 0.0 110.215 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t 71.36 170.37 0.32 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.142 1.777 . . . . 0.0 112.151 -168.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -155.63 -177.38 6.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.051 1.74 . . . . 0.0 110.966 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -144.76 178.39 8.03 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -113.15 140.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.375 1.47 . . . . 0.0 109.346 169.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -110.96 135.63 20.82 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.497 -1.239 . . . . 0.0 110.92 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.02 -36.69 85.18 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.294 2.662 . . . . 0.0 115.467 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -67.51 -31.88 72.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 120.9 -1.125 . . . . 0.0 111.779 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.88 -10.83 59.75 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.303 -1.498 . . . . 0.0 113.438 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.61 -58.89 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.41 -38.54 77.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.1 mmm -73.99 -6.69 48.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 mmt -118.01 -23.96 7.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.745 1.218 . . . . 0.0 111.516 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.88 -28.16 68.67 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.261 -0.9 . . . . 0.0 111.609 169.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.85 -5.61 42.07 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.48 1.06 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.412 2.285 . . . . 0.0 110.581 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.41 13.15 82.19 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.23 1.395 . . . . 0.0 114.553 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mm -89.29 152.01 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.47 1.135 . . . . 0.0 111.022 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -129.65 138.6 51.29 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 111.002 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 pt -135.8 -5.26 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -57.42 -33.11 67.54 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.26 -5.75 85.03 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -83.14 144.44 29.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.337 1.569 . . . . 0.0 112.873 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.3 p -133.79 171.72 13.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.845 2.058 . . . . 0.0 110.302 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.7 t -141.0 165.81 26.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.212 1.005 . . . . 0.0 112.398 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.25 155.02 30.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.61 1.564 . . . . 0.0 109.267 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.85 135.46 67.08 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.874 2.383 . . . . 0.0 113.215 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -54.52 -33.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -10.26 55.75 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -25.26 59.2 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.247 -0.908 . . . . 0.0 112.669 170.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.21 167.68 11.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.832 1.253 . . . . 0.0 112.499 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.94 115.86 30.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.122 1.369 . . . . 0.0 111.362 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.484 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -71.46 -19.31 62.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.09 -27.0 66.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.648 0.737 . . . . 0.0 112.304 -172.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.01 -10.88 57.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.037 1.735 . . . . 0.0 111.806 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -107.37 79.57 1.32 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 126.548 1.939 . . . . 0.0 108.786 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -66.13 -12.42 55.63 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -129.9 130.77 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.516 1.527 . . . . 0.0 109.169 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.4 t -134.14 128.77 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.134 -0.979 . . . . 0.0 109.512 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.8 121.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.253 1.021 . . . . 0.0 110.079 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -96.61 150.02 21.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 112.32 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.8 mp -126.27 35.13 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.829 1.252 . . . . 0.0 111.455 171.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.3 m -84.9 -30.28 24.53 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.783 0.833 . . . . 0.0 112.98 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.36 61.44 2.62 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.742 0.687 . . . . 0.0 111.98 -172.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 81.9 m 61.89 168.86 0.11 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.442 2.297 . . . . 0.0 113.799 -169.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.13 30.0 73.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.118 -0.988 . . . . 0.0 114.782 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.93 104.77 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.347 1.059 . . . . 0.0 110.264 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -81.75 116.29 21.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.891 0.876 . . . . 0.0 110.547 -175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.8 mt -142.37 139.81 18.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.534 -170.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -63.22 154.65 66.45 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.503 2.135 . . . . 0.0 110.188 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -58.36 -32.65 96.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.551 2.168 . . . . 0.0 114.691 -170.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 96.4 m95 -88.13 -3.25 58.91 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 m -118.81 -22.08 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.8 t -77.42 2.06 17.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.066 1.746 . . . . 0.0 114.514 -173.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.408 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.4 mp0 -49.64 158.26 0.47 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.497 2.319 . . . . 0.0 114.24 171.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.71 -33.37 73.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.34 126.51 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.419 1.087 . . . . 0.0 111.008 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -136.05 139.09 42.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.844 1.657 . . . . 0.0 110.255 169.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.95 157.83 39.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.636 1.174 . . . . 0.0 110.871 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -117.6 140.97 48.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.942 1.297 . . . . 0.0 110.571 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -108.63 140.15 42.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.582 1.553 . . . . 0.0 111.469 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.43 60.76 1.02 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.169 1.788 . . . . 0.0 106.495 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -107.64 124.56 50.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.073 2.149 . . . . 0.0 111.167 -167.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -81.27 157.98 24.96 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.324 1.05 . . . . 0.0 112.664 -172.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -95.07 123.81 56.08 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.592 1.157 . . . . 0.0 111.556 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.42 -9.47 11.35 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.56 2.173 . . . . 0.0 114.862 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -63.93 117.32 6.83 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 121.187 1.812 . . . . 0.0 112.595 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.61 -5.16 84.94 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.176 1.369 . . . . 0.0 114.694 -173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.8 178.1 5.42 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.741 1.616 . . . . 0.0 110.81 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.2 t -68.02 157.0 36.11 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.237 -0.915 . . . . 0.0 112.302 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.22 -24.15 66.14 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.144 -0.972 . . . . 0.0 111.365 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -66.38 -32.29 73.58 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.433 -0.792 . . . . 0.0 111.537 169.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.36 -39.18 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.94 -1.1 . . . . 0.0 110.425 173.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -59.03 -47.25 85.91 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.037 1.289 . . . . 0.0 111.289 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -68.23 -22.28 64.79 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.0 m -77.73 -57.34 3.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.97 -34.68 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 -171.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -55.88 -43.24 77.02 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.001 0.819 . . . . 0.0 112.953 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.04 -32.05 61.09 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.766 0.698 . . . . 0.0 112.051 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -68.44 -41.05 80.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.773 -0.84 . . . . 0.0 111.376 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.7 -49.11 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 0.0 110.174 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -54.42 -49.23 70.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.172 0.989 . . . . 0.0 112.202 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -71.57 -28.39 63.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.19 0.904 . . . . 0.0 112.696 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -72.16 -46.13 57.66 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.393 0.677 . . . . 0.0 111.181 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.6 t -58.05 -42.27 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.048 0.939 . . . . 0.0 111.289 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.06 -46.29 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.511 1.051 . . . . 0.0 111.935 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -40.45 95.99 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.58 0.627 . . . . 0.0 110.808 176.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.465 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -57.89 -51.24 70.41 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.215 1.006 . . . . 0.0 110.632 176.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.2 mt -70.6 -45.47 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.11 -26.0 68.05 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.9 pttt -91.21 -7.82 50.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.08 -16.71 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.883 1.673 . . . . 0.0 112.805 -175.782 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.39 138.94 49.55 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.192 0.906 . . . . 0.0 111.627 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -111.31 123.14 49.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.478 1.111 . . . . 0.0 111.161 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -93.21 107.08 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.875 1.67 . . . . 0.0 110.354 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -85.74 128.99 34.94 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.77 118.52 37.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.751 1.22 . . . . 0.0 108.727 169.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.3 136.18 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 0.0 111.163 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.2 t -130.43 173.43 10.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -64.93 152.0 44.32 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.62 150.91 46.11 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -169.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.4 t30 60.93 9.23 2.2 Favored 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -76.68 172.29 13.29 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.997 1.319 . . . . 0.0 111.368 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 p -118.21 3.27 12.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.617 1.167 . . . . 0.0 113.615 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -74.11 -33.31 63.55 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.518 1.508 . . . . 0.0 112.654 -169.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 p -65.71 -42.56 90.97 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.8 . . . . 0.0 111.736 169.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -64.14 -43.1 96.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.994 0.518 . . . . 0.0 112.175 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -39.54 91.63 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.454 -0.779 . . . . 0.0 111.874 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.21 -48.42 80.06 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.76 -38.73 75.9 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.597 0.635 . . . . 0.0 111.434 171.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.11 -62.38 6.19 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.106 1.336 . . . . 0.0 112.723 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -58.73 -33.61 70.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.004 1.402 . . . . 0.0 111.498 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.46 -30.36 64.5 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.684 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -73.99 -29.76 62.13 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.354 1.888 . . . . 0.0 112.771 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 m -74.98 -45.64 40.69 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.882 0.765 . . . . 0.0 112.22 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.3 -37.15 12.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.022 0.929 . . . . 0.0 112.588 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.82 2.18 60.44 Favored Glycine 0 N--CA 1.469 0.835 0 C-N-CA 125.527 1.537 . . . . 0.0 114.333 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 113.66 0.76 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.622 1.211 . . . . 0.0 111.724 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.1 19.96 79.79 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -124.0 -41.42 2.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.61 1.705 . . . . 0.0 112.383 -174.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -153.23 168.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.872 2.069 . . . . 0.0 110.424 177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.3 153.95 18.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 109.795 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.04 144.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.14 -0.975 . . . . 0.0 112.945 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -150.43 142.58 24.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.526 1.13 . . . . 0.0 110.721 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -103.52 148.62 25.73 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.188 1.395 . . . . 0.0 112.802 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -154.21 165.48 36.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 111.159 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.92 158.64 27.74 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -55.17 -36.8 66.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 118.124 0.962 . . . . 0.0 113.235 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.69 41.74 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.782 1.633 . . . . 0.0 109.651 169.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t 67.45 168.18 0.25 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.569 2.347 . . . . 0.0 115.983 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -137.92 170.61 15.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.708 2.403 . . . . 0.0 110.029 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -131.04 168.22 17.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -107.82 150.4 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.518 1.527 . . . . 0.0 108.164 169.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -136.92 133.41 18.7 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.888 -1.529 . . . . 0.0 109.94 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -52.98 -36.38 75.38 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.9 2.4 . . . . 0.0 115.139 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.1 m -69.36 -34.25 74.29 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.976 -1.078 . . . . 0.0 111.782 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.56 -13.29 60.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.031 -1.043 . . . . 0.0 113.184 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -77.69 -54.64 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.75 64.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -70.25 -9.84 57.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mmt -122.45 -29.89 4.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.449 1.1 . . . . 0.0 112.261 -169.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.59 -25.56 67.41 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.82 -1.175 . . . . 0.0 112.29 170.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.68 -13.88 62.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.274 1.03 . . . . 0.0 113.746 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.259 4.0 m -114.5 16.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.691 1.196 . . . . 0.0 111.604 168.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.03 73.36 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.036 1.779 . . . . 0.0 116.264 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.16 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.039 1.419 . . . . 0.0 112.05 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -129.16 121.38 27.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.27 3.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.351 1.46 . . . . 0.0 111.906 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -70.25 -34.11 72.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.572 -169.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.22 4.54 82.83 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.474 1.035 . . . . 0.0 114.645 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.78 156.68 26.81 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.08 1.44 . . . . 0.0 113.803 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -156.01 162.0 40.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.726 1.61 . . . . 0.0 110.21 173.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -103.26 172.51 6.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.904 1.281 . . . . 0.0 112.453 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -138.03 159.31 68.94 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.037 1.335 . . . . 0.0 109.981 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.78 138.06 83.57 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.336 2.691 . . . . 0.0 112.879 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 tt -58.1 -31.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.23 -11.13 60.68 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -20.95 57.75 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.246 -0.909 . . . . 0.0 112.642 171.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.28 167.56 11.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.79 1.236 . . . . 0.0 112.837 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.07 112.22 20.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.925 1.69 . . . . 0.0 110.358 175.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.502 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.23 -17.63 64.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.43 -26.06 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.183 0.993 . . . . 0.0 112.474 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.02 -1.3 57.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.913 1.685 . . . . 0.0 112.155 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -118.05 80.15 1.47 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.808 2.043 . . . . 0.0 108.115 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.05 -24.53 17.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.977 1.711 . . . . 0.0 113.186 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -134.28 130.65 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.789 1.635 . . . . 0.0 108.983 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.8 t -134.42 122.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.285 -0.884 . . . . 0.0 110.834 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.51 122.92 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.751 1.62 . . . . 0.0 108.899 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -88.9 144.54 26.13 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.243 1.417 . . . . 0.0 109.994 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.13 27.22 9.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.553 1.141 . . . . 0.0 111.781 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.8 m -92.6 -16.33 25.78 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.66 42.13 63.12 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-N 118.649 0.659 . . . . 0.0 113.06 -171.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.8 t 61.54 179.56 0.12 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.226 2.211 . . . . 0.0 113.556 -173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.77 24.38 74.16 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.317 0.96 . . . . 0.0 114.07 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 p -87.39 129.92 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.13 1.372 . . . . 0.0 111.108 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -83.87 57.77 4.31 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.583 1.153 . . . . 0.0 111.924 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -74.58 140.22 75.07 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.076 0.95 . . . . 0.0 112.491 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.95 151.56 83.87 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.151 1.9 . . . . 0.0 109.774 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.89 -21.11 72.9 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.104 2.536 . . . . 0.0 115.463 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.27 -13.19 61.45 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.502 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 95.5 m95 -91.48 -1.85 57.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.21 17.52 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.605 1.562 . . . . 0.0 113.427 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 t -124.64 1.48 8.22 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.095 1.758 . . . . 0.0 113.023 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.472 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.1 mp0 -58.9 163.4 3.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.771 2.829 . . . . 0.0 113.986 176.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.41 -35.62 81.5 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.7 125.9 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.976 0.91 . . . . 0.0 109.985 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -125.59 147.22 49.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.256 1.423 . . . . 0.0 110.715 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -139.33 157.79 45.28 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.39 1.076 . . . . 0.0 112.505 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -135.97 126.65 27.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.764 1.226 . . . . 0.0 108.234 168.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -111.28 132.14 54.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.678 1.591 . . . . 0.0 110.218 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -92.38 64.15 4.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.159 1.383 . . . . 0.0 109.771 -171.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.03 144.82 25.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.569 1.548 . . . . 0.0 114.075 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -93.88 160.4 14.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.596 1.558 . . . . 0.0 111.0 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -106.31 126.39 30.6 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.083 0.953 . . . . 0.0 111.787 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.41 -6.41 15.5 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.306 2.004 . . . . 0.0 113.64 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.95 125.08 17.39 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.084 1.311 . . . . 0.0 112.058 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.6 4.29 60.85 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.476 1.036 . . . . 0.0 115.422 -176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -93.03 178.27 5.8 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.985 1.393 . . . . 0.0 113.121 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.2 t -72.06 156.0 39.69 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.279 0.632 . . . . 0.0 110.554 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.53 -21.61 64.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.002 -1.061 . . . . 0.0 112.079 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.72 -28.08 67.35 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.232 -0.917 . . . . 0.0 111.244 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.86 -41.19 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.938 -1.101 . . . . 0.0 110.309 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -56.81 -48.45 77.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.946 1.248 . . . . 0.0 111.145 169.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -69.57 -18.73 63.66 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.3 m -82.71 -52.29 6.91 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.183 1.393 . . . . 0.0 111.945 169.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.13 -34.53 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.461 1.105 . . . . 0.0 111.396 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -54.12 -42.57 69.61 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.835 0.743 . . . . 0.0 112.099 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.64 -31.42 65.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.67 0.653 . . . . 0.0 112.913 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.16 -41.18 70.74 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.141 0.971 . . . . 0.0 110.782 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.72 -47.47 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.426 0.69 . . . . 0.0 110.549 169.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.24 -50.4 67.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.922 1.289 . . . . 0.0 112.639 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -70.12 -26.43 63.96 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.787 1.176 . . . . 0.0 112.635 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -72.96 -51.08 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.213 1.005 . . . . 0.0 110.807 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.59 -47.54 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.263 1.025 . . . . 0.0 111.735 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -62.5 -51.75 66.2 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.697 1.135 . . . . 0.0 112.574 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.14 -31.4 68.89 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.125 0.875 . . . . 0.0 111.964 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.12 -50.04 73.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.475 0.71 . . . . 0.0 110.784 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.23 -38.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 121.369 -0.832 . . . . 0.0 111.375 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -25.51 67.2 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -91.23 -11.92 36.78 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.8 pt -114.14 -17.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.254 1.316 0 C-N-CA 125.582 1.553 . . . . 0.0 111.973 172.099 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttm . . . . . 0 N--CA 1.501 2.075 0 CA-C-O 119.786 -0.149 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -71.31 143.44 50.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.183 0.993 . . . . 0.0 112.028 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -110.06 122.84 48.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.71 109.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.532 1.533 . . . . 0.0 110.352 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 ttm -89.63 126.93 35.82 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.586 0.63 . . . . 0.0 109.59 169.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -95.56 124.25 39.49 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.021 1.329 . . . . 0.0 109.343 169.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.9 m -128.13 143.09 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.524 1.13 . . . . 0.0 112.554 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.0 t -153.36 177.3 11.03 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -77.01 167.76 21.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.432 1.493 . . . . 0.0 111.846 170.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -63.58 -36.33 83.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 -169.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -69.7 -37.81 76.74 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 p -94.27 173.04 7.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -169.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.3 p -106.79 16.45 24.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.106 1.363 . . . . 0.0 111.841 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -62.4 -35.91 80.7 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.497 -1.377 . . . . 0.0 112.598 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -66.28 -44.14 84.38 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.195 0.907 . . . . 0.0 111.995 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -65.2 -43.97 89.89 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.493 -0.754 . . . . 0.0 111.887 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -39.11 79.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.6 1.16 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.53 92.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.34 -38.46 77.21 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.428 -0.795 . . . . 0.0 110.732 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.73 -58.6 9.94 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.522 1.534 . . . . 0.0 113.943 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 123' ' ' VAL . 44.9 m-85 -65.23 -30.54 71.43 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.969 1.384 . . . . 0.0 111.982 174.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.53 -32.82 70.43 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.903 -1.123 . . . . 0.0 113.962 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -70.57 -26.89 63.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 121.315 1.871 . . . . 0.0 112.666 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.5 m -74.91 -46.47 35.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.663 0.785 . . . . 0.0 112.454 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.6 mt -98.75 -29.34 13.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -169.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.18 2.2 87.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.78 1.657 . . . . 0.0 113.229 170.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.13 116.22 1.46 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.406 1.103 . . . . 0.0 112.284 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.78 11.42 84.58 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -119.84 -38.04 3.02 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.16 1.48 . . . . 0.0 111.793 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 pt -148.28 161.68 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.539 1.936 . . . . 0.0 112.001 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.56 147.75 22.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.97 142.86 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.993 -1.067 . . . . 0.0 112.465 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -146.43 153.04 40.0 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 p -128.71 144.02 51.07 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.515 1.126 . . . . 0.0 112.615 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t -155.29 162.27 40.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.282 1.433 . . . . 0.0 110.268 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.37 154.36 20.31 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.04 -1.038 . . . . 0.0 111.403 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.05 -40.27 97.2 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.067 -1.255 . . . . 0.0 111.519 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -111.17 34.23 4.18 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.654 1.582 . . . . 0.0 109.625 169.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 t 71.44 170.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.546 1.938 . . . . 0.0 111.357 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.5 p -149.41 -162.52 1.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.598 1.559 . . . . 0.0 110.294 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -155.35 174.88 14.6 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.683 -1.261 . . . . 0.0 114.388 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.39 154.14 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -127.78 130.83 23.6 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.174 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -54.78 -39.61 88.87 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.991 2.461 . . . . 0.0 114.503 -173.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -67.56 -31.69 71.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.11 -10.33 59.33 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.678 -1.263 . . . . 0.0 113.127 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.6 -57.77 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.13 79.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 75.4 mmm -73.97 -8.5 56.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.1 mmt -118.15 -25.91 6.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.086 1.355 . . . . 0.0 111.76 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.9 -30.61 67.93 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.986 -1.071 . . . . 0.0 111.783 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.91 -11.08 60.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 t -100.9 3.03 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 126.606 1.962 . . . . 0.0 110.477 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.75 12.25 81.74 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.383 1.468 . . . . 0.0 114.848 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -87.45 148.12 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 118.494 1.147 . . . . 0.0 111.197 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -132.46 101.11 5.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.462 1.505 . . . . 0.0 111.21 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.4 pt -125.38 -4.13 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.3 p -63.94 -27.02 68.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.609 1.095 . . . . 0.0 113.546 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.39 -5.25 89.73 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.877 1.227 . . . . 0.0 115.311 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -78.47 157.93 28.79 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.522 1.661 . . . . 0.0 113.374 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -134.41 -177.61 4.68 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.858 2.063 . . . . 0.0 110.887 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 t -151.07 161.44 42.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.29 1.036 . . . . 0.0 112.047 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -147.6 160.01 39.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.173 1.789 . . . . 0.0 109.671 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.85 133.99 54.26 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.347 2.698 . . . . 0.0 111.955 174.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.47 -32.32 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -9.63 51.36 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -22.03 59.15 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.167 0.894 . . . . 0.0 112.605 170.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.88 171.57 8.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.851 1.261 . . . . 0.0 112.8 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.49 113.96 21.56 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.574 1.55 . . . . 0.0 111.074 176.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.14 -11.73 59.66 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.706 -1.247 . . . . 0.0 113.857 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.15 -20.88 57.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.838 1.255 . . . . 0.0 112.98 174.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -103.25 -0.63 30.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.117 1.767 . . . . 0.0 113.166 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -125.26 77.5 1.64 Allowed 'General case' 0 C--N 1.345 0.406 0 C-N-CA 125.799 1.639 . . . . 0.0 109.206 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.99 -23.57 13.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.085 2.154 . . . . 0.0 113.488 -175.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.74 133.81 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.768 1.627 . . . . 0.0 108.186 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.57 122.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.988 -1.07 . . . . 0.0 110.353 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.63 118.05 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 108.167 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -88.64 154.91 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.083 0.953 . . . . 0.0 109.856 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.07 46.59 2.48 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.079 1.351 . . . . 0.0 110.852 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t -105.25 -36.31 7.27 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.394 1.478 . . . . 0.0 111.868 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.08 90.05 2.08 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.868 1.699 . . . . 0.0 112.379 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.3 p 37.08 45.33 0.46 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.255 2.222 . . . . 0.0 115.6 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -176.13 15.9 0.04 OUTLIER Glycine 0 CA--C 1.538 1.497 0 N-CA-C 117.017 1.567 . . . . 0.0 117.017 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.3 147.5 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.385 1.593 . . . . 0.0 111.978 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -99.46 59.5 1.11 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.357 1.063 . . . . 0.0 111.503 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -87.4 146.3 39.46 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -65.68 154.3 74.41 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 122.824 2.349 . . . . 0.0 110.153 168.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.72 -35.55 98.76 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.51 2.14 . . . . 0.0 115.668 -169.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.57 -23.76 67.18 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.086 -1.009 . . . . 0.0 113.355 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.4 -7.57 58.88 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.17 -22.82 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.25 1.42 . . . . 0.0 113.411 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -83.16 11.9 5.86 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.782 1.633 . . . . 0.0 113.508 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.65 165.92 11.65 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.767 1.627 . . . . 0.0 112.603 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.29 -36.51 83.91 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.659 -0.651 . . . . 0.0 112.726 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.7 130.0 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.861 0.865 . . . . 0.0 110.119 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -134.89 150.6 50.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.134 1.373 . . . . 0.0 111.873 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -141.74 158.04 44.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -139.63 81.17 1.81 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.668 0.787 . . . . 0.0 111.218 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -66.47 149.5 50.34 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.126 1.771 . . . . 0.0 113.127 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -114.04 60.6 0.67 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.339 1.856 . . . . 0.0 107.858 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -100.57 134.68 43.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.169 2.187 . . . . 0.0 112.527 -168.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.44 140.24 56.36 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.335 1.854 . . . . 0.0 112.644 -173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -93.04 112.06 54.39 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -78.69 -6.05 15.08 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.471 2.114 . . . . 0.0 113.496 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -53.72 122.79 10.64 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.689 1.131 . . . . 0.0 112.628 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.06 4.14 47.73 Favored Glycine 0 CA--C 1.541 1.695 0 N-CA-C 115.446 0.938 . . . . 0.0 115.446 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -101.18 -178.88 3.87 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.14 1.376 . . . . 0.0 112.476 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.7 m -78.04 162.31 26.81 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.977 0.911 . . . . 0.0 112.023 -171.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.02 -24.97 66.86 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.164 -0.96 . . . . 0.0 111.676 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.84 -28.33 69.49 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.161 -0.962 . . . . 0.0 111.796 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 -39.92 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.463 -1.398 . . . . 0.0 109.484 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -63.18 -36.55 84.01 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.433 1.015 . . . . 0.0 112.166 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -77.57 -20.8 53.47 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.125 -1.609 . . . . 0.0 113.827 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.3 m -91.73 -39.58 11.73 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.967 0.907 . . . . 0.0 111.63 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.8 p -59.27 -42.7 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 120.404 -1.435 . . . . 0.0 111.797 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -59.83 -43.34 94.63 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -32.05 65.51 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.849 -0.532 . . . . 0.0 112.828 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.37 -39.14 81.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.888 0.844 . . . . 0.0 112.064 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.64 -51.47 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.58 0.752 . . . . 0.0 109.91 169.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -57.19 -47.0 82.35 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.359 1.064 . . . . 0.0 112.61 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -68.73 -27.06 65.6 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.773 1.624 . . . . 0.0 112.531 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -73.16 -51.43 17.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 111.655 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 21' ' ' PHE . 34.4 m -59.52 -41.05 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.115 0.871 . . . . 0.0 112.761 169.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.84 -50.32 69.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.701 1.591 . . . . 0.0 112.389 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -70.61 -30.0 66.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.905 0.775 . . . . 0.0 112.063 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -50.0 70.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.698 0.799 . . . . 0.0 110.815 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -69.78 -41.17 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.274 -0.891 . . . . 0.0 110.705 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.65 -26.38 68.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.31 -14.79 34.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.9 pt -111.58 -18.3 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.543 1.137 . . . . 0.0 113.154 179.058 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -71.56 140.85 50.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.779 0.832 . . . . 0.0 111.851 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -111.09 126.46 54.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.325 1.05 . . . . 0.0 111.28 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.12 107.63 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.208 1.803 . . . . 0.0 109.826 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -87.64 127.9 35.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.141 0.428 . . . . 0.0 109.989 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.11 114.71 28.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.5 1.12 . . . . 0.0 109.69 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -111.46 136.26 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.699 1.2 . . . . 0.0 112.524 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.2 t -138.52 168.82 18.95 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.206 -0.934 . . . . 0.0 112.577 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -60.55 147.84 40.11 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.934 0.894 . . . . 0.0 109.86 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.21 154.57 37.69 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 52.23 42.36 30.75 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.582 1.553 . . . . 0.0 113.36 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -123.47 168.62 12.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.723 1.609 . . . . 0.0 110.686 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.8 t -117.96 6.02 12.16 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.248 1.019 . . . . 0.0 113.634 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -72.39 -37.49 68.7 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.248 -1.533 . . . . 0.0 111.175 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -62.3 -46.17 89.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.298 1.039 . . . . 0.0 111.621 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.04 -40.4 78.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.554 1.142 . . . . 0.0 111.979 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.7 mmm -68.6 -36.91 79.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.436 -0.79 . . . . 0.0 112.745 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.68 95.89 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.001 0.819 . . . . 0.0 111.451 173.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -60.46 -39.75 88.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.899 0.772 . . . . 0.0 111.323 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.55 -60.96 7.53 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.975 1.274 . . . . 0.0 112.894 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -60.31 -34.01 73.19 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.554 1.177 . . . . 0.0 111.734 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.12 -27.16 61.52 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 117.839 -1.077 . . . . 0.0 113.884 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -75.42 -28.66 59.47 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.295 1.861 . . . . 0.0 112.656 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -76.05 -45.99 31.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.623 0.769 . . . . 0.0 112.267 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.16 -30.36 12.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.436 1.094 . . . . 0.0 113.267 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.0 4.98 81.51 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.94 1.733 . . . . 0.0 113.692 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.69 109.33 0.19 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.553 1.176 . . . . 0.0 112.813 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.61 19.41 79.7 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -118.48 -37.2 3.35 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.079 1.439 . . . . 0.0 112.08 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -152.28 166.58 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.051 2.541 . . . . 0.0 109.82 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.57 151.27 21.39 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.385 0.674 . . . . 0.0 109.737 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 142.1 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.039 -1.038 . . . . 0.0 112.666 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 m -149.28 154.91 39.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.92 1.288 . . . . 0.0 110.578 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 p -127.11 145.61 50.68 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.61 1.164 . . . . 0.0 112.598 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -148.46 146.5 28.42 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.859 1.264 . . . . 0.0 111.243 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.87 143.05 17.64 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.5 -38.57 66.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.587 1.694 . . . . 0.0 112.604 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -122.74 45.44 2.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.789 1.635 . . . . 0.0 110.307 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.2 p 68.99 143.62 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.434 3.094 . . . . 0.0 116.776 -170.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -107.69 171.39 7.42 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.644 2.378 . . . . 0.0 111.566 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -141.3 144.17 34.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.916 1.286 . . . . 0.0 112.496 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.26 152.73 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.093 1.757 . . . . 0.0 110.75 171.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.48 149.82 68.62 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.522 1.129 . . . . 0.0 111.776 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.08 -35.83 74.02 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.404 2.736 . . . . 0.0 114.224 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -63.54 -39.39 94.29 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.492 -0.755 . . . . 0.0 112.006 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.72 -20.57 61.18 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.171 -0.956 . . . . 0.0 112.808 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.94 -54.26 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.14 67.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -170.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -69.72 -9.67 55.34 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 mmt -125.85 -28.89 3.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.309 1.044 . . . . 0.0 112.499 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.28 -24.85 67.52 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.868 -1.145 . . . . 0.0 112.101 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.35 -13.68 62.45 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.74 15.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.974 1.31 . . . . 0.0 111.641 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.94 10.94 71.14 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.957 1.742 . . . . 0.0 116.176 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -84.9 146.76 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.404 1.602 . . . . 0.0 111.958 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -116.13 129.34 56.28 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.79 1.636 . . . . 0.0 111.96 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.0 pt -135.29 -8.94 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.943 1.297 . . . . 0.0 113.707 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -60.29 -30.64 69.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.869 1.268 . . . . 0.0 114.094 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.33 1.9 84.66 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.76 1.171 . . . . 0.0 115.353 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -77.56 156.75 30.7 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.77 1.785 . . . . 0.0 112.674 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.3 p -133.25 175.43 9.41 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.564 1.946 . . . . 0.0 110.231 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -155.91 155.55 33.04 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -148.45 159.2 39.48 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.231 2.212 . . . . 0.0 109.472 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -55.38 143.11 78.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.389 2.726 . . . . 0.0 113.127 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.74 -31.49 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -169.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -13.7 60.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -20.01 58.53 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 119.084 0.856 . . . . 0.0 112.926 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -96.33 164.35 12.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.943 1.297 . . . . 0.0 112.625 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.11 109.71 19.24 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 111.348 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.88 -22.06 65.99 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.24 -25.61 68.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.696 1.198 . . . . 0.0 112.834 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.15 -3.07 58.74 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.993 1.717 . . . . 0.0 112.103 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -116.17 82.26 1.75 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.887 2.075 . . . . 0.0 108.428 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -25.52 21.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.835 1.654 . . . . 0.0 113.079 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.6 t -132.97 129.78 57.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.079 1.752 . . . . 0.0 109.085 -176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.61 120.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.196 -0.94 . . . . 0.0 110.719 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.51 120.46 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.169 1.388 . . . . 0.0 108.159 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -86.02 150.29 24.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.42 1.088 . . . . 0.0 109.721 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.83 44.09 3.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.082 1.353 . . . . 0.0 110.522 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.1 m -114.16 -13.36 12.41 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.11 13.54 82.63 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.409 1.005 . . . . 0.0 114.213 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.7 p -157.09 171.56 20.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.163 2.185 . . . . 0.0 110.643 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.54 -28.81 65.62 Favored Glycine 0 CA--C 1.542 1.77 0 O-C-N 121.608 -0.682 . . . . 0.0 113.607 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.304 0.3 OUTLIER 61.2 161.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 129.609 3.163 . . . . 0.0 115.288 173.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -70.4 108.54 4.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.975 -1.078 . . . . 0.0 110.122 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.0 mt -140.26 133.81 15.2 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.388 1.475 . . . . 0.0 111.027 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -60.39 152.27 68.5 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.293 1.995 . . . . 0.0 110.243 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.13 -21.84 73.17 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.035 2.49 . . . . 0.0 114.912 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -15.56 62.73 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.6 m95 -90.26 -3.16 57.98 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.15 13.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.674 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -118.12 -1.2 11.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.493 1.917 . . . . 0.0 112.775 -171.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.434 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.4 mp0 -56.05 159.67 3.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.587 2.755 . . . . 0.0 113.89 175.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.28 -34.98 79.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.22 129.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.172 0.989 . . . . 0.0 110.368 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -130.62 148.19 52.39 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.423 1.489 . . . . 0.0 111.29 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -142.0 161.75 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.759 1.224 . . . . 0.0 112.554 176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.08 124.24 21.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.85 1.26 . . . . 0.0 109.102 168.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -110.85 160.32 16.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.206 1.802 . . . . 0.0 112.4 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -122.79 50.6 1.5 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.475 1.51 . . . . 0.0 112.333 -168.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.19 137.52 36.7 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.229 -0.92 . . . . 0.0 112.636 -172.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 146.5 52.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.863 1.265 . . . . 0.0 108.556 169.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.46 119.22 65.66 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.95 0.9 . . . . 0.0 111.024 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.76 -11.31 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.143 1.895 . . . . 0.0 113.447 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.1 121.9 10.46 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.267 1.027 . . . . 0.0 112.076 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.22 1.76 64.97 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -100.58 -174.61 2.69 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.15 1.38 . . . . 0.0 111.89 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.5 t -74.01 157.5 36.02 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.476 -0.765 . . . . 0.0 112.028 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.91 -30.09 70.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.47 1.108 . . . . 0.0 111.646 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.98 -21.42 63.24 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.671 -1.268 . . . . 0.0 113.12 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.7 t -71.2 -40.52 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 120.36 -1.463 . . . . 0.0 110.102 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -56.83 -46.68 81.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.571 1.078 . . . . 0.0 110.826 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -68.77 -17.86 64.11 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.8 m -87.67 -43.47 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.912 1.285 . . . . 0.0 112.236 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -66.76 -38.74 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.703 -1.248 . . . . 0.0 111.501 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -57.46 -40.2 77.97 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.34 64.94 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.431 0.539 . . . . 0.0 112.881 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -68.76 -43.59 75.49 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.957 -0.731 . . . . 0.0 110.978 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.5 t -58.81 -47.49 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.747 -0.596 . . . . 0.0 110.414 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -57.12 -50.71 71.97 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.678 1.191 . . . . 0.0 112.422 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.19 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.878 1.217 . . . . 0.0 112.794 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -68.42 -50.72 50.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.472 0.709 . . . . 0.0 110.924 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.34 -48.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.646 1.178 . . . . 0.0 112.174 169.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -62.52 -50.82 69.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.832 1.196 . . . . 0.0 112.475 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -30.19 67.43 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.772 0.715 . . . . 0.0 111.899 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.43 -50.82 68.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.697 0.799 . . . . 0.0 110.613 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -70.74 -39.98 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.22 0.918 . . . . 0.0 111.165 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 -20.6 60.84 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -97.64 -10.9 24.25 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -113.55 -17.64 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 126.21 1.804 . . . . 0.0 112.499 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -71.42 144.07 49.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.063 0.945 . . . . 0.0 111.702 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.18 128.39 55.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.109 0.964 . . . . 0.0 111.284 170.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.66 118.33 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.249 1.819 . . . . 0.0 110.221 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.2 tpp -96.95 122.7 40.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -95.56 114.95 26.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.421 0.689 . . . . 0.0 110.438 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.91 147.06 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.45 1.1 . . . . 0.0 113.46 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 t -146.41 151.99 38.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -73.05 98.85 2.62 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.613 1.165 . . . . 0.0 109.818 174.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 52.55 -95.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.949 2.1 . . . . 0.0 113.046 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -40.0 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.172 2.189 . . . . 0.0 112.701 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.0 m -88.76 17.67 5.38 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -173.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.87 -33.51 75.86 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.508 1.504 . . . . 0.0 111.66 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.29 -39.72 24.78 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.839 1.256 . . . . 0.0 111.536 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.1 p -71.99 -40.44 68.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.535 1.061 . . . . 0.0 112.83 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.31 -32.15 71.1 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.91 0.777 . . . . 0.0 111.145 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -43.18 80.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.04 1.291 . . . . 0.0 112.378 169.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -43.52 97.02 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.266 0.485 . . . . 0.0 110.922 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.76 -43.71 97.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.817 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -44.86 96.67 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 119.805 1.184 . . . . 0.0 113.79 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.93 -37.9 76.03 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.444 -1.033 . . . . 0.0 111.14 171.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.47 -34.2 65.24 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.697 -1.252 . . . . 0.0 113.67 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.86 -22.52 64.21 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.908 1.231 . . . . 0.0 112.63 171.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 m -88.8 -46.88 8.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.814 1.246 . . . . 0.0 112.262 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.62 -33.45 12.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 112.886 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 5.76 77.67 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.939 1.733 . . . . 0.0 113.059 170.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.38 120.62 4.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.349 1.075 . . . . 0.0 111.433 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.95 77.88 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -110.42 -40.82 4.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.339 1.455 . . . . 0.0 111.045 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -148.6 159.35 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 112.762 -171.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.61 151.27 19.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.122 1.369 . . . . 0.0 107.53 168.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 t -139.9 139.88 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 120.89 -1.131 . . . . 0.0 112.177 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -141.6 154.68 45.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.677 1.591 . . . . 0.0 109.865 170.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.3 p -124.11 152.35 42.86 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.084 -1.01 . . . . 0.0 112.126 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 t -151.01 124.54 8.98 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.433 0.693 . . . . 0.0 112.717 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.24 127.14 8.64 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.98 -35.12 23.24 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -169.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -123.0 34.56 5.1 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.234 1.414 . . . . 0.0 112.605 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 p 66.99 161.83 0.17 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 127.759 2.423 . . . . 0.0 115.499 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -161.58 -163.52 1.0 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.165 1.386 . . . . 0.0 111.528 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -133.16 173.25 11.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.241 1.817 . . . . 0.0 113.21 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 t -85.55 167.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -129.43 125.71 22.59 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 120.337 -1.477 . . . . 0.0 111.714 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -55.79 -40.17 86.76 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.176 2.584 . . . . 0.0 114.651 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -64.42 -30.32 71.36 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.117 -0.989 . . . . 0.0 111.859 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.36 -5.43 52.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.3 mt -86.14 -57.05 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 168.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.11 75.34 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -170.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.4 -9.34 58.0 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 mmt -119.12 -27.85 5.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.127 0.971 . . . . 0.0 112.34 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.92 -30.38 65.87 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.786 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.8 -10.64 59.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.811 1.244 . . . . 0.0 113.923 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 8.5 p -121.77 24.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.932 1.693 . . . . 0.0 110.829 169.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.6 83.46 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.211 1.863 . . . . 0.0 116.63 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.22 147.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.789 1.295 . . . . 0.0 111.76 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -131.63 107.82 9.09 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.191 1.796 . . . . 0.0 110.597 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 pt -140.22 15.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 p -60.05 -27.64 67.11 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.698 -1.251 . . . . 0.0 113.825 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.08 9.22 39.36 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.161 1.362 . . . . 0.0 116.153 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -65.09 -50.58 65.55 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.264 2.032 . . . . 0.0 114.203 -169.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p 58.71 167.27 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.245 1.818 . . . . 0.0 114.38 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -144.63 131.15 19.87 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.027 -1.046 . . . . 0.0 112.166 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -132.53 158.61 75.23 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.001 1.721 . . . . 0.0 112.289 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.06 145.14 89.18 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.478 2.785 . . . . 0.0 113.524 -170.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.52 -34.23 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -169.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.52 -7.0 50.07 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -20.47 55.79 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.294 -0.879 . . . . 0.0 112.133 169.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -94.99 170.21 9.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.182 1.393 . . . . 0.0 112.264 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.22 111.69 18.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.974 1.71 . . . . 0.0 110.535 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -65.46 -23.05 66.82 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -169.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.29 -25.14 67.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.92 0.888 . . . . 0.0 112.758 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.73 -2.75 58.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.224 1.81 . . . . 0.0 111.946 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.9 84.65 2.11 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.117 2.167 . . . . 0.0 108.022 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.86 -28.05 8.73 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.055 1.742 . . . . 0.0 112.725 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.56 130.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.832 1.653 . . . . 0.0 109.003 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.1 t -131.5 126.99 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.297 -0.877 . . . . 0.0 109.097 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -126.2 124.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.464 1.106 . . . . 0.0 108.904 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -99.35 156.4 17.02 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.113 0.965 . . . . 0.0 111.599 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.24 52.88 2.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 110.937 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.3 m -116.6 -0.91 12.28 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.26 1.424 . . . . 0.0 114.763 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.5 49.01 4.54 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.086 0.857 . . . . 0.0 115.199 173.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.4 t 58.39 52.1 7.56 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.0 1.72 . . . . 0.0 112.761 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.06 111.15 0.24 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.137 1.351 . . . . 0.0 112.074 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.32 140.22 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.781 1.232 . . . . 0.0 111.228 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -88.37 115.5 25.92 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.805 0.842 . . . . 0.0 109.86 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.63 138.63 20.42 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.119 0.967 . . . . 0.0 112.914 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.99 151.76 82.97 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.483 2.122 . . . . 0.0 109.896 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -57.57 -29.97 86.9 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 115.255 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.73 -19.58 65.95 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.8 m95 -89.77 -3.45 58.15 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.75 -12.83 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -88.52 5.5 42.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.696 1.599 . . . . 0.0 113.765 -171.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.438 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.0 mp0 -59.23 160.43 6.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.146 2.179 . . . . 0.0 113.878 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.98 -33.24 75.28 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 127.06 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.834 0.854 . . . . 0.0 110.36 169.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -138.28 141.43 39.85 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.777 1.631 . . . . 0.0 111.127 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.96 162.44 38.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.405 1.482 . . . . 0.0 110.72 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -128.85 124.67 35.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.571 1.148 . . . . 0.0 111.581 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -102.89 161.67 13.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.197 1.799 . . . . 0.0 113.091 -172.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -95.64 -82.06 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.528 1.131 . . . . 0.0 111.496 -170.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 55.09 156.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.3 2.64 . . . . 0.0 115.853 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -90.25 178.05 6.26 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -117.74 117.84 35.46 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.462 -1.399 . . . . 0.0 111.209 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.03 -11.34 7.64 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.449 1.433 . . . . 0.0 113.261 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.25 106.1 0.69 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 120.644 1.565 . . . . 0.0 112.779 -172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.76 1.06 85.55 Favored Glycine 0 CA--C 1.543 1.785 0 C-N-CA 125.063 1.315 . . . . 0.0 115.718 -173.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -97.98 -171.7 2.21 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.09 1.756 . . . . 0.0 111.378 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.2 t -76.11 159.74 30.45 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.181 -0.949 . . . . 0.0 112.641 -170.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -58.48 -32.9 69.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.353 1.461 . . . . 0.0 111.295 176.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.19 -29.62 70.45 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 0.0 112.374 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.5 t -72.34 -42.21 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.907 -1.12 . . . . 0.0 110.263 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -58.8 -48.16 82.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.331 0.969 . . . . 0.0 111.56 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -69.83 -20.61 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.7 m -78.88 -56.01 4.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.591 1.156 . . . . 0.0 110.925 169.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.19 -35.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 0.0 111.387 -171.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.77 -42.77 72.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.828 0.74 . . . . 0.0 112.84 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.03 -34.75 61.55 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.808 0.718 . . . . 0.0 112.712 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -70.39 -41.47 72.97 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.457 0.629 . . . . 0.0 110.588 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.64 -45.82 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.651 -0.655 . . . . 0.0 110.975 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -55.28 -50.08 70.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.163 0.985 . . . . 0.0 111.788 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.29 -29.44 66.18 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.862 1.21 . . . . 0.0 113.013 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -68.6 -49.85 56.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.453 0.701 . . . . 0.0 111.196 173.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.64 -41.31 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.833 1.253 . . . . 0.0 111.731 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -62.04 -47.27 85.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.529 1.059 . . . . 0.0 112.131 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -38.77 92.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.553 0.615 . . . . 0.0 111.092 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.48 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.7 tm? -59.25 -53.52 57.38 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.5 1.12 . . . . 0.0 110.598 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.82 -42.34 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 118.754 0.706 . . . . 0.0 111.384 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.15 70.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -90.89 -20.1 22.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.4 -24.93 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 124.919 1.288 . . . . 0.0 114.273 -169.637 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 tpp . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.656 -0.211 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -68.9 135.5 51.13 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.668 1.187 . . . . 0.0 112.467 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -108.96 128.24 54.76 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.942 0.897 . . . . 0.0 111.862 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.31 120.69 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.871 1.668 . . . . 0.0 110.051 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.5 tpp -99.62 126.84 45.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -98.4 123.44 42.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.223 0.609 . . . . 0.0 111.197 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 m -125.84 141.64 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.22 1.008 . . . . 0.0 113.004 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t . . . . . 0 CA--C 1.551 0.996 0 O-C-N 121.404 -0.81 . . . . 0.0 112.357 179.487 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 p -66.4 -48.06 71.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.124 1.329 . . . . 0.0 111.232 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.77 -39.07 93.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.298 1.439 . . . . 0.0 111.719 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -40.53 77.15 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.944 1.297 . . . . 0.0 112.018 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.97 95.46 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.651 -0.656 . . . . 0.0 112.427 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -58.79 -41.08 85.86 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.789 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.7 -52.82 45.81 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.484 1.038 . . . . 0.0 113.25 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -65.3 -41.16 94.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.083 -1.246 . . . . 0.0 111.801 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.27 87.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -73.17 -20.93 60.8 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.536 1.062 . . . . 0.0 113.028 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -87.92 -44.84 10.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.225 1.01 . . . . 0.0 112.187 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.02 -37.58 10.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.213 1.005 . . . . 0.0 112.819 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.94 6.96 68.1 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.653 1.597 . . . . 0.0 113.99 170.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.27 -43.4 4.86 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.5 16.18 48.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.583 1.563 . . . . 0.0 114.651 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.09 -34.08 3.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.034 1.333 . . . . 0.0 112.477 -169.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -152.98 165.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.678 1.591 . . . . 0.0 113.149 -173.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.77 153.77 17.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 167.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.19 143.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.278 -1.514 . . . . 0.0 114.615 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.82 168.07 20.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.473 1.909 . . . . 0.0 108.933 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -140.49 153.7 46.32 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.859 -1.15 . . . . 0.0 112.167 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 p -153.82 -175.27 5.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.525 1.13 . . . . 0.0 110.186 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.14 166.53 26.68 Favored Glycine 0 N--CA 1.471 1.016 0 O-C-N 120.836 -1.165 . . . . 0.0 113.15 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.09 -38.34 85.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 122.013 -0.698 . . . . 0.0 112.076 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.21 40.6 3.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.125 1.77 . . . . 0.0 109.135 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t 73.84 178.09 0.23 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.661 2.384 . . . . 0.0 113.71 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -144.84 174.75 10.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.348 2.259 . . . . 0.0 110.935 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.4 ptt85 -140.37 158.45 44.0 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.16 156.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -135.15 131.05 19.57 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-O 117.38 -1.295 . . . . 0.0 111.386 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -55.46 -39.52 90.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.131 2.554 . . . . 0.0 114.721 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -67.65 -30.38 69.92 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.041 -1.037 . . . . 0.0 111.784 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.25 -10.14 59.19 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.824 -1.172 . . . . 0.0 113.432 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.74 -55.04 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.19 62.8 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -73.57 -9.69 58.94 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.2 mmt -121.79 -28.47 4.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.502 1.121 . . . . 0.0 112.311 -171.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -21.56 66.73 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.135 -0.978 . . . . 0.0 112.895 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.34 -11.09 60.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.4 1.08 . . . . 0.0 113.28 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -102.64 0.63 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 126.86 2.064 . . . . 0.0 110.452 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.71 13.77 79.2 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.143 1.354 . . . . 0.0 114.474 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mm -87.58 152.39 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.449 1.099 . . . . 0.0 110.96 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -127.68 137.33 52.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.975 1.31 . . . . 0.0 111.429 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 pt -139.56 -7.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.402 1.081 . . . . 0.0 113.551 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -57.22 -35.07 69.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.836 1.654 . . . . 0.0 114.973 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.78 -3.17 88.28 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.366 0.984 . . . . 0.0 115.293 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -78.76 157.96 28.36 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.037 1.418 . . . . 0.0 113.707 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -132.74 175.27 9.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.024 2.13 . . . . 0.0 111.287 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.4 t -154.09 156.48 37.34 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.164 0.985 . . . . 0.0 112.775 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -142.59 161.8 47.72 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.643 1.977 . . . . 0.0 108.598 169.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.99 135.64 70.04 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.844 2.363 . . . . 0.0 112.577 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 tt -53.85 -33.33 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.36 -12.28 61.47 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.86 59.0 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.114 0.87 . . . . 0.0 112.309 169.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.11 171.95 8.75 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.15 1.38 . . . . 0.0 112.07 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -98.11 -17.12 19.25 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -168.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.531 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . 60.15 -29.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.085 2.954 . . . . 0.0 116.947 -170.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.75 -36.25 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 113.07 -169.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -81.58 -0.7 43.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 111.909 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -112.25 77.83 1.08 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.714 2.006 . . . . 0.0 108.442 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.98 -24.17 8.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.07 1.748 . . . . 0.0 113.236 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.07 130.19 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.072 1.749 . . . . 0.0 108.778 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.78 121.61 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.661 -1.274 . . . . 0.0 110.29 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.58 120.22 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.072 1.349 . . . . 0.0 108.345 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -89.16 157.04 18.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.852 1.261 . . . . 0.0 109.667 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.46 43.19 3.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.442 1.097 . . . . 0.0 111.563 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.9 m . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 124.878 1.271 . . . . 0.0 112.151 -179.468 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.3 mt -142.41 138.0 16.04 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.47 1.108 . . . . 0.0 112.951 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -62.6 149.55 90.7 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.681 2.254 . . . . 0.0 110.664 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.83 -34.26 84.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.13 2.553 . . . . 0.0 115.121 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -63.04 -20.39 65.28 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.531 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 94.2 m95 -88.61 -6.34 57.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.32 1.448 . . . . 0.0 114.619 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.7 m -117.26 -20.81 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 -1.67 28.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.998 1.719 . . . . 0.0 114.243 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -49.88 155.98 0.8 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.031 2.532 . . . . 0.0 114.547 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.24 -34.1 73.21 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.61 128.5 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.63 1.172 . . . . 0.0 109.344 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.14 147.79 50.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.213 1.405 . . . . 0.0 111.239 171.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -141.77 159.49 42.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.045 1.338 . . . . 0.0 111.289 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -141.26 87.41 2.08 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.824 0.85 . . . . 0.0 110.318 169.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -67.29 140.74 57.34 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 113.477 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -91.17 55.25 2.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.959 2.104 . . . . 0.0 107.607 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.65 125.12 49.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.635 1.974 . . . . 0.0 111.117 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.45 162.19 22.18 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.541 1.536 . . . . 0.0 112.382 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.04 128.75 42.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 O-C-N 121.5 -0.75 . . . . 0.0 111.076 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 C-N-CA 121.84 1.693 . . . . 0.0 112.55 175.173 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 120.964 0.412 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.3 -25.49 68.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.929 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.0 -30.45 71.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.301 -0.874 . . . . 0.0 111.571 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.37 -40.88 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.91 -1.119 . . . . 0.0 110.541 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -57.23 -48.49 78.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.034 1.288 . . . . 0.0 111.275 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -69.36 -18.94 63.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.1 m -82.06 -55.55 4.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.838 1.255 . . . . 0.0 111.541 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.57 -29.57 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.093 0.957 . . . . 0.0 111.675 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -55.62 -42.75 75.38 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.533 1.06 . . . . 0.0 113.37 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 -32.38 62.89 Favored Glycine 0 N--CA 1.472 1.038 0 O-C-N 121.905 -0.497 . . . . 0.0 112.507 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.97 -39.01 83.43 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.95 -0.735 . . . . 0.0 111.43 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.37 -48.79 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 110.183 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.26 -48.85 70.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.009 0.924 . . . . 0.0 112.069 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -71.32 -28.58 64.19 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.887 1.221 . . . . 0.0 112.936 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -70.11 -49.72 47.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.783 0.833 . . . . 0.0 110.639 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.2 t -55.03 -49.35 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.499 1.12 . . . . 0.0 111.358 169.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.66 -51.46 65.06 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.409 1.004 . . . . 0.0 112.487 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.77 -30.88 68.56 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.832 0.742 . . . . 0.0 112.056 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.69 -50.5 66.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.541 0.737 . . . . 0.0 110.877 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.42 -37.82 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.028 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -26.67 68.89 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -85.17 -13.01 51.4 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 174.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -109.32 -25.38 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.911 1.684 . . . . 0.0 112.104 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 119.767 -0.158 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -70.32 141.02 52.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.069 0.948 . . . . 0.0 111.447 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -109.5 126.36 53.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.161 0.984 . . . . 0.0 111.6 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.9 t -96.98 111.67 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.947 1.699 . . . . 0.0 110.354 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.2 tpp -90.82 127.45 36.36 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.47 122.23 43.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.235 1.014 . . . . 0.0 111.124 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.96 142.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.1 t . . . . . 0 CA--C 1.548 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 112.425 -175.272 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -62.93 -50.96 68.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.255 1.389 . . . . 0.0 112.692 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -62.06 -38.53 89.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.255 1.022 . . . . 0.0 111.552 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.406 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 7.2 tpt -74.87 -39.26 61.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.004 0.922 . . . . 0.0 112.336 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.91 88.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.407 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -58.15 -49.5 76.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.492 169.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.53 -47.54 63.14 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 121.0 1.727 . . . . 0.0 114.409 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -67.28 -42.95 82.96 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.018 -1.283 . . . . 0.0 112.032 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.63 -31.59 69.78 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.981 -1.074 . . . . 0.0 113.338 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -65.14 -29.39 70.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 128.876 2.871 . . . . 0.0 112.751 172.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -90.49 -45.47 8.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.836 0.855 . . . . 0.0 112.102 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.03 -31.83 13.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.265 1.026 . . . . 0.0 113.345 -170.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.22 1.6 88.42 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.421 1.486 . . . . 0.0 114.166 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.78 117.56 2.57 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 118.453 1.126 . . . . 0.0 111.403 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.3 15.58 81.09 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.91 -40.03 2.34 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.075 1.437 . . . . 0.0 111.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.25 164.39 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.831 1.652 . . . . 0.0 111.553 170.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 153.96 19.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.94 0.896 . . . . 0.0 108.804 169.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.52 147.56 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 m -152.1 160.89 43.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.994 1.718 . . . . 0.0 108.83 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.3 p -135.05 154.91 51.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.211 -0.931 . . . . 0.0 112.68 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 t -150.76 129.63 12.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.044 0.938 . . . . 0.0 110.276 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.94 141.49 20.14 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.02 -34.55 63.58 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.038 1.419 . . . . 0.0 112.482 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.95 41.45 3.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.958 1.703 . . . . 0.0 110.956 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t 72.69 168.66 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.627 1.971 . . . . 0.0 112.894 -168.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -158.1 172.16 18.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.724 1.61 . . . . 0.0 112.372 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -126.14 162.94 24.21 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 0.0 114.506 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.0 m -121.89 116.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.691 1.596 . . . . 0.0 109.739 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.16 148.32 44.69 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.794 0.838 . . . . 0.0 111.398 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.5 -35.76 77.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.291 2.661 . . . . 0.0 113.852 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.0 m -61.19 -38.4 86.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.748 0.819 . . . . 0.0 112.061 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.49 60.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.078 -1.014 . . . . 0.0 113.357 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.47 -54.9 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.31 72.36 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -71.17 -7.71 48.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.217 1.007 . . . . 0.0 113.604 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.406 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 15.8 mmt -125.34 -27.24 3.5 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.59 1.156 . . . . 0.0 112.021 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.95 -27.39 66.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.064 -1.023 . . . . 0.0 112.139 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.37 -5.43 42.31 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.148 0.979 . . . . 0.0 113.041 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 t -108.99 3.14 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.622 2.369 . . . . 0.0 110.541 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.87 13.8 81.74 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.393 1.473 . . . . 0.0 114.667 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.95 151.57 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -133.17 135.05 44.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.698 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 pt -128.74 1.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.726 1.61 . . . . 0.0 112.465 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.9 p -65.48 -30.72 71.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.629 1.172 . . . . 0.0 113.769 -169.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.64 -0.42 89.24 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.431 1.015 . . . . 0.0 114.976 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -81.81 151.82 27.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.397 1.598 . . . . 0.0 112.697 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.7 p -124.94 176.02 6.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.353 1.861 . . . . 0.0 111.088 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -152.66 156.1 38.56 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 112.593 173.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -153.54 160.45 30.93 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.76 2.024 . . . . 0.0 109.272 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.35 140.07 87.76 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.341 2.694 . . . . 0.0 112.485 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.94 -30.41 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -11.9 60.39 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -21.51 56.23 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.061 0.846 . . . . 0.0 112.935 171.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -93.14 166.49 12.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.645 1.178 . . . . 0.0 112.805 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.19 109.02 17.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.542 1.537 . . . . 0.0 110.965 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.22 -15.06 62.86 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.625 -1.297 . . . . 0.0 113.666 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -57.54 -22.05 42.14 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.065 1.346 . . . . 0.0 113.131 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.17 -0.56 38.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.219 1.808 . . . . 0.0 113.037 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -124.92 76.96 1.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.242 1.817 . . . . 0.0 109.686 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -23.68 8.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.71 2.004 . . . . 0.0 113.38 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -133.33 127.86 54.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.642 1.577 . . . . 0.0 108.537 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.9 t -132.97 118.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.077 -1.015 . . . . 0.0 110.275 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -110.99 118.06 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.865 1.266 . . . . 0.0 107.932 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -87.9 155.8 19.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.123 0.969 . . . . 0.0 109.027 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.68 39.67 3.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.09 0.956 . . . . 0.0 110.885 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 CA--C 1.542 0.638 0 C-N-CA 124.972 1.309 . . . . 0.0 111.914 178.787 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -144.14 140.54 17.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.29 1.036 . . . . 0.0 113.155 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.47 153.73 72.93 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.549 2.166 . . . . 0.0 110.068 168.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.27 -32.48 96.96 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.184 2.589 . . . . 0.0 114.311 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.99 -24.39 67.0 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.932 -1.105 . . . . 0.0 113.765 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.4 -10.66 58.29 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.4 -22.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.125 1.37 . . . . 0.0 113.584 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -84.55 11.65 8.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.39 1.876 . . . . 0.0 113.527 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -67.68 166.8 14.42 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.722 1.609 . . . . 0.0 112.812 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.24 -35.89 82.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -133.32 128.69 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.472 0.709 . . . . 0.0 110.888 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -130.75 148.46 52.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.089 1.356 . . . . 0.0 111.613 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -142.06 161.16 38.68 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.448 1.499 . . . . 0.0 111.455 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.44 86.84 1.97 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.633 -0.667 . . . . 0.0 111.913 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -73.38 160.51 31.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.234 1.814 . . . . 0.0 114.017 -172.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -93.28 -84.39 0.3 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.156 0.983 . . . . 0.0 110.94 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 50.14 -166.21 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.51 1.924 . . . . 0.0 112.293 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.94 147.75 46.55 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.489 1.515 . . . . 0.0 107.443 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.98 129.79 52.81 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.314 0.961 . . . . 0.0 111.035 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo . . . . . 0 CA--C 1.54 0.777 0 C-N-CA 121.632 1.555 . . . . 0.0 114.731 178.594 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 120.759 0.314 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.96 -22.36 66.89 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.213 -0.929 . . . . 0.0 111.721 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.57 -32.39 73.7 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.047 -1.033 . . . . 0.0 111.305 169.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.22 -44.05 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.858 -1.151 . . . . 0.0 110.694 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -53.79 -49.26 68.67 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.285 0.948 . . . . 0.0 111.29 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -71.42 -16.41 62.39 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 m -95.6 -35.62 11.56 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.451 1.101 . . . . 0.0 112.755 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.81 -37.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 120.274 -1.517 . . . . 0.0 111.414 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -55.1 -42.71 73.23 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.51 -32.63 67.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.182 0.896 . . . . 0.0 113.023 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -69.8 -44.89 69.12 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.84 -0.8 . . . . 0.0 110.659 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.4 t -60.23 -42.54 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.158 -0.964 . . . . 0.0 111.063 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.17 -47.65 77.87 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.034 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.93 -29.25 65.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.139 1.336 . . . . 0.0 113.562 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -62.44 -54.3 42.16 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.022 0.828 . . . . 0.0 109.979 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.37 -51.08 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.28 1.432 . . . . 0.0 112.636 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.7 -49.64 75.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.996 1.271 . . . . 0.0 112.492 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -30.19 67.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.298 0.499 . . . . 0.0 111.875 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.47 -50.21 66.21 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.768 0.827 . . . . 0.0 111.168 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.73 -41.38 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.508 1.049 . . . . 0.0 110.944 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -23.81 66.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.36 -17.27 37.23 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.1 -23.47 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.253 1.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.884 179.695 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 119.761 -0.162 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mtmm -77.45 146.28 36.59 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 112.612 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -113.56 126.11 54.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.902 1.281 . . . . 0.0 111.189 170.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.75 109.17 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.675 1.59 . . . . 0.0 110.207 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.6 tpp -87.04 128.13 35.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.525 0.602 . . . . 0.0 109.849 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -98.75 123.43 42.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.688 1.195 . . . . 0.0 109.745 169.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.34 146.21 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.724 1.21 . . . . 0.0 112.788 -176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.474 0.726 0 O-C-N 121.487 -0.758 . . . . 0.0 111.401 172.634 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -66.96 -48.33 68.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.92 1.236 . . . . 0.0 112.01 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -65.76 -42.92 90.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.59 0.756 . . . . 0.0 111.941 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 tpt -64.92 -42.41 94.74 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.867 -1.146 . . . . 0.0 112.717 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.51 88.2 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.947 0.499 . . . . 0.0 112.149 173.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.82 -36.18 78.4 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.567 -0.708 . . . . 0.0 111.841 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.57 -53.08 46.19 Favored Glycine 0 N--CA 1.471 1.004 0 CA-C-N 119.472 1.033 . . . . 0.0 112.613 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -60.33 -38.93 85.29 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.683 -0.892 . . . . 0.0 111.409 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.83 73.16 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -75.28 -22.16 57.99 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.905 1.684 . . . . 0.0 113.07 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -79.41 -45.35 19.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.314 0.646 . . . . 0.0 111.688 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -98.24 -27.2 14.25 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.46 1.104 . . . . 0.0 113.113 -172.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.87 2.66 88.08 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.253 1.883 . . . . 0.0 113.903 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 112.15 0.44 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.512 1.156 . . . . 0.0 112.656 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.67 15.57 81.47 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.373 1.309 . . . . 0.0 116.373 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.99 -40.47 3.49 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.393 1.596 . . . . 0.0 112.314 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.33 165.84 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.361 2.264 . . . . 0.0 109.931 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.27 149.12 21.89 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 170.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.43 143.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.316 -0.865 . . . . 0.0 112.493 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 m -148.23 156.72 42.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.976 1.31 . . . . 0.0 110.187 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 p -128.3 150.47 50.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 113.321 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 t -155.43 156.71 35.8 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 110.124 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.59 153.05 17.61 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 169.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.1 mt -55.48 -34.52 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.997 1.398 . . . . 0.0 111.612 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -131.03 49.86 2.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.862 1.665 . . . . 0.0 109.715 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 t 68.63 170.37 0.29 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.475 1.91 . . . . 0.0 113.437 -169.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.2 p -146.08 169.56 18.45 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.42 1.888 . . . . 0.0 111.009 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -116.78 160.29 21.02 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.37 148.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.402 1.881 . . . . 0.0 107.058 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -136.4 131.53 18.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.748 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -54.81 -38.79 91.99 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.352 2.702 . . . . 0.0 115.273 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.0 m -67.77 -31.06 70.68 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.094 -1.004 . . . . 0.0 111.718 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.4 60.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.917 -1.114 . . . . 0.0 112.673 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.2 mt -72.19 -53.62 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 -35.68 60.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -170.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.68 -8.53 54.71 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.16 -0.962 . . . . 0.0 113.444 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.0 mmt -123.64 -28.49 3.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 112.261 -171.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.43 -26.69 68.04 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.681 1.128 . . . . 0.0 112.171 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -70.34 -12.05 61.32 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 113.799 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 3.6 m -114.7 13.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.046 1.339 . . . . 0.0 111.509 168.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.044 1.783 . . . . 0.0 116.298 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.4 mm -85.07 149.56 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.334 1.567 . . . . 0.0 111.872 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -122.27 133.08 54.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.178 1.391 . . . . 0.0 111.053 169.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.56 -13.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.641 1.177 . . . . 0.0 113.837 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 m -57.68 -31.91 66.81 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.368 1.467 . . . . 0.0 114.227 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.26 2.69 81.51 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.263 1.411 . . . . 0.0 115.728 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.32 161.62 29.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.509 1.655 . . . . 0.0 112.566 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -143.4 166.3 25.13 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 0.0 110.902 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -143.81 161.26 39.1 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.304 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -151.09 160.04 32.67 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.012 1.725 . . . . 0.0 109.973 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.51 135.02 67.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.805 3.004 . . . . 0.0 112.595 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.8 -31.76 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -12.1 60.68 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -21.19 57.85 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.071 0.851 . . . . 0.0 112.77 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -94.87 167.34 11.48 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.091 1.356 . . . . 0.0 112.825 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.46 109.56 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.761 1.624 . . . . 0.0 110.967 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.67 -20.05 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -170.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.51 -27.36 69.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.332 1.053 . . . . 0.0 112.422 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.92 -2.17 58.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.633 1.573 . . . . 0.0 112.386 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.92 80.05 1.49 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.938 2.095 . . . . 0.0 107.92 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -25.75 11.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.234 1.814 . . . . 0.0 113.165 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.1 t -132.3 132.47 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.194 1.798 . . . . 0.0 108.969 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.4 t -134.65 121.01 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.99 122.21 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.125 1.37 . . . . 0.0 108.552 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.9 t -93.33 155.05 17.63 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.674 1.19 . . . . 0.0 109.577 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.56 46.0 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.765 1.226 . . . . 0.0 111.387 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.4 m . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 124.804 1.242 . . . . 0.0 112.21 -178.622 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -141.14 138.6 18.01 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.45 1.1 . . . . 0.0 112.298 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 152.96 76.62 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.259 1.973 . . . . 0.0 110.244 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 -29.24 86.33 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.837 2.358 . . . . 0.0 115.501 -169.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.36 -17.9 64.93 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.506 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.3 m95 -90.99 -3.18 57.47 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.88 -2.04 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.963 1.305 . . . . 0.0 114.337 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -101.37 0.95 37.93 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.141 1.776 . . . . 0.0 113.287 -171.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.484 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.5 mp0 -53.85 159.05 1.8 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.921 2.488 . . . . 0.0 113.988 174.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.91 -34.57 78.25 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -134.05 130.37 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.005 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -133.12 149.03 52.13 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.336 1.454 . . . . 0.0 111.435 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -141.59 157.91 44.5 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.91 1.284 . . . . 0.0 111.351 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.5 88.73 2.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.795 0.838 . . . . 0.0 110.832 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -70.94 145.69 49.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.13 1.372 . . . . 0.0 113.752 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -101.73 60.56 0.88 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.727 2.011 . . . . 0.0 107.726 -174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.7 131.2 56.65 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.575 1.95 . . . . 0.0 111.148 -168.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -88.19 151.5 22.64 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.991 1.316 . . . . 0.0 112.138 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -93.72 126.2 50.56 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.975 0.51 . . . . 0.0 111.611 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo . . . . . 0 CA--C 1.548 1.187 0 C-N-CA 123.077 2.518 . . . . 0.0 114.074 -178.781 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.13 -26.12 68.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.108 0.963 . . . . 0.0 111.62 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.34 -34.28 77.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.412 -0.805 . . . . 0.0 111.25 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -69.02 -41.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.644 -1.285 . . . . 0.0 110.476 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -56.3 -48.25 77.04 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.996 1.271 . . . . 0.0 111.421 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -70.44 -17.73 63.0 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.0 m -89.22 -41.08 12.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.048 1.339 . . . . 0.0 112.293 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.69 -36.31 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.538 -1.351 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -56.15 -42.29 76.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.27 -31.5 63.64 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 123.328 0.489 . . . . 0.0 112.42 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -70.03 -39.0 76.04 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.901 -0.764 . . . . 0.0 111.527 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.46 -46.74 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.366 0.667 . . . . 0.0 110.036 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.87 -51.23 66.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.366 1.066 . . . . 0.0 112.008 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.91 -29.6 67.9 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.022 1.283 . . . . 0.0 112.487 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.4 mtt85 -69.83 -53.85 16.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.382 -0.824 . . . . 0.0 111.025 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -53.54 -49.89 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.899 1.279 . . . . 0.0 112.439 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -66.21 -47.11 74.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.52 1.055 . . . . 0.0 112.135 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -31.58 68.47 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.423 1.011 . . . . 0.0 111.973 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.23 -51.13 68.98 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.518 0.727 . . . . 0.0 110.53 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.2 mt -69.11 -38.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.496 -0.753 . . . . 0.0 111.173 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.82 -26.82 68.8 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -87.79 -15.61 36.42 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -109.67 -18.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 124.661 1.185 . . . . 0.0 113.143 179.303 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 119.908 -0.092 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -72.64 142.53 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.971 0.908 . . . . 0.0 112.07 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.15 127.72 54.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.373 1.069 . . . . 0.0 111.308 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.88 116.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.2 ttm -99.8 124.97 45.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 110.076 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -95.3 127.64 41.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.22 0.608 . . . . 0.0 110.207 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.49 139.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 0.0 112.731 -176.779 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 118.289 -0.863 . . . . 0.0 113.084 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 p -71.61 -49.9 35.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.971 1.26 . . . . 0.0 112.13 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -63.65 -33.1 74.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.263 0.625 . . . . 0.0 112.291 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 tpt -76.87 -41.58 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.174 -0.954 . . . . 0.0 112.337 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.85 94.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.39 -45.26 88.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.11 -46.59 77.75 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 119.778 1.172 . . . . 0.0 114.806 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.447 1.123 . . . . 0.0 111.593 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.14 -32.94 63.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.468 -1.395 . . . . 0.0 113.989 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -67.48 -22.67 65.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.323 1.419 . . . . 0.0 113.05 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.4 m -87.28 -47.64 8.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.496 1.118 . . . . 0.0 111.581 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.7 mt -95.42 -31.86 13.18 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.468 1.107 . . . . 0.0 113.313 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.47 3.08 87.26 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.704 1.621 . . . . 0.0 113.159 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.36 122.0 5.64 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 117.919 0.86 . . . . 0.0 111.841 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.44 79.29 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 118.732 -1.038 . . . . 0.0 115.453 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -121.66 -42.22 2.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.341 1.57 . . . . 0.0 111.039 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.93 161.18 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 112.95 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 153.76 18.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.74 145.39 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.812 -1.18 . . . . 0.0 113.661 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 m -142.84 147.36 35.28 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.435 1.894 . . . . 0.0 109.784 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -115.02 148.82 38.36 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.024 -1.048 . . . . 0.0 112.407 170.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 t -153.35 159.26 42.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.793 1.237 . . . . 0.0 110.531 -170.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.86 154.8 19.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.9 0.762 . . . . 0.0 112.036 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.79 -34.08 72.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.318 1.059 . . . . 0.0 112.132 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -132.49 29.59 4.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.234 1.414 . . . . 0.0 111.538 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 63.81 168.34 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.955 1.702 . . . . 0.0 114.712 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.491 ' H ' ' HB3' ' A' ' 62' ' ' SER . 7.5 t -163.21 -178.66 6.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.5 2.32 . . . . 0.0 111.828 -175.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -123.48 172.45 8.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.249 1.82 . . . . 0.0 114.485 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 147.02 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 125.675 1.59 . . . . 0.0 108.647 168.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.06 148.46 39.08 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 125.545 1.538 . . . . 0.0 111.511 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -54.81 -34.5 85.25 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.3 2.667 . . . . 0.0 113.871 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -61.25 -36.31 79.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.631 0.772 . . . . 0.0 112.099 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.34 -10.83 59.81 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.935 -1.103 . . . . 0.0 113.558 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.37 -53.1 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 168.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.05 68.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mmt -72.72 -9.52 58.73 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 mmt -124.56 -27.59 3.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.144 -170.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.3 -25.34 68.27 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.836 -1.165 . . . . 0.0 112.28 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.93 -9.47 58.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 t -105.69 4.67 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 126.888 2.075 . . . . 0.0 110.376 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.97 12.49 83.34 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.529 -1.357 . . . . 0.0 114.935 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.71 150.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 118.572 1.186 . . . . 0.0 111.069 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -135.46 97.24 3.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.286 1.434 . . . . 0.0 111.357 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.2 11.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.6 p -61.93 -27.52 68.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.632 -1.293 . . . . 0.0 113.365 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.28 -2.68 90.34 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.901 1.239 . . . . 0.0 115.031 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -87.7 156.24 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.849 1.324 . . . . 0.0 112.373 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 t -147.56 -178.24 6.14 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.715 1.606 . . . . 0.0 109.53 172.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.491 ' HB3' ' H ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -115.9 167.49 10.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.482 1.113 . . . . 0.0 112.606 175.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.49 155.52 39.1 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.2 1.4 . . . . 0.0 110.91 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.61 136.6 50.7 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.676 2.917 . . . . 0.0 113.755 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.406 HD11 ' CD2' ' A' ' 90' ' ' TRP . 10.8 tp -52.83 -36.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.719 1.207 . . . . 0.0 114.12 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.38 -10.81 59.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -17.37 52.25 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.09 0.859 . . . . 0.0 113.085 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -93.1 175.48 6.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.505 1.522 . . . . 0.0 112.9 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.16 109.55 13.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.929 1.692 . . . . 0.0 110.86 174.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.3 -16.41 64.02 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -169.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.51 -23.7 66.28 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.846 0.858 . . . . 0.0 112.413 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.15 -0.99 57.42 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.289 1.835 . . . . 0.0 112.077 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -119.22 82.33 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.176 2.19 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.11 -27.64 14.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.223 1.809 . . . . 0.0 113.09 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.99 127.8 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.584 1.554 . . . . 0.0 108.966 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -133.54 124.69 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.956 -1.09 . . . . 0.0 109.763 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mm -124.42 110.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.032 1.333 . . . . 0.0 109.358 -170.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 m -86.15 154.53 21.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.649 0.779 . . . . 0.0 110.983 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.47 44.0 2.84 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.234 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 125.782 1.633 . . . . 0.0 113.653 -179.377 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.3 mt -146.55 148.48 33.99 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.136 0.974 . . . . 0.0 112.99 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.66 152.51 80.09 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.663 2.242 . . . . 0.0 109.897 168.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.28 -23.77 75.51 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.303 2.668 . . . . 0.0 115.391 -169.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -16.36 62.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.8 m95 -91.34 -3.3 56.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.36 9.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 125.618 1.567 . . . . 0.0 113.85 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -111.39 -3.09 15.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.392 1.877 . . . . 0.0 113.152 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.446 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.5 mp0 -58.0 158.62 6.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.432 2.693 . . . . 0.0 114.31 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.42 -33.67 76.41 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.86 127.39 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.979 0.912 . . . . 0.0 109.825 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -135.84 148.43 48.66 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.621 1.568 . . . . 0.0 111.756 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -149.16 157.74 43.62 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.597 1.959 . . . . 0.0 110.366 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -137.66 77.32 1.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.423 0.63 . . . . 0.0 111.42 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -64.17 160.0 19.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.12 1.768 . . . . 0.0 114.417 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.15 43.17 1.51 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.139 1.776 . . . . 0.0 113.75 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.13 138.49 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.507 -0.746 . . . . 0.0 111.05 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -85.82 148.77 25.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.67 131.11 46.47 Favored Pre-proline 0 CA--C 1.538 0.498 0 O-C-N 121.464 -0.773 . . . . 0.0 111.162 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 CA--C 1.544 1.022 0 C-N-CA 122.054 1.836 . . . . 0.0 113.495 176.067 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.274 0.559 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.442 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -63.01 -27.61 69.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.379 1.072 . . . . 0.0 111.376 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.34 -31.7 72.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.953 . . . . 0.0 111.911 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.87 -41.73 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.978 -1.076 . . . . 0.0 110.438 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -56.05 -49.0 74.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.759 1.163 . . . . 0.0 111.442 170.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -70.13 -19.28 63.23 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.1 m -81.17 -54.36 5.58 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.857 1.263 . . . . 0.0 111.324 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.17 -34.52 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.555 1.142 . . . . 0.0 111.541 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -55.65 -41.01 72.98 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.213 0.915 . . . . 0.0 112.684 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.55 -33.02 64.08 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.774 0.702 . . . . 0.0 113.002 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -68.86 -40.53 79.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.113 0.956 . . . . 0.0 111.183 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.34 -49.92 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.167 0.987 . . . . 0.0 110.318 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -54.12 -49.01 70.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.411 1.084 . . . . 0.0 112.045 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -70.54 -28.98 65.34 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.802 1.183 . . . . 0.0 112.697 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -72.59 -47.98 43.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.78 -42.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.102 0.961 . . . . 0.0 111.626 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -61.29 -47.22 86.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.79 1.177 . . . . 0.0 112.183 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.13 -35.73 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.569 0.622 . . . . 0.0 112.016 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.487 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.9 tm? -56.96 -52.03 66.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.56 1.144 . . . . 0.0 110.699 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.86 -42.23 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.614 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.99 68.81 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -91.23 -6.62 53.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.68 -16.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.255 1.389 0 C-N-CA 125.467 1.507 . . . . 0.0 112.104 172.078 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -73.75 143.16 46.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.914 0.886 . . . . 0.0 111.835 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -108.67 124.37 50.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.731 1.212 . . . . 0.0 111.236 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.5 t -96.02 109.17 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 110.173 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -88.31 130.62 35.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.504 0.321 . . . . 0.0 110.201 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -104.01 124.29 48.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.302 1.041 . . . . 0.0 110.73 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.2 138.07 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.309 1.044 . . . . 0.0 113.757 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t . . . . . 0 CA--C 1.549 0.941 0 C-N-CA 124.213 1.005 . . . . 0.0 112.64 179.679 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -63.58 -43.36 97.21 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.196 0.907 . . . . 0.0 110.759 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -69.27 -40.09 78.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.626 0.77 . . . . 0.0 111.769 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.2 tpt -71.1 -38.21 72.36 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.234 -0.916 . . . . 0.0 112.562 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.57 98.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.333 0.653 . . . . 0.0 111.116 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.28 -40.19 77.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.914 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.05 -53.3 46.93 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 119.573 1.079 . . . . 0.0 113.53 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -61.52 -39.99 93.04 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.608 -0.937 . . . . 0.0 110.993 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.035 -1.041 . . . . 0.0 113.8 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -71.61 -22.04 61.76 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.789 1.177 . . . . 0.0 112.835 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -86.49 -43.91 12.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.939 0.895 . . . . 0.0 112.083 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.1 -35.13 11.45 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.775 0.83 . . . . 0.0 112.973 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.61 8.76 76.3 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 125.719 1.628 . . . . 0.0 114.188 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.17 -41.83 1.36 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -172.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 18.47 30.84 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.335 1.445 . . . . 0.0 115.078 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.69 -43.79 2.88 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.291 1.546 . . . . 0.0 111.941 -169.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -149.24 165.67 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.851 1.66 . . . . 0.0 112.087 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.55 152.08 22.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.625 0.77 . . . . 0.0 109.241 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.3 t -135.89 137.61 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.802 1.241 . . . . 0.0 111.047 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 m -144.6 154.26 42.64 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.102 1.361 . . . . 0.0 110.433 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -126.47 156.17 41.11 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.041 -1.037 . . . . 0.0 113.687 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -156.46 162.55 39.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 110.231 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.82 155.32 20.57 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.32 -0.862 . . . . 0.0 111.327 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.0 -30.42 70.93 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.527 -0.984 . . . . 0.0 112.006 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -129.46 38.53 3.86 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 72.2 177.91 0.25 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.224 1.809 . . . . 0.0 112.138 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -137.35 -173.39 3.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.462 1.905 . . . . 0.0 111.623 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.09 158.69 43.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 113.326 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.3 t -101.92 146.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -129.57 123.86 21.55 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.997 -1.002 . . . . 0.0 112.567 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.73 -37.76 91.7 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.264 2.643 . . . . 0.0 115.116 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -66.82 -31.44 72.07 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.457 -0.777 . . . . 0.0 111.763 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.13 80.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.647 1.112 . . . . 0.0 110.838 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 mt -54.87 -49.58 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.042 0.537 . . . . 0.0 109.552 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.76 61.92 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.9 mmt -78.21 -22.39 48.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.204 -0.935 . . . . 0.0 112.857 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.8 mmt -106.39 -16.84 14.45 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.59 -25.42 67.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.185 1.357 . . . . 0.0 112.835 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.47 -7.0 51.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.34 1.056 . . . . 0.0 113.319 172.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.9 t -106.33 3.08 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.914 2.086 . . . . 0.0 110.312 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.47 81.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.238 1.399 . . . . 0.0 114.815 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -90.88 154.73 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.577 1.151 . . . . 0.0 110.497 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -141.85 133.46 26.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.71 0.804 . . . . 0.0 111.549 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 pt -132.29 12.19 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.056 0.942 . . . . 0.0 113.535 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -57.44 -33.83 68.34 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.628 1.104 . . . . 0.0 112.593 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.33 3.29 86.66 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.029 1.3 . . . . 0.0 115.923 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -76.03 160.41 29.85 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.028 1.914 . . . . 0.0 113.183 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.3 p -133.31 171.82 13.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.28 1.832 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 t -149.64 161.82 41.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.413 1.085 . . . . 0.0 111.298 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.65 160.49 35.87 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.139 1.776 . . . . 0.0 109.62 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.7 135.52 64.53 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.179 2.586 . . . . 0.0 112.294 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.93 -30.92 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -171.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.85 -14.24 62.79 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -20.56 57.9 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 119.305 0.957 . . . . 0.0 113.029 173.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -95.39 167.42 11.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.774 1.23 . . . . 0.0 112.982 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 110.61 20.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.826 1.65 . . . . 0.0 111.098 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB1' HE22 ' A' ' 93' ' ' GLN . . . -67.52 -18.83 65.19 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -170.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.15 -26.88 68.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.665 1.186 . . . . 0.0 112.677 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.57 -2.84 58.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.73 1.612 . . . . 0.0 112.253 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -116.54 80.49 1.47 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.806 2.042 . . . . 0.0 107.882 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.65 -26.6 14.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 113.012 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -132.81 131.19 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.79 1.636 . . . . 0.0 109.381 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.52 120.69 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.238 -0.913 . . . . 0.0 110.598 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.91 120.62 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.079 1.352 . . . . 0.0 108.106 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -91.9 157.01 17.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.047 1.339 . . . . 0.0 109.848 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.41 45.35 2.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.607 0.763 . . . . 0.0 111.636 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.533 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -143.57 141.79 19.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.994 0.917 . . . . 0.0 113.142 -170.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.42 155.11 67.93 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.463 2.109 . . . . 0.0 110.11 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.38 -22.95 71.78 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.93 2.42 . . . . 0.0 115.016 -169.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.25 -16.97 61.93 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.489 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -91.07 -1.68 57.74 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.66 2.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.66 1.584 . . . . 0.0 114.085 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -109.19 7.94 25.65 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.923 1.689 . . . . 0.0 113.231 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.506 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.8 mp0 -62.06 162.91 8.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.446 2.298 . . . . 0.0 113.21 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.01 129.55 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.909 0.883 . . . . 0.0 110.177 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -133.21 148.53 52.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.557 1.543 . . . . 0.0 111.34 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -141.1 159.0 43.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.975 1.31 . . . . 0.0 111.871 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -141.75 99.18 3.49 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 0.0 110.19 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.88 153.84 34.35 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.893 1.277 . . . . 0.0 113.194 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -101.59 39.2 1.47 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.645 1.578 . . . . 0.0 112.374 -168.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 162.86 14.87 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.141 1.377 . . . . 0.0 113.684 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.22 154.23 40.46 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.774 1.629 . . . . 0.0 111.267 -174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -86.73 126.84 62.39 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 121.686 -0.634 . . . . 0.0 111.659 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 C-N-CA 122.746 2.297 . . . . 0.0 114.004 -179.159 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.75 -22.58 66.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.092 0.957 . . . . 0.0 111.625 170.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.76 -33.8 76.46 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.037 -1.039 . . . . 0.0 110.478 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.0 t -72.89 -35.96 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.799 -1.188 . . . . 0.0 110.649 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.03 -47.41 83.18 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.54 1.518 . . . . 0.0 110.417 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -68.78 -17.05 63.97 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.7 m -88.67 -41.38 12.64 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.224 1.409 . . . . 0.0 112.629 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -73.96 -34.15 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 120.533 -1.354 . . . . 0.0 111.371 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.93 -40.63 73.42 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.84 60.77 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.749 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.93 -43.04 75.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.902 0.851 . . . . 0.0 110.722 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.58 -48.12 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.294 0.638 . . . . 0.0 110.56 169.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -58.47 -49.58 76.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.731 1.212 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.47 -29.0 64.34 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.018 1.281 . . . . 0.0 112.263 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -68.41 -50.7 50.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.59 0.756 . . . . 0.0 111.214 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.53 -48.62 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.162 0.985 . . . . 0.0 111.527 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.88 -50.93 66.83 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.557 1.071 . . . . 0.0 112.625 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -31.09 67.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.652 0.66 . . . . 0.0 111.998 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.45 -51.69 66.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.394 0.677 . . . . 0.0 110.314 169.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.8 -36.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.148 -0.97 . . . . 0.0 111.464 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -85.48 -20.03 30.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 pt -101.59 -18.07 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 124.971 1.308 . . . . 0.0 113.071 177.614 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 119.192 -0.432 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -70.44 138.64 51.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.124 0.875 . . . . 0.0 111.242 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -111.17 125.47 53.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.472 1.109 . . . . 0.0 111.361 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 68.5 t -95.72 114.11 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.048 1.739 . . . . 0.0 110.037 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -96.53 125.78 41.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.897 0.771 . . . . 0.0 110.891 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -92.01 124.08 35.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.715 0.806 . . . . 0.0 108.886 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.55 132.24 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.293 1.037 . . . . 0.0 112.469 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 m -64.16 -38.99 93.06 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.622 1.101 . . . . 0.0 112.4 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -66.55 -44.24 82.88 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.734 0.413 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -39.24 82.12 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.773 0.829 . . . . 0.0 111.99 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.72 -46.01 92.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.43 -41.06 79.69 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.89 -63.76 4.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.722 1.153 . . . . 0.0 113.72 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -62.64 -34.85 77.9 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.699 1.25 . . . . 0.0 111.946 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.18 77.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -70.53 -27.89 64.51 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.883 1.674 . . . . 0.0 112.441 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.7 m -77.27 -46.02 24.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.363 1.065 . . . . 0.0 112.275 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.24 -27.76 14.85 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.036 0.934 . . . . 0.0 113.239 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 2.1 88.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.126 2.298 . . . . 0.0 113.608 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.42 114.79 1.03 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.409 1.104 . . . . 0.0 112.419 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.69 16.62 76.14 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.636 1.014 . . . . 0.0 115.636 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -119.08 -36.24 3.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.204 1.502 . . . . 0.0 111.92 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -150.61 166.32 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 127.544 2.338 . . . . 0.0 110.393 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.76 153.84 18.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 168.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.48 144.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.458 -1.401 . . . . 0.0 114.682 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -150.61 158.22 43.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.636 1.574 . . . . 0.0 110.726 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -123.55 149.18 45.56 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.016 1.726 . . . . 0.0 111.825 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 t -152.04 147.54 26.62 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.296 . . . . 0.0 110.586 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.87 143.47 17.09 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 168.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.69 -38.51 33.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.214 1.507 . . . . 0.0 112.22 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -123.74 40.87 3.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.838 1.655 . . . . 0.0 111.354 171.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 73.38 164.91 0.29 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.051 2.14 . . . . 0.0 114.333 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -148.4 166.84 26.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.294 2.238 . . . . 0.0 112.338 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -121.65 147.59 45.66 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.526 1.13 . . . . 0.0 113.756 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -80.18 -38.59 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 62.98 123.79 0.02 OUTLIER Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 128.815 2.846 . . . . 0.0 116.489 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 -38.95 79.79 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.929 3.086 . . . . 0.0 116.318 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -31.96 73.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.657 -1.277 . . . . 0.0 111.823 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.44 -8.19 58.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.653 -1.279 . . . . 0.0 113.603 172.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.81 -53.72 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 168.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.49 -33.52 60.8 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 mmt -71.86 -12.65 61.38 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.298 -0.876 . . . . 0.0 113.262 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.1 mmt -120.35 -27.25 5.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.593 1.157 . . . . 0.0 112.476 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.74 -25.15 68.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.852 -1.155 . . . . 0.0 112.637 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -70.63 -15.06 62.7 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.01 5.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 126.47 1.908 . . . . 0.0 110.664 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.18 12.37 83.31 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.389 1.471 . . . . 0.0 114.617 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -87.28 149.16 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.354 1.077 . . . . 0.0 111.312 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.47 125.52 44.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.45 1.5 . . . . 0.0 111.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.5 pt -134.49 -7.03 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.1 p -67.42 -28.23 67.73 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.125 1.33 . . . . 0.0 113.849 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.78 -2.11 90.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.843 1.211 . . . . 0.0 115.023 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -81.64 161.68 23.36 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.001 1.401 . . . . 0.0 112.469 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -140.31 -179.9 6.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.03 1.332 . . . . 0.0 111.376 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -154.44 160.84 41.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.066 1.346 . . . . 0.0 111.823 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -159.46 155.98 24.39 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.784 1.634 . . . . 0.0 108.799 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.56 136.26 63.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.361 2.707 . . . . 0.0 113.047 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.0 -33.15 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.68 -11.41 60.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.07 -24.44 59.5 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.215 -0.928 . . . . 0.0 112.373 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -93.35 165.65 12.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.906 1.282 . . . . 0.0 112.402 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.9 110.55 20.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.521 1.528 . . . . 0.0 111.118 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.54 -19.32 65.27 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -171.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.38 -26.37 67.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.28 1.032 . . . . 0.0 112.403 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -87.51 -1.67 58.09 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.002 1.721 . . . . 0.0 112.037 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.07 82.0 1.76 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.711 2.004 . . . . 0.0 108.154 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.28 -24.82 12.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.167 1.787 . . . . 0.0 113.018 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.7 t -133.9 130.74 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.777 1.631 . . . . 0.0 108.969 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.92 123.78 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.309 -0.869 . . . . 0.0 110.633 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.6 121.23 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.178 1.391 . . . . 0.0 107.962 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 t -85.21 147.71 26.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.511 1.124 . . . . 0.0 109.985 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -124.06 24.82 8.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.524 1.129 . . . . 0.0 112.456 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.8 m . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -171.7 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -139.84 136.95 17.77 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.615 1.166 . . . . 0.0 111.673 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.96 153.14 70.67 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.424 2.082 . . . . 0.0 110.064 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.71 -26.96 80.5 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.954 2.436 . . . . 0.0 114.104 -169.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.4 -19.62 65.85 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.499 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -90.1 -3.64 57.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -118.53 -9.76 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.79 1.236 . . . . 0.0 114.311 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -93.09 2.75 56.59 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.939 1.695 . . . . 0.0 113.511 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.1 mp0 -53.42 158.76 1.62 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.404 2.281 . . . . 0.0 113.775 174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -34.03 76.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -133.65 127.86 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.385 1.074 . . . . 0.0 110.05 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -130.91 148.27 52.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 111.103 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -141.88 159.09 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.672 1.189 . . . . 0.0 112.031 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.27 110.57 8.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.21 1.004 . . . . 0.0 108.882 168.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -87.68 145.66 26.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.6 1.16 . . . . 0.0 111.529 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -104.96 46.19 0.93 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.686 1.595 . . . . 0.0 108.555 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -102.02 132.81 47.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.572 2.349 . . . . 0.0 111.359 -168.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -90.34 151.85 21.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.317 1.447 . . . . 0.0 112.319 -173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -88.75 131.71 40.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.768 -0.582 . . . . 0.0 111.86 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.544 0.996 0 C-N-CA 122.7 2.267 . . . . 0.0 115.371 -177.077 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.341 0.591 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.87 -25.2 66.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.136 -0.977 . . . . 0.0 111.754 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.29 -29.37 70.46 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.228 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -72.0 -36.86 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 120.803 -1.186 . . . . 0.0 111.047 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -58.93 -46.73 87.25 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.435 1.471 . . . . 0.0 110.452 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -71.73 -18.21 62.15 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.109 0.964 . . . . 0.0 113.59 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 m -85.06 -52.87 5.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.575 1.55 . . . . 0.0 111.923 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.6 -31.92 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.934 1.294 . . . . 0.0 111.863 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -53.97 -43.42 69.91 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.601 1.091 . . . . 0.0 113.432 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.97 -32.74 65.93 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.771 0.701 . . . . 0.0 112.853 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -69.98 -40.34 75.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.41 -47.82 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.854 0.862 . . . . 0.0 110.329 171.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -57.0 -49.01 77.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.33 -28.36 66.17 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 121.376 1.898 . . . . 0.0 112.999 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -68.41 -49.0 63.17 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.473 -0.767 . . . . 0.0 111.654 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.7 m -62.24 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.022 0.828 . . . . 0.0 112.526 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -63.7 -50.72 68.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 120.207 1.367 . . . . 0.0 112.45 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.31 -31.06 69.29 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.951 0.796 . . . . 0.0 112.149 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.77 -49.72 69.63 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.396 0.678 . . . . 0.0 110.723 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.67 -40.76 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.988 -174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -27.04 68.84 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -88.49 -18.94 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -105.35 -18.36 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.256 1.4 0 C-N-CA 124.773 1.229 . . . . 0.0 113.222 179.054 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 119.75 -0.166 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -70.55 143.16 51.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.947 . . . . 0.0 111.94 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -110.73 126.23 54.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.015 . . . . 0.0 111.092 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.38 118.03 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.814 1.646 . . . . 0.0 109.995 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.5 tpp -97.81 119.44 36.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.651 0.659 . . . . 0.0 109.861 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.32 124.09 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.178 0.591 . . . . 0.0 110.391 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.03 144.54 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.242 1.017 . . . . 0.0 112.832 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.6 t . . . . . 0 N--CA 1.471 0.582 0 C-N-CA 125.243 1.417 . . . . 0.0 109.497 178.322 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -63.91 -44.48 92.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.701 1.592 . . . . 0.0 112.942 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -63.08 -37.31 86.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.731 0.812 . . . . 0.0 111.543 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.411 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 8.1 tpt -74.83 -36.95 62.4 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.35 94.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.946 0.898 . . . . 0.0 109.917 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.86 -43.88 94.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.157 0.89 . . . . 0.0 111.769 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.1 -52.56 48.47 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 119.556 1.071 . . . . 0.0 113.83 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -68.18 -39.39 82.53 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.81 -1.406 . . . . 0.0 111.588 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.13 74.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.855 -1.153 . . . . 0.0 113.699 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -78.31 -15.54 58.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.2 1.364 . . . . 0.0 113.579 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.5 m -89.46 -44.95 9.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.255 1.022 . . . . 0.0 111.917 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.71 -29.07 14.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.673 1.189 . . . . 0.0 113.375 -174.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.35 2.27 88.17 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 126.419 1.961 . . . . 0.0 113.977 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.55 115.46 1.14 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.438 1.119 . . . . 0.0 112.385 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.64 10.83 85.86 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.85 -40.36 4.02 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.652 1.726 . . . . 0.0 112.493 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -148.29 161.7 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.51 2.324 . . . . 0.0 109.782 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 144.34 26.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.84 142.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.198 -0.939 . . . . 0.0 112.576 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -148.96 160.27 43.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.849 1.66 . . . . 0.0 109.435 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 p -136.84 153.46 50.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.9 t -152.27 152.91 32.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.283 1.433 . . . . 0.0 110.611 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.59 140.98 16.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.71 -37.63 84.86 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.499 1.65 . . . . 0.0 111.018 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.74 33.78 4.36 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.814 1.646 . . . . 0.0 111.064 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 64.01 168.84 0.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.789 2.035 . . . . 0.0 114.491 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 81.9 p -150.3 167.35 27.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.746 1.619 . . . . 0.0 112.526 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -137.44 170.96 15.18 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.039 1.336 . . . . 0.0 112.099 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.23 112.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.99 0.9 . . . . 0.0 110.762 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -78.78 134.72 60.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.01 1.324 . . . . 0.0 110.534 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.54 -37.49 90.32 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.985 2.457 . . . . 0.0 115.092 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 m -65.98 -32.32 73.74 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.86 -1.15 . . . . 0.0 111.604 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.37 -5.76 44.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.573 -1.329 . . . . 0.0 113.93 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.31 -55.93 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 167.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.22 78.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 82.3 mmm -73.38 -1.75 19.43 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.411 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.5 mmt -121.34 -29.02 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.64 1.176 . . . . 0.0 111.207 -173.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.68 -27.5 64.88 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.324 0.65 . . . . 0.0 111.951 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.83 -15.87 63.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.595 1.158 . . . . 0.0 113.935 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -120.19 24.58 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 126.175 1.79 . . . . 0.0 111.042 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.92 12.36 84.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.723 1.63 . . . . 0.0 116.128 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mm -93.13 152.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 118.855 1.328 . . . . 0.0 111.466 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -134.54 136.26 42.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.004 1.322 . . . . 0.0 110.97 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.34 0.74 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.543 1.537 . . . . 0.0 112.485 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.6 p -62.37 -28.17 69.58 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -169.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.86 -4.48 88.69 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.625 1.107 . . . . 0.0 115.167 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -81.8 154.54 25.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.108 1.454 . . . . 0.0 113.406 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -134.12 178.87 6.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.007 2.123 . . . . 0.0 110.805 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -153.22 162.89 40.81 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.178 -0.951 . . . . 0.0 112.26 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.44 158.17 38.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.35 1.86 . . . . 0.0 109.085 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.02 136.55 73.47 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.262 2.641 . . . . 0.0 112.14 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.62 -29.95 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.23 -14.78 62.47 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.27 -19.87 59.47 Favored 'General case' 0 CA--C 1.553 1.079 0 O-C-N 121.421 -0.799 . . . . 0.0 113.149 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.44 170.39 9.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.176 1.39 . . . . 0.0 112.866 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.8 108.28 14.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 111.287 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.27 -18.66 65.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -170.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.01 -26.12 68.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.156 0.982 . . . . 0.0 112.507 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.16 -1.72 58.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.109 1.764 . . . . 0.0 111.851 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -118.11 82.02 1.77 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 127.122 2.169 . . . . 0.0 108.651 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.19 -27.06 13.14 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.095 1.758 . . . . 0.0 113.067 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.1 t -131.4 130.85 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.802 1.641 . . . . 0.0 108.706 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.7 t -133.77 126.33 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.079 -1.013 . . . . 0.0 109.838 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.2 mm -126.64 111.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.61 1.164 . . . . 0.0 109.687 -170.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.2 t -87.49 156.87 19.35 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.493 1.117 . . . . 0.0 112.145 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.6 41.48 3.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.643 1.577 . . . . 0.0 111.68 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 124.783 1.233 . . . . 0.0 112.4 -178.118 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 121.532 0.682 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.96 142.78 65.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.52 154.29 72.64 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.342 2.028 . . . . 0.0 109.952 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.17 -25.27 76.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.935 2.423 . . . . 0.0 114.868 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.07 -16.37 63.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.506 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.5 m95 -93.16 -2.23 55.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.94 0.93 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.345 1.458 . . . . 0.0 113.941 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -103.14 -1.14 29.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.319 1.848 . . . . 0.0 113.222 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.489 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.7 mp0 -54.88 161.55 1.56 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.241 2.616 . . . . 0.0 114.352 174.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.98 -35.01 79.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.8 mt -133.84 131.59 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.444 1.098 . . . . 0.0 110.465 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -141.32 149.4 41.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.403 1.481 . . . . 0.0 112.349 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -146.11 159.09 43.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.056 1.742 . . . . 0.0 110.304 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -138.99 86.62 2.15 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.403 0.681 . . . . 0.0 111.44 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -67.68 146.71 53.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.792 1.637 . . . . 0.0 113.631 -170.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -98.97 60.49 1.22 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.528 1.931 . . . . 0.0 107.691 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.27 127.52 55.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.116 1.766 . . . . 0.0 112.349 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.59 169.95 12.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.009 1.324 . . . . 0.0 113.96 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.91 119.61 57.77 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.185 0.994 . . . . 0.0 110.982 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo . . . . . 0 CA--C 1.542 0.904 0 C-N-CA 122.64 2.227 . . . . 0.0 113.521 176.423 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.404 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -62.99 -25.46 68.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.19 0.996 . . . . 0.0 111.884 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.44 -32.18 73.39 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.523 -0.736 . . . . 0.0 111.571 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.03 -38.66 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.276 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -58.04 -48.44 80.09 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.085 1.311 . . . . 0.0 110.882 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -66.82 -26.67 67.04 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -74.28 -55.46 6.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.569 0.748 . . . . 0.0 111.33 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -34.28 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 110.89 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -58.3 -42.15 86.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.452 1.024 . . . . 0.0 112.691 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.37 -34.4 74.39 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.408 0.528 . . . . 0.0 112.726 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -68.97 -39.76 79.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.357 1.079 . . . . 0.0 111.332 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.63 -51.41 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.1 0.96 . . . . 0.0 110.522 170.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 123' ' ' VAL . 14.6 tmtt? -54.59 -47.58 73.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.701 1.201 . . . . 0.0 112.554 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -68.44 -27.94 66.62 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.659 1.572 . . . . 0.0 112.842 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -72.48 -49.74 30.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.215 1.006 . . . . 0.0 111.52 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 120' ' ' LYS . 35.8 m -62.83 -40.66 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 118.323 -0.846 . . . . 0.0 113.244 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.29 -46.71 82.47 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.824 1.647 . . . . 0.0 111.689 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -70.31 -33.21 71.25 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.526 0.603 . . . . 0.0 112.56 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.94 -46.63 87.53 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.136 0.974 . . . . 0.0 111.092 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt -73.56 -43.4 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.365 -0.834 . . . . 0.0 110.56 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.38 -27.69 69.25 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -85.9 -12.74 49.82 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -114.93 -18.52 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.393 0 C-N-CA 124.676 1.19 . . . . 0.0 113.1 -179.623 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.5 2.051 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -71.96 142.5 49.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.215 1.006 . . . . 0.0 111.896 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -108.2 126.16 52.48 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.571 1.148 . . . . 0.0 111.028 171.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.36 113.89 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.881 2.072 . . . . 0.0 110.092 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.9 ttm -98.71 126.48 44.34 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.148 0.885 . . . . 0.0 110.627 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -93.28 127.05 38.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.184 0.994 . . . . 0.0 109.408 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.06 135.26 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.703 1.201 . . . . 0.0 113.197 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 p . . . . . 0 CA--C 1.543 0.674 0 C-N-CA 124.21 1.004 . . . . 0.0 112.6 -174.34 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -63.88 -37.32 86.94 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.323 1.42 . . . . 0.0 113.329 170.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.17 -45.62 66.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.827 0.451 . . . . 0.0 110.14 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.422 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 6.7 tpt -72.32 -38.62 68.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.3 86.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.551 0.614 . . . . 0.0 111.688 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -38.82 89.62 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.824 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.34 29.61 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 119.671 1.123 . . . . 0.0 113.655 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.47 -38.33 90.71 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.396 -1.061 . . . . 0.0 111.39 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.76 -34.7 76.02 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -72.12 -19.17 61.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.845 1.657 . . . . 0.0 113.215 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.2 m -89.26 -45.12 9.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.808 0.843 . . . . 0.0 111.971 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.94 -33.68 12.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.679 1.192 . . . . 0.0 113.009 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 4.94 81.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 125.679 1.609 . . . . 0.0 113.27 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.12 116.88 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 118.32 1.06 . . . . 0.0 111.725 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 14.63 76.91 Favored Glycine 0 CA--C 1.537 1.462 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.95 -44.39 3.81 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.245 1.522 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -145.71 162.21 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 126.465 1.906 . . . . 0.0 111.48 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.52 149.08 24.6 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -145.89 143.43 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.832 -1.167 . . . . 0.0 114.049 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.4 m -143.8 143.27 31.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.522 1.529 . . . . 0.0 110.871 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.3 p -106.86 145.25 32.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 0.0 111.677 170.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -156.36 154.46 30.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.533 1.133 . . . . 0.0 110.735 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.98 150.2 17.04 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.004 1.288 . . . . 0.0 110.653 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -52.88 -37.55 60.58 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.571 1.185 . . . . 0.0 112.413 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -126.11 39.42 3.95 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.47 . . . . 0.0 111.287 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 69.08 170.65 0.3 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.667 1.987 . . . . 0.0 114.177 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -159.15 167.84 28.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.113 2.565 . . . . 0.0 109.978 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 156.19 28.52 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -173.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.6 146.61 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.916 1.286 . . . . 0.0 109.542 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -126.23 126.76 24.72 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.885 -169.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.519 2.813 . . . . 0.0 115.085 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 m -64.4 -34.11 77.42 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.022 -1.049 . . . . 0.0 111.526 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.17 -10.15 59.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.161 -0.962 . . . . 0.0 113.186 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.6 mt -80.13 -56.83 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 167.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.68 72.61 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.7 mmt -69.75 -8.19 45.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.422 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.4 mmt -124.63 -26.38 3.84 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.459 1.104 . . . . 0.0 112.263 -169.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -26.66 68.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.844 -1.16 . . . . 0.0 111.658 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.37 -9.14 55.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.0 0.92 . . . . 0.0 113.372 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.47 1.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.466 2.306 . . . . 0.0 110.765 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.04 81.75 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.693 1.616 . . . . 0.0 114.836 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.16 150.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.857 1.263 . . . . 0.0 111.293 -174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -126.92 142.29 51.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.199 1.4 . . . . 0.0 112.489 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 pt -137.53 -1.96 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.422 1.889 . . . . 0.0 111.783 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.8 p -63.18 -34.02 76.73 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.73 2.8 87.78 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.635 1.112 . . . . 0.0 115.369 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -72.57 159.71 33.46 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 p -118.0 -176.24 3.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.072 2.549 . . . . 0.0 108.911 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.0 t -146.07 -73.27 0.23 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.011 -1.055 . . . . 0.0 111.216 170.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 63.95 154.18 0.12 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.556 2.343 . . . . 0.0 115.211 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.87 133.79 46.61 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.726 2.284 . . . . 0.0 111.991 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.5 tt -55.98 -34.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.38 -8.6 51.93 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -20.68 60.24 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.254 -0.904 . . . . 0.0 112.692 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.54 171.42 8.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.181 1.392 . . . . 0.0 112.807 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.9 114.54 27.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.016 1.726 . . . . 0.0 110.934 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -69.21 -18.3 63.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.88 -26.44 66.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.784 0.833 . . . . 0.0 112.542 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -86.98 -2.81 58.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.056 1.742 . . . . 0.0 112.132 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -114.86 81.9 1.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.8 2.04 . . . . 0.0 107.972 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.23 -28.7 12.21 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.755 1.622 . . . . 0.0 112.88 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -131.0 130.5 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 126.01 1.724 . . . . 0.0 108.851 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -133.23 128.8 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.153 -0.967 . . . . 0.0 109.763 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 mm -125.19 117.14 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 109.053 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.7 t -89.89 153.57 20.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 111.316 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -133.26 35.91 3.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.43 1.092 . . . . 0.0 111.972 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.6 m . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -169.007 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -143.44 140.51 17.66 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.711 1.204 . . . . 0.0 112.613 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -63.91 154.01 72.45 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.591 2.194 . . . . 0.0 110.449 168.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.48 -32.29 96.09 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.371 2.048 . . . . 0.0 114.728 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.28 -22.19 66.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.1 m95 -89.29 -3.16 58.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.46 -19.95 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 t -81.96 6.8 14.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.754 1.622 . . . . 0.0 114.354 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.6 mp0 -55.78 160.68 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.035 2.134 . . . . 0.0 113.721 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.36 -33.53 74.92 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.7 mt -131.69 124.58 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.114 0.966 . . . . 0.0 110.173 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -135.31 141.88 45.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.427 1.491 . . . . 0.0 110.521 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.4 159.1 39.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.011 1.324 . . . . 0.0 110.871 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.24 131.94 54.52 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.602 1.161 . . . . 0.0 111.327 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.9 m0 -103.48 162.42 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.786 1.635 . . . . 0.0 112.77 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -119.89 40.13 3.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.874 1.27 . . . . 0.0 112.871 -168.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.94 159.58 34.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.874 0.87 . . . . 0.0 111.081 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -106.06 162.08 13.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.412 1.485 . . . . 0.0 109.795 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -88.52 128.55 52.45 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.78 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 CA--C 1.546 1.092 0 C-N-CA 122.278 1.985 . . . . 0.0 112.804 169.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.41 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.6 mm? -63.21 -30.13 71.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.818 1.247 . . . . 0.0 111.858 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.05 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.346 -0.846 . . . . 0.0 111.749 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.53 -39.05 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 110.824 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -56.59 -47.2 80.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.09 1.314 . . . . 0.0 110.518 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -70.69 -19.28 62.79 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.1 m -82.03 -50.83 8.66 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.874 1.27 . . . . 0.0 112.211 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.74 -33.71 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.398 1.079 . . . . 0.0 111.517 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -54.1 -40.21 67.07 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.852 0.751 . . . . 0.0 112.922 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.68 -32.89 63.82 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.282 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -70.95 -40.77 71.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.396 1.098 . . . . 0.0 110.273 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.13 -52.42 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.133 0.973 . . . . 0.0 110.66 170.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -55.47 -48.82 73.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.009 1.324 . . . . 0.0 112.462 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.99 -28.8 66.93 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.905 1.684 . . . . 0.0 112.51 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -71.94 -47.48 52.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.474 0.709 . . . . 0.0 111.861 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.6 m -62.54 -35.32 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.008 0.822 . . . . 0.0 112.897 170.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.77 -46.21 90.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.887 1.221 . . . . 0.0 111.389 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.55 97.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.329 0.513 . . . . 0.0 111.051 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.492 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -59.31 -48.96 79.65 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.771 0.828 . . . . 0.0 111.199 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.51 -44.23 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.868 -0.52 . . . . 0.0 110.489 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.58 70.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.4 pttt -86.86 -13.24 45.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -115.24 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 124.516 1.127 . . . . 0.0 113.091 178.518 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 119.765 -0.159 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -69.85 138.68 52.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.479 1.112 . . . . 0.0 111.4 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -108.05 127.39 53.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.05 0.94 . . . . 0.0 110.923 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.84 119.48 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.063 1.745 . . . . 0.0 109.685 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.5 tpp -97.8 126.78 43.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.73 123.34 45.54 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.063 0.545 . . . . 0.0 111.152 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.17 149.22 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.164 0.985 . . . . 0.0 113.546 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 125.155 1.382 . . . . 0.0 109.007 176.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.6 p -70.69 -55.97 7.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.328 1.051 . . . . 0.0 113.543 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.66 -33.66 74.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.021 0.528 . . . . 0.0 110.232 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.9 tpt -71.89 -43.78 64.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.12 99.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.508 0.723 . . . . 0.0 111.637 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -43.91 95.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.858 169.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.38 -53.05 43.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.525 1.057 . . . . 0.0 113.176 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -61.38 -36.34 79.99 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.697 1.249 . . . . 0.0 111.535 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.98 -27.17 62.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -65.91 -46.31 78.77 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.844 1.656 . . . . 0.0 111.375 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -74.48 -38.27 62.96 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.0 1.32 . . . . 0.0 112.332 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.8 mt -96.29 -29.83 13.78 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.17 0.988 . . . . 0.0 113.038 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.59 6.34 77.86 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.772 1.653 . . . . 0.0 113.829 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.0 118.82 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.467 1.134 . . . . 0.0 111.408 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.08 14.97 80.04 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 118.743 -1.032 . . . . 0.0 115.589 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -124.27 -43.3 2.07 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.27 1.535 . . . . 0.0 111.913 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.98 157.87 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.663 1.185 . . . . 0.0 113.191 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.83 154.02 20.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.471 1.108 . . . . 0.0 109.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.97 140.54 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 121.238 -0.914 . . . . 0.0 113.093 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 m -144.89 154.02 42.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.328 1.451 . . . . 0.0 109.538 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.3 p -121.6 152.1 39.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.719 0.808 . . . . 0.0 112.794 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 t -151.83 150.71 30.42 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.324 1.049 . . . . 0.0 110.846 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.12 140.75 15.77 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 169.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.9 -41.99 92.86 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.518 1.659 . . . . 0.0 110.995 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.59 33.63 3.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.532 170.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t 64.27 170.93 0.18 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.387 1.875 . . . . 0.0 113.932 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.1 p -153.13 -172.62 4.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.098 1.759 . . . . 0.0 111.546 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -137.6 -147.92 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.258 1.423 . . . . 0.0 111.82 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.23 151.06 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 126.5 1.92 . . . . 0.0 107.304 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -123.74 126.64 25.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 CA-C-O 117.604 -1.189 . . . . 0.0 111.206 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -54.41 -39.22 88.51 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.324 2.683 . . . . 0.0 114.898 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 m -66.03 -32.57 74.13 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.996 -1.065 . . . . 0.0 111.872 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.2 -10.66 59.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.13 -0.981 . . . . 0.0 113.285 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.83 -53.77 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.39 61.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -170.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.05 -6.64 43.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.3 mmt -128.12 -29.51 2.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.93 0.892 . . . . 0.0 112.532 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.8 -25.49 67.52 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.893 -1.129 . . . . 0.0 111.855 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.95 -14.31 62.96 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.6 19.06 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.38 1.472 . . . . 0.0 111.584 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.81 76.08 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.801 1.667 . . . . 0.0 116.591 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mm -80.13 148.6 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.45 1.625 . . . . 0.0 112.151 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.55 111.4 11.72 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.166 1.786 . . . . 0.0 112.024 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.5 pt -140.98 -1.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.145 1.378 . . . . 0.0 113.693 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -61.84 -35.78 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -169.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.54 -2.45 90.05 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.332 0.968 . . . . 0.0 115.236 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -85.41 167.28 15.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.895 1.347 . . . . 0.0 114.327 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -139.88 -175.27 4.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.053 1.741 . . . . 0.0 110.586 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 t -145.24 165.49 28.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.67 1.588 . . . . 0.0 112.101 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.31 157.23 45.81 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.732 1.613 . . . . 0.0 110.299 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.12 139.55 90.28 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.418 2.745 . . . . 0.0 112.103 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -58.35 -31.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.18 -10.51 58.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.57 57.7 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.08 0.855 . . . . 0.0 112.789 170.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -94.4 170.4 9.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.061 1.345 . . . . 0.0 112.41 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 108.72 15.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.567 1.547 . . . . 0.0 111.155 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.66 -19.35 65.74 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.44 -26.53 68.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.866 0.866 . . . . 0.0 112.567 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.87 -2.67 58.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.343 1.857 . . . . 0.0 111.936 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -116.1 83.98 2.04 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.207 2.203 . . . . 0.0 108.235 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.21 -25.91 6.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.087 1.755 . . . . 0.0 113.049 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -133.36 130.26 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.848 1.659 . . . . 0.0 108.902 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -134.13 126.63 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.083 -1.01 . . . . 0.0 109.471 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.1 mm -127.03 116.58 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.589 1.156 . . . . 0.0 109.901 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -91.15 157.31 17.28 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.061 1.344 . . . . 0.0 111.651 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.65 35.89 4.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.176 1.39 . . . . 0.0 112.287 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 124.791 1.236 . . . . 0.0 112.204 -178.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 121.475 0.655 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 mt -84.23 142.42 40.93 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.85 154.97 70.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.612 2.208 . . . . 0.0 109.915 168.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.91 -28.99 81.67 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.917 2.411 . . . . 0.0 114.276 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.33 -19.44 65.81 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.82 -1.175 . . . . 0.0 113.814 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.494 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.5 m95 -91.6 -3.26 56.61 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 m -115.91 -16.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -83.79 4.24 29.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.863 1.665 . . . . 0.0 114.13 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.473 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.1 mp0 -58.07 159.74 5.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.972 2.109 . . . . 0.0 113.986 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -62.99 -34.05 76.71 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.32 127.85 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.817 0.847 . . . . 0.0 109.864 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.64 148.31 48.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.291 1.436 . . . . 0.0 111.821 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -147.22 157.41 43.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.829 1.652 . . . . 0.0 110.391 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -135.98 86.06 2.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.619 0.768 . . . . 0.0 111.018 169.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -66.98 146.61 54.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.836 1.655 . . . . 0.0 115.02 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -96.53 49.09 1.09 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.526 2.33 . . . . 0.0 108.742 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.14 134.51 40.37 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.254 1.822 . . . . 0.0 112.654 -167.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.1 179.27 6.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.098 1.359 . . . . 0.0 113.897 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -101.61 113.97 65.73 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.868 0.867 . . . . 0.0 111.806 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo . . . . . 0 CA--C 1.54 0.825 0 C-N-CA 121.559 1.506 . . . . 0.0 113.264 176.673 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.37 -30.07 67.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.814 0.846 . . . . 0.0 111.373 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.62 -35.15 79.49 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.242 -0.912 . . . . 0.0 110.919 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.97 -39.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.404 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -55.77 -47.75 76.48 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 121.147 1.794 . . . . 0.0 111.427 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -69.27 -15.04 63.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.267 1.027 . . . . 0.0 113.564 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.6 m -88.77 -49.23 6.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.659 1.584 . . . . 0.0 112.641 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -70.38 -31.76 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.24 -0.913 . . . . 0.0 111.073 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -56.24 -39.83 73.16 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 0.0 112.453 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.48 -34.6 68.06 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.071 0.843 . . . . 0.0 112.63 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -69.49 -43.2 73.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.059 0.93 . . . . 0.0 110.513 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.94 -47.2 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.377 0.671 . . . . 0.0 110.685 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -56.45 -49.41 74.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.55 1.14 . . . . 0.0 112.3 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.7 -29.84 62.52 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.017 1.28 . . . . 0.0 113.13 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -64.8 -50.85 65.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.477 0.711 . . . . 0.0 110.866 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.4 t -56.36 -46.21 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.868 1.267 . . . . 0.0 112.611 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.63 -49.05 78.11 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 120.099 1.318 . . . . 0.0 111.874 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -71.47 -32.61 68.48 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.433 0.561 . . . . 0.0 111.948 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.52 -48.33 81.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.971 0.908 . . . . 0.0 111.308 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.8 -43.17 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.683 0.674 . . . . 0.0 110.7 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.82 68.68 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.62 -11.84 58.09 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.9 pt -111.44 -28.3 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.256 1.418 0 C-N-CA 125.629 1.572 . . . . 0.0 112.108 -178.183 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttp . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -72.77 144.19 47.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.636 1.174 . . . . 0.0 112.316 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -112.06 125.76 54.44 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.196 0.998 . . . . 0.0 111.836 170.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.79 116.55 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.821 1.649 . . . . 0.0 110.585 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.52 126.08 43.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.375 0.989 . . . . 0.0 110.454 168.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -95.36 121.45 37.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.894 0.878 . . . . 0.0 110.323 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.29 136.35 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.086 0.954 . . . . 0.0 113.275 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 123.825 0.85 . . . . 0.0 112.216 -179.591 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -68.51 -47.29 67.36 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.621 1.555 . . . . 0.0 111.331 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.19 -38.58 91.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.581 1.153 . . . . 0.0 111.759 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.402 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 7.7 tpt -73.58 -38.23 65.22 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.687 0.795 . . . . 0.0 112.244 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.69 -44.14 90.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.229 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.87 -44.05 91.0 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.144 0.884 . . . . 0.0 112.052 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.51 -49.77 67.19 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 119.598 1.09 . . . . 0.0 113.267 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.3 -43.15 87.09 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.135 -1.215 . . . . 0.0 111.666 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.82 82.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.844 -1.16 . . . . 0.0 113.797 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -72.55 -16.54 61.76 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.57 1.077 . . . . 0.0 113.254 174.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.9 m -88.21 -44.71 10.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.69 1.196 . . . . 0.0 111.99 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -95.99 -34.6 11.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.21 1.004 . . . . 0.0 113.539 -171.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.94 5.33 85.03 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.77 1.652 . . . . 0.0 113.85 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.43 -44.9 4.19 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.25 18.99 41.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.416 1.484 . . . . 0.0 114.536 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -127.19 -38.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.767 1.227 . . . . 0.0 112.504 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.52 163.27 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.646 1.579 . . . . 0.0 112.248 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.25 152.6 18.22 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 168.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -148.61 145.22 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 120.631 -1.293 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -147.11 163.45 36.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.053 1.741 . . . . 0.0 108.827 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.4 p -134.01 154.55 51.05 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.725 -1.234 . . . . 0.0 111.747 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 t -145.94 142.25 28.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.481 1.112 . . . . 0.0 109.935 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.96 137.21 13.68 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.975 -0.453 . . . . 0.0 112.19 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.15 121.29 13.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 64.47 28.67 13.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.296 1.839 . . . . 0.0 113.775 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t 70.41 170.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.432 2.293 . . . . 0.0 114.062 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 62' ' ' SER . 82.1 p -152.71 179.12 8.91 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.699 1.6 . . . . 0.0 112.062 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 160.77 38.19 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.27 147.07 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.918 1.287 . . . . 0.0 109.07 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -119.63 132.19 24.12 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.65 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.88 -36.15 82.26 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.039 2.493 . . . . 0.0 114.795 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -69.57 -33.15 72.32 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.017 -1.052 . . . . 0.0 112.096 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 -13.44 61.14 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.044 -1.035 . . . . 0.0 113.21 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.07 -57.33 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.37 78.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -169.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mmt -68.46 -8.5 41.43 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.402 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 14.3 mmt -123.15 -27.25 4.2 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 -169.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.87 -27.59 68.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.173 -0.954 . . . . 0.0 111.891 169.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.29 -8.13 53.22 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.332 1.053 . . . . 0.0 113.408 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.61 -0.46 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.516 2.326 . . . . 0.0 110.772 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.54 14.44 78.22 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.276 1.417 . . . . 0.0 114.629 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 mm -92.62 153.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.872 1.269 . . . . 0.0 111.192 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -130.92 139.0 50.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.444 1.498 . . . . 0.0 111.859 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.6 pt -135.58 -6.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.694 1.198 . . . . 0.0 112.49 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -58.35 -34.41 70.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.583 1.553 . . . . 0.0 114.526 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.69 -3.82 89.32 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.474 1.035 . . . . 0.0 115.295 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -81.71 154.84 25.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.961 1.381 . . . . 0.0 113.424 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -130.42 178.06 6.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.83 2.052 . . . . 0.0 110.681 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 40' ' ' SER . 3.7 t -148.73 158.58 44.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.121 -0.987 . . . . 0.0 112.444 173.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -152.04 158.1 33.92 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.687 1.995 . . . . 0.0 109.284 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.03 140.89 95.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.344 2.696 . . . . 0.0 112.474 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -60.11 -29.62 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.54 -12.04 60.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -21.42 59.22 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.252 -0.905 . . . . 0.0 112.735 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 166.25 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.359 . . . . 0.0 112.523 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.89 107.05 14.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.485 1.514 . . . . 0.0 111.086 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -62.38 -16.18 53.11 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.874 -1.141 . . . . 0.0 113.799 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -59.26 -18.83 40.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.572 1.549 . . . . 0.0 113.063 176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.18 -0.51 28.41 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.463 1.905 . . . . 0.0 112.877 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -123.61 76.62 1.43 Allowed 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.831 1.652 . . . . 0.0 109.894 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.56 -23.75 11.61 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.661 1.984 . . . . 0.0 113.256 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.54 131.46 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.193 1.397 . . . . 0.0 109.329 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.62 126.35 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.876 -1.14 . . . . 0.0 110.391 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.07 119.69 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.364 1.465 . . . . 0.0 108.206 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 t -83.43 151.06 25.67 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.781 1.633 . . . . 0.0 110.112 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.05 38.25 4.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.129 -0.982 . . . . 0.0 111.765 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 98.7 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -169.768 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.83 131.87 12.69 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.599 1.16 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.97 148.28 89.51 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.762 2.308 . . . . 0.0 110.126 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.18 -29.55 83.95 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.657 2.905 . . . . 0.0 115.483 -169.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -63.84 -20.96 66.2 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.487 -1.383 . . . . 0.0 114.014 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.453 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 99.0 m95 -81.76 -15.42 54.34 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.401 -1.437 . . . . 0.0 114.526 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.22 -21.25 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.851 1.261 . . . . 0.0 113.524 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 t -84.56 13.37 5.67 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.974 1.71 . . . . 0.0 113.568 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -67.8 164.54 19.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 112.786 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.31 -34.85 78.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.6 mt -133.5 126.59 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 110.072 169.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.08 148.07 48.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.931 1.292 . . . . 0.0 110.79 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -141.53 162.34 35.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.519 1.128 . . . . 0.0 112.402 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.68 130.81 32.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 108.749 168.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -108.28 135.26 49.89 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.399 1.479 . . . . 0.0 111.014 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -93.81 44.24 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.18 1.392 . . . . 0.0 110.92 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.19 150.92 24.06 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.659 1.583 . . . . 0.0 112.651 -173.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.92 165.16 13.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.889 1.276 . . . . 0.0 110.477 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.1 134.23 19.9 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.853 -0.529 . . . . 0.0 112.168 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 CA--C 1.544 1.0 0 C-N-CA 121.866 1.71 . . . . 0.0 113.187 176.691 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.12 -33.12 74.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.919 0.887 . . . . 0.0 111.476 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.44 -34.89 79.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.726 -0.609 . . . . 0.0 111.198 169.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.8 t -69.53 -42.47 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 117.805 -1.093 . . . . 0.0 111.85 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -55.65 -48.9 74.22 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.951 1.705 . . . . 0.0 111.195 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -69.74 -19.31 63.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -84.36 -50.41 7.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 0.0 112.024 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.0 t -70.8 -30.97 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.588 1.155 . . . . 0.0 111.812 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -55.04 -42.26 72.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.274 0.943 . . . . 0.0 112.784 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.4 65.36 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.728 0.68 . . . . 0.0 112.849 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -68.57 -48.39 64.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.167 0.983 . . . . 0.0 109.681 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.15 -41.41 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.538 -0.726 . . . . 0.0 111.093 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.21 -50.11 73.89 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.096 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -70.82 -29.41 65.56 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.514 1.506 . . . . 0.0 113.335 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -63.48 -52.72 60.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 172.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.17 -50.84 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.138 1.375 . . . . 0.0 112.219 170.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.7 -49.99 70.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.847 1.203 . . . . 0.0 112.499 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -30.19 68.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.442 0.564 . . . . 0.0 112.142 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.15 -52.59 32.94 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.676 0.79 . . . . 0.0 110.876 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.8 -37.47 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.958 -1.089 . . . . 0.0 111.83 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.06 -26.48 68.86 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -87.78 -23.41 24.09 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -101.85 -20.09 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.254 1.338 0 C-N-CA 124.857 1.263 . . . . 0.0 113.829 -170.361 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -79.61 136.54 36.87 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.097 0.959 . . . . 0.0 112.419 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.33 128.17 53.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.643 1.177 . . . . 0.0 111.556 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.15 111.78 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.488 1.915 . . . . 0.0 110.319 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -92.8 122.45 35.2 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 169.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -93.31 114.91 27.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.998 0.519 . . . . 0.0 109.923 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.84 144.43 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.06 1.344 . . . . 0.0 111.985 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.541 0.624 0 O-C-N 121.274 -0.891 . . . . 0.0 112.855 176.215 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 119.627 -0.225 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -62.44 -46.53 88.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.863 1.265 . . . . 0.0 111.695 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.38 -33.93 67.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.394 0.678 . . . . 0.0 111.805 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -37.68 64.87 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.086 -1.009 . . . . 0.0 113.337 169.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -45.41 90.09 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.114 0.87 . . . . 0.0 110.919 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -57.92 -46.85 84.36 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.058 169.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.42 -49.19 46.26 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.826 1.194 . . . . 0.0 115.405 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -72.64 -36.11 67.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.024 1.412 . . . . 0.0 111.619 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.82 73.23 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -69.02 -26.36 64.95 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.582 1.537 . . . . 0.0 112.504 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.2 m -84.51 -44.93 13.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.08 0.952 . . . . 0.0 111.669 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -95.59 -32.36 12.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.27 1.028 . . . . 0.0 113.308 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 5.76 79.78 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 125.87 1.7 . . . . 0.0 113.351 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 115.42 1.1 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.318 1.059 . . . . 0.0 111.862 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.44 80.26 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 115.821 1.089 . . . . 0.0 115.821 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -119.55 -34.42 3.8 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.238 1.519 . . . . 0.0 111.906 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -149.88 166.96 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.739 2.016 . . . . 0.0 111.623 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.19 152.07 19.44 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -144.69 145.2 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.023 1.283 . . . . 0.0 113.858 -175.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -144.55 154.38 42.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.38 1.872 . . . . 0.0 110.001 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.8 p -118.76 152.27 36.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.594 1.088 . . . . 0.0 113.421 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 t -149.66 150.71 32.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.255 1.422 . . . . 0.0 111.012 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.62 18.12 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.2 mt -53.13 -40.8 64.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.668 1.734 . . . . 0.0 112.199 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -122.21 37.03 4.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.932 1.693 . . . . 0.0 111.074 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 72.97 151.5 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.272 2.229 . . . . 0.0 115.094 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -132.01 -169.34 2.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.195 1.798 . . . . 0.0 111.424 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.24 178.81 7.31 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.95 116.47 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.519 1.928 . . . . 0.0 109.25 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.8 148.91 52.51 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 118.673 -0.679 . . . . 0.0 112.065 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.28 -37.65 88.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.359 2.706 . . . . 0.0 113.892 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -65.48 -33.35 75.73 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.027 -1.046 . . . . 0.0 112.018 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.51 -10.74 59.85 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.4 mt -83.9 -53.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.17 68.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.86 -8.14 54.15 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 mmt -126.08 -27.35 3.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.284 1.033 . . . . 0.0 112.555 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.05 -25.13 67.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.787 -1.196 . . . . 0.0 111.985 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.39 -13.82 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.375 1.07 . . . . 0.0 113.544 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.28 18.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.422 1.489 . . . . 0.0 111.557 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.59 76.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.741 1.639 . . . . 0.0 116.611 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.2 mm -75.51 145.15 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.537 1.669 . . . . 0.0 111.6 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -133.77 97.92 4.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.641 1.576 . . . . 0.0 110.887 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 pt -132.75 11.93 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -58.47 -30.54 67.05 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.806 1.243 . . . . 0.0 113.333 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.43 -1.08 75.35 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.907 1.241 . . . . 0.0 115.348 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -74.76 140.13 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.703 1.751 . . . . 0.0 112.375 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.6 p -114.78 172.6 6.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.547 1.939 . . . . 0.0 110.343 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -145.44 158.71 43.79 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.304 -0.872 . . . . 0.0 111.783 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -150.03 157.59 37.53 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.779 1.632 . . . . 0.0 110.569 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.72 142.92 91.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.62 2.88 . . . . 0.0 113.098 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.88 -31.09 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -67.14 -13.22 61.74 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -21.02 57.16 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 112.916 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -94.62 166.85 11.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.878 1.271 . . . . 0.0 112.691 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.3 107.64 15.52 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 111.126 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -65.87 -21.4 66.46 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -169.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.57 -27.41 68.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.179 0.991 . . . . 0.0 112.487 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.16 -3.85 59.05 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.939 1.696 . . . . 0.0 112.187 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.15 80.32 1.44 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 127.119 2.168 . . . . 0.0 108.556 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.37 -27.65 10.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.767 1.627 . . . . 0.0 112.942 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.59 127.54 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.184 1.794 . . . . 0.0 108.835 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.82 124.65 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.15 -0.969 . . . . 0.0 109.251 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.17 124.25 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.417 1.087 . . . . 0.0 109.215 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -99.59 154.07 18.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.572 1.149 . . . . 0.0 111.938 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.87 35.15 3.79 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.111 1.364 . . . . 0.0 111.764 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.171 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.1 mt -142.51 139.93 18.11 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.62 1.168 . . . . 0.0 112.75 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.32 153.81 72.05 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.448 2.098 . . . . 0.0 110.167 168.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.86 -22.45 73.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.089 2.526 . . . . 0.0 115.167 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.99 -15.0 62.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.49 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.7 m95 -92.08 -1.56 57.13 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.78 10.62 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 125.887 1.675 . . . . 0.0 113.894 -175.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -112.52 -2.62 14.59 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.399 1.88 . . . . 0.0 112.826 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.445 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.7 mp0 -56.72 160.4 3.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.551 2.74 . . . . 0.0 113.95 175.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.84 -32.59 74.2 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.65 127.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.146 0.978 . . . . 0.0 110.513 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -139.38 141.33 37.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.247 1.419 . . . . 0.0 111.624 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -157.3 161.64 39.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 110.665 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.44 134.01 52.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 111.8 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -108.78 163.35 13.35 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.202 1.801 . . . . 0.0 112.104 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -130.33 62.14 1.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.856 1.262 . . . . 0.0 112.337 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.55 167.21 20.37 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.542 1.537 . . . . 0.0 111.418 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -117.52 158.83 23.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.967 1.307 . . . . 0.0 110.397 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -98.35 120.72 58.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 CA--C 1.542 0.885 0 C-N-CA 123.061 2.507 . . . . 0.0 114.094 -178.927 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.8 t . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.108 0.48 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.9 -25.09 67.36 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.996 0.918 . . . . 0.0 111.692 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.44 -31.97 73.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.887 -1.133 . . . . 0.0 111.729 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.1 t -72.73 -39.0 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.901 -1.125 . . . . 0.0 110.193 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -56.53 -49.33 75.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.687 1.131 . . . . 0.0 111.15 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -70.67 -17.05 62.85 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -83.07 -51.4 7.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.063 1.345 . . . . 0.0 111.967 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.35 -34.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.748 1.219 . . . . 0.0 111.484 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -57.12 -39.5 75.24 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.101 0.864 . . . . 0.0 112.728 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.12 -32.26 69.23 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.988 0.804 . . . . 0.0 112.935 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -71.78 -39.76 69.71 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.476 1.138 . . . . 0.0 110.967 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.38 -50.93 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.63 0.772 . . . . 0.0 110.552 170.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.448 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -54.08 -48.01 71.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 112.367 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -68.32 -26.66 65.73 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 120.984 1.72 . . . . 0.0 112.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -75.54 -47.69 25.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.904 0.882 . . . . 0.0 111.8 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.9 m -61.19 -36.5 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.8 0.727 . . . . 0.0 112.252 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -61.78 -47.26 85.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.9 1.227 . . . . 0.0 111.833 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -40.16 95.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.46 0.573 . . . . 0.0 111.106 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.485 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -58.74 -48.21 81.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.801 0.84 . . . . 0.0 111.388 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -73.13 -47.95 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.34 -25.42 68.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.9 pttt -87.68 -7.49 57.35 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.13 -18.36 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.0 p . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.135 1.374 . . . . 0.0 113.617 178.238 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -71.18 141.45 50.69 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.403 1.081 . . . . 0.0 111.221 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.96 128.57 55.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.072 0.949 . . . . 0.0 111.769 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.4 t -99.64 110.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.624 1.57 . . . . 0.0 110.161 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 tpp -90.65 124.07 34.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.181 0.446 . . . . 0.0 110.475 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.3 123.57 39.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.832 0.853 . . . . 0.0 109.918 169.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 m -118.98 134.51 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.08 0.855 . . . . 0.0 112.623 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t . . . . . 0 CA--C 1.55 0.944 0 C-N-CA 125.121 1.368 . . . . 0.0 110.43 174.528 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 p -70.28 -43.69 69.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.119 1.327 . . . . 0.0 112.119 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.38 -34.3 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.456 0.703 . . . . 0.0 111.634 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 tpt -74.93 -38.37 61.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.07 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.13 87.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.431 0.559 . . . . 0.0 111.495 169.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -58.84 -40.85 85.44 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.349 -0.844 . . . . 0.0 111.824 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.97 -48.82 83.93 Favored Glycine 0 N--CA 1.474 1.228 0 CA-C-N 119.433 1.015 . . . . 0.0 113.784 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB3' HG21 ' A' ' 123' ' ' VAL . 40.0 m-85 -66.28 -40.01 89.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.073 -1.251 . . . . 0.0 111.365 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.12 85.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -68.77 -28.95 67.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.168 1.349 . . . . 0.0 112.641 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 m -78.42 -44.47 24.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.693 0.797 . . . . 0.0 111.773 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.5 mt -96.99 -31.77 12.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.973 0.909 . . . . 0.0 113.216 -171.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.13 7.03 72.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.821 1.677 . . . . 0.0 113.602 169.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.51 118.73 2.35 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.514 1.157 . . . . 0.0 112.024 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.35 11.61 85.14 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -116.9 -40.63 3.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.721 1.76 . . . . 0.0 112.377 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -150.51 162.65 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.784 1.633 . . . . 0.0 111.644 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.56 150.18 21.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.49 148.43 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.139 -0.975 . . . . 0.0 112.634 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -150.86 154.35 37.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.362 1.465 . . . . 0.0 109.248 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.3 p -127.49 155.01 44.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.6 t -155.78 167.12 31.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.585 1.554 . . . . 0.0 110.234 -170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.96 159.31 26.96 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.242 -0.911 . . . . 0.0 112.332 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -62.0 -38.26 87.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.324 1.062 . . . . 0.0 111.9 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.78 44.4 2.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.699 2.0 . . . . 0.0 108.756 170.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 t 66.5 176.96 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.15 1.78 . . . . 0.0 113.394 -169.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 94.9 p -146.23 -175.14 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.975 2.11 . . . . 0.0 110.423 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -145.78 172.64 13.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.13 141.75 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.758 1.623 . . . . 0.0 108.197 168.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -123.47 129.11 25.0 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.594 -171.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.68 -38.44 84.52 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.216 2.611 . . . . 0.0 115.381 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -63.74 -36.43 83.85 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.856 -0.528 . . . . 0.0 111.533 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.23 85.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.157 0.89 . . . . 0.0 111.171 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.5 mt -53.57 -51.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.36 79.37 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.1 mmt -67.09 -23.35 65.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 mmt -106.68 -18.93 13.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -61.32 -29.25 69.76 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.482 -1.386 . . . . 0.0 112.497 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -6.85 49.37 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.057 0.943 . . . . 0.0 113.302 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.8 0.49 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 126.943 2.097 . . . . 0.0 110.508 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 14.38 79.9 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.204 1.383 . . . . 0.0 114.629 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 mm -88.89 157.3 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.1 1.36 . . . . 0.0 110.619 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.87 143.26 49.4 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.463 1.105 . . . . 0.0 112.188 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.74 4.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.088 1.755 . . . . 0.0 112.106 168.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.4 p -63.2 -30.56 71.68 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.48 -4.14 73.94 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.76 1.171 . . . . 0.0 115.565 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -87.73 148.81 24.58 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.304 1.552 . . . . 0.0 113.043 -174.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.2 t -144.42 172.63 12.68 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.362 1.865 . . . . 0.0 109.951 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 t -133.31 167.19 20.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.929 1.292 . . . . 0.0 112.867 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -146.11 157.89 49.17 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.427 1.491 . . . . 0.0 111.034 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 134.97 65.52 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.723 2.948 . . . . 0.0 112.828 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -57.48 -32.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -169.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.93 -9.16 54.04 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.79 59.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 121.365 -0.835 . . . . 0.0 112.9 170.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.95 167.78 11.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 113.219 -175.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.02 112.19 22.27 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.595 1.558 . . . . 0.0 111.056 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.15 -15.55 63.78 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.455 -1.403 . . . . 0.0 113.529 -175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.9 -20.44 23.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.845 1.258 . . . . 0.0 113.191 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.72 -0.39 34.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.596 1.959 . . . . 0.0 113.053 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.5 77.03 1.61 Allowed 'General case' 0 C--N 1.346 0.428 0 C-N-CA 125.97 1.708 . . . . 0.0 109.739 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.29 -23.56 15.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.831 2.052 . . . . 0.0 113.252 -177.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.66 127.76 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.313 1.445 . . . . 0.0 108.8 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.0 t -136.18 124.87 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.01 -1.056 . . . . 0.0 111.055 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.36 121.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.559 1.544 . . . . 0.0 108.612 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -87.29 137.99 31.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.672 1.189 . . . . 0.0 111.449 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.85 11.7 20.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.505 1.122 . . . . 0.0 112.735 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m . . . . . 0 CA--C 1.55 0.969 0 C-N-CA 125.622 1.569 . . . . 0.0 112.537 169.909 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -141.68 137.67 16.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.22 1.008 . . . . 0.0 112.454 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.46 151.35 80.32 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.541 2.16 . . . . 0.0 110.032 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.67 -31.28 94.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.084 2.523 . . . . 0.0 114.672 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.89 -23.81 66.55 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.862 -1.148 . . . . 0.0 113.756 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.6 m95 -83.87 -9.72 58.54 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.47 -1.394 . . . . 0.0 114.686 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.1 m -117.04 -21.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.19 1.396 . . . . 0.0 113.569 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -83.55 14.29 3.89 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.154 1.782 . . . . 0.0 113.562 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -71.69 168.21 18.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.88 1.672 . . . . 0.0 113.078 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.84 -35.97 82.84 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.503 -0.748 . . . . 0.0 112.747 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.68 125.98 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.761 0.709 . . . . 0.0 110.731 170.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -122.18 144.43 48.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.742 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -133.82 154.36 51.08 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.272 1.029 . . . . 0.0 112.463 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.15 125.08 34.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.073 0.949 . . . . 0.0 110.523 169.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -110.99 150.74 28.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.775 1.63 . . . . 0.0 110.354 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -119.57 47.1 1.77 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.18 1.792 . . . . 0.0 108.253 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -96.71 126.9 42.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.058 2.143 . . . . 0.0 112.303 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -84.26 147.61 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.159 1.784 . . . . 0.0 112.556 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.06 123.31 69.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.286 1.434 . . . . 0.0 112.066 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 122.946 2.431 . . . . 0.0 114.482 -175.061 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 120.957 0.408 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.62 -20.13 64.47 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 0.0 112.137 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.43 -31.58 72.74 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.012 -1.055 . . . . 0.0 110.218 168.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 t -72.62 -38.64 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.425 175.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.53 -49.14 73.41 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.164 1.347 . . . . 0.0 110.848 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.84 -15.86 63.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 m -87.12 -41.46 13.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.557 1.543 . . . . 0.0 112.744 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.05 -40.06 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.13 -1.606 . . . . 0.0 111.311 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -57.79 -42.2 83.68 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.53 65.82 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 123.701 0.667 . . . . 0.0 112.388 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -69.15 -39.07 79.02 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.596 -0.943 . . . . 0.0 111.879 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.46 -49.19 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.392 0.677 . . . . 0.0 110.388 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -56.96 -48.01 79.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.047 1.339 . . . . 0.0 112.725 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -68.26 -27.97 66.8 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.766 1.621 . . . . 0.0 112.33 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -71.35 -50.47 31.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.95 0.9 . . . . 0.0 111.567 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.477 HG21 ' HB3' ' A' ' 21' ' ' PHE . 31.2 m -59.83 -43.27 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.373 0.988 . . . . 0.0 112.6 170.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.07 -51.66 63.05 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 120.161 1.346 . . . . 0.0 112.393 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.667 0.667 . . . . 0.0 111.728 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.48 -48.03 76.76 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.24 0.616 . . . . 0.0 111.304 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.96 -43.93 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.924 0.784 . . . . 0.0 110.747 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.6 -25.8 66.79 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.19 -16.78 54.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -107.59 -26.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.252 1.421 . . . . 0.0 112.051 -179.862 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.819 -0.134 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -70.45 142.28 51.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.39 1.076 . . . . 0.0 111.809 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -110.92 129.34 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.478 1.111 . . . . 0.0 111.351 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.9 t -99.63 114.96 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.292 1.837 . . . . 0.0 110.085 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.6 tpp -94.85 128.46 41.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.434 0.561 . . . . 0.0 110.369 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -100.28 113.41 26.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.156 0.982 . . . . 0.0 110.591 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.44 137.59 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 p . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 110.944 171.523 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.4 p -71.2 -59.93 2.51 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -73.63 -26.75 60.92 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.637 -0.664 . . . . 0.0 111.859 -172.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.15 -37.41 69.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.22 95.4 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.609 0.641 . . . . 0.0 111.188 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -57.95 -43.97 86.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.115 0.87 . . . . 0.0 111.684 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.39 -50.98 60.47 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.409 1.004 . . . . 0.0 113.556 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -68.8 -40.82 79.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.208 -1.172 . . . . 0.0 111.705 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.39 95.67 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -71.46 -28.46 63.97 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.242 0.928 . . . . 0.0 112.386 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 m -79.18 -42.55 25.82 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.358 0.663 . . . . 0.0 111.77 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -90.14 -32.95 16.43 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.889 0.876 . . . . 0.0 112.716 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 10.66 68.22 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.885 1.707 . . . . 0.0 113.906 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.29 119.18 2.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.491 1.146 . . . . 0.0 111.615 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.98 13.22 83.91 Favored Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -120.2 -41.72 2.61 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.284 1.542 . . . . 0.0 111.423 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.59 159.3 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.894 1.677 . . . . 0.0 112.072 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.66 20.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.15 0.98 . . . . 0.0 109.193 169.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -141.64 141.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.009 -1.057 . . . . 0.0 112.925 -173.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 m -146.18 163.71 34.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.397 1.879 . . . . 0.0 109.514 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 p -140.61 153.54 46.1 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.785 -1.197 . . . . 0.0 112.542 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t -151.66 150.51 30.33 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.095 0.958 . . . . 0.0 111.215 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.01 134.35 9.81 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.24 1.4 . . . . 0.0 110.054 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 72.4 mt -50.34 -35.9 29.77 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.281 1.041 . . . . 0.0 112.907 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -118.69 28.95 8.0 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.953 1.701 . . . . 0.0 112.462 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 m 64.63 168.59 0.18 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.402 1.881 . . . . 0.0 114.124 -170.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t -164.33 173.58 12.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.454 1.102 . . . . 0.0 112.179 172.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -133.7 146.89 51.24 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.441 1.496 . . . . 0.0 113.099 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.2 m -64.82 140.23 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.411 0.624 . . . . 0.0 111.676 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -103.15 122.36 45.64 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.161 1.384 . . . . 0.0 111.584 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.8 -37.83 77.02 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.466 2.778 . . . . 0.0 115.305 -172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.6 m -64.39 -40.02 95.01 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.629 -0.67 . . . . 0.0 111.384 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.1 97.29 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.135 0.88 . . . . 0.0 111.664 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -54.8 -52.55 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 118.558 0.617 . . . . 0.0 109.554 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.79 82.91 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.6 mmt -67.56 -24.46 65.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.25 1.02 . . . . 0.0 113.198 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mmt -108.69 -19.59 13.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.02 -28.72 69.25 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.541 -1.349 . . . . 0.0 112.563 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.9 -8.31 53.64 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.172 -0.955 . . . . 0.0 113.347 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.85 3.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 127.153 2.181 . . . . 0.0 110.635 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 13.85 82.76 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.385 1.469 . . . . 0.0 114.762 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.3 mm -83.62 147.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 118.557 1.178 . . . . 0.0 111.184 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.74 126.42 52.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.978 1.711 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.86 -5.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 169.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.9 p -62.49 -27.02 68.85 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.09 1.314 . . . . 0.0 114.458 -169.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.54 -6.35 88.68 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.759 1.171 . . . . 0.0 115.476 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -84.7 149.14 26.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.27 1.535 . . . . 0.0 112.644 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 t -144.25 165.64 27.31 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.009 1.724 . . . . 0.0 109.618 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -132.76 144.19 50.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.163 0.985 . . . . 0.0 112.835 -171.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -139.76 159.8 63.55 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.112 1.765 . . . . 0.0 111.413 -171.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.91 138.5 79.34 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.632 2.888 . . . . 0.0 112.537 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.98 -29.49 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.44 -11.26 60.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -18.35 58.83 Favored 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.359 -0.838 . . . . 0.0 112.544 169.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -99.07 170.99 8.31 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.68 1.592 . . . . 0.0 112.238 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.62 113.61 18.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 110.749 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.89 -20.28 65.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -169.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.74 -27.34 68.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.078 0.951 . . . . 0.0 112.376 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.28 -3.22 58.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.133 1.773 . . . . 0.0 112.152 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -116.96 82.11 1.75 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.877 2.071 . . . . 0.0 108.108 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.21 -25.46 9.24 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.182 1.793 . . . . 0.0 113.138 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.69 131.28 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.108 1.763 . . . . 0.0 109.279 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -136.43 120.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 120.992 -1.068 . . . . 0.0 110.721 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.77 120.25 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 108.092 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -88.46 149.24 23.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.015 0.926 . . . . 0.0 110.078 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -123.7 30.78 6.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.127 0.971 . . . . 0.0 111.32 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -169.634 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 121.096 0.474 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.1 mt -74.76 136.57 73.88 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.217 -0.927 . . . . 0.0 112.188 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.68 150.86 86.56 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 122.35 2.033 . . . . 0.0 110.281 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.94 -22.0 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.353 2.702 . . . . 0.0 115.221 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.75 -13.52 61.74 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 96.9 m95 -91.89 -3.52 55.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.47 14.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.565 1.546 . . . . 0.0 113.425 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -120.65 -0.99 10.11 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.21 1.804 . . . . 0.0 112.996 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.485 HE22 ' HB1' ' A' ' 70' ' ' ALA . 13.7 mp0 -58.29 160.05 5.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.389 2.676 . . . . 0.0 114.138 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -63.81 -34.49 78.02 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.37 122.51 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.93 . . . . 0.0 109.086 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -124.25 146.74 48.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.188 1.395 . . . . 0.0 110.963 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -140.83 159.1 42.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.222 1.009 . . . . 0.0 112.437 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -132.22 117.14 17.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.681 1.192 . . . . 0.0 109.692 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -106.85 153.13 22.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.069 1.348 . . . . 0.0 111.586 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.08 79.86 1.75 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 110.379 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.62 152.46 18.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.024 1.33 . . . . 0.0 111.354 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -84.85 148.16 26.43 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.211 0.605 . . . . 0.0 109.445 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.04 130.73 59.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.556 -0.715 . . . . 0.0 112.143 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 CA--C 1.54 0.782 0 C-N-CA 121.908 1.739 . . . . 0.0 114.216 -177.127 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.6 p . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.9 -26.91 66.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.858 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.88 -39.1 93.41 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.935 -1.103 . . . . 0.0 110.415 169.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.65 -36.69 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.208 0.913 . . . . 0.0 111.587 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -55.42 -45.41 76.72 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.888 1.676 . . . . 0.0 110.529 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -69.46 -19.93 63.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.0 m -79.36 -52.41 8.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.761 1.224 . . . . 0.0 111.718 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.24 -33.34 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.338 1.055 . . . . 0.0 111.317 -172.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -56.67 -39.44 73.78 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.924 0.783 . . . . 0.0 112.765 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.23 65.9 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.079 0.847 . . . . 0.0 112.878 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -69.82 -39.36 76.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.092 0.946 . . . . 0.0 111.166 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.11 -47.57 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.813 0.845 . . . . 0.0 110.966 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.461 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -55.25 -47.7 75.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.187 1.395 . . . . 0.0 112.792 177.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -68.64 -27.46 66.03 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.651 1.568 . . . . 0.0 112.686 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -71.58 -49.44 40.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.064 0.945 . . . . 0.0 111.693 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.2 m -60.9 -41.1 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.947 0.794 . . . . 0.0 112.891 170.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -63.9 -51.69 63.33 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.15 1.341 . . . . 0.0 112.485 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -69.31 -30.14 68.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.914 0.779 . . . . 0.0 112.375 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.88 -49.74 71.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.966 0.907 . . . . 0.0 110.901 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.57 -39.94 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.182 -0.949 . . . . 0.0 110.585 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.27 -26.72 67.96 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -90.77 -18.12 25.48 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -104.37 -16.99 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.649 1.179 . . . . 0.0 112.935 178.785 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.5 2.057 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -71.29 143.48 50.31 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.151 0.98 . . . . 0.0 111.804 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.6 129.36 55.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.363 1.065 . . . . 0.0 111.469 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.45 116.28 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.452 1.901 . . . . 0.0 109.9 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -94.6 125.47 39.27 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 169.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -99.32 113.39 25.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.577 0.751 . . . . 0.0 111.275 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.07 144.06 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.392 1.077 . . . . 0.0 112.69 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 t . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 124.03 0.932 . . . . 0.0 111.583 171.559 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 p -64.5 -52.92 55.42 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.363 0.983 . . . . 0.0 111.213 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -63.49 -39.04 93.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.547 1.139 . . . . 0.0 111.643 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.2 tpt -77.25 -35.2 55.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.903 0.881 . . . . 0.0 112.312 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.48 95.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.459 0.572 . . . . 0.0 110.736 169.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.35 -43.81 98.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.933 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.56 -48.02 73.36 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.666 1.121 . . . . 0.0 113.705 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -66.44 -44.23 83.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.129 0.964 . . . . 0.0 111.739 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.36 75.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -27.67 64.09 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.423 1.011 . . . . 0.0 112.584 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 m -88.71 -41.65 12.45 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.908 0.883 . . . . 0.0 112.548 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.58 -34.63 14.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.7 0.8 . . . . 0.0 112.617 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.34 8.55 64.05 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.598 1.57 . . . . 0.0 113.696 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.36 117.85 1.94 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.341 1.071 . . . . 0.0 112.0 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.72 13.91 82.6 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -119.19 -40.14 2.85 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.165 1.482 . . . . 0.0 111.847 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.11 160.01 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.355 1.862 . . . . 0.0 110.998 171.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 150.86 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.466 0.707 . . . . 0.0 109.469 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -141.23 140.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.223 -0.923 . . . . 0.0 112.531 -173.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -144.4 159.49 42.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.205 1.802 . . . . 0.0 109.051 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.9 p -133.72 158.83 42.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 113.46 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.1 t -148.1 146.15 28.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.98 1.312 . . . . 0.0 111.192 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.01 139.25 15.17 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.5 mt -52.8 -42.96 65.57 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.019 1.909 . . . . 0.0 113.002 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.4 38.95 3.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.28 1.432 . . . . 0.0 110.89 171.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t 69.58 171.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.068 2.147 . . . . 0.0 114.302 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 t -157.91 -169.1 2.71 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.284 1.833 . . . . 0.0 110.038 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 167.7 21.58 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.87 166.49 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.402 1.081 . . . . 0.0 109.159 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -138.11 126.94 14.51 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.432 -1.418 . . . . 0.0 111.626 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.61 -40.22 85.96 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.926 2.417 . . . . 0.0 114.304 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.91 -34.3 77.81 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.243 -0.91 . . . . 0.0 111.273 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 -2.74 23.43 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.371 -1.456 . . . . 0.0 114.154 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -87.43 -54.78 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 167.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -28.85 61.65 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 73.2 mmm -78.27 -6.01 53.72 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.326 -0.859 . . . . 0.0 113.205 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.3 mmt -120.33 -26.36 5.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.71 1.204 . . . . 0.0 111.815 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.13 -20.52 65.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 112.439 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.07 -11.15 60.62 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 171.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 t -107.98 5.88 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 127.092 2.157 . . . . 0.0 110.622 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.07 14.04 82.63 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.561 -1.337 . . . . 0.0 114.396 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.21 154.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.999 1.32 . . . . 0.0 110.27 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.18 149.12 41.02 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.291 1.037 . . . . 0.0 110.957 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.3 pt -133.78 -2.1 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.171 1.789 . . . . 0.0 113.122 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -54.66 -37.91 66.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.598 1.159 . . . . 0.0 113.836 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.32 -1.2 90.37 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 116.145 1.218 . . . . 0.0 116.145 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -76.61 160.77 29.12 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.748 1.774 . . . . 0.0 113.319 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 57.9 p -135.24 167.52 20.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.713 2.005 . . . . 0.0 110.484 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 t -144.18 158.83 43.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.535 1.134 . . . . 0.0 111.376 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -150.95 163.71 22.77 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 126.352 1.861 . . . . 0.0 110.177 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -60.49 146.22 97.27 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.5 2.8 . . . . 0.0 113.566 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.16 -32.31 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.076 0.95 . . . . 0.0 113.486 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.46 -13.76 61.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -21.19 46.61 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.332 0.969 . . . . 0.0 113.354 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.77 169.46 10.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.054 1.342 . . . . 0.0 112.825 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.0 108.41 15.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 110.892 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.71 -20.3 65.94 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -169.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.68 -24.89 67.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.028 0.931 . . . . 0.0 112.533 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.57 -2.01 58.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.456 1.902 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.89 82.05 1.74 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.946 2.098 . . . . 0.0 108.11 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.35 -28.19 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.765 1.626 . . . . 0.0 113.004 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -130.15 130.29 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.893 1.677 . . . . 0.0 108.627 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -131.49 126.51 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.095 -1.003 . . . . 0.0 109.262 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.3 mm -126.72 133.92 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.697 1.199 . . . . 0.0 109.214 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.2 t -109.01 148.67 30.41 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.969 1.308 . . . . 0.0 112.098 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.21 55.55 1.66 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.974 1.31 . . . . 0.0 109.677 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -169.601 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.8 mt -141.74 140.28 19.82 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.386 1.074 . . . . 0.0 112.443 -175.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 151.5 82.51 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.252 1.968 . . . . 0.0 110.286 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.44 -26.91 79.93 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 115.535 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.512 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.0 m95 -89.16 -3.05 58.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.58 18.0 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.295 1.438 . . . . 0.0 113.352 -173.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -122.29 -0.7 9.3 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.402 1.881 . . . . 0.0 112.87 -172.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.4 mp0 -57.24 163.62 2.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.861 2.864 . . . . 0.0 113.987 174.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.09 -34.79 78.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -131.62 127.46 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.906 0.883 . . . . 0.0 111.037 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -137.28 140.3 41.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.492 1.517 . . . . 0.0 111.333 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -156.57 156.38 33.49 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.116 1.366 . . . . 0.0 111.006 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -113.78 142.85 45.55 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.876 1.27 . . . . 0.0 110.954 170.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -110.82 142.28 43.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.964 1.705 . . . . 0.0 111.572 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -104.73 59.59 0.7 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.957 1.703 . . . . 0.0 107.29 -169.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.02 132.0 53.44 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.422 1.889 . . . . 0.0 112.002 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -88.65 163.26 15.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.748 1.619 . . . . 0.0 112.869 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.66 138.82 37.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 122.1 -0.375 . . . . 0.0 111.136 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 CA--C 1.54 0.776 0 C-N-CA 122.342 2.028 . . . . 0.0 114.46 174.95 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.479 0.975 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.07 -27.7 68.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.148 0.979 . . . . 0.0 112.455 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.6 -25.83 61.47 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.692 -1.255 . . . . 0.0 111.85 169.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 71.3 t -75.37 -33.38 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.876 -1.14 . . . . 0.0 109.866 169.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.37 -44.63 92.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.035 1.743 . . . . 0.0 109.594 168.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.2 m -76.8 -54.03 7.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.487 0.715 . . . . 0.0 111.461 170.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.98 -34.8 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 0.0 111.344 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -57.85 -44.53 86.62 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 112.255 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.41 -29.65 67.9 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.691 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -67.55 -51.07 55.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.38 1.09 . . . . 0.0 110.256 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.6 t -57.44 -43.66 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.521 -0.737 . . . . 0.0 110.857 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.25 -48.65 73.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.709 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -72.8 -29.79 63.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.132 1.333 . . . . 0.0 113.504 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -63.74 -52.23 61.39 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.075 0.852 . . . . 0.0 109.937 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.49 -42.99 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.021 1.328 . . . . 0.0 112.546 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -61.69 -45.97 91.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.976 1.262 . . . . 0.0 111.633 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -38.39 89.22 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.535 0.607 . . . . 0.0 111.302 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.469 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -58.96 -51.13 71.39 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.898 0.879 . . . . 0.0 110.928 174.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.0 -44.3 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.651 0.66 . . . . 0.0 111.032 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.96 -23.52 66.44 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.6 pttt -94.17 -6.87 43.83 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -122.15 -17.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.168 1.787 . . . . 0.0 112.339 -178.822 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 111.244 0.091 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -69.1 133.49 48.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.835 1.254 . . . . 0.0 112.141 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -103.82 123.47 47.15 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.19 0.996 . . . . 0.0 111.129 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 111.0 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 126.104 1.762 . . . . 0.0 109.897 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.1 tpp -90.67 129.65 36.75 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.684 0.393 . . . . 0.0 110.091 168.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -100.0 124.67 45.62 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.727 0.811 . . . . 0.0 109.731 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.95 143.05 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.701 1.2 . . . . 0.0 112.525 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.4 t . . . . . 0 CA--C 1.544 0.75 0 C-N-CA 124.738 1.215 . . . . 0.0 110.369 175.611 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 . . . . . 0 C--O 1.216 -0.709 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -63.59 -52.96 58.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.788 1.235 . . . . 0.0 112.217 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -67.08 -34.89 78.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.272 0.629 . . . . 0.0 111.466 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.91 71.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.058 0.543 . . . . 0.0 112.313 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.71 86.67 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.508 -0.745 . . . . 0.0 112.698 173.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.15 -40.68 77.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.921 0.782 . . . . 0.0 111.896 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.27 -53.54 43.99 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-N 119.188 0.904 . . . . 0.0 112.961 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.47 ' HB3' HG21 ' A' ' 123' ' ' VAL . 43.2 m-85 -65.97 -40.97 91.71 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.243 -1.151 . . . . 0.0 111.881 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.81 94.27 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -76.41 -29.05 56.89 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.53 1.059 . . . . 0.0 112.624 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m -77.5 -43.57 31.71 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 0.0 111.647 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.51 -33.12 13.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.67 0.788 . . . . 0.0 112.491 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.5 11.82 57.6 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.671 1.605 . . . . 0.0 113.221 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.11 122.77 5.49 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.433 1.116 . . . . 0.0 111.551 171.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.01 8.8 87.3 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 116.029 1.172 . . . . 0.0 116.029 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -118.68 -31.04 4.96 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.649 1.724 . . . . 0.0 112.998 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.13 156.52 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 112.248 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.73 144.73 25.02 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.98 138.64 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.451 1.478 . . . . 0.0 113.487 -169.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 m -149.43 161.5 41.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.577 1.551 . . . . 0.0 110.274 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 p -137.4 150.62 47.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.314 1.054 . . . . 0.0 113.759 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 t -145.43 157.93 43.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.435 1.894 . . . . 0.0 110.099 -169.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.15 146.03 18.08 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.462 -0.774 . . . . 0.0 111.614 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -58.52 -42.68 88.26 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.976 0.888 . . . . 0.0 110.728 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.91 40.44 1.81 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.352 1.461 . . . . 0.0 111.287 173.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 t 65.17 178.56 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.407 1.883 . . . . 0.0 114.417 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -152.99 165.61 35.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 112.453 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.61 -179.82 6.54 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.76 -173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.75 113.61 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.065 0.946 . . . . 0.0 110.186 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.73 143.92 44.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.458 1.103 . . . . 0.0 110.993 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.87 -37.12 76.8 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.354 2.703 . . . . 0.0 113.857 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -61.21 -39.63 90.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.63 0.772 . . . . 0.0 112.17 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -13.21 60.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.8 mt -78.19 -53.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.43 64.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.8 mmt -70.47 -12.06 61.32 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 mmt -121.9 -28.64 4.42 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.269 1.028 . . . . 0.0 112.603 -169.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.35 -24.72 67.97 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.724 -1.235 . . . . 0.0 112.568 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.22 -10.73 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 11.5 p -121.38 26.2 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.188 1.795 . . . . 0.0 110.397 169.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.66 9.31 86.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.014 1.768 . . . . 0.0 116.774 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.06 147.76 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 118.84 1.32 . . . . 0.0 111.915 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.78 127.87 54.76 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.696 1.598 . . . . 0.0 111.506 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.0 pt -138.04 -6.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 p -64.19 -27.52 69.12 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.73 -1.231 . . . . 0.0 114.318 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.56 -6.72 89.16 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.594 1.092 . . . . 0.0 115.211 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -83.64 152.25 24.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.195 1.497 . . . . 0.0 113.116 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -145.32 177.62 8.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.481 1.912 . . . . 0.0 108.819 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -152.68 174.88 13.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.487 1.04 . . . . 0.0 113.765 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.87 163.14 28.62 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.937 2.095 . . . . 0.0 110.159 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.15 142.42 94.4 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.458 2.772 . . . . 0.0 113.247 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.97 -35.09 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.41 -11.81 60.22 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 CA--C 1.553 1.085 0 O-C-N 121.25 -0.906 . . . . 0.0 113.117 172.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -94.14 169.18 10.44 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.987 1.315 . . . . 0.0 112.832 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.23 107.47 12.59 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.411 1.484 . . . . 0.0 111.725 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.44 -20.16 65.47 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.42 -24.99 68.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.793 1.237 . . . . 0.0 112.895 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.74 -4.11 56.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.084 1.754 . . . . 0.0 112.106 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -114.7 82.97 1.81 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.452 1.901 . . . . 0.0 108.114 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -51.15 -26.9 7.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.857 1.663 . . . . 0.0 113.364 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -134.25 133.25 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.722 1.609 . . . . 0.0 109.287 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.62 121.19 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.866 -1.146 . . . . 0.0 110.91 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.08 124.19 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 108.522 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 t -91.19 152.29 20.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.666 1.586 . . . . 0.0 110.957 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.77 52.32 2.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.005 1.322 . . . . 0.0 110.028 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.84 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 121.359 0.6 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.52 139.01 41.11 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.926 0.891 . . . . 0.0 112.996 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -63.29 152.69 78.61 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.301 2.0 . . . . 0.0 109.662 168.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.18 -22.1 73.61 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.218 2.612 . . . . 0.0 115.384 -169.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.54 -14.29 61.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.493 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -91.92 -1.43 57.29 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.8 14.76 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.904 1.682 . . . . 0.0 113.757 -174.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -118.89 -0.96 11.1 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.246 1.819 . . . . 0.0 112.877 -171.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.471 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.7 mp0 -59.8 161.44 6.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.251 2.62 . . . . 0.0 113.897 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.03 -33.93 76.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.5 mt -132.9 127.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.791 0.836 . . . . 0.0 110.394 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -130.03 149.26 51.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.178 1.391 . . . . 0.0 111.568 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -144.83 161.12 40.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.758 1.223 . . . . 0.0 112.182 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.21 128.54 26.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 167.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -106.86 146.81 30.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.368 1.467 . . . . 0.0 111.379 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -107.83 59.3 0.62 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.4 1.88 . . . . 0.0 106.864 -173.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.56 117.32 33.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.493 1.917 . . . . 0.0 112.335 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.89 159.47 32.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.823 1.296 . . . . 0.0 113.64 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.21 118.8 70.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 126.568 1.947 . . . . 0.0 113.113 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 C-N-CA 121.887 1.725 . . . . 0.0 113.385 175.01 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.015 0.436 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.78 -30.03 71.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.833 1.253 . . . . 0.0 111.542 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -72.73 -23.8 60.89 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.741 -1.225 . . . . 0.0 112.301 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.94 -35.9 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.958 -1.089 . . . . 0.0 109.961 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.95 -47.63 84.38 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.656 1.571 . . . . 0.0 110.593 169.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -65.87 -21.85 66.49 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -80.03 -53.96 6.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.608 1.163 . . . . 0.0 111.845 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.79 -32.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.383 1.073 . . . . 0.0 111.343 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -57.17 -39.79 76.01 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.355 0.98 . . . . 0.0 113.016 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.65 -35.43 74.18 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.746 0.688 . . . . 0.0 112.171 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -68.59 -39.15 81.06 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.954 -0.733 . . . . 0.0 111.578 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.02 -49.08 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.637 170.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -56.13 -47.42 78.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.983 1.313 . . . . 0.0 112.417 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -69.18 -26.79 65.02 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.824 1.647 . . . . 0.0 112.624 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -72.98 -50.07 25.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.913 0.885 . . . . 0.0 111.299 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' A' ' 21' ' ' PHE . 34.8 m -59.79 -42.14 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.213 0.915 . . . . 0.0 112.565 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.24 -51.41 63.79 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.31 1.414 . . . . 0.0 112.464 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -31.97 70.71 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.917 0.781 . . . . 0.0 112.08 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.49 -48.44 75.17 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.425 0.69 . . . . 0.0 111.019 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.5 mt -72.95 -41.02 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.856 -174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.62 -26.25 68.59 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.83 -14.49 44.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.18 -23.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.601 1.56 . . . . 0.0 112.035 -179.478 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.0 tpp . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -70.22 150.67 46.19 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.178 0.899 . . . . 0.0 111.447 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.54 118.08 32.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 110.169 170.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.75 112.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.918 1.687 . . . . 0.0 109.584 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.3 ttm -95.1 122.34 37.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.851 0.75 . . . . 0.0 109.899 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -88.16 127.82 35.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.116 0.566 . . . . 0.0 109.982 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.97 145.94 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.686 1.194 . . . . 0.0 112.492 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 123.733 0.813 . . . . 0.0 111.801 -177.677 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.7 p -68.83 -43.14 76.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.408 1.003 . . . . 0.0 112.411 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.0 -35.03 71.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.719 0.808 . . . . 0.0 111.424 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.3 tpt -73.06 -37.63 66.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.063 1.345 . . . . 0.0 112.18 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.94 -44.87 91.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.25 0.477 . . . . 0.0 111.786 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -60.84 -38.83 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.379 -0.819 . . . . 0.0 111.823 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.62 72.89 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.113 1.324 . . . . 0.0 113.089 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -66.86 -44.43 81.02 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.169 -1.195 . . . . 0.0 111.81 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.44 72.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.778 -1.201 . . . . 0.0 114.05 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -72.23 -23.03 61.17 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.87 1.214 . . . . 0.0 112.867 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -86.07 -44.66 12.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.188 0.995 . . . . 0.0 112.037 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 mt -95.84 -35.85 11.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.23 1.012 . . . . 0.0 113.031 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.96 7.69 80.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.964 1.745 . . . . 0.0 113.575 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -38.93 -45.34 1.17 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.7 17.92 27.47 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.485 1.517 . . . . 0.0 114.787 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -116.63 -28.68 6.33 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.6 pt -157.59 163.97 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 127.603 2.361 . . . . 0.0 110.485 -171.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 147.03 24.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 167.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.5 145.43 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.745 -1.222 . . . . 0.0 113.62 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -148.88 157.97 43.82 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.791 2.036 . . . . 0.0 109.237 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.4 p -131.12 156.8 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.6 -1.312 . . . . 0.0 112.914 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -153.56 155.87 36.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.704 1.202 . . . . 0.0 109.793 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.3 145.46 18.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.31 -31.83 69.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.646 1.223 . . . . 0.0 111.913 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -123.33 35.48 4.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.161 1.785 . . . . 0.0 110.215 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t 71.36 170.37 0.32 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.142 1.777 . . . . 0.0 112.151 -168.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -155.63 -177.38 6.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.051 1.74 . . . . 0.0 110.966 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -144.76 178.39 8.03 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -113.15 140.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.375 1.47 . . . . 0.0 109.346 169.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -110.96 135.63 20.82 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.497 -1.239 . . . . 0.0 110.92 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.02 -36.69 85.18 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.294 2.662 . . . . 0.0 115.467 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -67.51 -31.88 72.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 120.9 -1.125 . . . . 0.0 111.779 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.88 -10.83 59.75 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.303 -1.498 . . . . 0.0 113.438 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.61 -58.89 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.41 -38.54 77.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.1 mmm -73.99 -6.69 48.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 mmt -118.01 -23.96 7.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.745 1.218 . . . . 0.0 111.516 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.88 -28.16 68.67 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.261 -0.9 . . . . 0.0 111.609 169.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.85 -5.61 42.07 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.48 1.06 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.412 2.285 . . . . 0.0 110.581 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.41 13.15 82.19 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.23 1.395 . . . . 0.0 114.553 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mm -89.29 152.01 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.47 1.135 . . . . 0.0 111.022 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -129.65 138.6 51.29 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 111.002 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 pt -135.8 -5.26 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -57.42 -33.11 67.54 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.26 -5.75 85.03 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -83.14 144.44 29.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.337 1.569 . . . . 0.0 112.873 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.3 p -133.79 171.72 13.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.845 2.058 . . . . 0.0 110.302 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.7 t -141.0 165.81 26.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.212 1.005 . . . . 0.0 112.398 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.25 155.02 30.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.61 1.564 . . . . 0.0 109.267 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.85 135.46 67.08 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.874 2.383 . . . . 0.0 113.215 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -54.52 -33.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -10.26 55.75 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -25.26 59.2 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.247 -0.908 . . . . 0.0 112.669 170.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.21 167.68 11.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.832 1.253 . . . . 0.0 112.499 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.94 115.86 30.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.122 1.369 . . . . 0.0 111.362 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.484 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -71.46 -19.31 62.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.09 -27.0 66.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.648 0.737 . . . . 0.0 112.304 -172.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.01 -10.88 57.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.037 1.735 . . . . 0.0 111.806 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -107.37 79.57 1.32 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 126.548 1.939 . . . . 0.0 108.786 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -66.13 -12.42 55.63 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -129.9 130.77 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.516 1.527 . . . . 0.0 109.169 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.4 t -134.14 128.77 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.134 -0.979 . . . . 0.0 109.512 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.8 121.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.253 1.021 . . . . 0.0 110.079 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -96.61 150.02 21.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 112.32 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.8 mp -126.27 35.13 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.829 1.252 . . . . 0.0 111.455 171.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 123.783 0.833 . . . . 0.0 112.98 -174.856 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.8 mt -142.37 139.81 18.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.534 -170.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -63.22 154.65 66.45 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.503 2.135 . . . . 0.0 110.188 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -58.36 -32.65 96.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.551 2.168 . . . . 0.0 114.691 -170.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 96.4 m95 -88.13 -3.25 58.91 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 m -118.81 -22.08 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.8 t -77.42 2.06 17.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.066 1.746 . . . . 0.0 114.514 -173.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.408 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.4 mp0 -49.64 158.26 0.47 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.497 2.319 . . . . 0.0 114.24 171.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.71 -33.37 73.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.34 126.51 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.419 1.087 . . . . 0.0 111.008 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -136.05 139.09 42.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.844 1.657 . . . . 0.0 110.255 169.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.95 157.83 39.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.636 1.174 . . . . 0.0 110.871 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -117.6 140.97 48.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.942 1.297 . . . . 0.0 110.571 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -108.63 140.15 42.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.582 1.553 . . . . 0.0 111.469 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.43 60.76 1.02 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.169 1.788 . . . . 0.0 106.495 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -107.64 124.56 50.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.073 2.149 . . . . 0.0 111.167 -167.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -81.27 157.98 24.96 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.324 1.05 . . . . 0.0 112.664 -172.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -95.07 123.81 56.08 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.592 1.157 . . . . 0.0 111.556 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.546 1.102 0 C-N-CA 122.56 2.173 . . . . 0.0 114.862 178.402 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.22 -24.15 66.14 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.144 -0.972 . . . . 0.0 111.365 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -66.38 -32.29 73.58 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.433 -0.792 . . . . 0.0 111.537 169.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.36 -39.18 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.94 -1.1 . . . . 0.0 110.425 173.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -59.03 -47.25 85.91 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.037 1.289 . . . . 0.0 111.289 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -68.23 -22.28 64.79 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.0 m -77.73 -57.34 3.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.97 -34.68 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 -171.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -55.88 -43.24 77.02 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.001 0.819 . . . . 0.0 112.953 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.04 -32.05 61.09 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.766 0.698 . . . . 0.0 112.051 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -68.44 -41.05 80.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.773 -0.84 . . . . 0.0 111.376 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.7 -49.11 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 0.0 110.174 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -54.42 -49.23 70.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.172 0.989 . . . . 0.0 112.202 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -71.57 -28.39 63.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.19 0.904 . . . . 0.0 112.696 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -72.16 -46.13 57.66 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.393 0.677 . . . . 0.0 111.181 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.6 t -58.05 -42.27 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.048 0.939 . . . . 0.0 111.289 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.06 -46.29 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.511 1.051 . . . . 0.0 111.935 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -40.45 95.99 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.58 0.627 . . . . 0.0 110.808 176.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.465 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -57.89 -51.24 70.41 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.215 1.006 . . . . 0.0 110.632 176.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.2 mt -70.6 -45.47 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.11 -26.0 68.05 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.9 pttt -91.21 -7.82 50.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.08 -16.71 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.883 1.673 . . . . 0.0 112.805 -175.782 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.39 138.94 49.55 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.192 0.906 . . . . 0.0 111.627 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -111.31 123.14 49.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.478 1.111 . . . . 0.0 111.161 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -93.21 107.08 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.875 1.67 . . . . 0.0 110.354 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -85.74 128.99 34.94 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.77 118.52 37.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.751 1.22 . . . . 0.0 108.727 169.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.3 136.18 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 0.0 111.163 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 174.263 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 p -65.71 -42.56 90.97 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.8 . . . . 0.0 111.736 169.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -64.14 -43.1 96.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.994 0.518 . . . . 0.0 112.175 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -39.54 91.63 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.454 -0.779 . . . . 0.0 111.874 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.21 -48.42 80.06 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.76 -38.73 75.9 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.597 0.635 . . . . 0.0 111.434 171.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.11 -62.38 6.19 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.106 1.336 . . . . 0.0 112.723 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -58.73 -33.61 70.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.004 1.402 . . . . 0.0 111.498 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.46 -30.36 64.5 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.684 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -73.99 -29.76 62.13 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.354 1.888 . . . . 0.0 112.771 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 m -74.98 -45.64 40.69 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.882 0.765 . . . . 0.0 112.22 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.3 -37.15 12.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.022 0.929 . . . . 0.0 112.588 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.82 2.18 60.44 Favored Glycine 0 N--CA 1.469 0.835 0 C-N-CA 125.527 1.537 . . . . 0.0 114.333 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 113.66 0.76 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.622 1.211 . . . . 0.0 111.724 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.1 19.96 79.79 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -124.0 -41.42 2.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.61 1.705 . . . . 0.0 112.383 -174.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -153.23 168.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.872 2.069 . . . . 0.0 110.424 177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.3 153.95 18.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 109.795 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.04 144.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.14 -0.975 . . . . 0.0 112.945 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -150.43 142.58 24.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.526 1.13 . . . . 0.0 110.721 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -103.52 148.62 25.73 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.188 1.395 . . . . 0.0 112.802 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -154.21 165.48 36.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 111.159 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.92 158.64 27.74 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -55.17 -36.8 66.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 118.124 0.962 . . . . 0.0 113.235 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.69 41.74 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.782 1.633 . . . . 0.0 109.651 169.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t 67.45 168.18 0.25 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.569 2.347 . . . . 0.0 115.983 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -137.92 170.61 15.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.708 2.403 . . . . 0.0 110.029 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -131.04 168.22 17.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -107.82 150.4 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.518 1.527 . . . . 0.0 108.164 169.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -136.92 133.41 18.7 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.888 -1.529 . . . . 0.0 109.94 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -52.98 -36.38 75.38 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.9 2.4 . . . . 0.0 115.139 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.1 m -69.36 -34.25 74.29 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.976 -1.078 . . . . 0.0 111.782 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.56 -13.29 60.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.031 -1.043 . . . . 0.0 113.184 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -77.69 -54.64 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.75 64.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -70.25 -9.84 57.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mmt -122.45 -29.89 4.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.449 1.1 . . . . 0.0 112.261 -169.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.59 -25.56 67.41 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.82 -1.175 . . . . 0.0 112.29 170.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.68 -13.88 62.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.274 1.03 . . . . 0.0 113.746 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.259 4.0 m -114.5 16.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.691 1.196 . . . . 0.0 111.604 168.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.03 73.36 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.036 1.779 . . . . 0.0 116.264 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.16 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.039 1.419 . . . . 0.0 112.05 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -129.16 121.38 27.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.27 3.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.351 1.46 . . . . 0.0 111.906 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -70.25 -34.11 72.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.572 -169.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.22 4.54 82.83 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.474 1.035 . . . . 0.0 114.645 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.78 156.68 26.81 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.08 1.44 . . . . 0.0 113.803 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -156.01 162.0 40.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.726 1.61 . . . . 0.0 110.21 173.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -103.26 172.51 6.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.904 1.281 . . . . 0.0 112.453 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -138.03 159.31 68.94 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.037 1.335 . . . . 0.0 109.981 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.78 138.06 83.57 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.336 2.691 . . . . 0.0 112.879 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 tt -58.1 -31.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.23 -11.13 60.68 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -20.95 57.75 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.246 -0.909 . . . . 0.0 112.642 171.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.28 167.56 11.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.79 1.236 . . . . 0.0 112.837 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.07 112.22 20.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.925 1.69 . . . . 0.0 110.358 175.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.502 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.23 -17.63 64.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.43 -26.06 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.183 0.993 . . . . 0.0 112.474 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.02 -1.3 57.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.913 1.685 . . . . 0.0 112.155 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -118.05 80.15 1.47 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.808 2.043 . . . . 0.0 108.115 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.05 -24.53 17.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.977 1.711 . . . . 0.0 113.186 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -134.28 130.65 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.789 1.635 . . . . 0.0 108.983 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.8 t -134.42 122.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.285 -0.884 . . . . 0.0 110.834 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.51 122.92 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.751 1.62 . . . . 0.0 108.899 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -88.9 144.54 26.13 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.243 1.417 . . . . 0.0 109.994 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.13 27.22 9.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.553 1.141 . . . . 0.0 111.781 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.799 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 121.61 0.719 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -74.58 140.22 75.07 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.076 0.95 . . . . 0.0 112.491 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.95 151.56 83.87 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.151 1.9 . . . . 0.0 109.774 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.89 -21.11 72.9 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.104 2.536 . . . . 0.0 115.463 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.27 -13.19 61.45 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.502 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 95.5 m95 -91.48 -1.85 57.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.21 17.52 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.605 1.562 . . . . 0.0 113.427 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 t -124.64 1.48 8.22 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.095 1.758 . . . . 0.0 113.023 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.472 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.1 mp0 -58.9 163.4 3.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.771 2.829 . . . . 0.0 113.986 176.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.41 -35.62 81.5 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.7 125.9 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.976 0.91 . . . . 0.0 109.985 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -125.59 147.22 49.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.256 1.423 . . . . 0.0 110.715 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -139.33 157.79 45.28 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.39 1.076 . . . . 0.0 112.505 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -135.97 126.65 27.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.764 1.226 . . . . 0.0 108.234 168.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -111.28 132.14 54.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.678 1.591 . . . . 0.0 110.218 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -92.38 64.15 4.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.159 1.383 . . . . 0.0 109.771 -171.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.03 144.82 25.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.569 1.548 . . . . 0.0 114.075 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -93.88 160.4 14.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.596 1.558 . . . . 0.0 111.0 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -106.31 126.39 30.6 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.083 0.953 . . . . 0.0 111.787 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo . . . . . 0 CA--C 1.543 0.952 0 C-N-CA 122.306 2.004 . . . . 0.0 113.64 -178.588 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.693 0.282 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.53 -21.61 64.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.002 -1.061 . . . . 0.0 112.079 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.72 -28.08 67.35 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.232 -0.917 . . . . 0.0 111.244 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.86 -41.19 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.938 -1.101 . . . . 0.0 110.309 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -56.81 -48.45 77.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.946 1.248 . . . . 0.0 111.145 169.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -69.57 -18.73 63.66 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.3 m -82.71 -52.29 6.91 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.183 1.393 . . . . 0.0 111.945 169.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.13 -34.53 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.461 1.105 . . . . 0.0 111.396 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -54.12 -42.57 69.61 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.835 0.743 . . . . 0.0 112.099 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.64 -31.42 65.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.67 0.653 . . . . 0.0 112.913 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.16 -41.18 70.74 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.141 0.971 . . . . 0.0 110.782 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.72 -47.47 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.426 0.69 . . . . 0.0 110.549 169.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.24 -50.4 67.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.922 1.289 . . . . 0.0 112.639 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -70.12 -26.43 63.96 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.787 1.176 . . . . 0.0 112.635 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -72.96 -51.08 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.213 1.005 . . . . 0.0 110.807 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.59 -47.54 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.263 1.025 . . . . 0.0 111.735 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -62.5 -51.75 66.2 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.697 1.135 . . . . 0.0 112.574 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.14 -31.4 68.89 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.125 0.875 . . . . 0.0 111.964 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.12 -50.04 73.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.475 0.71 . . . . 0.0 110.784 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.23 -38.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 121.369 -0.832 . . . . 0.0 111.375 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -25.51 67.2 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -91.23 -11.92 36.78 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.8 pt -114.14 -17.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.254 1.316 0 C-N-CA 125.582 1.553 . . . . 0.0 111.973 172.099 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttm . . . . . 0 N--CA 1.501 2.075 0 CA-C-O 119.786 -0.149 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -71.31 143.44 50.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.183 0.993 . . . . 0.0 112.028 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -110.06 122.84 48.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.71 109.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.532 1.533 . . . . 0.0 110.352 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 ttm -89.63 126.93 35.82 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.586 0.63 . . . . 0.0 109.59 169.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -95.56 124.25 39.49 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.021 1.329 . . . . 0.0 109.343 169.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.9 m -128.13 143.09 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.524 1.13 . . . . 0.0 112.554 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -174.987 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -66.28 -44.14 84.38 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.195 0.907 . . . . 0.0 111.995 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -65.2 -43.97 89.89 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.493 -0.754 . . . . 0.0 111.887 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -39.11 79.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.6 1.16 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.53 92.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.34 -38.46 77.21 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.428 -0.795 . . . . 0.0 110.732 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.73 -58.6 9.94 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.522 1.534 . . . . 0.0 113.943 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 123' ' ' VAL . 44.9 m-85 -65.23 -30.54 71.43 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.969 1.384 . . . . 0.0 111.982 174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.53 -32.82 70.43 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.903 -1.123 . . . . 0.0 113.962 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -70.57 -26.89 63.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 121.315 1.871 . . . . 0.0 112.666 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.5 m -74.91 -46.47 35.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.663 0.785 . . . . 0.0 112.454 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.6 mt -98.75 -29.34 13.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -169.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.18 2.2 87.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.78 1.657 . . . . 0.0 113.229 170.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.13 116.22 1.46 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.406 1.103 . . . . 0.0 112.284 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.78 11.42 84.58 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -119.84 -38.04 3.02 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.16 1.48 . . . . 0.0 111.793 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 pt -148.28 161.68 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.539 1.936 . . . . 0.0 112.001 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.56 147.75 22.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.97 142.86 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.993 -1.067 . . . . 0.0 112.465 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -146.43 153.04 40.0 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 p -128.71 144.02 51.07 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.515 1.126 . . . . 0.0 112.615 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t -155.29 162.27 40.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.282 1.433 . . . . 0.0 110.268 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.37 154.36 20.31 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.04 -1.038 . . . . 0.0 111.403 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.05 -40.27 97.2 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.067 -1.255 . . . . 0.0 111.519 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -111.17 34.23 4.18 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.654 1.582 . . . . 0.0 109.625 169.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 t 71.44 170.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.546 1.938 . . . . 0.0 111.357 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.5 p -149.41 -162.52 1.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.598 1.559 . . . . 0.0 110.294 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -155.35 174.88 14.6 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.683 -1.261 . . . . 0.0 114.388 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.39 154.14 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -127.78 130.83 23.6 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.174 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -54.78 -39.61 88.87 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.991 2.461 . . . . 0.0 114.503 -173.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -67.56 -31.69 71.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.11 -10.33 59.33 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.678 -1.263 . . . . 0.0 113.127 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.6 -57.77 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.13 79.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 75.4 mmm -73.97 -8.5 56.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.1 mmt -118.15 -25.91 6.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.086 1.355 . . . . 0.0 111.76 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.9 -30.61 67.93 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.986 -1.071 . . . . 0.0 111.783 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.91 -11.08 60.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 t -100.9 3.03 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 126.606 1.962 . . . . 0.0 110.477 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.75 12.25 81.74 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.383 1.468 . . . . 0.0 114.848 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -87.45 148.12 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 118.494 1.147 . . . . 0.0 111.197 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -132.46 101.11 5.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.462 1.505 . . . . 0.0 111.21 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.4 pt -125.38 -4.13 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.3 p -63.94 -27.02 68.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.609 1.095 . . . . 0.0 113.546 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.39 -5.25 89.73 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.877 1.227 . . . . 0.0 115.311 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -78.47 157.93 28.79 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.522 1.661 . . . . 0.0 113.374 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -134.41 -177.61 4.68 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.858 2.063 . . . . 0.0 110.887 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 t -151.07 161.44 42.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.29 1.036 . . . . 0.0 112.047 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -147.6 160.01 39.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.173 1.789 . . . . 0.0 109.671 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.85 133.99 54.26 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.347 2.698 . . . . 0.0 111.955 174.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.47 -32.32 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -9.63 51.36 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -22.03 59.15 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.167 0.894 . . . . 0.0 112.605 170.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.88 171.57 8.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.851 1.261 . . . . 0.0 112.8 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.49 113.96 21.56 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.574 1.55 . . . . 0.0 111.074 176.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.14 -11.73 59.66 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.706 -1.247 . . . . 0.0 113.857 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.15 -20.88 57.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.838 1.255 . . . . 0.0 112.98 174.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -103.25 -0.63 30.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.117 1.767 . . . . 0.0 113.166 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -125.26 77.5 1.64 Allowed 'General case' 0 C--N 1.345 0.406 0 C-N-CA 125.799 1.639 . . . . 0.0 109.206 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.99 -23.57 13.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.085 2.154 . . . . 0.0 113.488 -175.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.74 133.81 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.768 1.627 . . . . 0.0 108.186 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.57 122.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.988 -1.07 . . . . 0.0 110.353 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.63 118.05 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 108.167 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -88.64 154.91 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.083 0.953 . . . . 0.0 109.856 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.07 46.59 2.48 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.079 1.351 . . . . 0.0 110.852 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t . . . . . 0 CA--C 1.544 0.72 0 C-N-CA 125.394 1.478 . . . . 0.0 111.868 179.253 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.1 t30 . . . . . 0 CA--C 1.548 0.867 0 CA-C-O 121.571 0.7 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -87.4 146.3 39.46 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -65.68 154.3 74.41 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 122.824 2.349 . . . . 0.0 110.153 168.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.72 -35.55 98.76 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.51 2.14 . . . . 0.0 115.668 -169.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.57 -23.76 67.18 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.086 -1.009 . . . . 0.0 113.355 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.4 -7.57 58.88 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.17 -22.82 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.25 1.42 . . . . 0.0 113.411 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -83.16 11.9 5.86 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.782 1.633 . . . . 0.0 113.508 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.65 165.92 11.65 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.767 1.627 . . . . 0.0 112.603 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.29 -36.51 83.91 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.659 -0.651 . . . . 0.0 112.726 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.7 130.0 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.861 0.865 . . . . 0.0 110.119 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -134.89 150.6 50.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.134 1.373 . . . . 0.0 111.873 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -141.74 158.04 44.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -139.63 81.17 1.81 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.668 0.787 . . . . 0.0 111.218 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -66.47 149.5 50.34 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.126 1.771 . . . . 0.0 113.127 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -114.04 60.6 0.67 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.339 1.856 . . . . 0.0 107.858 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -100.57 134.68 43.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.169 2.187 . . . . 0.0 112.527 -168.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.44 140.24 56.36 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.335 1.854 . . . . 0.0 112.644 -173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -93.04 112.06 54.39 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 CA--C 1.542 0.905 0 C-N-CA 122.471 2.114 . . . . 0.0 113.496 -178.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.373 0.606 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.02 -24.97 66.86 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.164 -0.96 . . . . 0.0 111.676 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.84 -28.33 69.49 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.161 -0.962 . . . . 0.0 111.796 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 -39.92 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.463 -1.398 . . . . 0.0 109.484 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -63.18 -36.55 84.01 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.433 1.015 . . . . 0.0 112.166 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -77.57 -20.8 53.47 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.125 -1.609 . . . . 0.0 113.827 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.3 m -91.73 -39.58 11.73 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.967 0.907 . . . . 0.0 111.63 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.8 p -59.27 -42.7 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 120.404 -1.435 . . . . 0.0 111.797 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -59.83 -43.34 94.63 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -32.05 65.51 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.849 -0.532 . . . . 0.0 112.828 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.37 -39.14 81.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.888 0.844 . . . . 0.0 112.064 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.64 -51.47 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.58 0.752 . . . . 0.0 109.91 169.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -57.19 -47.0 82.35 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.359 1.064 . . . . 0.0 112.61 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -68.73 -27.06 65.6 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.773 1.624 . . . . 0.0 112.531 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -73.16 -51.43 17.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 111.655 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 21' ' ' PHE . 34.4 m -59.52 -41.05 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.115 0.871 . . . . 0.0 112.761 169.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.84 -50.32 69.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.701 1.591 . . . . 0.0 112.389 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -70.61 -30.0 66.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.905 0.775 . . . . 0.0 112.063 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -50.0 70.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.698 0.799 . . . . 0.0 110.815 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -69.78 -41.17 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.274 -0.891 . . . . 0.0 110.705 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.65 -26.38 68.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.31 -14.79 34.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.9 pt -111.58 -18.3 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.543 1.137 . . . . 0.0 113.154 179.058 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -71.56 140.85 50.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.779 0.832 . . . . 0.0 111.851 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -111.09 126.46 54.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.325 1.05 . . . . 0.0 111.28 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.12 107.63 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.208 1.803 . . . . 0.0 109.826 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -87.64 127.9 35.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.141 0.428 . . . . 0.0 109.989 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.11 114.71 28.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.5 1.12 . . . . 0.0 109.69 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -111.46 136.26 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.699 1.2 . . . . 0.0 112.524 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.474 0.744 0 O-C-N 121.206 -0.934 . . . . 0.0 112.577 178.644 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -62.3 -46.17 89.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.298 1.039 . . . . 0.0 111.621 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.04 -40.4 78.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.554 1.142 . . . . 0.0 111.979 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.7 mmm -68.6 -36.91 79.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.436 -0.79 . . . . 0.0 112.745 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.68 95.89 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.001 0.819 . . . . 0.0 111.451 173.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -60.46 -39.75 88.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.899 0.772 . . . . 0.0 111.323 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.55 -60.96 7.53 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.975 1.274 . . . . 0.0 112.894 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -60.31 -34.01 73.19 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.554 1.177 . . . . 0.0 111.734 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.12 -27.16 61.52 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 117.839 -1.077 . . . . 0.0 113.884 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -75.42 -28.66 59.47 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.295 1.861 . . . . 0.0 112.656 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -76.05 -45.99 31.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.623 0.769 . . . . 0.0 112.267 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.16 -30.36 12.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.436 1.094 . . . . 0.0 113.267 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.0 4.98 81.51 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.94 1.733 . . . . 0.0 113.692 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.69 109.33 0.19 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.553 1.176 . . . . 0.0 112.813 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.61 19.41 79.7 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -118.48 -37.2 3.35 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.079 1.439 . . . . 0.0 112.08 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -152.28 166.58 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.051 2.541 . . . . 0.0 109.82 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.57 151.27 21.39 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.385 0.674 . . . . 0.0 109.737 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 142.1 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.039 -1.038 . . . . 0.0 112.666 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 m -149.28 154.91 39.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.92 1.288 . . . . 0.0 110.578 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 p -127.11 145.61 50.68 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.61 1.164 . . . . 0.0 112.598 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -148.46 146.5 28.42 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.859 1.264 . . . . 0.0 111.243 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.87 143.05 17.64 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.5 -38.57 66.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.587 1.694 . . . . 0.0 112.604 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -122.74 45.44 2.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.789 1.635 . . . . 0.0 110.307 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.2 p 68.99 143.62 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.434 3.094 . . . . 0.0 116.776 -170.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -107.69 171.39 7.42 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.644 2.378 . . . . 0.0 111.566 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -141.3 144.17 34.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.916 1.286 . . . . 0.0 112.496 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.26 152.73 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.093 1.757 . . . . 0.0 110.75 171.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.48 149.82 68.62 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.522 1.129 . . . . 0.0 111.776 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.08 -35.83 74.02 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.404 2.736 . . . . 0.0 114.224 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -63.54 -39.39 94.29 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.492 -0.755 . . . . 0.0 112.006 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.72 -20.57 61.18 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.171 -0.956 . . . . 0.0 112.808 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.94 -54.26 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.14 67.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -170.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -69.72 -9.67 55.34 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 mmt -125.85 -28.89 3.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.309 1.044 . . . . 0.0 112.499 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.28 -24.85 67.52 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.868 -1.145 . . . . 0.0 112.101 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.35 -13.68 62.45 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.74 15.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.974 1.31 . . . . 0.0 111.641 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.94 10.94 71.14 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.957 1.742 . . . . 0.0 116.176 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -84.9 146.76 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.404 1.602 . . . . 0.0 111.958 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -116.13 129.34 56.28 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.79 1.636 . . . . 0.0 111.96 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.0 pt -135.29 -8.94 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.943 1.297 . . . . 0.0 113.707 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -60.29 -30.64 69.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.869 1.268 . . . . 0.0 114.094 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.33 1.9 84.66 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.76 1.171 . . . . 0.0 115.353 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -77.56 156.75 30.7 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.77 1.785 . . . . 0.0 112.674 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.3 p -133.25 175.43 9.41 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.564 1.946 . . . . 0.0 110.231 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -155.91 155.55 33.04 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -148.45 159.2 39.48 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.231 2.212 . . . . 0.0 109.472 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -55.38 143.11 78.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.389 2.726 . . . . 0.0 113.127 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.74 -31.49 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -169.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -13.7 60.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -20.01 58.53 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 119.084 0.856 . . . . 0.0 112.926 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -96.33 164.35 12.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.943 1.297 . . . . 0.0 112.625 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.11 109.71 19.24 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 111.348 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.88 -22.06 65.99 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.24 -25.61 68.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.696 1.198 . . . . 0.0 112.834 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.15 -3.07 58.74 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.993 1.717 . . . . 0.0 112.103 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -116.17 82.26 1.75 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.887 2.075 . . . . 0.0 108.428 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -25.52 21.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.835 1.654 . . . . 0.0 113.079 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.6 t -132.97 129.78 57.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.079 1.752 . . . . 0.0 109.085 -176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.61 120.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.196 -0.94 . . . . 0.0 110.719 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.51 120.46 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.169 1.388 . . . . 0.0 108.159 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -86.02 150.29 24.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.42 1.088 . . . . 0.0 109.721 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.83 44.09 3.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.082 1.353 . . . . 0.0 110.522 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.983 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.0 mt -140.26 133.81 15.2 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.388 1.475 . . . . 0.0 111.027 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -60.39 152.27 68.5 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.293 1.995 . . . . 0.0 110.243 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.13 -21.84 73.17 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.035 2.49 . . . . 0.0 114.912 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -15.56 62.73 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.6 m95 -90.26 -3.16 57.98 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.15 13.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.674 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -118.12 -1.2 11.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.493 1.917 . . . . 0.0 112.775 -171.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.434 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.4 mp0 -56.05 159.67 3.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.587 2.755 . . . . 0.0 113.89 175.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.28 -34.98 79.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.22 129.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.172 0.989 . . . . 0.0 110.368 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -130.62 148.19 52.39 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.423 1.489 . . . . 0.0 111.29 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -142.0 161.75 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.759 1.224 . . . . 0.0 112.554 176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.08 124.24 21.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.85 1.26 . . . . 0.0 109.102 168.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -110.85 160.32 16.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.206 1.802 . . . . 0.0 112.4 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -122.79 50.6 1.5 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.475 1.51 . . . . 0.0 112.333 -168.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.19 137.52 36.7 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.229 -0.92 . . . . 0.0 112.636 -172.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 146.5 52.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.863 1.265 . . . . 0.0 108.556 169.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.46 119.22 65.66 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.95 0.9 . . . . 0.0 111.024 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 C-N-CA 122.143 1.895 . . . . 0.0 113.447 -177.317 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.043 0.449 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.91 -30.09 70.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.47 1.108 . . . . 0.0 111.646 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.98 -21.42 63.24 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.671 -1.268 . . . . 0.0 113.12 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.7 t -71.2 -40.52 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 120.36 -1.463 . . . . 0.0 110.102 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -56.83 -46.68 81.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.571 1.078 . . . . 0.0 110.826 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -68.77 -17.86 64.11 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.8 m -87.67 -43.47 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.912 1.285 . . . . 0.0 112.236 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -66.76 -38.74 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.703 -1.248 . . . . 0.0 111.501 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -57.46 -40.2 77.97 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.34 64.94 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.431 0.539 . . . . 0.0 112.881 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -68.76 -43.59 75.49 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.957 -0.731 . . . . 0.0 110.978 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.5 t -58.81 -47.49 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.747 -0.596 . . . . 0.0 110.414 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -57.12 -50.71 71.97 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.678 1.191 . . . . 0.0 112.422 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.19 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.878 1.217 . . . . 0.0 112.794 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -68.42 -50.72 50.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.472 0.709 . . . . 0.0 110.924 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.34 -48.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.646 1.178 . . . . 0.0 112.174 169.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -62.52 -50.82 69.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.832 1.196 . . . . 0.0 112.475 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -30.19 67.43 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.772 0.715 . . . . 0.0 111.899 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.43 -50.82 68.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.697 0.799 . . . . 0.0 110.613 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -70.74 -39.98 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.22 0.918 . . . . 0.0 111.165 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 -20.6 60.84 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -97.64 -10.9 24.25 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -113.55 -17.64 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 126.21 1.804 . . . . 0.0 112.499 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -71.42 144.07 49.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.063 0.945 . . . . 0.0 111.702 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.18 128.39 55.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.109 0.964 . . . . 0.0 111.284 170.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.66 118.33 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.249 1.819 . . . . 0.0 110.221 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.2 tpp -96.95 122.7 40.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -95.56 114.95 26.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.421 0.689 . . . . 0.0 110.438 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.91 147.06 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.45 1.1 . . . . 0.0 113.46 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.63 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.536 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.1 p -71.99 -40.44 68.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.535 1.061 . . . . 0.0 112.83 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.31 -32.15 71.1 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.91 0.777 . . . . 0.0 111.145 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -43.18 80.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.04 1.291 . . . . 0.0 112.378 169.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -43.52 97.02 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.266 0.485 . . . . 0.0 110.922 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.76 -43.71 97.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.817 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -44.86 96.67 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 119.805 1.184 . . . . 0.0 113.79 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.93 -37.9 76.03 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.444 -1.033 . . . . 0.0 111.14 171.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.47 -34.2 65.24 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.697 -1.252 . . . . 0.0 113.67 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.86 -22.52 64.21 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.908 1.231 . . . . 0.0 112.63 171.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 m -88.8 -46.88 8.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.814 1.246 . . . . 0.0 112.262 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.62 -33.45 12.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 112.886 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 5.76 77.67 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.939 1.733 . . . . 0.0 113.059 170.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.38 120.62 4.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.349 1.075 . . . . 0.0 111.433 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.95 77.88 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -110.42 -40.82 4.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.339 1.455 . . . . 0.0 111.045 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -148.6 159.35 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 112.762 -171.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.61 151.27 19.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.122 1.369 . . . . 0.0 107.53 168.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 t -139.9 139.88 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 120.89 -1.131 . . . . 0.0 112.177 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -141.6 154.68 45.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.677 1.591 . . . . 0.0 109.865 170.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.3 p -124.11 152.35 42.86 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.084 -1.01 . . . . 0.0 112.126 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 t -151.01 124.54 8.98 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.433 0.693 . . . . 0.0 112.717 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.24 127.14 8.64 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.98 -35.12 23.24 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -169.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -123.0 34.56 5.1 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.234 1.414 . . . . 0.0 112.605 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 p 66.99 161.83 0.17 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 127.759 2.423 . . . . 0.0 115.499 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -161.58 -163.52 1.0 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.165 1.386 . . . . 0.0 111.528 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -133.16 173.25 11.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.241 1.817 . . . . 0.0 113.21 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 t -85.55 167.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -129.43 125.71 22.59 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 120.337 -1.477 . . . . 0.0 111.714 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -55.79 -40.17 86.76 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.176 2.584 . . . . 0.0 114.651 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -64.42 -30.32 71.36 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.117 -0.989 . . . . 0.0 111.859 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.36 -5.43 52.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.3 mt -86.14 -57.05 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 168.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.11 75.34 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -170.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.4 -9.34 58.0 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 mmt -119.12 -27.85 5.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.127 0.971 . . . . 0.0 112.34 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.92 -30.38 65.87 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.786 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.8 -10.64 59.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.811 1.244 . . . . 0.0 113.923 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 8.5 p -121.77 24.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.932 1.693 . . . . 0.0 110.829 169.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.6 83.46 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.211 1.863 . . . . 0.0 116.63 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.22 147.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.789 1.295 . . . . 0.0 111.76 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -131.63 107.82 9.09 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.191 1.796 . . . . 0.0 110.597 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 pt -140.22 15.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 p -60.05 -27.64 67.11 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.698 -1.251 . . . . 0.0 113.825 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.08 9.22 39.36 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.161 1.362 . . . . 0.0 116.153 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -65.09 -50.58 65.55 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.264 2.032 . . . . 0.0 114.203 -169.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p 58.71 167.27 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.245 1.818 . . . . 0.0 114.38 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -144.63 131.15 19.87 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.027 -1.046 . . . . 0.0 112.166 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -132.53 158.61 75.23 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.001 1.721 . . . . 0.0 112.289 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.06 145.14 89.18 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.478 2.785 . . . . 0.0 113.524 -170.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.52 -34.23 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -169.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.52 -7.0 50.07 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -20.47 55.79 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.294 -0.879 . . . . 0.0 112.133 169.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -94.99 170.21 9.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.182 1.393 . . . . 0.0 112.264 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.22 111.69 18.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.974 1.71 . . . . 0.0 110.535 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -65.46 -23.05 66.82 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -169.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.29 -25.14 67.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.92 0.888 . . . . 0.0 112.758 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.73 -2.75 58.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.224 1.81 . . . . 0.0 111.946 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.9 84.65 2.11 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.117 2.167 . . . . 0.0 108.022 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.86 -28.05 8.73 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.055 1.742 . . . . 0.0 112.725 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.56 130.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.832 1.653 . . . . 0.0 109.003 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.1 t -131.5 126.99 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.297 -0.877 . . . . 0.0 109.097 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -126.2 124.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.464 1.106 . . . . 0.0 108.904 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -99.35 156.4 17.02 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.113 0.965 . . . . 0.0 111.599 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.24 52.88 2.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 110.937 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.3 m . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 125.26 1.424 . . . . 0.0 114.763 -170.758 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.63 138.63 20.42 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.119 0.967 . . . . 0.0 112.914 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.99 151.76 82.97 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.483 2.122 . . . . 0.0 109.896 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -57.57 -29.97 86.9 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 115.255 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.73 -19.58 65.95 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.8 m95 -89.77 -3.45 58.15 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.75 -12.83 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -88.52 5.5 42.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.696 1.599 . . . . 0.0 113.765 -171.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.438 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.0 mp0 -59.23 160.43 6.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.146 2.179 . . . . 0.0 113.878 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.98 -33.24 75.28 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 127.06 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.834 0.854 . . . . 0.0 110.36 169.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -138.28 141.43 39.85 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.777 1.631 . . . . 0.0 111.127 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.96 162.44 38.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.405 1.482 . . . . 0.0 110.72 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -128.85 124.67 35.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.571 1.148 . . . . 0.0 111.581 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -102.89 161.67 13.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.197 1.799 . . . . 0.0 113.091 -172.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -95.64 -82.06 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.528 1.131 . . . . 0.0 111.496 -170.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 55.09 156.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.3 2.64 . . . . 0.0 115.853 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -90.25 178.05 6.26 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -117.74 117.84 35.46 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.462 -1.399 . . . . 0.0 111.209 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 C-N-CA 121.449 1.433 . . . . 0.0 113.261 179.798 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -58.48 -32.9 69.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.353 1.461 . . . . 0.0 111.295 176.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.19 -29.62 70.45 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 0.0 112.374 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.5 t -72.34 -42.21 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.907 -1.12 . . . . 0.0 110.263 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -58.8 -48.16 82.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.331 0.969 . . . . 0.0 111.56 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -69.83 -20.61 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.7 m -78.88 -56.01 4.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.591 1.156 . . . . 0.0 110.925 169.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.19 -35.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 0.0 111.387 -171.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.77 -42.77 72.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.828 0.74 . . . . 0.0 112.84 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.03 -34.75 61.55 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.808 0.718 . . . . 0.0 112.712 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -70.39 -41.47 72.97 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.457 0.629 . . . . 0.0 110.588 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.64 -45.82 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.651 -0.655 . . . . 0.0 110.975 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -55.28 -50.08 70.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.163 0.985 . . . . 0.0 111.788 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.29 -29.44 66.18 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.862 1.21 . . . . 0.0 113.013 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -68.6 -49.85 56.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.453 0.701 . . . . 0.0 111.196 173.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.64 -41.31 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.833 1.253 . . . . 0.0 111.731 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -62.04 -47.27 85.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.529 1.059 . . . . 0.0 112.131 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -38.77 92.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.553 0.615 . . . . 0.0 111.092 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.48 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.7 tm? -59.25 -53.52 57.38 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.5 1.12 . . . . 0.0 110.598 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.82 -42.34 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 118.754 0.706 . . . . 0.0 111.384 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.15 70.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -90.89 -20.1 22.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.4 -24.93 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 124.919 1.288 . . . . 0.0 114.273 -169.637 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 tpp . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.656 -0.211 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -68.9 135.5 51.13 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.668 1.187 . . . . 0.0 112.467 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -108.96 128.24 54.76 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.942 0.897 . . . . 0.0 111.862 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.31 120.69 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.871 1.668 . . . . 0.0 110.051 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.5 tpp -99.62 126.84 45.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -98.4 123.44 42.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.223 0.609 . . . . 0.0 111.197 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 m -125.84 141.64 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.22 1.008 . . . . 0.0 113.004 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t -153.56 -174.48 4.97 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 121.404 -0.81 . . . . 0.0 112.357 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -72.23 164.99 25.32 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.085 1.754 . . . . 0.0 112.509 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.74 -47.36 70.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.795 1.638 . . . . 0.0 115.188 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -92.31 5.81 49.18 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.1 m -85.75 151.64 23.68 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.083 1.353 . . . . 0.0 113.315 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.9 p -111.89 -11.89 13.84 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.492 1.117 . . . . 0.0 113.605 169.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -62.0 -24.13 66.85 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.249 -1.532 . . . . 0.0 114.407 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.2 p -66.4 -48.06 71.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.124 1.329 . . . . 0.0 111.232 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.77 -39.07 93.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.298 1.439 . . . . 0.0 111.719 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -40.53 77.15 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.944 1.297 . . . . 0.0 112.018 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.97 95.46 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.651 -0.656 . . . . 0.0 112.427 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -58.79 -41.08 85.86 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.789 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.7 -52.82 45.81 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.484 1.038 . . . . 0.0 113.25 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -65.3 -41.16 94.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.083 -1.246 . . . . 0.0 111.801 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.27 87.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -73.17 -20.93 60.8 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.536 1.062 . . . . 0.0 113.028 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -87.92 -44.84 10.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.225 1.01 . . . . 0.0 112.187 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.02 -37.58 10.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.213 1.005 . . . . 0.0 112.819 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.94 6.96 68.1 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.653 1.597 . . . . 0.0 113.99 170.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.27 -43.4 4.86 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.5 16.18 48.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.583 1.563 . . . . 0.0 114.651 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.09 -34.08 3.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.034 1.333 . . . . 0.0 112.477 -169.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -152.98 165.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.678 1.591 . . . . 0.0 113.149 -173.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.77 153.77 17.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 167.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.19 143.73 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.278 -1.514 . . . . 0.0 114.615 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -142.82 168.07 20.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.473 1.909 . . . . 0.0 108.933 169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -140.49 153.7 46.32 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.859 -1.15 . . . . 0.0 112.167 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 p -153.82 -175.27 5.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.525 1.13 . . . . 0.0 110.186 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.14 166.53 26.68 Favored Glycine 0 N--CA 1.471 1.016 0 O-C-N 120.836 -1.165 . . . . 0.0 113.15 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.09 -38.34 85.94 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 122.013 -0.698 . . . . 0.0 112.076 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.21 40.6 3.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.125 1.77 . . . . 0.0 109.135 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t 73.84 178.09 0.23 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.661 2.384 . . . . 0.0 113.71 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.6 p -144.84 174.75 10.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.348 2.259 . . . . 0.0 110.935 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.4 ptt85 -140.37 158.45 44.0 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.16 156.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -135.15 131.05 19.57 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-O 117.38 -1.295 . . . . 0.0 111.386 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -55.46 -39.52 90.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.131 2.554 . . . . 0.0 114.721 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -67.65 -30.38 69.92 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.041 -1.037 . . . . 0.0 111.784 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.25 -10.14 59.19 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.824 -1.172 . . . . 0.0 113.432 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.74 -55.04 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.19 62.8 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -170.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -73.57 -9.69 58.94 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.2 mmt -121.79 -28.47 4.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.502 1.121 . . . . 0.0 112.311 -171.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -21.56 66.73 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.135 -0.978 . . . . 0.0 112.895 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.34 -11.09 60.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.4 1.08 . . . . 0.0 113.28 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -102.64 0.63 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 126.86 2.064 . . . . 0.0 110.452 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.71 13.77 79.2 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.143 1.354 . . . . 0.0 114.474 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mm -87.58 152.39 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.449 1.099 . . . . 0.0 110.96 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -127.68 137.33 52.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.975 1.31 . . . . 0.0 111.429 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 pt -139.56 -7.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.402 1.081 . . . . 0.0 113.551 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -57.22 -35.07 69.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.836 1.654 . . . . 0.0 114.973 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.78 -3.17 88.28 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.366 0.984 . . . . 0.0 115.293 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -78.76 157.96 28.36 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.037 1.418 . . . . 0.0 113.707 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -132.74 175.27 9.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.024 2.13 . . . . 0.0 111.287 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.4 t -154.09 156.48 37.34 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.164 0.985 . . . . 0.0 112.775 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -142.59 161.8 47.72 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.643 1.977 . . . . 0.0 108.598 169.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.99 135.64 70.04 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.844 2.363 . . . . 0.0 112.577 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 tt -53.85 -33.33 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.36 -12.28 61.47 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.86 59.0 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.114 0.87 . . . . 0.0 112.309 169.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.11 171.95 8.75 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.15 1.38 . . . . 0.0 112.07 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -98.11 -17.12 19.25 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -168.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.531 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . 60.15 -29.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.085 2.954 . . . . 0.0 116.947 -170.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.75 -36.25 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 113.07 -169.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -81.58 -0.7 43.47 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.143 2.177 . . . . 0.0 111.909 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -112.25 77.83 1.08 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.714 2.006 . . . . 0.0 108.442 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.98 -24.17 8.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.07 1.748 . . . . 0.0 113.236 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.8 t -133.07 130.19 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.072 1.749 . . . . 0.0 108.778 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.1 t -134.78 121.61 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.661 -1.274 . . . . 0.0 110.29 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.58 120.22 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.072 1.349 . . . . 0.0 108.345 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.6 t -89.16 157.04 18.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.852 1.261 . . . . 0.0 109.667 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.46 43.19 3.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.442 1.097 . . . . 0.0 111.563 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.9 m -108.15 -28.93 9.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.878 1.271 . . . . 0.0 112.151 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.47 100.36 1.06 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.985 1.755 . . . . 0.0 113.666 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 67.8 m 49.17 34.02 5.56 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.65 1.58 . . . . 0.0 114.647 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.03 105.18 0.18 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.758 1.171 . . . . 0.0 112.464 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 p -142.38 143.76 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.266 1.426 . . . . 0.0 111.15 174.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -89.35 114.25 25.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.435 0.694 . . . . 0.0 109.627 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.3 mt -142.41 138.0 16.04 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.47 1.108 . . . . 0.0 112.951 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -62.6 149.55 90.7 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.681 2.254 . . . . 0.0 110.664 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.83 -34.26 84.53 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.13 2.553 . . . . 0.0 115.121 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -63.04 -20.39 65.28 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.531 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 94.2 m95 -88.61 -6.34 57.58 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.32 1.448 . . . . 0.0 114.619 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.7 m -117.26 -20.81 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -76.6 -1.67 28.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.998 1.719 . . . . 0.0 114.243 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -49.88 155.98 0.8 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.031 2.532 . . . . 0.0 114.547 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.24 -34.1 73.21 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.61 128.5 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.63 1.172 . . . . 0.0 109.344 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.14 147.79 50.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.213 1.405 . . . . 0.0 111.239 171.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -141.77 159.49 42.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.045 1.338 . . . . 0.0 111.289 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -141.26 87.41 2.08 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.824 0.85 . . . . 0.0 110.318 169.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -67.29 140.74 57.34 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.307 1.443 . . . . 0.0 113.477 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -91.17 55.25 2.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.959 2.104 . . . . 0.0 107.607 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.65 125.12 49.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.635 1.974 . . . . 0.0 111.117 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.45 162.19 22.18 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.541 1.536 . . . . 0.0 112.382 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.04 128.75 42.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 O-C-N 121.5 -0.75 . . . . 0.0 111.076 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.23 -12.56 19.14 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.84 1.693 . . . . 0.0 112.55 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -49.41 126.72 13.78 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.462 1.028 . . . . 0.0 112.705 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.01 0.04 59.57 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 115.623 1.009 . . . . 0.0 115.623 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -101.74 -174.85 2.69 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.239 1.416 . . . . 0.0 112.29 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 t -76.3 156.58 33.3 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.481 0.712 . . . . 0.0 111.94 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.3 -25.49 68.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.929 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.0 -30.45 71.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.301 -0.874 . . . . 0.0 111.571 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -73.37 -40.88 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 120.91 -1.119 . . . . 0.0 110.541 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -57.23 -48.49 78.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.034 1.288 . . . . 0.0 111.275 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -69.36 -18.94 63.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.1 m -82.06 -55.55 4.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.838 1.255 . . . . 0.0 111.541 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.57 -29.57 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.093 0.957 . . . . 0.0 111.675 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -55.62 -42.75 75.38 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.533 1.06 . . . . 0.0 113.37 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 -32.38 62.89 Favored Glycine 0 N--CA 1.472 1.038 0 O-C-N 121.905 -0.497 . . . . 0.0 112.507 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.97 -39.01 83.43 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.95 -0.735 . . . . 0.0 111.43 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.37 -48.79 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 110.183 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.26 -48.85 70.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.009 0.924 . . . . 0.0 112.069 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -71.32 -28.58 64.19 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.887 1.221 . . . . 0.0 112.936 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -70.11 -49.72 47.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.783 0.833 . . . . 0.0 110.639 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.2 t -55.03 -49.35 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.499 1.12 . . . . 0.0 111.358 169.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.66 -51.46 65.06 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.409 1.004 . . . . 0.0 112.487 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.77 -30.88 68.56 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.832 0.742 . . . . 0.0 112.056 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.69 -50.5 66.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.541 0.737 . . . . 0.0 110.877 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.42 -37.82 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.028 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -26.67 68.89 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -85.17 -13.01 51.4 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 174.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -109.32 -25.38 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.911 1.684 . . . . 0.0 112.104 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 119.767 -0.158 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -70.32 141.02 52.36 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.069 0.948 . . . . 0.0 111.447 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -109.5 126.36 53.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.161 0.984 . . . . 0.0 111.6 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.9 t -96.98 111.67 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.947 1.699 . . . . 0.0 110.354 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.2 tpp -90.82 127.45 36.36 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.47 122.23 43.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.235 1.014 . . . . 0.0 111.124 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.96 142.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.1 t -157.33 174.75 14.96 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 112.425 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.88 159.65 19.24 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.962 1.305 . . . . 0.0 112.523 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -55.39 -45.46 76.63 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -169.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -82.65 -16.64 47.51 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 m -76.25 152.48 36.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.807 1.243 . . . . 0.0 113.338 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.0 p -111.11 -7.4 14.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -49.98 -37.19 31.25 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 120.959 1.709 . . . . 0.0 113.52 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -62.93 -50.96 68.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.255 1.389 . . . . 0.0 112.692 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -62.06 -38.53 89.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.255 1.022 . . . . 0.0 111.552 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.406 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 7.2 tpt -74.87 -39.26 61.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.004 0.922 . . . . 0.0 112.336 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.91 88.47 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.407 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -58.15 -49.5 76.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.492 169.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.53 -47.54 63.14 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 121.0 1.727 . . . . 0.0 114.409 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -67.28 -42.95 82.96 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.018 -1.283 . . . . 0.0 112.032 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.63 -31.59 69.78 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.981 -1.074 . . . . 0.0 113.338 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -65.14 -29.39 70.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 128.876 2.871 . . . . 0.0 112.751 172.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -90.49 -45.47 8.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.836 0.855 . . . . 0.0 112.102 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.03 -31.83 13.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.265 1.026 . . . . 0.0 113.345 -170.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.22 1.6 88.42 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.421 1.486 . . . . 0.0 114.166 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.78 117.56 2.57 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 118.453 1.126 . . . . 0.0 111.403 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.3 15.58 81.09 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.91 -40.03 2.34 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.075 1.437 . . . . 0.0 111.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.25 164.39 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.831 1.652 . . . . 0.0 111.553 170.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 153.96 19.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.94 0.896 . . . . 0.0 108.804 169.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.52 147.56 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 m -152.1 160.89 43.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.994 1.718 . . . . 0.0 108.83 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.3 p -135.05 154.91 51.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.211 -0.931 . . . . 0.0 112.68 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 t -150.76 129.63 12.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.044 0.938 . . . . 0.0 110.276 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.94 141.49 20.14 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 169.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.02 -34.55 63.58 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.038 1.419 . . . . 0.0 112.482 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.95 41.45 3.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.958 1.703 . . . . 0.0 110.956 169.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 t 72.69 168.66 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.627 1.971 . . . . 0.0 112.894 -168.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 77.6 p -158.1 172.16 18.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.724 1.61 . . . . 0.0 112.372 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -126.14 162.94 24.21 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.316 1.446 . . . . 0.0 114.506 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.0 m -121.89 116.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.691 1.596 . . . . 0.0 109.739 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.16 148.32 44.69 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.794 0.838 . . . . 0.0 111.398 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.5 -35.76 77.47 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.291 2.661 . . . . 0.0 113.852 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.0 m -61.19 -38.4 86.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.748 0.819 . . . . 0.0 112.061 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.49 60.94 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.078 -1.014 . . . . 0.0 113.357 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.47 -54.9 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.69 -33.31 72.36 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -71.17 -7.71 48.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.217 1.007 . . . . 0.0 113.604 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.406 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 15.8 mmt -125.34 -27.24 3.5 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.59 1.156 . . . . 0.0 112.021 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.95 -27.39 66.76 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.064 -1.023 . . . . 0.0 112.139 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.37 -5.43 42.31 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.148 0.979 . . . . 0.0 113.041 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 t -108.99 3.14 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.622 2.369 . . . . 0.0 110.541 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.87 13.8 81.74 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 125.393 1.473 . . . . 0.0 114.667 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.95 151.57 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -133.17 135.05 44.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.698 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 pt -128.74 1.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.726 1.61 . . . . 0.0 112.465 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.9 p -65.48 -30.72 71.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.629 1.172 . . . . 0.0 113.769 -169.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.64 -0.42 89.24 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.431 1.015 . . . . 0.0 114.976 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -81.81 151.82 27.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.397 1.598 . . . . 0.0 112.697 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.7 p -124.94 176.02 6.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.353 1.861 . . . . 0.0 111.088 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -152.66 156.1 38.56 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 112.593 173.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -153.54 160.45 30.93 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.76 2.024 . . . . 0.0 109.272 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.35 140.07 87.76 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.341 2.694 . . . . 0.0 112.485 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.94 -30.41 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -11.9 60.39 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -21.51 56.23 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.061 0.846 . . . . 0.0 112.935 171.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -93.14 166.49 12.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.645 1.178 . . . . 0.0 112.805 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.19 109.02 17.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.542 1.537 . . . . 0.0 110.965 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.22 -15.06 62.86 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.625 -1.297 . . . . 0.0 113.666 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -57.54 -22.05 42.14 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.065 1.346 . . . . 0.0 113.131 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.17 -0.56 38.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.219 1.808 . . . . 0.0 113.037 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -124.92 76.96 1.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.242 1.817 . . . . 0.0 109.686 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -23.68 8.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.71 2.004 . . . . 0.0 113.38 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -133.33 127.86 54.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.642 1.577 . . . . 0.0 108.537 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.9 t -132.97 118.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.077 -1.015 . . . . 0.0 110.275 -175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -110.99 118.06 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.865 1.266 . . . . 0.0 107.932 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -87.9 155.8 19.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.123 0.969 . . . . 0.0 109.027 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.68 39.67 3.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.09 0.956 . . . . 0.0 110.885 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.7 m -102.6 -26.68 13.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.972 1.309 . . . . 0.0 111.914 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.03 102.18 1.39 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.018 1.771 . . . . 0.0 113.038 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . 0.257 28.6 p 39.03 40.41 0.46 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.884 2.074 . . . . 0.0 115.33 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.81 108.05 0.2 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.567 1.556 . . . . 0.0 111.803 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.69 142.22 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.131 1.372 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -89.87 114.84 26.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.578 0.751 . . . . 0.0 110.072 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -144.14 140.54 17.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.29 1.036 . . . . 0.0 113.155 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.47 153.73 72.93 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.549 2.166 . . . . 0.0 110.068 168.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.27 -32.48 96.96 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.184 2.589 . . . . 0.0 114.311 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.99 -24.39 67.0 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.932 -1.105 . . . . 0.0 113.765 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.4 -10.66 58.29 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.4 -22.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.125 1.37 . . . . 0.0 113.584 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -84.55 11.65 8.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.39 1.876 . . . . 0.0 113.527 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -67.68 166.8 14.42 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.722 1.609 . . . . 0.0 112.812 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -64.24 -35.89 82.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -133.32 128.69 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.472 0.709 . . . . 0.0 110.888 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -130.75 148.46 52.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.089 1.356 . . . . 0.0 111.613 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -142.06 161.16 38.68 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.448 1.499 . . . . 0.0 111.455 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.44 86.84 1.97 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.633 -0.667 . . . . 0.0 111.913 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -73.38 160.51 31.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.234 1.814 . . . . 0.0 114.017 -172.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -93.28 -84.39 0.3 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.156 0.983 . . . . 0.0 110.94 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 50.14 -166.21 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.51 1.924 . . . . 0.0 112.293 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.94 147.75 46.55 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.489 1.515 . . . . 0.0 107.443 168.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.98 129.79 52.81 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.314 0.961 . . . . 0.0 111.035 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -69.37 -14.99 38.26 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.632 1.555 . . . . 0.0 114.731 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -53.43 124.45 14.84 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.367 0.985 . . . . 0.0 112.867 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.78 3.73 60.13 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.405 1.002 . . . . 0.0 115.452 -177.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -103.62 -177.9 3.5 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.388 1.475 . . . . 0.0 112.68 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t -73.75 155.13 39.21 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.59 -0.694 . . . . 0.0 111.606 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.96 -22.36 66.89 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.213 -0.929 . . . . 0.0 111.721 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.57 -32.39 73.7 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.047 -1.033 . . . . 0.0 111.305 169.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.22 -44.05 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.858 -1.151 . . . . 0.0 110.694 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -53.79 -49.26 68.67 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.285 0.948 . . . . 0.0 111.29 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -71.42 -16.41 62.39 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 m -95.6 -35.62 11.56 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.451 1.101 . . . . 0.0 112.755 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.81 -37.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 120.274 -1.517 . . . . 0.0 111.414 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -55.1 -42.71 73.23 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.51 -32.63 67.75 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.182 0.896 . . . . 0.0 113.023 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -69.8 -44.89 69.12 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.84 -0.8 . . . . 0.0 110.659 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.4 t -60.23 -42.54 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.158 -0.964 . . . . 0.0 111.063 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.17 -47.65 77.87 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.034 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.93 -29.25 65.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.139 1.336 . . . . 0.0 113.562 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -62.44 -54.3 42.16 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.022 0.828 . . . . 0.0 109.979 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.37 -51.08 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.28 1.432 . . . . 0.0 112.636 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.7 -49.64 75.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.996 1.271 . . . . 0.0 112.492 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -30.19 67.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.298 0.499 . . . . 0.0 111.875 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.47 -50.21 66.21 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.768 0.827 . . . . 0.0 111.168 170.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.73 -41.38 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.508 1.049 . . . . 0.0 110.944 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.01 -23.81 66.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.36 -17.27 37.23 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.1 -23.47 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.253 1.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.884 179.695 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 119.761 -0.162 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mtmm -77.45 146.28 36.59 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 112.612 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -113.56 126.11 54.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.902 1.281 . . . . 0.0 111.189 170.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.75 109.17 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.675 1.59 . . . . 0.0 110.207 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.6 tpp -87.04 128.13 35.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.525 0.602 . . . . 0.0 109.849 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -98.75 123.43 42.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.688 1.195 . . . . 0.0 109.745 169.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.34 146.21 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.724 1.21 . . . . 0.0 112.788 -176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -149.45 171.03 17.23 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.487 -0.758 . . . . 0.0 111.401 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -67.77 159.28 30.56 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.144 -0.973 . . . . 0.0 111.573 169.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . 0.25 6.0 ppt_? -61.13 -32.93 72.63 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 -168.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -87.47 57.09 4.23 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.971 0.805 . . . . 0.0 111.284 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -153.71 156.73 38.35 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.255 1.022 . . . . 0.0 113.746 -171.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.7 p -110.7 -5.24 15.05 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.058 1.743 . . . . 0.0 112.974 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -60.05 -37.88 81.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.592 1.957 . . . . 0.0 114.268 -169.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -66.96 -48.33 68.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.92 1.236 . . . . 0.0 112.01 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -65.76 -42.92 90.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.59 0.756 . . . . 0.0 111.941 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 tpt -64.92 -42.41 94.74 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.867 -1.146 . . . . 0.0 112.717 175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.51 88.2 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.947 0.499 . . . . 0.0 112.149 173.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -60.82 -36.18 78.4 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.567 -0.708 . . . . 0.0 111.841 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.57 -53.08 46.19 Favored Glycine 0 N--CA 1.471 1.004 0 CA-C-N 119.472 1.033 . . . . 0.0 112.613 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -60.33 -38.93 85.29 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.683 -0.892 . . . . 0.0 111.409 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.83 73.16 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -75.28 -22.16 57.99 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.905 1.684 . . . . 0.0 113.07 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -79.41 -45.35 19.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.314 0.646 . . . . 0.0 111.688 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -98.24 -27.2 14.25 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.46 1.104 . . . . 0.0 113.113 -172.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.87 2.66 88.08 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.253 1.883 . . . . 0.0 113.903 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 112.15 0.44 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.512 1.156 . . . . 0.0 112.656 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.67 15.57 81.47 Favored Glycine 0 CA--C 1.542 1.755 0 N-CA-C 116.373 1.309 . . . . 0.0 116.373 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.99 -40.47 3.49 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.393 1.596 . . . . 0.0 112.314 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.33 165.84 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.361 2.264 . . . . 0.0 109.931 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.27 149.12 21.89 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 170.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.43 143.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.316 -0.865 . . . . 0.0 112.493 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 m -148.23 156.72 42.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.976 1.31 . . . . 0.0 110.187 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 p -128.3 150.47 50.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.345 1.058 . . . . 0.0 113.321 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 t -155.43 156.71 35.8 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 110.124 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.59 153.05 17.61 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 169.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.1 mt -55.48 -34.52 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.997 1.398 . . . . 0.0 111.612 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -131.03 49.86 2.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.862 1.665 . . . . 0.0 109.715 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 t 68.63 170.37 0.29 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.475 1.91 . . . . 0.0 113.437 -169.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.2 p -146.08 169.56 18.45 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.42 1.888 . . . . 0.0 111.009 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -116.78 160.29 21.02 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.37 148.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.402 1.881 . . . . 0.0 107.058 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -136.4 131.53 18.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.748 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -54.81 -38.79 91.99 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.352 2.702 . . . . 0.0 115.273 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.0 m -67.77 -31.06 70.68 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.094 -1.004 . . . . 0.0 111.718 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.4 60.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.917 -1.114 . . . . 0.0 112.673 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 59.2 mt -72.19 -53.62 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 -35.68 60.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -170.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.68 -8.53 54.71 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.16 -0.962 . . . . 0.0 113.444 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.0 mmt -123.64 -28.49 3.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.366 1.066 . . . . 0.0 112.261 -171.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.43 -26.69 68.04 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.681 1.128 . . . . 0.0 112.171 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -70.34 -12.05 61.32 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 113.799 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 3.6 m -114.7 13.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.046 1.339 . . . . 0.0 111.509 168.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.044 1.783 . . . . 0.0 116.298 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.4 mm -85.07 149.56 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.334 1.567 . . . . 0.0 111.872 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -122.27 133.08 54.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.178 1.391 . . . . 0.0 111.053 169.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.56 -13.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.641 1.177 . . . . 0.0 113.837 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 m -57.68 -31.91 66.81 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.368 1.467 . . . . 0.0 114.227 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.26 2.69 81.51 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.263 1.411 . . . . 0.0 115.728 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.32 161.62 29.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.509 1.655 . . . . 0.0 112.566 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -143.4 166.3 25.13 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 0.0 110.902 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -143.81 161.26 39.1 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.512 1.525 . . . . 0.0 111.304 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -151.09 160.04 32.67 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.012 1.725 . . . . 0.0 109.973 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.51 135.02 67.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.805 3.004 . . . . 0.0 112.595 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.8 -31.76 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -170.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.43 -12.1 60.68 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -21.19 57.85 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.071 0.851 . . . . 0.0 112.77 171.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -94.87 167.34 11.48 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.091 1.356 . . . . 0.0 112.825 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.46 109.56 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.761 1.624 . . . . 0.0 110.967 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.67 -20.05 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -170.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.51 -27.36 69.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.332 1.053 . . . . 0.0 112.422 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.92 -2.17 58.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.633 1.573 . . . . 0.0 112.386 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -118.92 80.05 1.49 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.938 2.095 . . . . 0.0 107.92 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.64 -25.75 11.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.234 1.814 . . . . 0.0 113.165 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.1 t -132.3 132.47 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.194 1.798 . . . . 0.0 108.969 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.4 t -134.65 121.01 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.99 122.21 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.125 1.37 . . . . 0.0 108.552 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.9 t -93.33 155.05 17.63 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.674 1.19 . . . . 0.0 109.577 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.56 46.0 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.765 1.226 . . . . 0.0 111.387 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.4 m -109.26 -32.63 7.12 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.804 1.242 . . . . 0.0 112.21 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.63 97.24 1.29 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.076 1.798 . . . . 0.0 113.538 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.1 m 48.11 36.36 6.42 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.968 1.707 . . . . 0.0 114.661 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.53 106.33 0.19 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.578 1.085 . . . . 0.0 112.449 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.4 p -141.09 141.62 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.413 1.485 . . . . 0.0 110.718 173.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -84.45 115.88 22.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.686 -0.633 . . . . 0.0 109.455 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.4 mt -141.14 138.6 18.01 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.45 1.1 . . . . 0.0 112.298 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 152.96 76.62 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.259 1.973 . . . . 0.0 110.244 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 -29.24 86.33 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.837 2.358 . . . . 0.0 115.501 -169.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.36 -17.9 64.93 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.506 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.3 m95 -90.99 -3.18 57.47 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.88 -2.04 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.963 1.305 . . . . 0.0 114.337 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -101.37 0.95 37.93 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.141 1.776 . . . . 0.0 113.287 -171.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.484 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.5 mp0 -53.85 159.05 1.8 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.921 2.488 . . . . 0.0 113.988 174.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.91 -34.57 78.25 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -134.05 130.37 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.005 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -133.12 149.03 52.13 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.336 1.454 . . . . 0.0 111.435 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -141.59 157.91 44.5 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.91 1.284 . . . . 0.0 111.351 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -142.5 88.73 2.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.795 0.838 . . . . 0.0 110.832 169.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -70.94 145.69 49.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.13 1.372 . . . . 0.0 113.752 -169.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -101.73 60.56 0.88 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.727 2.011 . . . . 0.0 107.726 -174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.7 131.2 56.65 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.575 1.95 . . . . 0.0 111.148 -168.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -88.19 151.5 22.64 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.991 1.316 . . . . 0.0 112.138 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -93.72 126.2 50.56 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.975 0.51 . . . . 0.0 111.611 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.37 -5.29 13.42 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.077 2.518 . . . . 0.0 114.074 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -64.25 111.51 2.64 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 119.998 -1.689 . . . . 0.0 112.766 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.68 -3.66 74.89 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.538 1.542 . . . . 0.0 114.435 -173.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -98.54 178.18 5.09 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.171 1.788 . . . . 0.0 111.055 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 t -70.57 156.44 39.42 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.559 0.743 . . . . 0.0 112.279 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.13 -26.12 68.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.108 0.963 . . . . 0.0 111.62 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.34 -34.28 77.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.412 -0.805 . . . . 0.0 111.25 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -69.02 -41.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.644 -1.285 . . . . 0.0 110.476 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -56.3 -48.25 77.04 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.996 1.271 . . . . 0.0 111.421 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -70.44 -17.73 63.0 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.0 m -89.22 -41.08 12.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.048 1.339 . . . . 0.0 112.293 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.69 -36.31 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.538 -1.351 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -56.15 -42.29 76.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.27 -31.5 63.64 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 123.328 0.489 . . . . 0.0 112.42 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -70.03 -39.0 76.04 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.901 -0.764 . . . . 0.0 111.527 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.46 -46.74 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.366 0.667 . . . . 0.0 110.036 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.87 -51.23 66.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.366 1.066 . . . . 0.0 112.008 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.91 -29.6 67.9 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.022 1.283 . . . . 0.0 112.487 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.4 mtt85 -69.83 -53.85 16.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.382 -0.824 . . . . 0.0 111.025 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -53.54 -49.89 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.899 1.279 . . . . 0.0 112.439 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -66.21 -47.11 74.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.52 1.055 . . . . 0.0 112.135 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -31.58 68.47 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.423 1.011 . . . . 0.0 111.973 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.23 -51.13 68.98 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.518 0.727 . . . . 0.0 110.53 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.2 mt -69.11 -38.84 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.496 -0.753 . . . . 0.0 111.173 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.82 -26.82 68.8 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -87.79 -15.61 36.42 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -109.67 -18.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 124.661 1.185 . . . . 0.0 113.143 179.303 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 119.908 -0.092 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -72.64 142.53 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.971 0.908 . . . . 0.0 112.07 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.15 127.72 54.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.373 1.069 . . . . 0.0 111.308 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -99.88 116.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.553 1.941 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.2 ttm -99.8 124.97 45.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 110.076 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -95.3 127.64 41.5 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.22 0.608 . . . . 0.0 110.207 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.49 139.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.55 166.53 24.34 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 0.0 112.731 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -86.22 177.8 7.39 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.944 0.897 . . . . 0.0 111.553 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -54.26 150.64 8.29 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.961 1.304 . . . . 0.0 113.428 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t30 51.43 58.6 5.33 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.973 1.709 . . . . 0.0 112.562 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.8 t -138.9 143.98 38.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.333 1.053 . . . . 0.0 113.086 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.2 p -106.51 -6.38 18.16 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.662 0.785 . . . . 0.0 112.897 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -64.5 -28.02 69.37 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.641 1.176 . . . . 0.0 113.084 -169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.1 p -71.61 -49.9 35.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.971 1.26 . . . . 0.0 112.13 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -63.65 -33.1 74.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.263 0.625 . . . . 0.0 112.291 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 tpt -76.87 -41.58 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.174 -0.954 . . . . 0.0 112.337 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.85 94.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.717 0.407 . . . . 0.0 111.421 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.39 -45.26 88.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.11 -46.59 77.75 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 119.778 1.172 . . . . 0.0 114.806 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.447 1.123 . . . . 0.0 111.593 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.14 -32.94 63.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.468 -1.395 . . . . 0.0 113.989 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -67.48 -22.67 65.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 120.323 1.419 . . . . 0.0 113.05 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.4 m -87.28 -47.64 8.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.496 1.118 . . . . 0.0 111.581 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.7 mt -95.42 -31.86 13.18 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.468 1.107 . . . . 0.0 113.313 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.47 3.08 87.26 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.704 1.621 . . . . 0.0 113.159 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.36 122.0 5.64 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 117.919 0.86 . . . . 0.0 111.841 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.04 12.44 79.29 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-O 118.732 -1.038 . . . . 0.0 115.453 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -121.66 -42.22 2.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.341 1.57 . . . . 0.0 111.039 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.93 161.18 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 112.95 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 153.76 18.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.74 145.39 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.812 -1.18 . . . . 0.0 113.661 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.0 m -142.84 147.36 35.28 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.435 1.894 . . . . 0.0 109.784 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -115.02 148.82 38.36 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.024 -1.048 . . . . 0.0 112.407 170.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 t -153.35 159.26 42.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.793 1.237 . . . . 0.0 110.531 -170.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.86 154.8 19.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.9 0.762 . . . . 0.0 112.036 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.2 mt -59.79 -34.08 72.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.318 1.059 . . . . 0.0 112.132 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -132.49 29.59 4.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.234 1.414 . . . . 0.0 111.538 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 63.81 168.34 0.15 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.955 1.702 . . . . 0.0 114.712 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.491 ' H ' ' HB3' ' A' ' 62' ' ' SER . 7.5 t -163.21 -178.66 6.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.5 2.32 . . . . 0.0 111.828 -175.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -123.48 172.45 8.72 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.249 1.82 . . . . 0.0 114.485 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 147.02 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 125.675 1.59 . . . . 0.0 108.647 168.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.06 148.46 39.08 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 125.545 1.538 . . . . 0.0 111.511 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -54.81 -34.5 85.25 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.3 2.667 . . . . 0.0 113.871 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.1 m -61.25 -36.31 79.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.631 0.772 . . . . 0.0 112.099 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.34 -10.83 59.81 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.935 -1.103 . . . . 0.0 113.558 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.37 -53.1 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 168.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.05 68.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mmt -72.72 -9.52 58.73 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 mmt -124.56 -27.59 3.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.331 1.052 . . . . 0.0 112.144 -170.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.3 -25.34 68.27 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.836 -1.165 . . . . 0.0 112.28 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.93 -9.47 58.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 t -105.69 4.67 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 126.888 2.075 . . . . 0.0 110.376 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.97 12.49 83.34 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.529 -1.357 . . . . 0.0 114.935 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.71 150.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 118.572 1.186 . . . . 0.0 111.069 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -135.46 97.24 3.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.286 1.434 . . . . 0.0 111.357 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.2 11.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.6 p -61.93 -27.52 68.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.632 -1.293 . . . . 0.0 113.365 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.28 -2.68 90.34 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.901 1.239 . . . . 0.0 115.031 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -87.7 156.24 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.849 1.324 . . . . 0.0 112.373 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 t -147.56 -178.24 6.14 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.715 1.606 . . . . 0.0 109.53 172.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.491 ' HB3' ' H ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -115.9 167.49 10.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.482 1.113 . . . . 0.0 112.606 175.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.49 155.52 39.1 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.2 1.4 . . . . 0.0 110.91 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.61 136.6 50.7 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.676 2.917 . . . . 0.0 113.755 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.406 HD11 ' CD2' ' A' ' 90' ' ' TRP . 10.8 tp -52.83 -36.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.719 1.207 . . . . 0.0 114.12 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.38 -10.81 59.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -17.37 52.25 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.09 0.859 . . . . 0.0 113.085 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -93.1 175.48 6.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.505 1.522 . . . . 0.0 112.9 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.16 109.55 13.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.929 1.692 . . . . 0.0 110.86 174.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.3 -16.41 64.02 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -169.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.51 -23.7 66.28 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.846 0.858 . . . . 0.0 112.413 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.15 -0.99 57.42 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.289 1.835 . . . . 0.0 112.077 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -119.22 82.33 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.176 2.19 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.11 -27.64 14.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.223 1.809 . . . . 0.0 113.09 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.4 t -131.99 127.8 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.584 1.554 . . . . 0.0 108.966 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -133.54 124.69 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.956 -1.09 . . . . 0.0 109.763 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.7 mm -124.42 110.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.032 1.333 . . . . 0.0 109.358 -170.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 m -86.15 154.53 21.28 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.649 0.779 . . . . 0.0 110.983 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.47 44.0 2.84 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.611 0.764 . . . . 0.0 112.234 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 86.1 m -106.39 0.94 25.3 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.782 1.633 . . . . 0.0 113.653 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.25 69.07 1.44 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.518 1.532 . . . . 0.0 114.042 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 63.2 m 48.75 45.83 21.79 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.45 1.5 . . . . 0.0 113.778 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.13 14.76 0.07 OUTLIER Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.968 1.27 . . . . 0.0 115.887 -172.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -63.02 144.97 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.265 1.533 . . . . 0.0 111.265 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -106.09 128.76 54.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.963 0.905 . . . . 0.0 109.159 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.3 mt -146.55 148.48 33.99 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.136 0.974 . . . . 0.0 112.99 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.66 152.51 80.09 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.663 2.242 . . . . 0.0 109.897 168.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.28 -23.77 75.51 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.303 2.668 . . . . 0.0 115.391 -169.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -16.36 62.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.8 m95 -91.34 -3.3 56.92 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.36 9.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 125.618 1.567 . . . . 0.0 113.85 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -111.39 -3.09 15.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.392 1.877 . . . . 0.0 113.152 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.446 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.5 mp0 -58.0 158.62 6.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.432 2.693 . . . . 0.0 114.31 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.42 -33.67 76.41 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.86 127.39 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.979 0.912 . . . . 0.0 109.825 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -135.84 148.43 48.66 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.621 1.568 . . . . 0.0 111.756 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -149.16 157.74 43.62 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.597 1.959 . . . . 0.0 110.366 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -137.66 77.32 1.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.423 0.63 . . . . 0.0 111.42 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -64.17 160.0 19.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.12 1.768 . . . . 0.0 114.417 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.15 43.17 1.51 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.139 1.776 . . . . 0.0 113.75 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.13 138.49 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.507 -0.746 . . . . 0.0 111.05 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -85.82 148.77 25.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.67 131.11 46.47 Favored Pre-proline 0 CA--C 1.538 0.498 0 O-C-N 121.464 -0.773 . . . . 0.0 111.162 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.15 -7.56 17.23 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.054 1.836 . . . . 0.0 113.495 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -52.61 124.38 13.56 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.304 1.411 . . . . 0.0 112.062 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.78 4.53 66.64 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -107.07 178.7 4.48 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.523 1.529 . . . . 0.0 112.657 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t -72.04 158.49 35.87 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.944 0.898 . . . . 0.0 112.229 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.442 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -63.01 -27.61 69.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.379 1.072 . . . . 0.0 111.376 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.34 -31.7 72.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.953 . . . . 0.0 111.911 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.87 -41.73 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.978 -1.076 . . . . 0.0 110.438 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -56.05 -49.0 74.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.759 1.163 . . . . 0.0 111.442 170.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -70.13 -19.28 63.23 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.1 m -81.17 -54.36 5.58 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.857 1.263 . . . . 0.0 111.324 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.17 -34.52 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.555 1.142 . . . . 0.0 111.541 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -55.65 -41.01 72.98 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.213 0.915 . . . . 0.0 112.684 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.55 -33.02 64.08 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.774 0.702 . . . . 0.0 113.002 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -68.86 -40.53 79.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.113 0.956 . . . . 0.0 111.183 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.34 -49.92 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.167 0.987 . . . . 0.0 110.318 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -54.12 -49.01 70.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.411 1.084 . . . . 0.0 112.045 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -70.54 -28.98 65.34 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.802 1.183 . . . . 0.0 112.697 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -72.59 -47.98 43.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.78 -42.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.102 0.961 . . . . 0.0 111.626 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -61.29 -47.22 86.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.79 1.177 . . . . 0.0 112.183 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.13 -35.73 78.57 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.569 0.622 . . . . 0.0 112.016 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.487 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.9 tm? -56.96 -52.03 66.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.56 1.144 . . . . 0.0 110.699 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.86 -42.23 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.614 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.99 68.81 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -91.23 -6.62 53.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.68 -16.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.255 1.389 0 C-N-CA 125.467 1.507 . . . . 0.0 112.104 172.078 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -73.75 143.16 46.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.914 0.886 . . . . 0.0 111.835 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -108.67 124.37 50.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.731 1.212 . . . . 0.0 111.236 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.5 t -96.02 109.17 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.046 1.738 . . . . 0.0 110.173 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -88.31 130.62 35.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.504 0.321 . . . . 0.0 110.201 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -104.01 124.29 48.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.302 1.041 . . . . 0.0 110.73 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.2 138.07 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.309 1.044 . . . . 0.0 113.757 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -144.08 176.96 8.91 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.213 1.005 . . . . 0.0 112.64 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -79.01 158.51 27.91 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.785 1.234 . . . . 0.0 111.884 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -50.68 -40.95 55.14 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -168.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -72.57 -17.04 61.74 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.1 t -90.79 159.92 16.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.5 p -113.44 4.65 16.37 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.064 1.746 . . . . 0.0 111.877 168.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 -73.58 -25.58 60.42 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.056 -1.653 . . . . 0.0 113.098 -170.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -63.58 -43.36 97.21 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.196 0.907 . . . . 0.0 110.759 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -69.27 -40.09 78.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.626 0.77 . . . . 0.0 111.769 173.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.2 tpt -71.1 -38.21 72.36 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.234 -0.916 . . . . 0.0 112.562 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.57 98.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.333 0.653 . . . . 0.0 111.116 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.28 -40.19 77.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.914 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.05 -53.3 46.93 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 119.573 1.079 . . . . 0.0 113.53 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -61.52 -39.99 93.04 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.608 -0.937 . . . . 0.0 110.993 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.035 -1.041 . . . . 0.0 113.8 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -71.61 -22.04 61.76 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.789 1.177 . . . . 0.0 112.835 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -86.49 -43.91 12.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.939 0.895 . . . . 0.0 112.083 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.1 -35.13 11.45 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.775 0.83 . . . . 0.0 112.973 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.61 8.76 76.3 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 125.719 1.628 . . . . 0.0 114.188 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.17 -41.83 1.36 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -172.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 18.47 30.84 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.335 1.445 . . . . 0.0 115.078 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.69 -43.79 2.88 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.291 1.546 . . . . 0.0 111.941 -169.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -149.24 165.67 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.851 1.66 . . . . 0.0 112.087 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.55 152.08 22.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.625 0.77 . . . . 0.0 109.241 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.3 t -135.89 137.61 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.802 1.241 . . . . 0.0 111.047 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 m -144.6 154.26 42.64 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.102 1.361 . . . . 0.0 110.433 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.5 p -126.47 156.17 41.11 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.041 -1.037 . . . . 0.0 113.687 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -156.46 162.55 39.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 110.231 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.82 155.32 20.57 Favored Glycine 0 N--CA 1.465 0.586 0 O-C-N 121.32 -0.862 . . . . 0.0 111.327 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.0 -30.42 70.93 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.527 -0.984 . . . . 0.0 112.006 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -129.46 38.53 3.86 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 t 72.2 177.91 0.25 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.224 1.809 . . . . 0.0 112.138 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -137.35 -173.39 3.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.462 1.905 . . . . 0.0 111.623 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.09 158.69 43.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 113.326 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.3 t -101.92 146.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -129.57 123.86 21.55 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.997 -1.002 . . . . 0.0 112.567 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.73 -37.76 91.7 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.264 2.643 . . . . 0.0 115.116 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -66.82 -31.44 72.07 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.457 -0.777 . . . . 0.0 111.763 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.13 80.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.647 1.112 . . . . 0.0 110.838 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 mt -54.87 -49.58 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.042 0.537 . . . . 0.0 109.552 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.76 61.92 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.9 mmt -78.21 -22.39 48.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.204 -0.935 . . . . 0.0 112.857 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.8 mmt -106.39 -16.84 14.45 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.59 -25.42 67.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.185 1.357 . . . . 0.0 112.835 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.47 -7.0 51.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.34 1.056 . . . . 0.0 113.319 172.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.9 t -106.33 3.08 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 126.914 2.086 . . . . 0.0 110.312 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.47 81.45 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.238 1.399 . . . . 0.0 114.815 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -90.88 154.73 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.577 1.151 . . . . 0.0 110.497 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -141.85 133.46 26.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.71 0.804 . . . . 0.0 111.549 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 pt -132.29 12.19 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.056 0.942 . . . . 0.0 113.535 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -57.44 -33.83 68.34 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.628 1.104 . . . . 0.0 112.593 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.33 3.29 86.66 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.029 1.3 . . . . 0.0 115.923 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -76.03 160.41 29.85 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.028 1.914 . . . . 0.0 113.183 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.3 p -133.31 171.82 13.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.28 1.832 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 t -149.64 161.82 41.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.413 1.085 . . . . 0.0 111.298 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.65 160.49 35.87 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.139 1.776 . . . . 0.0 109.62 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.7 135.52 64.53 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.179 2.586 . . . . 0.0 112.294 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.93 -30.92 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -171.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.85 -14.24 62.79 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -20.56 57.9 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 119.305 0.957 . . . . 0.0 113.029 173.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -95.39 167.42 11.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.774 1.23 . . . . 0.0 112.982 -175.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.63 110.61 20.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.826 1.65 . . . . 0.0 111.098 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB1' HE22 ' A' ' 93' ' ' GLN . . . -67.52 -18.83 65.19 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -170.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.15 -26.88 68.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.665 1.186 . . . . 0.0 112.677 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.57 -2.84 58.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.73 1.612 . . . . 0.0 112.253 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -116.54 80.49 1.47 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.806 2.042 . . . . 0.0 107.882 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.65 -26.6 14.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.385 1.474 . . . . 0.0 113.012 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -132.81 131.19 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.79 1.636 . . . . 0.0 109.381 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.52 120.69 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 121.238 -0.913 . . . . 0.0 110.598 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.91 120.62 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.079 1.352 . . . . 0.0 108.106 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -91.9 157.01 17.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.047 1.339 . . . . 0.0 109.848 169.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -131.41 45.35 2.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.607 0.763 . . . . 0.0 111.636 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -122.84 16.53 10.16 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.48 44.51 95.11 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.695 1.134 . . . . 0.0 114.116 171.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 78.2 m 64.1 5.22 2.35 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.21 1.804 . . . . 0.0 114.83 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.57 18.71 49.99 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.307 1.908 . . . . 0.0 115.109 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -71.93 141.42 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.42 1.61 . . . . 0.0 110.959 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -108.95 125.95 52.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.887 1.275 . . . . 0.0 108.954 169.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -143.57 141.79 19.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.994 0.917 . . . . 0.0 113.142 -170.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.42 155.11 67.93 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.463 2.109 . . . . 0.0 110.11 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.38 -22.95 71.78 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.93 2.42 . . . . 0.0 115.016 -169.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.25 -16.97 61.93 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.489 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -91.07 -1.68 57.74 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.66 2.67 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.66 1.584 . . . . 0.0 114.085 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -109.19 7.94 25.65 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.923 1.689 . . . . 0.0 113.231 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.506 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.8 mp0 -62.06 162.91 8.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.446 2.298 . . . . 0.0 113.21 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.34 -35.95 82.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.01 129.55 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.909 0.883 . . . . 0.0 110.177 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -133.21 148.53 52.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.557 1.543 . . . . 0.0 111.34 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -141.1 159.0 43.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.975 1.31 . . . . 0.0 111.871 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -141.75 99.18 3.49 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.008 0.923 . . . . 0.0 110.19 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.88 153.84 34.35 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.893 1.277 . . . . 0.0 113.194 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -101.59 39.2 1.47 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.645 1.578 . . . . 0.0 112.374 -168.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.47 162.86 14.87 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.141 1.377 . . . . 0.0 113.684 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.22 154.23 40.46 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.774 1.629 . . . . 0.0 111.267 -174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -86.73 126.84 62.39 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 121.686 -0.634 . . . . 0.0 111.659 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.06 -13.92 4.31 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.746 2.297 . . . . 0.0 114.004 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -63.56 -34.35 77.6 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.549 1.068 . . . . 0.0 113.207 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.02 5.07 51.67 Favored Glycine 0 CA--C 1.541 1.683 0 O-C-N 121.409 -0.807 . . . . 0.0 114.43 171.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -136.95 -165.63 1.77 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.769 2.028 . . . . 0.0 111.875 -169.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.4 t -78.85 158.75 28.07 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.216 1.006 . . . . 0.0 112.599 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.75 -22.58 66.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.092 0.957 . . . . 0.0 111.625 170.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.76 -33.8 76.46 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.037 -1.039 . . . . 0.0 110.478 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.0 t -72.89 -35.96 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 120.799 -1.188 . . . . 0.0 110.649 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.03 -47.41 83.18 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.54 1.518 . . . . 0.0 110.417 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -68.78 -17.05 63.97 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.7 m -88.67 -41.38 12.64 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.224 1.409 . . . . 0.0 112.629 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -73.96 -34.15 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 120.533 -1.354 . . . . 0.0 111.371 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -55.93 -40.63 73.42 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.84 60.77 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.749 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.93 -43.04 75.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.902 0.851 . . . . 0.0 110.722 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.58 -48.12 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.294 0.638 . . . . 0.0 110.56 169.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -58.47 -49.58 76.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.731 1.212 . . . . 0.0 112.463 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.47 -29.0 64.34 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.018 1.281 . . . . 0.0 112.263 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -68.41 -50.7 50.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.59 0.756 . . . . 0.0 111.214 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.53 -48.62 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.162 0.985 . . . . 0.0 111.527 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.88 -50.93 66.83 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.557 1.071 . . . . 0.0 112.625 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -31.09 67.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.652 0.66 . . . . 0.0 111.998 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.45 -51.69 66.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.394 0.677 . . . . 0.0 110.314 169.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.8 -36.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.148 -0.97 . . . . 0.0 111.464 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -85.48 -20.03 30.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 pt -101.59 -18.07 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 124.971 1.308 . . . . 0.0 113.071 177.614 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 119.192 -0.432 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -70.44 138.64 51.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.124 0.875 . . . . 0.0 111.242 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -111.17 125.47 53.82 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.472 1.109 . . . . 0.0 111.361 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 68.5 t -95.72 114.11 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.048 1.739 . . . . 0.0 110.037 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -96.53 125.78 41.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.897 0.771 . . . . 0.0 110.891 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -92.01 124.08 35.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.715 0.806 . . . . 0.0 108.886 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.55 132.24 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.293 1.037 . . . . 0.0 112.469 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.9 p -138.26 172.04 13.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.17 169.16 18.13 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.972 0.909 . . . . 0.0 111.019 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -46.68 89.11 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -87.05 61.26 6.68 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.052 0.941 . . . . 0.0 111.443 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 t -150.35 149.23 29.8 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.243 1.017 . . . . 0.0 113.436 -171.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.2 m -113.81 -1.29 13.95 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.223 1.809 . . . . 0.0 112.101 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -62.58 -45.22 93.9 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.196 1.798 . . . . 0.0 112.696 -169.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 m -64.16 -38.99 93.06 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.622 1.101 . . . . 0.0 112.4 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -66.55 -44.24 82.88 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.734 0.413 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -39.24 82.12 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.773 0.829 . . . . 0.0 111.99 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.72 -46.01 92.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 171.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.43 -41.06 79.69 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.89 -63.76 4.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.722 1.153 . . . . 0.0 113.72 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -62.64 -34.85 77.9 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.699 1.25 . . . . 0.0 111.946 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.18 77.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -70.53 -27.89 64.51 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.883 1.674 . . . . 0.0 112.441 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.7 m -77.27 -46.02 24.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.363 1.065 . . . . 0.0 112.275 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.24 -27.76 14.85 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.036 0.934 . . . . 0.0 113.239 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 2.1 88.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 127.126 2.298 . . . . 0.0 113.608 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.42 114.79 1.03 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.409 1.104 . . . . 0.0 112.419 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.69 16.62 76.14 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.636 1.014 . . . . 0.0 115.636 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -119.08 -36.24 3.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.204 1.502 . . . . 0.0 111.92 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -150.61 166.32 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 127.544 2.338 . . . . 0.0 110.393 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.76 153.84 18.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 168.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.48 144.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.458 -1.401 . . . . 0.0 114.682 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 m -150.61 158.22 43.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.636 1.574 . . . . 0.0 110.726 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -123.55 149.18 45.56 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.016 1.726 . . . . 0.0 111.825 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 t -152.04 147.54 26.62 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.941 1.296 . . . . 0.0 110.586 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.87 143.47 17.09 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 168.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.69 -38.51 33.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.214 1.507 . . . . 0.0 112.22 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -123.74 40.87 3.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.838 1.655 . . . . 0.0 111.354 171.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 73.38 164.91 0.29 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.051 2.14 . . . . 0.0 114.333 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -148.4 166.84 26.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.294 2.238 . . . . 0.0 112.338 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -121.65 147.59 45.66 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.526 1.13 . . . . 0.0 113.756 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -80.18 -38.59 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 62.98 123.79 0.02 OUTLIER Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 128.815 2.846 . . . . 0.0 116.489 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 -38.95 79.79 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.929 3.086 . . . . 0.0 116.318 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -31.96 73.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.657 -1.277 . . . . 0.0 111.823 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.44 -8.19 58.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.653 -1.279 . . . . 0.0 113.603 172.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.81 -53.72 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 168.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.49 -33.52 60.8 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 mmt -71.86 -12.65 61.38 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.298 -0.876 . . . . 0.0 113.262 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.1 mmt -120.35 -27.25 5.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.593 1.157 . . . . 0.0 112.476 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.74 -25.15 68.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.852 -1.155 . . . . 0.0 112.637 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -70.63 -15.06 62.7 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.01 5.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 126.47 1.908 . . . . 0.0 110.664 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.18 12.37 83.31 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.389 1.471 . . . . 0.0 114.617 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -87.28 149.16 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.354 1.077 . . . . 0.0 111.312 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -124.47 125.52 44.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.45 1.5 . . . . 0.0 111.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.5 pt -134.49 -7.03 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.1 p -67.42 -28.23 67.73 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.125 1.33 . . . . 0.0 113.849 -169.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.78 -2.11 90.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.843 1.211 . . . . 0.0 115.023 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -81.64 161.68 23.36 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.001 1.401 . . . . 0.0 112.469 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -140.31 -179.9 6.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.03 1.332 . . . . 0.0 111.376 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -154.44 160.84 41.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.066 1.346 . . . . 0.0 111.823 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -159.46 155.98 24.39 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.784 1.634 . . . . 0.0 108.799 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.56 136.26 63.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.361 2.707 . . . . 0.0 113.047 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.0 -33.15 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.68 -11.41 60.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.07 -24.44 59.5 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.215 -0.928 . . . . 0.0 112.373 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -93.35 165.65 12.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.906 1.282 . . . . 0.0 112.402 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.9 110.55 20.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.521 1.528 . . . . 0.0 111.118 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.54 -19.32 65.27 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -171.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.38 -26.37 67.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.28 1.032 . . . . 0.0 112.403 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -87.51 -1.67 58.09 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.002 1.721 . . . . 0.0 112.037 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.07 82.0 1.76 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.711 2.004 . . . . 0.0 108.154 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.28 -24.82 12.53 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.167 1.787 . . . . 0.0 113.018 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.7 t -133.9 130.74 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.777 1.631 . . . . 0.0 108.969 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.92 123.78 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.309 -0.869 . . . . 0.0 110.633 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.6 121.23 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.178 1.391 . . . . 0.0 107.962 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 t -85.21 147.71 26.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.511 1.124 . . . . 0.0 109.985 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 mp -124.06 24.82 8.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.524 1.129 . . . . 0.0 112.456 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.8 m -83.59 -19.6 35.23 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -171.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.75 60.1 5.58 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.002 0.811 . . . . 0.0 112.122 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.4 t 62.56 173.02 0.14 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.098 2.159 . . . . 0.0 113.5 -169.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.17 33.84 86.42 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 121.113 -0.992 . . . . 0.0 114.643 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.9 p -90.93 137.12 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.405 1.082 . . . . 0.0 111.592 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -95.38 122.91 38.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.432 1.093 . . . . 0.0 109.54 170.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -139.84 136.95 17.77 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.615 1.166 . . . . 0.0 111.673 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.96 153.14 70.67 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.424 2.082 . . . . 0.0 110.064 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.71 -26.96 80.5 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.954 2.436 . . . . 0.0 114.104 -169.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.4 -19.62 65.85 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.499 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -90.1 -3.64 57.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -118.53 -9.76 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.79 1.236 . . . . 0.0 114.311 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -93.09 2.75 56.59 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.939 1.695 . . . . 0.0 113.511 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.1 mp0 -53.42 158.76 1.62 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.404 2.281 . . . . 0.0 113.775 174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -34.03 76.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -133.65 127.86 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.385 1.074 . . . . 0.0 110.05 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -130.91 148.27 52.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 111.103 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -141.88 159.09 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.672 1.189 . . . . 0.0 112.031 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.27 110.57 8.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.21 1.004 . . . . 0.0 108.882 168.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -87.68 145.66 26.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.6 1.16 . . . . 0.0 111.529 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -104.96 46.19 0.93 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.686 1.595 . . . . 0.0 108.555 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -102.02 132.81 47.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.572 2.349 . . . . 0.0 111.359 -168.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -90.34 151.85 21.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.317 1.447 . . . . 0.0 112.319 -173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -88.75 131.71 40.77 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.768 -0.582 . . . . 0.0 111.86 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -86.85 -15.01 4.05 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.7 2.267 . . . . 0.0 115.371 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -70.0 -30.0 67.21 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.016 1.735 . . . . 0.0 113.289 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.7 4.03 46.35 Favored Glycine 0 CA--C 1.54 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 114.046 169.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -136.49 -169.64 2.5 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.156 1.783 . . . . 0.0 113.063 -169.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 t -77.23 161.33 28.24 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.019 0.928 . . . . 0.0 112.157 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.87 -25.2 66.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.136 -0.977 . . . . 0.0 111.754 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.29 -29.37 70.46 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.228 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.1 t -72.0 -36.86 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 120.803 -1.186 . . . . 0.0 111.047 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -58.93 -46.73 87.25 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.435 1.471 . . . . 0.0 110.452 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -71.73 -18.21 62.15 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.109 0.964 . . . . 0.0 113.59 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.3 m -85.06 -52.87 5.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.575 1.55 . . . . 0.0 111.923 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -63.6 -31.92 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.934 1.294 . . . . 0.0 111.863 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -53.97 -43.42 69.91 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.601 1.091 . . . . 0.0 113.432 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.97 -32.74 65.93 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.771 0.701 . . . . 0.0 112.853 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -69.98 -40.34 75.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.41 -47.82 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.854 0.862 . . . . 0.0 110.329 171.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -57.0 -49.01 77.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.33 -28.36 66.17 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 121.376 1.898 . . . . 0.0 112.999 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -68.41 -49.0 63.17 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.473 -0.767 . . . . 0.0 111.654 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.7 m -62.24 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.022 0.828 . . . . 0.0 112.526 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -63.7 -50.72 68.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 120.207 1.367 . . . . 0.0 112.45 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.31 -31.06 69.29 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.951 0.796 . . . . 0.0 112.149 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.77 -49.72 69.63 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.396 0.678 . . . . 0.0 110.723 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.67 -40.76 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.988 -174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -27.04 68.84 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -88.49 -18.94 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -105.35 -18.36 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.256 1.4 0 C-N-CA 124.773 1.229 . . . . 0.0 113.222 179.054 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 119.75 -0.166 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -70.55 143.16 51.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.947 . . . . 0.0 111.94 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -110.73 126.23 54.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.239 1.015 . . . . 0.0 111.092 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.38 118.03 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.814 1.646 . . . . 0.0 109.995 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.5 tpp -97.81 119.44 36.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.651 0.659 . . . . 0.0 109.861 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -90.32 124.09 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.178 0.591 . . . . 0.0 110.391 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.03 144.54 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.242 1.017 . . . . 0.0 112.832 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.6 t -147.44 164.17 34.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.243 1.417 . . . . 0.0 109.497 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -73.1 -55.86 5.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.186 1.357 . . . . 0.0 113.201 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -146.46 178.04 8.58 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 127.063 2.145 . . . . 0.0 113.122 -169.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.266 39.6 t30 60.61 -128.01 0.96 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.925 2.49 . . . . 0.0 116.361 169.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 t -139.5 -169.88 2.79 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.049 1.339 . . . . 0.0 113.245 -169.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.7 t 50.86 -128.45 2.32 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.119 1.768 . . . . 0.0 110.262 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 39.43 -102.87 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.588 1.955 . . . . 0.0 114.762 169.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -63.91 -44.48 92.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 120.701 1.592 . . . . 0.0 112.942 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -63.08 -37.31 86.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.731 0.812 . . . . 0.0 111.543 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.411 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 8.1 tpt -74.83 -36.95 62.4 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.35 94.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.946 0.898 . . . . 0.0 109.917 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.86 -43.88 94.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.157 0.89 . . . . 0.0 111.769 169.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.1 -52.56 48.47 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 119.556 1.071 . . . . 0.0 113.83 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -68.18 -39.39 82.53 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.81 -1.406 . . . . 0.0 111.588 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.13 74.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.855 -1.153 . . . . 0.0 113.699 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -78.31 -15.54 58.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.2 1.364 . . . . 0.0 113.579 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.5 m -89.46 -44.95 9.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.255 1.022 . . . . 0.0 111.917 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.71 -29.07 14.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.673 1.189 . . . . 0.0 113.375 -174.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.35 2.27 88.17 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 126.419 1.961 . . . . 0.0 113.977 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.55 115.46 1.14 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.438 1.119 . . . . 0.0 112.385 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.64 10.83 85.86 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.85 -40.36 4.02 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.652 1.726 . . . . 0.0 112.493 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -148.29 161.7 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.51 2.324 . . . . 0.0 109.782 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 144.34 26.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.84 142.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.198 -0.939 . . . . 0.0 112.576 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -148.96 160.27 43.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.849 1.66 . . . . 0.0 109.435 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 p -136.84 153.46 50.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.9 t -152.27 152.91 32.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.283 1.433 . . . . 0.0 110.611 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.59 140.98 16.41 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.71 -37.63 84.86 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.499 1.65 . . . . 0.0 111.018 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.74 33.78 4.36 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.814 1.646 . . . . 0.0 111.064 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 64.01 168.84 0.16 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.789 2.035 . . . . 0.0 114.491 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 81.9 p -150.3 167.35 27.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.746 1.619 . . . . 0.0 112.526 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -137.44 170.96 15.18 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.039 1.336 . . . . 0.0 112.099 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.23 112.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.99 0.9 . . . . 0.0 110.762 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -78.78 134.72 60.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.01 1.324 . . . . 0.0 110.534 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.54 -37.49 90.32 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.985 2.457 . . . . 0.0 115.092 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 m -65.98 -32.32 73.74 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.86 -1.15 . . . . 0.0 111.604 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.37 -5.76 44.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.573 -1.329 . . . . 0.0 113.93 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.31 -55.93 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 167.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.22 78.51 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 82.3 mmm -73.38 -1.75 19.43 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.411 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.5 mmt -121.34 -29.02 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.64 1.176 . . . . 0.0 111.207 -173.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.68 -27.5 64.88 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.324 0.65 . . . . 0.0 111.951 169.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.83 -15.87 63.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.595 1.158 . . . . 0.0 113.935 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -120.19 24.58 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 126.175 1.79 . . . . 0.0 111.042 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.92 12.36 84.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.723 1.63 . . . . 0.0 116.128 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mm -93.13 152.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 118.855 1.328 . . . . 0.0 111.466 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -134.54 136.26 42.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.004 1.322 . . . . 0.0 110.97 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.34 0.74 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.543 1.537 . . . . 0.0 112.485 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.6 p -62.37 -28.17 69.58 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -169.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.86 -4.48 88.69 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.625 1.107 . . . . 0.0 115.167 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -81.8 154.54 25.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.108 1.454 . . . . 0.0 113.406 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -134.12 178.87 6.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.007 2.123 . . . . 0.0 110.805 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 t -153.22 162.89 40.81 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.178 -0.951 . . . . 0.0 112.26 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -149.44 158.17 38.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.35 1.86 . . . . 0.0 109.085 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.02 136.55 73.47 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.262 2.641 . . . . 0.0 112.14 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.62 -29.95 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.23 -14.78 62.47 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.27 -19.87 59.47 Favored 'General case' 0 CA--C 1.553 1.079 0 O-C-N 121.421 -0.799 . . . . 0.0 113.149 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.44 170.39 9.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.176 1.39 . . . . 0.0 112.866 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.8 108.28 14.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 111.287 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.27 -18.66 65.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -170.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.01 -26.12 68.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.156 0.982 . . . . 0.0 112.507 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.16 -1.72 58.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.109 1.764 . . . . 0.0 111.851 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -118.11 82.02 1.77 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 127.122 2.169 . . . . 0.0 108.651 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.19 -27.06 13.14 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.095 1.758 . . . . 0.0 113.067 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.1 t -131.4 130.85 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.802 1.641 . . . . 0.0 108.706 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.7 t -133.77 126.33 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.079 -1.013 . . . . 0.0 109.838 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.2 mm -126.64 111.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.61 1.164 . . . . 0.0 109.687 -170.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.2 t -87.49 156.87 19.35 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.493 1.117 . . . . 0.0 112.145 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.6 41.48 3.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.643 1.577 . . . . 0.0 111.68 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.6 m -106.32 -27.81 10.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.783 1.233 . . . . 0.0 112.4 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.05 88.48 1.65 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.774 1.654 . . . . 0.0 113.995 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.0 t 46.3 42.97 11.06 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.843 1.657 . . . . 0.0 114.233 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.85 106.96 0.19 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.165 1.364 . . . . 0.0 111.941 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -145.49 142.46 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.153 1.381 . . . . 0.0 111.545 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -88.79 52.14 2.34 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.4 1.08 . . . . 0.0 112.502 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.96 142.78 65.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.52 154.29 72.64 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.342 2.028 . . . . 0.0 109.952 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.17 -25.27 76.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.935 2.423 . . . . 0.0 114.868 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.07 -16.37 63.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.506 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.5 m95 -93.16 -2.23 55.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.94 0.93 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.345 1.458 . . . . 0.0 113.941 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -103.14 -1.14 29.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.319 1.848 . . . . 0.0 113.222 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.489 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.7 mp0 -54.88 161.55 1.56 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.241 2.616 . . . . 0.0 114.352 174.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.98 -35.01 79.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 78.8 mt -133.84 131.59 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.444 1.098 . . . . 0.0 110.465 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -141.32 149.4 41.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.403 1.481 . . . . 0.0 112.349 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -146.11 159.09 43.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.056 1.742 . . . . 0.0 110.304 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -138.99 86.62 2.15 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.403 0.681 . . . . 0.0 111.44 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -67.68 146.71 53.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.792 1.637 . . . . 0.0 113.631 -170.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -98.97 60.49 1.22 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.528 1.931 . . . . 0.0 107.691 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.27 127.52 55.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.116 1.766 . . . . 0.0 112.349 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.59 169.95 12.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.009 1.324 . . . . 0.0 113.96 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.91 119.61 57.77 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.185 0.994 . . . . 0.0 110.982 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.18 -10.92 19.43 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.64 2.227 . . . . 0.0 113.521 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -58.16 127.59 32.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.106 1.321 . . . . 0.0 111.573 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.2 2.62 87.59 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.189 0.9 . . . . 0.0 115.012 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -111.66 -179.54 3.73 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.773 1.629 . . . . 0.0 111.835 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 t -73.95 159.61 32.52 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.709 0.804 . . . . 0.0 112.573 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.404 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -62.99 -25.46 68.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.19 0.996 . . . . 0.0 111.884 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.44 -32.18 73.39 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.523 -0.736 . . . . 0.0 111.571 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.03 -38.66 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.002 -1.061 . . . . 0.0 110.276 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -58.04 -48.44 80.09 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.085 1.311 . . . . 0.0 110.882 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -66.82 -26.67 67.04 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -74.28 -55.46 6.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.569 0.748 . . . . 0.0 111.33 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -34.28 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 110.89 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -58.3 -42.15 86.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.452 1.024 . . . . 0.0 112.691 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.37 -34.4 74.39 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.408 0.528 . . . . 0.0 112.726 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -68.97 -39.76 79.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.357 1.079 . . . . 0.0 111.332 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.63 -51.41 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.1 0.96 . . . . 0.0 110.522 170.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 123' ' ' VAL . 14.6 tmtt? -54.59 -47.58 73.17 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.701 1.201 . . . . 0.0 112.554 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -68.44 -27.94 66.62 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.659 1.572 . . . . 0.0 112.842 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.0 mtt85 -72.48 -49.74 30.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.215 1.006 . . . . 0.0 111.52 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 120' ' ' LYS . 35.8 m -62.83 -40.66 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 118.323 -0.846 . . . . 0.0 113.244 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.29 -46.71 82.47 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.824 1.647 . . . . 0.0 111.689 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -70.31 -33.21 71.25 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.526 0.603 . . . . 0.0 112.56 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.94 -46.63 87.53 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.136 0.974 . . . . 0.0 111.092 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt -73.56 -43.4 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 121.365 -0.834 . . . . 0.0 110.56 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.38 -27.69 69.25 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -85.9 -12.74 49.82 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -114.93 -18.52 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.393 0 C-N-CA 124.676 1.19 . . . . 0.0 113.1 -179.623 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.5 2.051 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -71.96 142.5 49.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.215 1.006 . . . . 0.0 111.896 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -108.2 126.16 52.48 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.571 1.148 . . . . 0.0 111.028 171.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.36 113.89 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.881 2.072 . . . . 0.0 110.092 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.9 ttm -98.71 126.48 44.34 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.148 0.885 . . . . 0.0 110.627 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -93.28 127.05 38.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.184 0.994 . . . . 0.0 109.408 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.06 135.26 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.703 1.201 . . . . 0.0 113.197 -172.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 p -146.08 178.45 8.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.21 1.004 . . . . 0.0 112.6 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -89.11 161.2 16.65 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.212 1.005 . . . . 0.0 111.797 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -35.22 64.63 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -86.36 5.15 36.17 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.408 1.483 . . . . 0.0 114.747 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 p -117.21 158.02 25.01 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.6 p -114.95 4.3 14.75 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.8 1.24 . . . . 0.0 114.209 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -66.04 -34.57 78.39 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.984 1.714 . . . . 0.0 112.452 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.2 m -63.88 -37.32 86.94 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.323 1.42 . . . . 0.0 113.329 170.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.17 -45.62 66.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.827 0.451 . . . . 0.0 110.14 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.422 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 6.7 tpt -72.32 -38.62 68.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.3 86.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.551 0.614 . . . . 0.0 111.688 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -38.82 89.62 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.824 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.34 29.61 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 119.671 1.123 . . . . 0.0 113.655 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.47 -38.33 90.71 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.396 -1.061 . . . . 0.0 111.39 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.76 -34.7 76.02 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -72.12 -19.17 61.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.845 1.657 . . . . 0.0 113.215 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.2 m -89.26 -45.12 9.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.808 0.843 . . . . 0.0 111.971 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.94 -33.68 12.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.679 1.192 . . . . 0.0 113.009 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 4.94 81.74 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 125.679 1.609 . . . . 0.0 113.27 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.12 116.88 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 118.32 1.06 . . . . 0.0 111.725 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 14.63 76.91 Favored Glycine 0 CA--C 1.537 1.462 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.95 -44.39 3.81 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.245 1.522 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -145.71 162.21 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 126.465 1.906 . . . . 0.0 111.48 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.52 149.08 24.6 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -145.89 143.43 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.832 -1.167 . . . . 0.0 114.049 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.4 m -143.8 143.27 31.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.522 1.529 . . . . 0.0 110.871 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.3 p -106.86 145.25 32.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 0.0 111.677 170.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -156.36 154.46 30.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.533 1.133 . . . . 0.0 110.735 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.98 150.2 17.04 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.004 1.288 . . . . 0.0 110.653 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -52.88 -37.55 60.58 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.571 1.185 . . . . 0.0 112.413 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -126.11 39.42 3.95 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.47 . . . . 0.0 111.287 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t 69.08 170.65 0.3 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.667 1.987 . . . . 0.0 114.177 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -159.15 167.84 28.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.113 2.565 . . . . 0.0 109.978 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.57 156.19 28.52 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -173.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.6 146.61 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.916 1.286 . . . . 0.0 109.542 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -126.23 126.76 24.72 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.885 -169.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.519 2.813 . . . . 0.0 115.085 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 m -64.4 -34.11 77.42 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.022 -1.049 . . . . 0.0 111.526 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.17 -10.15 59.18 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.161 -0.962 . . . . 0.0 113.186 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.6 mt -80.13 -56.83 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 167.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.68 72.61 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.7 mmt -69.75 -8.19 45.9 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.422 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 13.4 mmt -124.63 -26.38 3.84 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.459 1.104 . . . . 0.0 112.263 -169.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -26.66 68.48 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.844 -1.16 . . . . 0.0 111.658 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.37 -9.14 55.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.0 0.92 . . . . 0.0 113.372 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.47 1.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.466 2.306 . . . . 0.0 110.765 170.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.04 81.75 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.693 1.616 . . . . 0.0 114.836 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.16 150.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.857 1.263 . . . . 0.0 111.293 -174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -126.92 142.29 51.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.199 1.4 . . . . 0.0 112.489 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.2 pt -137.53 -1.96 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.422 1.889 . . . . 0.0 111.783 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.8 p -63.18 -34.02 76.73 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.73 2.8 87.78 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.635 1.112 . . . . 0.0 115.369 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -72.57 159.71 33.46 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 p -118.0 -176.24 3.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.072 2.549 . . . . 0.0 108.911 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.0 t -146.07 -73.27 0.23 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.011 -1.055 . . . . 0.0 111.216 170.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 63.95 154.18 0.12 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.556 2.343 . . . . 0.0 115.211 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.87 133.79 46.61 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.726 2.284 . . . . 0.0 111.991 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.5 tt -55.98 -34.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.38 -8.6 51.93 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -20.68 60.24 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.254 -0.904 . . . . 0.0 112.692 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.54 171.42 8.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.181 1.392 . . . . 0.0 112.807 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.9 114.54 27.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.016 1.726 . . . . 0.0 110.934 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -69.21 -18.3 63.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.88 -26.44 66.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.784 0.833 . . . . 0.0 112.542 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -86.98 -2.81 58.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.056 1.742 . . . . 0.0 112.132 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -114.86 81.9 1.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.8 2.04 . . . . 0.0 107.972 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.23 -28.7 12.21 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.755 1.622 . . . . 0.0 112.88 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -131.0 130.5 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 126.01 1.724 . . . . 0.0 108.851 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -133.23 128.8 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.153 -0.967 . . . . 0.0 109.763 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 mm -125.19 117.14 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.671 1.188 . . . . 0.0 109.053 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.7 t -89.89 153.57 20.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 111.316 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -133.26 35.91 3.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.43 1.092 . . . . 0.0 111.972 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.6 m -96.61 -12.54 23.8 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.86 57.52 7.78 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 119.62 1.1 . . . . 0.0 112.613 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 67.4 m 64.26 -25.1 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 129.311 3.044 . . . . 0.0 116.311 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.21 39.89 1.68 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.988 1.756 . . . . 0.0 115.889 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 p -98.74 151.0 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.385 1.474 . . . . 0.0 111.711 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -128.73 129.53 45.86 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.425 1.49 . . . . 0.0 108.977 169.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -143.44 140.51 17.66 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.711 1.204 . . . . 0.0 112.613 -173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -63.91 154.01 72.45 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.591 2.194 . . . . 0.0 110.449 168.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -58.48 -32.29 96.09 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.371 2.048 . . . . 0.0 114.728 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.28 -22.19 66.72 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.1 m95 -89.29 -3.16 58.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.46 -19.95 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 t -81.96 6.8 14.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.754 1.622 . . . . 0.0 114.354 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.6 mp0 -55.78 160.68 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.035 2.134 . . . . 0.0 113.721 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.36 -33.53 74.92 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.7 mt -131.69 124.58 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.114 0.966 . . . . 0.0 110.173 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -135.31 141.88 45.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.427 1.491 . . . . 0.0 110.521 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.4 159.1 39.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.011 1.324 . . . . 0.0 110.871 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.24 131.94 54.52 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.602 1.161 . . . . 0.0 111.327 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.9 m0 -103.48 162.42 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.786 1.635 . . . . 0.0 112.77 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -119.89 40.13 3.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.874 1.27 . . . . 0.0 112.871 -168.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.94 159.58 34.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.874 0.87 . . . . 0.0 111.081 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -106.06 162.08 13.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.412 1.485 . . . . 0.0 109.795 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -88.52 128.55 52.45 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.78 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.51 -13.53 16.5 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.278 1.985 . . . . 0.0 112.804 169.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -51.23 -42.99 61.36 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.647 1.979 . . . . 0.0 114.67 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -89.51 10.63 72.74 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.547 1.07 . . . . 0.0 114.62 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -132.14 -173.0 3.03 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.697 1.599 . . . . 0.0 113.015 -169.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.9 t -80.0 164.18 23.65 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.465 1.106 . . . . 0.0 113.024 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.41 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.6 mm? -63.21 -30.13 71.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.818 1.247 . . . . 0.0 111.858 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.05 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.346 -0.846 . . . . 0.0 111.749 170.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.53 -39.05 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 110.824 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -56.59 -47.2 80.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.09 1.314 . . . . 0.0 110.518 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -70.69 -19.28 62.79 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.1 m -82.03 -50.83 8.66 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.874 1.27 . . . . 0.0 112.211 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.74 -33.71 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.398 1.079 . . . . 0.0 111.517 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -54.1 -40.21 67.07 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.852 0.751 . . . . 0.0 112.922 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.68 -32.89 63.82 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.282 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -70.95 -40.77 71.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.396 1.098 . . . . 0.0 110.273 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.13 -52.42 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.133 0.973 . . . . 0.0 110.66 170.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -55.47 -48.82 73.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.009 1.324 . . . . 0.0 112.462 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.99 -28.8 66.93 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.905 1.684 . . . . 0.0 112.51 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -71.94 -47.48 52.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.474 0.709 . . . . 0.0 111.861 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.6 m -62.54 -35.32 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.008 0.822 . . . . 0.0 112.897 170.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -61.77 -46.21 90.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.887 1.221 . . . . 0.0 111.389 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.55 97.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.329 0.513 . . . . 0.0 111.051 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.492 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -59.31 -48.96 79.65 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.771 0.828 . . . . 0.0 111.199 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.51 -44.23 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.868 -0.52 . . . . 0.0 110.489 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.58 70.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.4 pttt -86.86 -13.24 45.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -115.24 -18.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 124.516 1.127 . . . . 0.0 113.091 178.518 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 119.765 -0.159 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -69.85 138.68 52.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.479 1.112 . . . . 0.0 111.4 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -108.05 127.39 53.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.05 0.94 . . . . 0.0 110.923 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.84 119.48 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.063 1.745 . . . . 0.0 109.685 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.5 tpp -97.8 126.78 43.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.73 123.34 45.54 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.063 0.545 . . . . 0.0 111.152 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.17 149.22 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.164 0.985 . . . . 0.0 113.546 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -146.53 158.7 43.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.155 1.382 . . . . 0.0 109.007 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -62.55 -47.8 82.28 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.524 1.056 . . . . 0.0 111.706 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.01 -40.3 0.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -76.29 109.81 10.29 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -169.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -25.59 65.8 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.046 1.738 . . . . 0.0 113.947 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.5 m -62.7 -7.4 4.8 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -104.47 -55.47 2.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.114 0.966 . . . . 0.0 111.656 168.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.6 p -70.69 -55.97 7.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.328 1.051 . . . . 0.0 113.543 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.66 -33.66 74.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.021 0.528 . . . . 0.0 110.232 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.9 tpt -71.89 -43.78 64.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.12 99.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.508 0.723 . . . . 0.0 111.637 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -43.91 95.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.858 169.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.38 -53.05 43.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.525 1.057 . . . . 0.0 113.176 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -61.38 -36.34 79.99 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.697 1.249 . . . . 0.0 111.535 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.98 -27.17 62.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -65.91 -46.31 78.77 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.844 1.656 . . . . 0.0 111.375 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -74.48 -38.27 62.96 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.0 1.32 . . . . 0.0 112.332 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.8 mt -96.29 -29.83 13.78 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.17 0.988 . . . . 0.0 113.038 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.59 6.34 77.86 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.772 1.653 . . . . 0.0 113.829 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.0 118.82 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.467 1.134 . . . . 0.0 111.408 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.08 14.97 80.04 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 118.743 -1.032 . . . . 0.0 115.589 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -124.27 -43.3 2.07 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.27 1.535 . . . . 0.0 111.913 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.98 157.87 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.663 1.185 . . . . 0.0 113.191 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.83 154.02 20.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.471 1.108 . . . . 0.0 109.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.97 140.54 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 121.238 -0.914 . . . . 0.0 113.093 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 m -144.89 154.02 42.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.328 1.451 . . . . 0.0 109.538 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.3 p -121.6 152.1 39.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.719 0.808 . . . . 0.0 112.794 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 t -151.83 150.71 30.42 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.324 1.049 . . . . 0.0 110.846 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.12 140.75 15.77 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 169.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.9 -41.99 92.86 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.518 1.659 . . . . 0.0 110.995 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.59 33.63 3.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 111.532 170.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t 64.27 170.93 0.18 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.387 1.875 . . . . 0.0 113.932 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.1 p -153.13 -172.62 4.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.098 1.759 . . . . 0.0 111.546 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -137.6 -147.92 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.258 1.423 . . . . 0.0 111.82 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.23 151.06 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 126.5 1.92 . . . . 0.0 107.304 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -123.74 126.64 25.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 CA-C-O 117.604 -1.189 . . . . 0.0 111.206 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -54.41 -39.22 88.51 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.324 2.683 . . . . 0.0 114.898 -174.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 m -66.03 -32.57 74.13 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.996 -1.065 . . . . 0.0 111.872 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.2 -10.66 59.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.13 -0.981 . . . . 0.0 113.285 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.83 -53.77 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.39 61.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -170.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.05 -6.64 43.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.3 mmt -128.12 -29.51 2.51 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.93 0.892 . . . . 0.0 112.532 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.8 -25.49 67.52 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.893 -1.129 . . . . 0.0 111.855 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.95 -14.31 62.96 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.6 19.06 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.38 1.472 . . . . 0.0 111.584 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.81 76.08 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.801 1.667 . . . . 0.0 116.591 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mm -80.13 148.6 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 119.45 1.625 . . . . 0.0 112.151 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.55 111.4 11.72 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.166 1.786 . . . . 0.0 112.024 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.5 pt -140.98 -1.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.145 1.378 . . . . 0.0 113.693 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -61.84 -35.78 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -169.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.54 -2.45 90.05 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.332 0.968 . . . . 0.0 115.236 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -85.41 167.28 15.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.895 1.347 . . . . 0.0 114.327 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -139.88 -175.27 4.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.053 1.741 . . . . 0.0 110.586 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 t -145.24 165.49 28.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.67 1.588 . . . . 0.0 112.101 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -147.31 157.23 45.81 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.732 1.613 . . . . 0.0 110.299 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.12 139.55 90.28 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.418 2.745 . . . . 0.0 112.103 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -58.35 -31.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.18 -10.51 58.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.57 57.7 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.08 0.855 . . . . 0.0 112.789 170.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -94.4 170.4 9.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.061 1.345 . . . . 0.0 112.41 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 108.72 15.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.567 1.547 . . . . 0.0 111.155 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.66 -19.35 65.74 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -169.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.44 -26.53 68.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.866 0.866 . . . . 0.0 112.567 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.87 -2.67 58.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.343 1.857 . . . . 0.0 111.936 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -116.1 83.98 2.04 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.207 2.203 . . . . 0.0 108.235 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.21 -25.91 6.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.087 1.755 . . . . 0.0 113.049 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -133.36 130.26 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.848 1.659 . . . . 0.0 108.902 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -134.13 126.63 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.083 -1.01 . . . . 0.0 109.471 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.1 mm -127.03 116.58 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.589 1.156 . . . . 0.0 109.901 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -91.15 157.31 17.28 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.061 1.344 . . . . 0.0 111.651 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.65 35.89 4.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.176 1.39 . . . . 0.0 112.287 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -95.77 -32.76 12.55 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.791 1.236 . . . . 0.0 112.204 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.18 93.41 1.97 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.711 1.624 . . . . 0.0 113.388 170.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 61.6 m 48.58 34.82 5.29 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.045 1.738 . . . . 0.0 114.93 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.7 105.79 0.19 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.591 1.567 . . . . 0.0 111.924 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.77 143.24 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.091 1.356 . . . . 0.0 111.373 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -88.93 55.28 3.29 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.339 1.055 . . . . 0.0 112.436 -172.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 mt -84.23 142.42 40.93 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.85 154.97 70.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.612 2.208 . . . . 0.0 109.915 168.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.91 -28.99 81.67 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.917 2.411 . . . . 0.0 114.276 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.33 -19.44 65.81 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.82 -1.175 . . . . 0.0 113.814 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.494 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.5 m95 -91.6 -3.26 56.61 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 m -115.91 -16.8 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -83.79 4.24 29.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.863 1.665 . . . . 0.0 114.13 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.473 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.1 mp0 -58.07 159.74 5.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.972 2.109 . . . . 0.0 113.986 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -62.99 -34.05 76.71 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.32 127.85 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.817 0.847 . . . . 0.0 109.864 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.64 148.31 48.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.291 1.436 . . . . 0.0 111.821 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -147.22 157.41 43.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.829 1.652 . . . . 0.0 110.391 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -135.98 86.06 2.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.619 0.768 . . . . 0.0 111.018 169.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -66.98 146.61 54.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.836 1.655 . . . . 0.0 115.02 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -96.53 49.09 1.09 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.526 2.33 . . . . 0.0 108.742 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.14 134.51 40.37 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.254 1.822 . . . . 0.0 112.654 -167.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.1 179.27 6.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.098 1.359 . . . . 0.0 113.897 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -101.61 113.97 65.73 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.868 0.867 . . . . 0.0 111.806 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -77.32 -25.43 8.41 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.559 1.506 . . . . 0.0 113.264 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.87 -19.77 64.25 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -86.57 3.59 86.9 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.838 0.732 . . . . 0.0 113.705 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -136.82 -168.74 2.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.369 1.868 . . . . 0.0 112.408 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 p -74.8 168.62 19.52 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.37 -30.07 67.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.814 0.846 . . . . 0.0 111.373 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.62 -35.15 79.49 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.242 -0.912 . . . . 0.0 110.919 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.97 -39.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.404 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -55.77 -47.75 76.48 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 121.147 1.794 . . . . 0.0 111.427 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -69.27 -15.04 63.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.267 1.027 . . . . 0.0 113.564 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.6 m -88.77 -49.23 6.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.659 1.584 . . . . 0.0 112.641 170.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -70.38 -31.76 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.24 -0.913 . . . . 0.0 111.073 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -56.24 -39.83 73.16 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 0.0 112.453 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.48 -34.6 68.06 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.071 0.843 . . . . 0.0 112.63 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -69.49 -43.2 73.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.059 0.93 . . . . 0.0 110.513 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.94 -47.2 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.377 0.671 . . . . 0.0 110.685 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -56.45 -49.41 74.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.55 1.14 . . . . 0.0 112.3 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.7 -29.84 62.52 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.017 1.28 . . . . 0.0 113.13 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -64.8 -50.85 65.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.477 0.711 . . . . 0.0 110.866 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.4 t -56.36 -46.21 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.868 1.267 . . . . 0.0 112.611 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.63 -49.05 78.11 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 120.099 1.318 . . . . 0.0 111.874 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -71.47 -32.61 68.48 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.433 0.561 . . . . 0.0 111.948 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.52 -48.33 81.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.971 0.908 . . . . 0.0 111.308 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.8 -43.17 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.683 0.674 . . . . 0.0 110.7 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.82 68.68 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.62 -11.84 58.09 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.9 pt -111.44 -28.3 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.256 1.418 0 C-N-CA 125.629 1.572 . . . . 0.0 112.108 -178.183 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttp . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -72.77 144.19 47.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.636 1.174 . . . . 0.0 112.316 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -112.06 125.76 54.44 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.196 0.998 . . . . 0.0 111.836 170.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.79 116.55 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.821 1.649 . . . . 0.0 110.585 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.52 126.08 43.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.375 0.989 . . . . 0.0 110.454 168.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -95.36 121.45 37.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.894 0.878 . . . . 0.0 110.323 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.29 136.35 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.086 0.954 . . . . 0.0 113.275 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 t -148.62 176.35 10.41 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.825 0.85 . . . . 0.0 112.216 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -72.46 164.38 26.48 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.706 1.203 . . . . 0.0 112.925 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -51.15 -48.62 61.8 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -169.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -82.52 -6.48 59.35 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.6 m -94.43 144.79 25.26 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.201 1.4 . . . . 0.0 113.066 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.9 p -103.03 -11.48 18.11 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -61.41 -22.81 65.35 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.028 -1.67 . . . . 0.0 115.165 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 p -68.51 -47.29 67.36 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.621 1.555 . . . . 0.0 111.331 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.19 -38.58 91.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.581 1.153 . . . . 0.0 111.759 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.402 ' SD ' ' HG3' ' A' ' 50' ' ' MET . 7.7 tpt -73.58 -38.23 65.22 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.687 0.795 . . . . 0.0 112.244 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.69 -44.14 90.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.229 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.87 -44.05 91.0 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.144 0.884 . . . . 0.0 112.052 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.51 -49.77 67.19 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 119.598 1.09 . . . . 0.0 113.267 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.3 -43.15 87.09 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.135 -1.215 . . . . 0.0 111.666 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.82 82.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.844 -1.16 . . . . 0.0 113.797 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -72.55 -16.54 61.76 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.57 1.077 . . . . 0.0 113.254 174.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.9 m -88.21 -44.71 10.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.69 1.196 . . . . 0.0 111.99 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -95.99 -34.6 11.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.21 1.004 . . . . 0.0 113.539 -171.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.94 5.33 85.03 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.77 1.652 . . . . 0.0 113.85 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.43 -44.9 4.19 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.25 18.99 41.16 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.416 1.484 . . . . 0.0 114.536 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -127.19 -38.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.767 1.227 . . . . 0.0 112.504 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.52 163.27 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.646 1.579 . . . . 0.0 112.248 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.25 152.6 18.22 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 168.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -148.61 145.22 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 120.631 -1.293 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 m -147.11 163.45 36.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.053 1.741 . . . . 0.0 108.827 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.4 p -134.01 154.55 51.05 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 120.725 -1.234 . . . . 0.0 111.747 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 t -145.94 142.25 28.53 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.481 1.112 . . . . 0.0 109.935 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.96 137.21 13.68 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 121.975 -0.453 . . . . 0.0 112.19 172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.15 121.29 13.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 64.47 28.67 13.49 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.296 1.839 . . . . 0.0 113.775 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t 70.41 170.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.432 2.293 . . . . 0.0 114.062 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 62' ' ' SER . 82.1 p -152.71 179.12 8.91 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.699 1.6 . . . . 0.0 112.062 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 160.77 38.19 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.27 147.07 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.918 1.287 . . . . 0.0 109.07 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -119.63 132.19 24.12 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.65 -169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.88 -36.15 82.26 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.039 2.493 . . . . 0.0 114.795 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -69.57 -33.15 72.32 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.017 -1.052 . . . . 0.0 112.096 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 -13.44 61.14 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.044 -1.035 . . . . 0.0 113.21 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.07 -57.33 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.37 78.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -169.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mmt -68.46 -8.5 41.43 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.402 ' HG3' ' SD ' ' A' ' 17' ' ' MET . 14.3 mmt -123.15 -27.25 4.2 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 -169.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.87 -27.59 68.24 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.173 -0.954 . . . . 0.0 111.891 169.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.29 -8.13 53.22 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.332 1.053 . . . . 0.0 113.408 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.61 -0.46 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.516 2.326 . . . . 0.0 110.772 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.54 14.44 78.22 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.276 1.417 . . . . 0.0 114.629 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 mm -92.62 153.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.872 1.269 . . . . 0.0 111.192 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -130.92 139.0 50.03 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.444 1.498 . . . . 0.0 111.859 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.6 pt -135.58 -6.66 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.694 1.198 . . . . 0.0 112.49 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -58.35 -34.41 70.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.583 1.553 . . . . 0.0 114.526 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.69 -3.82 89.32 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.474 1.035 . . . . 0.0 115.295 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -81.71 154.84 25.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.961 1.381 . . . . 0.0 113.424 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.6 p -130.42 178.06 6.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.83 2.052 . . . . 0.0 110.681 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 40' ' ' SER . 3.7 t -148.73 158.58 44.25 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.121 -0.987 . . . . 0.0 112.444 173.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -152.04 158.1 33.92 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.687 1.995 . . . . 0.0 109.284 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.03 140.89 95.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.344 2.696 . . . . 0.0 112.474 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.1 tt -60.11 -29.62 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.54 -12.04 60.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -21.42 59.22 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.252 -0.905 . . . . 0.0 112.735 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 166.25 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.359 . . . . 0.0 112.523 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.89 107.05 14.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.485 1.514 . . . . 0.0 111.086 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -62.38 -16.18 53.11 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.874 -1.141 . . . . 0.0 113.799 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -59.26 -18.83 40.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.572 1.549 . . . . 0.0 113.063 176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.18 -0.51 28.41 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.463 1.905 . . . . 0.0 112.877 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -123.61 76.62 1.43 Allowed 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.831 1.652 . . . . 0.0 109.894 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.56 -23.75 11.61 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.661 1.984 . . . . 0.0 113.256 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.54 131.46 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.193 1.397 . . . . 0.0 109.329 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.62 126.35 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.876 -1.14 . . . . 0.0 110.391 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.07 119.69 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.364 1.465 . . . . 0.0 108.206 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 t -83.43 151.06 25.67 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.781 1.633 . . . . 0.0 110.112 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.05 38.25 4.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.129 -0.982 . . . . 0.0 111.765 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 98.7 m -127.2 17.2 7.17 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.64 34.07 88.51 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 120.716 -1.24 . . . . 0.0 113.821 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 75.1 m 61.41 -1.15 0.32 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.881 2.472 . . . . 0.0 115.841 -169.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.84 57.96 4.53 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.474 1.512 . . . . 0.0 111.524 169.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.35 139.35 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.301 1.44 . . . . 0.0 111.673 -169.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -99.44 117.71 34.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.125 0.97 . . . . 0.0 109.521 172.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.83 131.87 12.69 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.599 1.16 . . . . 0.0 111.867 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.97 148.28 89.51 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.762 2.308 . . . . 0.0 110.126 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.18 -29.55 83.95 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.657 2.905 . . . . 0.0 115.483 -169.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -63.84 -20.96 66.2 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.487 -1.383 . . . . 0.0 114.014 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.453 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 99.0 m95 -81.76 -15.42 54.34 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.401 -1.437 . . . . 0.0 114.526 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.22 -21.25 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.851 1.261 . . . . 0.0 113.524 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.9 t -84.56 13.37 5.67 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.974 1.71 . . . . 0.0 113.568 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -67.8 164.54 19.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 112.786 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.31 -34.85 78.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.6 mt -133.5 126.59 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.789 0.836 . . . . 0.0 110.072 169.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.08 148.07 48.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.931 1.292 . . . . 0.0 110.79 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -141.53 162.34 35.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.519 1.128 . . . . 0.0 112.402 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.68 130.81 32.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 108.749 168.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -108.28 135.26 49.89 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.399 1.479 . . . . 0.0 111.014 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -93.81 44.24 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.18 1.392 . . . . 0.0 110.92 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.19 150.92 24.06 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.659 1.583 . . . . 0.0 112.651 -173.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.92 165.16 13.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.889 1.276 . . . . 0.0 110.477 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.1 134.23 19.9 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.853 -0.529 . . . . 0.0 112.168 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -85.44 -12.03 6.84 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 121.866 1.71 . . . . 0.0 113.187 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -45.38 -42.08 9.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.688 1.995 . . . . 0.0 114.587 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.32 15.04 57.95 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.194 1.378 . . . . 0.0 115.903 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -126.08 -174.62 3.15 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 119.044 1.422 . . . . 0.0 114.071 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.5 p -71.81 164.7 25.53 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.451 1.5 . . . . 0.0 114.415 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.12 -33.12 74.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.919 0.887 . . . . 0.0 111.476 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.44 -34.89 79.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.726 -0.609 . . . . 0.0 111.198 169.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.8 t -69.53 -42.47 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 117.805 -1.093 . . . . 0.0 111.85 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -55.65 -48.9 74.22 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.951 1.705 . . . . 0.0 111.195 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -69.74 -19.31 63.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -84.36 -50.41 7.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 0.0 112.024 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.0 t -70.8 -30.97 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.588 1.155 . . . . 0.0 111.812 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -55.04 -42.26 72.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.274 0.943 . . . . 0.0 112.784 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.4 65.36 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.728 0.68 . . . . 0.0 112.849 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -68.57 -48.39 64.34 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.167 0.983 . . . . 0.0 109.681 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.15 -41.41 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.538 -0.726 . . . . 0.0 111.093 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.21 -50.11 73.89 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.096 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -70.82 -29.41 65.56 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.514 1.506 . . . . 0.0 113.335 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -63.48 -52.72 60.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 172.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -54.17 -50.84 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.138 1.375 . . . . 0.0 112.219 170.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.7 -49.99 70.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.847 1.203 . . . . 0.0 112.499 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -30.19 68.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.442 0.564 . . . . 0.0 112.142 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.15 -52.59 32.94 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.676 0.79 . . . . 0.0 110.876 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.8 -37.47 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 O-C-N 120.958 -1.089 . . . . 0.0 111.83 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.06 -26.48 68.86 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -87.78 -23.41 24.09 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -101.85 -20.09 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.254 1.338 0 C-N-CA 124.857 1.263 . . . . 0.0 113.829 -170.361 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -79.61 136.54 36.87 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.097 0.959 . . . . 0.0 112.419 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.33 128.17 53.8 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.643 1.177 . . . . 0.0 111.556 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.15 111.78 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.488 1.915 . . . . 0.0 110.319 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.9 tpp -92.8 122.45 35.2 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 169.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -93.31 114.91 27.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.998 0.519 . . . . 0.0 109.923 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.84 144.43 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.06 1.344 . . . . 0.0 111.985 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t -148.16 170.46 17.79 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.274 -0.891 . . . . 0.0 112.855 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -62.59 163.23 9.27 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.437 1.495 . . . . 0.0 110.781 169.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -59.15 143.29 49.26 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.282 1.033 . . . . 0.0 112.474 -173.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 52.51 44.51 29.92 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.855 1.262 . . . . 0.0 113.303 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.3 p -109.32 -26.66 9.92 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -169.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 t 57.52 1.89 0.13 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.452 1.901 . . . . 0.0 116.026 -169.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -76.27 -37.69 57.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 119.131 -2.231 . . . . 0.0 110.397 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -62.44 -46.53 88.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.863 1.265 . . . . 0.0 111.695 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.38 -33.93 67.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.394 0.678 . . . . 0.0 111.805 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -37.68 64.87 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.086 -1.009 . . . . 0.0 113.337 169.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -45.41 90.09 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.114 0.87 . . . . 0.0 110.919 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -57.92 -46.85 84.36 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.058 169.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.42 -49.19 46.26 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.826 1.194 . . . . 0.0 115.405 177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -72.64 -36.11 67.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.024 1.412 . . . . 0.0 111.619 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.82 73.23 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -69.02 -26.36 64.95 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.582 1.537 . . . . 0.0 112.504 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.2 m -84.51 -44.93 13.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.08 0.952 . . . . 0.0 111.669 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -95.59 -32.36 12.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.27 1.028 . . . . 0.0 113.308 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 5.76 79.78 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 125.87 1.7 . . . . 0.0 113.351 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 115.42 1.1 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.318 1.059 . . . . 0.0 111.862 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.37 15.44 80.26 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 115.821 1.089 . . . . 0.0 115.821 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -119.55 -34.42 3.8 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.238 1.519 . . . . 0.0 111.906 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -149.88 166.96 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.739 2.016 . . . . 0.0 111.623 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.19 152.07 19.44 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -144.69 145.2 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.023 1.283 . . . . 0.0 113.858 -175.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -144.55 154.38 42.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.38 1.872 . . . . 0.0 110.001 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.8 p -118.76 152.27 36.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.594 1.088 . . . . 0.0 113.421 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 t -149.66 150.71 32.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.255 1.422 . . . . 0.0 111.012 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.62 18.12 Favored Glycine 0 N--CA 1.47 0.923 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.2 mt -53.13 -40.8 64.49 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.668 1.734 . . . . 0.0 112.199 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -122.21 37.03 4.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.932 1.693 . . . . 0.0 111.074 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 t 72.97 151.5 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.272 2.229 . . . . 0.0 115.094 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -132.01 -169.34 2.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.195 1.798 . . . . 0.0 111.424 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -142.24 178.81 7.31 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.95 116.47 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.519 1.928 . . . . 0.0 109.25 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.8 148.91 52.51 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 118.673 -0.679 . . . . 0.0 112.065 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.28 -37.65 88.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.359 2.706 . . . . 0.0 113.892 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.9 m -65.48 -33.35 75.73 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.027 -1.046 . . . . 0.0 112.018 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.51 -10.74 59.85 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.4 mt -83.9 -53.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.17 68.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -72.86 -8.14 54.15 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 mmt -126.08 -27.35 3.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.284 1.033 . . . . 0.0 112.555 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.05 -25.13 67.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.787 -1.196 . . . . 0.0 111.985 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.39 -13.82 62.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.375 1.07 . . . . 0.0 113.544 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.28 18.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.422 1.489 . . . . 0.0 111.557 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.59 76.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.741 1.639 . . . . 0.0 116.611 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.2 mm -75.51 145.15 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.537 1.669 . . . . 0.0 111.6 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -133.77 97.92 4.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.641 1.576 . . . . 0.0 110.887 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.3 pt -132.75 11.93 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -58.47 -30.54 67.05 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.806 1.243 . . . . 0.0 113.333 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.43 -1.08 75.35 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.907 1.241 . . . . 0.0 115.348 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -74.76 140.13 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.703 1.751 . . . . 0.0 112.375 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.6 p -114.78 172.6 6.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.547 1.939 . . . . 0.0 110.343 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -145.44 158.71 43.79 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.304 -0.872 . . . . 0.0 111.783 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -150.03 157.59 37.53 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.779 1.632 . . . . 0.0 110.569 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.72 142.92 91.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.62 2.88 . . . . 0.0 113.098 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.88 -31.09 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -67.14 -13.22 61.74 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -21.02 57.16 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.171 0.896 . . . . 0.0 112.916 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -94.62 166.85 11.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.878 1.271 . . . . 0.0 112.691 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.3 107.64 15.52 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 111.126 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -65.87 -21.4 66.46 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -169.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.57 -27.41 68.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.179 0.991 . . . . 0.0 112.487 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.16 -3.85 59.05 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.939 1.696 . . . . 0.0 112.187 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.15 80.32 1.44 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 127.119 2.168 . . . . 0.0 108.556 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -51.37 -27.65 10.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.767 1.627 . . . . 0.0 112.942 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.59 127.54 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.184 1.794 . . . . 0.0 108.835 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.82 124.65 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.15 -0.969 . . . . 0.0 109.251 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.17 124.25 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.417 1.087 . . . . 0.0 109.215 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -99.59 154.07 18.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.572 1.149 . . . . 0.0 111.938 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.87 35.15 3.79 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.111 1.364 . . . . 0.0 111.764 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.1 m -91.83 -11.82 35.42 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.74 56.11 8.78 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-N 119.464 1.029 . . . . 0.0 112.979 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 75.8 m 64.88 162.25 0.13 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 128.377 2.671 . . . . 0.0 114.582 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.78 27.68 72.94 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 115.776 1.07 . . . . 0.0 115.776 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.14 123.69 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.614 1.207 . . . . 0.0 111.15 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -84.3 121.82 28.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.874 0.87 . . . . 0.0 109.516 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.1 mt -142.51 139.93 18.11 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.62 1.168 . . . . 0.0 112.75 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.32 153.81 72.05 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.448 2.098 . . . . 0.0 110.167 168.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.86 -22.45 73.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.089 2.526 . . . . 0.0 115.167 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.99 -15.0 62.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.49 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.7 m95 -92.08 -1.56 57.13 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.78 10.62 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 125.887 1.675 . . . . 0.0 113.894 -175.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -112.52 -2.62 14.59 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 126.399 1.88 . . . . 0.0 112.826 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.445 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.7 mp0 -56.72 160.4 3.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.551 2.74 . . . . 0.0 113.95 175.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.84 -32.59 74.2 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.2 mt -131.65 127.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.146 0.978 . . . . 0.0 110.513 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -139.38 141.33 37.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.247 1.419 . . . . 0.0 111.624 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -157.3 161.64 39.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 110.665 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.44 134.01 52.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 111.8 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -108.78 163.35 13.35 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.202 1.801 . . . . 0.0 112.104 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -130.33 62.14 1.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.856 1.262 . . . . 0.0 112.337 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.55 167.21 20.37 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.542 1.537 . . . . 0.0 111.418 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -117.52 158.83 23.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.967 1.307 . . . . 0.0 110.397 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -98.35 120.72 58.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.69 -5.74 16.28 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.061 2.507 . . . . 0.0 114.094 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -56.44 131.29 48.02 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.881 1.219 . . . . 0.0 111.691 170.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.99 0.73 65.85 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.075 0.845 . . . . 0.0 114.767 -171.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -108.49 -178.47 3.61 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.213 1.805 . . . . 0.0 111.239 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.8 t -73.34 157.12 37.58 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.051 -1.031 . . . . 0.0 112.177 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.9 -25.09 67.36 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.996 0.918 . . . . 0.0 111.692 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.44 -31.97 73.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.887 -1.133 . . . . 0.0 111.729 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.1 t -72.73 -39.0 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.901 -1.125 . . . . 0.0 110.193 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -56.53 -49.33 75.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.687 1.131 . . . . 0.0 111.15 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -70.67 -17.05 62.85 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -83.07 -51.4 7.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.063 1.345 . . . . 0.0 111.967 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.35 -34.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.748 1.219 . . . . 0.0 111.484 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -57.12 -39.5 75.24 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.101 0.864 . . . . 0.0 112.728 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.12 -32.26 69.23 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.988 0.804 . . . . 0.0 112.935 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -71.78 -39.76 69.71 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.476 1.138 . . . . 0.0 110.967 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.38 -50.93 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.63 0.772 . . . . 0.0 110.552 170.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.448 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -54.08 -48.01 71.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.16 1.384 . . . . 0.0 112.367 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -68.32 -26.66 65.73 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 120.984 1.72 . . . . 0.0 112.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -75.54 -47.69 25.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.904 0.882 . . . . 0.0 111.8 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.9 m -61.19 -36.5 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.8 0.727 . . . . 0.0 112.252 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -61.78 -47.26 85.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.9 1.227 . . . . 0.0 111.833 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -40.16 95.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.46 0.573 . . . . 0.0 111.106 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.485 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.1 tm? -58.74 -48.21 81.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.801 0.84 . . . . 0.0 111.388 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -73.13 -47.95 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.34 -25.42 68.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 38.9 pttt -87.68 -7.49 57.35 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.13 -18.36 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.0 p . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.135 1.374 . . . . 0.0 113.617 178.238 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -71.18 141.45 50.69 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.403 1.081 . . . . 0.0 111.221 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -110.96 128.57 55.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.072 0.949 . . . . 0.0 111.769 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.4 t -99.64 110.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.624 1.57 . . . . 0.0 110.161 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 tpp -90.65 124.07 34.78 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.181 0.446 . . . . 0.0 110.475 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.3 123.57 39.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.832 0.853 . . . . 0.0 109.918 169.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 m -118.98 134.51 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.08 0.855 . . . . 0.0 112.623 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -140.22 -152.77 0.43 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.121 1.368 . . . . 0.0 110.43 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -148.13 156.18 42.3 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.019 -1.676 . . . . 0.0 115.373 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 45.3 -110.53 0.22 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 129.151 2.98 . . . . 0.0 116.294 169.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -85.02 -19.52 31.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -168.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 p -82.57 149.76 27.29 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.01 1.277 . . . . 0.0 112.538 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.9 p -94.96 6.18 49.79 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -56.59 -39.23 73.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.116 1.766 . . . . 0.0 113.79 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 p -70.28 -43.69 69.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.119 1.327 . . . . 0.0 112.119 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.38 -34.3 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.456 0.703 . . . . 0.0 111.634 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 tpt -74.93 -38.37 61.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.07 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.13 87.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.431 0.559 . . . . 0.0 111.495 169.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -58.84 -40.85 85.44 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.349 -0.844 . . . . 0.0 111.824 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.97 -48.82 83.93 Favored Glycine 0 N--CA 1.474 1.228 0 CA-C-N 119.433 1.015 . . . . 0.0 113.784 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB3' HG21 ' A' ' 123' ' ' VAL . 40.0 m-85 -66.28 -40.01 89.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.073 -1.251 . . . . 0.0 111.365 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.12 85.33 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -68.77 -28.95 67.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.168 1.349 . . . . 0.0 112.641 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.9 m -78.42 -44.47 24.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.693 0.797 . . . . 0.0 111.773 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.5 mt -96.99 -31.77 12.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.973 0.909 . . . . 0.0 113.216 -171.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.13 7.03 72.99 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.821 1.677 . . . . 0.0 113.602 169.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.51 118.73 2.35 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.514 1.157 . . . . 0.0 112.024 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.35 11.61 85.14 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -116.9 -40.63 3.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.721 1.76 . . . . 0.0 112.377 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -150.51 162.65 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.784 1.633 . . . . 0.0 111.644 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.56 150.18 21.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.49 148.43 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.139 -0.975 . . . . 0.0 112.634 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -150.86 154.35 37.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.362 1.465 . . . . 0.0 109.248 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.3 p -127.49 155.01 44.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.6 t -155.78 167.12 31.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.585 1.554 . . . . 0.0 110.234 -170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.96 159.31 26.96 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.242 -0.911 . . . . 0.0 112.332 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -62.0 -38.26 87.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.324 1.062 . . . . 0.0 111.9 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.78 44.4 2.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.699 2.0 . . . . 0.0 108.756 170.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 t 66.5 176.96 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.15 1.78 . . . . 0.0 113.394 -169.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 94.9 p -146.23 -175.14 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.975 2.11 . . . . 0.0 110.423 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -145.78 172.64 13.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.13 141.75 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.758 1.623 . . . . 0.0 108.197 168.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -123.47 129.11 25.0 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.594 -171.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.68 -38.44 84.52 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.216 2.611 . . . . 0.0 115.381 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -63.74 -36.43 83.85 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.856 -0.528 . . . . 0.0 111.533 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.23 85.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.157 0.89 . . . . 0.0 111.171 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.5 mt -53.57 -51.17 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.36 79.37 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.1 mmt -67.09 -23.35 65.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 mmt -106.68 -18.93 13.81 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -61.32 -29.25 69.76 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.482 -1.386 . . . . 0.0 112.497 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -6.85 49.37 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.057 0.943 . . . . 0.0 113.302 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.8 0.49 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 126.943 2.097 . . . . 0.0 110.508 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.69 14.38 79.9 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.204 1.383 . . . . 0.0 114.629 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 mm -88.89 157.3 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.1 1.36 . . . . 0.0 110.619 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -132.87 143.26 49.4 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.463 1.105 . . . . 0.0 112.188 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.74 4.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.088 1.755 . . . . 0.0 112.106 168.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.4 p -63.2 -30.56 71.68 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.48 -4.14 73.94 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.76 1.171 . . . . 0.0 115.565 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -87.73 148.81 24.58 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.304 1.552 . . . . 0.0 113.043 -174.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.2 t -144.42 172.63 12.68 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.362 1.865 . . . . 0.0 109.951 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 t -133.31 167.19 20.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.929 1.292 . . . . 0.0 112.867 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -146.11 157.89 49.17 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.427 1.491 . . . . 0.0 111.034 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 134.97 65.52 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.723 2.948 . . . . 0.0 112.828 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -57.48 -32.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -169.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.93 -9.16 54.04 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -20.79 59.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 121.365 -0.835 . . . . 0.0 112.9 170.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.95 167.78 11.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 113.219 -175.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.02 112.19 22.27 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.595 1.558 . . . . 0.0 111.056 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.15 -15.55 63.78 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.455 -1.403 . . . . 0.0 113.529 -175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.9 -20.44 23.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.845 1.258 . . . . 0.0 113.191 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.72 -0.39 34.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.596 1.959 . . . . 0.0 113.053 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -125.5 77.03 1.61 Allowed 'General case' 0 C--N 1.346 0.428 0 C-N-CA 125.97 1.708 . . . . 0.0 109.739 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.29 -23.56 15.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.831 2.052 . . . . 0.0 113.252 -177.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.66 127.76 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.313 1.445 . . . . 0.0 108.8 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.0 t -136.18 124.87 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.01 -1.056 . . . . 0.0 111.055 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.36 121.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.559 1.544 . . . . 0.0 108.612 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.2 t -87.29 137.99 31.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.672 1.189 . . . . 0.0 111.449 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.85 11.7 20.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.505 1.122 . . . . 0.0 112.735 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m -105.02 12.23 32.49 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.622 1.569 . . . . 0.0 112.537 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.75 -178.84 35.31 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.688 1.137 . . . . 0.0 114.06 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.3 t -63.47 -24.87 68.01 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.103 0.961 . . . . 0.0 112.738 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.78 3.59 12.15 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 125.444 1.497 . . . . 0.0 115.62 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.27 137.46 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.204 1.402 . . . . 0.0 110.73 173.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -85.73 119.22 25.82 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -141.68 137.67 16.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.22 1.008 . . . . 0.0 112.454 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.46 151.35 80.32 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.541 2.16 . . . . 0.0 110.032 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.67 -31.28 94.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.084 2.523 . . . . 0.0 114.672 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.89 -23.81 66.55 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.862 -1.148 . . . . 0.0 113.756 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 98.6 m95 -83.87 -9.72 58.54 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.47 -1.394 . . . . 0.0 114.686 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.1 m -117.04 -21.81 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.19 1.396 . . . . 0.0 113.569 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -83.55 14.29 3.89 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.154 1.782 . . . . 0.0 113.562 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -71.69 168.21 18.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.88 1.672 . . . . 0.0 113.078 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.84 -35.97 82.84 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.503 -0.748 . . . . 0.0 112.747 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.68 125.98 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.761 0.709 . . . . 0.0 110.731 170.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -122.18 144.43 48.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.742 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -133.82 154.36 51.08 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.272 1.029 . . . . 0.0 112.463 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.15 125.08 34.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.073 0.949 . . . . 0.0 110.523 169.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -110.99 150.74 28.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.775 1.63 . . . . 0.0 110.354 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -119.57 47.1 1.77 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.18 1.792 . . . . 0.0 108.253 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -96.71 126.9 42.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.058 2.143 . . . . 0.0 112.303 -168.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -84.26 147.61 27.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.159 1.784 . . . . 0.0 112.556 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.06 123.31 69.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.286 1.434 . . . . 0.0 112.066 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.91 -11.62 3.15 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.946 2.431 . . . . 0.0 114.482 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.73 -20.22 65.92 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -169.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.93 9.47 63.77 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.746 1.165 . . . . 0.0 114.195 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -120.02 -172.57 2.37 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.981 1.712 . . . . 0.0 113.512 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 t -74.29 158.16 34.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.988 0.915 . . . . 0.0 111.348 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.62 -20.13 64.47 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 0.0 112.137 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.43 -31.58 72.74 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.012 -1.055 . . . . 0.0 110.218 168.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 t -72.62 -38.64 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.425 175.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.53 -49.14 73.41 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.164 1.347 . . . . 0.0 110.848 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.84 -15.86 63.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 m -87.12 -41.46 13.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.557 1.543 . . . . 0.0 112.744 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.05 -40.06 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.13 -1.606 . . . . 0.0 111.311 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -57.79 -42.2 83.68 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.53 65.82 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 123.701 0.667 . . . . 0.0 112.388 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -69.15 -39.07 79.02 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.596 -0.943 . . . . 0.0 111.879 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.46 -49.19 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.392 0.677 . . . . 0.0 110.388 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -56.96 -48.01 79.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.047 1.339 . . . . 0.0 112.725 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -68.26 -27.97 66.8 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.766 1.621 . . . . 0.0 112.33 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -71.35 -50.47 31.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.95 0.9 . . . . 0.0 111.567 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.477 HG21 ' HB3' ' A' ' 21' ' ' PHE . 31.2 m -59.83 -43.27 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.373 0.988 . . . . 0.0 112.6 170.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.07 -51.66 63.05 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 120.161 1.346 . . . . 0.0 112.393 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.667 0.667 . . . . 0.0 111.728 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -64.48 -48.03 76.76 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.24 0.616 . . . . 0.0 111.304 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 64.8 mt -72.96 -43.93 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.924 0.784 . . . . 0.0 110.747 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.6 -25.8 66.79 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.19 -16.78 54.07 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -107.59 -26.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.252 1.421 . . . . 0.0 112.051 -179.862 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.819 -0.134 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -70.45 142.28 51.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.39 1.076 . . . . 0.0 111.809 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -110.92 129.34 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.478 1.111 . . . . 0.0 111.351 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.9 t -99.63 114.96 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.292 1.837 . . . . 0.0 110.085 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.6 tpp -94.85 128.46 41.62 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.434 0.561 . . . . 0.0 110.369 169.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -100.28 113.41 26.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.156 0.982 . . . . 0.0 110.591 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.44 137.59 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 p -132.07 178.73 6.57 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 110.944 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -73.66 -61.0 1.99 Allowed 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.849 -1.157 . . . . 0.0 111.833 170.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -152.82 25.38 0.57 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -174.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -133.59 106.42 7.4 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.9 m -67.48 -22.62 65.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.7 m -66.93 -15.92 63.99 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.245 0.929 . . . . 0.0 111.891 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -94.07 -64.41 1.08 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.744 0.818 . . . . 0.0 109.579 168.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.4 p -71.2 -59.93 2.51 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -169.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -73.63 -26.75 60.92 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.637 -0.664 . . . . 0.0 111.859 -172.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 tpt -72.15 -37.41 69.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.22 95.4 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.609 0.641 . . . . 0.0 111.188 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -57.95 -43.97 86.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.115 0.87 . . . . 0.0 111.684 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.39 -50.98 60.47 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.409 1.004 . . . . 0.0 113.556 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -68.8 -40.82 79.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.208 -1.172 . . . . 0.0 111.705 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.39 95.67 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -71.46 -28.46 63.97 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.242 0.928 . . . . 0.0 112.386 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 m -79.18 -42.55 25.82 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.358 0.663 . . . . 0.0 111.77 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.8 mt -90.14 -32.95 16.43 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.889 0.876 . . . . 0.0 112.716 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 10.66 68.22 Favored Glycine 0 N--CA 1.468 0.78 0 C-N-CA 125.885 1.707 . . . . 0.0 113.906 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.29 119.18 2.82 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.491 1.146 . . . . 0.0 111.615 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.98 13.22 83.91 Favored Glycine 0 CA--C 1.538 1.514 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -120.2 -41.72 2.61 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.284 1.542 . . . . 0.0 111.423 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.59 159.3 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.894 1.677 . . . . 0.0 112.072 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.66 20.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.15 0.98 . . . . 0.0 109.193 169.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -141.64 141.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.009 -1.057 . . . . 0.0 112.925 -173.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 m -146.18 163.71 34.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.397 1.879 . . . . 0.0 109.514 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 p -140.61 153.54 46.1 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.785 -1.197 . . . . 0.0 112.542 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t -151.66 150.51 30.33 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.095 0.958 . . . . 0.0 111.215 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.01 134.35 9.81 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.24 1.4 . . . . 0.0 110.054 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 72.4 mt -50.34 -35.9 29.77 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.281 1.041 . . . . 0.0 112.907 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -118.69 28.95 8.0 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.953 1.701 . . . . 0.0 112.462 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 m 64.63 168.59 0.18 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.402 1.881 . . . . 0.0 114.124 -170.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t -164.33 173.58 12.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.454 1.102 . . . . 0.0 112.179 172.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -133.7 146.89 51.24 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.441 1.496 . . . . 0.0 113.099 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.2 m -64.82 140.23 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.411 0.624 . . . . 0.0 111.676 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -103.15 122.36 45.64 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.161 1.384 . . . . 0.0 111.584 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.8 -37.83 77.02 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.466 2.778 . . . . 0.0 115.305 -172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.6 m -64.39 -40.02 95.01 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.629 -0.67 . . . . 0.0 111.384 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.1 97.29 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.135 0.88 . . . . 0.0 111.664 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 mt -54.8 -52.55 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 118.558 0.617 . . . . 0.0 109.554 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.65 -37.79 82.91 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.6 mmt -67.56 -24.46 65.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.25 1.02 . . . . 0.0 113.198 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mmt -108.69 -19.59 13.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.02 -28.72 69.25 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.541 -1.349 . . . . 0.0 112.563 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.9 -8.31 53.64 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.172 -0.955 . . . . 0.0 113.347 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.85 3.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 127.153 2.181 . . . . 0.0 110.635 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 13.85 82.76 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.385 1.469 . . . . 0.0 114.762 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.3 mm -83.62 147.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 118.557 1.178 . . . . 0.0 111.184 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.74 126.42 52.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.978 1.711 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.86 -5.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 169.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.9 p -62.49 -27.02 68.85 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.09 1.314 . . . . 0.0 114.458 -169.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.54 -6.35 88.68 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.759 1.171 . . . . 0.0 115.476 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -84.7 149.14 26.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.27 1.535 . . . . 0.0 112.644 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 t -144.25 165.64 27.31 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.009 1.724 . . . . 0.0 109.618 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -132.76 144.19 50.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.163 0.985 . . . . 0.0 112.835 -171.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -139.76 159.8 63.55 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.112 1.765 . . . . 0.0 111.413 -171.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.91 138.5 79.34 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.632 2.888 . . . . 0.0 112.537 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.98 -29.49 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.44 -11.26 60.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -18.35 58.83 Favored 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.359 -0.838 . . . . 0.0 112.544 169.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -99.07 170.99 8.31 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.68 1.592 . . . . 0.0 112.238 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.62 113.61 18.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 110.749 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.89 -20.28 65.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -169.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.74 -27.34 68.84 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.078 0.951 . . . . 0.0 112.376 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.28 -3.22 58.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.133 1.773 . . . . 0.0 112.152 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -116.96 82.11 1.75 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.877 2.071 . . . . 0.0 108.108 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.21 -25.46 9.24 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.182 1.793 . . . . 0.0 113.138 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.69 131.28 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.108 1.763 . . . . 0.0 109.279 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.1 t -136.43 120.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 120.992 -1.068 . . . . 0.0 110.721 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.77 120.25 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.908 1.283 . . . . 0.0 108.092 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -88.46 149.24 23.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.015 0.926 . . . . 0.0 110.078 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mp -123.7 30.78 6.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.127 0.971 . . . . 0.0 111.32 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m -99.69 -17.92 17.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.88 41.25 6.39 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-N 119.45 1.023 . . . . 0.0 113.857 -174.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.9 t 66.59 -39.94 0.35 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.274 3.03 . . . . 0.0 116.365 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.66 97.07 0.87 Allowed Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.472 1.034 . . . . 0.0 110.678 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.03 142.73 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.377 1.071 . . . . 0.0 111.806 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -89.87 48.99 1.65 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.95 1.3 . . . . 0.0 112.275 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.1 mt -74.76 136.57 73.88 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.217 -0.927 . . . . 0.0 112.188 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.68 150.86 86.56 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 122.35 2.033 . . . . 0.0 110.281 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.94 -22.0 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.353 2.702 . . . . 0.0 115.221 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.75 -13.52 61.74 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 96.9 m95 -91.89 -3.52 55.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.47 14.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.565 1.546 . . . . 0.0 113.425 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -120.65 -0.99 10.11 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.21 1.804 . . . . 0.0 112.996 -169.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.485 HE22 ' HB1' ' A' ' 70' ' ' ALA . 13.7 mp0 -58.29 160.05 5.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.389 2.676 . . . . 0.0 114.138 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -63.81 -34.49 78.02 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.37 122.51 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.93 . . . . 0.0 109.086 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -124.25 146.74 48.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.188 1.395 . . . . 0.0 110.963 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -140.83 159.1 42.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.222 1.009 . . . . 0.0 112.437 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -132.22 117.14 17.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.681 1.192 . . . . 0.0 109.692 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -106.85 153.13 22.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.069 1.348 . . . . 0.0 111.586 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.08 79.86 1.75 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 110.379 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.62 152.46 18.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.024 1.33 . . . . 0.0 111.354 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -84.85 148.16 26.43 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.211 0.605 . . . . 0.0 109.445 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -82.04 130.73 59.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.556 -0.715 . . . . 0.0 112.143 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.96 -24.35 1.37 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.908 1.739 . . . . 0.0 114.216 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -71.82 -28.22 63.44 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.045 1.293 . . . . 0.0 113.628 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.59 2.63 52.92 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 123.856 0.741 . . . . 0.0 113.472 169.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -136.1 -165.03 1.64 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.106 2.162 . . . . 0.0 111.326 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.6 p -78.31 166.0 23.19 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.9 -26.91 66.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.858 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.88 -39.1 93.41 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.935 -1.103 . . . . 0.0 110.415 169.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.65 -36.69 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.208 0.913 . . . . 0.0 111.587 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -55.42 -45.41 76.72 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.888 1.676 . . . . 0.0 110.529 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -69.46 -19.93 63.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.0 m -79.36 -52.41 8.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.761 1.224 . . . . 0.0 111.718 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.24 -33.34 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.338 1.055 . . . . 0.0 111.317 -172.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -56.67 -39.44 73.78 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.924 0.783 . . . . 0.0 112.765 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.23 65.9 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.079 0.847 . . . . 0.0 112.878 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -69.82 -39.36 76.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.092 0.946 . . . . 0.0 111.166 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.11 -47.57 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.813 0.845 . . . . 0.0 110.966 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.461 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.1 tmtt? -55.25 -47.7 75.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.187 1.395 . . . . 0.0 112.792 177.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -68.64 -27.46 66.03 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.651 1.568 . . . . 0.0 112.686 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -71.58 -49.44 40.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.064 0.945 . . . . 0.0 111.693 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 120' ' ' LYS . 34.2 m -60.9 -41.1 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 118.947 0.794 . . . . 0.0 112.891 170.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -63.9 -51.69 63.33 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.15 1.341 . . . . 0.0 112.485 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -69.31 -30.14 68.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.914 0.779 . . . . 0.0 112.375 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.88 -49.74 71.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.966 0.907 . . . . 0.0 110.901 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.57 -39.94 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.182 -0.949 . . . . 0.0 110.585 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.27 -26.72 67.96 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -90.77 -18.12 25.48 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.0 pt -104.37 -16.99 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.649 1.179 . . . . 0.0 112.935 178.785 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.5 2.057 0 CA-C-O 119.676 -0.202 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -71.29 143.48 50.31 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.151 0.98 . . . . 0.0 111.804 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -109.6 129.36 55.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.363 1.065 . . . . 0.0 111.469 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.45 116.28 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.452 1.901 . . . . 0.0 109.9 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.7 tpp -94.6 125.47 39.27 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 169.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -99.32 113.39 25.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.577 0.751 . . . . 0.0 111.275 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.07 144.06 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.392 1.077 . . . . 0.0 112.69 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 t -144.43 167.31 22.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.03 0.932 . . . . 0.0 111.583 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -65.15 162.23 17.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.331 1.453 . . . . 0.0 111.005 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -59.5 148.11 34.3 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.175 0.99 . . . . 0.0 112.675 -170.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.5 t30 54.55 46.63 24.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.971 1.308 . . . . 0.0 113.237 171.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.0 t -136.57 143.57 43.7 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.378 1.471 . . . . 0.0 111.611 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.7 p -83.43 -10.21 58.54 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -65.27 -35.32 80.66 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.772 1.629 . . . . 0.0 113.653 -169.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 p -64.5 -52.92 55.42 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.363 0.983 . . . . 0.0 111.213 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -63.49 -39.04 93.4 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.547 1.139 . . . . 0.0 111.643 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.2 tpt -77.25 -35.2 55.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.903 0.881 . . . . 0.0 112.312 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.48 95.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.459 0.572 . . . . 0.0 110.736 169.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.35 -43.81 98.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.933 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.56 -48.02 73.36 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.666 1.121 . . . . 0.0 113.705 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -66.44 -44.23 83.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.129 0.964 . . . . 0.0 111.739 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.36 75.28 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -27.67 64.09 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.423 1.011 . . . . 0.0 112.584 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 m -88.71 -41.65 12.45 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.908 0.883 . . . . 0.0 112.548 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.7 mt -91.58 -34.63 14.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.7 0.8 . . . . 0.0 112.617 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.34 8.55 64.05 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.598 1.57 . . . . 0.0 113.696 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.36 117.85 1.94 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.341 1.071 . . . . 0.0 112.0 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.72 13.91 82.6 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -119.19 -40.14 2.85 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.165 1.482 . . . . 0.0 111.847 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.11 160.01 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.355 1.862 . . . . 0.0 110.998 171.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 150.86 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.466 0.707 . . . . 0.0 109.469 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -141.23 140.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.223 -0.923 . . . . 0.0 112.531 -173.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -144.4 159.49 42.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.205 1.802 . . . . 0.0 109.051 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.9 p -133.72 158.83 42.29 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 113.46 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.1 t -148.1 146.15 28.69 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.98 1.312 . . . . 0.0 111.192 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.01 139.25 15.17 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.5 mt -52.8 -42.96 65.57 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.019 1.909 . . . . 0.0 113.002 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.4 38.95 3.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.28 1.432 . . . . 0.0 110.89 171.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t 69.58 171.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.068 2.147 . . . . 0.0 114.302 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 t -157.91 -169.1 2.71 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.284 1.833 . . . . 0.0 110.038 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 167.7 21.58 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.87 166.49 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.402 1.081 . . . . 0.0 109.159 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -138.11 126.94 14.51 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.432 -1.418 . . . . 0.0 111.626 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.61 -40.22 85.96 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.926 2.417 . . . . 0.0 114.304 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -65.91 -34.3 77.81 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.243 -0.91 . . . . 0.0 111.273 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 -2.74 23.43 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.371 -1.456 . . . . 0.0 114.154 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -87.43 -54.78 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 167.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -28.85 61.65 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 73.2 mmm -78.27 -6.01 53.72 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.326 -0.859 . . . . 0.0 113.205 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.3 mmt -120.33 -26.36 5.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.71 1.204 . . . . 0.0 111.815 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.13 -20.52 65.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 112.439 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.07 -11.15 60.62 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 171.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 t -107.98 5.88 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 127.092 2.157 . . . . 0.0 110.622 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.07 14.04 82.63 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.561 -1.337 . . . . 0.0 114.396 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 mm -93.21 154.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.999 1.32 . . . . 0.0 110.27 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.18 149.12 41.02 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.291 1.037 . . . . 0.0 110.957 170.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.3 pt -133.78 -2.1 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.171 1.789 . . . . 0.0 113.122 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -54.66 -37.91 66.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.598 1.159 . . . . 0.0 113.836 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.32 -1.2 90.37 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 116.145 1.218 . . . . 0.0 116.145 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -76.61 160.77 29.12 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.748 1.774 . . . . 0.0 113.319 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 57.9 p -135.24 167.52 20.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.713 2.005 . . . . 0.0 110.484 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 t -144.18 158.83 43.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.535 1.134 . . . . 0.0 111.376 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -150.95 163.71 22.77 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 126.352 1.861 . . . . 0.0 110.177 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -60.49 146.22 97.27 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.5 2.8 . . . . 0.0 113.566 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.16 -32.31 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.076 0.95 . . . . 0.0 113.486 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.46 -13.76 61.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -21.19 46.61 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.332 0.969 . . . . 0.0 113.354 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -91.77 169.46 10.69 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.054 1.342 . . . . 0.0 112.825 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.0 108.41 15.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 110.892 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.71 -20.3 65.94 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -169.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.68 -24.89 67.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.028 0.931 . . . . 0.0 112.533 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.57 -2.01 58.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.456 1.902 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.89 82.05 1.74 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.946 2.098 . . . . 0.0 108.11 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.35 -28.19 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.765 1.626 . . . . 0.0 113.004 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -130.15 130.29 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.893 1.677 . . . . 0.0 108.627 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -131.49 126.51 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.095 -1.003 . . . . 0.0 109.262 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.3 mm -126.72 133.92 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.697 1.199 . . . . 0.0 109.214 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.2 t -109.01 148.67 30.41 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.969 1.308 . . . . 0.0 112.098 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.21 55.55 1.66 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.974 1.31 . . . . 0.0 109.677 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -114.68 -13.39 12.1 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.28 61.39 1.91 Allowed Glycine 0 CA--C 1.535 1.294 0 CA-C-N 119.664 1.12 . . . . 0.0 114.249 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.2 m 58.48 29.74 18.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.285 1.834 . . . . 0.0 114.801 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -169.88 112.93 0.49 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.301 0.953 . . . . 0.0 111.495 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.19 133.25 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.889 1.276 . . . . 0.0 110.691 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -89.6 119.38 29.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.63 0.772 . . . . 0.0 109.512 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.8 mt -141.74 140.28 19.82 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.386 1.074 . . . . 0.0 112.443 -175.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 151.5 82.51 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.252 1.968 . . . . 0.0 110.286 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.44 -26.91 79.93 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 115.535 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.43 -16.7 64.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.512 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.0 m95 -89.16 -3.05 58.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.58 18.0 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.295 1.438 . . . . 0.0 113.352 -173.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -122.29 -0.7 9.3 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.402 1.881 . . . . 0.0 112.87 -172.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.465 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.4 mp0 -57.24 163.62 2.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.861 2.864 . . . . 0.0 113.987 174.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.09 -34.79 78.85 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.1 mt -131.62 127.46 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.906 0.883 . . . . 0.0 111.037 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -137.28 140.3 41.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.492 1.517 . . . . 0.0 111.333 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -156.57 156.38 33.49 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.116 1.366 . . . . 0.0 111.006 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -113.78 142.85 45.55 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.876 1.27 . . . . 0.0 110.954 170.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -110.82 142.28 43.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.964 1.705 . . . . 0.0 111.572 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -104.73 59.59 0.7 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.957 1.703 . . . . 0.0 107.29 -169.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.02 132.0 53.44 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.422 1.889 . . . . 0.0 112.002 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -88.65 163.26 15.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.748 1.619 . . . . 0.0 112.869 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.66 138.82 37.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 122.1 -0.375 . . . . 0.0 111.136 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -91.54 -22.06 0.56 Allowed 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.342 2.028 . . . . 0.0 114.46 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.33 -34.51 74.74 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -169.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.81 -8.7 73.54 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 119.555 -0.581 . . . . 0.0 113.849 171.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -110.79 -83.85 0.57 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.53 1.532 . . . . 0.0 112.831 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t -168.78 156.16 7.5 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.314 1.046 . . . . 0.0 112.18 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.07 -27.7 68.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.148 0.979 . . . . 0.0 112.455 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.6 -25.83 61.47 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.692 -1.255 . . . . 0.0 111.85 169.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 71.3 t -75.37 -33.38 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.876 -1.14 . . . . 0.0 109.866 169.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.37 -44.63 92.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.035 1.743 . . . . 0.0 109.594 168.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.2 m -76.8 -54.03 7.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.487 0.715 . . . . 0.0 111.461 170.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.98 -34.8 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 0.0 111.344 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -57.85 -44.53 86.62 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 112.255 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.41 -29.65 67.9 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.691 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -67.55 -51.07 55.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.38 1.09 . . . . 0.0 110.256 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.6 t -57.44 -43.66 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.521 -0.737 . . . . 0.0 110.857 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.25 -48.65 73.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.709 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -72.8 -29.79 63.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.132 1.333 . . . . 0.0 113.504 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -63.74 -52.23 61.39 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.075 0.852 . . . . 0.0 109.937 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.49 -42.99 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.021 1.328 . . . . 0.0 112.546 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -61.69 -45.97 91.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.976 1.262 . . . . 0.0 111.633 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -38.39 89.22 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.535 0.607 . . . . 0.0 111.302 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.469 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -58.96 -51.13 71.39 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.898 0.879 . . . . 0.0 110.928 174.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.0 -44.3 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.651 0.66 . . . . 0.0 111.032 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.96 -23.52 66.44 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.6 pttt -94.17 -6.87 43.83 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -122.15 -17.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.168 1.787 . . . . 0.0 112.339 -178.822 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 111.244 0.091 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -69.1 133.49 48.12 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.835 1.254 . . . . 0.0 112.141 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -103.82 123.47 47.15 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.19 0.996 . . . . 0.0 111.129 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 111.0 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 126.104 1.762 . . . . 0.0 109.897 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.1 tpp -90.67 129.65 36.75 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.684 0.393 . . . . 0.0 110.091 168.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -100.0 124.67 45.62 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.727 0.811 . . . . 0.0 109.731 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.95 143.05 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.701 1.2 . . . . 0.0 112.525 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.4 t -143.02 168.12 20.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.738 1.215 . . . . 0.0 110.369 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -64.85 -66.79 0.5 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.491 1.041 . . . . 0.0 111.223 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -166.96 -50.59 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.133 1.773 . . . . 0.0 112.761 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -55.34 129.34 38.16 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.587 1.555 . . . . 0.0 114.491 -169.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 t 60.41 9.75 2.15 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.311 2.245 . . . . 0.0 116.358 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.8 m 43.88 44.23 5.7 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.695 1.998 . . . . 0.0 115.968 169.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -60.43 -23.04 64.1 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 126.949 2.1 . . . . 0.0 111.851 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -63.59 -52.96 58.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.788 1.235 . . . . 0.0 112.217 169.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -67.08 -34.89 78.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.272 0.629 . . . . 0.0 111.466 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.91 71.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.058 0.543 . . . . 0.0 112.313 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.71 86.67 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.508 -0.745 . . . . 0.0 112.698 173.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.15 -40.68 77.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.921 0.782 . . . . 0.0 111.896 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.27 -53.54 43.99 Favored Glycine 0 N--CA 1.469 0.868 0 CA-C-N 119.188 0.904 . . . . 0.0 112.961 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.47 ' HB3' HG21 ' A' ' 123' ' ' VAL . 43.2 m-85 -65.97 -40.97 91.71 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.243 -1.151 . . . . 0.0 111.881 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.81 94.27 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -76.41 -29.05 56.89 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.53 1.059 . . . . 0.0 112.624 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m -77.5 -43.57 31.71 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 0.0 111.647 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.51 -33.12 13.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.67 0.788 . . . . 0.0 112.491 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.5 11.82 57.6 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.671 1.605 . . . . 0.0 113.221 169.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.11 122.77 5.49 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.433 1.116 . . . . 0.0 111.551 171.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.01 8.8 87.3 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 116.029 1.172 . . . . 0.0 116.029 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -118.68 -31.04 4.96 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.649 1.724 . . . . 0.0 112.998 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.13 156.52 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 112.248 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.73 144.73 25.02 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.98 138.64 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.451 1.478 . . . . 0.0 113.487 -169.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 m -149.43 161.5 41.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.577 1.551 . . . . 0.0 110.274 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 p -137.4 150.62 47.8 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.314 1.054 . . . . 0.0 113.759 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 t -145.43 157.93 43.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.435 1.894 . . . . 0.0 110.099 -169.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.15 146.03 18.08 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.462 -0.774 . . . . 0.0 111.614 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -58.52 -42.68 88.26 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.976 0.888 . . . . 0.0 110.728 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.91 40.44 1.81 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.352 1.461 . . . . 0.0 111.287 173.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 t 65.17 178.56 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.407 1.883 . . . . 0.0 114.417 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -152.99 165.61 35.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 112.453 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.61 -179.82 6.54 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.76 -173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.75 113.61 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.065 0.946 . . . . 0.0 110.186 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.73 143.92 44.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.458 1.103 . . . . 0.0 110.993 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.87 -37.12 76.8 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.354 2.703 . . . . 0.0 113.857 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -61.21 -39.63 90.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.63 0.772 . . . . 0.0 112.17 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -13.21 60.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.8 mt -78.19 -53.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.43 64.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.8 mmt -70.47 -12.06 61.32 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 mmt -121.9 -28.64 4.42 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.269 1.028 . . . . 0.0 112.603 -169.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.35 -24.72 67.97 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.724 -1.235 . . . . 0.0 112.568 170.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.22 -10.73 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 11.5 p -121.38 26.2 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.188 1.795 . . . . 0.0 110.397 169.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.66 9.31 86.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.014 1.768 . . . . 0.0 116.774 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.06 147.76 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 118.84 1.32 . . . . 0.0 111.915 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.78 127.87 54.76 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.696 1.598 . . . . 0.0 111.506 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.0 pt -138.04 -6.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 p -64.19 -27.52 69.12 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.73 -1.231 . . . . 0.0 114.318 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.56 -6.72 89.16 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.594 1.092 . . . . 0.0 115.211 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -83.64 152.25 24.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.195 1.497 . . . . 0.0 113.116 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -145.32 177.62 8.69 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.481 1.912 . . . . 0.0 108.819 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -152.68 174.88 13.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.487 1.04 . . . . 0.0 113.765 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.87 163.14 28.62 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.937 2.095 . . . . 0.0 110.159 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.15 142.42 94.4 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.458 2.772 . . . . 0.0 113.247 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -52.97 -35.09 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.41 -11.81 60.22 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 CA--C 1.553 1.085 0 O-C-N 121.25 -0.906 . . . . 0.0 113.117 172.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -94.14 169.18 10.44 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.987 1.315 . . . . 0.0 112.832 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.23 107.47 12.59 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.411 1.484 . . . . 0.0 111.725 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.44 -20.16 65.47 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.42 -24.99 68.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.793 1.237 . . . . 0.0 112.895 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.74 -4.11 56.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.084 1.754 . . . . 0.0 112.106 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -114.7 82.97 1.81 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.452 1.901 . . . . 0.0 108.114 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -51.15 -26.9 7.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.857 1.663 . . . . 0.0 113.364 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -134.25 133.25 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.722 1.609 . . . . 0.0 109.287 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.62 121.19 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.866 -1.146 . . . . 0.0 110.91 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.08 124.19 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 108.522 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 t -91.19 152.29 20.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.666 1.586 . . . . 0.0 110.957 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.77 52.32 2.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.005 1.322 . . . . 0.0 110.028 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 75.0 m -116.38 -20.79 9.57 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.17 52.21 6.36 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 119.096 0.862 . . . . 0.0 113.114 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.3 t 61.77 172.11 0.12 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.643 2.377 . . . . 0.0 114.06 -172.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.25 20.37 73.16 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.496 1.045 . . . . 0.0 115.165 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.32 130.68 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.39 1.076 . . . . 0.0 111.436 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -84.46 62.52 7.3 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.725 1.21 . . . . 0.0 111.456 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.52 139.01 41.11 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.926 0.891 . . . . 0.0 112.996 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -63.29 152.69 78.61 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.301 2.0 . . . . 0.0 109.662 168.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.18 -22.1 73.61 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.218 2.612 . . . . 0.0 115.384 -169.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.54 -14.29 61.61 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.493 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.4 m95 -91.92 -1.43 57.29 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.8 14.76 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.904 1.682 . . . . 0.0 113.757 -174.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -118.89 -0.96 11.1 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.246 1.819 . . . . 0.0 112.877 -171.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.471 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.7 mp0 -59.8 161.44 6.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.251 2.62 . . . . 0.0 113.897 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.03 -33.93 76.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.5 mt -132.9 127.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.791 0.836 . . . . 0.0 110.394 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -130.03 149.26 51.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.178 1.391 . . . . 0.0 111.568 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -144.83 161.12 40.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.758 1.223 . . . . 0.0 112.182 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.21 128.54 26.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 167.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -106.86 146.81 30.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.368 1.467 . . . . 0.0 111.379 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -107.83 59.3 0.62 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.4 1.88 . . . . 0.0 106.864 -173.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.56 117.32 33.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.493 1.917 . . . . 0.0 112.335 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.89 159.47 32.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.823 1.296 . . . . 0.0 113.64 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.21 118.8 70.99 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 126.568 1.947 . . . . 0.0 113.113 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -81.2 -25.1 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 121.887 1.725 . . . . 0.0 113.385 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -62.7 126.1 26.2 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.365 0.984 . . . . 0.0 111.576 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.47 -1.38 87.75 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.369 -1.239 . . . . 0.0 115.287 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -93.65 -88.61 0.23 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.691 1.746 . . . . 0.0 112.193 170.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.0 t -161.79 156.09 22.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.385 1.074 . . . . 0.0 110.957 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.78 -30.03 71.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.833 1.253 . . . . 0.0 111.542 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -72.73 -23.8 60.89 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.741 -1.225 . . . . 0.0 112.301 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.94 -35.9 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.958 -1.089 . . . . 0.0 109.961 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.95 -47.63 84.38 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.656 1.571 . . . . 0.0 110.593 169.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -65.87 -21.85 66.49 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.8 m -80.03 -53.96 6.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.608 1.163 . . . . 0.0 111.845 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.79 -32.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.383 1.073 . . . . 0.0 111.343 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -57.17 -39.79 76.01 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.355 0.98 . . . . 0.0 113.016 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.65 -35.43 74.18 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.746 0.688 . . . . 0.0 112.171 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -68.59 -39.15 81.06 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.954 -0.733 . . . . 0.0 111.578 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.02 -49.08 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.637 170.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -56.13 -47.42 78.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.983 1.313 . . . . 0.0 112.417 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -69.18 -26.79 65.02 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.824 1.647 . . . . 0.0 112.624 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -72.98 -50.07 25.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.913 0.885 . . . . 0.0 111.299 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' A' ' 21' ' ' PHE . 34.8 m -59.79 -42.14 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.213 0.915 . . . . 0.0 112.565 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.24 -51.41 63.79 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.31 1.414 . . . . 0.0 112.464 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -31.97 70.71 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.917 0.781 . . . . 0.0 112.08 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.49 -48.44 75.17 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.425 0.69 . . . . 0.0 111.019 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 78.5 mt -72.95 -41.02 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.856 -174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.62 -26.25 68.59 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -85.83 -14.49 44.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.0 pt -111.18 -23.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.601 1.56 . . . . 0.0 112.035 -179.478 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.0 tpp . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -70.22 150.67 46.19 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.178 0.899 . . . . 0.0 111.447 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.54 118.08 32.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.189 0.996 . . . . 0.0 110.169 170.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.75 112.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.918 1.687 . . . . 0.0 109.584 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.3 ttm -95.1 122.34 37.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.851 0.75 . . . . 0.0 109.899 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -88.16 127.82 35.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.116 0.566 . . . . 0.0 109.982 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.97 145.94 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.686 1.194 . . . . 0.0 112.492 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.0 t -154.9 162.72 41.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.733 0.813 . . . . 0.0 111.801 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.94 165.79 24.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.778 0.831 . . . . 0.0 110.858 169.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.0 ttt180 -64.07 -18.28 64.21 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -169.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -73.63 -10.31 59.57 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -169.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 p -146.62 179.02 7.84 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -169.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.6 p -100.0 13.66 33.22 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.49 1.516 . . . . 0.0 113.904 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.38 -37.7 78.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.604 1.547 . . . . 0.0 113.356 -169.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.7 p -68.83 -43.14 76.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.408 1.003 . . . . 0.0 112.411 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.0 -35.03 71.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.719 0.808 . . . . 0.0 111.424 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.3 tpt -73.06 -37.63 66.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.063 1.345 . . . . 0.0 112.18 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.94 -44.87 91.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.25 0.477 . . . . 0.0 111.786 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -60.84 -38.83 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.379 -0.819 . . . . 0.0 111.823 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.62 72.89 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.113 1.324 . . . . 0.0 113.089 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -66.86 -44.43 81.02 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.169 -1.195 . . . . 0.0 111.81 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.44 72.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.778 -1.201 . . . . 0.0 114.05 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -72.23 -23.03 61.17 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.87 1.214 . . . . 0.0 112.867 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -86.07 -44.66 12.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.188 0.995 . . . . 0.0 112.037 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 mt -95.84 -35.85 11.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.23 1.012 . . . . 0.0 113.031 -173.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.96 7.69 80.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.964 1.745 . . . . 0.0 113.575 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -38.93 -45.34 1.17 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.7 17.92 27.47 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.485 1.517 . . . . 0.0 114.787 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -116.63 -28.68 6.33 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.306 1.443 . . . . 0.0 113.623 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.6 pt -157.59 163.97 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 127.603 2.361 . . . . 0.0 110.485 -171.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 147.03 24.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 167.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.5 145.43 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 120.745 -1.222 . . . . 0.0 113.62 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -148.88 157.97 43.82 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.791 2.036 . . . . 0.0 109.237 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.4 p -131.12 156.8 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.6 -1.312 . . . . 0.0 112.914 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -153.56 155.87 36.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.704 1.202 . . . . 0.0 109.793 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.3 145.46 18.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.31 -31.83 69.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.646 1.223 . . . . 0.0 111.913 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -123.33 35.48 4.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.161 1.785 . . . . 0.0 110.215 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 t 71.36 170.37 0.32 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.142 1.777 . . . . 0.0 112.151 -168.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -155.63 -177.38 6.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.051 1.74 . . . . 0.0 110.966 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -144.76 178.39 8.03 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -113.15 140.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.375 1.47 . . . . 0.0 109.346 169.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -110.96 135.63 20.82 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.497 -1.239 . . . . 0.0 110.92 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -54.02 -36.69 85.18 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.294 2.662 . . . . 0.0 115.467 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -67.51 -31.88 72.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 120.9 -1.125 . . . . 0.0 111.779 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.88 -10.83 59.75 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.303 -1.498 . . . . 0.0 113.438 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.61 -58.89 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.41 -38.54 77.96 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -169.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.1 mmm -73.99 -6.69 48.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 mmt -118.01 -23.96 7.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.745 1.218 . . . . 0.0 111.516 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -60.88 -28.16 68.67 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.261 -0.9 . . . . 0.0 111.609 169.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.85 -5.61 42.07 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.48 1.06 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.412 2.285 . . . . 0.0 110.581 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.41 13.15 82.19 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.23 1.395 . . . . 0.0 114.553 -176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mm -89.29 152.01 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.47 1.135 . . . . 0.0 111.022 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -129.65 138.6 51.29 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 111.002 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.5 pt -135.8 -5.26 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -57.42 -33.11 67.54 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.26 -5.75 85.03 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -83.14 144.44 29.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.337 1.569 . . . . 0.0 112.873 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.3 p -133.79 171.72 13.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.845 2.058 . . . . 0.0 110.302 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.7 t -141.0 165.81 26.51 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.212 1.005 . . . . 0.0 112.398 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.25 155.02 30.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.61 1.564 . . . . 0.0 109.267 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.85 135.46 67.08 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.874 2.383 . . . . 0.0 113.215 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -54.52 -33.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -10.26 55.75 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -25.26 59.2 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.247 -0.908 . . . . 0.0 112.669 170.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -92.21 167.68 11.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.832 1.253 . . . . 0.0 112.499 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.94 115.86 30.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.122 1.369 . . . . 0.0 111.362 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.484 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -71.46 -19.31 62.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.09 -27.0 66.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.648 0.737 . . . . 0.0 112.304 -172.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.01 -10.88 57.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.037 1.735 . . . . 0.0 111.806 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -107.37 79.57 1.32 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 126.548 1.939 . . . . 0.0 108.786 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -66.13 -12.42 55.63 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -129.9 130.77 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.516 1.527 . . . . 0.0 109.169 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 68.4 t -134.14 128.77 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.134 -0.979 . . . . 0.0 109.512 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.8 121.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.253 1.021 . . . . 0.0 110.079 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 t -96.61 150.02 21.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 112.32 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.8 mp -126.27 35.13 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.829 1.252 . . . . 0.0 111.455 171.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.3 m -84.9 -30.28 24.53 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.783 0.833 . . . . 0.0 112.98 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.36 61.44 2.62 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.742 0.687 . . . . 0.0 111.98 -172.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 81.9 m 61.89 168.86 0.11 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.442 2.297 . . . . 0.0 113.799 -169.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.13 30.0 73.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.118 -0.988 . . . . 0.0 114.782 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.93 104.77 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.347 1.059 . . . . 0.0 110.264 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -81.75 116.29 21.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.891 0.876 . . . . 0.0 110.547 -175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.8 mt -142.37 139.81 18.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.534 -170.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -63.22 154.65 66.45 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.503 2.135 . . . . 0.0 110.188 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -58.36 -32.65 96.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.551 2.168 . . . . 0.0 114.691 -170.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 96.4 m95 -88.13 -3.25 58.91 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 m -118.81 -22.08 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.8 t -77.42 2.06 17.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.066 1.746 . . . . 0.0 114.514 -173.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.408 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.4 mp0 -49.64 158.26 0.47 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.497 2.319 . . . . 0.0 114.24 171.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.71 -33.37 73.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.34 126.51 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.419 1.087 . . . . 0.0 111.008 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -136.05 139.09 42.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.844 1.657 . . . . 0.0 110.255 169.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.95 157.83 39.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.636 1.174 . . . . 0.0 110.871 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -117.6 140.97 48.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.942 1.297 . . . . 0.0 110.571 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -108.63 140.15 42.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.582 1.553 . . . . 0.0 111.469 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.43 60.76 1.02 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.169 1.788 . . . . 0.0 106.495 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -107.64 124.56 50.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.073 2.149 . . . . 0.0 111.167 -167.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -81.27 157.98 24.96 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.324 1.05 . . . . 0.0 112.664 -172.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -95.07 123.81 56.08 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.592 1.157 . . . . 0.0 111.556 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.42 -9.47 11.35 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.56 2.173 . . . . 0.0 114.862 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -63.93 117.32 6.83 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 121.187 1.812 . . . . 0.0 112.595 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.61 -5.16 84.94 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.176 1.369 . . . . 0.0 114.694 -173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.8 178.1 5.42 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.741 1.616 . . . . 0.0 110.81 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.2 t -68.02 157.0 36.11 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.237 -0.915 . . . . 0.0 112.302 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.22 -24.15 66.14 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.144 -0.972 . . . . 0.0 111.365 170.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -66.38 -32.29 73.58 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.433 -0.792 . . . . 0.0 111.537 169.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.36 -39.18 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 120.94 -1.1 . . . . 0.0 110.425 173.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -59.03 -47.25 85.91 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.037 1.289 . . . . 0.0 111.289 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -68.23 -22.28 64.79 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.0 m -77.73 -57.34 3.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.97 -34.68 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 -171.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -55.88 -43.24 77.02 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.001 0.819 . . . . 0.0 112.953 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.04 -32.05 61.09 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.766 0.698 . . . . 0.0 112.051 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -68.44 -41.05 80.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.773 -0.84 . . . . 0.0 111.376 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.7 -49.11 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 0.0 110.174 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -54.42 -49.23 70.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.172 0.989 . . . . 0.0 112.202 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -71.57 -28.39 63.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.19 0.904 . . . . 0.0 112.696 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -72.16 -46.13 57.66 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.393 0.677 . . . . 0.0 111.181 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.6 t -58.05 -42.27 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.048 0.939 . . . . 0.0 111.289 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.06 -46.29 91.27 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.511 1.051 . . . . 0.0 111.935 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -40.45 95.99 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.58 0.627 . . . . 0.0 110.808 176.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.465 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 3.0 tm? -57.89 -51.24 70.41 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.215 1.006 . . . . 0.0 110.632 176.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.2 mt -70.6 -45.47 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.11 -26.0 68.05 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 37.9 pttt -91.21 -7.82 50.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.08 -16.71 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.883 1.673 . . . . 0.0 112.805 -175.782 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.39 138.94 49.55 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.192 0.906 . . . . 0.0 111.627 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -111.31 123.14 49.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.478 1.111 . . . . 0.0 111.161 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -93.21 107.08 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.875 1.67 . . . . 0.0 110.354 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -85.74 128.99 34.94 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.77 118.52 37.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.751 1.22 . . . . 0.0 108.727 169.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.6 m -115.3 136.18 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 0.0 111.163 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.2 t -130.43 173.43 10.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -64.93 152.0 44.32 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.62 150.91 46.11 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -169.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.4 t30 60.93 9.23 2.2 Favored 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -76.68 172.29 13.29 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.997 1.319 . . . . 0.0 111.368 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 p -118.21 3.27 12.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.617 1.167 . . . . 0.0 113.615 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -74.11 -33.31 63.55 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.518 1.508 . . . . 0.0 112.654 -169.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 p -65.71 -42.56 90.97 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.961 0.8 . . . . 0.0 111.736 169.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.8 mm-40 -64.14 -43.1 96.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.994 0.518 . . . . 0.0 112.175 174.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -39.54 91.63 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.454 -0.779 . . . . 0.0 111.874 175.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.21 -48.42 80.06 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.76 -38.73 75.9 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.597 0.635 . . . . 0.0 111.434 171.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.11 -62.38 6.19 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.106 1.336 . . . . 0.0 112.723 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -58.73 -33.61 70.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.004 1.402 . . . . 0.0 111.498 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.46 -30.36 64.5 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.684 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -73.99 -29.76 62.13 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.354 1.888 . . . . 0.0 112.771 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 m -74.98 -45.64 40.69 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.882 0.765 . . . . 0.0 112.22 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.1 mt -92.3 -37.15 12.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.022 0.929 . . . . 0.0 112.588 -173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.82 2.18 60.44 Favored Glycine 0 N--CA 1.469 0.835 0 C-N-CA 125.527 1.537 . . . . 0.0 114.333 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 113.66 0.76 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.622 1.211 . . . . 0.0 111.724 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.1 19.96 79.79 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -124.0 -41.42 2.22 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.61 1.705 . . . . 0.0 112.383 -174.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -153.23 168.97 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.872 2.069 . . . . 0.0 110.424 177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.3 153.95 18.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 109.795 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.04 144.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.14 -0.975 . . . . 0.0 112.945 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -150.43 142.58 24.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.526 1.13 . . . . 0.0 110.721 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -103.52 148.62 25.73 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.188 1.395 . . . . 0.0 112.802 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -154.21 165.48 36.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 111.159 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.92 158.64 27.74 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -55.17 -36.8 66.26 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 118.124 0.962 . . . . 0.0 113.235 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.69 41.74 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.782 1.633 . . . . 0.0 109.651 169.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t 67.45 168.18 0.25 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.569 2.347 . . . . 0.0 115.983 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -137.92 170.61 15.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.708 2.403 . . . . 0.0 110.029 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -131.04 168.22 17.76 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -107.82 150.4 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.518 1.527 . . . . 0.0 108.164 169.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -136.92 133.41 18.7 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.888 -1.529 . . . . 0.0 109.94 -169.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -52.98 -36.38 75.38 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.9 2.4 . . . . 0.0 115.139 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.1 m -69.36 -34.25 74.29 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.976 -1.078 . . . . 0.0 111.782 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.56 -13.29 60.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.031 -1.043 . . . . 0.0 113.184 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -77.69 -54.64 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 167.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.75 64.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmt -70.25 -9.84 57.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mmt -122.45 -29.89 4.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.449 1.1 . . . . 0.0 112.261 -169.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.59 -25.56 67.41 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.82 -1.175 . . . . 0.0 112.29 170.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.68 -13.88 62.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.274 1.03 . . . . 0.0 113.746 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.259 4.0 m -114.5 16.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.691 1.196 . . . . 0.0 111.604 168.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.03 73.36 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.036 1.779 . . . . 0.0 116.264 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.16 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.039 1.419 . . . . 0.0 112.05 -174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -129.16 121.38 27.6 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.27 3.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.351 1.46 . . . . 0.0 111.906 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -70.25 -34.11 72.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.572 -169.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.22 4.54 82.83 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.474 1.035 . . . . 0.0 114.645 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.78 156.68 26.81 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.08 1.44 . . . . 0.0 113.803 -169.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -156.01 162.0 40.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.726 1.61 . . . . 0.0 110.21 173.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -103.26 172.51 6.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.904 1.281 . . . . 0.0 112.453 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -138.03 159.31 68.94 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.037 1.335 . . . . 0.0 109.981 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.78 138.06 83.57 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.336 2.691 . . . . 0.0 112.879 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 tt -58.1 -31.45 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.23 -11.13 60.68 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -20.95 57.75 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.246 -0.909 . . . . 0.0 112.642 171.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -96.28 167.56 11.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.79 1.236 . . . . 0.0 112.837 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.07 112.22 20.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.925 1.69 . . . . 0.0 110.358 175.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.502 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -67.23 -17.63 64.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.43 -26.06 68.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.183 0.993 . . . . 0.0 112.474 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.02 -1.3 57.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.913 1.685 . . . . 0.0 112.155 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -118.05 80.15 1.47 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 126.808 2.043 . . . . 0.0 108.115 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.05 -24.53 17.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.977 1.711 . . . . 0.0 113.186 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -134.28 130.65 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.789 1.635 . . . . 0.0 108.983 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.8 t -134.42 122.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.285 -0.884 . . . . 0.0 110.834 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.51 122.92 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.751 1.62 . . . . 0.0 108.899 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -88.9 144.54 26.13 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.243 1.417 . . . . 0.0 109.994 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.13 27.22 9.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.553 1.141 . . . . 0.0 111.781 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.8 m -92.6 -16.33 25.78 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.66 42.13 63.12 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-N 118.649 0.659 . . . . 0.0 113.06 -171.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.8 t 61.54 179.56 0.12 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.226 2.211 . . . . 0.0 113.556 -173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.77 24.38 74.16 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.317 0.96 . . . . 0.0 114.07 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 p -87.39 129.92 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.13 1.372 . . . . 0.0 111.108 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -83.87 57.77 4.31 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.583 1.153 . . . . 0.0 111.924 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -74.58 140.22 75.07 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.076 0.95 . . . . 0.0 112.491 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.95 151.56 83.87 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.151 1.9 . . . . 0.0 109.774 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.89 -21.11 72.9 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.104 2.536 . . . . 0.0 115.463 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.27 -13.19 61.45 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.502 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 95.5 m95 -91.48 -1.85 57.41 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.21 17.52 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.605 1.562 . . . . 0.0 113.427 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 t -124.64 1.48 8.22 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.095 1.758 . . . . 0.0 113.023 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.472 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.1 mp0 -58.9 163.4 3.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.771 2.829 . . . . 0.0 113.986 176.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.41 -35.62 81.5 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.4 mt -132.7 125.9 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.976 0.91 . . . . 0.0 109.985 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -125.59 147.22 49.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.256 1.423 . . . . 0.0 110.715 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -139.33 157.79 45.28 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.39 1.076 . . . . 0.0 112.505 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -135.97 126.65 27.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.764 1.226 . . . . 0.0 108.234 168.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -111.28 132.14 54.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.678 1.591 . . . . 0.0 110.218 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -92.38 64.15 4.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.159 1.383 . . . . 0.0 109.771 -171.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.03 144.82 25.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.569 1.548 . . . . 0.0 114.075 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -93.88 160.4 14.75 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.596 1.558 . . . . 0.0 111.0 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -106.31 126.39 30.6 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.083 0.953 . . . . 0.0 111.787 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.41 -6.41 15.5 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.306 2.004 . . . . 0.0 113.64 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.95 125.08 17.39 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.084 1.311 . . . . 0.0 112.058 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.6 4.29 60.85 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.476 1.036 . . . . 0.0 115.422 -176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -93.03 178.27 5.8 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.985 1.393 . . . . 0.0 113.121 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.2 t -72.06 156.0 39.69 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.279 0.632 . . . . 0.0 110.554 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.53 -21.61 64.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.002 -1.061 . . . . 0.0 112.079 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.72 -28.08 67.35 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.232 -0.917 . . . . 0.0 111.244 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.86 -41.19 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 120.938 -1.101 . . . . 0.0 110.309 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -56.81 -48.45 77.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.946 1.248 . . . . 0.0 111.145 169.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -69.57 -18.73 63.66 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.3 m -82.71 -52.29 6.91 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.183 1.393 . . . . 0.0 111.945 169.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.13 -34.53 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.461 1.105 . . . . 0.0 111.396 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -54.12 -42.57 69.61 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.835 0.743 . . . . 0.0 112.099 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.64 -31.42 65.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.67 0.653 . . . . 0.0 112.913 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.16 -41.18 70.74 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.141 0.971 . . . . 0.0 110.782 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.72 -47.47 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.426 0.69 . . . . 0.0 110.549 169.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -54.24 -50.4 67.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.922 1.289 . . . . 0.0 112.639 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -70.12 -26.43 63.96 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.787 1.176 . . . . 0.0 112.635 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -72.96 -51.08 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.213 1.005 . . . . 0.0 110.807 174.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.59 -47.54 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.263 1.025 . . . . 0.0 111.735 169.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -62.5 -51.75 66.2 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.697 1.135 . . . . 0.0 112.574 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.14 -31.4 68.89 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.125 0.875 . . . . 0.0 111.964 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.12 -50.04 73.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.475 0.71 . . . . 0.0 110.784 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.23 -38.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 121.369 -0.832 . . . . 0.0 111.375 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -25.51 67.2 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -91.23 -11.92 36.78 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.8 pt -114.14 -17.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.254 1.316 0 C-N-CA 125.582 1.553 . . . . 0.0 111.973 172.099 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttm . . . . . 0 N--CA 1.501 2.075 0 CA-C-O 119.786 -0.149 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -71.31 143.44 50.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.183 0.993 . . . . 0.0 112.028 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -110.06 122.84 48.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.71 109.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.532 1.533 . . . . 0.0 110.352 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.0 ttm -89.63 126.93 35.82 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.586 0.63 . . . . 0.0 109.59 169.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -95.56 124.25 39.49 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.021 1.329 . . . . 0.0 109.343 169.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.9 m -128.13 143.09 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.524 1.13 . . . . 0.0 112.554 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.0 t -153.36 177.3 11.03 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -77.01 167.76 21.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.432 1.493 . . . . 0.0 111.846 170.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -63.58 -36.33 83.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 -169.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -69.7 -37.81 76.74 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 p -94.27 173.04 7.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -169.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.3 p -106.79 16.45 24.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.106 1.363 . . . . 0.0 111.841 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -62.4 -35.91 80.7 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.497 -1.377 . . . . 0.0 112.598 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -66.28 -44.14 84.38 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.195 0.907 . . . . 0.0 111.995 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -65.2 -43.97 89.89 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.493 -0.754 . . . . 0.0 111.887 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -39.11 79.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.6 1.16 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.53 92.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.34 -38.46 77.21 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.428 -0.795 . . . . 0.0 110.732 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.73 -58.6 9.94 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.522 1.534 . . . . 0.0 113.943 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 123' ' ' VAL . 44.9 m-85 -65.23 -30.54 71.43 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.969 1.384 . . . . 0.0 111.982 174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.53 -32.82 70.43 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.903 -1.123 . . . . 0.0 113.962 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -70.57 -26.89 63.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 121.315 1.871 . . . . 0.0 112.666 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.5 m -74.91 -46.47 35.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.663 0.785 . . . . 0.0 112.454 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.6 mt -98.75 -29.34 13.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -169.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.18 2.2 87.4 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.78 1.657 . . . . 0.0 113.229 170.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.13 116.22 1.46 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.406 1.103 . . . . 0.0 112.284 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.78 11.42 84.58 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 115.767 1.067 . . . . 0.0 115.767 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -119.84 -38.04 3.02 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.16 1.48 . . . . 0.0 111.793 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 pt -148.28 161.68 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.539 1.936 . . . . 0.0 112.001 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.56 147.75 22.96 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.97 142.86 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.993 -1.067 . . . . 0.0 112.465 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -146.43 153.04 40.0 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 p -128.71 144.02 51.07 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.515 1.126 . . . . 0.0 112.615 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t -155.29 162.27 40.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.282 1.433 . . . . 0.0 110.268 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.37 154.36 20.31 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.04 -1.038 . . . . 0.0 111.403 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.05 -40.27 97.2 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.067 -1.255 . . . . 0.0 111.519 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -111.17 34.23 4.18 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.654 1.582 . . . . 0.0 109.625 169.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 t 71.44 170.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.546 1.938 . . . . 0.0 111.357 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.5 p -149.41 -162.52 1.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.598 1.559 . . . . 0.0 110.294 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -155.35 174.88 14.6 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.683 -1.261 . . . . 0.0 114.388 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.39 154.14 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -127.78 130.83 23.6 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.174 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -54.78 -39.61 88.87 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.991 2.461 . . . . 0.0 114.503 -173.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -67.56 -31.69 71.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.11 -10.33 59.33 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.678 -1.263 . . . . 0.0 113.127 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.6 -57.77 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.13 79.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 75.4 mmm -73.97 -8.5 56.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.1 mmt -118.15 -25.91 6.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.086 1.355 . . . . 0.0 111.76 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.9 -30.61 67.93 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.986 -1.071 . . . . 0.0 111.783 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.91 -11.08 60.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 t -100.9 3.03 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 126.606 1.962 . . . . 0.0 110.477 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.75 12.25 81.74 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.383 1.468 . . . . 0.0 114.848 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -87.45 148.12 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 118.494 1.147 . . . . 0.0 111.197 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -132.46 101.11 5.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.462 1.505 . . . . 0.0 111.21 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.4 pt -125.38 -4.13 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.3 p -63.94 -27.02 68.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.609 1.095 . . . . 0.0 113.546 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.39 -5.25 89.73 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.877 1.227 . . . . 0.0 115.311 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -78.47 157.93 28.79 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.522 1.661 . . . . 0.0 113.374 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -134.41 -177.61 4.68 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.858 2.063 . . . . 0.0 110.887 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 t -151.07 161.44 42.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.29 1.036 . . . . 0.0 112.047 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -147.6 160.01 39.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.173 1.789 . . . . 0.0 109.671 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.85 133.99 54.26 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.347 2.698 . . . . 0.0 111.955 174.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.47 -32.32 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -9.63 51.36 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -22.03 59.15 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.167 0.894 . . . . 0.0 112.605 170.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.88 171.57 8.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.851 1.261 . . . . 0.0 112.8 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.49 113.96 21.56 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.574 1.55 . . . . 0.0 111.074 176.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.14 -11.73 59.66 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.706 -1.247 . . . . 0.0 113.857 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.15 -20.88 57.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.838 1.255 . . . . 0.0 112.98 174.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -103.25 -0.63 30.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.117 1.767 . . . . 0.0 113.166 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -125.26 77.5 1.64 Allowed 'General case' 0 C--N 1.345 0.406 0 C-N-CA 125.799 1.639 . . . . 0.0 109.206 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.99 -23.57 13.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.085 2.154 . . . . 0.0 113.488 -175.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.8 t -135.74 133.81 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.768 1.627 . . . . 0.0 108.186 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.57 122.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.988 -1.07 . . . . 0.0 110.353 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.63 118.05 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.763 1.225 . . . . 0.0 108.167 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -88.64 154.91 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.083 0.953 . . . . 0.0 109.856 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.07 46.59 2.48 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.079 1.351 . . . . 0.0 110.852 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t -105.25 -36.31 7.27 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.394 1.478 . . . . 0.0 111.868 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.08 90.05 2.08 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.868 1.699 . . . . 0.0 112.379 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.3 p 37.08 45.33 0.46 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.255 2.222 . . . . 0.0 115.6 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -176.13 15.9 0.04 OUTLIER Glycine 0 CA--C 1.538 1.497 0 N-CA-C 117.017 1.567 . . . . 0.0 117.017 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.3 147.5 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.385 1.593 . . . . 0.0 111.978 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -99.46 59.5 1.11 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.357 1.063 . . . . 0.0 111.503 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -87.4 146.3 39.46 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -65.68 154.3 74.41 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 122.824 2.349 . . . . 0.0 110.153 168.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.72 -35.55 98.76 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.51 2.14 . . . . 0.0 115.668 -169.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.57 -23.76 67.18 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.086 -1.009 . . . . 0.0 113.355 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.4 -7.57 58.88 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.17 -22.82 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.25 1.42 . . . . 0.0 113.411 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 t -83.16 11.9 5.86 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.782 1.633 . . . . 0.0 113.508 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -65.65 165.92 11.65 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.767 1.627 . . . . 0.0 112.603 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.29 -36.51 83.91 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.659 -0.651 . . . . 0.0 112.726 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.7 130.0 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.861 0.865 . . . . 0.0 110.119 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -134.89 150.6 50.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.134 1.373 . . . . 0.0 111.873 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -141.74 158.04 44.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -139.63 81.17 1.81 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.668 0.787 . . . . 0.0 111.218 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -66.47 149.5 50.34 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.126 1.771 . . . . 0.0 113.127 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -114.04 60.6 0.67 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.339 1.856 . . . . 0.0 107.858 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -100.57 134.68 43.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.169 2.187 . . . . 0.0 112.527 -168.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.44 140.24 56.36 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.335 1.854 . . . . 0.0 112.644 -173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -93.04 112.06 54.39 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -78.69 -6.05 15.08 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.471 2.114 . . . . 0.0 113.496 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -53.72 122.79 10.64 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.689 1.131 . . . . 0.0 112.628 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.06 4.14 47.73 Favored Glycine 0 CA--C 1.541 1.695 0 N-CA-C 115.446 0.938 . . . . 0.0 115.446 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -101.18 -178.88 3.87 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.14 1.376 . . . . 0.0 112.476 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.7 m -78.04 162.31 26.81 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.977 0.911 . . . . 0.0 112.023 -171.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.02 -24.97 66.86 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.164 -0.96 . . . . 0.0 111.676 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.84 -28.33 69.49 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.161 -0.962 . . . . 0.0 111.796 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 -39.92 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.463 -1.398 . . . . 0.0 109.484 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -63.18 -36.55 84.01 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.433 1.015 . . . . 0.0 112.166 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -77.57 -20.8 53.47 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.125 -1.609 . . . . 0.0 113.827 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.3 m -91.73 -39.58 11.73 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.967 0.907 . . . . 0.0 111.63 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.8 p -59.27 -42.7 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 120.404 -1.435 . . . . 0.0 111.797 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -59.83 -43.34 94.63 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -32.05 65.51 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.849 -0.532 . . . . 0.0 112.828 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.37 -39.14 81.87 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.888 0.844 . . . . 0.0 112.064 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.64 -51.47 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.58 0.752 . . . . 0.0 109.91 169.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 123' ' ' VAL . 15.0 tmtt? -57.19 -47.0 82.35 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.359 1.064 . . . . 0.0 112.61 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -68.73 -27.06 65.6 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.773 1.624 . . . . 0.0 112.531 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -73.16 -51.43 17.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.211 1.004 . . . . 0.0 111.655 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 21' ' ' PHE . 34.4 m -59.52 -41.05 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.115 0.871 . . . . 0.0 112.761 169.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.84 -50.32 69.33 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.701 1.591 . . . . 0.0 112.389 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -70.61 -30.0 66.54 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.905 0.775 . . . . 0.0 112.063 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -50.0 70.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.698 0.799 . . . . 0.0 110.815 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.4 mt -69.78 -41.17 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.274 -0.891 . . . . 0.0 110.705 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.65 -26.38 68.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.31 -14.79 34.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.9 pt -111.58 -18.3 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.543 1.137 . . . . 0.0 113.154 179.058 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -71.56 140.85 50.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.779 0.832 . . . . 0.0 111.851 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -111.09 126.46 54.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.325 1.05 . . . . 0.0 111.28 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.12 107.63 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.208 1.803 . . . . 0.0 109.826 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.8 tpp -87.64 127.9 35.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.141 0.428 . . . . 0.0 109.989 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.11 114.71 28.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.5 1.12 . . . . 0.0 109.69 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -111.46 136.26 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.699 1.2 . . . . 0.0 112.524 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.2 t -138.52 168.82 18.95 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.206 -0.934 . . . . 0.0 112.577 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -60.55 147.84 40.11 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.934 0.894 . . . . 0.0 109.86 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.21 154.57 37.69 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -169.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 52.23 42.36 30.75 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.582 1.553 . . . . 0.0 113.36 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -123.47 168.62 12.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.723 1.609 . . . . 0.0 110.686 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.8 t -117.96 6.02 12.16 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.248 1.019 . . . . 0.0 113.634 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -72.39 -37.49 68.7 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.248 -1.533 . . . . 0.0 111.175 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -62.3 -46.17 89.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.298 1.039 . . . . 0.0 111.621 170.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.04 -40.4 78.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.554 1.142 . . . . 0.0 111.979 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.7 mmm -68.6 -36.91 79.33 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.436 -0.79 . . . . 0.0 112.745 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.39 -44.68 95.89 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.001 0.819 . . . . 0.0 111.451 173.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -60.46 -39.75 88.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.899 0.772 . . . . 0.0 111.323 169.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.55 -60.96 7.53 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.975 1.274 . . . . 0.0 112.894 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -60.31 -34.01 73.19 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.554 1.177 . . . . 0.0 111.734 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.12 -27.16 61.52 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 117.839 -1.077 . . . . 0.0 113.884 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -75.42 -28.66 59.47 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.295 1.861 . . . . 0.0 112.656 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -76.05 -45.99 31.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.623 0.769 . . . . 0.0 112.267 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.16 -30.36 12.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.436 1.094 . . . . 0.0 113.267 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.0 4.98 81.51 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.94 1.733 . . . . 0.0 113.692 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.69 109.33 0.19 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.553 1.176 . . . . 0.0 112.813 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.61 19.41 79.7 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -118.48 -37.2 3.35 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.079 1.439 . . . . 0.0 112.08 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pp -152.28 166.58 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.051 2.541 . . . . 0.0 109.82 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.57 151.27 21.39 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.385 0.674 . . . . 0.0 109.737 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 142.1 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.039 -1.038 . . . . 0.0 112.666 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 m -149.28 154.91 39.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.92 1.288 . . . . 0.0 110.578 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 p -127.11 145.61 50.68 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.61 1.164 . . . . 0.0 112.598 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -148.46 146.5 28.42 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.859 1.264 . . . . 0.0 111.243 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.87 143.05 17.64 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.5 -38.57 66.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.587 1.694 . . . . 0.0 112.604 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -122.74 45.44 2.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.789 1.635 . . . . 0.0 110.307 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.2 p 68.99 143.62 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.434 3.094 . . . . 0.0 116.776 -170.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -107.69 171.39 7.42 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.644 2.378 . . . . 0.0 111.566 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -141.3 144.17 34.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.916 1.286 . . . . 0.0 112.496 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.26 152.73 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.093 1.757 . . . . 0.0 110.75 171.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.48 149.82 68.62 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.522 1.129 . . . . 0.0 111.776 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.08 -35.83 74.02 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.404 2.736 . . . . 0.0 114.224 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -63.54 -39.39 94.29 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.492 -0.755 . . . . 0.0 112.006 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.72 -20.57 61.18 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.171 -0.956 . . . . 0.0 112.808 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 mt -70.94 -54.26 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.14 67.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -170.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.8 mmt -69.72 -9.67 55.34 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 mmt -125.85 -28.89 3.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.309 1.044 . . . . 0.0 112.499 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.28 -24.85 67.52 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.868 -1.145 . . . . 0.0 112.101 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.35 -13.68 62.45 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.74 15.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.974 1.31 . . . . 0.0 111.641 168.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.94 10.94 71.14 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.957 1.742 . . . . 0.0 116.176 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -84.9 146.76 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.404 1.602 . . . . 0.0 111.958 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -116.13 129.34 56.28 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.79 1.636 . . . . 0.0 111.96 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.0 pt -135.29 -8.94 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.943 1.297 . . . . 0.0 113.707 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -60.29 -30.64 69.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.869 1.268 . . . . 0.0 114.094 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.33 1.9 84.66 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.76 1.171 . . . . 0.0 115.353 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -77.56 156.75 30.7 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.77 1.785 . . . . 0.0 112.674 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.3 p -133.25 175.43 9.41 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.564 1.946 . . . . 0.0 110.231 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 t -155.91 155.55 33.04 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -148.45 159.2 39.48 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.231 2.212 . . . . 0.0 109.472 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -55.38 143.11 78.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.389 2.726 . . . . 0.0 113.127 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.74 -31.49 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -169.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -13.7 60.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -20.01 58.53 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 119.084 0.856 . . . . 0.0 112.926 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -96.33 164.35 12.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.943 1.297 . . . . 0.0 112.625 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.11 109.71 19.24 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.811 1.644 . . . . 0.0 111.348 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -66.88 -22.06 65.99 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.24 -25.61 68.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.696 1.198 . . . . 0.0 112.834 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -89.15 -3.07 58.74 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.993 1.717 . . . . 0.0 112.103 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -116.17 82.26 1.75 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.887 2.075 . . . . 0.0 108.428 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -25.52 21.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.835 1.654 . . . . 0.0 113.079 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.6 t -132.97 129.78 57.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.079 1.752 . . . . 0.0 109.085 -176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.61 120.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.196 -0.94 . . . . 0.0 110.719 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.51 120.46 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.169 1.388 . . . . 0.0 108.159 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -86.02 150.29 24.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.42 1.088 . . . . 0.0 109.721 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.83 44.09 3.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.082 1.353 . . . . 0.0 110.522 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.1 m -114.16 -13.36 12.41 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.11 13.54 82.63 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.409 1.005 . . . . 0.0 114.213 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.7 p -157.09 171.56 20.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.163 2.185 . . . . 0.0 110.643 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.54 -28.81 65.62 Favored Glycine 0 CA--C 1.542 1.77 0 O-C-N 121.608 -0.682 . . . . 0.0 113.607 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.304 0.3 OUTLIER 61.2 161.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 129.609 3.163 . . . . 0.0 115.288 173.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -70.4 108.54 4.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.975 -1.078 . . . . 0.0 110.122 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.0 mt -140.26 133.81 15.2 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.388 1.475 . . . . 0.0 111.027 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -60.39 152.27 68.5 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.293 1.995 . . . . 0.0 110.243 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.13 -21.84 73.17 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.035 2.49 . . . . 0.0 114.912 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -15.56 62.73 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.6 m95 -90.26 -3.16 57.98 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.15 13.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.523 1.529 . . . . 0.0 113.674 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -118.12 -1.2 11.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.493 1.917 . . . . 0.0 112.775 -171.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.434 HE22 ' HB1' ' A' ' 70' ' ' ALA . 14.4 mp0 -56.05 159.67 3.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.587 2.755 . . . . 0.0 113.89 175.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.28 -34.98 79.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.22 129.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.172 0.989 . . . . 0.0 110.368 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -130.62 148.19 52.39 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.423 1.489 . . . . 0.0 111.29 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -142.0 161.75 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.759 1.224 . . . . 0.0 112.554 176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.08 124.24 21.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.85 1.26 . . . . 0.0 109.102 168.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -110.85 160.32 16.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.206 1.802 . . . . 0.0 112.4 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -122.79 50.6 1.5 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.475 1.51 . . . . 0.0 112.333 -168.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.19 137.52 36.7 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.229 -0.92 . . . . 0.0 112.636 -172.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.67 146.5 52.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.863 1.265 . . . . 0.0 108.556 169.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.46 119.22 65.66 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.95 0.9 . . . . 0.0 111.024 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.76 -11.31 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.143 1.895 . . . . 0.0 113.447 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.1 121.9 10.46 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.267 1.027 . . . . 0.0 112.076 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.22 1.76 64.97 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -100.58 -174.61 2.69 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.15 1.38 . . . . 0.0 111.89 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.5 t -74.01 157.5 36.02 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.476 -0.765 . . . . 0.0 112.028 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.91 -30.09 70.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.47 1.108 . . . . 0.0 111.646 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.98 -21.42 63.24 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.671 -1.268 . . . . 0.0 113.12 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.7 t -71.2 -40.52 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 120.36 -1.463 . . . . 0.0 110.102 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -56.83 -46.68 81.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.571 1.078 . . . . 0.0 110.826 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -68.77 -17.86 64.11 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.8 m -87.67 -43.47 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.912 1.285 . . . . 0.0 112.236 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -66.76 -38.74 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.703 -1.248 . . . . 0.0 111.501 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -57.46 -40.2 77.97 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.34 64.94 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.431 0.539 . . . . 0.0 112.881 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -68.76 -43.59 75.49 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.957 -0.731 . . . . 0.0 110.978 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 83.5 t -58.81 -47.49 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.747 -0.596 . . . . 0.0 110.414 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -57.12 -50.71 71.97 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.678 1.191 . . . . 0.0 112.422 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.19 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.878 1.217 . . . . 0.0 112.794 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -68.42 -50.72 50.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.472 0.709 . . . . 0.0 110.924 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.34 -48.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.646 1.178 . . . . 0.0 112.174 169.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -62.52 -50.82 69.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.832 1.196 . . . . 0.0 112.475 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -30.19 67.43 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.772 0.715 . . . . 0.0 111.899 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.43 -50.82 68.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.697 0.799 . . . . 0.0 110.613 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -70.74 -39.98 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.22 0.918 . . . . 0.0 111.165 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 -20.6 60.84 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -97.64 -10.9 24.25 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 pt -113.55 -17.64 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 126.21 1.804 . . . . 0.0 112.499 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -71.42 144.07 49.89 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.063 0.945 . . . . 0.0 111.702 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -111.18 128.39 55.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.109 0.964 . . . . 0.0 111.284 170.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.66 118.33 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.249 1.819 . . . . 0.0 110.221 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.2 tpp -96.95 122.7 40.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -95.56 114.95 26.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.421 0.689 . . . . 0.0 110.438 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.91 147.06 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.45 1.1 . . . . 0.0 113.46 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 t -146.41 151.99 38.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -73.05 98.85 2.62 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.613 1.165 . . . . 0.0 109.818 174.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 52.55 -95.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.949 2.1 . . . . 0.0 113.046 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -40.0 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.172 2.189 . . . . 0.0 112.701 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.0 m -88.76 17.67 5.38 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -173.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.87 -33.51 75.86 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.508 1.504 . . . . 0.0 111.66 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.29 -39.72 24.78 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.839 1.256 . . . . 0.0 111.536 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.1 p -71.99 -40.44 68.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.535 1.061 . . . . 0.0 112.83 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.31 -32.15 71.1 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.91 0.777 . . . . 0.0 111.145 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -43.18 80.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.04 1.291 . . . . 0.0 112.378 169.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -43.52 97.02 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.266 0.485 . . . . 0.0 110.922 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.76 -43.71 97.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.817 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.83 -44.86 96.67 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 119.805 1.184 . . . . 0.0 113.79 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.93 -37.9 76.03 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.444 -1.033 . . . . 0.0 111.14 171.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.47 -34.2 65.24 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.697 -1.252 . . . . 0.0 113.67 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.86 -22.52 64.21 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.908 1.231 . . . . 0.0 112.63 171.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.0 m -88.8 -46.88 8.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.814 1.246 . . . . 0.0 112.262 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.62 -33.45 12.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 112.886 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 5.76 77.67 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.939 1.733 . . . . 0.0 113.059 170.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.38 120.62 4.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.349 1.075 . . . . 0.0 111.433 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.95 77.88 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -110.42 -40.82 4.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.339 1.455 . . . . 0.0 111.045 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -148.6 159.35 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 112.762 -171.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.61 151.27 19.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.122 1.369 . . . . 0.0 107.53 168.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 t -139.9 139.88 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 120.89 -1.131 . . . . 0.0 112.177 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -141.6 154.68 45.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.677 1.591 . . . . 0.0 109.865 170.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.3 p -124.11 152.35 42.86 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.084 -1.01 . . . . 0.0 112.126 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 t -151.01 124.54 8.98 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.433 0.693 . . . . 0.0 112.717 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.24 127.14 8.64 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 mp -49.98 -35.12 23.24 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -169.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -123.0 34.56 5.1 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.234 1.414 . . . . 0.0 112.605 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 p 66.99 161.83 0.17 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 127.759 2.423 . . . . 0.0 115.499 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -161.58 -163.52 1.0 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.165 1.386 . . . . 0.0 111.528 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -133.16 173.25 11.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.241 1.817 . . . . 0.0 113.21 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 t -85.55 167.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -129.43 125.71 22.59 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 120.337 -1.477 . . . . 0.0 111.714 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -55.79 -40.17 86.76 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.176 2.584 . . . . 0.0 114.651 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -64.42 -30.32 71.36 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.117 -0.989 . . . . 0.0 111.859 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.36 -5.43 52.2 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.3 mt -86.14 -57.05 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 168.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.11 75.34 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -170.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -71.4 -9.34 58.0 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 mmt -119.12 -27.85 5.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.127 0.971 . . . . 0.0 112.34 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -57.92 -30.38 65.87 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.786 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.8 -10.64 59.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.811 1.244 . . . . 0.0 113.923 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 8.5 p -121.77 24.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.932 1.693 . . . . 0.0 110.829 169.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.6 83.46 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.211 1.863 . . . . 0.0 116.63 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.22 147.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.789 1.295 . . . . 0.0 111.76 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -131.63 107.82 9.09 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.191 1.796 . . . . 0.0 110.597 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 pt -140.22 15.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 177.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.5 p -60.05 -27.64 67.11 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.698 -1.251 . . . . 0.0 113.825 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.08 9.22 39.36 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.161 1.362 . . . . 0.0 116.153 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -65.09 -50.58 65.55 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.264 2.032 . . . . 0.0 114.203 -169.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 p 58.71 167.27 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.245 1.818 . . . . 0.0 114.38 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -144.63 131.15 19.87 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.027 -1.046 . . . . 0.0 112.166 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -132.53 158.61 75.23 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.001 1.721 . . . . 0.0 112.289 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.06 145.14 89.18 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.478 2.785 . . . . 0.0 113.524 -170.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.52 -34.23 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -169.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.52 -7.0 50.07 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -20.47 55.79 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.294 -0.879 . . . . 0.0 112.133 169.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -94.99 170.21 9.58 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.182 1.393 . . . . 0.0 112.264 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.22 111.69 18.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.974 1.71 . . . . 0.0 110.535 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -65.46 -23.05 66.82 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -169.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.29 -25.14 67.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.92 0.888 . . . . 0.0 112.758 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.73 -2.75 58.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.224 1.81 . . . . 0.0 111.946 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.9 84.65 2.11 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 127.117 2.167 . . . . 0.0 108.022 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.86 -28.05 8.73 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.055 1.742 . . . . 0.0 112.725 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.56 130.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.832 1.653 . . . . 0.0 109.003 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.1 t -131.5 126.99 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.297 -0.877 . . . . 0.0 109.097 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 mm -126.2 124.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.464 1.106 . . . . 0.0 108.904 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.1 t -99.35 156.4 17.02 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.113 0.965 . . . . 0.0 111.599 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.24 52.88 2.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 110.937 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.3 m -116.6 -0.91 12.28 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.26 1.424 . . . . 0.0 114.763 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.5 49.01 4.54 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.086 0.857 . . . . 0.0 115.199 173.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.4 t 58.39 52.1 7.56 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.0 1.72 . . . . 0.0 112.761 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.06 111.15 0.24 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.137 1.351 . . . . 0.0 112.074 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.32 140.22 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.781 1.232 . . . . 0.0 111.228 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -88.37 115.5 25.92 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.805 0.842 . . . . 0.0 109.86 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.63 138.63 20.42 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.119 0.967 . . . . 0.0 112.914 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.99 151.76 82.97 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.483 2.122 . . . . 0.0 109.896 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -57.57 -29.97 86.9 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 115.255 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.73 -19.58 65.95 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 97.8 m95 -89.77 -3.45 58.15 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.3 m -116.75 -12.83 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -88.52 5.5 42.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.696 1.599 . . . . 0.0 113.765 -171.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.438 HE22 ' HB1' ' A' ' 70' ' ' ALA . 15.0 mp0 -59.23 160.43 6.47 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.146 2.179 . . . . 0.0 113.878 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.98 -33.24 75.28 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 127.06 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.834 0.854 . . . . 0.0 110.36 169.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -138.28 141.43 39.85 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.777 1.631 . . . . 0.0 111.127 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.96 162.44 38.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.405 1.482 . . . . 0.0 110.72 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -128.85 124.67 35.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.571 1.148 . . . . 0.0 111.581 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -102.89 161.67 13.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.197 1.799 . . . . 0.0 113.091 -172.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -95.64 -82.06 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.528 1.131 . . . . 0.0 111.496 -170.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 55.09 156.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.3 2.64 . . . . 0.0 115.853 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -90.25 178.05 6.26 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -117.74 117.84 35.46 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.462 -1.399 . . . . 0.0 111.209 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.03 -11.34 7.64 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.449 1.433 . . . . 0.0 113.261 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.25 106.1 0.69 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 120.644 1.565 . . . . 0.0 112.779 -172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.76 1.06 85.55 Favored Glycine 0 CA--C 1.543 1.785 0 C-N-CA 125.063 1.315 . . . . 0.0 115.718 -173.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -97.98 -171.7 2.21 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.09 1.756 . . . . 0.0 111.378 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.2 t -76.11 159.74 30.45 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.181 -0.949 . . . . 0.0 112.641 -170.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 109' ' ' LEU . 2.4 mm? -58.48 -32.9 69.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.353 1.461 . . . . 0.0 111.295 176.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.19 -29.62 70.45 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 0.0 112.374 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.5 t -72.34 -42.21 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.907 -1.12 . . . . 0.0 110.263 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -58.8 -48.16 82.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.331 0.969 . . . . 0.0 111.56 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -69.83 -20.61 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.7 m -78.88 -56.01 4.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.591 1.156 . . . . 0.0 110.925 169.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.8 t -64.19 -35.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 0.0 111.387 -171.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -54.77 -42.77 72.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.828 0.74 . . . . 0.0 112.84 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.03 -34.75 61.55 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.808 0.718 . . . . 0.0 112.712 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -70.39 -41.47 72.97 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.457 0.629 . . . . 0.0 110.588 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.64 -45.82 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 O-C-N 121.651 -0.655 . . . . 0.0 110.975 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 tmtt? -55.28 -50.08 70.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.163 0.985 . . . . 0.0 111.788 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.29 -29.44 66.18 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.862 1.21 . . . . 0.0 113.013 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -68.6 -49.85 56.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.453 0.701 . . . . 0.0 111.196 173.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.64 -41.31 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.833 1.253 . . . . 0.0 111.731 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -62.04 -47.27 85.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.529 1.059 . . . . 0.0 112.131 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -38.77 92.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.553 0.615 . . . . 0.0 111.092 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.48 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 2.7 tm? -59.25 -53.52 57.38 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.5 1.12 . . . . 0.0 110.598 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.82 -42.34 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 118.754 0.706 . . . . 0.0 111.384 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.15 70.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 126' ' ' LEU . 36.8 pttt -90.89 -20.1 22.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.4 -24.93 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 124.919 1.288 . . . . 0.0 114.273 -169.637 . . . . . . . . 0 0 . 1 stop_ save_